{"meta":{"query_hash":"e82fe8a4975b","filters":{"venue":"Leukemia"},"cohort_total":464,"direct_labels_cover":0,"predictions_cover":464,"exported":464,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e82fe8a4975b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Leukemia"},"results":[{"id":"W11840263","doi":"10.1038/sj.leu.2402329","title":"From Products to Product Lines Using Model Matching and Refactoring.","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Advanced Software Engineering Methodologies","field":"Computer Science","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Code refactoring; Computer science; Software product line; Unified Modeling Language; Product (mathematics); Set (abstract data type); Matching (statistics); Quality (philosophy); Variable (mathematics); Programming language; Data mining; Software; Mathematics; Software development","score_opus":0.053977866993208674,"score_gpt":0.3085524249807872,"score_spread":0.25457455798757855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W11840263","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47116435,0.00003503735,0.5276464,0.00015792206,0.00064541155,0.00006622251,0.0000011440143,0.00027601683,0.000007449051],"genre_scores_gemma":[0.2933534,0.0000019012028,0.7061677,0.00005309196,0.000334938,0.0000046640816,5.1711817e-7,0.000013286457,0.0000704802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892724,0.000021909183,0.00013797957,0.00053287327,0.0001399731,0.00024005334],"domain_scores_gemma":[0.9989553,0.00015988208,0.00004212165,0.00069681555,0.000063792075,0.00008205636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002588847,0.00014742154,0.00015756488,0.00007067616,0.000076696975,0.00009522337,0.0004621269,0.00005094291,4.961728e-7],"category_scores_gemma":[0.0010609208,0.00013643605,0.000014401896,0.00021304251,0.000021852758,0.00045929305,0.00039295695,0.00029725107,0.0000043422247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002797432,0.0000032816304,0.000092005386,0.000016191327,0.000004839414,0.0000046689047,0.0015618489,0.41597596,0.5658338,0.0009786087,0.00003363285,0.015492327],"study_design_scores_gemma":[0.0003251425,0.000038682767,0.0035276173,0.00010019417,0.000014793589,0.000046435034,0.00004092648,0.4006914,0.46259,0.12985477,0.001755966,0.0010140801],"about_ca_topic_score_codex":0.00011478352,"about_ca_topic_score_gemma":0.000006515459,"teacher_disagreement_score":0.17852126,"about_ca_system_score_codex":0.00008056892,"about_ca_system_score_gemma":0.00010819409,"threshold_uncertainty_score":0.5563701},"labels":[],"label_agreement":null},{"id":"W1517954749","doi":"10.1038/leu.2010.117","title":"Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Cancer Research Institute","keywords":"Mantle cell lymphoma; Apoptosis; Cancer research; Tumor necrosis factor alpha; NF-κB; Lymphoma; Signal transduction; NFKB1; Medicine; Immunology; Cell biology; Biology; Transcription factor; Genetics; Gene","score_opus":0.00678752369883891,"score_gpt":0.2298998000547284,"score_spread":0.22311227635588948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517954749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097973,0.00037615479,0.00000791017,0.0005697467,0.00021404664,0.00065584446,0.000014179346,0.00006163388,0.007120766],"genre_scores_gemma":[0.99814785,0.000033458582,0.0003310401,0.0006845607,0.00019896816,0.00023405516,0.00003423839,0.000037283964,0.00029854395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985674,0.00007746257,0.00029547283,0.00039186917,0.0002607149,0.000407055],"domain_scores_gemma":[0.9989765,0.00043425683,0.00012452112,0.00029184355,0.000045786706,0.00012706501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029573592,0.00025625806,0.00033466186,0.000090687376,0.00017010864,0.00006866069,0.00013087294,0.00018464541,0.00008970482],"category_scores_gemma":[0.000074672476,0.00016891977,0.00011738044,0.00029345075,0.00008419445,0.00011171572,0.000078516474,0.00023827222,0.00014504865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012078936,0.0005810055,0.05041712,0.00010573974,0.000120051525,0.00009725796,0.0016981709,0.000015053512,0.8831716,0.00018816104,0.0028991483,0.060585875],"study_design_scores_gemma":[0.004409762,0.00017372885,0.024134511,0.00015113736,0.00009836295,0.00002513465,0.00036402917,0.00012836207,0.9689485,0.000112457026,0.0012636194,0.00019039301],"about_ca_topic_score_codex":0.0014837937,"about_ca_topic_score_gemma":0.00007569675,"teacher_disagreement_score":0.08577688,"about_ca_system_score_codex":0.00059921923,"about_ca_system_score_gemma":0.00020257148,"threshold_uncertainty_score":0.6888348},"labels":[],"label_agreement":null},{"id":"W1525555980","doi":"10.1038/leu.2015.168","title":"BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Nilotinib; Internal medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Oncology; Imatinib mesylate; Mutation; Biology; Cancer; Genetics","score_opus":0.04711676767517604,"score_gpt":0.3224659356603377,"score_spread":0.2753491679851617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525555980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205613,0.0012826674,0.0011047613,0.00023775309,0.00019720799,0.0040127737,0.00005300401,0.0002901137,0.00076556095],"genre_scores_gemma":[0.977075,0.00024639294,0.012036728,0.000110439825,0.00076635194,0.0025276577,0.0010733729,0.00019800955,0.005966084],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99580723,0.00006457478,0.0011302673,0.0010874566,0.00070463767,0.0012058294],"domain_scores_gemma":[0.99767107,0.00023352864,0.0004214536,0.0008533834,0.00022702228,0.00059353135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035733116,0.0008355803,0.0010820233,0.00040281698,0.00024987178,0.00006405065,0.0002397555,0.00030987192,0.00025590236],"category_scores_gemma":[0.00016029908,0.0006145873,0.00015826694,0.0006398921,0.00013366893,0.00033302835,0.000083483705,0.00034882722,0.00019031404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.058281973,0.0043533826,0.012346215,0.00899437,0.0046369736,0.009753504,0.034569576,0.09851523,0.026454821,0.00020722965,0.0033882014,0.7384985],"study_design_scores_gemma":[0.5074535,0.03990821,0.012340507,0.004574588,0.0013363628,0.0025202562,0.0013484457,0.11022129,0.23419507,0.00012708551,0.08308564,0.0028890583],"about_ca_topic_score_codex":0.00080570154,"about_ca_topic_score_gemma":0.005948204,"teacher_disagreement_score":0.7356095,"about_ca_system_score_codex":0.16278246,"about_ca_system_score_gemma":0.03273449,"threshold_uncertainty_score":0.9996306},"labels":[],"label_agreement":null},{"id":"W1543281767","doi":"10.1038/leu.2015.126","title":"Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98–HOXA9-induced myeloid disease","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; Canada's Michael Smith Genome Sciences Centre; Queen Elizabeth II Health Sciences Centre; Atlantic Cancer Research Institute; University of British Columbia; Dalhousie University; University of New Brunswick; BC Cancer Agency; Izaak Walton Killam Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cancer research; Zebrafish; Myeloid leukemia; Myeloid; Haematopoiesis; Epigenetics; Stem cell; Cell biology; Genetics; Gene","score_opus":0.03785584022500494,"score_gpt":0.27075404967679784,"score_spread":0.2328982094517929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543281767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950898,0.0026838763,0.001020002,0.00007835161,0.00008508985,0.00019786629,0.000016318621,0.00001014157,0.00081850693],"genre_scores_gemma":[0.99811774,0.00035039146,0.0009840579,0.00010878335,0.00010775437,0.000032882625,0.000059160488,0.000030098323,0.00020915599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880856,0.00007800536,0.00032423355,0.0003175379,0.00022194743,0.00024969951],"domain_scores_gemma":[0.99909985,0.000013269237,0.0001139139,0.00045756937,0.00011466008,0.00020070812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002618997,0.0001703383,0.00019534063,0.000081736864,0.00002874616,0.000014578091,0.00021392034,0.00015878951,0.0000064354463],"category_scores_gemma":[0.00013833711,0.0001667152,0.00008877113,0.00012843034,0.000054631066,0.0000064010123,0.000081958846,0.00008631776,0.000004791639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034305896,0.000085288266,0.019211171,0.000025886053,0.000021979795,0.0000036980962,0.0002870186,0.017642112,0.9602953,0.0001169593,0.00022120718,0.0017463305],"study_design_scores_gemma":[0.0018427178,0.00029115376,0.034624875,0.000028343815,0.000014542218,6.7332536e-7,0.00007575642,0.009565235,0.94938695,0.0027058565,0.0011247402,0.00033915252],"about_ca_topic_score_codex":0.0001316528,"about_ca_topic_score_gemma":0.000110315355,"teacher_disagreement_score":0.015413704,"about_ca_system_score_codex":0.0000711793,"about_ca_system_score_gemma":0.0005320969,"threshold_uncertainty_score":0.67984486},"labels":[],"label_agreement":null},{"id":"W1547750496","doi":"10.1038/leu.2015.155","title":"Antileukemia multifunctionality of CD4+ T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"University of Warwick; Uehara Memorial Foundation; Fujita Health University; Takeda Science Foundation","keywords":"Cytotoxic T cell; CD8; Biology; Interleukin 21; Adoptive cell transfer; Leukemia; T-cell receptor; T cell; Natural killer T cell; Interleukin 3; Immunotherapy; Cancer research; Interleukin 12; Streptamer; ZAP70; Immunology; Molecular biology; Antigen; Immune system; Genetics","score_opus":0.02644519815614984,"score_gpt":0.25639002476318545,"score_spread":0.2299448266070356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547750496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199724,0.0016498895,0.0018857031,0.00017399486,0.0002968061,0.0007102079,0.00015642522,0.00009348026,0.0030362739],"genre_scores_gemma":[0.98551774,0.0010905617,0.0027762598,0.00015489946,0.00030656336,0.00003393638,0.00024625368,0.000085398424,0.0097884005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974009,0.00013921148,0.00055553776,0.0005673342,0.0008337036,0.00050334935],"domain_scores_gemma":[0.99812615,0.00021102944,0.00005250647,0.00057976233,0.00040709745,0.00062345894],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037150382,0.00031324156,0.0005594492,0.00017064439,0.000046811925,0.000030346895,0.00018748073,0.00034736062,0.0012846887],"category_scores_gemma":[0.00006505975,0.00029111104,0.00014242016,0.00047084398,0.00025910753,0.00006419694,0.000051984545,0.0005387234,0.00008805425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011655971,0.00016890612,0.00083920435,0.00010850473,0.00008126498,0.000018301518,0.0002345218,0.000100998026,0.953159,0.0000224969,0.04001507,0.0040861373],"study_design_scores_gemma":[0.0076455325,0.0005733698,0.0037379363,0.000035488098,0.00006342822,0.000026185693,0.00006882234,0.0022310622,0.8660703,0.000019706013,0.1192418,0.0002864082],"about_ca_topic_score_codex":0.00018156323,"about_ca_topic_score_gemma":0.0000037435743,"teacher_disagreement_score":0.08708873,"about_ca_system_score_codex":0.0008080205,"about_ca_system_score_gemma":0.0008571912,"threshold_uncertainty_score":0.9999541},"labels":[],"label_agreement":null},{"id":"W1582839313","doi":"10.1038/sj.leu.2403740","title":"Reply to ‘Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4’ by Chow et al","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Apoptosis; Imatinib; Haematopoiesis; Cancer research; Leukemia; Hematology; Medicine; Immunology; Internal medicine; Biology; Cell biology; Genetics; Stem cell","score_opus":0.01520192161925808,"score_gpt":0.29503351891131174,"score_spread":0.27983159729205365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582839313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898964,0.00023012079,0.000060331284,0.0065132673,0.000044869295,0.0006348413,0.000018675757,0.00007236421,0.0025291343],"genre_scores_gemma":[0.9795805,0.00010443168,0.007590777,0.011528663,0.00009055731,0.00012684119,0.00005689021,0.000059484046,0.00086181634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728787,0.00010315152,0.000549964,0.0005818701,0.00089368486,0.0005834781],"domain_scores_gemma":[0.9983788,0.000265363,0.00015460956,0.0007603778,0.0001290817,0.0003117749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005067046,0.00027669314,0.0005747685,0.00025733668,0.00004550736,0.00002836982,0.00028982694,0.00014871306,0.00021094525],"category_scores_gemma":[0.00031188517,0.00021080827,0.00006684332,0.00059655774,0.00013058803,0.00021623612,0.00016763862,0.00034082937,0.00008721492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0039463975,0.0005349017,0.004440415,0.0004127849,0.00010210939,0.00008697724,0.0039264765,0.0014664086,0.5999187,0.00012871987,0.3692831,0.015752975],"study_design_scores_gemma":[0.019941136,0.0005835966,0.0024918225,0.0009764431,0.000024949599,0.0000648977,0.00023975396,0.00092604564,0.93859226,0.000017804536,0.03586862,0.0002726657],"about_ca_topic_score_codex":0.0048591397,"about_ca_topic_score_gemma":0.00011510614,"teacher_disagreement_score":0.33867353,"about_ca_system_score_codex":0.015096026,"about_ca_system_score_gemma":0.006077327,"threshold_uncertainty_score":0.9995573},"labels":[],"label_agreement":null},{"id":"W1870122945","doi":"10.1038/leu.2015.264","title":"Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Leukemia; Dynamics (music); Somatic evolution in cancer; Hematology; Myeloid leukemia; Oncology; Medicine; Biology; Cancer research; Internal medicine; Cancer; Psychology","score_opus":0.09765468801876845,"score_gpt":0.3593394590796658,"score_spread":0.2616847710608974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1870122945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434274,0.00018499637,0.0002731199,0.0014288644,0.00011762723,0.0016383155,0.000094736504,0.00005393498,0.0018656345],"genre_scores_gemma":[0.98981094,0.00000837448,0.008552908,0.00028933125,0.00019993556,0.00013140021,0.00014741291,0.000053395237,0.0008062892],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977104,0.00016874877,0.00058793044,0.00038070968,0.0005944375,0.00055776065],"domain_scores_gemma":[0.9982601,0.0003137048,0.00020456257,0.0006167557,0.00032273665,0.00028217267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013483627,0.00021788516,0.0005331716,0.0001892188,0.00007175524,0.000025828414,0.00029417014,0.00024317572,0.00002542854],"category_scores_gemma":[0.00083265314,0.00016012798,0.0001548411,0.00053014944,0.0007249696,0.0001071024,0.00015439063,0.000615947,0.00001869744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03720716,0.0038067629,0.15650696,0.0055603483,0.0012299285,0.034304585,0.028738147,0.0020471876,0.098371655,0.07084237,0.23097277,0.33041215],"study_design_scores_gemma":[0.089186236,0.010464553,0.10685638,0.0033314978,0.00085184263,0.026609827,0.02208654,0.63812757,0.032479256,0.039055243,0.028347889,0.0026031772],"about_ca_topic_score_codex":0.0008688552,"about_ca_topic_score_gemma":0.00096353993,"teacher_disagreement_score":0.6360804,"about_ca_system_score_codex":0.008849016,"about_ca_system_score_gemma":0.0022195934,"threshold_uncertainty_score":0.99495584},"labels":[],"label_agreement":null},{"id":"W1952112347","doi":"10.1038/leu.2015.194","title":"Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Cancer research; Myeloid leukemia; Transplantation; Progenitor cell; Leukemia; Stem cell; Population; Chemotherapy; Cytotoxic T cell; Haematopoiesis; Biology; Myeloid; Immunology; Pharmacology; Medicine; Internal medicine; In vitro; Cell biology","score_opus":0.008297899115649385,"score_gpt":0.22086681214195628,"score_spread":0.2125689130263069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952112347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976068,0.00011877869,0.00016276173,0.000019682335,0.00026932155,0.00016761426,0.000024906485,0.000021432037,0.0016087034],"genre_scores_gemma":[0.99772835,0.000027129374,0.0016559701,0.0001396043,0.00027126857,0.0000054748934,0.00005824972,0.000039101546,0.000074830845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989587,0.00008800954,0.00029084014,0.00030063468,0.00017056681,0.0001912515],"domain_scores_gemma":[0.9990025,0.000018795066,0.0002861638,0.00031825594,0.00028729512,0.00008697281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015637114,0.00017731175,0.00025161303,0.000054872016,0.000048433205,0.000010956786,0.00015865407,0.00024206983,0.000009933817],"category_scores_gemma":[0.00013832613,0.00017407497,0.000110117595,0.00015369654,0.00008670747,0.0000132505575,0.00011486474,0.0001749666,0.0000062517106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047710125,0.00004474801,0.00014171461,0.00004902329,0.00008465858,0.0000025093796,0.00069686165,0.00011041261,0.9923345,0.000006677095,0.0035663017,0.002485482],"study_design_scores_gemma":[0.0009903267,0.00044734613,0.00076480873,0.000028421551,0.000034233723,0.0000045827296,0.00039392052,0.0004909717,0.98929745,0.00003685526,0.00732952,0.00018159149],"about_ca_topic_score_codex":0.00019085575,"about_ca_topic_score_gemma":0.000021365431,"teacher_disagreement_score":0.0037632182,"about_ca_system_score_codex":0.000087828645,"about_ca_system_score_gemma":0.00023736848,"threshold_uncertainty_score":0.70985717},"labels":[],"label_agreement":null},{"id":"W1955256573","doi":"10.1038/leu.2015.237","title":"Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Oncology; Medicine; Germinal center; Immunophenotyping; International Prognostic Index; Cancer research; B cell; Immunology; Antibody","score_opus":0.03606321623262632,"score_gpt":0.30399122009957463,"score_spread":0.2679280038669483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955256573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373466,0.0011448597,0.0000490791,0.0029511808,0.0002609727,0.00079852215,0.00028927712,0.000040827814,0.00073061936],"genre_scores_gemma":[0.9947897,0.00015969909,0.0018021128,0.0010555615,0.0004065072,0.00031462786,0.001138104,0.000017677068,0.00031597735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843204,0.000070791386,0.00048084033,0.0005237439,0.0002247081,0.0002678542],"domain_scores_gemma":[0.99825966,0.000932005,0.00014523558,0.00037166488,0.0000761645,0.00021528418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030604925,0.00024571543,0.00052870106,0.000030227518,0.00006714651,0.00005090493,0.000115609895,0.00019463553,0.000011861008],"category_scores_gemma":[0.00067462557,0.00012953911,0.00017587705,0.000058559453,0.00015436784,0.000044342432,0.000106727406,0.00008194327,0.000013558269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007429558,0.0065470217,0.9719019,0.000009232985,0.000188283,0.0019062236,0.00016008744,4.25176e-7,0.000049330327,0.00016425886,0.013845855,0.004484427],"study_design_scores_gemma":[0.06210827,0.00054561626,0.8937962,0.000059238922,0.00022430535,0.00036644403,0.00011744231,0.00019308602,0.00014515272,0.00027067453,0.042031456,0.00014211683],"about_ca_topic_score_codex":0.0005665634,"about_ca_topic_score_gemma":0.00046399285,"teacher_disagreement_score":0.0781057,"about_ca_system_score_codex":0.0009477629,"about_ca_system_score_gemma":0.0005311344,"threshold_uncertainty_score":0.52824515},"labels":[],"label_agreement":null},{"id":"W1965807814","doi":"10.1038/leu.2015.57","title":"IL10 receptor is a novel therapeutic target in DLBCLs","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Germinal center; Interleukin 10; Cancer research; STAT3; Cytokine; B cell; Immunology; Signal transduction; Antibody; Cell biology","score_opus":0.0441758864175798,"score_gpt":0.290553981244657,"score_spread":0.24637809482707718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965807814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165214,0.0012925705,0.00004256788,0.003849074,0.00024382299,0.00034440268,0.00001664299,0.00005551509,0.012503253],"genre_scores_gemma":[0.99016553,0.000048060785,0.0020133946,0.0054264655,0.00013907613,0.000066970126,0.000028134464,0.000019125639,0.002093262],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917805,0.000013589787,0.00016912833,0.00021181468,0.00020540415,0.00022199198],"domain_scores_gemma":[0.9994644,0.00003275019,0.000036152185,0.00025153742,0.000045321154,0.00016982363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001097744,0.0001268477,0.00023099054,0.00006531858,0.00001614867,0.000012942131,0.000058148464,0.000089196474,0.00026972307],"category_scores_gemma":[0.000031378317,0.000094860334,0.0000628298,0.00016095229,0.000026237949,0.000047995014,0.000022941538,0.000082053164,0.00058981933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052171864,0.0019701167,0.84005165,0.00006882853,0.0003032407,0.00018534133,0.0050584376,0.000026969228,0.007209782,0.0025118738,0.11307471,0.029017337],"study_design_scores_gemma":[0.025454834,0.0008337147,0.35261807,0.00023224275,0.00012822943,0.00008358013,0.0004930771,0.00087874586,0.029528357,0.0010268887,0.58833414,0.00038813523],"about_ca_topic_score_codex":0.0004052768,"about_ca_topic_score_gemma":0.000017452021,"teacher_disagreement_score":0.48743358,"about_ca_system_score_codex":0.0012383508,"about_ca_system_score_gemma":0.00046047388,"threshold_uncertainty_score":0.75811315},"labels":[],"label_agreement":null},{"id":"W1966347937","doi":"10.1038/sj.leu.2404440","title":"Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia","year":2006,"lang":"en","type":"article","venue":"Leukemia","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba","funders":"","keywords":"Medicine; Nausea; Vomiting; Gastroenterology; Lactulose; Internal medicine; Intestinal permeability; Chemotherapy; Immunology","score_opus":0.020963721844660426,"score_gpt":0.315301827352493,"score_spread":0.29433810550783257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966347937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607044,0.00032346183,0.0007243321,0.00082156353,0.00057899917,0.00076271355,0.0000047043127,0.00018524184,0.0005285404],"genre_scores_gemma":[0.99228513,0.00039188223,0.00373108,0.00017565963,0.0013357222,0.00018950505,0.00007925567,0.00003700354,0.0017747446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893886,0.000020045167,0.00026274315,0.00032985854,0.00016293091,0.00028553559],"domain_scores_gemma":[0.999463,0.000038600203,0.00010975429,0.00017204524,0.00009626613,0.00012032175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121891775,0.00017284261,0.00020861794,0.00010677803,0.00021983784,0.00001921769,0.000020864143,0.0001403666,0.000031345346],"category_scores_gemma":[0.000024830404,0.00014547115,0.00005932253,0.0001493063,0.000040169532,0.00013758533,0.000013748777,0.00019567752,0.000009900767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007296535,0.0002880782,0.3553833,0.0008455899,0.00021369262,0.00006124356,0.00019022172,0.00017036231,0.2764542,0.00024973368,0.009021145,0.34982586],"study_design_scores_gemma":[0.007123554,0.0014437857,0.87298965,0.00024385452,0.00018081187,0.00070778007,0.000019262949,0.00080117077,0.1070122,0.0008206873,0.008447177,0.00021006553],"about_ca_topic_score_codex":0.0011137724,"about_ca_topic_score_gemma":0.000041384672,"teacher_disagreement_score":0.5176063,"about_ca_system_score_codex":0.0022123775,"about_ca_system_score_gemma":0.00029511715,"threshold_uncertainty_score":0.59321415},"labels":[],"label_agreement":null},{"id":"W1967849589","doi":"10.1038/sj.leu.2403554","title":"Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro","year":2004,"lang":"en","type":"letter","venue":"Leukemia","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Wellcome Trust","keywords":"In vitro; Cancer research; Erythropoiesis; Biology; Hematology; Immunology; Virology; Medicine; Genetics; Anemia; Internal medicine","score_opus":0.012626697818748346,"score_gpt":0.2658908183834729,"score_spread":0.2532641205647245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967849589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578906,0.0007833539,0.00017361705,0.011851675,0.00017054444,0.00052172027,0.00016714924,0.000017008006,0.00052588776],"genre_scores_gemma":[0.92986447,0.00047559902,0.0001926938,0.062265266,0.0014963583,0.00009427046,0.0040903003,0.00013706967,0.0013839647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794054,0.00018437895,0.00039968343,0.0005758415,0.00043243382,0.00046714835],"domain_scores_gemma":[0.998904,0.000024252966,0.00022502743,0.0006903183,0.000101811194,0.000054628465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015273501,0.0003358281,0.00038914703,0.0001964084,0.000037392892,0.00002306907,0.00042237772,0.0011869014,0.00007891805],"category_scores_gemma":[0.000045307148,0.00032712502,0.00019322726,0.00012755522,0.00012284705,0.0000043051227,0.00015384736,0.0009190084,0.000017123122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012358393,0.000027484726,0.000083195926,0.00015345459,0.000067449546,0.000031189065,0.000039470535,0.00015261977,0.9166592,0.0000011984049,0.08066748,0.0008814352],"study_design_scores_gemma":[0.0018420283,0.0006948695,0.00027351247,0.00019791162,0.00001813396,0.000009352386,0.000009077669,0.000058821523,0.952656,0.000135604,0.043729976,0.0003747317],"about_ca_topic_score_codex":0.00017328352,"about_ca_topic_score_gemma":0.00007067499,"teacher_disagreement_score":0.055924565,"about_ca_system_score_codex":0.0003946486,"about_ca_system_score_gemma":0.00082771253,"threshold_uncertainty_score":0.9999181},"labels":[],"label_agreement":null},{"id":"W1969056568","doi":"10.1038/leu.2015.2","title":"Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma","year":2014,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Hematology; Internal medicine; Immunology","score_opus":0.011221830440637548,"score_gpt":0.2583113693289272,"score_spread":0.24708953888828963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969056568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94921285,0.00017519479,0.000027251406,0.047435094,0.00017011473,0.0020749085,0.000496055,0.0001337071,0.00027482325],"genre_scores_gemma":[0.7554208,0.00016217875,0.00081956765,0.24057049,0.0007050455,0.00085741124,0.0005537285,0.00017972273,0.0007310579],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99616855,0.00025350018,0.00072807586,0.00110528,0.0008921365,0.0008524357],"domain_scores_gemma":[0.99626964,0.0012448321,0.0005667676,0.00097528525,0.0003900014,0.00055348536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004229866,0.00085058506,0.0017576772,0.0005453015,0.00015881745,0.000081330545,0.00029032488,0.0008597819,0.0001072606],"category_scores_gemma":[0.0008591419,0.00064098986,0.00023944181,0.0007504515,0.0001240138,0.000067923946,0.00016969204,0.0004916793,0.00013294084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042771062,0.00020779626,0.48266506,0.00029652653,0.0016792507,0.0007624909,0.00037381751,0.000016773145,0.0001540379,0.0000029388332,0.5012634,0.012150206],"study_design_scores_gemma":[0.016948866,0.0024038225,0.8505595,0.0040029828,0.0030161315,0.00006925684,0.00002933081,0.00011964516,0.015473974,0.000017227532,0.10646633,0.00089295895],"about_ca_topic_score_codex":0.008116794,"about_ca_topic_score_gemma":0.00052777183,"teacher_disagreement_score":0.39479706,"about_ca_system_score_codex":0.002633629,"about_ca_system_score_gemma":0.0009789333,"threshold_uncertainty_score":0.99960417},"labels":[],"label_agreement":null},{"id":"W1969322812","doi":"10.1038/leu.2013.259","title":"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Acute leukemia; Conditioning regimen; Cord blood; Transplantation; Conditioning; Retrospective cohort study; Regimen; Leukemia; Internal medicine; Oncology; Hematopoietic stem cell transplantation","score_opus":0.02935788467648874,"score_gpt":0.2998399476674065,"score_spread":0.27048206299091776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969322812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969629,0.00004765477,0.00039835265,0.000023254199,0.000043936394,0.0021017147,0.000040177547,0.00001669054,0.00036532487],"genre_scores_gemma":[0.99891835,0.00003475081,0.00079390104,0.000018450954,0.000012996493,0.000106849664,0.00003684574,0.00003456703,0.00004329335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977128,0.00015964828,0.0009955232,0.0003588606,0.00053903816,0.00023414196],"domain_scores_gemma":[0.99815,0.00042378448,0.00081877963,0.0003017518,0.0002445197,0.000061177336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020888356,0.00030000173,0.0012183269,0.00022377721,0.00004766096,0.000012081338,0.00010946109,0.00012201335,0.000035057554],"category_scores_gemma":[0.000020784253,0.00018482363,0.00009034173,0.00037805727,0.00034105786,0.00013597151,0.000022217117,0.00029340672,6.840758e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028509194,0.00046164225,0.90642166,0.0007816977,0.0010664851,0.00006631344,0.03778434,0.0003644845,0.024254974,0.00013105659,0.0000026810033,0.00015548509],"study_design_scores_gemma":[0.024619063,0.002838561,0.801959,0.0035628572,0.0022610505,0.00004693624,0.0048126015,0.0013800379,0.15828866,0.000048265858,1.4591069e-7,0.0001828465],"about_ca_topic_score_codex":0.0010670288,"about_ca_topic_score_gemma":0.0004275855,"teacher_disagreement_score":0.1340337,"about_ca_system_score_codex":0.00042555953,"about_ca_system_score_gemma":0.00024048006,"threshold_uncertainty_score":0.7536889},"labels":[],"label_agreement":null},{"id":"W1969355036","doi":"10.1038/leu.2011.153","title":"The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology of the People's Republic of China; Deutsche Krebshilfe; National Natural Science Foundation of China; Canadian Institutes of Health Research; Universität Ulm; Deutsche Forschungsgemeinschaft","keywords":"Myeloid leukemia; Fusion protein; Leucine zipper; Biology; Fusion gene; Leukemia; Cell biology; Cancer research; Gene; Computational biology; Genetics; Transcription factor; Recombinant DNA","score_opus":0.021843322858401883,"score_gpt":0.27397117694640616,"score_spread":0.25212785408800426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969355036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900183,0.00054237864,0.00013127972,0.0013230024,0.0001526038,0.0015175465,0.000037706188,0.00003391359,0.0062432457],"genre_scores_gemma":[0.9956281,0.00032638415,0.0021982049,0.0004997646,0.00011235461,0.0001127115,0.000009402173,0.00006375269,0.0010493301],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99627095,0.00039222295,0.000995241,0.00058063096,0.00088719866,0.0008737766],"domain_scores_gemma":[0.9971005,0.00089517067,0.0004184903,0.0010419557,0.00024071438,0.00030321043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027459257,0.00037611782,0.00087204826,0.00038306706,0.0002353447,0.0000329156,0.00081032654,0.00031386892,0.000045077348],"category_scores_gemma":[0.00052554265,0.00022736767,0.00018344042,0.0011697127,0.0010531024,0.00010835038,0.00060863263,0.0011771439,0.00004179998],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033400856,0.0005952961,0.08505944,0.0014417645,0.0020767308,0.0017640126,0.18224543,0.00030349838,0.5926356,0.063047975,0.018793631,0.018635789],"study_design_scores_gemma":[0.065910615,0.0029219573,0.40421382,0.003343791,0.0009281138,0.0014833998,0.0860251,0.0029858893,0.39689174,0.008937925,0.02409296,0.002264695],"about_ca_topic_score_codex":0.0023460523,"about_ca_topic_score_gemma":0.00057322823,"teacher_disagreement_score":0.31915435,"about_ca_system_score_codex":0.0029945055,"about_ca_system_score_gemma":0.0016553582,"threshold_uncertainty_score":0.92717844},"labels":[],"label_agreement":null},{"id":"W1969451930","doi":"10.1038/sj.leu.2402969","title":"Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada); University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"American Society of Hematology","keywords":"Haploinsufficiency; Chromosomal translocation; Biology; ABL; Derivative chromosome; Breakpoint; breakpoint cluster region; Fluorescence in situ hybridization; Comparative genomic hybridization; Genetics; Myeloid leukemia; Fusion gene; Chromosome; Chromosome 9; Chromosome 22; Molecular biology; Gene; Cancer research; Phenotype","score_opus":0.037264299172111,"score_gpt":0.28984141519557416,"score_spread":0.25257711602346317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969451930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173224,0.0037382427,0.001106883,0.0010050953,0.0001924855,0.0014170068,0.00004744485,0.000115137234,0.0006454657],"genre_scores_gemma":[0.9963987,0.00048983685,0.001788778,0.0002976653,0.00015889997,0.00018544454,0.00019624435,0.00011058112,0.00037386286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959984,0.00031237295,0.0012571953,0.00090226426,0.0007745371,0.00075525034],"domain_scores_gemma":[0.997453,0.00062394363,0.00057558017,0.00096237264,0.00019506595,0.00019004056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050258747,0.0006104105,0.001058604,0.00030616435,0.00017210463,0.00004975022,0.00035675307,0.00031333568,0.00021052311],"category_scores_gemma":[0.0003154145,0.00044019803,0.00025606394,0.0010015357,0.00044358443,0.00038438823,0.000047415884,0.00073826953,0.00006766789],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0120511195,0.0011974304,0.14083505,0.002469435,0.0042495024,0.0039761914,0.02764728,0.008914349,0.76780623,0.0103846155,0.0038354383,0.016633358],"study_design_scores_gemma":[0.07243189,0.005422638,0.63446814,0.00829593,0.0024011964,0.002310289,0.009057818,0.020450853,0.2374396,0.0017887665,0.0032756932,0.0026571925],"about_ca_topic_score_codex":0.0051539424,"about_ca_topic_score_gemma":0.0025520232,"teacher_disagreement_score":0.53036666,"about_ca_system_score_codex":0.013268883,"about_ca_system_score_gemma":0.003670581,"threshold_uncertainty_score":0.999805},"labels":[],"label_agreement":null},{"id":"W1969986792","doi":"10.1038/sj.leu.2403184","title":"Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Stem cell; Homing (biology); Biology; Bone marrow; Haematopoiesis; Adult stem cell; Stem cell transplantation for articular cartilage repair; Stem cell marker; Amniotic stem cells; Neural stem cell; CXCR4; Cell biology; Mesenchymal stem cell; Transdifferentiation; Clinical uses of mesenchymal stem cells; Neurosphere; Endothelial stem cell; Immunology; Chemokine; In vitro; Inflammation","score_opus":0.030068198749574157,"score_gpt":0.26942724851353395,"score_spread":0.23935904976395977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969986792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871528,0.001172476,0.0006306869,0.0000976419,0.00012994246,0.0016536283,0.000033186505,0.000030543764,0.009099097],"genre_scores_gemma":[0.9930467,0.00012369695,0.0010659843,0.00047731114,0.00014737541,0.00006107255,0.0000074611976,0.00004953991,0.0050208634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726164,0.0004170601,0.00044054238,0.0005654387,0.00059260905,0.0007227265],"domain_scores_gemma":[0.99773985,0.0013487102,0.00013799002,0.00038447432,0.00012992276,0.00025905724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008547425,0.00029810733,0.0004765208,0.00015745558,0.00018211512,0.00013473319,0.00019785138,0.00019802173,0.00008342173],"category_scores_gemma":[0.00009502353,0.00022001524,0.00012145137,0.00022228647,0.00014420027,0.00016177395,0.00007943571,0.00067433494,0.000054879372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007946243,0.00023749424,0.0048624636,0.0015364167,0.00004479093,0.0012952158,0.008851962,0.00012182247,0.9609621,0.00012769393,0.0077177947,0.0134476125],"study_design_scores_gemma":[0.008581704,0.0014237084,0.043814044,0.0011119783,0.0002722105,0.0001352616,0.0022584326,0.011291691,0.9168143,0.00008896825,0.013334623,0.00087306934],"about_ca_topic_score_codex":0.00022100822,"about_ca_topic_score_gemma":0.000029986246,"teacher_disagreement_score":0.0441478,"about_ca_system_score_codex":0.00035347286,"about_ca_system_score_gemma":0.0001796614,"threshold_uncertainty_score":0.8971961},"labels":[],"label_agreement":null},{"id":"W1970504379","doi":"10.1038/sj.leu.2403649","title":"Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Cancer Research Society","keywords":"Haematopoiesis; Stem cell; Immunology; CD38; Biology; Myelopoiesis; CD34; Cancer research; Myeloid leukemia; Myeloid; Progenitor cell; Leukemia; Population; Medicine; Cell biology","score_opus":0.016088792945409554,"score_gpt":0.23343800847961527,"score_spread":0.21734921553420572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970504379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204826,0.005325616,0.000043901073,0.00024675057,0.00010656273,0.0013044605,0.00008988846,0.00005982763,0.0007747422],"genre_scores_gemma":[0.99501014,0.00046336596,0.000196678,0.00016690262,0.00013937346,0.00007349053,0.000040622446,0.000070424816,0.003838999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971873,0.0000928396,0.00079570385,0.00066355953,0.0007275746,0.0005330106],"domain_scores_gemma":[0.99772954,0.00008051744,0.00043313822,0.0013747583,0.00013173523,0.00025033642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020253067,0.00045887183,0.0007810849,0.00012669427,0.00014747649,0.000015727606,0.00038445447,0.00015595823,0.000046410776],"category_scores_gemma":[0.000020086476,0.00032008198,0.00028331755,0.00024794575,0.00035614756,0.00010990586,0.0003413799,0.00043087316,0.00001270259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042271623,0.000517875,0.011102995,0.0018097885,0.00027714626,0.00001712323,0.0012198914,0.009594755,0.96305674,0.00021630332,0.0007547482,0.011009896],"study_design_scores_gemma":[0.01367544,0.00041565395,0.15055493,0.0016042823,0.0013363359,0.000062814994,0.00012731695,0.049550015,0.78049165,0.00010290967,0.0013913439,0.0006873241],"about_ca_topic_score_codex":0.0001845516,"about_ca_topic_score_gemma":0.000053026844,"teacher_disagreement_score":0.18256512,"about_ca_system_score_codex":0.0101513,"about_ca_system_score_gemma":0.0028131162,"threshold_uncertainty_score":0.99992514},"labels":[],"label_agreement":null},{"id":"W1970778176","doi":"10.1038/sj.leu.2403470","title":"Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma","year":2004,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Centrosome; Lymphoma; Pathology; Cancer research; Biology; Medicine; Cell; Genetics; Cell cycle; Lung cancer","score_opus":0.00785674257229205,"score_gpt":0.22358401517627852,"score_spread":0.21572727260398647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970778176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4146948,0.010262629,0.00004409082,0.4477941,0.003099032,0.004275195,0.0022998753,0.00056924176,0.11696103],"genre_scores_gemma":[0.39148748,0.0005591551,0.00020162777,0.5869167,0.0030361656,0.00028183137,0.003612373,0.00016154186,0.013743118],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997009,0.00008030598,0.00055199454,0.00071464386,0.0005976414,0.0010464567],"domain_scores_gemma":[0.9987336,0.000252349,0.00020158841,0.00057192845,0.00007895363,0.00016159356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008458014,0.0006505046,0.0009964404,0.0003577073,0.00008404056,0.00006572732,0.0001851039,0.0009915377,0.0002470526],"category_scores_gemma":[0.00003376711,0.0005605942,0.0003366341,0.00024883798,0.00009402952,0.00010434778,0.00009535988,0.00067204784,0.00069512136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002925986,0.001361021,0.013895274,0.0011648072,0.00041229874,0.046174712,0.0009793412,0.000029160601,0.000016280605,0.0003249439,0.93422765,0.0011218924],"study_design_scores_gemma":[0.04233347,0.0009540507,0.06480555,0.0024247207,0.0007846087,0.00068679044,0.00014930932,0.000052243035,0.0020664125,0.0003212959,0.88439965,0.0010218777],"about_ca_topic_score_codex":0.0014021,"about_ca_topic_score_gemma":0.00012329489,"teacher_disagreement_score":0.1391226,"about_ca_system_score_codex":0.0087885335,"about_ca_system_score_gemma":0.0017205541,"threshold_uncertainty_score":0.9996846},"labels":[],"label_agreement":null},{"id":"W1972372858","doi":"10.1038/leu.2014.150","title":"Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Myeloid leukemia; Myeloid; Biology; Progenitor cell; Leukemia; Haematopoiesis; Immunology; Stem cell; Transplantation; Medicine; Cell biology; Internal medicine","score_opus":0.01375171160497574,"score_gpt":0.28717615250764833,"score_spread":0.2734244409026726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972372858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193604,0.000032191685,0.0008518661,0.00082885165,0.0001570542,0.001563525,0.000023967988,0.00016862985,0.014437898],"genre_scores_gemma":[0.9850071,0.000027523602,0.0041098646,0.0025839808,0.0005715835,0.00032446595,0.00007460096,0.00016078491,0.007140082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99537176,0.00023084019,0.0007363231,0.0011466527,0.0010877938,0.001426631],"domain_scores_gemma":[0.99692583,0.00051492953,0.00016911594,0.0011179195,0.00044262732,0.0008295774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007643311,0.00066356163,0.0011003178,0.00069234264,0.00028799835,0.00012898525,0.00062157476,0.00042504413,0.00022394795],"category_scores_gemma":[0.0006538718,0.0005139149,0.00011950328,0.0017531435,0.00040884878,0.00030235646,0.0003518073,0.0011593553,0.0008308703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009449442,0.0005034935,0.034760386,0.00071231317,0.0012564104,0.003992369,0.014957319,0.002899179,0.8502181,0.0040641134,0.061932877,0.015253985],"study_design_scores_gemma":[0.07507571,0.013347519,0.16026737,0.004236038,0.0009355399,0.002112336,0.0029335395,0.017322533,0.6824112,0.0011778454,0.0360488,0.004131568],"about_ca_topic_score_codex":0.0027425482,"about_ca_topic_score_gemma":0.0009695174,"teacher_disagreement_score":0.16780692,"about_ca_system_score_codex":0.0105661275,"about_ca_system_score_gemma":0.0038330297,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W1972467214","doi":"10.1038/leu.2009.253","title":"Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Vincristine; Chemotherapy; Asparaginase; Cancer; Internal medicine; Acute lymphocytic leukemia; Pediatrics; Clinical trial; Surgery; Leukemia; Lymphoblastic Leukemia; Cyclophosphamide","score_opus":0.02372343446026951,"score_gpt":0.32627417251912916,"score_spread":0.3025507380588596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972467214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559283,0.00015732282,0.004371057,0.0012356181,0.00022868879,0.034428235,0.00080577796,0.00033226528,0.0025127116],"genre_scores_gemma":[0.9710331,0.00021442777,0.006134881,0.0028983564,0.001028916,0.012202839,0.0010228992,0.00021074589,0.0052538533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944847,0.000087757966,0.0013395564,0.0012926914,0.0013138358,0.0014814276],"domain_scores_gemma":[0.99599856,0.00039962307,0.00066368753,0.0014909874,0.000687053,0.00076010317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043271933,0.00081104744,0.00138703,0.00042034208,0.00018976214,0.00009133848,0.00077465567,0.0005244486,0.000077506884],"category_scores_gemma":[0.0005403974,0.00063429016,0.0003266135,0.00082043133,0.00067777745,0.00045158196,0.0001415084,0.00058844825,0.000054717653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.15505488,0.003993458,0.2724283,0.004297953,0.016357925,0.0076462654,0.0059289867,0.018700896,0.119753644,0.0023480293,0.22377126,0.16971841],"study_design_scores_gemma":[0.13831031,0.007795238,0.7940944,0.0037637819,0.0026938098,0.0013894052,0.000039915943,0.0049222466,0.036738966,0.00017238337,0.008269753,0.0018097773],"about_ca_topic_score_codex":0.0014459175,"about_ca_topic_score_gemma":0.0004771451,"teacher_disagreement_score":0.5216661,"about_ca_system_score_codex":0.0090531,"about_ca_system_score_gemma":0.0142724095,"threshold_uncertainty_score":0.99961084},"labels":[],"label_agreement":null},{"id":"W1973883869","doi":"10.1038/sj.leu.2404061","title":"Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); University of Toronto; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"TLR7; Biology; Chronic lymphocytic leukemia; Immunology; Toll-like receptor; Cytokine; Cancer research; Acquired immune system; Leukemia; Cell biology; Immune system; Innate immune system","score_opus":0.005018325160233023,"score_gpt":0.20487112437735921,"score_spread":0.1998527992171262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973883869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562926,0.0013586574,0.0002346973,0.000031616913,0.006614261,0.00034882492,0.0000021197275,0.0001561181,0.005624434],"genre_scores_gemma":[0.9719594,0.0002014914,0.00004089843,0.00045377904,0.00017491971,0.000031587024,0.000107720654,0.000034558132,0.02699563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865454,0.00016299426,0.00042576663,0.0003391401,0.0000691166,0.00034846328],"domain_scores_gemma":[0.99893606,0.00023161482,0.00026668044,0.00046865185,0.000073811316,0.000023173838],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013155075,0.00025855188,0.000319494,0.00019374976,0.0001551225,0.000013093863,0.00020408575,0.0003784091,0.0015474856],"category_scores_gemma":[0.000047740505,0.00024792145,0.00016872423,0.0001491306,0.00010897773,0.00024426024,0.000046732777,0.0004197842,0.0044984827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035908457,0.0000326567,0.000008962697,0.00008020028,0.000120254466,5.3136216e-7,0.00020303235,0.0021808622,0.9410259,0.00015157663,0.03802432,0.017812591],"study_design_scores_gemma":[0.002114583,0.0005294766,0.00043725243,0.0001679838,0.000026617581,0.0000080132095,0.000039416485,0.00020677572,0.7791688,0.00000507889,0.2171089,0.00018712823],"about_ca_topic_score_codex":0.00019001192,"about_ca_topic_score_gemma":0.0000058153405,"teacher_disagreement_score":0.17908458,"about_ca_system_score_codex":0.011939583,"about_ca_system_score_gemma":0.0009740814,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W1974046893","doi":"10.1038/leu.2012.196","title":"Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fondation de France; Terry Fox Foundation","keywords":"Stem cell; Haematopoiesis; Biology; Myeloid leukemia; Myeloid; Cancer research; CD34; Hematopoietic stem cell; Cell biology; Ex vivo; Leukemia; Fusion gene; Cord blood; Immunology; In vivo; Gene; Genetics","score_opus":0.02291217344348628,"score_gpt":0.25289705516832994,"score_spread":0.22998488172484366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974046893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238473,0.0021170438,0.0037942075,0.00002324249,0.0005490458,0.00068584003,0.000023897326,0.00008019906,0.00034176424],"genre_scores_gemma":[0.9937873,0.00025913052,0.003511475,0.00011833111,0.0009560091,0.000024607349,0.00007692663,0.00007069547,0.0011955563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975859,0.00010178739,0.0006114613,0.00045726763,0.0006086438,0.00063495],"domain_scores_gemma":[0.99866194,0.00008562309,0.0003052665,0.00049483695,0.00011245753,0.00033989197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036171474,0.0003859431,0.00056916795,0.0002313126,0.00017271112,0.000022175203,0.00008434765,0.0002702293,0.00035880518],"category_scores_gemma":[0.000014385975,0.0003480229,0.00013491244,0.00025832388,0.00013963337,0.00045869907,0.0001333701,0.0003062604,0.000057426263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042166267,0.00008751763,0.017071454,0.00027379644,0.00010397978,0.000013835849,0.0005605758,0.00066069077,0.9747648,0.000043031974,0.00027226194,0.005726399],"study_design_scores_gemma":[0.008845761,0.00047472698,0.025675757,0.00043422534,0.00039435545,0.00070584327,0.0001790006,0.022182932,0.93977875,0.000013564025,0.0009228059,0.00039228436],"about_ca_topic_score_codex":0.00024997618,"about_ca_topic_score_gemma":0.0000129686305,"teacher_disagreement_score":0.034986053,"about_ca_system_score_codex":0.0067052986,"about_ca_system_score_gemma":0.0015901711,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W1974862201","doi":"10.1038/sj.leu.2403928","title":"Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients","year":2005,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Internal medicine; Leukemia; Imatinib mesylate; Myeloid; Hematology; Cancer research; Oncology; Immunology","score_opus":0.025523139557030814,"score_gpt":0.2673035791016141,"score_spread":0.2417804395445833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974862201","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8484586,0.001733396,0.000018371908,0.12803745,0.0018846699,0.0070867385,0.0010624642,0.00065364223,0.011064701],"genre_scores_gemma":[0.18834744,0.000924655,0.006412532,0.57407707,0.017649928,0.001430069,0.019572787,0.0018553713,0.18973014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888549,0.00047764325,0.0025649306,0.0028397162,0.0022039379,0.003058887],"domain_scores_gemma":[0.9926828,0.0005180474,0.00097271486,0.0036097302,0.00033808433,0.0018786083],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00042574338,0.0022183731,0.0028741302,0.0014101786,0.00037736943,0.00015853398,0.0014235966,0.0028890881,0.0026256323],"category_scores_gemma":[0.0007813388,0.0021833142,0.0006469942,0.001738375,0.00022427259,0.00020060953,0.00070437544,0.006613335,0.0023184484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00062208105,0.00013837666,0.0034837152,0.0007341485,0.00039648666,0.0022497955,0.0011143967,0.00059042894,0.0051807794,0.00000426948,0.9716255,0.01386004],"study_design_scores_gemma":[0.040468916,0.001285321,0.028965103,0.0051639862,0.0010126744,0.00041964496,0.000062565545,0.00081354525,0.0018810577,0.00006723678,0.91726977,0.002590197],"about_ca_topic_score_codex":0.020663433,"about_ca_topic_score_gemma":0.002190121,"teacher_disagreement_score":0.6601111,"about_ca_system_score_codex":0.08722208,"about_ca_system_score_gemma":0.029539675,"threshold_uncertainty_score":0.9990556},"labels":[],"label_agreement":null},{"id":"W1976171159","doi":"10.1038/leu.2012.176","title":"Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Leukaemia and Lymphoma Research; National Institute for Health and Care Research; Cancer Research UK","keywords":"Minimal residual disease; Internal medicine; Medicine; Oncology; Mutant; Cancer research; Leukemia; Biology; Gene; Genetics","score_opus":0.025384323550563446,"score_gpt":0.3120951070682729,"score_spread":0.28671078351770946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976171159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987972,0.000040475188,0.000025189094,0.00010745405,0.0004969102,0.002250352,0.00015068433,0.000079031466,0.00887788],"genre_scores_gemma":[0.9963924,0.00007029132,0.000093360075,0.00039023405,0.00061872124,0.0001920125,0.00022039187,0.00011464292,0.0019079129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953039,0.0003318702,0.0011558536,0.00056266773,0.0013657879,0.0012798802],"domain_scores_gemma":[0.9959839,0.0016044806,0.00043419827,0.0010308602,0.0004058205,0.00054075103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066438015,0.0005964781,0.0009000386,0.00079839467,0.00014273594,0.000035677247,0.00047760538,0.0004252578,0.00039185397],"category_scores_gemma":[0.0020339093,0.00037982728,0.0004036689,0.0021145937,0.00018297543,0.00020027864,0.00012508813,0.00081251905,0.0009195981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049934402,0.0035284248,0.91309625,0.00022081993,0.000522104,0.00015904721,0.0014814893,0.0017450319,0.0013431463,0.0003521826,0.026356926,0.0012601841],"study_design_scores_gemma":[0.1413195,0.00654588,0.8442243,0.00013478218,0.0008511915,0.00002586831,0.00007389456,0.004256756,0.0017587028,0.000032009637,0.00017293118,0.0006042097],"about_ca_topic_score_codex":0.000929575,"about_ca_topic_score_gemma":0.000015963291,"teacher_disagreement_score":0.0913851,"about_ca_system_score_codex":0.014485298,"about_ca_system_score_gemma":0.0038507816,"threshold_uncertainty_score":0.99986535},"labels":[],"label_agreement":null},{"id":"W1976615153","doi":"10.1038/sj.leu.2404624","title":"A tumor suppressor and oncogene: the WT1 story","year":2007,"lang":"en","type":"review","venue":"Leukemia","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":476,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Wilms' tumor; Biology; Cancer research; Suppressor; Oncogene; Tumor suppressor gene; Transcription factor; Gene; Cancer; Leukemia; Carcinogenesis; Genetics; Cell cycle","score_opus":0.019908573510684827,"score_gpt":0.2988031246577936,"score_spread":0.27889455114710876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976615153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003140456,0.9965401,0.000014123269,0.00002215277,0.0002938007,0.00027764667,0.000027639186,0.000009292725,0.0025011878],"genre_scores_gemma":[0.00005422571,0.99397385,0.000029969302,0.00029290217,0.00063079945,0.000043075117,0.00010445233,0.00004151286,0.0048292154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989674,0.00009559231,0.00021317569,0.00036320384,0.00011155239,0.00024906517],"domain_scores_gemma":[0.9993336,0.000033299806,0.00014572173,0.00037996037,0.000023386116,0.000084020605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020993291,0.00028323714,0.00044322226,0.00003520544,0.00010695447,0.000021691207,0.00027711477,0.00041567368,0.000012097712],"category_scores_gemma":[0.000027793063,0.000153388,0.0002633684,0.0000815249,0.00015770421,0.0000010326966,0.00012750612,0.000458301,0.000026713786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014137394,0.000005102322,5.61508e-7,0.001867957,0.00025933364,0.000032891207,0.000015888794,0.000003035079,0.00031766962,0.000021141715,0.019840695,0.9776216],"study_design_scores_gemma":[0.00013307056,0.000054570464,0.0000017214386,0.0008370803,0.00025597276,0.00021238728,0.0000078241665,9.008693e-7,0.0004011,0.0000049447594,0.9978699,0.0002204929],"about_ca_topic_score_codex":0.000018504341,"about_ca_topic_score_gemma":0.000009229857,"teacher_disagreement_score":0.97802925,"about_ca_system_score_codex":0.000120554374,"about_ca_system_score_gemma":0.00053703465,"threshold_uncertainty_score":0.6254981},"labels":[],"label_agreement":null},{"id":"W1977693378","doi":"10.1038/sj.leu.2403112","title":"Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Apoptosis; Programmed cell death; Caspase; Caspase 8; Leukemia; Cell culture; Cancer research; Viability assay; Biology; Flip; Downregulation and upregulation; Intrinsic apoptosis; Chemistry; Immunology; Biochemistry; Genetics","score_opus":0.018689794074309717,"score_gpt":0.26835058163641035,"score_spread":0.24966078756210064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977693378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938553,0.0000546753,0.0038678173,0.00039386787,0.000039455528,0.0011029659,0.000014876959,0.000022322649,0.0006487003],"genre_scores_gemma":[0.99211943,0.00003226391,0.0066698873,0.00019745734,0.000045471137,0.00006667041,0.00002301819,0.00003612262,0.00080965576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986748,0.00010499241,0.0003457398,0.00033303435,0.0002274155,0.00031398464],"domain_scores_gemma":[0.9990626,0.00032571575,0.00007878292,0.00025582267,0.00013118247,0.00014590913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273619,0.00015274236,0.00034882492,0.00036132507,0.000047688543,0.000019853062,0.0000540554,0.00015469937,0.000031363554],"category_scores_gemma":[0.0005911683,0.00014591229,0.000058359772,0.00047512798,0.000051050407,0.000113642054,0.000026151443,0.0001646644,0.0000061579553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033601135,0.000036909874,0.0007290732,0.00026008024,0.000019787196,0.0000034680133,0.0011993507,0.000321464,0.984194,0.0007334698,0.00018221451,0.01198419],"study_design_scores_gemma":[0.0033604319,0.0003024059,0.008762697,0.0003414693,0.00003623343,0.000015875135,0.00030132986,0.008517072,0.9767913,0.00028581405,0.0011059269,0.00017941084],"about_ca_topic_score_codex":0.00010355545,"about_ca_topic_score_gemma":0.00003173124,"teacher_disagreement_score":0.011804779,"about_ca_system_score_codex":0.0008576223,"about_ca_system_score_gemma":0.0003625512,"threshold_uncertainty_score":0.595013},"labels":[],"label_agreement":null},{"id":"W1978957651","doi":"10.1038/leu.2011.110","title":"ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; South East Regional Health Authority; Kreftforeningen; Leukemia and Lymphoma Society","keywords":"Chronic lymphocytic leukemia; In vitro; Leukemia; Cancer research; Medicine; Immunology; Internal medicine; Biology; Genetics","score_opus":0.035535395726893716,"score_gpt":0.26725897851514024,"score_spread":0.23172358278824653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978957651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97812325,0.0017192086,0.000012221375,0.008368308,0.00015850578,0.0049500307,0.000118590426,0.00032559692,0.0062243147],"genre_scores_gemma":[0.889794,0.00013382595,0.00023255221,0.10287539,0.0012961236,0.00089420425,0.0026858833,0.0005591237,0.0015289226],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98876333,0.00094599236,0.0014901223,0.0022458252,0.0034749152,0.003079796],"domain_scores_gemma":[0.99373645,0.0015944787,0.0007502978,0.003050915,0.0003106766,0.0005571624],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0010377531,0.001885992,0.0029275,0.0014913862,0.00027093577,0.00026304807,0.002365402,0.0018217169,0.00032736344],"category_scores_gemma":[0.00021108729,0.0012721544,0.00036940278,0.0022877941,0.0017304743,0.00025729835,0.00073722453,0.0055896756,0.0006629525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06775801,0.0010182523,0.0038317158,0.009063128,0.0054812976,0.1927038,0.010283898,0.007150202,0.011815159,0.000095589116,0.6888483,0.0019506008],"study_design_scores_gemma":[0.6536856,0.0069696605,0.031045258,0.01835524,0.0035305175,0.021066727,0.00096614263,0.059674785,0.034402885,0.00012639098,0.16229662,0.007880121],"about_ca_topic_score_codex":0.08469043,"about_ca_topic_score_gemma":0.0025935853,"teacher_disagreement_score":0.58592767,"about_ca_system_score_codex":0.40943265,"about_ca_system_score_gemma":0.19309247,"threshold_uncertainty_score":0.9994741},"labels":[],"label_agreement":null},{"id":"W1979497236","doi":"10.1038/leu.2011.329","title":"Oral high-dose glucocorticoids and Ofatumumab in fludarabine-resistant Chronic Lymphocytic Leukemia","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Health Canada; GlaxoSmithKline","keywords":"Ofatumumab; Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Internal medicine; Oncology; Cancer research; Immunology; Chemotherapy; Cyclophosphamide","score_opus":0.02322131647054599,"score_gpt":0.2723016917277518,"score_spread":0.24908037525720583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979497236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92193496,0.014650175,0.00004258952,0.040199157,0.0021809393,0.0061440007,0.00023962189,0.000982357,0.013626184],"genre_scores_gemma":[0.6102299,0.004863479,0.0025249969,0.3018336,0.013665176,0.0015133391,0.0027896143,0.0017231819,0.060856704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99051034,0.0003688676,0.0018630581,0.002365489,0.002010774,0.0028814853],"domain_scores_gemma":[0.9944288,0.00048279102,0.0005179214,0.0036071402,0.00029622082,0.0006670941],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0007758776,0.0015914082,0.0027356218,0.0013184736,0.00019203448,0.00018151675,0.0013484464,0.0031692036,0.0011972779],"category_scores_gemma":[0.00066662254,0.0014574983,0.00047704586,0.0011308482,0.0011501563,0.0003017664,0.0011535059,0.0054405495,0.0008691481],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0025549629,0.00006147171,0.00016654187,0.006527341,0.00068240974,0.04415811,0.00052414427,0.0001217268,0.0029327776,0.0002895804,0.93448234,0.007498603],"study_design_scores_gemma":[0.16165034,0.0034988967,0.0055266134,0.006563437,0.0017847536,0.006489188,0.00010422952,0.030354362,0.0047122836,0.0025991423,0.7723844,0.0043323613],"about_ca_topic_score_codex":0.040642213,"about_ca_topic_score_gemma":0.0013595775,"teacher_disagreement_score":0.3117365,"about_ca_system_score_codex":0.47001544,"about_ca_system_score_gemma":0.15827893,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W1979706247","doi":"10.1038/leu.2013.40","title":"Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"GRB2; Signal transducing adaptor protein; Downstream (manufacturing); Cancer research; Leukemia; Lymphoid leukemia; breakpoint cluster region; Biology; Cell biology; Immunology; Signal transduction; Receptor; Genetics; Business","score_opus":0.015447981150308895,"score_gpt":0.25329396121420267,"score_spread":0.23784598006389376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979706247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852385,0.0010201131,0.000103175174,0.0007004572,0.0005217404,0.0029902104,0.00032011658,0.00040007452,0.0087056095],"genre_scores_gemma":[0.9790997,0.00029624428,0.0033740134,0.0011108512,0.00032067232,0.0006075443,0.0010109029,0.00018855713,0.013991499],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956546,0.000073556344,0.0013728639,0.0009950754,0.0007782272,0.0011256728],"domain_scores_gemma":[0.99631834,0.00049016875,0.00058308896,0.0014796018,0.00051808206,0.0006107171],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029019802,0.00071415893,0.001286858,0.00033782783,0.00015060669,0.000043001713,0.0004390482,0.00074906164,0.0026138653],"category_scores_gemma":[0.00053039525,0.0006245859,0.0005388614,0.00072023744,0.00032619407,0.0003709078,0.000147147,0.0003924171,0.0012155247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025883124,0.0011273356,0.039147776,0.0021789176,0.004295309,0.00024169424,0.003733404,0.00019847688,0.43306452,0.0008049553,0.44635612,0.06626318],"study_design_scores_gemma":[0.15549515,0.0066812993,0.066395134,0.0042514727,0.0042593875,0.0015188786,0.001775772,0.07816955,0.5698607,0.0029726275,0.104321286,0.004298734],"about_ca_topic_score_codex":0.0030667335,"about_ca_topic_score_gemma":0.00003168724,"teacher_disagreement_score":0.34203485,"about_ca_system_score_codex":0.01004095,"about_ca_system_score_gemma":0.00443753,"threshold_uncertainty_score":0.99962056},"labels":[],"label_agreement":null},{"id":"W1980294911","doi":"10.1038/sj.leu.2402486","title":"Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Matrigel; Angiogenesis; Chronic myelogenous leukemia; Hepatocyte growth factor; Matrix metalloproteinase; Cancer research; CD34; Biology; Bone marrow; Neovascularization; Immunology; Stem cell; Leukemia; Cell biology; Receptor","score_opus":0.027155013535768484,"score_gpt":0.27273693512783276,"score_spread":0.24558192159206427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980294911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338466,0.004398389,0.000013043862,0.000055054395,0.000105348845,0.0010999261,0.00015619227,0.00009286717,0.00069453294],"genre_scores_gemma":[0.99669975,0.0006784271,0.0009056353,0.000095022944,0.00007009905,0.000054141936,0.000049387134,0.00007939242,0.0013681459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973483,0.00010860096,0.00061802566,0.00072591135,0.00039490417,0.0008042214],"domain_scores_gemma":[0.9988443,0.00023265713,0.00016620997,0.00043767397,0.00004102979,0.00027812642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020793978,0.00050846196,0.00083984627,0.00065837253,0.00009871631,0.000040166604,0.00015576303,0.0002980848,0.00060077105],"category_scores_gemma":[0.00006728836,0.00046273498,0.00021064361,0.00073231384,0.00008621508,0.00022824669,0.00017571672,0.00029447975,0.00008454371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009055261,0.00047933473,0.4656941,0.00069002766,0.0011354644,0.0072787795,0.0059343707,0.0019354647,0.5080435,0.00006148649,0.0011015532,0.006740388],"study_design_scores_gemma":[0.026399283,0.00093590387,0.33203632,0.0015680186,0.0010364312,0.0008630218,0.0008790936,0.02881503,0.604238,0.0001869818,0.0012492641,0.0017927062],"about_ca_topic_score_codex":0.0036717039,"about_ca_topic_score_gemma":0.00040310036,"teacher_disagreement_score":0.13365778,"about_ca_system_score_codex":0.0038927842,"about_ca_system_score_gemma":0.00020821429,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W1980473329","doi":"10.1038/sj.leu.2402444","title":"Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia","year":2002,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; clone (Java method); Biology; Progenitor cell; Stem cell theory of aging; Myeloid leukemia; Myeloid; Cancer research; Autocrine signalling; Immunology; Cell biology; Leukemia; Genetics; Stem cell factor; Cell culture; Gene","score_opus":0.04371995112838308,"score_gpt":0.33159713711425187,"score_spread":0.2878771859858688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980473329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025540297,0.9911364,0.0003423839,0.000024839987,0.0003360895,0.0029413318,0.00017491273,0.00008730562,0.0024027613],"genre_scores_gemma":[0.046673838,0.95011884,0.00044178366,0.00006379299,0.0005347875,0.00031403845,0.00043961935,0.0002777348,0.0011355502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992735,0.00061653287,0.0028943,0.0011888398,0.0013235734,0.0012417142],"domain_scores_gemma":[0.99464333,0.001307277,0.0013596357,0.0022292077,0.00019609189,0.00026446278],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00086591474,0.0012780568,0.0045571127,0.0006153537,0.00010331545,0.00003537233,0.00106548,0.0012971639,0.0010016615],"category_scores_gemma":[0.00014079636,0.00090761535,0.0012824401,0.0014902749,0.00042629472,0.00016127017,0.00020981781,0.0020404535,0.00017346353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008633078,0.00089958584,0.000002907439,0.10046662,0.0006615132,0.00073589385,0.0007035205,0.000067301284,0.0010460872,0.00076859933,0.001079553,0.8934821],"study_design_scores_gemma":[0.046742957,0.008127008,0.000035225486,0.18377788,0.018246438,0.0035177725,0.00054895965,0.007571066,0.018834803,0.0004697497,0.70867395,0.0034541741],"about_ca_topic_score_codex":0.00026096473,"about_ca_topic_score_gemma":0.00007146292,"teacher_disagreement_score":0.89002794,"about_ca_system_score_codex":0.029207947,"about_ca_system_score_gemma":0.010433123,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W1980557548","doi":"10.1038/sj.leu.2404456","title":"Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia","year":2006,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; Cytotoxic T cell; Cancer research; Tumor microenvironment; Toll-like receptor; Immunology; Biology; Leukemia; Immune system; Innate immune system; In vitro","score_opus":0.047142453018663454,"score_gpt":0.3546140683536116,"score_spread":0.30747161533494816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980557548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001484969,0.9866638,0.0000058973133,0.000023229337,0.0005534854,0.004115507,0.00010514153,0.00010251637,0.00694546],"genre_scores_gemma":[0.00042145533,0.985279,0.00012885526,0.00008393788,0.0014073789,0.001028251,0.000997787,0.00022349223,0.010429841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99329495,0.00055945833,0.002052111,0.0012265898,0.0014609493,0.0014059587],"domain_scores_gemma":[0.9951359,0.001133632,0.00069614954,0.0026403847,0.00012725836,0.00026667217],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006837723,0.0012290744,0.004396527,0.00071747846,0.00012568501,0.00007697371,0.0010867174,0.0011428632,0.00031437606],"category_scores_gemma":[0.00010705141,0.00075972796,0.0015953998,0.0016151695,0.0005272701,0.000087281165,0.00013071334,0.00080507743,0.00079823367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015577827,0.0003154622,0.000004514173,0.033551544,0.00058681343,0.0015803277,0.0004361998,0.0001348637,0.0000060884154,0.00015399308,0.020286085,0.9427883],"study_design_scores_gemma":[0.014268015,0.001402912,0.000006072639,0.012071509,0.0014553108,0.0014677484,0.000038498387,0.0012521652,0.00003377884,0.000016929389,0.9674087,0.0005783375],"about_ca_topic_score_codex":0.009208652,"about_ca_topic_score_gemma":0.00068528374,"teacher_disagreement_score":0.94712263,"about_ca_system_score_codex":0.63018423,"about_ca_system_score_gemma":0.21707612,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W1981154777","doi":"10.1038/leu.2013.253","title":"Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Transplantation; Minimal residual disease; Gastroenterology; Confidence interval; Population; Hematopoietic stem cell transplantation; Oncology; Surgery; Leukemia","score_opus":0.018221627587227725,"score_gpt":0.2633497789427754,"score_spread":0.24512815135554766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981154777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979698,0.000355896,0.0000025726195,0.00037318992,0.000057869063,0.00088305894,0.0002694233,0.000021363277,0.00006682574],"genre_scores_gemma":[0.99862856,0.00024928074,0.00033893966,0.00011550791,0.00008042217,0.0000475031,0.00041771852,0.000032876058,0.00008920446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983069,0.000083711195,0.0004610118,0.0004875328,0.0003178036,0.00034309804],"domain_scores_gemma":[0.9988349,0.00013468055,0.00014169651,0.00028506285,0.00017756473,0.00042609574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010540927,0.00032350858,0.0005367259,0.00014434308,0.0000518571,0.00001950225,0.000057228302,0.00013868994,0.00012991222],"category_scores_gemma":[0.00013109368,0.00026041802,0.00008766553,0.0001150917,0.00019520233,0.00018976117,0.00007072121,0.00021706749,0.0000064475566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006338627,0.00021807503,0.9733164,0.00036794887,0.00014827093,0.00029181814,0.0020641512,0.000023921364,0.015821842,0.0000011971014,0.0005811667,0.00082659465],"study_design_scores_gemma":[0.009677356,0.0006335273,0.9840257,0.0005828115,0.000213785,0.000020635753,0.000077832236,0.00074571813,0.0037278994,0.00003276176,0.000039850736,0.00022213368],"about_ca_topic_score_codex":0.0021417546,"about_ca_topic_score_gemma":0.0002533772,"teacher_disagreement_score":0.012093944,"about_ca_system_score_codex":0.0012599195,"about_ca_system_score_gemma":0.0003516292,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W1982055936","doi":"10.1038/leu.2010.62","title":"Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Multiple myeloma; Internal medicine; Proportional hazards model; Oncology; N-terminal telopeptide; Bone disease; Anemia; Prognostic variable; Multivariate analysis; Surgery; Osteoporosis","score_opus":0.012762669748116708,"score_gpt":0.2628066936860707,"score_spread":0.250044023937954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982055936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972067,0.00003147725,0.00017990217,0.00023430542,0.000044690183,0.0018426495,0.00014104311,0.00003746306,0.0002817702],"genre_scores_gemma":[0.9952689,0.0000023970413,0.0033881129,0.00003912664,0.000044626257,0.0005620816,0.00049480755,0.000026462614,0.00017349653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989549,0.000019728705,0.00016652115,0.00030100727,0.0002297333,0.00032811565],"domain_scores_gemma":[0.99885786,0.00032255746,0.000042232572,0.00028911507,0.00012413046,0.00036411177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083302046,0.00014598023,0.00021174629,0.000099884426,0.000096281496,0.000025503718,0.00005716379,0.000053755244,0.000023073813],"category_scores_gemma":[0.0005799787,0.00010981893,0.000032809246,0.00013257132,0.00011335906,0.00007745763,0.00003781195,0.00018089524,0.000012849117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008489031,0.00033700562,0.9920764,0.00012832656,0.00004196092,0.000022057837,0.000029561186,0.0000032598439,0.00029918106,0.00031784465,0.0000439366,0.0058515947],"study_design_scores_gemma":[0.011839283,0.00031750364,0.9833192,0.00006986433,0.000065902976,0.000003971137,0.000012782554,0.0036754159,0.00004167481,0.00010928372,0.0004314516,0.00011364743],"about_ca_topic_score_codex":0.00011534162,"about_ca_topic_score_gemma":0.00033333874,"teacher_disagreement_score":0.01099038,"about_ca_system_score_codex":0.00010700144,"about_ca_system_score_gemma":0.00026150848,"threshold_uncertainty_score":0.4478286},"labels":[],"label_agreement":null},{"id":"W1983149827","doi":"10.1038/leu.2012.337","title":"Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts","year":2012,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Malignancy; Chemotherapy; Oncology; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Internal medicine; Leukemia; Pediatrics","score_opus":0.02834101545756412,"score_gpt":0.3005966286689919,"score_spread":0.27225561321142777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983149827","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11825135,0.0049770437,0.0011886542,0.6541349,0.0034349535,0.021873422,0.025462398,0.0011168708,0.16956037],"genre_scores_gemma":[0.06633244,0.00015176377,0.013105155,0.79964346,0.015100678,0.0016882383,0.038658395,0.00077343936,0.06454644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604756,0.000109423105,0.00089347793,0.00068932946,0.0010191458,0.001241078],"domain_scores_gemma":[0.9970244,0.0005544867,0.00037854994,0.0014641348,0.00034251763,0.00023587511],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0003393653,0.0006120366,0.0014070995,0.00059228385,0.00008939158,0.000026026959,0.0007807719,0.002038159,0.00026702345],"category_scores_gemma":[0.00040910588,0.0005399383,0.0004549672,0.00037054066,0.00034420582,0.00014490254,0.0003412764,0.0027620285,0.000103371414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025478334,0.000089954425,0.00020798229,0.0028470473,0.0002780152,0.00029173688,0.00033655192,0.0000027602102,0.048229698,0.000082941624,0.947163,0.00021552795],"study_design_scores_gemma":[0.019896785,0.0006067677,0.0031695638,0.0012294345,0.0009997546,0.00051886315,0.00007133979,0.00016160725,0.012495601,0.0020358008,0.9578443,0.0009701787],"about_ca_topic_score_codex":0.00027899176,"about_ca_topic_score_gemma":0.000030394553,"teacher_disagreement_score":0.14550851,"about_ca_system_score_codex":0.006707455,"about_ca_system_score_gemma":0.002432152,"threshold_uncertainty_score":0.9997052},"labels":[],"label_agreement":null},{"id":"W1984842749","doi":"10.1038/sj.leu.2404321","title":"Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas","year":2006,"lang":"en","type":"article","venue":"Leukemia","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia; Michael Smith Health Research BC; Mayo Clinic","keywords":"Cancer research; Provirus; Biology; Lymphoma; Autocrine signalling; Cell culture; Gene knockdown; Leukemia; Tumor necrosis factor alpha; Immunology; Gene; Genetics","score_opus":0.01994729732596368,"score_gpt":0.25129012767325504,"score_spread":0.23134283034729136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984842749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98237425,0.0147176245,0.000017974204,0.000009581869,0.00017563374,0.00034035812,0.000054485492,0.000035856654,0.0022742073],"genre_scores_gemma":[0.99662113,0.00018581086,0.00012847302,0.00002529745,0.00002754413,0.000036168047,0.000055397068,0.000023602764,0.0028965492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985084,0.00010395744,0.0005917961,0.00035050983,0.00005100652,0.00039433915],"domain_scores_gemma":[0.9990558,0.00024530495,0.00026813775,0.00035015185,0.00006318405,0.000017443128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001931764,0.00021239898,0.00054395536,0.0001602,0.00011373948,0.000004136914,0.00031987566,0.00030193423,0.00005464525],"category_scores_gemma":[0.000031698823,0.00018776351,0.00015682646,0.00016799085,0.0002744265,0.000084676205,0.00009821662,0.00017132133,0.000024229088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002472813,0.00020611855,0.00559571,0.00013662748,0.0000633593,0.000039248032,0.0003473665,0.00009977575,0.9909153,0.0007908751,0.0007077486,0.00085058244],"study_design_scores_gemma":[0.0049554943,0.002679017,0.014270545,0.00043340927,0.00021174105,0.0012381296,0.0007124648,0.000072726376,0.9684247,0.0039803865,0.002473577,0.00054784195],"about_ca_topic_score_codex":0.0067193992,"about_ca_topic_score_gemma":0.000917745,"teacher_disagreement_score":0.02249064,"about_ca_system_score_codex":0.00037560042,"about_ca_system_score_gemma":0.00030069082,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W1985337146","doi":"10.1038/leu.2010.53","title":"Novel insight into stem cell mobilization-Plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; European Commission; National Cancer Institute; National Institutes of Health; University of Alberta","keywords":"Haematopoiesis; Progenitor cell; Bone marrow; Cell biology; Stem cell; Chemotaxis; Stromal cell; Biology; Sphingosine-1-phosphate; Immunology; Chemistry; Biochemistry; Sphingosine; Cancer research; Receptor","score_opus":0.023259746152852322,"score_gpt":0.24098513193828697,"score_spread":0.21772538578543466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985337146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978749,0.00052726205,0.0003362006,0.00008618284,0.000113796494,0.00091365434,0.00012657813,0.0000103774255,0.000011044463],"genre_scores_gemma":[0.99879724,0.00007466699,0.0005972935,0.00013716747,0.00013180017,0.000079856785,0.000094226205,0.00003856243,0.00004918759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984642,0.00007845339,0.00050773134,0.00042139934,0.0002896839,0.0002385149],"domain_scores_gemma":[0.9988936,0.000099095305,0.00034955906,0.0004163006,0.0001587485,0.00008265845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002514078,0.0002625968,0.0003606866,0.00005256849,0.00014843296,0.000048169153,0.00029135565,0.0001519067,0.00002257954],"category_scores_gemma":[0.000026274116,0.00019052274,0.00007101814,0.000223838,0.00007864865,0.000026392714,0.00013511264,0.00016157671,5.9008255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017443633,0.00015985261,0.003349573,0.00025171795,0.000050826908,0.0000018330526,0.0031069783,0.00094944524,0.99173397,0.000017837621,0.0000199102,0.00018362839],"study_design_scores_gemma":[0.001842124,0.00005086443,0.015073865,0.00011702011,0.000067543915,0.000015837504,0.0007171197,0.0026569802,0.9790425,0.0000021703527,0.00020661726,0.00020740338],"about_ca_topic_score_codex":0.00082290627,"about_ca_topic_score_gemma":0.000461135,"teacher_disagreement_score":0.012691506,"about_ca_system_score_codex":0.000038483602,"about_ca_system_score_gemma":0.00012211112,"threshold_uncertainty_score":0.77692914},"labels":[],"label_agreement":null},{"id":"W1985361166","doi":"10.1038/leu.2015.88","title":"Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Cancer Research UK","keywords":"Oncolytic virus; Antibody-dependent cell-mediated cytotoxicity; Cytotoxicity; Cytotoxic T cell; Chronic lymphocytic leukemia; Immunology; Panobinostat; Cancer research; Immune system; Immunotherapy; CD20; Antibody; Biology; Monoclonal antibody; Virology; Leukemia; Histone deacetylase; Histone","score_opus":0.020667407665535938,"score_gpt":0.29878647265889785,"score_spread":0.2781190649933619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985361166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896532,0.0047088587,0.00040474237,0.00004991086,0.00032426175,0.0005384167,0.000050792743,0.00009061066,0.0041791867],"genre_scores_gemma":[0.9946719,0.0010602957,0.00011702584,0.00061968376,0.0009078022,0.000076993114,0.00057887216,0.00009460097,0.0018728245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966422,0.00028698007,0.0004874861,0.00088846334,0.00075415894,0.0009407307],"domain_scores_gemma":[0.9979471,0.000042784315,0.00018111548,0.0010715618,0.00023503718,0.00052239746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008219842,0.00044367704,0.00044426703,0.0001348635,0.00016804169,0.000092241135,0.00080933486,0.0004497156,0.000079028425],"category_scores_gemma":[0.0002494593,0.00043796794,0.00018626865,0.00032664253,0.00027398966,0.000017909577,0.00031582254,0.00036616705,0.0009544213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012132509,0.000072160685,0.00022164235,0.000046576984,0.000107713124,0.00008621622,0.0000620672,0.0012444501,0.9937905,0.0000082284805,0.001843831,0.0013033405],"study_design_scores_gemma":[0.0052364804,0.002366844,0.00005911463,0.000041618125,0.000025024423,0.000019065325,0.00008030537,0.0025438813,0.98049253,0.000060928687,0.008538419,0.0005357828],"about_ca_topic_score_codex":0.00023621625,"about_ca_topic_score_gemma":0.00055950123,"teacher_disagreement_score":0.013297986,"about_ca_system_score_codex":0.004659704,"about_ca_system_score_gemma":0.007366093,"threshold_uncertainty_score":0.99982345},"labels":[],"label_agreement":null},{"id":"W1985600634","doi":"10.1038/leu.2008.96","title":"Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Minimal residual disease; Medicine; Donor lymphocyte infusion; Internal medicine; Transplantation; Oncology; Leukemia; Stem cell; Hematopoietic stem cell transplantation; Chronic lymphocytic leukemia; Immunology; Biology","score_opus":0.0493512382754655,"score_gpt":0.3138478957526695,"score_spread":0.264496657477204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985600634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911966,0.0018267257,0.0013846223,0.00018703294,0.0012309172,0.0028524,0.0010091,0.000190774,0.000121866855],"genre_scores_gemma":[0.99116224,0.0012832336,0.00042899733,0.00013090292,0.0018142632,0.0009014215,0.00043688476,0.00014024465,0.0037017898],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947459,0.0005958782,0.0012262075,0.0011602673,0.0012040476,0.0010677141],"domain_scores_gemma":[0.9910765,0.0066796755,0.0003672553,0.0012650386,0.00029260886,0.000318893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013265371,0.000590693,0.00078264746,0.00019798616,0.00053768116,0.00012151495,0.0005896326,0.00043447397,0.00005920509],"category_scores_gemma":[0.0005895514,0.0004497863,0.00048413506,0.00040753503,0.00039590267,0.00029222097,0.00012659866,0.0005846108,0.00020659539],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.94322735,0.00011352511,0.002113894,0.001075313,0.00062213,0.0038163837,0.01776441,0.0013509732,0.024830816,0.000014462818,0.0032986186,0.0017721102],"study_design_scores_gemma":[0.6620714,0.0063825096,0.12919258,0.002407415,0.001584886,0.0009679729,0.0032795174,0.024544556,0.16545849,0.00009311424,0.002373276,0.0016443095],"about_ca_topic_score_codex":0.0065986346,"about_ca_topic_score_gemma":0.0007425762,"teacher_disagreement_score":0.28115597,"about_ca_system_score_codex":0.10489587,"about_ca_system_score_gemma":0.04036346,"threshold_uncertainty_score":0.9997954},"labels":[],"label_agreement":null},{"id":"W1986093701","doi":"10.1038/sj.leu.2402455","title":"Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Mitoxantrone; Etoposide; Pharmacokinetics; Pharmacology; Medicine; Myeloid leukemia; Cytarabine; Toxicity; Chemotherapy; Internal medicine","score_opus":0.006500770798625346,"score_gpt":0.22555092475615057,"score_spread":0.21905015395752522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986093701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958159,0.0003919107,0.00025135378,0.00032273988,0.000045119057,0.000420421,0.0000135397695,0.00004700313,0.0026920484],"genre_scores_gemma":[0.99367243,0.000591708,0.0026116702,0.00014055357,0.00008615169,0.000025108458,0.00003105964,0.000036017776,0.0028052798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892044,0.000012301492,0.0002674997,0.0002918673,0.00023781757,0.0002700448],"domain_scores_gemma":[0.99947596,0.000016978944,0.00009807,0.00023195929,0.00004554035,0.00013149508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047819016,0.00021002856,0.00038989855,0.00016322854,0.000038159393,0.000007827942,0.00007490413,0.000057627913,0.00019735584],"category_scores_gemma":[0.0000023515197,0.00014530613,0.00003970501,0.0003102028,0.00012401186,0.0001041852,0.000012932767,0.00033243434,0.0000077834975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032884101,0.0004921616,0.78325903,0.0003296864,0.0015846704,0.0012319292,0.0016938958,0.0006005455,0.19148102,0.00047602176,0.0007917294,0.0147709],"study_design_scores_gemma":[0.013472958,0.00087625964,0.8864865,0.00074463105,0.001051238,0.0017092348,0.0001672535,0.0011467951,0.09237619,0.000045550813,0.0014804766,0.00044294848],"about_ca_topic_score_codex":0.00021405834,"about_ca_topic_score_gemma":0.00026885082,"teacher_disagreement_score":0.10322744,"about_ca_system_score_codex":0.00024532195,"about_ca_system_score_gemma":0.000105258194,"threshold_uncertainty_score":0.5925412},"labels":[],"label_agreement":null},{"id":"W1986716910","doi":"10.1038/sj.leu.2404323","title":"Restoration of shp1 expression by 5-AZA-2′-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma","year":2006,"lang":"en","type":"article","venue":"Leukemia","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta; Hospital Research Foundation","keywords":"Anaplastic lymphoma kinase; Deoxycytidine; Anaplastic large-cell lymphoma; Downregulation and upregulation; Cancer research; Lymphoma; Biology; Internal medicine; Medicine; Genetics; Cancer; Immunology; Gene","score_opus":0.007082090437612535,"score_gpt":0.22679686927604248,"score_spread":0.21971477883842994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986716910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955254,0.00009637989,0.0022250372,0.000041279338,0.000037742477,0.00026117536,0.0001655597,0.000025446114,0.0016219327],"genre_scores_gemma":[0.99848264,0.000003968508,0.00036832903,0.000039789862,0.00005322152,0.000011394632,0.00067922147,0.000024769708,0.00033667227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986645,0.00006403682,0.00050388183,0.00023445056,0.00033209604,0.00020106383],"domain_scores_gemma":[0.99896896,0.00017014453,0.000402173,0.00016763677,0.00024431417,0.000046766072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017585076,0.00015844774,0.000343332,0.0002047251,0.000053472708,0.000009348113,0.000048540533,0.00013017449,0.00008910516],"category_scores_gemma":[0.00007103893,0.00013777739,0.00006837028,0.0004058849,0.00003997067,0.00015954208,0.00001662558,0.00012329669,0.0000028544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000607316,0.000525217,0.006057239,0.000057051977,0.000022528871,0.000015751475,0.00049546617,0.0018412366,0.9880209,0.000052401905,0.002216964,0.00008793322],"study_design_scores_gemma":[0.005242495,0.0006306016,0.049255736,0.0010265646,0.00007575345,0.000007891844,0.00016915567,0.007813346,0.9354396,0.00005079426,0.00015271523,0.00013537488],"about_ca_topic_score_codex":0.0007422849,"about_ca_topic_score_gemma":0.00012756234,"teacher_disagreement_score":0.05258132,"about_ca_system_score_codex":0.00057205703,"about_ca_system_score_gemma":0.00020629677,"threshold_uncertainty_score":0.5618399},"labels":[],"label_agreement":null},{"id":"W1987130154","doi":"10.1038/leu.2009.100","title":"Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation","keywords":"Apoptosis; Cancer research; Biology; Mantle cell lymphoma; Tumor necrosis factor alpha; STAT1; Signal transduction; Lymphoma; Molecular biology; Cell biology; Immunology; Biochemistry","score_opus":0.01327014297712055,"score_gpt":0.258905328367161,"score_spread":0.24563518539004048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987130154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823334,0.00037765424,0.000087829845,0.00048451507,0.00020357942,0.0006590935,0.000012254346,0.00009951266,0.01574216],"genre_scores_gemma":[0.99635935,0.00017927308,0.0008897371,0.0015528764,0.00009973639,0.00011608585,0.000028782597,0.000029140212,0.0007449926],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823374,0.00007262866,0.00034467765,0.00051997445,0.00036071625,0.00046827138],"domain_scores_gemma":[0.9992318,0.00010248063,0.000107028216,0.000373815,0.00004473489,0.00014010406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000140491,0.00032059374,0.0005001719,0.00015005769,0.00006486879,0.00004397861,0.0001394071,0.00018587848,0.000109799425],"category_scores_gemma":[0.000028648525,0.00026029104,0.00015330635,0.0002537604,0.000028220855,0.0001626411,0.00005407517,0.0001365929,0.00025089385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00423801,0.02239801,0.043418415,0.00091924216,0.0011926239,0.0070248903,0.031526063,0.00010578152,0.3570916,0.027367406,0.011518826,0.49319914],"study_design_scores_gemma":[0.015100151,0.0018155326,0.11939916,0.00034797878,0.00017007867,0.00009847373,0.0004742933,0.00007178526,0.85639423,0.004628371,0.0011281129,0.00037180405],"about_ca_topic_score_codex":0.0011088327,"about_ca_topic_score_gemma":0.00006107127,"teacher_disagreement_score":0.49930266,"about_ca_system_score_codex":0.0035466966,"about_ca_system_score_gemma":0.00042837084,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W1988190168","doi":"10.1038/sj.leu.2404503","title":"High incidence of CALM-AF10 fusion and the identification of a novel fusion transcript in acute megakaryoblastic leukemia in children without Down's syndrome","year":2006,"lang":"en","type":"letter","venue":"Leukemia","topic":"Plant Disease Resistance and Genetics","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Acute megakaryoblastic leukemia; Incidence (geometry); Fusion transcript; Leukemia; Medicine; Down syndrome; Identification (biology); Acute leukemia; Fusion; Immunology; Fusion gene; Biology; Genetics; Gene; Botany","score_opus":0.006127922021105259,"score_gpt":0.19196916966026026,"score_spread":0.185841247639155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988190168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173605,0.00064863375,0.000010711396,0.005964732,0.000072185445,0.0006249021,0.00091114664,0.000013355718,0.000018279807],"genre_scores_gemma":[0.99484235,0.00053551036,0.00003442704,0.0032573373,0.000120568155,0.000036771995,0.0009512471,0.0000035096573,0.00021829734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99774534,0.0001421619,0.00084027275,0.0004631223,0.00049235096,0.00031676327],"domain_scores_gemma":[0.99905866,0.00022421329,0.00046684424,0.00015678677,0.000055579545,0.000037923033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003370388,0.00029156148,0.0006311087,0.00007801235,0.00006629389,0.000033916713,0.00046760018,0.00050923246,0.000017253069],"category_scores_gemma":[0.000028403605,0.00011912935,0.00012137152,0.0004909731,0.00027778244,0.00009462126,0.00007969738,0.0006031609,0.0000021796686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000959908,0.00018254509,0.06786902,0.00059743493,0.00016824258,0.00028956615,0.00038705155,0.0014504292,0.89884406,0.00011466174,0.02557009,0.0035669627],"study_design_scores_gemma":[0.0016122761,0.00008220521,0.99319047,0.0006407507,0.00016229226,0.000080179045,0.000019240777,0.00075239985,0.0020067308,0.0005196494,0.00058428023,0.00034955677],"about_ca_topic_score_codex":0.007399264,"about_ca_topic_score_gemma":0.0032461355,"teacher_disagreement_score":0.9253214,"about_ca_system_score_codex":0.0002527416,"about_ca_system_score_gemma":0.00009436346,"threshold_uncertainty_score":0.99921054},"labels":[],"label_agreement":null},{"id":"W1989803279","doi":"10.1038/sj.leu.2405087","title":"Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Renal function; Internal medicine; Creatinine; Adverse effect; Proteasome inhibitor; Urology; Phases of clinical research; Gastroenterology; Toxicity; Surgery","score_opus":0.019329333024487288,"score_gpt":0.2877653199784997,"score_spread":0.2684359869540124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989803279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979819,0.0000520283,0.0000026352354,0.00008238896,0.00001106374,0.0013780722,0.00013951474,0.000012174507,0.00034022823],"genre_scores_gemma":[0.9994405,0.000029613946,0.00012968735,0.00003927303,0.000031098607,0.000018107437,0.00020379988,0.000011623711,0.00009628494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876195,0.00008005784,0.00028818444,0.00025304052,0.0004048602,0.00021188433],"domain_scores_gemma":[0.9991538,0.00022882022,0.00007725385,0.00035978557,0.00005545076,0.00012487128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013599225,0.0001246504,0.00025158675,0.000051796364,0.00007803566,0.000005059023,0.00007460754,0.00003502475,0.00002235538],"category_scores_gemma":[0.00013935652,0.000067631205,0.000023758139,0.00016633086,0.000108419285,0.000045254303,0.000047935115,0.00017090126,0.0000063558196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04159952,0.0027169005,0.9445051,0.000005904545,0.00020576987,0.00025420435,0.0023063961,0.0000067273454,0.00004953379,8.228761e-7,0.00026995546,0.008079195],"study_design_scores_gemma":[0.12829691,0.0032555752,0.8678113,0.00007466373,0.000042456893,0.0000036083695,0.00010990844,0.000090743684,0.00014476078,0.0000018990171,0.00011436597,0.00005380502],"about_ca_topic_score_codex":0.0016741544,"about_ca_topic_score_gemma":0.00012766468,"teacher_disagreement_score":0.086697385,"about_ca_system_score_codex":0.00018687334,"about_ca_system_score_gemma":0.00018143606,"threshold_uncertainty_score":0.27579206},"labels":[],"label_agreement":null},{"id":"W1990020715","doi":"10.1038/leu.2008.84","title":"Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":354,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Medicine; Imatinib; Chronic myelogenous leukemia; Internal medicine; Gastroenterology; Neutropenia; Imatinib mesylate; Leukemia; Oncology; Chemotherapy; Myeloid leukemia","score_opus":0.022184882067737867,"score_gpt":0.27956515176368274,"score_spread":0.25738026969594485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990020715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944185,0.001202267,0.000045336437,0.00015895293,0.00007591945,0.002917719,0.000057843517,0.00014278998,0.0009806454],"genre_scores_gemma":[0.99076104,0.00022889121,0.0039574956,0.00041068357,0.00016746162,0.00063835515,0.00012470406,0.0001622736,0.0035490815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951293,0.0002026025,0.0010208708,0.001284744,0.0009952936,0.0013672088],"domain_scores_gemma":[0.99743295,0.00027431335,0.00033939804,0.0013209609,0.00019909065,0.0004332667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002927289,0.00078218494,0.0011947969,0.00064857275,0.00022678907,0.00003737899,0.00044461025,0.00029183223,0.0002551586],"category_scores_gemma":[0.00023080024,0.0005807923,0.00007777153,0.0019843257,0.0003386978,0.00030264602,0.00010790952,0.0008288924,0.00014514072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.13566715,0.002358692,0.7639591,0.0023070492,0.00071723317,0.013558595,0.012859497,0.019659707,0.024205325,0.00004948822,0.0025466408,0.0221115],"study_design_scores_gemma":[0.09871811,0.011149656,0.8609933,0.004171972,0.00013868335,0.00035502933,0.00015325024,0.00054845866,0.019371321,0.000013164067,0.0031224347,0.0012646202],"about_ca_topic_score_codex":0.0015113321,"about_ca_topic_score_gemma":0.015882285,"teacher_disagreement_score":0.09703418,"about_ca_system_score_codex":0.0498163,"about_ca_system_score_gemma":0.021064734,"threshold_uncertainty_score":0.99966437},"labels":[],"label_agreement":null},{"id":"W1990175055","doi":"10.1038/sj.leu.2401721","title":"P53 mutations in hairy cell leukemia","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Alexander von Humboldt-Stiftung","keywords":"Hairy cell leukemia; Leukemia; Cancer research; Mutation; Biology; Genetics; Gene","score_opus":0.01617999130065075,"score_gpt":0.2880168064529689,"score_spread":0.27183681515231817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990175055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80944854,0.00037422875,0.000030573035,0.00024725177,0.00008475052,0.0004730437,0.000007601876,0.0001419252,0.18919206],"genre_scores_gemma":[0.9461403,0.00018848386,0.001085943,0.00087020727,0.00026057733,0.00008369143,0.00008105048,0.00006418225,0.051225577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974956,0.00007529781,0.0004975779,0.0005347213,0.00061976037,0.00077703607],"domain_scores_gemma":[0.9986146,0.00019535347,0.000048985872,0.0007363979,0.00007258632,0.0003320534],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000299491,0.0002586978,0.0004108086,0.00027793125,0.000094959,0.000040467876,0.00025811803,0.00026134285,0.0050355],"category_scores_gemma":[0.000102533275,0.00024628965,0.00014523485,0.0007894792,0.00019056398,0.00016714685,0.00005882401,0.0006473455,0.0036545857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0063824323,0.0022530055,0.028190732,0.003923784,0.00055541773,0.025649289,0.018367192,0.056984216,0.04112555,0.0035747243,0.206448,0.6065456],"study_design_scores_gemma":[0.15983187,0.0013541396,0.06823094,0.0013088778,0.0003807922,0.0030446262,0.0015524313,0.34573224,0.052274883,0.0028850292,0.36092815,0.0024760053],"about_ca_topic_score_codex":0.0034946778,"about_ca_topic_score_gemma":0.00030084472,"teacher_disagreement_score":0.60406965,"about_ca_system_score_codex":0.050571356,"about_ca_system_score_gemma":0.017034283,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W1992419413","doi":"10.1038/leu.2009.301","title":"FES kinases are required for oncogenic FLT3 signaling","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Fondation de France; Ligue Contre le Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Kinase; Receptor tyrosine kinase; Cancer research; Haematopoiesis; Biology; Fms-Like Tyrosine Kinase 3; Myeloid leukemia; Tyrosine kinase; Cell; Cell cycle; Cell biology; Signal transduction; Mutation; Stem cell; Genetics; Gene","score_opus":0.04264703591099411,"score_gpt":0.3336378850491636,"score_spread":0.29099084913816947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992419413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969827,0.00016004423,0.00008688235,0.00041324343,0.00018583334,0.00059017964,0.000037739537,0.00008775289,0.001455641],"genre_scores_gemma":[0.9924465,0.000013050784,0.0043811505,0.00017421204,0.00046908198,0.0001298981,0.000094807205,0.000029430814,0.0022618782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898434,0.000014751463,0.00015928803,0.00024771027,0.00022801897,0.00036587773],"domain_scores_gemma":[0.99910223,0.00018325672,0.000057085294,0.0003053362,0.000112202615,0.00023986989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012176514,0.00012993737,0.0002262183,0.000075949814,0.00012136815,0.000025179783,0.000090754715,0.000106403786,0.0002123445],"category_scores_gemma":[0.00050132436,0.00010193295,0.00013794978,0.000093772775,0.00005775979,0.00005813368,0.000030167512,0.000203144,0.00012755554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012980762,0.00021534001,0.07756101,0.00029054104,0.00032384341,0.00044992636,0.00016069376,0.0000032918508,0.84186304,0.00038483422,0.004857521,0.07259188],"study_design_scores_gemma":[0.017674182,0.0011397504,0.13152823,0.00033012388,0.00030540777,0.00019698164,0.00030226365,0.0022146516,0.804142,0.0022551902,0.039429095,0.0004821519],"about_ca_topic_score_codex":0.000120073906,"about_ca_topic_score_gemma":0.00010750802,"teacher_disagreement_score":0.07210972,"about_ca_system_score_codex":0.00018980254,"about_ca_system_score_gemma":0.00029662045,"threshold_uncertainty_score":0.4156705},"labels":[],"label_agreement":null},{"id":"W1993474153","doi":"10.1038/leu.2009.156","title":"Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Internal medicine; Myeloid leukemia; Oncology; Imatinib mesylate; Gastroenterology","score_opus":0.00565248787314487,"score_gpt":0.2579140445945823,"score_spread":0.2522615567214374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993474153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956075,0.00082214887,0.00016561548,0.00039533785,0.00008376104,0.0023791974,0.0001498327,0.00017622528,0.00022041542],"genre_scores_gemma":[0.9972736,0.00004838073,0.0009561076,0.00034274478,0.000058843118,0.0001531142,0.00067125016,0.00012197278,0.00037393358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505115,0.0006472997,0.001008629,0.0011713931,0.00090468297,0.0012168463],"domain_scores_gemma":[0.9977179,0.0005231404,0.0003789679,0.00089698925,0.00011896894,0.00036402297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009907355,0.00077740074,0.0011454996,0.0007282475,0.00014896912,0.00006975035,0.00026072553,0.00051265565,0.000041366657],"category_scores_gemma":[0.0010371787,0.0007224074,0.00018582755,0.0012729208,0.00018415657,0.0004125608,0.000112061905,0.0010961066,0.00001928091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.14130336,0.0041031106,0.69222903,0.00085328834,0.0029116462,0.0140042715,0.00826545,0.02125656,0.062315114,0.00083273486,0.00081259425,0.05111281],"study_design_scores_gemma":[0.110892,0.010508221,0.80261016,0.002210269,0.00043180937,0.00005267914,0.00017358616,0.06906588,0.0029480443,0.0001737079,0.00007721701,0.0008564534],"about_ca_topic_score_codex":0.00054757803,"about_ca_topic_score_gemma":0.0010747514,"teacher_disagreement_score":0.11038109,"about_ca_system_score_codex":0.092053756,"about_ca_system_score_gemma":0.009262124,"threshold_uncertainty_score":0.9995227},"labels":[],"label_agreement":null},{"id":"W1994002042","doi":"10.1038/leu.2010.30","title":"Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Hospital for Sick Children","funders":"National Cancer Institute; Ontario Institute for Cancer Research; Cancer Research Society","keywords":"Down syndrome; Leukemia; Bone marrow; Myeloid leukemia; clone (Java method); GATA1; Immunology; Biology; Trisomy; Somatic evolution in cancer; Myeloid; Nod; Cancer research; Haematopoiesis; Medicine; Genetics; Stem cell; Cancer; In vivo; DNA","score_opus":0.024135977880562008,"score_gpt":0.2631661623230431,"score_spread":0.23903018444248106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994002042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075884,0.00012813308,0.00021789756,0.00074073696,0.00048079604,0.00083378,0.0000751997,0.00019961121,0.0065649995],"genre_scores_gemma":[0.99447185,0.00012735263,0.0018644508,0.0005487908,0.00068351906,0.000114328985,0.00014680356,0.000099024066,0.0019438694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955578,0.00015066526,0.0009183469,0.0010883813,0.0010675727,0.0012172619],"domain_scores_gemma":[0.99740773,0.0007887648,0.00018987089,0.00072339183,0.00017141743,0.000718829],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091077667,0.00060138974,0.0010381974,0.00065879,0.00028209315,0.00013086667,0.00038927738,0.000695965,0.0007294046],"category_scores_gemma":[0.0002840074,0.00053644826,0.00019916124,0.00078191125,0.00054352573,0.0003722006,0.00022179635,0.0031591002,0.0002649203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008414812,0.00016617565,0.46167755,0.0011084175,0.00049136265,0.002748047,0.0028908048,0.00019946703,0.4746881,0.00094664254,0.010612249,0.043629684],"study_design_scores_gemma":[0.005955112,0.0004391998,0.9725523,0.00027773678,0.00014704933,0.0008753535,0.00043756442,0.002489317,0.012058202,0.00031940176,0.0037555895,0.0006931462],"about_ca_topic_score_codex":0.0012654596,"about_ca_topic_score_gemma":0.00033078477,"teacher_disagreement_score":0.5108748,"about_ca_system_score_codex":0.0036532758,"about_ca_system_score_gemma":0.0033926298,"threshold_uncertainty_score":0.9997087},"labels":[],"label_agreement":null},{"id":"W1995082806","doi":"10.1038/leu.2012.109","title":"RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Fusion gene; Chronic myelomonocytic leukemia; Cancer research; Biology; Haematopoiesis; Myeloproliferative neoplasm; Chromosomal translocation; Leukemia; Tyrosine kinase; ABL; Gene; Stem cell; Immunology; Genetics; Myelodysplastic syndromes; Signal transduction; Myelofibrosis; Bone marrow","score_opus":0.017099378474052566,"score_gpt":0.2591504653778369,"score_spread":0.24205108690378435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995082806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940594,0.0039777854,0.00016769515,0.00022583117,0.00013047461,0.0007310003,0.000012002042,0.00010203042,0.0005937765],"genre_scores_gemma":[0.9966434,0.001205017,0.00020180047,0.0002286896,0.00029777535,0.0002563213,0.00013536323,0.000044469685,0.0009871251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984724,0.00007453056,0.0002722886,0.0003758995,0.00031870895,0.00048615824],"domain_scores_gemma":[0.99896663,0.0001463855,0.00022404086,0.0003018065,0.00009806707,0.0002630567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013507232,0.0003152636,0.0004720296,0.000093013914,0.00018195332,0.00003928549,0.00005466815,0.00017568626,0.000119868426],"category_scores_gemma":[0.0000818013,0.00022767526,0.000063485546,0.00019208103,0.00007359351,0.00019782552,0.000051862844,0.00022327167,0.00005498348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027202212,0.0002308518,0.96576154,0.00019955798,0.00043609118,0.000051898238,0.00070447364,0.000059131235,0.005727983,0.0002346893,0.0006935077,0.02562827],"study_design_scores_gemma":[0.0032663087,0.0005579201,0.9483881,0.00061824924,0.00043114056,0.000050062205,0.00007112795,0.0024792394,0.043040305,0.000037877016,0.0007701269,0.0002895333],"about_ca_topic_score_codex":0.00008453149,"about_ca_topic_score_gemma":0.0002383632,"teacher_disagreement_score":0.03731232,"about_ca_system_score_codex":0.004493875,"about_ca_system_score_gemma":0.00043834173,"threshold_uncertainty_score":0.9993277},"labels":[],"label_agreement":null},{"id":"W1995576598","doi":"10.1038/sj.leu.2404800","title":"Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution","year":2007,"lang":"en","type":"letter","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Somatic evolution in cancer; Hematology; Oncology; Immunology; Internal medicine; Cancer research; Biology; Cancer","score_opus":0.12111152545305151,"score_gpt":0.38385046946697643,"score_spread":0.26273894401392495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995576598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935057,0.012374432,0.0008666684,0.043881778,0.0003467613,0.0069547812,0.00015610237,0.000043742286,0.00031872204],"genre_scores_gemma":[0.98187834,0.00021799674,0.001538383,0.013286121,0.001184662,0.00062093185,0.0007348384,0.000049255596,0.00048947043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973728,0.00014998465,0.00042682764,0.0004543824,0.0011525226,0.00044348682],"domain_scores_gemma":[0.99505913,0.0038482423,0.00017244853,0.0003249174,0.0004988527,0.000096408934],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011851544,0.00023698084,0.0004576263,0.00041608568,0.000045354565,0.0000119071465,0.000090476686,0.0005524257,0.000045456167],"category_scores_gemma":[0.01002694,0.00021050636,0.00011180067,0.00019626395,0.00012592322,0.00009759412,0.000044106215,0.00066752185,0.000014155591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022506183,0.0001796851,0.6082123,0.0048204246,0.0003905443,0.00074317906,0.00025840054,0.000078254234,0.0011491085,0.000019419136,0.301486,0.080412105],"study_design_scores_gemma":[0.011447072,0.00062178174,0.9588221,0.003413203,0.000538035,0.00006828307,0.000020783571,0.015843792,0.00068976893,0.00039315713,0.007886967,0.00025509213],"about_ca_topic_score_codex":0.0007522074,"about_ca_topic_score_gemma":0.00028475857,"teacher_disagreement_score":0.35060978,"about_ca_system_score_codex":0.0023472249,"about_ca_system_score_gemma":0.0011548868,"threshold_uncertainty_score":0.998312},"labels":[],"label_agreement":null},{"id":"W1996122750","doi":"10.1038/leu.2008.395","title":"The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Phosphorylation; Protein kinase B; Cancer research; Biology; AKT1; Clonogenic assay; PTEN; Internal medicine; Cytogenetics; Myeloid leukemia; PI3K/AKT/mTOR pathway; Oncology; Apoptosis; Medicine; Genetics; Gene","score_opus":0.030125440859411753,"score_gpt":0.27579310577551125,"score_spread":0.24566766491609948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996122750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951174,0.00014910016,0.00006330967,0.0022473964,0.00009525086,0.00087196496,0.00032639768,0.00007081153,0.0010583544],"genre_scores_gemma":[0.99364114,0.0010238012,0.00037538982,0.0014898257,0.00011808851,0.000023785215,0.00012842909,0.000066479726,0.0031330576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670124,0.00017436052,0.0006086637,0.000608267,0.0012061973,0.00070124655],"domain_scores_gemma":[0.9978909,0.000582731,0.0003502826,0.0006881632,0.0002822697,0.00020568017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079606153,0.00043432106,0.0007053276,0.00021579895,0.0001951501,0.00004698436,0.0002893954,0.0003503138,0.000030510966],"category_scores_gemma":[0.0004923387,0.00029860364,0.00008775741,0.0005439279,0.00023137325,0.00010185232,0.00009181973,0.0011184999,0.000018772307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08843808,0.002108698,0.37459722,0.00038171452,0.004601265,0.002359639,0.004662814,0.010872187,0.29815105,0.0071271188,0.024244726,0.1824555],"study_design_scores_gemma":[0.011550528,0.0042021433,0.79792786,0.00034549684,0.00019399126,0.000031448904,0.000062929634,0.0043650027,0.18029697,0.0003295354,0.00037908368,0.00031502228],"about_ca_topic_score_codex":0.0011785646,"about_ca_topic_score_gemma":0.00035003832,"teacher_disagreement_score":0.42333063,"about_ca_system_score_codex":0.0021369942,"about_ca_system_score_gemma":0.00086649496,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W1996346417","doi":"10.1038/leu.2014.183","title":"Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Survivin; Haematopoiesis; Stem cell; Biology; Cancer research; Gene; Hematology; Hematopoietic stem cell; Cell biology; Immunology; Genetics","score_opus":0.006505756812290964,"score_gpt":0.19570644263785666,"score_spread":0.1892006858255657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996346417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630458,0.00096492504,0.03545858,0.00003611616,0.000083760635,0.0002036595,0.0000052057353,0.00001273681,0.00018924891],"genre_scores_gemma":[0.9976169,0.00021373229,0.0011191647,0.000034019366,0.00006184379,0.000016092212,0.000056736568,0.000020224934,0.00086127326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992339,0.00005237177,0.00017430114,0.0002779336,0.00012660203,0.00013486129],"domain_scores_gemma":[0.9995065,0.0000080712725,0.000095549134,0.00026297226,0.00008414712,0.000042769865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010480822,0.00013878387,0.00014737346,0.000023323428,0.000075984586,0.000018028602,0.000058719594,0.00011842576,0.0000088879515],"category_scores_gemma":[0.0000034256932,0.00010996562,0.00004380556,0.00006371005,0.00005904453,0.000007445373,0.000051837786,0.000036489837,0.000002321201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003864752,0.000019780195,0.0009440562,0.00006723325,0.00003984604,4.6089454e-7,0.00007657544,0.007105216,0.98754555,0.0010190951,0.00007056117,0.003072958],"study_design_scores_gemma":[0.0003981463,0.00029756548,0.0009024337,0.000028642535,0.000045052544,0.000011891816,0.000062788575,0.0038756358,0.99173725,0.00039433216,0.0020890648,0.00015718462],"about_ca_topic_score_codex":0.000030378435,"about_ca_topic_score_gemma":0.00002226672,"teacher_disagreement_score":0.034571145,"about_ca_system_score_codex":0.000016895485,"about_ca_system_score_gemma":0.000037414815,"threshold_uncertainty_score":0.4484268},"labels":[],"label_agreement":null},{"id":"W1996490450","doi":"10.1038/sj.leu.2403785","title":"Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Cancer research; Population; Myeloid leukemia; Biology; Phosphoinositide 3-kinase; Haematopoiesis; Immunology; Leukemia; Imatinib; K562 cells; Pharmacology; Stem cell; Medicine; PI3K/AKT/mTOR pathway; Cell biology; Signal transduction","score_opus":0.012521974893370829,"score_gpt":0.27002299353954295,"score_spread":0.25750101864617214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996490450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842945,0.000771563,0.000016674392,0.0032301906,0.000111960115,0.00091910857,0.0000292137,0.000043326774,0.010583515],"genre_scores_gemma":[0.98773485,0.00011078757,0.004368778,0.00096432946,0.00017311431,0.000075478114,0.000016403275,0.000034906654,0.0065213214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814534,0.00008052651,0.00052582484,0.0003849168,0.00043221412,0.00043120518],"domain_scores_gemma":[0.99883485,0.00017987816,0.00017763994,0.0005842331,0.00008312513,0.00014028858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028707,0.00023816264,0.00045395835,0.000119871846,0.00005410165,0.000012436138,0.00023187656,0.00010089099,0.00012742703],"category_scores_gemma":[0.0001328925,0.00016962197,0.00011294194,0.00037391484,0.00011822868,0.00007508065,0.00008820584,0.000308038,0.00018459291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031502543,0.0004011841,0.0011227358,0.00026260223,0.00021772679,0.00015056584,0.009038265,0.000663452,0.93569046,0.0002840573,0.014126109,0.034892596],"study_design_scores_gemma":[0.0033618156,0.00010620844,0.016468382,0.00038678487,0.000075221076,0.000013643471,0.00036091774,0.00021992456,0.956582,0.00003550585,0.022212734,0.00017686722],"about_ca_topic_score_codex":0.00021503256,"about_ca_topic_score_gemma":0.00017996348,"teacher_disagreement_score":0.03471573,"about_ca_system_score_codex":0.0040288703,"about_ca_system_score_gemma":0.0008260613,"threshold_uncertainty_score":0.9997945},"labels":[],"label_agreement":null},{"id":"W1996620981","doi":"10.1038/sj.leu.2403703","title":"Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"National Cancer Institute; University of Alabama at Birmingham","keywords":"Lymphoblast; Methotrexate; Medicine; Progenitor cell; Leukemia; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Antimetabolite; Internal medicine; Oncology; Vincristine; Chemotherapy; Pharmacology; Immunology; Stem cell; Cell culture; Biology; Cyclophosphamide","score_opus":0.03164074259694681,"score_gpt":0.3408437748785574,"score_spread":0.30920303228161056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996620981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961833,0.00073517585,0.00014630466,0.00010313003,0.000039979623,0.0024708833,0.000029674098,0.00007095396,0.00022063186],"genre_scores_gemma":[0.99037015,0.00059055834,0.008193002,0.00009351136,0.000194694,0.00024062367,0.000038958722,0.00010044544,0.00017803417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957446,0.000492801,0.0011977919,0.001041172,0.0006424327,0.0008812333],"domain_scores_gemma":[0.9976943,0.0008419835,0.00040851708,0.0005555538,0.00010874588,0.00039088057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008616849,0.0006519854,0.0014616011,0.0012332068,0.00008316852,0.00004303114,0.00021447417,0.00039674368,0.000025824509],"category_scores_gemma":[0.0001506651,0.00050359685,0.00009653104,0.0011839175,0.00023054148,0.00031579137,0.00023799064,0.00039738062,0.000017021935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021277047,0.0009577361,0.97186,0.000106940184,0.00035344594,0.0003426167,0.0020576273,0.00087180885,0.0035225188,0.000015291811,0.000008878596,0.017775418],"study_design_scores_gemma":[0.044485036,0.004870353,0.93144286,0.00007115799,0.0010400695,0.0009144225,0.0005608106,0.01402326,0.0020783986,0.000028688222,0.000022748583,0.00046219342],"about_ca_topic_score_codex":0.0035123357,"about_ca_topic_score_gemma":0.0009947218,"teacher_disagreement_score":0.042357333,"about_ca_system_score_codex":0.0112897875,"about_ca_system_score_gemma":0.0019070606,"threshold_uncertainty_score":0.99974155},"labels":[],"label_agreement":null},{"id":"W1997062198","doi":"10.1038/leu.2012.331","title":"CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Homing (biology); Bone marrow; Haematopoiesis; Neutrophilia; breakpoint cluster region; Leukemia; Biology; Cancer research; Spleen; Immunology; ABL; Transplantation; Myeloid; Myeloid leukemia; Chronic myelogenous leukemia; Stem cell; Medicine; Internal medicine; Signal transduction; Cell biology; Receptor; Genetics; Tyrosine kinase","score_opus":0.026546077606185665,"score_gpt":0.2824213171881071,"score_spread":0.25587523958192143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997062198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895882,0.0029430294,0.0017679532,0.0006759645,0.00036313088,0.0015431797,0.00024658293,0.00014920508,0.002722732],"genre_scores_gemma":[0.9766536,0.00016173898,0.016184594,0.0007073773,0.00040622146,0.00017971013,0.0006185315,0.00010370443,0.004984538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975113,0.00007163531,0.00073369505,0.0004546138,0.0005157877,0.0007129696],"domain_scores_gemma":[0.99793273,0.00048714946,0.00047720317,0.00064643926,0.00021604545,0.00024042209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034941503,0.00037555737,0.00078774197,0.000120221164,0.00012698787,0.000012239114,0.00012238113,0.00034108662,0.00042289458],"category_scores_gemma":[0.00051704125,0.00034620127,0.00026187117,0.00041345126,0.0001594657,0.00046157886,0.00006382349,0.00016128973,0.00008880048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021334342,0.00047244044,0.026011473,0.0009898606,0.001175383,0.000013125378,0.008510973,0.000029357276,0.787225,0.00046669363,0.15594266,0.017029557],"study_design_scores_gemma":[0.016978065,0.0005008068,0.02445244,0.00043006692,0.0008922185,0.00007446646,0.0005437754,0.0021458128,0.91855335,0.00062808517,0.034239743,0.0005611723],"about_ca_topic_score_codex":0.00056151964,"about_ca_topic_score_gemma":0.0000122978445,"teacher_disagreement_score":0.13132831,"about_ca_system_score_codex":0.004300895,"about_ca_system_score_gemma":0.0007403414,"threshold_uncertainty_score":0.99989897},"labels":[],"label_agreement":null},{"id":"W1997254819","doi":"10.1038/leu.2014.245","title":"Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"National Institute for Health and Care Research; National Cancer Institute; National Institutes of Health; National Heart, Lung, and Blood Institute; Huntsman Cancer Institute; University of Utah; American Society of Hematology","keywords":"Myeloid leukemia; Cancer research; breakpoint cluster region; Tyrosine kinase; Philadelphia chromosome; STAT protein; Biology; STAT3; Medicine; Signal transduction; Internal medicine; Cell biology; Chromosomal translocation; Biochemistry; Receptor","score_opus":0.016181650942108654,"score_gpt":0.2565663677557162,"score_spread":0.2403847168136075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997254819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924181,0.0014959932,0.000043557568,0.00088274234,0.00017606062,0.0009860416,0.00002026342,0.00019037651,0.0037868721],"genre_scores_gemma":[0.996928,0.0007883398,0.00041255873,0.0006515085,0.00024579154,0.000139143,0.00012329269,0.000085551714,0.0006258454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967409,0.00029350232,0.000729197,0.00088641135,0.0005658661,0.0007841534],"domain_scores_gemma":[0.99790466,0.00033161824,0.0002385749,0.0011080336,0.00009527982,0.00032185562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007727223,0.0005268897,0.00083020405,0.00029067465,0.00015646702,0.00006763853,0.000205671,0.00037465422,0.00024959774],"category_scores_gemma":[0.00034450582,0.00046294185,0.00013226617,0.00043055112,0.00031185793,0.0002284491,0.00016456183,0.00070899946,0.00010925902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065611843,0.0012005556,0.051346872,0.0023532563,0.00082409906,0.0010056561,0.004516968,0.00040075483,0.6872133,0.007842126,0.004500888,0.23223436],"study_design_scores_gemma":[0.07726216,0.0064254096,0.6530685,0.0032792646,0.00043049364,0.0003818198,0.00062668434,0.008028521,0.21704009,0.01002778,0.021148382,0.0022808937],"about_ca_topic_score_codex":0.0022025905,"about_ca_topic_score_gemma":0.00045052345,"teacher_disagreement_score":0.60172164,"about_ca_system_score_codex":0.011708109,"about_ca_system_score_gemma":0.0019904533,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W1998284950","doi":"10.1038/leu.2008.194","title":"A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Cancer research; Apoptosis; Leukemia; Cell culture; Biology; Retinoic acid; Glutathione; Toxicity; Chemistry; Pharmacology; Immunology; Medicine; Biochemistry; Internal medicine; Enzyme; Genetics","score_opus":0.02835118201510681,"score_gpt":0.24335583206342196,"score_spread":0.21500465004831515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998284950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906606,0.0012517659,0.0065710233,0.00009218147,0.00013984577,0.00013486856,0.00001828556,0.00003690586,0.002689031],"genre_scores_gemma":[0.9932374,0.00054348516,0.0040072137,0.00020960579,0.00042771114,0.000014975864,0.000036989855,0.000040839717,0.0014817958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985014,0.00004545849,0.00024695814,0.00060277345,0.00022116353,0.00038223734],"domain_scores_gemma":[0.99920195,0.00003085628,0.00013119975,0.00039935295,0.00008216735,0.00015446698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001243726,0.00028284662,0.00027238036,0.00003877369,0.00028731354,0.000076974306,0.00023873434,0.0002880239,0.000021679913],"category_scores_gemma":[0.000113809976,0.00025923786,0.00011634063,0.00009895025,0.0003954661,0.000015233823,0.00021622986,0.00024452672,0.000014331564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019210143,0.00007391783,0.0013250904,0.000096156335,0.000023057586,0.000045042118,0.00008970312,0.000038375925,0.99580854,0.000018088516,0.0015933549,0.000696592],"study_design_scores_gemma":[0.0011560195,0.00018207541,0.003669247,0.00004098996,0.000027950719,0.00022241673,0.00004207482,0.00033320117,0.9668349,0.000032272015,0.027075728,0.00038311307],"about_ca_topic_score_codex":0.000086288346,"about_ca_topic_score_gemma":0.000011334126,"teacher_disagreement_score":0.02897361,"about_ca_system_score_codex":0.00006819983,"about_ca_system_score_gemma":0.0005625718,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W1998936478","doi":"10.1038/leu.2008.221","title":"Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Dasatinib; Medicine; Internal medicine; Chronic myelogenous leukemia; Imatinib; Neutropenia; Tolerability; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Oncology; Nilotinib; Immunology; Leukemia; Adverse effect; Chemotherapy","score_opus":0.015000299361486464,"score_gpt":0.26624099219016034,"score_spread":0.2512406928286739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998936478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654835,0.0004176753,0.000026405609,0.00005235849,0.00005498561,0.0016726393,0.000060486636,0.000056576035,0.0011105381],"genre_scores_gemma":[0.99745864,0.0003298521,0.0013587892,0.0001135329,0.0000663993,0.00008163855,0.00016473758,0.000074109616,0.00035229317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996794,0.00009828153,0.001093309,0.00070161227,0.00063069386,0.0006821089],"domain_scores_gemma":[0.998325,0.0003069254,0.0003356085,0.00067210663,0.00010511203,0.00025524854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002148243,0.0004891697,0.0010649961,0.00038864888,0.00008809961,0.000010634128,0.00018158878,0.00021413084,0.00023885039],"category_scores_gemma":[0.000200892,0.00035825215,0.00007489072,0.00080764305,0.0003555468,0.00017977887,0.00010135133,0.00053884386,0.000022003715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12025755,0.0050192093,0.75228655,0.0028653264,0.00079561496,0.0053088292,0.013355121,0.0029126836,0.01768565,0.000141764,0.0012172969,0.0781544],"study_design_scores_gemma":[0.14958778,0.0038462353,0.83684385,0.001881494,0.00011408244,0.00015072936,0.00011232001,0.0027114127,0.0033282342,0.000006775683,0.00095217035,0.00046493008],"about_ca_topic_score_codex":0.0015358563,"about_ca_topic_score_gemma":0.001423404,"teacher_disagreement_score":0.08455728,"about_ca_system_score_codex":0.012410152,"about_ca_system_score_gemma":0.0050938637,"threshold_uncertainty_score":0.99988693},"labels":[],"label_agreement":null},{"id":"W1999453504","doi":"10.1038/sj.leu.2402882","title":"Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Deutsche Krebshilfe","keywords":"Nod; Severe combined immunodeficiency; Progenitor cell; Leukemia; Myeloid leukemia; Bone marrow; Immunology; Biology; Stem cell; Myeloid; Granulocyte macrophage colony-stimulating factor; Transplantation; Cancer research; Medicine; Cytokine; Molecular biology; Internal medicine; In vivo","score_opus":0.015742832408852683,"score_gpt":0.26424608089777396,"score_spread":0.24850324848892127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999453504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955993,0.00025652596,0.00036172886,0.000055077417,0.00018700557,0.002966922,0.0001553422,0.00005760812,0.0003604841],"genre_scores_gemma":[0.99646354,0.00008236939,0.002454321,0.00010851819,0.000051890933,0.00020010551,0.0002870918,0.00009160244,0.0002605346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966101,0.00013456318,0.0012250945,0.0008439989,0.00041211952,0.00077411684],"domain_scores_gemma":[0.9987156,0.00019249717,0.0002847524,0.00040967303,0.00014578462,0.0002517159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058769557,0.0005290011,0.00093483576,0.0004414109,0.000131707,0.000033185246,0.00023585341,0.0003751884,0.000057452962],"category_scores_gemma":[0.00002722154,0.0005072291,0.00023717253,0.0004691696,0.00016779447,0.00011182909,0.0000247441,0.00043511775,0.0000116341225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025529158,0.00022881202,0.011449971,0.0013088877,0.00012327476,0.000031827796,0.004760456,0.000011042118,0.98152083,0.00020959649,0.00003800534,0.00006199365],"study_design_scores_gemma":[0.009057337,0.00063363,0.011245944,0.00038399093,0.0004252909,0.000043203177,0.0008938707,0.000119686716,0.97650546,0.00008750238,0.00015351214,0.0004505965],"about_ca_topic_score_codex":0.00062672823,"about_ca_topic_score_gemma":0.00060090976,"teacher_disagreement_score":0.008802046,"about_ca_system_score_codex":0.0016145292,"about_ca_system_score_gemma":0.00056767865,"threshold_uncertainty_score":0.9997379},"labels":[],"label_agreement":null},{"id":"W1999578399","doi":"10.1038/leu.2014.201","title":"The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing","year":2014,"lang":"en","type":"letter","venue":"Leukemia","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Universitair Medisch Centrum Groningen; KWF Kankerbestrijding","keywords":"Exome sequencing; Lymphoma; Exome; Hodgkin lymphoma; Biology; Computational biology; Genetics; Cancer research; Medicine; Mutation; Immunology; Gene","score_opus":0.007787918536682257,"score_gpt":0.21634826827356102,"score_spread":0.20856034973687876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999578399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87184924,0.013704691,0.0018484488,0.09876267,0.0024921077,0.00093456975,0.0023048325,0.0000511879,0.008052251],"genre_scores_gemma":[0.48178214,0.0018491641,0.0010965181,0.46282917,0.016561937,0.00017788424,0.015142738,0.00030138387,0.020259066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987349,0.000051742183,0.00034721504,0.00036618524,0.00019901422,0.00030095788],"domain_scores_gemma":[0.9988497,0.00018524863,0.00030366555,0.00049182214,0.00012585633,0.00004373504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013488374,0.00025993917,0.0002463849,0.00003484712,0.00009932422,0.000055370758,0.00040900352,0.0005813249,0.000010211454],"category_scores_gemma":[0.000100008474,0.000211624,0.00015992146,0.000051673524,0.000106829284,0.0000016374906,0.000111402784,0.00021180465,0.000016123722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023293589,0.0000043699506,0.00007565097,0.0000674908,0.00003823373,0.000017789436,0.000014807932,0.00012324876,0.083803765,0.0000026269036,0.9145993,0.0012294124],"study_design_scores_gemma":[0.00060438755,0.000120827426,0.00005308573,0.00002431756,0.000044032164,0.000025592806,0.0000112436455,0.00033997247,0.078269824,0.00007101788,0.9201732,0.00026246402],"about_ca_topic_score_codex":0.00008452477,"about_ca_topic_score_gemma":0.000034164314,"teacher_disagreement_score":0.39006713,"about_ca_system_score_codex":0.00012379533,"about_ca_system_score_gemma":0.0006722181,"threshold_uncertainty_score":0.8629777},"labels":[],"label_agreement":null},{"id":"W2000069677","doi":"10.1038/leu.2009.147","title":"Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Placebo; Multiple myeloma; Internal medicine; Gastroenterology; Refractory (planetary science); Phases of clinical research; Surgery; Clinical trial; Pathology","score_opus":0.04957727320909769,"score_gpt":0.3301043192462646,"score_spread":0.28052704603716694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000069677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970112,0.0002867045,0.00003831524,0.00022184639,0.00014435295,0.0018519972,0.00021051703,0.000036964324,0.00019811511],"genre_scores_gemma":[0.9978054,0.00013829922,0.00042044593,0.0003059165,0.00014662332,0.00004228795,0.00047924407,0.000039000144,0.00062276627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671495,0.00054218026,0.0008209063,0.00054862647,0.0008621254,0.00051120174],"domain_scores_gemma":[0.99600935,0.0024822906,0.00037454296,0.00070193666,0.0001316461,0.0003002284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008720608,0.00037596095,0.0012345512,0.00017103022,0.00009904275,0.000035533554,0.00019838412,0.00020075284,0.00017176752],"category_scores_gemma":[0.00230197,0.00020504811,0.00016010577,0.00024051941,0.00013724918,0.00015489358,0.000050737184,0.00050561276,0.000012601739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24067588,0.0018182136,0.64471257,0.00005963315,0.0007315143,0.00063969934,0.00088848814,0.000015489548,0.005571169,0.000018561548,0.0005741532,0.10429463],"study_design_scores_gemma":[0.19282138,0.0040634032,0.7981959,0.000484238,0.00017132093,0.0000034863267,0.000043238422,0.00016348,0.003727319,0.000026729309,0.00011029067,0.00018922254],"about_ca_topic_score_codex":0.0017848676,"about_ca_topic_score_gemma":0.0012390476,"teacher_disagreement_score":0.15348333,"about_ca_system_score_codex":0.000771089,"about_ca_system_score_gemma":0.00049515016,"threshold_uncertainty_score":0.8361619},"labels":[],"label_agreement":null},{"id":"W2000989756","doi":"10.1038/leu.2010.152","title":"Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; Intracellular; Receptor; Leukemia; Pathogenesis; Biology; Signal transduction; Cancer research; Immunology; Cell biology; Biochemistry","score_opus":0.009074870538864481,"score_gpt":0.2579788714183722,"score_spread":0.24890400087950773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000989756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322724,0.00014040721,0.00046768461,0.00009375084,0.00039840766,0.00028556676,0.00001223155,0.000049551025,0.0053251865],"genre_scores_gemma":[0.9920646,0.000095974996,0.00036890642,0.00021874093,0.0008770829,0.000057901892,0.0002820698,0.000035492692,0.005999207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986708,0.00004173781,0.00023580325,0.00040767883,0.00025263536,0.00039130176],"domain_scores_gemma":[0.9990826,0.000012587853,0.00008120123,0.00056280574,0.00010808501,0.00015267207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021222653,0.00018771125,0.00014381779,0.000077584526,0.00014614972,0.00006695954,0.00027860884,0.00028513483,0.00048248938],"category_scores_gemma":[0.00012860015,0.00017790499,0.00009918131,0.00013795079,0.000106753025,0.000011344541,0.000112321635,0.00028676068,0.00038561504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006934286,0.000004842751,0.000392733,0.00002132157,0.000018813053,0.000005514298,0.000023850434,0.00017478073,0.98701775,0.00020061558,0.001400095,0.010670367],"study_design_scores_gemma":[0.0016554398,0.00020678765,0.017338043,0.000014973013,0.000010341853,0.000057335594,0.000011136969,0.008046736,0.69258744,0.00009140206,0.279637,0.00034338247],"about_ca_topic_score_codex":0.00020232431,"about_ca_topic_score_gemma":0.0003359739,"teacher_disagreement_score":0.29443032,"about_ca_system_score_codex":0.001027223,"about_ca_system_score_gemma":0.0025034354,"threshold_uncertainty_score":0.72547555},"labels":[],"label_agreement":null},{"id":"W2002970935","doi":"10.1038/sj.leu.2405042","title":"The BCL-2 promoter (−938C&gt;A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancerfonden; Cancer Research Society","keywords":"IGHV@; Chronic lymphocytic leukemia; Genotype; Biology; CD38; Oncology; Internal medicine; Immunology; Gene; Leukemia; Genetics; Medicine; Stem cell","score_opus":0.03896092242002661,"score_gpt":0.3598508428679902,"score_spread":0.32088992044796355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002970935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541075,0.0015117057,0.00028791252,0.0011366913,0.0016110669,0.002081568,0.000019819621,0.0003741406,0.0075663733],"genre_scores_gemma":[0.97273684,0.00072497834,0.00040607675,0.0016235397,0.0024233907,0.00012322167,0.000036675632,0.00017248216,0.021752829],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9911512,0.00032982617,0.002729767,0.0013387053,0.0019427749,0.0025077132],"domain_scores_gemma":[0.99382925,0.00234812,0.00040664847,0.0023045596,0.00022164117,0.0008897579],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066276975,0.0007089057,0.0012358872,0.00043412464,0.00038423715,0.0001528746,0.0011478753,0.0008888385,0.00025429664],"category_scores_gemma":[0.0018263723,0.00043003887,0.0006019822,0.0009581634,0.0011823456,0.00026069727,0.00058979535,0.001888664,0.0009465076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.032680575,0.0010073341,0.2933979,0.0052687456,0.0033660568,0.031138439,0.0044410154,0.002215604,0.0640976,0.010596954,0.04447703,0.5073128],"study_design_scores_gemma":[0.1892179,0.003530007,0.33719328,0.002087454,0.0007614035,0.003937284,0.000624745,0.18079737,0.032700755,0.0012581444,0.2448909,0.003000782],"about_ca_topic_score_codex":0.003217946,"about_ca_topic_score_gemma":0.0022678624,"teacher_disagreement_score":0.504312,"about_ca_system_score_codex":0.3399936,"about_ca_system_score_gemma":0.07908624,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W2003724153","doi":"10.1038/leu.2013.54","title":"The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Samuel Waxman Cancer Research Foundation","keywords":"HMOX1; Cytoprotection; Arsenic trioxide; Heme oxygenase; Apoptosis; Cancer research; Chemistry; Cytotoxic T cell; Reactive oxygen species; Heme; Cytotoxicity; Pharmacology; Cell biology; Biology; Enzyme; Biochemistry; In vitro","score_opus":0.007554132731740544,"score_gpt":0.21683825888217007,"score_spread":0.20928412615042952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003724153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937882,0.0005386789,0.0016667253,0.00012476156,0.0004768611,0.0005222194,0.0000084137655,0.00003652187,0.0028376475],"genre_scores_gemma":[0.9952822,0.00047172236,0.00018208644,0.00026799485,0.00029114325,0.00018104806,0.00008160911,0.000044923272,0.0031972844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980409,0.00009384676,0.00044158232,0.0005700554,0.00028988198,0.0005637352],"domain_scores_gemma":[0.9989536,0.00005867308,0.00015449351,0.0006065706,0.00010347487,0.00012320696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003393429,0.00027057412,0.00020029613,0.000057924197,0.00020932053,0.00012409127,0.0005378676,0.00041034113,0.000047394078],"category_scores_gemma":[0.00019902916,0.00021985699,0.000111775036,0.00021811402,0.00019072302,0.000017020651,0.00019254506,0.0004578711,0.00025089204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048971055,0.00004600623,0.001064194,0.000020327323,0.000030400934,0.0000056858203,0.000030916723,0.00022574258,0.99290514,0.000033680688,0.001816842,0.0037721097],"study_design_scores_gemma":[0.0017054862,0.00020999226,0.00785514,0.000038737166,0.000019939078,0.00008347853,0.00018731462,0.0014579254,0.9607863,0.00043890398,0.026709294,0.0005075207],"about_ca_topic_score_codex":0.0005543462,"about_ca_topic_score_gemma":0.00013680183,"teacher_disagreement_score":0.032118853,"about_ca_system_score_codex":0.00037826304,"about_ca_system_score_gemma":0.00048185684,"threshold_uncertainty_score":0.8965508},"labels":[],"label_agreement":null},{"id":"W2004153775","doi":"10.1038/sj.leu.2401965","title":"Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994","year":2000,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Oncology; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Concomitant; Internal medicine; Chemotherapy; Pediatric oncology; Pediatrics; Disease; Leukemia; Cancer","score_opus":0.06882341099705908,"score_gpt":0.39277865687756974,"score_spread":0.32395524588051067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004153775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005362511,0.98240507,0.00004225358,0.00006591736,0.001119291,0.006488907,0.003622933,0.0002499057,0.0006431907],"genre_scores_gemma":[0.00040710613,0.9841327,0.0015492823,0.00014072952,0.0040999944,0.0025940605,0.0035627326,0.0004016217,0.0031117604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99019676,0.00054565765,0.003827831,0.0024738766,0.0011482983,0.001807567],"domain_scores_gemma":[0.9853547,0.009370309,0.00198755,0.002126578,0.0005133214,0.00064751715],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00060299074,0.002190086,0.0108481925,0.0012315386,0.00033822207,0.00004488758,0.0010192898,0.0018533544,0.00006760429],"category_scores_gemma":[0.0014102365,0.001542218,0.0023960294,0.0013145785,0.0008403601,0.00017389272,0.0006129314,0.0010388404,0.0002626742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002679225,0.0008173218,0.00006340705,0.029777404,0.027231283,0.0018827665,0.0021355536,0.000018902922,0.0000062214353,0.000028319626,0.01861013,0.9167495],"study_design_scores_gemma":[0.0565268,0.018950032,0.0004388814,0.03230068,0.09728663,0.0016769617,0.0005128747,0.000079679914,0.000036927097,0.00028057044,0.78928393,0.0026260396],"about_ca_topic_score_codex":0.00034460158,"about_ca_topic_score_gemma":0.0001515358,"teacher_disagreement_score":0.9141234,"about_ca_system_score_codex":0.0707388,"about_ca_system_score_gemma":0.023104044,"threshold_uncertainty_score":0.99944246},"labels":[],"label_agreement":null},{"id":"W2005559239","doi":"10.1038/leu.2014.299","title":"Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stem Cell Network","keywords":"Erg; CD34; Biology; Progenitor cell; Haematopoiesis; Cancer research; Stem cell; Leukemia; Myeloid; Myeloid leukemia; Molecular biology; Immunology; Cell biology","score_opus":0.008953837421727014,"score_gpt":0.2608036794394963,"score_spread":0.2518498420177693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005559239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975846,0.00086454843,0.000049894577,0.00014118577,0.000057205063,0.00079279265,0.000011419728,0.00004989913,0.00044848045],"genre_scores_gemma":[0.9956965,0.0001557397,0.003666293,0.000078523786,0.000090018664,0.000038189744,0.000043757416,0.000059783564,0.0001712373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975123,0.00020731425,0.0006471235,0.0005288103,0.00065900304,0.00044549766],"domain_scores_gemma":[0.9984127,0.00028403834,0.00026505202,0.00061725103,0.00021845274,0.00020245084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005089459,0.00030347786,0.00074525655,0.00039393074,0.00004192313,0.0000121712355,0.00023263456,0.00042742395,0.000048177448],"category_scores_gemma":[0.00072573166,0.00024847154,0.000109707005,0.0004583304,0.0002692732,0.00012261493,0.00022847908,0.00062717433,0.0000037005404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009039496,0.00015703296,0.013011921,0.00076508755,0.00008325159,0.00006665131,0.00036855997,0.00011882295,0.97630316,0.0006073936,0.00031597016,0.0072981757],"study_design_scores_gemma":[0.0049781753,0.0012454739,0.036448833,0.0013249826,0.00010318376,0.0000554749,0.00009793821,0.0018690622,0.95234245,0.0011663431,0.00013531091,0.00023276886],"about_ca_topic_score_codex":0.0010906268,"about_ca_topic_score_gemma":0.000017179269,"teacher_disagreement_score":0.02396073,"about_ca_system_score_codex":0.0003448072,"about_ca_system_score_gemma":0.00060484034,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W2006233042","doi":"10.1038/sj.leu.2403717","title":"Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Lysosome; Cathepsin B; Cathepsin; Programmed cell death; Apoptosis; Biology; Mitochondrial permeability transition pore; Mitochondrion; Caspase; Cathepsin D; Caspase 2; Caspase 8; Mitochondrial apoptosis-induced channel; Cytochrome c; Biochemistry","score_opus":0.007911096800070235,"score_gpt":0.21747526462552488,"score_spread":0.20956416782545464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006233042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938173,0.000040633724,0.0055357167,0.00010284596,0.00012262838,0.00018783304,0.0000041386115,0.0000071395407,0.00018175124],"genre_scores_gemma":[0.99777234,0.00004509734,0.0015470256,0.000060374015,0.0001827388,0.000013319909,0.000051388044,0.000015527214,0.00031221294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992462,0.000036115183,0.00019121265,0.000280492,0.000109869405,0.00013613976],"domain_scores_gemma":[0.99965787,0.00001019624,0.00008640616,0.00016526828,0.000031428473,0.000048803264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000908614,0.00012304341,0.00012982645,0.00007147123,0.000049773756,0.000015957057,0.000048412167,0.00020063453,0.000012976546],"category_scores_gemma":[0.000023579685,0.000118827666,0.000030155506,0.000059989376,0.000024112,0.000012195074,0.000057677542,0.00007318204,0.000001137202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089788344,0.000024090941,0.000079940604,0.000015345633,0.000012690581,4.4381522e-7,0.000088571986,0.00010643411,0.99289185,0.0008288349,0.000023212251,0.005838813],"study_design_scores_gemma":[0.0012101872,0.0001774759,0.0035403087,0.000017623977,0.000016213959,0.0000063038055,0.000104932704,0.0006479405,0.9933688,0.0005821271,0.0001936516,0.00013445407],"about_ca_topic_score_codex":0.00018759417,"about_ca_topic_score_gemma":0.00022640101,"teacher_disagreement_score":0.0057043587,"about_ca_system_score_codex":0.00005933863,"about_ca_system_score_gemma":0.000054019623,"threshold_uncertainty_score":0.48456517},"labels":[],"label_agreement":null},{"id":"W2006474544","doi":"10.1038/leu.2008.341","title":"A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Induction therapy; Medicine; Leukemia; Internal medicine; Oncology; Induction chemotherapy; Myeloid; Cancer research; Immunology; Chemotherapy","score_opus":0.01980105232891731,"score_gpt":0.28967510237767397,"score_spread":0.26987405004875664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006474544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600506,0.000063786836,0.000108078086,0.000034776196,0.00002747641,0.0036115495,0.000048882397,0.00005313765,0.000047256795],"genre_scores_gemma":[0.998,0.00018419795,0.00058675325,0.000098191194,0.000045275905,0.00020571172,0.0004564206,0.0000526322,0.00037080955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982966,0.00009559467,0.00034193462,0.00045544034,0.0005088688,0.00030153984],"domain_scores_gemma":[0.9988764,0.00011293236,0.00023248774,0.00028543198,0.000318362,0.00017438503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001861252,0.00025370877,0.00049039675,0.00022245523,0.0001644206,0.000021979225,0.000074681775,0.00013188442,0.00004091226],"category_scores_gemma":[0.000038656795,0.00018963731,0.000036609403,0.00032275458,0.00033218917,0.00021501804,0.000036371322,0.00028846023,0.0000015777302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12387323,0.0054878495,0.8119162,0.00036823575,0.00417187,0.000645604,0.011030651,0.000055378143,0.017431676,0.000076707904,0.0039575603,0.020985052],"study_design_scores_gemma":[0.15083799,0.024904612,0.8207044,0.000112251175,0.00033086157,0.00013481216,0.00034391382,0.00055553945,0.0015843159,0.00001618503,0.00022540952,0.00024969602],"about_ca_topic_score_codex":0.0002538806,"about_ca_topic_score_gemma":0.000036716134,"teacher_disagreement_score":0.026964758,"about_ca_system_score_codex":0.00064397906,"about_ca_system_score_gemma":0.0008704474,"threshold_uncertainty_score":0.7733185},"labels":[],"label_agreement":null},{"id":"W2007419319","doi":"10.1038/sj.leu.2404251","title":"Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal","year":2006,"lang":"en","type":"article","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"University of Melbourne","keywords":"Telomerase reverse transcriptase; Telomerase; Biology; Haematopoiesis; CD34; Cord blood; Cytokine; Telomere; Progenitor cell; Cancer research; Autocrine signalling; Leukemia; Immunology; Stem cell; Cell biology; Cell culture; Genetics; Gene","score_opus":0.012187975095093135,"score_gpt":0.23713587791475882,"score_spread":0.22494790281966567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007419319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646115,0.0008053769,0.00007454291,0.00034423984,0.00018271283,0.0013447982,0.00016906067,0.00025328176,0.00036481261],"genre_scores_gemma":[0.99573493,0.00003295951,0.0014728125,0.00063587644,0.00044046144,0.00011630592,0.00018762673,0.00008115838,0.0012978613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972542,0.00008803127,0.0005921957,0.00083792594,0.0005671965,0.000660428],"domain_scores_gemma":[0.998629,0.00004525484,0.0001743048,0.0006335856,0.0001024941,0.00041541262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015677296,0.0005050257,0.0006677771,0.00014962618,0.00028596804,0.00007885006,0.00020694532,0.00029712086,0.00015025021],"category_scores_gemma":[0.00003873228,0.00045812954,0.00012742716,0.00035148446,0.00021372184,0.00021489922,0.000048269816,0.0005872135,0.000062303574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002040098,0.00024482474,0.0067636557,0.00025070013,0.000047428777,0.00040251794,0.00047662636,0.0000011730534,0.9836063,0.000072265284,0.007045528,0.0008850071],"study_design_scores_gemma":[0.0051056626,0.0005346693,0.021364624,0.00048762438,0.00023256286,0.00014803857,0.00027415276,0.000089244786,0.96386373,0.00026032637,0.006894286,0.0007450947],"about_ca_topic_score_codex":0.006103559,"about_ca_topic_score_gemma":0.0001412481,"teacher_disagreement_score":0.019742548,"about_ca_system_score_codex":0.0003558951,"about_ca_system_score_gemma":0.00031466858,"threshold_uncertainty_score":0.99978703},"labels":[],"label_agreement":null},{"id":"W2007928660","doi":"10.1038/sj.leu.2403464","title":"Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a ‘small-cell variant’ of ALCL","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; CD43; Lymphoma; Cancer research; Cell culture; Biology; Immunophenotyping; CD8; Large cell; Cell; CD5; Anaplastic lymphoma kinase; Antigen; Pathology; Immunology; CD20; Medicine; Cancer; Genetics; Adenocarcinoma","score_opus":0.017347393300795187,"score_gpt":0.23909509657034667,"score_spread":0.22174770326955148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007928660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874069,0.0016141284,0.0022064028,0.0001582009,0.00021284413,0.0007566162,0.00043016844,0.000051928313,0.007162821],"genre_scores_gemma":[0.98847514,0.00033864134,0.009706016,0.00040470067,0.00013557544,0.00007087094,0.00026468973,0.0000534442,0.0005509468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977867,0.00002638947,0.00071357936,0.0005271326,0.000458786,0.0004874304],"domain_scores_gemma":[0.9982233,0.00022573749,0.0003779803,0.00071679265,0.00016678024,0.00028939242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014706339,0.000368259,0.00077188946,0.00017115017,0.00005058666,0.00001490565,0.00021069283,0.0002234424,0.00016580318],"category_scores_gemma":[0.00005168385,0.00030949156,0.00027137308,0.00034889727,0.00006859689,0.0000757001,0.00012513026,0.00010681237,0.000077888944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00811295,0.23528413,0.09458467,0.005648292,0.002689126,0.0057137655,0.010232742,0.014477866,0.58726406,0.0042161057,0.01228816,0.019488104],"study_design_scores_gemma":[0.13602644,0.0025429232,0.029001717,0.00091048505,0.0014757813,0.00005987516,0.00034799342,0.0019882643,0.8222291,0.00020645406,0.0046830317,0.0005279691],"about_ca_topic_score_codex":0.003823068,"about_ca_topic_score_gemma":0.00019601673,"teacher_disagreement_score":0.23496498,"about_ca_system_score_codex":0.0012444648,"about_ca_system_score_gemma":0.0012080141,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W2009036226","doi":"10.1038/leu.2012.123","title":"Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Cumulative incidence; Minimal residual disease; Internal medicine; Hazard ratio; Transplantation; Oncology; Incidence (geometry); Gastroenterology; Acute leukemia; Leukemia; Confidence interval","score_opus":0.012600167359528113,"score_gpt":0.30422506382761116,"score_spread":0.29162489646808304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009036226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940416,0.0003301465,0.0024160235,0.00005500422,0.00010102609,0.0013866614,0.0013402713,0.00008967763,0.00023957081],"genre_scores_gemma":[0.99456465,0.0002406723,0.0023776675,0.00011910689,0.00045825526,0.00028218527,0.0014897243,0.0001122357,0.00035551668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956088,0.0002172179,0.0010629911,0.00081492617,0.0010102497,0.0012858071],"domain_scores_gemma":[0.9968216,0.000436823,0.00026948535,0.00088749925,0.00023708075,0.0013475186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058804016,0.00059090764,0.0010764527,0.0009941094,0.00009883893,0.000038352613,0.0003726973,0.00036476023,0.0003800386],"category_scores_gemma":[0.00023123,0.00048773433,0.00070696516,0.0014713391,0.00019539396,0.0005578564,0.000052010826,0.00042756234,0.00002262952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06291592,0.0014479383,0.89856905,0.0013028895,0.004358392,0.0014223311,0.0037587266,0.0019900568,0.021640314,0.0000455242,0.0006199033,0.0019289706],"study_design_scores_gemma":[0.0130103715,0.0021812946,0.96106225,0.0003951417,0.0098181255,0.00032934593,0.000060743005,0.010002956,0.0025752017,0.00003111237,0.000035506288,0.00049793505],"about_ca_topic_score_codex":0.00045253706,"about_ca_topic_score_gemma":0.000061502134,"teacher_disagreement_score":0.06249323,"about_ca_system_score_codex":0.0036566476,"about_ca_system_score_gemma":0.004914438,"threshold_uncertainty_score":0.9997574},"labels":[],"label_agreement":null},{"id":"W2010241557","doi":"10.1038/sj.leu.2403661","title":"Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Lymphoma Research Foundation","keywords":"Chromosomal translocation; Follicular lymphoma; Lymphoma; Biology; Immunoglobulin heavy chain; Gene rearrangement; Karyotype; Cytogenetics; Cancer research; Fusion gene; Immunology; Antibody; Chromosome; Genetics; Gene","score_opus":0.013295007816813257,"score_gpt":0.25425943796400846,"score_spread":0.2409644301471952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010241557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319375,0.003926717,0.00027348782,0.0006006193,0.000038240752,0.00050829945,0.000006490012,0.000037228237,0.0014151694],"genre_scores_gemma":[0.9977388,0.000319202,0.001137873,0.000108054555,0.00011558577,0.00002949012,0.00002783695,0.000032903346,0.00049026415],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983507,0.000051832933,0.00041830388,0.0003409232,0.00045659512,0.00038166065],"domain_scores_gemma":[0.99919695,0.00011188228,0.00009934922,0.0003586492,0.00008588499,0.00014729406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002180837,0.00019432236,0.00041251633,0.00017295833,0.00002930865,0.000015815624,0.00011917969,0.00013903542,0.00006958308],"category_scores_gemma":[0.000027939654,0.00016012316,0.000045189932,0.0003746068,0.00023929072,0.00010583636,0.000035888035,0.00020854523,0.000026305746],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0035344397,0.0038441785,0.008225524,0.0032260064,0.00034025317,0.0007136081,0.011011142,0.0039366814,0.44783795,0.0024198024,0.0020925512,0.51281786],"study_design_scores_gemma":[0.18495022,0.0023723652,0.010580117,0.0017212504,0.00021306492,0.0009509637,0.0007483748,0.032936502,0.75495595,0.00014379519,0.009694686,0.0007326947],"about_ca_topic_score_codex":0.0024723439,"about_ca_topic_score_gemma":0.0004156432,"teacher_disagreement_score":0.51208514,"about_ca_system_score_codex":0.013528404,"about_ca_system_score_gemma":0.005704669,"threshold_uncertainty_score":0.99993205},"labels":[],"label_agreement":null},{"id":"W2010305809","doi":"10.1038/sj.leu.2401779","title":"Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health","keywords":"CD22; Immunotoxin; Propidium iodide; CD19; Cytotoxicity; B cell; Monoclonal antibody; Cancer research; Antigen; Cytotoxic T cell; CD33; Fluorescein isothiocyanate; Saporin; Acute lymphocytic leukemia; Molecular biology; Medicine; Immunology; Antibody; Chemistry; In vitro; Leukemia; Biology; Apoptosis; CD34; Lymphoblastic Leukemia; Stem cell; Biochemistry; Programmed cell death","score_opus":0.004229346843111661,"score_gpt":0.20204435452104508,"score_spread":0.19781500767793342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010305809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438643,0.0023812545,0.000063696054,0.000035898578,0.0006094615,0.0008889697,0.00010539927,0.00010668742,0.0014221893],"genre_scores_gemma":[0.9949635,0.0013091567,0.00021959134,0.00040578286,0.000039291506,0.00018738971,0.00008416393,0.000065165426,0.002725922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724704,0.0003469548,0.0006245492,0.0007662974,0.00007563704,0.0009395482],"domain_scores_gemma":[0.99893713,0.00031174353,0.00017274992,0.0004931581,0.000031467946,0.000053748463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035867837,0.00050263735,0.0007474276,0.00034468484,0.0001927921,0.00005120275,0.00038509927,0.00066327077,0.00035251377],"category_scores_gemma":[0.000042292424,0.0004958228,0.00013531963,0.00042447107,0.00021862652,0.00026969338,0.00013194971,0.0009205079,0.0007445575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009552467,0.000091032016,0.00053420133,0.000035707835,0.000120086996,0.00015214147,0.0011844654,0.0005167406,0.9613003,0.000041874973,0.00013625252,0.03493195],"study_design_scores_gemma":[0.009628557,0.00035357822,0.026935393,0.0005259604,0.000079829326,0.00014580866,0.0005608439,0.0008862114,0.95181304,0.00034521346,0.0077312463,0.0009943356],"about_ca_topic_score_codex":0.0005328137,"about_ca_topic_score_gemma":0.0001533725,"teacher_disagreement_score":0.033937614,"about_ca_system_score_codex":0.0016295923,"about_ca_system_score_gemma":0.00025153128,"threshold_uncertainty_score":0.99974936},"labels":[],"label_agreement":null},{"id":"W2011521348","doi":"10.1038/sj.leu.2402870","title":"Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Armand-Frappier Foundation","keywords":"Lymphoma; Biology; Cancer research; Transcriptome; Downregulation and upregulation; Phenotype; Gene expression; Gene; BCL10; Cell culture; Immunology; Genetics","score_opus":0.010671000404705032,"score_gpt":0.2423387516149195,"score_spread":0.23166775121021446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011521348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686,0.0008676983,0.000029058938,0.00002550656,0.00024323659,0.00019984752,0.000010628917,0.000033601795,0.0017303809],"genre_scores_gemma":[0.9990234,0.000025860663,0.000115113544,0.00009431628,0.000011436939,0.000020749067,0.000071645576,0.000015661739,0.0006218491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988964,0.0002494078,0.0002391324,0.00028775184,0.00003804666,0.00028922077],"domain_scores_gemma":[0.9993231,0.000048283047,0.00032435593,0.00019605638,0.000089055575,0.000019095796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015837583,0.00015178528,0.00027732766,0.000088275774,0.000058440193,0.000004847542,0.000108458014,0.00029869276,0.00039245322],"category_scores_gemma":[0.000055180255,0.00011928884,0.000035598485,0.00023898449,0.00013073547,0.000060361785,0.000019195299,0.00013513178,0.000019246021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011114399,0.00056372443,0.09507354,0.00004748434,0.00022922298,0.000033229535,0.00313118,0.0001381926,0.85937744,0.0006732721,0.0010952605,0.038526013],"study_design_scores_gemma":[0.004274496,0.0010880871,0.16542004,0.00017414345,0.00003567572,0.000042747535,0.0002065016,0.000022691884,0.8261112,0.00033066358,0.0020516198,0.00024214547],"about_ca_topic_score_codex":0.000197991,"about_ca_topic_score_gemma":0.00025341156,"teacher_disagreement_score":0.07034649,"about_ca_system_score_codex":0.0002448439,"about_ca_system_score_gemma":0.00024234965,"threshold_uncertainty_score":0.48644575},"labels":[],"label_agreement":null},{"id":"W2012153991","doi":"10.1038/sj.leu.2404609","title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":358,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"CD38; Imatinib mesylate; Myeloid leukemia; Stem cell; Haematopoiesis; Cancer research; Biology; CD34; Myeloid; breakpoint cluster region; Leukemia; Imatinib; Immunology; Cell biology; Receptor; Genetics","score_opus":0.012187320014432932,"score_gpt":0.25831486054924735,"score_spread":0.24612754053481442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012153991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806381,0.007542918,0.00081501034,0.00041414416,0.00051781913,0.0017847143,0.00009549234,0.00034398562,0.0078478055],"genre_scores_gemma":[0.9699125,0.00030801893,0.006044204,0.0006018627,0.0004496383,0.000073974785,0.00007819103,0.0001489406,0.02238264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99600255,0.000114863615,0.00094598916,0.00089743384,0.000900808,0.0011383329],"domain_scores_gemma":[0.9968264,0.0005161409,0.00037743527,0.0014054901,0.00033938608,0.00053511886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007028898,0.0006517421,0.0010232087,0.00039374077,0.000174016,0.000041323743,0.00054901355,0.00047202758,0.00020447212],"category_scores_gemma":[0.00010274552,0.0005784337,0.0003080234,0.00094192766,0.00022664422,0.00017593878,0.00022327233,0.00069915113,0.00014317056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026513906,0.00018428404,0.0069752033,0.0011132674,0.00078362576,0.0006361609,0.0034756889,0.00054780196,0.92557526,0.00065558474,0.022189304,0.035212435],"study_design_scores_gemma":[0.007052118,0.00062307925,0.060014635,0.0007790599,0.00017806645,0.00006704868,0.0006852782,0.00006251096,0.8931037,0.000102897335,0.036739282,0.0005923291],"about_ca_topic_score_codex":0.0010237314,"about_ca_topic_score_gemma":0.0021015422,"teacher_disagreement_score":0.05303943,"about_ca_system_score_codex":0.016331285,"about_ca_system_score_gemma":0.0035656355,"threshold_uncertainty_score":0.9996667},"labels":[],"label_agreement":null},{"id":"W2012680794","doi":"10.1038/leu.2014.218","title":"A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"CTD; Medicine; Cyclophosphamide; Thalidomide; Internal medicine; Dexamethasone; AL amyloidosis; Bortezomib; Oncology; Multiple myeloma; Gastroenterology; Surgery; Chemotherapy; Immunology","score_opus":0.013595133730268123,"score_gpt":0.2777912198010993,"score_spread":0.26419608607083117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012680794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98998666,0.007776753,0.0005006691,0.000241902,0.00024293872,0.0005621818,0.00007183542,0.00004906539,0.0005679844],"genre_scores_gemma":[0.9866209,0.005193793,0.0073200217,0.00034484145,0.00007612916,0.00013505487,0.00011032492,0.000092104914,0.000106802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966818,0.00034316265,0.0008950905,0.0010617797,0.0003391474,0.0006789862],"domain_scores_gemma":[0.99748135,0.0006632612,0.0006228705,0.00083054416,0.00010173846,0.00030023613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006606267,0.00061839144,0.0011315643,0.00018005645,0.0001299569,0.00005326114,0.00033220358,0.00049788953,0.000032741835],"category_scores_gemma":[0.0010087767,0.00061489403,0.00017884182,0.0003574893,0.00039553264,0.000025863224,0.00036206056,0.0003831623,0.00001111423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018464599,0.0002653644,0.9207545,0.000082403865,0.00043762143,0.000011295795,0.00038259986,0.0003155061,0.048772812,0.00012721278,0.0009736598,0.026030548],"study_design_scores_gemma":[0.016849129,0.0012758435,0.68666375,0.00013167309,0.0004169027,0.000019134022,0.0006925631,0.0018158859,0.28546265,0.00022113211,0.005420733,0.0010306294],"about_ca_topic_score_codex":0.0026453428,"about_ca_topic_score_gemma":0.0012282869,"teacher_disagreement_score":0.23668982,"about_ca_system_score_codex":0.00019932262,"about_ca_system_score_gemma":0.00015297135,"threshold_uncertainty_score":0.9996302},"labels":[],"label_agreement":null},{"id":"W2012876387","doi":"10.1038/leu.2012.329","title":"PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; York University; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; CD5; Peroxisome proliferator-activated receptor; Downregulation and upregulation; Biology; Lipoprotein lipase; Cancer research; Peroxisome proliferator-activated receptor alpha; Internal medicine; Endocrinology; Receptor; Leukemia; Nuclear receptor; Immunology; Adipose tissue; Antibody; Medicine; Transcription factor; Biochemistry","score_opus":0.03439344377669197,"score_gpt":0.3255027107052507,"score_spread":0.29110926692855876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012876387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272289,0.030389339,0.0073912092,0.0009065493,0.0020527178,0.0053376774,0.00012843598,0.0009873757,0.025577776],"genre_scores_gemma":[0.9737119,0.00032737944,0.0026144406,0.003306426,0.0028392917,0.00056291104,0.00012004338,0.00021603658,0.016301576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951878,0.000087525805,0.000707647,0.00076254643,0.0009869284,0.0022675053],"domain_scores_gemma":[0.9968123,0.0004842683,0.0001856436,0.0013703726,0.0002463011,0.0009011526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00084726483,0.0005906568,0.00087146065,0.0002843724,0.0002778729,0.000074423726,0.00050308957,0.00050311926,0.0016498496],"category_scores_gemma":[0.00024200042,0.00051283895,0.0005175643,0.0006185614,0.00031256783,0.0003795462,0.00019293981,0.00050210964,0.0016180851],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010054686,0.0008309858,0.009482462,0.012782711,0.0059567653,0.0006450239,0.014117161,0.0026332678,0.10530777,0.022050083,0.62177706,0.19436201],"study_design_scores_gemma":[0.062305514,0.0016381635,0.0015741859,0.00045099997,0.0007057678,0.0015380725,0.00026346988,0.18365951,0.10313126,0.001477309,0.6419689,0.0012868445],"about_ca_topic_score_codex":0.0007998658,"about_ca_topic_score_gemma":0.000015103499,"teacher_disagreement_score":0.25305963,"about_ca_system_score_codex":0.32634827,"about_ca_system_score_gemma":0.07328864,"threshold_uncertainty_score":0.9997323},"labels":[],"label_agreement":null},{"id":"W2013169247","doi":"10.1038/leu.2014.191","title":"Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Work flow; Flow cytometry; Myeloid; Working group; Medical physics; Family medicine; Pathology; Internal medicine; Immunology; Bone marrow; Computer science","score_opus":0.07863022784703433,"score_gpt":0.34813966630218435,"score_spread":0.26950943845515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013169247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8214515,0.00036076832,0.16056144,0.010949243,0.0005925817,0.0029937904,0.00036863596,0.00006628299,0.0026557478],"genre_scores_gemma":[0.9534623,0.00009956436,0.043106303,0.00064508256,0.0011552791,0.00013777861,0.0011848288,0.00006482477,0.00014402682],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996099,0.00048408803,0.0016308088,0.00057499856,0.0007959662,0.00041516448],"domain_scores_gemma":[0.9935047,0.004378747,0.00060970994,0.000784219,0.0006575303,0.00006509498],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006913272,0.00028251807,0.0005998825,0.00061914284,0.00009440696,0.00006961719,0.00094089494,0.0001982198,0.000010531791],"category_scores_gemma":[0.015533954,0.00018505815,0.00019358132,0.00119449,0.0001596987,0.00016678528,0.00013759338,0.0006491022,0.000006664783],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008635173,0.00027343747,0.03597372,0.0012093281,0.00043423517,0.00004743236,0.00672272,0.004797641,0.1991791,0.00513502,0.035920624,0.7016716],"study_design_scores_gemma":[0.008249494,0.0004089417,0.17409462,0.0030839525,0.00012161001,0.000034889123,0.0022133687,0.80166245,0.0026804043,0.00063192676,0.0065491125,0.00026921372],"about_ca_topic_score_codex":0.0003927064,"about_ca_topic_score_gemma":0.00024347598,"teacher_disagreement_score":0.7968648,"about_ca_system_score_codex":0.0013729698,"about_ca_system_score_gemma":0.0004541507,"threshold_uncertainty_score":0.99275863},"labels":[],"label_agreement":null},{"id":"W2013658560","doi":"10.1038/leu.2013.151","title":"Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institutes of Health; Medical College of Wisconsin; National Heart, Lung, and Blood Institute; Sundhed og Sygdom, Det Frie Forskningsråd; Leukemia and Lymphoma Society","keywords":"Progenitor cell; Chronic myelogenous leukemia; Cancer research; Haematopoiesis; Bcl-xL; Bone marrow; Biology; Stem cell; CD34; Apoptosis; Stromal cell; Leukemia; Immunology; Medicine; Programmed cell death; Cell biology; Genetics","score_opus":0.03132524855511329,"score_gpt":0.3029187906383001,"score_spread":0.27159354208318676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013658560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692618,0.0077915923,0.0061408374,0.006740231,0.0003764195,0.008980413,0.00010522413,0.000127069,0.00047637298],"genre_scores_gemma":[0.9043563,0.00047555382,0.057080936,0.0020138181,0.000393607,0.001105716,0.000203195,0.00012721929,0.034243643],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975355,0.00002731941,0.00060245005,0.0007044731,0.0003670437,0.00076321047],"domain_scores_gemma":[0.99819225,0.00015708659,0.00030044775,0.0006702551,0.00020586234,0.00047412014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001730168,0.00036885316,0.0006607531,0.0000576466,0.00016461789,0.000043957618,0.00018122297,0.0001604787,0.00031531695],"category_scores_gemma":[0.00010118856,0.00028455397,0.00017012031,0.0001729347,0.000107118685,0.00019370108,0.000112103495,0.00012549908,0.000041203988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003543362,0.0005896509,0.13270995,0.004476577,0.0015174715,0.00005133013,0.002994613,0.00012112735,0.004824227,0.0003366056,0.71857905,0.130256],"study_design_scores_gemma":[0.08215688,0.002354818,0.18109725,0.014607656,0.0023067633,0.00010596234,0.00082372985,0.07841592,0.06276251,0.0178089,0.5550156,0.0025440047],"about_ca_topic_score_codex":0.0001984363,"about_ca_topic_score_gemma":0.000011922101,"teacher_disagreement_score":0.16356348,"about_ca_system_score_codex":0.0011044954,"about_ca_system_score_gemma":0.0017104198,"threshold_uncertainty_score":0.99996066},"labels":[],"label_agreement":null},{"id":"W2013768460","doi":"10.1038/leu.2008.321","title":"Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia","year":2008,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Ligue Contre le Cancer; Canadian Institutes of Health Research; Fondation de France; Association pour la Recherche sur le Cancer","keywords":"Chronic lymphocytic leukemia; Programmed cell death; Leukemia; Apoptosis; Caspase; Cancer research; Immunology; Medicine; Hematology; Biology; Genetics","score_opus":0.033716042398247985,"score_gpt":0.29016451868140697,"score_spread":0.256448476283159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013768460","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81724304,0.012559001,0.0009412097,0.07421347,0.0053081387,0.014779719,0.00031179996,0.0019635165,0.072680086],"genre_scores_gemma":[0.1916267,0.00389647,0.0023352266,0.4342543,0.02217321,0.00049479783,0.002246537,0.0015887032,0.34138405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98841864,0.00027439912,0.0017785361,0.0027387748,0.0032778042,0.003511867],"domain_scores_gemma":[0.99390787,0.00043836414,0.0004246211,0.0034316008,0.00038349946,0.0014140668],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.000535066,0.0017503026,0.0026368736,0.0017591855,0.00021868838,0.00014649444,0.0015944397,0.0033251517,0.0011902249],"category_scores_gemma":[0.00029155766,0.0017118226,0.0006869029,0.0019834598,0.00021817017,0.00021969475,0.0008591558,0.005828365,0.0053054197],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00078476185,0.000027062199,0.00005319971,0.0013475067,0.0002647108,0.04799789,0.0008720594,0.018904971,0.0010796753,0.000011596397,0.9276118,0.0010447286],"study_design_scores_gemma":[0.060150824,0.0015164872,0.0003335002,0.0025038265,0.0005542624,0.006606633,0.000048186295,0.08667693,0.004465827,0.00013123664,0.8344781,0.00253421],"about_ca_topic_score_codex":0.071364775,"about_ca_topic_score_gemma":0.0019946601,"teacher_disagreement_score":0.6256164,"about_ca_system_score_codex":0.7069571,"about_ca_system_score_gemma":0.36536542,"threshold_uncertainty_score":0.99972284},"labels":[],"label_agreement":null},{"id":"W2014050718","doi":"10.1038/leu.2008.175","title":"BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Lymphoma Research Foundation","keywords":"Bortezomib; Chronic lymphocytic leukemia; Proteasome inhibitor; MAPK/ERK pathway; Kinase; Biology; Cancer research; Phosphorylation; Apoptosis; Leukemia; Pharmacology; Biochemistry; Immunology","score_opus":0.020814705753791504,"score_gpt":0.2719792681412461,"score_spread":0.2511645623874546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014050718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508464,0.001301033,0.00030574307,0.00032633895,0.0002429049,0.0015954113,0.00001115092,0.00013991691,0.0009928776],"genre_scores_gemma":[0.99602115,0.0006476984,0.00029123767,0.00035313208,0.00040484752,0.00014334606,0.000037403515,0.000094792165,0.0020063948],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99636114,0.00025227296,0.0006333671,0.0009552087,0.0008825375,0.00091545295],"domain_scores_gemma":[0.9976622,0.0006868942,0.00019399052,0.00081195455,0.00023848496,0.0004064716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007096534,0.0005048888,0.0006995095,0.00038496303,0.00031541503,0.00008293988,0.000212199,0.0002693235,0.00007675313],"category_scores_gemma":[0.00035815814,0.000367259,0.00010308634,0.0010469453,0.00035370231,0.0003249564,0.00018820078,0.000680356,0.00032933927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006069897,0.00015757006,0.0012512307,0.0013704614,0.00061178854,0.0064162277,0.007964662,0.4231298,0.5255128,0.0002772426,0.008660029,0.01857827],"study_design_scores_gemma":[0.013525014,0.0007624038,0.008776033,0.000963587,0.00018508249,0.0028509318,0.00037722447,0.7145397,0.25542793,0.000027048869,0.0019530484,0.0006119665],"about_ca_topic_score_codex":0.0071445205,"about_ca_topic_score_gemma":0.0011662012,"teacher_disagreement_score":0.29140994,"about_ca_system_score_codex":0.16809429,"about_ca_system_score_gemma":0.029660724,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W2015003025","doi":"10.1038/leu.2009.26","title":"Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Dexamethasone; Cyclophosphamide; Bortezomib; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Gastroenterology; Surgery; Toxicity; Phases of clinical research; Chemotherapy","score_opus":0.060046710051175414,"score_gpt":0.39750959534053243,"score_spread":0.33746288528935703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015003025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945288,0.00041869018,0.00016058848,0.0014277702,0.00026353198,0.0030551204,0.000036599333,0.00007353099,0.000035381676],"genre_scores_gemma":[0.992181,0.00027013101,0.0057793376,0.00038428683,0.00042416656,0.00029689513,0.00013967669,0.000028565397,0.0004959198],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9975767,0.00029799898,0.00071593333,0.00058734405,0.00029031013,0.0005316758],"domain_scores_gemma":[0.9969276,0.002039902,0.0001456929,0.00037223808,0.000103987215,0.00041054134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013644476,0.00025636298,0.0006688042,0.00023577298,0.0001605526,0.000034518678,0.00009053325,0.00029278887,0.0000309156],"category_scores_gemma":[0.0067219855,0.00021627579,0.000150249,0.0003245208,0.00012061626,0.00016344419,0.000043020606,0.00041293073,0.0000106502075],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6140288,0.002409073,0.021756379,0.000025959744,0.00011032696,0.00055925624,0.00021445265,0.000005900174,0.0054670284,0.000029232737,0.0010855163,0.35430804],"study_design_scores_gemma":[0.48272493,0.01652889,0.4913576,0.0000866316,0.000080816775,0.000027559214,0.00006739226,0.0019826626,0.0047646854,0.00030612785,0.0018723704,0.00020032153],"about_ca_topic_score_codex":0.00042429386,"about_ca_topic_score_gemma":0.00009663782,"teacher_disagreement_score":0.46960124,"about_ca_system_score_codex":0.00045103004,"about_ca_system_score_gemma":0.00058557926,"threshold_uncertainty_score":0.8819471},"labels":[],"label_agreement":null},{"id":"W2015678735","doi":"10.1038/leu.2013.337","title":"The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases","year":2013,"lang":"en","type":"review","venue":"Leukemia","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":283,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Biology; Haematopoiesis; Myeloid; Chromosomal translocation; Lymphopoiesis; Stem cell; Molecular biology; Cancer research; Gene; Genetics","score_opus":0.017913439294793443,"score_gpt":0.28529608873008044,"score_spread":0.267382649435287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015678735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021377262,0.9967432,0.0001591727,0.000040088733,0.000096573094,0.0006288388,0.000027823415,0.000009209016,0.00015735716],"genre_scores_gemma":[0.0015501064,0.99694675,0.00018837524,0.000019223544,0.0001724457,0.00030954805,0.00025882298,0.000052594143,0.00050210924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984791,0.00015147694,0.0005057906,0.0004443211,0.00014174261,0.0002775352],"domain_scores_gemma":[0.9990258,0.00010355218,0.00018762184,0.0005347954,0.00004648041,0.000101713595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018533911,0.00032327598,0.0005737402,0.000061118735,0.00012694542,0.00008462165,0.00027797956,0.00034611925,0.000009233587],"category_scores_gemma":[0.000093021816,0.0002213586,0.00019718127,0.00014414519,0.00011400949,0.0000035868575,0.00008949686,0.00016164902,0.000021676055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004547246,0.00002272922,0.000063750864,0.0023171932,0.000094980525,0.0000035140076,0.000037517162,0.0000075515954,0.0006741192,0.00011825772,0.00029749592,0.99635834],"study_design_scores_gemma":[0.00022153712,0.000042826352,0.00010287943,0.0008692386,0.00016044865,0.000014012984,0.00002198919,0.000017190489,0.0016513948,0.00051353965,0.99600875,0.00037618898],"about_ca_topic_score_codex":0.000044218217,"about_ca_topic_score_gemma":0.000053841995,"teacher_disagreement_score":0.99598217,"about_ca_system_score_codex":0.00007952093,"about_ca_system_score_gemma":0.00037387616,"threshold_uncertainty_score":0.9026742},"labels":[],"label_agreement":null},{"id":"W2015880063","doi":"10.1038/leu.2009.174","title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","year":2009,"lang":"en","type":"review","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":878,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Saint John Regional Hospital; Dalhousie University","funders":"National Cancer Institute; National Institute on Aging","keywords":"Multiple myeloma; Chromosomal translocation; Biology; Cancer research; Hematology; Cytogenetics; Comparative genomic hybridization; Gene expression profiling; Gene; Oncology; Genetics; Chromosome; Immunology; Gene expression; Medicine","score_opus":0.0645365481067835,"score_gpt":0.36010654349522536,"score_spread":0.29556999538844186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015880063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041983843,0.9849616,0.0001191466,0.00016183738,0.00021305264,0.0021789488,0.00004678159,0.000090412155,0.01218621],"genre_scores_gemma":[0.0010733684,0.9928744,0.00218033,0.00017283148,0.00030693208,0.0002675434,0.0023441012,0.00009326918,0.00068724086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963749,0.00021952725,0.001210513,0.00073230016,0.0009852722,0.00047749875],"domain_scores_gemma":[0.9975725,0.00021789176,0.000742404,0.0009641485,0.00020645601,0.00029661285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039308873,0.0005798784,0.0022716257,0.00042492143,0.0000595679,0.000029918214,0.00052308344,0.00041156876,0.00023069701],"category_scores_gemma":[0.0005226615,0.00045077573,0.0009739947,0.00063231355,0.00009168199,0.00008162195,0.00012201212,0.00068022805,0.00026053318],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045910354,0.00014926255,0.00012214667,0.023997819,0.00059213856,0.00047462087,0.0000072964117,1.02391354e-7,0.000058018002,0.00022079474,0.0012991537,0.9730327],"study_design_scores_gemma":[0.0011344542,0.00011949002,0.0012416103,0.094519585,0.0011770293,0.0002743683,0.000002392767,0.000060593367,0.000025475947,0.000013884595,0.9011445,0.00028660477],"about_ca_topic_score_codex":0.000021158003,"about_ca_topic_score_gemma":0.000003915982,"teacher_disagreement_score":0.97274613,"about_ca_system_score_codex":0.0015507538,"about_ca_system_score_gemma":0.00066407915,"threshold_uncertainty_score":0.9997944},"labels":[],"label_agreement":null},{"id":"W2016487786","doi":"10.1038/leu.2011.266","title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Follicular lymphoma; Lymphoma; Biology; Cancer research; Gene; Hematology; Immunology; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.016547806026892365,"score_gpt":0.2576666314970746,"score_spread":0.2411188254701822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016487786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372517,0.0003291109,0.0000063972766,0.06074977,0.00011893629,0.0010905669,0.000053279615,0.000041533902,0.00035872473],"genre_scores_gemma":[0.89575493,0.00035849158,0.0006827316,0.10092492,0.00036467853,0.00041193626,0.0005567561,0.000084207866,0.0008613377],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99820167,0.00012501595,0.00050354825,0.0005402048,0.0002025919,0.0004269874],"domain_scores_gemma":[0.99888796,0.0001299907,0.00020260472,0.00053069205,0.00008391099,0.0001648736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013885925,0.00042234105,0.0007692049,0.00041597665,0.000047054476,0.000026000782,0.00010232208,0.0006781492,0.00004766032],"category_scores_gemma":[0.000059834023,0.0003164601,0.00021612244,0.0003176371,0.000049825485,0.000050046565,0.000044964854,0.00028760804,0.00004514211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009217446,0.0010409905,0.18330905,0.00051488687,0.0016648853,0.017071871,0.0016247787,0.00018828349,0.0015603363,0.00034447593,0.7812186,0.010540143],"study_design_scores_gemma":[0.016071841,0.0036399115,0.89035416,0.0029677679,0.0013276144,0.001290036,0.000018390492,0.00013793836,0.04333058,0.00073580735,0.039234914,0.00089106074],"about_ca_topic_score_codex":0.0029307024,"about_ca_topic_score_gemma":0.000042744614,"teacher_disagreement_score":0.74198365,"about_ca_system_score_codex":0.0023167846,"about_ca_system_score_gemma":0.0005861089,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2016888349","doi":"10.1038/sj.leu.2404936","title":"Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Université du Québec à Trois-Rivières; Institut National de la Recherche Scientifique","funders":"National Cancer Institute; Canadian Institutes of Health Research; Vlaamse regering","keywords":"Lymphoma; Leukemia; Cancer research; Biology; Cell culture; Matrix metalloproteinase; Immunology; BCL10; Pathology; Medicine","score_opus":0.004676629433799454,"score_gpt":0.2240045200240656,"score_spread":0.21932789059026614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016888349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943622,0.0009335841,0.0011407009,0.0000034629968,0.00007067534,0.00015458188,0.000009376884,0.0000049416954,0.0033205145],"genre_scores_gemma":[0.9985526,0.00013256678,0.00088617165,0.000026576172,0.000047804217,0.0000055384517,0.000026366557,0.000015155418,0.0003072026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990807,0.00002187739,0.00032577664,0.00024092132,0.00012912335,0.00020159679],"domain_scores_gemma":[0.999515,0.00002949148,0.00015279799,0.00019903682,0.000049785547,0.000053910564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035019586,0.00012191195,0.0001622786,0.00008981336,0.000021023718,0.0000050476065,0.00010880626,0.00016754802,0.000004090541],"category_scores_gemma":[0.000055878645,0.00012428503,0.0000532612,0.00012347217,0.000045203942,0.0000053995636,0.00007770482,0.00005229805,0.0000016772451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009476292,0.00006758917,0.00024863315,0.00009962505,0.0000037965717,0.000004049401,0.00011345403,0.000020749056,0.99689645,0.00006210324,0.000087858905,0.0023009086],"study_design_scores_gemma":[0.00081095117,0.00018859706,0.0011266683,0.00008168409,0.000009640265,0.000005253281,0.00015174743,0.00021100495,0.9968177,0.000036460508,0.00043261205,0.00012769904],"about_ca_topic_score_codex":0.00008617573,"about_ca_topic_score_gemma":0.000028232475,"teacher_disagreement_score":0.0041904566,"about_ca_system_score_codex":0.0001211986,"about_ca_system_score_gemma":0.00013332526,"threshold_uncertainty_score":0.5068196},"labels":[],"label_agreement":null},{"id":"W2018925795","doi":"10.1038/sj.leu.2403489","title":"The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bundesministerium für Bildung und Forschung; Børnecancerfonden","keywords":"Juvenile myelomonocytic leukemia; International Prognostic Scoring System; Myelodysplastic syndromes; Medicine; Cytopenia; Internal medicine; Oncology; Cytogenetics; Bone marrow; Leukemia; Stem cell; Biology; Haematopoiesis","score_opus":0.01381745438902266,"score_gpt":0.2584082319384484,"score_spread":0.24459077754942576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018925795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897433,0.00078909344,0.0023655654,0.0017390976,0.000930756,0.0023650713,0.000045257697,0.0003626449,0.00242821],"genre_scores_gemma":[0.99437976,0.0001510826,0.0024107096,0.00026675736,0.0006227809,0.00060138525,0.00007397764,0.000121765894,0.0013717592],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9966916,0.000049035636,0.0006991291,0.00077883137,0.00081272505,0.0009686652],"domain_scores_gemma":[0.9974974,0.00092297595,0.00020836305,0.0006739972,0.00026718312,0.0004300927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007519896,0.00043371253,0.0005791333,0.00026307112,0.00065330626,0.00026369063,0.00062485295,0.00024981808,0.000018034614],"category_scores_gemma":[0.0012121128,0.00032820078,0.00019530712,0.0003816989,0.00029646792,0.00024299078,0.00033899237,0.0007770162,0.00018383896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016581694,0.0019514395,0.094254196,0.023931954,0.016167011,0.021727938,0.020492021,0.03350383,0.07091756,0.34208176,0.038222402,0.3201682],"study_design_scores_gemma":[0.1059638,0.00792305,0.5662987,0.015811164,0.0035925827,0.0647395,0.0108070625,0.12298108,0.018342735,0.009047232,0.06933325,0.005159821],"about_ca_topic_score_codex":0.00018494518,"about_ca_topic_score_gemma":0.000044051776,"teacher_disagreement_score":0.47204453,"about_ca_system_score_codex":0.010141985,"about_ca_system_score_gemma":0.0036085506,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W2023394407","doi":"10.1038/sj.leu.2404968","title":"Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"Bernische Krebsliga","keywords":"Telomere; Telomerase; Prolymphocytic leukemia; clone (Java method); Biology; Leukemia; Immunology; Molecular biology; Cancer research; Chronic lymphocytic leukemia; Genetics; DNA; Gene","score_opus":0.013162096867894388,"score_gpt":0.2573210061522848,"score_spread":0.24415890928439044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023394407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288625,0.0008861312,0.00015714727,0.00015757453,0.00024521456,0.00072559965,0.0000101617115,0.00019332045,0.00473861],"genre_scores_gemma":[0.9957358,0.0003902964,0.0009963397,0.0006767264,0.00028708074,0.00003091973,0.000023158627,0.000073264695,0.0017863954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697745,0.00006329146,0.0005846335,0.000827321,0.00056449405,0.0009828267],"domain_scores_gemma":[0.9983337,0.00027511068,0.000107806205,0.00066033815,0.00008665891,0.0005363974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069131015,0.00047445516,0.0007473818,0.0005380809,0.00013817435,0.00004951878,0.00020144852,0.00036213547,0.00007112628],"category_scores_gemma":[0.00014995557,0.0004353611,0.00011099396,0.00078944385,0.0002776076,0.00027093175,0.00012115471,0.00069360615,0.00007883368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024855875,0.00043806282,0.40697998,0.0008624444,0.000082986895,0.0030065735,0.0011877447,0.000045305456,0.22389747,0.00024341512,0.001298589,0.35947186],"study_design_scores_gemma":[0.0042608753,0.000282533,0.8116745,0.00021189438,0.000084295854,0.00030389172,0.00027446533,0.0005524157,0.17886096,0.00009936646,0.0028076181,0.0005872049],"about_ca_topic_score_codex":0.0019404163,"about_ca_topic_score_gemma":0.0004221706,"teacher_disagreement_score":0.4046945,"about_ca_system_score_codex":0.0028412272,"about_ca_system_score_gemma":0.0010598405,"threshold_uncertainty_score":0.9998098},"labels":[],"label_agreement":null},{"id":"W2025786811","doi":"10.1038/leu.2012.292","title":"Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Cohort; Hematopoietic stem cell transplantation; Overlap syndrome; Disease; Cohort study; Severity of illness","score_opus":0.02784713237683133,"score_gpt":0.3433766293923122,"score_spread":0.3155294970154809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025786811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947645,0.00052347535,0.00005764424,0.000069313355,0.0006671782,0.0015730994,0.00008636287,0.000104377796,0.0021540269],"genre_scores_gemma":[0.99893147,0.00006795894,0.000051089028,0.00004919175,0.0002333219,0.00008704575,0.00007402509,0.00005965389,0.00044623108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782646,0.00009112789,0.0005251404,0.00034693375,0.0005808147,0.000629525],"domain_scores_gemma":[0.9981115,0.00029214798,0.00019527512,0.00077030505,0.00007566547,0.0005551351],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023404296,0.00035160137,0.00063280616,0.00017016025,0.00006929708,0.00001365863,0.00015995509,0.00011751747,0.0012412167],"category_scores_gemma":[0.0000972755,0.00026718946,0.00033405004,0.00024894232,0.00010174461,0.00013697357,0.00003175864,0.00029559762,0.00037108833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027541816,0.0013673204,0.98279095,0.00080540526,0.0018540799,0.0003081824,0.0023706092,0.000061603336,0.004480042,0.00008666409,0.00038397918,0.002736996],"study_design_scores_gemma":[0.013997024,0.0036301177,0.9784566,0.00012702151,0.001529512,0.00001881041,0.0001617558,0.00006800983,0.0016797949,0.0000017884705,0.00008141378,0.0002481328],"about_ca_topic_score_codex":0.00014762071,"about_ca_topic_score_gemma":0.000026993946,"teacher_disagreement_score":0.011242842,"about_ca_system_score_codex":0.0034608701,"about_ca_system_score_gemma":0.0017188304,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W2026048257","doi":"10.1038/sj.leu.2402196","title":"Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"Plant biochemistry and biosynthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; Institute for Biological Sciences; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Medical Research Council; University of Pennsylvania","keywords":"Lovastatin; Geranylgeranylation; Farnesyl pyrophosphate; Geranylgeranyl pyrophosphate; Mevalonic acid; Mevalonate pathway; Farnesyl-diphosphate farnesyltransferase; Biology; Apoptosis; Farnesol; Dolichol; Farnesyltransferase inhibitor; Geranylgeraniol; Myeloid leukemia; HMG-CoA reductase; Hydroxymethylglutaryl-CoA reductase; Biochemistry; Pharmacology; Cancer research; Prenylation; Cholesterol; Farnesyltransferase; Reductase; Enzyme; ATP synthase; Biosynthesis","score_opus":0.012112117017045669,"score_gpt":0.2491729031369084,"score_spread":0.23706078611986273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026048257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971426,0.000047498383,0.0012610016,0.000087930326,0.00009373787,0.00048143728,0.00017694666,0.000025169269,0.0006836755],"genre_scores_gemma":[0.9956049,0.000046094596,0.0013733524,0.00014046425,0.00043729172,0.00006550002,0.00039198846,0.000036411533,0.0019040015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984039,0.000038676604,0.0004315377,0.000527759,0.00020714782,0.00039097512],"domain_scores_gemma":[0.99906725,0.000022640448,0.0002730511,0.00040825675,0.00013408282,0.000094728115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019306545,0.0002831664,0.0002927515,0.000057471745,0.00017589885,0.000037584105,0.0002890967,0.00036562135,0.00006060629],"category_scores_gemma":[0.00003380744,0.00028577622,0.00024112922,0.0001410098,0.00006669324,0.00001067671,0.00007416631,0.0001310381,0.000007007871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029065195,0.00003668303,0.0000869294,0.00009145388,0.00016971873,0.0000028814172,0.000077609766,0.000021631045,0.99585366,0.000013873965,0.0014099397,0.0019449879],"study_design_scores_gemma":[0.0009444041,0.0002158557,0.00009449713,0.0000648627,0.00010076743,0.000013898905,0.0000403804,0.0002056565,0.9946727,0.00005637256,0.0032447402,0.00034585258],"about_ca_topic_score_codex":0.00007413289,"about_ca_topic_score_gemma":0.000012019966,"teacher_disagreement_score":0.0018348004,"about_ca_system_score_codex":0.00010662815,"about_ca_system_score_gemma":0.00023994118,"threshold_uncertainty_score":0.99995947},"labels":[],"label_agreement":null},{"id":"W2026192507","doi":"10.1038/leu.2013.9","title":"Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; University of Waterloo","funders":"","keywords":"Parthenolide; Vildagliptin; Pharmacology; Myeloid leukemia; Clonogenic assay; Leukemia; Viability assay; Cancer research; Medicine; Apoptosis; Chemistry; Immunology; Biochemistry; Internal medicine; Metformin","score_opus":0.011514007363516305,"score_gpt":0.24158533704655283,"score_spread":0.23007132968303654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026192507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619645,0.00014606286,0.00033830636,0.00041052693,0.000017625362,0.00026035408,0.000011901131,0.00007372784,0.0025450457],"genre_scores_gemma":[0.99802643,0.00014354888,0.0003569475,0.00027842514,0.0001250577,0.000032025404,0.00003675085,0.000018554847,0.0009822571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881583,0.000053542564,0.00031683827,0.00030482648,0.00025774614,0.00025123655],"domain_scores_gemma":[0.99917537,0.00006931799,0.00017794016,0.00027028652,0.00013195419,0.00017515369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012158708,0.00019008027,0.00043254194,0.00017504428,0.00007452258,0.000030688072,0.000042355383,0.00012852169,0.0008581677],"category_scores_gemma":[0.000079041136,0.00016152188,0.00013493643,0.00024303012,0.00022817284,0.00028276193,0.000044270568,0.00021372594,0.00014108529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025835696,0.00008703391,0.004282936,0.00016098414,0.000053608124,0.00001736868,0.00021301373,0.000007917538,0.98705286,0.00008547918,0.000989557,0.0070233783],"study_design_scores_gemma":[0.0012404472,0.00013705893,0.05415724,0.0007462048,0.000108879365,0.000051384326,0.00032011216,0.0014921166,0.940868,0.00044118543,0.00022541267,0.00021194859],"about_ca_topic_score_codex":0.0003816201,"about_ca_topic_score_gemma":0.000016878626,"teacher_disagreement_score":0.049874302,"about_ca_system_score_codex":0.0001415976,"about_ca_system_score_gemma":0.0001270907,"threshold_uncertainty_score":0.9396334},"labels":[],"label_agreement":null},{"id":"W2026214119","doi":"10.1038/sj.leu.2404856","title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation; U.S. Department of Health and Human Services","keywords":"BCL6; Diffuse large B-cell lymphoma; Biology; Lymphoma; Chromosomal translocation; Cancer research; Germinal center; B cell; Molecular biology; Gene; Genetics; Immunology; Antibody","score_opus":0.01082582329923507,"score_gpt":0.23512892316808737,"score_spread":0.2243030998688523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026214119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710655,0.00035305906,0.0015609395,0.00009897138,0.000048420636,0.00022771962,0.0000992836,0.000008747862,0.00049631594],"genre_scores_gemma":[0.99959755,0.000052694093,0.000054099466,0.00011072054,0.000026128231,0.000023884519,0.00008240661,0.000008723935,0.00004378238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991891,0.000027294616,0.00029035355,0.0001831869,0.00014279243,0.00016727386],"domain_scores_gemma":[0.99943507,0.0001806497,0.00010144328,0.0001527874,0.000053162952,0.000076910306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088426044,0.00013929718,0.00028982176,0.000094457726,0.000027010661,0.0000053037543,0.00003223859,0.00005871388,0.000032127715],"category_scores_gemma":[0.000022510309,0.000093037605,0.00007209581,0.00007786489,0.00008476664,0.000031393025,0.000030392328,0.000039002978,0.0000012394958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021222094,0.0034653184,0.95795333,0.00011298224,0.000093950934,0.00011374888,0.00082493905,0.0000033003937,0.032170452,0.0028403492,0.000024701181,0.002184706],"study_design_scores_gemma":[0.009021899,0.00019767789,0.78825736,0.00009739162,0.000045908284,0.00002088397,0.0003688669,0.000099292025,0.20159014,0.00019292193,0.000041182717,0.000066452805],"about_ca_topic_score_codex":0.000403214,"about_ca_topic_score_gemma":0.00027680153,"teacher_disagreement_score":0.16969594,"about_ca_system_score_codex":0.0002966521,"about_ca_system_score_gemma":0.00010205807,"threshold_uncertainty_score":0.37939635},"labels":[],"label_agreement":null},{"id":"W2028492419","doi":"10.1038/leu.2014.162","title":"Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"IRF8; Biology; Myeloid; Retinoic acid; Myeloid leukemia; Cancer research; Immune system; Interferon regulatory factors; Tretinoin; Transcription factor; Cellular differentiation; Signal transduction; Myelopoiesis; Psychological repression; Immunology; Cell biology; Gene expression; Gene; Innate immune system; Haematopoiesis; Stem cell; Genetics","score_opus":0.006251910443762406,"score_gpt":0.22976570309877456,"score_spread":0.22351379265501214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028492419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782954,0.00046087033,0.018279629,0.000033844044,0.00007964911,0.00013609334,0.000009682661,0.000020263447,0.0026845867],"genre_scores_gemma":[0.9979889,0.000047460235,0.0007820398,0.00011237546,0.00010407473,0.000019961783,0.00014053957,0.000021336227,0.0007833558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871796,0.00021461185,0.0003222573,0.00037013067,0.00017773425,0.00019729263],"domain_scores_gemma":[0.9990604,0.00009093237,0.00023948045,0.00041307203,0.00013890986,0.000057199966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004696363,0.0001669121,0.00019511323,0.000040624604,0.00009167016,0.000017153201,0.0002066501,0.00024410835,0.000024869296],"category_scores_gemma":[0.0007501745,0.0001567892,0.0000796865,0.000103460836,0.0001741356,0.000010571514,0.000103089435,0.00013399847,0.000004960239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082371477,0.000023279055,0.00016881754,0.000045219273,0.000019093128,6.0342614e-7,0.000086988235,0.00034134198,0.9961034,0.00006253674,0.0015858287,0.0007391601],"study_design_scores_gemma":[0.0008150874,0.00019124513,0.00012770979,0.00012258108,0.000012641382,0.000004388368,0.00007671908,0.00009808063,0.9874162,0.00011213816,0.010838822,0.00018436449],"about_ca_topic_score_codex":0.000017738463,"about_ca_topic_score_gemma":2.0933712e-7,"teacher_disagreement_score":0.019693473,"about_ca_system_score_codex":0.000059813116,"about_ca_system_score_gemma":0.00023153405,"threshold_uncertainty_score":0.6393678},"labels":[],"label_agreement":null},{"id":"W2028626714","doi":"10.1038/leu.2015.51","title":"INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"NPM1; Myeloid leukemia; Oncology; Internal medicine; Carcinogenesis; Cancer research; Biomarker; Leukemia; Medicine; Hematology; Haematopoiesis; Myeloid; Cytarabine; Biology; Immunology; Stem cell; Cancer; Karyotype; Gene; Genetics; Chromosome","score_opus":0.06164805654009614,"score_gpt":0.3624402128200965,"score_spread":0.30079215628000033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028626714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885233,0.0010070066,0.000030836494,0.0024264676,0.00010506536,0.0008294285,0.000036388872,0.0001518783,0.0068896334],"genre_scores_gemma":[0.9762381,0.00096335565,0.0022389686,0.005829346,0.00023257187,0.00006829066,0.0000800262,0.00011212977,0.01423726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598926,0.00033558047,0.0009299606,0.0008796798,0.0010463778,0.00081913825],"domain_scores_gemma":[0.9974358,0.00045182696,0.0002822866,0.0007813051,0.00032015683,0.0007286081],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00169982,0.00043537072,0.0010369476,0.00026827774,0.00009900719,0.000070549504,0.0003391036,0.00059650245,0.000084358144],"category_scores_gemma":[0.0009586749,0.00031803892,0.00012617063,0.0007418269,0.00039439488,0.00029743966,0.00021417541,0.0016025647,0.00008022545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010162825,0.00022608611,0.87528425,0.0000790301,0.0005078435,0.0016151351,0.00149149,0.000008225417,0.0047966302,0.00015714957,0.099044725,0.006626582],"study_design_scores_gemma":[0.056588348,0.0020974404,0.8794952,0.0014884075,0.00018005063,0.00019012406,0.0004915259,0.001868756,0.004340904,0.00078390684,0.051375527,0.0010998028],"about_ca_topic_score_codex":0.0003000412,"about_ca_topic_score_gemma":0.0001891817,"teacher_disagreement_score":0.047669195,"about_ca_system_score_codex":0.004295976,"about_ca_system_score_gemma":0.002997073,"threshold_uncertainty_score":0.99992716},"labels":[],"label_agreement":null},{"id":"W2029484942","doi":"10.1038/sj.leu.2404612","title":"Expression and mutation status of candidate kinases in multiple myeloma","year":2007,"lang":"en","type":"letter","venue":"Leukemia","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Kinome; Biology; Genetics; Receptor tyrosine kinase; Bruton's tyrosine kinase; Cancer research; Kinase; Mutation; Tyrosine kinase; Gene; Signal transduction","score_opus":0.01286646278170853,"score_gpt":0.2607289235500534,"score_spread":0.24786246076834487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029484942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946863,0.0028116978,0.0002678757,0.0011505578,0.0002754043,0.00023723819,0.00017529602,0.000011687137,0.00038393316],"genre_scores_gemma":[0.953064,0.00058065745,0.0011199177,0.04078825,0.0014186023,0.000043388125,0.0022708126,0.00008001592,0.00063433027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986773,0.000060543745,0.0002915669,0.00040991834,0.00018573685,0.0003749336],"domain_scores_gemma":[0.99932647,0.00005387298,0.00020138342,0.00030879234,0.000059781127,0.000049715592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010418939,0.00021571324,0.00023474904,0.00011838019,0.00002683999,0.000012737043,0.00013053353,0.0007223986,0.000017314926],"category_scores_gemma":[0.000118916294,0.0002148873,0.000051996118,0.000074204756,0.000103134385,0.0000035856856,0.00008574383,0.00039963558,0.0000019267543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016027868,0.000010070528,0.0061632665,0.0002554408,0.000030340003,0.00017131926,0.00010436136,0.00015640036,0.7379683,5.143789e-7,0.25141245,0.0035672402],"study_design_scores_gemma":[0.00095420517,0.00013715791,0.0029863,0.00021847716,0.00001712668,0.0000141768305,0.000019440438,0.000055547385,0.63921994,0.000020495183,0.35607815,0.00027899828],"about_ca_topic_score_codex":0.00077725266,"about_ca_topic_score_gemma":0.00023044049,"teacher_disagreement_score":0.104665704,"about_ca_system_score_codex":0.00018232114,"about_ca_system_score_gemma":0.00027411684,"threshold_uncertainty_score":0.87628496},"labels":[],"label_agreement":null},{"id":"W2029964462","doi":"10.1038/leu.2015.9","title":"BIN1 tumor suppressor regulates Fas/Fas ligand–mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health; Terry Fox Research Institute; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of Pennsylvania","keywords":"Fas ligand; Apoptosis; Cancer research; Biology; Fas receptor; Gene knockdown; Flip; Cutaneous T-cell lymphoma; Programmed cell death; Lymphoma; Mycosis fungoides; Immunology","score_opus":0.02786052069972659,"score_gpt":0.28531555246493523,"score_spread":0.2574550317652086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029964462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800997,0.0009127914,0.000018197416,0.0015287874,0.00023078312,0.0011740652,0.000047720972,0.00024341214,0.015744552],"genre_scores_gemma":[0.98825204,0.00014761965,0.00063324615,0.0012711795,0.00022560362,0.00013810041,0.0002062721,0.00013610699,0.008989802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99600375,0.00018425912,0.0007000024,0.0008533443,0.0011271017,0.0011315285],"domain_scores_gemma":[0.9976272,0.0003638309,0.0001536525,0.00087188074,0.00042243642,0.00056102965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031435414,0.00051412947,0.00087462354,0.0003577993,0.00010832042,0.000096819516,0.0004185911,0.00032496374,0.00021324743],"category_scores_gemma":[0.001131274,0.00046265541,0.00018506206,0.0010257291,0.00022503542,0.00020595112,0.00022033305,0.000411476,0.000963145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011658556,0.004188581,0.09797854,0.0011258968,0.00055399607,0.012377029,0.020974202,0.0011746396,0.7082455,0.00021930221,0.13513702,0.006366723],"study_design_scores_gemma":[0.026359031,0.0019230611,0.0016208533,0.0004615941,0.00015598173,0.0060340967,0.0034096774,0.011800554,0.91927975,0.0011657791,0.026519565,0.0012700484],"about_ca_topic_score_codex":0.0026148146,"about_ca_topic_score_gemma":0.00028542764,"teacher_disagreement_score":0.21103425,"about_ca_system_score_codex":0.0039519053,"about_ca_system_score_gemma":0.002059791,"threshold_uncertainty_score":0.99987173},"labels":[],"label_agreement":null},{"id":"W2030023709","doi":"10.1038/sj.leu.2401891","title":"Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; University of Alberta; National Institute of Allergy and Infectious Diseases; American Society of Hematology","keywords":"CXCR4; Chemokine; Chemokine receptor; CXCL14; Haematopoiesis; Biology; Chemokine receptor CCR5; CCL13; Cell biology; Chemotaxis; CXCL2; XCL2; Immunology; Receptor; Stem cell; Inflammation; Biochemistry","score_opus":0.00911296565516504,"score_gpt":0.2223907179540977,"score_spread":0.21327775229893267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030023709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558914,0.0031265581,0.0000016445896,0.000066480236,0.000024957786,0.00018974334,0.00010338996,0.000014510282,0.0008835974],"genre_scores_gemma":[0.9963956,0.00051620335,0.000009109567,0.000014873507,0.0000053700396,0.000012349459,0.00009214122,0.000006737906,0.0029476362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993012,0.000079544945,0.00021599686,0.00019502366,0.000026015294,0.00018221895],"domain_scores_gemma":[0.9995835,0.00010935756,0.00008067485,0.00017837407,0.00002219073,0.000025900528],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008623914,0.00012930506,0.00024725488,0.000021619893,0.00010714873,0.0000036253055,0.0001260456,0.00019092436,0.0010987604],"category_scores_gemma":[0.000014045708,0.000067037385,0.000046382058,0.000078103614,0.0005664192,0.000019785968,0.00006130901,0.0001683827,0.000028875917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007800864,0.00008980641,0.011193482,0.000027653923,0.000029738489,6.136127e-7,0.0004713191,0.000001162474,0.9832903,0.000015099616,0.00273006,0.00207277],"study_design_scores_gemma":[0.0012935541,0.00022450484,0.008925028,0.00004338174,0.000009730675,0.000009469463,0.00011341269,0.0000015925559,0.9860879,0.00010118769,0.0031201006,0.000070143855],"about_ca_topic_score_codex":0.00005040091,"about_ca_topic_score_gemma":0.0000020644345,"teacher_disagreement_score":0.0027976078,"about_ca_system_score_codex":0.000022160095,"about_ca_system_score_gemma":0.000029747822,"threshold_uncertainty_score":0.9998144},"labels":[],"label_agreement":null},{"id":"W2030870757","doi":"10.1038/leu.2013.287","title":"Delineating MEIS1 cis-regulatory elements active in hematopoietic cells","year":2013,"lang":"en","type":"letter","venue":"Leukemia","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Biotechnology and Biological Sciences Research Council; Medical Research Council; Canadian Institutes of Health Research; Terry Fox Foundation; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Cancer Research UK; Wellcome Trust","keywords":"Haematopoiesis; Hematology; Hematopoietic cell; Cancer research; Biology; Immunology; Stem cell; Genetics","score_opus":0.011404650554669995,"score_gpt":0.23410825871722216,"score_spread":0.22270360816255216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030870757","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8915849,0.008250237,0.00012418514,0.07041837,0.009347643,0.002795337,0.00029415404,0.0004722167,0.016712988],"genre_scores_gemma":[0.21575797,0.000230134,0.00032311992,0.545383,0.0013003628,0.00047337796,0.00232144,0.00034158424,0.23386905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971197,0.0005044608,0.0008200645,0.0005953133,0.000086698274,0.0008737446],"domain_scores_gemma":[0.9985775,0.00029696917,0.00036453712,0.00064819225,0.00009490675,0.000017908365],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00020953974,0.0005380095,0.0007537714,0.00036343947,0.00011517703,0.0000358135,0.00057604566,0.0018859567,0.004358791],"category_scores_gemma":[0.00006807235,0.00049654575,0.0002245576,0.00013039741,0.00019280337,0.00011443635,0.00022299665,0.0030508307,0.006727085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001137252,0.000022569819,0.000028921246,0.000092589595,0.00019467364,0.00007742839,0.0004056375,0.0000030860786,0.12751046,0.000012963838,0.868507,0.0030309188],"study_design_scores_gemma":[0.0013073476,0.00013521532,0.00025414067,0.00036177554,0.000052890526,0.0000752445,0.000215823,0.000013245818,0.23775843,0.00005010716,0.759213,0.0005628225],"about_ca_topic_score_codex":0.0004433402,"about_ca_topic_score_gemma":0.000018790506,"teacher_disagreement_score":0.6758269,"about_ca_system_score_codex":0.0008937362,"about_ca_system_score_gemma":0.00035083992,"threshold_uncertainty_score":0.99974865},"labels":[],"label_agreement":null},{"id":"W2030873172","doi":"10.1038/sj.leu.2402114","title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","year":2001,"lang":"en","type":"review","venue":"Leukemia","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":492,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Ligue Contre le Cancer; Alberta Cancer Foundation; Friedreich's Ataxia Research Alliance","keywords":"Nucleoside transporter; Nucleoside analogue; Cladribine; Nucleoside; Fludarabine; Pharmacology; Intracellular; Transporter; Drug resistance; Gemcitabine; ATP-binding cassette transporter; Deoxycytidine kinase; Mechanism of action; Drug; Biology; Cancer research; Biochemistry; In vitro; Chemotherapy; Deoxycytidine; Genetics; Gene","score_opus":0.01701804877374928,"score_gpt":0.27686460238096444,"score_spread":0.25984655360721515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030873172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014622329,0.995676,0.0012950426,0.000007872197,0.00007144993,0.00015994137,0.000035929308,0.000010597255,0.0025969713],"genre_scores_gemma":[0.00056088815,0.99373776,0.0011557601,0.000037772472,0.00022023557,0.00001387008,0.0002616542,0.000041177103,0.0039708796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988398,0.000077323035,0.00038016072,0.0003911282,0.00011272854,0.00019883631],"domain_scores_gemma":[0.9992409,0.000026962327,0.00027466659,0.000353546,0.00004348618,0.00006043523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013830369,0.00028504827,0.0006826485,0.00005823994,0.000044132386,0.0000248144,0.0002262904,0.00030114915,0.000020371268],"category_scores_gemma":[0.000025230864,0.00024772534,0.00019473828,0.00013403759,0.00007705727,0.0000041555,0.00010750135,0.00016571955,0.000004230038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026923354,0.00018394724,0.000028553852,0.09403889,0.0030918422,0.00058678194,0.0005379414,0.000108541404,0.009775454,0.037246935,0.50977707,0.3443548],"study_design_scores_gemma":[0.0001560177,0.000036590613,0.0000011088508,0.0022492595,0.00025987378,0.000036366662,0.0000871944,9.1724536e-7,0.0004058673,0.0008632258,0.9956149,0.00028872068],"about_ca_topic_score_codex":0.00004800784,"about_ca_topic_score_gemma":0.000027710706,"teacher_disagreement_score":0.48583776,"about_ca_system_score_codex":0.000037006732,"about_ca_system_score_gemma":0.00040692248,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W2031102851","doi":"10.1038/leu.2010.144","title":"The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration","year":2010,"lang":"en","type":"letter","venue":"Leukemia","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute","keywords":"Somatic cell; Biology; Genetics; Internal medicine; Cancer research; Medicine; Gene","score_opus":0.02378700966577329,"score_gpt":0.2755916467597153,"score_spread":0.251804637093942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031102851","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19284137,0.00035983027,0.00012421882,0.79103464,0.004839578,0.0027405382,0.0000959771,0.00020425585,0.0077596107],"genre_scores_gemma":[0.15322505,0.00011232244,0.001371568,0.8273393,0.0049062865,0.00048435113,0.0006791928,0.00023531761,0.011646615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609905,0.00017397871,0.00117561,0.0007739073,0.0010382334,0.0007392041],"domain_scores_gemma":[0.99665755,0.00058015436,0.00060463184,0.001808729,0.00022850269,0.00012044797],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00056760403,0.00057563477,0.00082440034,0.00022502287,0.00020807123,0.00016717435,0.0004803903,0.0023268347,0.000529218],"category_scores_gemma":[0.00063597737,0.00041901125,0.00020932047,0.00042676265,0.00021806585,0.000065771164,0.00014775775,0.007051274,0.00018951502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013911173,0.00002514107,0.00062081113,0.0002817675,0.0001559252,0.0027468195,0.000496714,0.000009505317,0.0037648093,0.00000945278,0.98790044,0.0038495127],"study_design_scores_gemma":[0.0018357966,0.00029999053,0.007183246,0.00058477325,0.00031680724,0.0015282058,0.000026366348,0.0030591872,0.004270095,0.0005006672,0.97979826,0.00059661595],"about_ca_topic_score_codex":0.0014131394,"about_ca_topic_score_gemma":0.00101067,"teacher_disagreement_score":0.03961631,"about_ca_system_score_codex":0.0016017745,"about_ca_system_score_gemma":0.0019246968,"threshold_uncertainty_score":0.9998262},"labels":[],"label_agreement":null},{"id":"W2031759349","doi":"10.1038/sj.leu.2403917","title":"Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Haematopoiesis; Telomerase; Biology; Cancer research; Leukemia; Myeloid; Stem cell; Myeloid leukemia; Telomerase reverse transcriptase; Immunology; Genetics; Gene","score_opus":0.04273951744049179,"score_gpt":0.3378140450614088,"score_spread":0.295074527620917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031759349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942721,0.00041020845,0.0011375506,0.00067048304,0.000038024216,0.0015402694,0.000007338875,0.000029913786,0.001894077],"genre_scores_gemma":[0.99645513,0.000101375095,0.0020785658,0.00048740598,0.00020379564,0.00018998074,0.00002179894,0.00002935031,0.000432585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980267,0.00013717043,0.0006494611,0.00025752242,0.00049169926,0.00043739114],"domain_scores_gemma":[0.9988128,0.0004468608,0.00011702508,0.00041419332,0.00013124435,0.000077868426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009960313,0.00018448736,0.00035319556,0.00016712263,0.00012839561,0.000014797136,0.00034346007,0.00012807752,0.00006142977],"category_scores_gemma":[0.00017826147,0.00013699692,0.00013288579,0.0003765532,0.00008191026,0.00024419813,0.000031377866,0.00035303712,0.000035339144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007235021,0.00023084553,0.009124942,0.0021133937,0.00009105476,0.000026615098,0.017940583,0.008316718,0.9396248,0.0004833443,0.003309635,0.018014599],"study_design_scores_gemma":[0.012873271,0.0015107489,0.076619245,0.0024123418,0.00030043835,0.00031384357,0.0019222792,0.06237425,0.83753383,0.00014445923,0.0033198048,0.0006754777],"about_ca_topic_score_codex":0.00023007143,"about_ca_topic_score_gemma":0.00012002549,"teacher_disagreement_score":0.102090925,"about_ca_system_score_codex":0.0012182097,"about_ca_system_score_gemma":0.0006396862,"threshold_uncertainty_score":0.5586573},"labels":[],"label_agreement":null},{"id":"W2032259218","doi":"10.1038/leu.2010.162","title":"Innate immunity as orchestrator of stem cell mobilization","year":2010,"lang":"en","type":"review","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; European Commission","keywords":"Haematopoiesis; Stem cell; Mobilization; Innate immune system; Progenitor cell; Immunology; Immunity; Biology; Inflammation; Regeneration (biology); Immune system; Cell biology","score_opus":0.03893453485375623,"score_gpt":0.32047007179715975,"score_spread":0.2815355369434035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032259218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004299878,0.9783462,0.00012948428,0.0000040950636,0.00028152656,0.0014155009,0.000046184094,0.0000776368,0.015399455],"genre_scores_gemma":[0.0010681922,0.99625957,0.00040729405,0.000022786406,0.000090445465,0.00007001281,0.00045373075,0.000080841986,0.0015471509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813175,0.00015760692,0.00086582656,0.00029877198,0.00033507228,0.00021098075],"domain_scores_gemma":[0.9983148,0.00023456394,0.00049717445,0.0006939691,0.00012310277,0.00013636351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003370821,0.00034366077,0.0014516427,0.0001913719,0.000034668523,0.000011713576,0.00019862897,0.00079175644,0.00016850821],"category_scores_gemma":[0.000020880989,0.00028273664,0.00031719613,0.00039104896,0.000077413504,0.00004708775,0.000024589774,0.00088247366,0.00025988874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028414439,0.000115487885,0.00004356874,0.17317396,0.0001084983,0.00006876669,0.0005290616,0.0000011130478,0.00091451436,0.0003062403,0.00010247125,0.8246079],"study_design_scores_gemma":[0.0009210334,0.0002128283,0.000035752804,0.024353012,0.002381396,0.00037121537,0.000092075556,0.000015953185,0.0069817835,0.00003099584,0.9642034,0.00040050878],"about_ca_topic_score_codex":0.000069232134,"about_ca_topic_score_gemma":0.0000042714382,"teacher_disagreement_score":0.96410096,"about_ca_system_score_codex":0.0003376467,"about_ca_system_score_gemma":0.0021408768,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W2032847865","doi":"10.1038/sj.leu.2403796","title":"Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells","year":2005,"lang":"en","type":"review","venue":"Leukemia","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Stem cell; Haematopoiesis; Bone marrow; CD34; CXCR4; Biology; Population; Induced pluripotent stem cell; Adult stem cell; Immunology; Cell biology; Endothelial stem cell; Cancer research; Medicine; Embryonic stem cell; Genetics; In vitro; Chemokine; Inflammation; Gene","score_opus":0.09553070849956367,"score_gpt":0.36929796159158274,"score_spread":0.27376725309201905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032847865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002888435,0.9898738,0.000013678608,0.000016611377,0.00015031942,0.0018303891,0.00006716717,0.000035174686,0.005124389],"genre_scores_gemma":[0.0022817913,0.9839988,0.0006702242,0.000017515484,0.00018865819,0.00008171712,0.000085908796,0.000116867006,0.012558555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630964,0.00019180388,0.0015048538,0.0004750598,0.0010171995,0.00050141604],"domain_scores_gemma":[0.9973788,0.00022545565,0.0007263084,0.0011483354,0.00020935686,0.0003116911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004513633,0.00044091203,0.0031637093,0.00048637038,0.000042223815,0.000011268757,0.00035027933,0.00054309686,0.0007720508],"category_scores_gemma":[0.000047000172,0.00035598053,0.0008817222,0.0006741306,0.00014471225,0.000038721955,0.00017090655,0.000651131,0.0005905339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045987326,0.00024007476,0.00004425237,0.12773234,0.000363448,0.00031804468,0.00019851823,0.0000080341815,0.00049241015,0.0002966651,0.001471565,0.86878866],"study_design_scores_gemma":[0.0009769971,0.0005388922,0.00001640507,0.030816877,0.0017240047,0.0011190743,0.000035553716,0.00003556381,0.0011363986,0.0000412187,0.9630807,0.00047832698],"about_ca_topic_score_codex":0.0001854964,"about_ca_topic_score_gemma":0.00001673256,"teacher_disagreement_score":0.9616091,"about_ca_system_score_codex":0.00093277794,"about_ca_system_score_gemma":0.0017768338,"threshold_uncertainty_score":0.9998892},"labels":[],"label_agreement":null},{"id":"W2033070843","doi":"10.1038/leu.2010.302","title":"The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Groupement des Entreprises Françaises dans la lutte contre le Cancer; Ligue Contre le Cancer","keywords":"Isotype; breakpoint cluster region; Biology; Germinal center; Immunoglobulin D; Lymphoma; Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Cancer research; Antibody; B cell; Gene expression profiling; Immunology; Molecular biology; Gene; Monoclonal antibody; Gene expression; Genetics; Chromosome","score_opus":0.011765748620751363,"score_gpt":0.2329931367322983,"score_spread":0.22122738811154694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033070843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833203,0.00856229,0.000004529294,0.000686697,0.00011583067,0.0006093912,0.000008416566,0.000009818266,0.0016709759],"genre_scores_gemma":[0.9973882,0.0011681546,0.00005546528,0.00063144515,0.00002210565,0.00011296054,0.0000018225082,0.00001649183,0.0006033457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992602,0.000044628367,0.00017981483,0.00015946142,0.0001360065,0.0002199227],"domain_scores_gemma":[0.9990322,0.00034817855,0.0000819936,0.00044165007,0.00005197211,0.000044031734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002148463,0.000122069956,0.00018119221,0.0000200967,0.00011900031,0.000011434929,0.00014681749,0.000061772174,0.000008039098],"category_scores_gemma":[0.00011533644,0.000050348066,0.00010657964,0.00010845514,0.00012133543,0.000022403374,0.00007199425,0.000046098885,0.000011165905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006168906,0.01683743,0.6990485,0.0010446559,0.0025291492,0.00066915987,0.03257875,0.000010522656,0.014262431,0.09762436,0.009617545,0.11960855],"study_design_scores_gemma":[0.06276986,0.0011039537,0.6244838,0.00040953196,0.00091617584,0.00010120577,0.002380401,0.000966487,0.25558886,0.006943904,0.043998204,0.00033760726],"about_ca_topic_score_codex":0.00049871014,"about_ca_topic_score_gemma":0.00026632615,"teacher_disagreement_score":0.24132644,"about_ca_system_score_codex":0.00017081847,"about_ca_system_score_gemma":0.00018932312,"threshold_uncertainty_score":0.20531346},"labels":[],"label_agreement":null},{"id":"W2033172239","doi":"10.1038/leu.2011.99","title":"Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital","funders":"National Institutes of Health; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Ex vivo; Medicine; Granzyme; Immunotherapy; Perforin; CD8; Immunology; Myeloid leukemia; Leukemia; Granzyme B; Cancer research; CD34; Adoptive cell transfer; Peripheral blood mononuclear cell; Granzyme A; T cell; In vivo; Stem cell; Biology; Immune system; In vitro","score_opus":0.014339668091707055,"score_gpt":0.2535317871441942,"score_spread":0.23919211905248716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033172239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891921,0.00027107526,0.00061808235,0.000007924288,0.0005735138,0.0014061104,0.00013454726,0.00013255102,0.007664053],"genre_scores_gemma":[0.99469495,0.00022989007,0.0016782837,0.0001699849,0.00021369776,0.000058423724,0.00010021449,0.0001275334,0.002727021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968245,0.00021544196,0.00068066723,0.0007094644,0.00083575805,0.000734177],"domain_scores_gemma":[0.9978541,0.00025382396,0.00032134648,0.00103222,0.00027347662,0.00026503185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000360816,0.00050481025,0.0011092438,0.00026758722,0.00008686374,0.000024977973,0.00045911528,0.00043703796,0.005489744],"category_scores_gemma":[0.000038195274,0.00041713376,0.00045445838,0.00035172317,0.0003178688,0.0001318864,0.00015091313,0.00068336655,0.0001858274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057728374,0.00047213354,0.009579931,0.00012755011,0.0003774314,0.00007168972,0.002751344,0.000022270267,0.96847576,0.0000038571957,0.0008026408,0.011542557],"study_design_scores_gemma":[0.018765932,0.0032400806,0.05972113,0.00015884588,0.00018047835,0.0000152559705,0.00015194912,0.0005946944,0.9158785,0.000020052574,0.00088914623,0.00038395546],"about_ca_topic_score_codex":0.0055298503,"about_ca_topic_score_gemma":0.000024959709,"teacher_disagreement_score":0.05259728,"about_ca_system_score_codex":0.0012879071,"about_ca_system_score_gemma":0.0006006829,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W2033428882","doi":"10.1038/sj.leu.2403812","title":"RBM15 and MKL1 mutational screening in megakaryoblastic leukemia cell lines and clinical samples","year":2005,"lang":"en","type":"letter","venue":"Leukemia","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Sick Kids Foundation; American Lebanese Syrian Associated Charities","keywords":"Acute megakaryoblastic leukemia; Medicine; Leukemia; Oncology; Internal medicine; Cancer research; Immunology","score_opus":0.01795573941665285,"score_gpt":0.2540024096499394,"score_spread":0.23604667023328657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033428882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788811,0.0027922695,0.00092312886,0.015125931,0.00027182372,0.00030017944,0.00025678662,0.000024652472,0.0014241169],"genre_scores_gemma":[0.86565703,0.0016056494,0.011149337,0.09994958,0.011217485,0.000059053335,0.0031651224,0.0001252889,0.0070714722],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982472,0.000114623814,0.0005534272,0.0005969089,0.00015087087,0.0003369838],"domain_scores_gemma":[0.9992965,0.0001483637,0.00018321442,0.00024104831,0.0000585264,0.00007238716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021863852,0.00031767212,0.0003500201,0.00009404698,0.00009719673,0.00007833649,0.00016453708,0.0008788663,0.00008640499],"category_scores_gemma":[0.0000828709,0.00031933346,0.000093826464,0.000051140734,0.00016752654,0.000008535542,0.00019678629,0.0007025312,0.000009030375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021717705,0.00008190815,0.08241014,0.0009472736,0.0005357738,0.00045996654,0.00051690853,0.0023738062,0.0051951027,0.00017326727,0.8945804,0.012508251],"study_design_scores_gemma":[0.003242354,0.00038003377,0.09081705,0.00022619547,0.00022104311,0.00028410193,0.0002574497,0.0025014945,0.0020986083,0.0003325768,0.8982529,0.0013861872],"about_ca_topic_score_codex":0.00020315283,"about_ca_topic_score_gemma":0.00012723095,"teacher_disagreement_score":0.113224104,"about_ca_system_score_codex":0.00008169442,"about_ca_system_score_gemma":0.00041921172,"threshold_uncertainty_score":0.99992585},"labels":[],"label_agreement":null},{"id":"W2034266037","doi":"10.1038/leu.2014.255","title":"Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Bortezomib; MARCKS; Gene knockdown; Cancer research; Drug resistance; Proteasome; Biology; Kinome; Proteasome inhibitor; Multiple myeloma; Pharmacology; Cell culture; Phosphorylation; Medicine; Immunology; Cell biology; Protein kinase C","score_opus":0.03353693951535806,"score_gpt":0.3167081932484534,"score_spread":0.2831712537330953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034266037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968539,0.0005442989,0.00020130836,0.00020613801,0.000044652326,0.00041026136,0.000014171132,0.00003086375,0.0016943908],"genre_scores_gemma":[0.99618375,0.0001779266,0.0028427092,0.000049569575,0.000052287127,0.000030805568,0.000014987685,0.000020926782,0.00062703894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844784,0.00012744412,0.0003271492,0.00038285798,0.0003464046,0.00036829562],"domain_scores_gemma":[0.9986467,0.0006891212,0.00011868724,0.00028949603,0.00006406674,0.00019194122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046783529,0.00017510646,0.00049900875,0.00010869423,0.00005650516,0.000015635584,0.000102006714,0.000103507045,0.000021495918],"category_scores_gemma":[0.0008492205,0.0001453575,0.00006900352,0.00016893608,0.00015127372,0.0001902799,0.00010340509,0.00032330342,0.0000061483956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029380862,0.00056597515,0.8957292,0.00076184614,0.00015484563,0.00012231422,0.0007307474,0.00019550759,0.057174113,0.00036827332,0.00056124676,0.040697854],"study_design_scores_gemma":[0.009077127,0.00016469622,0.86429584,0.00046562668,0.00003513833,0.0000061425185,0.000080949765,0.057439394,0.066977695,0.00073599775,0.0004879314,0.00023344737],"about_ca_topic_score_codex":0.0007783017,"about_ca_topic_score_gemma":0.00033620678,"teacher_disagreement_score":0.057243887,"about_ca_system_score_codex":0.00019588055,"about_ca_system_score_gemma":0.00017961541,"threshold_uncertainty_score":0.5927506},"labels":[],"label_agreement":null},{"id":"W2034457052","doi":"10.1038/sj.leu.2403247","title":"Imatinib sensitizes CLL lymphocytes to chlorambucil","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Jewish General Hospital; Leukemia Research Foundation","keywords":"Chlorambucil; Imatinib; Cancer research; Medicine; Chronic lymphocytic leukemia; Leukemia; Hematology; Imatinib mesylate; Immunology; Oncology; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.02185953892160975,"score_gpt":0.30061950718219543,"score_spread":0.2787599682605857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034457052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90364796,0.0003147119,0.00029503444,0.00057104405,0.00043998478,0.0007295547,0.0000089911655,0.00025543058,0.09373728],"genre_scores_gemma":[0.96842843,0.000049842336,0.0060810745,0.0032542853,0.0003108695,0.00006256795,0.000020570053,0.00008169525,0.02171065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997264,0.00009455642,0.00041759445,0.00058284955,0.0007852839,0.00085566955],"domain_scores_gemma":[0.9978784,0.00025877892,0.00006126985,0.00092091324,0.00022926732,0.000651373],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005340576,0.00029856578,0.000501528,0.00021102627,0.00012533015,0.00006732985,0.00018120553,0.0001971849,0.000744469],"category_scores_gemma":[0.0012949958,0.00026252118,0.00016287052,0.0006369039,0.00012729836,0.0000956601,0.000104187515,0.000272456,0.003295488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006045812,0.0010926975,0.0062241284,0.0033373921,0.0016064815,0.013800044,0.012487771,0.0033871625,0.19453014,0.05829686,0.6214226,0.07776892],"study_design_scores_gemma":[0.056472775,0.0010607879,0.0029037397,0.0006647624,0.00022939587,0.006002805,0.0011384494,0.013175193,0.44254225,0.0014829084,0.4729788,0.0013481303],"about_ca_topic_score_codex":0.0005118217,"about_ca_topic_score_gemma":0.0000374708,"teacher_disagreement_score":0.24801213,"about_ca_system_score_codex":0.032403782,"about_ca_system_score_gemma":0.014737836,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W2036954783","doi":"10.1038/sj.leu.2403696","title":"Transplantable cell lines generated with NUP98–Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Hox gene; Fusion gene; Biology; Gene; DNA; Cancer research; Genetics; Cell fusion; Cell culture; Cell biology; Transcription factor","score_opus":0.006053653991817164,"score_gpt":0.25613171289350145,"score_spread":0.2500780589016843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036954783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856935,0.0032601634,0.010259016,0.00007199926,0.00008440661,0.00027757703,0.00003734761,0.00002723096,0.00028873945],"genre_scores_gemma":[0.9932519,0.0009559267,0.002882783,0.00007758995,0.00020687802,0.000028087872,0.0002359544,0.000043740813,0.0023171082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879354,0.000023782106,0.0002607511,0.00038491498,0.00021226639,0.00032471816],"domain_scores_gemma":[0.99945796,0.0000071899553,0.00007506357,0.00025136958,0.00007333648,0.00013509448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009814082,0.00023057174,0.00019455426,0.00007193613,0.00007098589,0.000030530406,0.00019349137,0.00019402064,0.00002217562],"category_scores_gemma":[0.000005723644,0.00019516064,0.000052270356,0.00016471633,0.000017006982,0.000011561192,0.000060454917,0.0001024655,0.000011718356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001329181,0.000038403872,0.00044845635,0.00008779336,0.000025015435,0.0000029886194,0.00007710255,0.021106686,0.97353673,0.0000029482464,0.0011707045,0.0033702664],"study_design_scores_gemma":[0.0009174616,0.0002908963,0.00018982908,0.000089947614,0.000031200812,0.00001956233,0.000053854274,0.0011573985,0.98149204,5.1275595e-7,0.015489616,0.00026769235],"about_ca_topic_score_codex":0.000024880283,"about_ca_topic_score_gemma":0.0000937333,"teacher_disagreement_score":0.019949287,"about_ca_system_score_codex":0.00011214033,"about_ca_system_score_gemma":0.00016877578,"threshold_uncertainty_score":0.795842},"labels":[],"label_agreement":null},{"id":"W2037393425","doi":"10.1038/sj.leu.2404566","title":"Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion","year":2007,"lang":"en","type":"letter","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Toronto Rehabilitation Institute","keywords":"Stem cell; Haematopoiesis; Transplantation; Hematopoietic stem cell transplantation; In vitro; Immunology; Cancer research; Biology; Hematopoietic cell; Cell; Oncology; Medicine; Internal medicine; Cell biology; Genetics","score_opus":0.014627221816568205,"score_gpt":0.27294873553643234,"score_spread":0.2583215137198641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037393425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926473,0.00023336391,0.00036699063,0.0013443043,0.004135559,0.00076322915,0.00000833421,0.00005418767,0.00044672808],"genre_scores_gemma":[0.96999353,0.00012410575,0.000029930052,0.026585322,0.00009826104,0.00003786783,0.00058808154,0.00004920597,0.0024936993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963466,0.0008964415,0.0015157933,0.0006437584,0.00013011447,0.0004672756],"domain_scores_gemma":[0.99757886,0.0013819888,0.00049617095,0.00046058334,0.000060174563,0.000022212294],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006355661,0.00043103698,0.0011058409,0.0005111293,0.000047353875,0.000017420285,0.00023476234,0.001926153,0.000051149687],"category_scores_gemma":[0.000051799925,0.0003986671,0.00033210992,0.0001640871,0.00017038493,0.00009647211,0.00003429099,0.0031479946,0.00033710815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094940225,0.0023925363,0.18011,0.0069603706,0.00030459327,0.0009439553,0.0027266257,0.00005416601,0.7190994,0.000007882995,0.073699966,0.004206452],"study_design_scores_gemma":[0.010146809,0.0012418125,0.08962924,0.00080587104,0.00022460148,0.0000788885,0.000100158235,0.000036567773,0.8846547,0.000027536302,0.012306332,0.00074750447],"about_ca_topic_score_codex":0.0005868729,"about_ca_topic_score_gemma":0.000099495315,"teacher_disagreement_score":0.16555525,"about_ca_system_score_codex":0.00057721767,"about_ca_system_score_gemma":0.00013440524,"threshold_uncertainty_score":0.9998465},"labels":[],"label_agreement":null},{"id":"W2037904434","doi":"10.1038/sj.leu.2402165","title":"The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Montreal Children's Hospital","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Lymphoblast; Methotrexate; Lymphoblastic Leukemia; Medicine; Leukemia; Progenitor cell; Cancer research; Acute lymphocytic leukemia; Internal medicine; Oncology; Biology; Immunology; Stem cell; Genetics; Cell culture; Gene","score_opus":0.011786266522313979,"score_gpt":0.277527503981215,"score_spread":0.26574123745890105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037904434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610776,0.00035257885,0.00015533813,0.0005771131,0.00006682197,0.0024661836,0.00001260814,0.000028403367,0.00023317838],"genre_scores_gemma":[0.9987464,0.00036332247,0.00023009715,0.00007713136,0.00014022063,0.00023613569,0.000011539564,0.000059509806,0.00013564272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961904,0.000742626,0.0008197356,0.00050588604,0.0011198123,0.0006215271],"domain_scores_gemma":[0.9963462,0.0019811543,0.00071795745,0.00059355836,0.000255659,0.000105476385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001454794,0.00036158346,0.00066813006,0.0003007884,0.00021263935,0.000039845596,0.00044103415,0.00028609193,0.000006837878],"category_scores_gemma":[0.00026713024,0.00017868905,0.00008569129,0.002054639,0.000273086,0.00019680744,0.00012415227,0.0005419268,0.0000031638453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004384401,0.001028837,0.9623842,0.00016782482,0.00041789314,0.00011370761,0.010911503,0.0029019555,0.012269637,0.000041670824,0.000054187443,0.00532415],"study_design_scores_gemma":[0.021464119,0.0023992977,0.96016,0.00015618428,0.0006897524,0.00025377824,0.0031957407,0.0076774694,0.0036975923,0.000042917538,0.000036774632,0.00022633877],"about_ca_topic_score_codex":0.001469886,"about_ca_topic_score_gemma":0.0038087892,"teacher_disagreement_score":0.017079718,"about_ca_system_score_codex":0.006540025,"about_ca_system_score_gemma":0.0034239797,"threshold_uncertainty_score":0.9972737},"labels":[],"label_agreement":null},{"id":"W2038778317","doi":"10.1038/leu.2010.27","title":"Targeting PKCδ-mediated topoisomerase IIβ overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Retinoic acid; Biology; Acute promyelocytic leukemia; Cell culture; Cellular differentiation; Cell biology; Molecular biology; Protein kinase C; Tretinoin; Cancer research; Kinase; Biochemistry; Gene; Genetics","score_opus":0.004330259488182984,"score_gpt":0.2125653894110509,"score_spread":0.2082351299228679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038778317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708587,0.00079086784,0.00018317648,0.0001353348,0.00028304785,0.00026424992,0.00001592312,0.000031264884,0.0012102886],"genre_scores_gemma":[0.9974523,0.00024499852,0.00031320294,0.0002755895,0.00048406876,0.00004940829,0.00040800698,0.000040346917,0.00073206634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828666,0.000119289485,0.00041259106,0.00050376996,0.0002645045,0.0004131597],"domain_scores_gemma":[0.9990124,0.00005532292,0.00020560068,0.0005342189,0.000093962,0.00009849718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000319799,0.00027271872,0.00019625048,0.000057196146,0.00017825198,0.00006353862,0.0004101161,0.0003851168,0.00007699872],"category_scores_gemma":[0.00037842413,0.00019927537,0.000097859556,0.00019391628,0.000100245445,0.000011041423,0.00018699546,0.00054658286,0.000021682219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014058883,0.000055008033,0.0032881717,0.00006236651,0.000009137125,0.000009139259,0.00010486726,0.000072687864,0.9947059,0.000022344257,0.0013484039,0.0001813826],"study_design_scores_gemma":[0.0010515024,0.0001048037,0.003034196,0.000044582746,0.000016487647,0.000007118619,0.000101568716,0.0011628328,0.98658264,0.00014015856,0.0074574114,0.0002967152],"about_ca_topic_score_codex":0.00007318707,"about_ca_topic_score_gemma":0.000081377475,"teacher_disagreement_score":0.0081232805,"about_ca_system_score_codex":0.000076203185,"about_ca_system_score_gemma":0.00023207649,"threshold_uncertainty_score":0.8126214},"labels":[],"label_agreement":null},{"id":"W2039301616","doi":"10.1038/leu.2011.113","title":"TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atomic Energy (Canada)","funders":"National Natural Science Foundation of China","keywords":"Downregulation and upregulation; Lymphoma; Knockout mouse; Cancer research; TLR4; Biology; Immunology; Medicine; Gene; Genetics; Inflammation","score_opus":0.010406997059694008,"score_gpt":0.20093167771226958,"score_spread":0.19052468065257558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039301616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481551,0.009710023,0.00024889054,0.020910537,0.010871491,0.0019044399,0.00028389326,0.00030334157,0.0076122824],"genre_scores_gemma":[0.7445782,0.0005342217,0.00013098541,0.113697,0.0015715412,0.0002596357,0.019992592,0.00022405885,0.119011775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982763,0.00027947643,0.00055353355,0.0005140007,0.00006381939,0.00031288608],"domain_scores_gemma":[0.9986593,0.0001649956,0.0006342998,0.0004194395,0.00010538102,0.00001656358],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000101066886,0.00037108143,0.0005084922,0.00019249028,0.00013780725,0.000023645018,0.00020878432,0.0018270133,0.0016632066],"category_scores_gemma":[0.000060448026,0.00035959063,0.000136844,0.00009505463,0.00011064998,0.00018276052,0.000060085447,0.0008855122,0.0006824583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011472024,0.000016325797,0.000017790333,0.000037136797,0.0001701966,0.000002018832,0.0002531908,2.2826188e-7,0.4577438,0.000005419167,0.5357145,0.005924709],"study_design_scores_gemma":[0.0013449555,0.00012111081,0.002509715,0.000095365605,0.00009488023,0.000028735643,0.000029146444,0.00000877418,0.31644103,0.000057672325,0.6789787,0.00028989618],"about_ca_topic_score_codex":0.003315619,"about_ca_topic_score_gemma":0.000013479769,"teacher_disagreement_score":0.20357691,"about_ca_system_score_codex":0.00035835904,"about_ca_system_score_gemma":0.00017965154,"threshold_uncertainty_score":0.9998856},"labels":[],"label_agreement":null},{"id":"W2039573384","doi":"10.1038/sj.leu.2405037","title":"Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Transplantation; Total body irradiation; Sibling; Acute lymphocytic leukemia; Chemotherapy; Internal medicine; Regimen; Chemotherapy regimen; Cyclophosphamide; Leukemia; Pediatrics; Oncology; Surgery; Lymphoblastic Leukemia; Psychology","score_opus":0.008860728886685102,"score_gpt":0.29342999070199055,"score_spread":0.28456926181530545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039573384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942815,0.00007942148,0.00026803106,0.00022933702,0.00009415275,0.004796526,0.00018170266,0.000025217492,0.000044126486],"genre_scores_gemma":[0.99851096,0.00013492118,0.00042121677,0.0001914765,0.00009809742,0.00042136153,0.00007087262,0.000059677677,0.00009139976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966115,0.00052406226,0.00078512524,0.00064780435,0.00073741475,0.00069412],"domain_scores_gemma":[0.99810505,0.00083495135,0.00019010923,0.00036880118,0.00031078394,0.00019028374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001626721,0.0003432377,0.00070641795,0.0004934417,0.00012628947,0.000057695477,0.00030352033,0.000296049,0.000020267724],"category_scores_gemma":[0.000106869345,0.0001805558,0.00006251206,0.00086313847,0.00041084897,0.00021436418,0.00006625149,0.00066140207,3.437388e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117308594,0.0005076214,0.850412,0.00021437224,0.0008225048,0.00044791657,0.027947798,0.00005277754,0.0015064108,0.000023718914,0.0000137096185,0.0007425769],"study_design_scores_gemma":[0.078653306,0.0020548964,0.9095645,0.0007178488,0.00030168358,0.0011208116,0.0032128973,0.0036938398,0.00046222724,0.000012198478,0.0000076433425,0.00019814789],"about_ca_topic_score_codex":0.00087451347,"about_ca_topic_score_gemma":0.006391291,"teacher_disagreement_score":0.059152495,"about_ca_system_score_codex":0.0028180394,"about_ca_system_score_gemma":0.0013397636,"threshold_uncertainty_score":0.7369075},"labels":[],"label_agreement":null},{"id":"W2040596732","doi":"10.1038/leu.2012.153","title":"A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission","year":2012,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Vrije Universiteit Brussel; Eisai; Fonds Wetenschappelijk Onderzoek; Stem Cell Network","keywords":"Decitabine; Myeloid leukemia; Medicine; Randomized controlled trial; Internal medicine; Leukemia; Oncology; Complete remission; Maintenance therapy; Myeloid; Cytarabine; Intensive care medicine; Chemotherapy; Biology","score_opus":0.0290794654399181,"score_gpt":0.2998485099609,"score_spread":0.27076904452098194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040596732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769513,0.00054105336,0.00008454278,0.0067803264,0.0004973655,0.014157016,0.0003505008,0.00005640381,0.0005814869],"genre_scores_gemma":[0.9496504,0.00043701284,0.003033722,0.028731255,0.0019061348,0.003920825,0.009405756,0.00054068025,0.0023742123],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99402046,0.0005901063,0.0014862258,0.0010375694,0.0016163798,0.0012492843],"domain_scores_gemma":[0.9956568,0.0014161533,0.0007287377,0.001058667,0.00094005704,0.00019957704],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000995363,0.0008340993,0.0030645826,0.0009622597,0.000088550456,0.000027076143,0.00060945534,0.0009894104,0.00014576277],"category_scores_gemma":[0.0004227584,0.00060695084,0.00042934762,0.00072497723,0.0003575833,0.00017428893,0.00018042208,0.0029627602,0.0000151042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8655142,0.0005273402,0.019974446,0.0011903517,0.0017732,0.000628281,0.0032755327,0.00008737734,0.00011199172,0.000019219591,0.104094684,0.002803328],"study_design_scores_gemma":[0.9293958,0.003978767,0.02054715,0.0014603097,0.0005120377,0.000015164995,0.0006011596,0.00044114076,0.00006641932,0.000035480858,0.042231288,0.00071531517],"about_ca_topic_score_codex":0.0013135439,"about_ca_topic_score_gemma":0.0001925233,"teacher_disagreement_score":0.06388152,"about_ca_system_score_codex":0.011816188,"about_ca_system_score_gemma":0.0032896025,"threshold_uncertainty_score":0.9996382},"labels":[],"label_agreement":null},{"id":"W2042882717","doi":"10.1038/sj.leu.2402059","title":"The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Transcription factor; Cancer research; Oncogene; Molecular biology; Promoter; Gene expression; Regulation of gene expression; Tumor suppressor gene; Cell culture; Gene; Jurkat cells; Cell cycle; Immunology; T cell; Carcinogenesis; Genetics","score_opus":0.011713504002836177,"score_gpt":0.23533271003886944,"score_spread":0.22361920603603325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042882717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611604,0.0019530618,0.001048956,0.00014000719,0.00021679889,0.00026989964,0.000051647345,0.000005308564,0.00019830336],"genre_scores_gemma":[0.99723846,0.0012224606,0.0009006043,0.00014118273,0.0000811625,0.000029890301,0.000017904003,0.000019119716,0.00034920123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988524,0.00016606509,0.0002587728,0.00029626006,0.00019429297,0.00023221385],"domain_scores_gemma":[0.9993796,0.000029361187,0.00014019111,0.0003467504,0.0000507808,0.000053356554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020384733,0.00016132946,0.00016018272,0.000029965351,0.000107414926,0.000021914286,0.00030037243,0.0001522111,0.000025968835],"category_scores_gemma":[0.000037363305,0.00010194059,0.00008883987,0.000118572636,0.00010820332,0.000009770144,0.00007462714,0.00014666558,0.0000018262439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010309166,0.0000120554605,0.00017897217,0.0000103616285,0.00002187793,0.0000014324818,0.00024230522,0.00016746987,0.9942336,0.000018514093,0.00013815498,0.0048721796],"study_design_scores_gemma":[0.00061112794,0.00009143155,0.0030173347,0.000019420882,0.000016142729,0.000006549714,0.00019809029,0.00006385709,0.9899014,0.0003945057,0.005559703,0.00012039226],"about_ca_topic_score_codex":0.000056212877,"about_ca_topic_score_gemma":0.000069906164,"teacher_disagreement_score":0.0054215477,"about_ca_system_score_codex":0.00007853443,"about_ca_system_score_gemma":0.00016914222,"threshold_uncertainty_score":0.41570166},"labels":[],"label_agreement":null},{"id":"W2042938402","doi":"10.1038/leu.2014.29","title":"Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031","year":2014,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; BC Children's Hospital; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; World Health Organization","keywords":"Lymphoblastic Leukemia; Pediatric oncology; Medicine; Philadelphia chromosome; Internal medicine; Oncology; Leukemia; Hematology; Pediatrics; Genetics; Cancer; Chromosomal translocation; Biology; Gene","score_opus":0.010108944254262297,"score_gpt":0.2593136477111495,"score_spread":0.24920470345688722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042938402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95783144,0.00032522678,0.00011399977,0.02931397,0.0009106642,0.006679253,0.0040080654,0.000463239,0.00035411483],"genre_scores_gemma":[0.86863583,0.0010044011,0.0006884301,0.10862855,0.010162306,0.00046827312,0.009334702,0.0006123628,0.0004651662],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9852943,0.001964895,0.002851587,0.004412993,0.0027418716,0.0027343994],"domain_scores_gemma":[0.99135876,0.0026786376,0.001666724,0.003055845,0.00037649105,0.0008635364],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00127825,0.0023862093,0.0042353556,0.0016738913,0.00039762657,0.00024679408,0.0017384276,0.004401769,0.00014931137],"category_scores_gemma":[0.001886646,0.0021831146,0.00049783365,0.0012605409,0.0012078417,0.00040966994,0.0014840277,0.010044926,0.0006667854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008582855,0.00094354723,0.10820817,0.00029846057,0.007075753,0.009881571,0.0020757606,0.0001970449,0.0002494515,0.000007859374,0.85921025,0.003269286],"study_design_scores_gemma":[0.105222434,0.006698562,0.86607563,0.003000871,0.005092931,0.0021093485,0.00017915375,0.0018450933,0.00011321385,0.00039722296,0.0064305384,0.0028350125],"about_ca_topic_score_codex":0.049454585,"about_ca_topic_score_gemma":0.00097233127,"teacher_disagreement_score":0.8527797,"about_ca_system_score_codex":0.041626535,"about_ca_system_score_gemma":0.00837815,"threshold_uncertainty_score":0.99888754},"labels":[],"label_agreement":null},{"id":"W2044250831","doi":"10.1038/leu.2014.10","title":"A role for oleoylethanolamide in chronic lymphocytic leukemia","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; York University; Sunnybrook Hospital; Medical Council of Canada","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada","keywords":"Chronic lymphocytic leukemia; Endocrinology; Internal medicine; Fatty acid amide hydrolase; Lipolysis; Endocannabinoid system; Chemistry; Leukemia; Cancer cell; Receptor; Cannabinoid receptor; Biology; Cancer research; Adipose tissue; Cancer; Medicine","score_opus":0.010394423540837637,"score_gpt":0.24715442341963503,"score_spread":0.2367599998787974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044250831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663731,0.0005135976,0.00075897435,0.00010251563,0.00015929475,0.00043987005,0.0000031560503,0.00013794137,0.031511553],"genre_scores_gemma":[0.99174136,0.000024460267,0.0008514069,0.0016542517,0.00048022182,0.00015379574,0.000034132587,0.000031770294,0.0050285724],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99887186,0.000029511186,0.00026476002,0.0002875387,0.00015646065,0.00038989188],"domain_scores_gemma":[0.9991993,0.00022402269,0.000058171125,0.0003383427,0.00004365818,0.00013655386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025610402,0.000161488,0.00036186338,0.0001443002,0.00004256917,0.000015569087,0.00008356897,0.0001439859,0.00013296123],"category_scores_gemma":[0.00042100227,0.00014456367,0.00010884403,0.00019293764,0.000047497615,0.00005900285,0.000022820483,0.00013236832,0.00022412984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017015457,0.00007802053,0.031249637,0.0020462347,0.00027218735,0.00003659051,0.0010856171,0.008915247,0.8013646,0.0121692475,0.025253005,0.11582808],"study_design_scores_gemma":[0.028780531,0.0013966117,0.070187666,0.0008013642,0.00024083187,0.0000631505,0.00017742625,0.57753813,0.12708864,0.004322033,0.188743,0.0006606145],"about_ca_topic_score_codex":0.00031512635,"about_ca_topic_score_gemma":0.00005223746,"teacher_disagreement_score":0.67427593,"about_ca_system_score_codex":0.013914978,"about_ca_system_score_gemma":0.0029696834,"threshold_uncertainty_score":0.9898704},"labels":[],"label_agreement":null},{"id":"W2045103043","doi":"10.1038/sj.leu.2403335","title":"Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Cancer research; Imatinib mesylate; K562 cells; Tyrosine kinase; ABL; Stem cell; Growth factor; Cell biology; Imatinib; Leukemia; Immunology; Signal transduction; Myeloid leukemia; Receptor","score_opus":0.015433312532936694,"score_gpt":0.24942036779335638,"score_spread":0.23398705526041969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045103043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961694,0.00016562069,0.00026050906,0.00016619169,0.00019609713,0.00068741123,0.000022516286,0.00008316184,0.0022490958],"genre_scores_gemma":[0.99800444,0.000064551954,0.0008159235,0.000272448,0.00021649244,0.00004962222,0.000101637124,0.000061305036,0.00041359343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976973,0.00005454713,0.00064976944,0.00063887244,0.0004663575,0.00049316406],"domain_scores_gemma":[0.9988983,0.00015122893,0.00018888415,0.00046396418,0.00005294342,0.00024467736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017316181,0.00042530903,0.0006913367,0.00028891393,0.00012278024,0.000023650828,0.00013358226,0.00023689005,0.00016485626],"category_scores_gemma":[0.00003643904,0.00036903846,0.00015462401,0.00021527383,0.000079637844,0.00010561932,0.00006452751,0.000621116,0.000026029735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017825208,0.0027452374,0.06097801,0.0010221512,0.0008945539,0.00112031,0.0026545639,0.001069143,0.91868746,0.00505397,0.00015117356,0.0038408968],"study_design_scores_gemma":[0.049222037,0.00230006,0.3534568,0.0011564854,0.00064416765,0.00019981618,0.00017166388,0.00029455184,0.59048057,0.0011852524,0.00026314083,0.0006254663],"about_ca_topic_score_codex":0.0014724922,"about_ca_topic_score_gemma":0.0006277204,"teacher_disagreement_score":0.3282069,"about_ca_system_score_codex":0.003296582,"about_ca_system_score_gemma":0.00094668084,"threshold_uncertainty_score":0.99987614},"labels":[],"label_agreement":null},{"id":"W2045794442","doi":"10.1038/sj.leu.2403921","title":"ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas","year":2005,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Center for Long-Term Cybersecurity, University of California Berkeley; Deutsche Krebshilfe","keywords":"Lymphoma; Clathrin; Anaplastic lymphoma kinase; Fusion gene; Cancer research; Medicine; Pathology; Virology; Biology; Internal medicine; Genetics; Gene","score_opus":0.006942954419659957,"score_gpt":0.21738802117515313,"score_spread":0.21044506675549318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045794442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64983547,0.0039526303,0.000055171728,0.3202402,0.000568395,0.003228663,0.0006134408,0.00020004644,0.021305988],"genre_scores_gemma":[0.6307418,0.0017192606,0.0006460911,0.34285635,0.00969595,0.0004154227,0.0011344674,0.00030065258,0.012490049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572974,0.00012497736,0.00072505267,0.001071663,0.0012418095,0.001106734],"domain_scores_gemma":[0.9972365,0.00031306947,0.0005206392,0.001468498,0.00016474511,0.00029652967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019021216,0.0009487187,0.0012544144,0.00041440196,0.00023855499,0.000064312946,0.0004998267,0.0008776884,0.00022394369],"category_scores_gemma":[0.000027618655,0.00057539216,0.00047914844,0.0006866731,0.000101402096,0.00009048351,0.0002892596,0.00057852356,0.0005610283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006399114,0.0035337277,0.0124942735,0.00039185173,0.00057918084,0.0050380314,0.0014119816,0.000011293973,0.000047153677,0.00008593563,0.9680081,0.007758545],"study_design_scores_gemma":[0.041238364,0.0023632618,0.056595247,0.00058509514,0.0031439979,0.0006635884,0.00010239835,0.00007167808,0.005493615,0.000026957436,0.8886342,0.0010815753],"about_ca_topic_score_codex":0.0011514486,"about_ca_topic_score_gemma":0.00021025266,"teacher_disagreement_score":0.079373896,"about_ca_system_score_codex":0.0033439288,"about_ca_system_score_gemma":0.0014595236,"threshold_uncertainty_score":0.99966973},"labels":[],"label_agreement":null},{"id":"W2045908279","doi":"10.1038/leu.2008.115","title":"Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Megakaryocyte; Essential thrombocythemia; Polycythemia vera; Mutation; Hematology; Myelofibrosis; Cancer research; Myeloproliferative Disorders; Thrombocytosis; Genetics; Biology; Immunology; Haematopoiesis; Medicine; Gene; Platelet; Bone marrow; Stem cell","score_opus":0.01361377132491346,"score_gpt":0.2427615797508115,"score_spread":0.22914780842589805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045908279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414045,0.0001424282,0.00028552246,0.00033673103,0.000066669,0.0007358095,0.000020583804,0.000082367806,0.0041894615],"genre_scores_gemma":[0.9961696,0.0002468416,0.002054129,0.00035141196,0.00014420373,0.00018290301,0.0001447182,0.000023393965,0.00068278424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989041,0.00002895247,0.00022425575,0.00026069858,0.0003503126,0.00023165457],"domain_scores_gemma":[0.99934715,0.00008929195,0.000083043284,0.0001879353,0.00014409565,0.00014850238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053311775,0.00019950153,0.0003180829,0.000074026924,0.00027692365,0.000020990527,0.000039067145,0.00009404966,0.00009991152],"category_scores_gemma":[0.000036064303,0.00014846172,0.000049924318,0.00013241173,0.00016567568,0.00017276661,0.000022748756,0.00009469311,0.00004994915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031061733,0.0050459756,0.43423513,0.0019588615,0.005695136,0.11627254,0.07639215,0.0025844784,0.1873301,0.014632323,0.07001875,0.054772843],"study_design_scores_gemma":[0.03443127,0.0058805244,0.6165737,0.00059192546,0.0015599625,0.08317496,0.0013155189,0.009586467,0.22882353,0.00036830647,0.016411893,0.0012819567],"about_ca_topic_score_codex":0.00014076247,"about_ca_topic_score_gemma":0.00021480532,"teacher_disagreement_score":0.18233857,"about_ca_system_score_codex":0.0005641442,"about_ca_system_score_gemma":0.00038554452,"threshold_uncertainty_score":0.6054093},"labels":[],"label_agreement":null},{"id":"W2047597898","doi":"10.1038/leu.2014.30","title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":449,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; BC Children's Hospital; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Minimal residual disease; Imatinib; Internal medicine; Chemotherapy; Cohort; Imatinib mesylate; Acute lymphocytic leukemia; Oncology; Induction chemotherapy; Philadelphia chromosome; Leukemia; Lymphoblastic Leukemia; Chromosomal translocation; Myeloid leukemia","score_opus":0.011997918928736855,"score_gpt":0.2883121082159874,"score_spread":0.27631418928725054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047597898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233407,0.0001982466,0.0010753783,0.00027041032,0.00057004025,0.0027392465,0.0000666611,0.00017962091,0.002566317],"genre_scores_gemma":[0.9964925,0.00025990608,0.0006177981,0.00042770404,0.0010633465,0.0002723449,0.00028518512,0.00018193219,0.00039926445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99321645,0.0006317437,0.0016936434,0.0013984741,0.0015563192,0.0015033701],"domain_scores_gemma":[0.9956129,0.0013480411,0.0006536177,0.0013420192,0.00039463682,0.00064875407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011874774,0.0008378247,0.0020035126,0.0011648278,0.00017041725,0.00005094275,0.00092441693,0.00075946894,0.0002448302],"category_scores_gemma":[0.0008436455,0.00076143607,0.00038852534,0.001841621,0.00043348642,0.00032621672,0.0006467639,0.001275619,0.00030162494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005207927,0.0028812203,0.9620854,0.0007687866,0.001573086,0.002500013,0.0038052648,0.0002838474,0.008932625,0.00037126432,0.0032880534,0.008302464],"study_design_scores_gemma":[0.046618383,0.0075125005,0.93791753,0.00029847864,0.001510774,0.0009093565,0.00020262355,0.0030319423,0.0011278357,0.00010234089,0.000027952503,0.00074026495],"about_ca_topic_score_codex":0.000704061,"about_ca_topic_score_gemma":0.0003179992,"teacher_disagreement_score":0.041410457,"about_ca_system_score_codex":0.012291504,"about_ca_system_score_gemma":0.004580934,"threshold_uncertainty_score":0.99948364},"labels":[],"label_agreement":null},{"id":"W2048337856","doi":"10.1038/sj.leu.2404655","title":"The outcome of intensive induction therapy in patients ⩾70 years with acute myeloid leukemia","year":2007,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Israel Cancer Association","keywords":"Myeloid leukemia; Medicine; Induction therapy; Internal medicine; Oncology; Myeloid; Cytarabine; Hematology; Leukemia; Intensive care medicine; Chemotherapy","score_opus":0.02528736010437574,"score_gpt":0.2957891180866036,"score_spread":0.27050175798222786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048337856","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90801495,0.0002771041,0.000032633452,0.08600804,0.0008307579,0.002672369,0.00007111589,0.00010968179,0.0019833392],"genre_scores_gemma":[0.12360623,0.0023945011,0.0011667243,0.8410056,0.0053978804,0.00034481223,0.0020871174,0.00078049494,0.023216646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946581,0.00021596279,0.001182042,0.0008681416,0.0018474498,0.0012282724],"domain_scores_gemma":[0.9955742,0.0004676093,0.0006645623,0.0014888145,0.0016384363,0.00016640086],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007561251,0.0007096138,0.0012754594,0.00087219424,0.00012352866,0.000057686564,0.0007793652,0.001663424,0.00006660263],"category_scores_gemma":[0.0004050368,0.00046139644,0.00029939116,0.0011217812,0.0007539924,0.00016371656,0.00021330286,0.0070364983,0.0001206433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004051262,0.0000481463,0.05859664,0.00019405763,0.0010609137,0.002595223,0.00075614924,0.000010844938,0.00029821097,0.000012143186,0.90268356,0.02969283],"study_design_scores_gemma":[0.015251436,0.0030788162,0.37966543,0.00076135393,0.00035433058,0.00032092372,0.0005051542,0.000060592265,0.0020100141,0.00008271969,0.59685946,0.0010497638],"about_ca_topic_score_codex":0.0014036169,"about_ca_topic_score_gemma":0.00008915581,"teacher_disagreement_score":0.78440875,"about_ca_system_score_codex":0.00894309,"about_ca_system_score_gemma":0.00261166,"threshold_uncertainty_score":0.99978375},"labels":[],"label_agreement":null},{"id":"W2049874438","doi":"10.1038/leu.2013.225","title":"Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Cancer Institute; U.S. Public Health Service; National Institutes of Health; Institut National Du Cancer","keywords":"Internal medicine; Multiple myeloma; Multivariate analysis; Univariate analysis; Medicine; Oncology; Gastroenterology","score_opus":0.014070746508805087,"score_gpt":0.24729362050359605,"score_spread":0.23322287399479097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049874438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967891,0.000011969461,0.0000080412465,0.00021747123,0.0000721146,0.0023217571,0.000012578166,0.00001392175,0.00055307185],"genre_scores_gemma":[0.99910754,0.0000070246538,0.00003551528,0.00018052055,0.000020391853,0.00035613246,0.00002673446,0.000019673585,0.0002464419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821335,0.00008947142,0.00024910798,0.0002798546,0.0008373974,0.00033083034],"domain_scores_gemma":[0.9989883,0.000083866944,0.00014004474,0.00046877208,0.00021411697,0.000104944185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004211983,0.00017520107,0.00018734748,0.00008612461,0.00009826707,0.000023640998,0.00019791404,0.000079357815,0.000084004954],"category_scores_gemma":[0.00020403643,0.000081200225,0.00005842428,0.00028518928,0.00011262918,0.00011964773,0.000076162585,0.00025799722,0.000055102868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002677214,0.00034920085,0.99076,0.00003044368,0.000032563625,0.000006326426,0.0019258681,0.0000020161342,0.00006184273,0.000009563068,0.00018494559,0.0063694613],"study_design_scores_gemma":[0.004677793,0.0006447612,0.99220914,0.00024078767,0.000017771517,0.0000029910773,0.00017483176,0.00015911159,0.0017318961,0.000019639121,0.000043298263,0.000077970835],"about_ca_topic_score_codex":0.0017579442,"about_ca_topic_score_gemma":0.00020728068,"teacher_disagreement_score":0.0062914905,"about_ca_system_score_codex":0.00055476255,"about_ca_system_score_gemma":0.00013344407,"threshold_uncertainty_score":0.3311249},"labels":[],"label_agreement":null},{"id":"W2051030733","doi":"10.1038/leu.2008.314","title":"The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed–Sternberg cells","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke","funders":"College of Medicine, University of Cincinnati; University of Manitoba","keywords":"Telomere; Shelterin; Mitosis; Biology; Reed–Sternberg cell; Cell nucleus; Telomerase; Cytoplasm; Cell biology; Molecular biology; DNA; Genetics; Immunology; Lymphoma","score_opus":0.009640676778479889,"score_gpt":0.20832621679499436,"score_spread":0.19868554001651448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051030733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955877,0.00015218342,0.00046860133,0.001980469,0.00025590413,0.00034862023,0.000023631079,0.00006852975,0.0011143291],"genre_scores_gemma":[0.9958276,0.0004586657,0.0007565753,0.0017312702,0.0002793342,0.000004709047,0.000034331126,0.00004274765,0.0008647448],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987456,0.00008273231,0.00032524418,0.00024509878,0.00036843575,0.00023288825],"domain_scores_gemma":[0.9989321,0.00018167627,0.000098142766,0.00052961934,0.00015292128,0.00010553894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001418751,0.00015553385,0.00023194718,0.000055601762,0.00030709457,0.000021393658,0.00024257242,0.00010968687,0.00030190113],"category_scores_gemma":[0.000107909196,0.00009454611,0.000064776315,0.00045477558,0.0001695888,0.00007072992,0.00003836459,0.00021087183,0.0001732062],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011553126,0.00022387404,0.01718162,0.00013471548,0.00028925596,0.00018870109,0.036834728,0.00042292092,0.8056308,0.0003823641,0.07702764,0.060528077],"study_design_scores_gemma":[0.0033360764,0.00056379335,0.5805156,0.00042832538,0.00032121147,0.00020291812,0.0038963666,0.0018046363,0.29141423,0.0001559127,0.116692066,0.0006688163],"about_ca_topic_score_codex":0.0009042285,"about_ca_topic_score_gemma":0.00007797227,"teacher_disagreement_score":0.56333405,"about_ca_system_score_codex":0.00015075211,"about_ca_system_score_gemma":0.00014438995,"threshold_uncertainty_score":0.38554785},"labels":[],"label_agreement":null},{"id":"W2051200223","doi":"10.1038/leu.2010.303","title":"Differential expression of the BCR gene in sequential stages of murine hematopoietic hierarchy","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Haematopoiesis; Biology; Hierarchy; Gene; breakpoint cluster region; Gene expression; Genetics; Cancer research; Computational biology; Stem cell","score_opus":0.015163481234680866,"score_gpt":0.21762511439981336,"score_spread":0.2024616331651325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051200223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960245,0.002190599,0.00003384455,0.0041268053,0.0026473745,0.00044505898,0.00015770152,0.00003676494,0.00075942976],"genre_scores_gemma":[0.97957534,0.00020948867,0.00004560547,0.0051487423,0.0002673935,0.000037050373,0.0004408253,0.000058786372,0.014216774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758047,0.0005521006,0.00078794383,0.00045785363,0.000088288594,0.0005333643],"domain_scores_gemma":[0.9982689,0.00013014516,0.00060462876,0.0009220493,0.00006363335,0.000010636898],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009804581,0.00040311876,0.000880212,0.00023862794,0.00007451631,0.0000048098177,0.00097422703,0.0018005124,0.002582914],"category_scores_gemma":[0.000026827242,0.00027475366,0.0003299946,0.00014210913,0.0008240311,0.000039201783,0.0006012379,0.0022014333,0.00008263587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012613674,0.00008723062,0.00067805767,0.00027045497,0.000123416,0.000035843917,0.00044745026,0.0000012632487,0.90213954,0.000039537324,0.09591919,0.00013185757],"study_design_scores_gemma":[0.0015951426,0.00011527162,0.0005736835,0.00027839924,0.0000892581,0.00006522105,0.000020885343,2.819983e-7,0.9395928,0.00031599036,0.05710448,0.00024858533],"about_ca_topic_score_codex":0.0007098106,"about_ca_topic_score_gemma":0.000027274069,"teacher_disagreement_score":0.038814716,"about_ca_system_score_codex":0.00012879857,"about_ca_system_score_gemma":0.0002506336,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W2052126847","doi":"10.1038/leu.2008.129","title":"Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Texas MD Anderson Cancer Center; Alberta Cancer Foundation","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Autocrine signalling; Cancer research; Biology; Cell culture; Molecular biology; Lymphoma; Chemistry; Immunology; Medicine; Pathology","score_opus":0.01204600280183415,"score_gpt":0.2481504776560066,"score_spread":0.23610447485417244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052126847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782056,0.00033777702,0.00015062696,0.00013838823,0.00014231472,0.0006976278,0.0001530058,0.000043972213,0.00051574886],"genre_scores_gemma":[0.99800766,0.00020457142,0.00088693644,0.00020272302,0.000081454535,0.000074448,0.0001238355,0.000022496455,0.00039588465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984503,0.000053807187,0.00044021817,0.00037506476,0.00031962077,0.00036099934],"domain_scores_gemma":[0.9990858,0.00016827733,0.00012646314,0.0002894209,0.000092901224,0.00023717064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013332095,0.00022378347,0.00050811836,0.00015729557,0.00008675154,0.000007750349,0.00006519991,0.0001054652,0.00015469354],"category_scores_gemma":[0.0001184556,0.0001828553,0.00007638264,0.0002453099,0.000039924595,0.00008473439,0.00007553988,0.00007136026,0.000046359655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043666135,0.004877254,0.80339926,0.0004575796,0.00012173569,0.0011510941,0.0025864756,0.001014699,0.1510907,0.00022576819,0.022277312,0.008431495],"study_design_scores_gemma":[0.02286248,0.0009511732,0.77163386,0.00033111274,0.00007731105,0.00006170254,0.000054820004,0.0025684508,0.19293994,0.000024762045,0.008273772,0.00022063075],"about_ca_topic_score_codex":0.00045925486,"about_ca_topic_score_gemma":0.000063139116,"teacher_disagreement_score":0.041849237,"about_ca_system_score_codex":0.0009251061,"about_ca_system_score_gemma":0.00026941407,"threshold_uncertainty_score":0.7456623},"labels":[],"label_agreement":null},{"id":"W2052710970","doi":"10.1038/leu.2012.100","title":"Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis","year":2012,"lang":"en","type":"review","venue":"Leukemia","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":383,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Amyloidosis Foundation","keywords":"Clinical trial; AL amyloidosis; Amyloidosis; Medicine; Drug development; Clinical research; Consensus conference; Intensive care medicine; Medical physics; Pathology; Immunoglobulin light chain; Immunology; Drug; Internal medicine; Pharmacology; Antibody","score_opus":0.5067914328514087,"score_gpt":0.5326453283260147,"score_spread":0.025853895474606037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052710970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047463295,0.9914161,0.000036151123,0.0002941531,0.0007054016,0.0025902723,0.00014606201,0.0000127498615,0.00005278477],"genre_scores_gemma":[0.0055933557,0.9908765,0.0008577077,0.00017586192,0.0010528011,0.00085965585,0.00015331141,0.000080586506,0.0003502351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884139,0.0014793533,0.008833487,0.00070398266,0.00016971004,0.00039957074],"domain_scores_gemma":[0.9850916,0.0042077657,0.009425291,0.0008842582,0.00027161962,0.000119452656],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.016740099,0.00053939613,0.0049209404,0.0001007792,0.00006870727,0.000025491718,0.00032588642,0.0009329254,0.0000063634393],"category_scores_gemma":[0.04334885,0.00031417355,0.0015359935,0.00013144087,0.00015248724,0.000002705004,0.00020458597,0.0002704825,0.000003550296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001096538,0.00008001788,0.005434399,0.010893737,0.001984354,0.000013835817,0.00003570373,0.000006991131,0.0005398863,0.00007491181,0.013900628,0.96692586],"study_design_scores_gemma":[0.0013314108,0.00017049331,0.000103327955,0.004662343,0.0031257095,0.00018094304,0.000117966614,0.000011048329,0.00075464,0.0000102173335,0.9891075,0.00042443536],"about_ca_topic_score_codex":0.000118794145,"about_ca_topic_score_gemma":0.000062065556,"teacher_disagreement_score":0.97520685,"about_ca_system_score_codex":0.00011201711,"about_ca_system_score_gemma":0.00085822376,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W2052739233","doi":"10.1038/leu.2014.229","title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hôpital Maisonneuve-Rosemont; Alberta Cancer Foundation; Hamilton Health Sciences; Dalhousie University; CancerCare Manitoba; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Regimen; Young adult; Confidence interval; Pediatrics; Internal medicine; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Leukemia","score_opus":0.018212182323537506,"score_gpt":0.2860786902423308,"score_spread":0.2678665079187933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052739233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98509204,0.00009780452,0.010981547,0.00016443754,0.00027461429,0.002398182,0.00010520806,0.00029812712,0.0005880085],"genre_scores_gemma":[0.9883067,0.00008091462,0.007215102,0.0004901248,0.0009991939,0.0004044016,0.00024258743,0.0002515713,0.0020093876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99478567,0.0001623252,0.0011825371,0.0011181226,0.0014210265,0.0013303064],"domain_scores_gemma":[0.99497557,0.001731718,0.0006229546,0.0015022089,0.00041617386,0.0007513575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006673695,0.0006944834,0.0014799009,0.0005655007,0.00015771232,0.00006947729,0.00074605097,0.0005196862,0.00014405746],"category_scores_gemma":[0.0010332166,0.0005826006,0.00041714148,0.000844644,0.00035225283,0.00025151004,0.00022223916,0.0005320331,0.00014017244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026341964,0.00075774646,0.90168524,0.0049423333,0.0024024667,0.0025124762,0.003855272,0.0009177973,0.019975537,0.00044191958,0.026639976,0.009527303],"study_design_scores_gemma":[0.123312116,0.0056482926,0.84519035,0.0011044298,0.003291923,0.00048464167,0.0002097437,0.013172243,0.0049969866,0.000113851835,0.00087034644,0.0016050887],"about_ca_topic_score_codex":0.0005298445,"about_ca_topic_score_gemma":0.00017284196,"teacher_disagreement_score":0.096970156,"about_ca_system_score_codex":0.004901753,"about_ca_system_score_gemma":0.0034566186,"threshold_uncertainty_score":0.9996625},"labels":[],"label_agreement":null},{"id":"W2053576108","doi":"10.1038/sj.leu.2403349","title":"Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Biology; Lineage (genetic); B cell; Immunophenotyping; Antibody; Molecular biology; Flow cytometry; Gene; Immunology; Cancer research; Genetics","score_opus":0.00942356419119408,"score_gpt":0.2496461599503586,"score_spread":0.24022259575916452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053576108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271345,0.00014920707,0.00049739383,0.0006813854,0.00017666956,0.0018641294,0.000038803893,0.00010661544,0.0037723717],"genre_scores_gemma":[0.9948437,0.000034977027,0.0024877707,0.0004339508,0.00025532668,0.00019893955,0.000021272795,0.000099971934,0.0016240617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99605817,0.00013372801,0.0008610556,0.0006949066,0.0013442166,0.0009079015],"domain_scores_gemma":[0.9977313,0.00016117639,0.0002909772,0.0013116853,0.00017305839,0.00033178093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038787047,0.0004541298,0.00074056746,0.00031843042,0.00014313607,0.000029732922,0.00076986256,0.00042794345,0.0001218434],"category_scores_gemma":[0.0006639075,0.0003072536,0.00029346836,0.0011237462,0.00038735327,0.00020104456,0.0004923363,0.0008348954,0.00012762373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0015988365,0.0006283283,0.00401314,0.0005368631,0.0002212248,0.00061747635,0.002271753,0.0028044097,0.98128444,0.001634958,0.0024063112,0.0019822773],"study_design_scores_gemma":[0.029181292,0.00081990194,0.10588371,0.0048584687,0.00023996248,0.0006286042,0.00038437542,0.0015337972,0.8528105,0.0022636908,0.00071835396,0.0006773206],"about_ca_topic_score_codex":0.0007159121,"about_ca_topic_score_gemma":0.00006485625,"teacher_disagreement_score":0.1284739,"about_ca_system_score_codex":0.010908154,"about_ca_system_score_gemma":0.009263232,"threshold_uncertainty_score":0.99993795},"labels":[],"label_agreement":null},{"id":"W2053665007","doi":"10.1038/sj.leu.2403177","title":"Telomerase is limiting the growth of acute myeloid leukemia cells","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Deutsche Forschungsgemeinschaft","keywords":"Telomerase; Telomerase reverse transcriptase; Biology; Telomere; K562 cells; Myeloid leukemia; Cancer research; Leukemia; Molecular biology; Population; Cell culture; Stem cell; Immunology; Cell biology; Medicine; Gene; Genetics","score_opus":0.01455707066749831,"score_gpt":0.2442381842396083,"score_spread":0.22968111357211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053665007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97886956,0.00060688064,0.00014824672,0.00069806556,0.0004020095,0.00045646698,0.00003837176,0.00011914364,0.018661255],"genre_scores_gemma":[0.9888613,0.0006914946,0.0018030546,0.0039595896,0.00022615408,0.000021833552,0.000016292917,0.000063381354,0.0043568714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755275,0.00011624782,0.00062539836,0.0004930843,0.00058104674,0.0006314453],"domain_scores_gemma":[0.99816775,0.00026331187,0.0002592844,0.0008204498,0.00022893716,0.00026024596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004294705,0.00035589674,0.0005788646,0.00016054601,0.00021611647,0.000033820805,0.0003283902,0.00020895938,0.00046401878],"category_scores_gemma":[0.00021238787,0.00025355798,0.0002748822,0.00069182547,0.00029212984,0.0001364562,0.00006462965,0.00057386793,0.00020808383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005284789,0.00025470715,0.04888166,0.00082261214,0.0010488149,0.0007298984,0.007216249,0.000031599968,0.8503372,0.007419176,0.063654035,0.019075587],"study_design_scores_gemma":[0.0022204418,0.00024586183,0.013946338,0.00022643973,0.000459713,0.00030102325,0.0006508761,0.00024899273,0.95677996,0.00040401347,0.024077287,0.0004390571],"about_ca_topic_score_codex":0.0002986249,"about_ca_topic_score_gemma":0.000009120429,"teacher_disagreement_score":0.10644277,"about_ca_system_score_codex":0.00057028607,"about_ca_system_score_gemma":0.0009993039,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2053997093","doi":"10.1038/leu.2008.319","title":"Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Heart, Lung, and Blood Institute; Howard Hughes Medical Institute","keywords":"Telomere; Allele; Biology; clone (Java method); Internal medicine; Population; Haematopoiesis; Stem cell; Genetics; Gastroenterology; Molecular biology; Medicine; DNA; Gene","score_opus":0.020583033961096918,"score_gpt":0.2731370967227952,"score_spread":0.2525540627616983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053997093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867509,0.00064560527,0.000016367068,0.0024284942,0.000044663004,0.00094781513,0.000055465298,0.00006601804,0.009044673],"genre_scores_gemma":[0.9902365,0.0014299708,0.0022319118,0.0023622063,0.00014970626,0.00007322821,0.00002213417,0.00005953438,0.0034347936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975511,0.00015062868,0.00040445855,0.00076858315,0.00049192953,0.0006332979],"domain_scores_gemma":[0.9985065,0.00042523324,0.000100467434,0.00033811995,0.000234627,0.00039505438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002599437,0.00038777548,0.0006688311,0.0003475552,0.0002512345,0.000042113184,0.00012603328,0.00032004784,0.000101156875],"category_scores_gemma":[0.00044177886,0.0003436408,0.000062484454,0.00058110966,0.00062146975,0.00035337172,0.00019458773,0.0011223705,0.000056184184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01865263,0.0007975527,0.415124,0.0011542017,0.001874379,0.01583533,0.29341093,0.000072020055,0.08532741,0.0037730394,0.08282434,0.081154175],"study_design_scores_gemma":[0.012230706,0.0013096505,0.89421296,0.0004297287,0.0001026174,0.002840193,0.002953728,0.004261751,0.0781974,0.0009843247,0.0016822038,0.00079475256],"about_ca_topic_score_codex":0.0007878545,"about_ca_topic_score_gemma":0.000092350136,"teacher_disagreement_score":0.47908896,"about_ca_system_score_codex":0.0013839379,"about_ca_system_score_gemma":0.0013735218,"threshold_uncertainty_score":0.99990153},"labels":[],"label_agreement":null},{"id":"W2055241026","doi":"10.1038/leu.2011.137","title":"Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biology; Clonogenic assay; Stem cell; Leukemia; Progenitor cell; Haematopoiesis; Cancer research; Cellular differentiation; Population; Small hairpin RNA; Immunology; Cell culture; Cell biology; Genetics; Medicine; Gene","score_opus":0.022837575014579215,"score_gpt":0.26479060160628703,"score_spread":0.2419530265917078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055241026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243075,0.0006528366,0.00026834136,0.00103746,0.00014406793,0.0021243978,0.00006274083,0.000025931178,0.0032534504],"genre_scores_gemma":[0.9961453,0.00031611221,0.0009905358,0.000531024,0.000110243294,0.00020570657,0.000017322924,0.000054204782,0.0016295245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975078,0.0002539032,0.00080173765,0.00033967794,0.0005795071,0.0005173872],"domain_scores_gemma":[0.99719757,0.0007250725,0.0004639582,0.0012560415,0.00027808957,0.00007926658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024242532,0.00020010915,0.0003446266,0.0001254761,0.00015703702,0.000022865152,0.0009790391,0.00015650307,0.00010849754],"category_scores_gemma":[0.00060793187,0.000099817604,0.00021110731,0.00062961417,0.00058571,0.00010598723,0.00013212106,0.0007247995,0.000055428885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009038626,0.0005292176,0.009308533,0.0011396542,0.00052945333,0.00003172605,0.12945344,0.00045021175,0.74512506,0.030068021,0.05672266,0.017603382],"study_design_scores_gemma":[0.017095068,0.0026022855,0.1952862,0.000599388,0.0008370033,0.00016889512,0.08354293,0.059802823,0.56519204,0.008423705,0.065509446,0.0009401971],"about_ca_topic_score_codex":0.0019511105,"about_ca_topic_score_gemma":0.00012829107,"teacher_disagreement_score":0.18597767,"about_ca_system_score_codex":0.0011158411,"about_ca_system_score_gemma":0.0013499422,"threshold_uncertainty_score":0.40704438},"labels":[],"label_agreement":null},{"id":"W2056771226","doi":"10.1038/leu.2013.373","title":"GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"GATA1; Eosinophil; Cancer research; Haematopoiesis; Biology; Eosinophilia; Ectopic expression; Progenitor cell; Gene knockdown; Immunology; Cell biology; Stem cell; Genetics; Gene","score_opus":0.01673979098268131,"score_gpt":0.26526912931153923,"score_spread":0.24852933832885793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056771226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069566,0.0002752116,0.00004559278,0.0013858521,0.00013352874,0.0015247246,0.000014576613,0.00008529555,0.005839552],"genre_scores_gemma":[0.9964136,0.0001216014,0.0011243783,0.00044592985,0.00011243908,0.00024369992,0.00008412667,0.000059596125,0.0013946552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970901,0.00013395151,0.0007798801,0.00055698893,0.0007661186,0.0006729852],"domain_scores_gemma":[0.99848634,0.00014494457,0.00014927876,0.000666852,0.0002445948,0.00030800523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041419663,0.0003252596,0.00069825834,0.00054869044,0.000064079686,0.00004246285,0.00031965092,0.00037821932,0.00067899906],"category_scores_gemma":[0.00021302167,0.00028325204,0.00014757563,0.0008264055,0.000229627,0.00043451367,0.00007988962,0.0008514516,0.0004025689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012464698,0.00065865146,0.050793555,0.0018194435,0.0004199883,0.0009298674,0.007084107,0.0018297491,0.86951315,0.0011707436,0.024925195,0.039609082],"study_design_scores_gemma":[0.010046545,0.0015907001,0.8684004,0.0009918762,0.00015097718,0.0011527032,0.00085827766,0.010303833,0.10249899,0.00078530953,0.0024056144,0.0008147626],"about_ca_topic_score_codex":0.002970675,"about_ca_topic_score_gemma":0.00007453529,"teacher_disagreement_score":0.81760687,"about_ca_system_score_codex":0.003259909,"about_ca_system_score_gemma":0.00204407,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W2057466518","doi":"10.1038/leu.2015.112","title":"The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Cancer research; BMI1; Myeloid leukemia; Autophagy; Gene silencing; Cyclin; Clonogenic assay; Medicine; Stem cell; Cell biology; Biology; Cell cycle; Apoptosis; Cancer; Internal medicine; Genetics","score_opus":0.021654751335144867,"score_gpt":0.28179576665741746,"score_spread":0.2601410153222726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057466518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560004,0.0007571157,0.00053725246,0.00022853701,0.00029012293,0.00085426023,0.0000064777964,0.000025470727,0.0017007303],"genre_scores_gemma":[0.99525774,0.000104169645,0.00052178255,0.0001585872,0.0005435234,0.00021116868,0.00008385504,0.0000375887,0.003081603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982398,0.00015141879,0.00043056108,0.0005003595,0.0002635922,0.000414224],"domain_scores_gemma":[0.9988799,0.000021915675,0.00013201991,0.00065140007,0.00012698576,0.00018777647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069164304,0.00021549556,0.00017678905,0.00006326116,0.000118083575,0.00009502278,0.00031512725,0.00025751267,0.000008946555],"category_scores_gemma":[0.0002567012,0.00017939485,0.000065848515,0.00018859339,0.000040557272,0.000010336301,0.0001579292,0.00018970174,0.00007216676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101551785,0.0000139432805,0.0004372939,0.0000123027085,0.000011861737,0.0000051870265,0.00013388952,0.0029875718,0.9873477,0.0000833584,0.0009221741,0.007943123],"study_design_scores_gemma":[0.0007703985,0.0006589294,0.0022035013,0.000017917859,0.0000069875705,0.000002043945,0.00004176194,0.000677366,0.96437424,0.00032155833,0.030691626,0.00023367866],"about_ca_topic_score_codex":0.00028330385,"about_ca_topic_score_gemma":0.00090537244,"teacher_disagreement_score":0.02976945,"about_ca_system_score_codex":0.0007608712,"about_ca_system_score_gemma":0.0018978877,"threshold_uncertainty_score":0.73155093},"labels":[],"label_agreement":null},{"id":"W2057745710","doi":"10.1038/leu.2015.75","title":"Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service","keywords":"Medicine; Busulfan; Cyclophosphamide; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Immunosuppression; Bone marrow; Leukemia; Gastroenterology; Fludarabine; Oncology; Stem cell; Immunology; Surgery; Chemotherapy; Biology","score_opus":0.020024717769117507,"score_gpt":0.2505414231018332,"score_spread":0.23051670533271568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057745710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95979935,0.00069846533,0.031506795,0.00067445735,0.00022856567,0.0017346356,0.00008843026,0.00023060812,0.0050386847],"genre_scores_gemma":[0.9765011,0.00007347192,0.020117408,0.00090490706,0.000107282336,0.00049941585,0.00042536965,0.000061777246,0.0013092727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980549,0.00006682944,0.0005087089,0.0004729653,0.00043730333,0.00045926453],"domain_scores_gemma":[0.99881995,0.00019477689,0.00013866952,0.00033025624,0.00023198026,0.0002843595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030229145,0.000327836,0.0005480234,0.00014420704,0.00006565374,0.000029009185,0.0001222049,0.00028143908,0.00007353052],"category_scores_gemma":[0.00003284587,0.00028315987,0.00018868818,0.0002233034,0.00010192513,0.00015898977,0.000013194517,0.00017761969,0.00016455117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015683979,0.0013918454,0.257296,0.05483874,0.0009838428,0.005640272,0.09334576,0.0010334168,0.52912706,0.007110255,0.031147655,0.0024011333],"study_design_scores_gemma":[0.027504822,0.002112858,0.11960518,0.0024230254,0.002935356,0.006434446,0.0052271634,0.00054534205,0.8113494,0.008340747,0.011239589,0.0022820672],"about_ca_topic_score_codex":0.000017114811,"about_ca_topic_score_gemma":0.000021207228,"teacher_disagreement_score":0.2822223,"about_ca_system_score_codex":0.00046583847,"about_ca_system_score_gemma":0.0005430018,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W2058194048","doi":"10.1038/leu.2009.3","title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; Genome Canada; National Institutes of Health; University of Nebraska Medical Center","keywords":"Biology; Cancer research; Gene; Genetics; Tumor suppressor gene; DNA methylation; Gene expression; Carcinogenesis","score_opus":0.01996315013138833,"score_gpt":0.249111750891657,"score_spread":0.22914860076026866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058194048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920264,0.002893314,0.0003326058,0.00039907693,0.0027261197,0.00023402445,0.000017464485,0.00007022679,0.0013007652],"genre_scores_gemma":[0.99297816,0.00003448005,0.00021486911,0.0009903358,0.000075517295,0.000018019431,0.00023936015,0.0000100040625,0.005439281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884164,0.00008199992,0.0003235233,0.00037022907,0.000050599494,0.00033198245],"domain_scores_gemma":[0.99956626,0.000044770917,0.00013693105,0.00017188575,0.00005459278,0.00002559205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000899886,0.00023074016,0.00026253605,0.00012976171,0.00021890384,0.000056569574,0.00011670497,0.00010977686,0.00027162232],"category_scores_gemma":[0.00003679673,0.0002055158,0.00009471154,0.00016169844,0.00009218903,0.00028602328,0.000047264748,0.00030902927,0.00012488432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025182814,0.00009628434,0.0030972066,0.000014486953,0.00004010106,0.000008435722,0.00009101091,0.000080203135,0.9893595,0.00051644957,0.0062531987,0.00019128753],"study_design_scores_gemma":[0.003458196,0.000296848,0.38641402,0.000063309235,0.00008094723,0.00078352203,0.00027559412,0.000356919,0.5956918,0.00025821672,0.011840277,0.0004803703],"about_ca_topic_score_codex":0.00023904502,"about_ca_topic_score_gemma":0.000040803756,"teacher_disagreement_score":0.39366773,"about_ca_system_score_codex":0.00028414954,"about_ca_system_score_gemma":0.00012939105,"threshold_uncertainty_score":0.8380691},"labels":[],"label_agreement":null},{"id":"W2060193341","doi":"10.1038/sj.leu.2403673","title":"High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Trisomy; Concordance; Context (archaeology); Internal medicine; Oncology; Lymphoblastic Leukemia; Medicine; Chromosome; Cancer; Leukemia; Biology; Genetics; Gene","score_opus":0.010846199776074835,"score_gpt":0.274874083981728,"score_spread":0.2640278842056532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060193341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98317856,0.008227015,0.00032932052,0.0012305346,0.00011150306,0.004878652,0.001600053,0.00020679373,0.0002375443],"genre_scores_gemma":[0.981158,0.010215003,0.0036118908,0.0011746635,0.00085522095,0.0019611227,0.000580695,0.00020307838,0.00024030317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925715,0.0010047614,0.0012902846,0.0018959242,0.001516204,0.0017213703],"domain_scores_gemma":[0.99389464,0.002989607,0.0014315648,0.00067048066,0.0004598705,0.00055382587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012722785,0.0012093082,0.0025561526,0.000462689,0.00082701584,0.00018699009,0.00062758574,0.00082504295,0.000108535496],"category_scores_gemma":[0.0006756648,0.0008178379,0.0001419937,0.0012556718,0.0014911995,0.00065990427,0.0006959186,0.0022616582,0.00001373771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009422596,0.0005550795,0.94778585,0.00007388105,0.0061970516,0.0001454073,0.0034630485,0.00027155803,0.000104227045,0.0000698664,0.009586681,0.022324728],"study_design_scores_gemma":[0.065690696,0.0129191615,0.9115585,0.00035812927,0.0044896808,0.0005840035,0.0015305667,0.0010152074,0.0002555334,0.00019070785,0.000269516,0.001138281],"about_ca_topic_score_codex":0.011332901,"about_ca_topic_score_gemma":0.010801852,"teacher_disagreement_score":0.056268103,"about_ca_system_score_codex":0.01830267,"about_ca_system_score_gemma":0.0041054985,"threshold_uncertainty_score":0.99942726},"labels":[],"label_agreement":null},{"id":"W2062894106","doi":"10.1038/leu.2013.187","title":"Monosomal karyotype in MDS: explaining the poor prognosis?","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Internal medicine; Myelodysplastic syndromes; Multivariate analysis; Myeloid leukemia; International Prognostic Scoring System; Karyotype; Oncology; Medicine; Prognostic variable; Gastroenterology; Biology; Bone marrow; Chromosome; Genetics; Gene","score_opus":0.02215683526851599,"score_gpt":0.2820200830860277,"score_spread":0.25986324781751174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062894106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96973765,0.0002932337,0.000021353082,0.008239884,0.00010017138,0.0011638344,0.0000016044107,0.000105069936,0.020337228],"genre_scores_gemma":[0.99239373,0.000053501903,0.0010885815,0.0023793844,0.0003320391,0.00048372895,0.000017202061,0.000046299476,0.003205507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817115,0.00009763227,0.00032797313,0.00034917606,0.00041799314,0.000636047],"domain_scores_gemma":[0.9989763,0.00024247794,0.00005905374,0.00042726984,0.00010886483,0.00018607244],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033911818,0.00019494245,0.00028636292,0.00016625614,0.00010637654,0.000066886445,0.0003270941,0.00016278909,0.00077252724],"category_scores_gemma":[0.000287494,0.00012620591,0.000084513165,0.0005191182,0.00014091165,0.00021817298,0.0001704548,0.00083784194,0.0017381106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069580774,0.00031619795,0.56695807,0.0003095005,0.00027379204,0.00095253903,0.005565329,0.00013300189,0.053610068,0.003080057,0.2494013,0.118704356],"study_design_scores_gemma":[0.006766821,0.00066715875,0.91199183,0.00041146047,0.00007243224,0.00035350365,0.003005018,0.027152427,0.017354919,0.00089721614,0.03075285,0.0005743739],"about_ca_topic_score_codex":0.0016049092,"about_ca_topic_score_gemma":0.000057965724,"teacher_disagreement_score":0.34503376,"about_ca_system_score_codex":0.0011196621,"about_ca_system_score_gemma":0.000705955,"threshold_uncertainty_score":0.9990392},"labels":[],"label_agreement":null},{"id":"W2063853379","doi":"10.1038/leu.2011.34","title":"A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Imatinib; Mitoxantrone; Myeloid leukemia; Internal medicine; Cytarabine; Imatinib mesylate; Etoposide; Oncology; Refractory (planetary science); Gastroenterology; Pharmacology; Chemotherapy; Biology","score_opus":0.038890731830352694,"score_gpt":0.293776129030658,"score_spread":0.2548853972003053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063853379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942272,0.00007654621,0.0009390827,0.00006142149,0.00014270585,0.0039511463,0.00012245688,0.000106337226,0.0003731336],"genre_scores_gemma":[0.9961567,0.000048290687,0.0022274712,0.000089732646,0.00010475306,0.00039375346,0.00037742333,0.00009428452,0.00050761143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973091,0.00024769214,0.00088174816,0.0006179364,0.0005566598,0.00038685944],"domain_scores_gemma":[0.99717474,0.00039583107,0.0010129212,0.0007097178,0.0005658613,0.00014093751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049424655,0.00044364692,0.000879958,0.00038340894,0.00021878198,0.000008999546,0.0001303273,0.00029870606,0.00008579808],"category_scores_gemma":[0.00015140921,0.00036243198,0.0001717341,0.0004847313,0.00022352644,0.00041937607,0.00005798501,0.0004605152,0.0000069765015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19922556,0.0056080148,0.0008505935,0.00019648249,0.002076047,0.00010099948,0.035529595,0.00013402097,0.7435815,0.00009926762,0.00067462487,0.011923341],"study_design_scores_gemma":[0.16457413,0.11343228,0.019277431,0.0011209988,0.0013357413,0.00016930807,0.0058592707,0.0016454958,0.69162714,0.0001813028,0.0002018019,0.00057507306],"about_ca_topic_score_codex":0.0007766375,"about_ca_topic_score_gemma":0.000027631755,"teacher_disagreement_score":0.107824266,"about_ca_system_score_codex":0.0052174567,"about_ca_system_score_gemma":0.0019934657,"threshold_uncertainty_score":0.99988276},"labels":[],"label_agreement":null},{"id":"W2064307348","doi":"10.1038/leu.2010.72","title":"Allogeneic marrow transplantation in children with acute leukemia: careful comparison with chemotherapy alternatives required","year":2010,"lang":"en","type":"letter","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Chemotherapy; Bone marrow transplantation; Leukemia; Transplantation; Acute leukemia; Oncology; Hematology; Internal medicine; Intensive care medicine","score_opus":0.012288356015948507,"score_gpt":0.2613677170900343,"score_spread":0.2490793610740858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064307348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95911634,0.00015170596,0.0016755217,0.03406886,0.00018446638,0.0023781487,0.00020547339,0.00021879621,0.0020007116],"genre_scores_gemma":[0.79878056,0.0012405342,0.011588615,0.16758257,0.0025833743,0.00055779296,0.0141907185,0.0006662211,0.0028095928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962503,0.00013373399,0.0007581586,0.0010600269,0.0010473098,0.00075050694],"domain_scores_gemma":[0.9983691,0.00012281285,0.00044888663,0.00076486595,0.00014099093,0.0001533727],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00018225086,0.0008555902,0.0013158065,0.00047319898,0.00008089037,0.000063945234,0.00037393166,0.0019919756,0.00013604407],"category_scores_gemma":[0.000004540893,0.00065391004,0.00014654516,0.00040280126,0.00026175613,0.0001780814,0.0000102662925,0.0044696135,0.000049295566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009176689,0.00029135347,0.80899155,0.004941001,0.0069809495,0.018287696,0.015067348,0.000517723,0.049914926,0.000039035585,0.08074182,0.005049894],"study_design_scores_gemma":[0.07028083,0.0046782875,0.6146196,0.009901784,0.008988126,0.030403214,0.00035584986,0.0008930421,0.20969108,0.00010759761,0.044516213,0.0055643492],"about_ca_topic_score_codex":0.00085417787,"about_ca_topic_score_gemma":0.00064600643,"teacher_disagreement_score":0.19437194,"about_ca_system_score_codex":0.001376305,"about_ca_system_score_gemma":0.0013197327,"threshold_uncertainty_score":0.99959123},"labels":[],"label_agreement":null},{"id":"W2065246270","doi":"10.1038/sj.leu.2402978","title":"A cholesterol-dependent CD20 epitope detected by the FMC7 antibody","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epitope; CD20; CD5; clone (Java method); Biology; Immunology; Antigen; Biochemistry","score_opus":0.00958142924610323,"score_gpt":0.27489725244236524,"score_spread":0.265315823196262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065246270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922015,0.00054896704,0.0016814774,0.0001988232,0.00012524222,0.0003224523,0.000015733156,0.000019597692,0.0048862128],"genre_scores_gemma":[0.99230146,0.00012704503,0.00009950914,0.00046783825,0.0001004597,0.000040325795,0.00009431539,0.000021417209,0.0067476323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988622,0.00015858674,0.0001532641,0.00029528863,0.00023080825,0.00029983008],"domain_scores_gemma":[0.9992854,0.0000128166475,0.000045038734,0.00046785298,0.00009658611,0.000092323615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024874444,0.00013309272,0.00008954151,0.000024800875,0.00014637949,0.00006094296,0.0002586447,0.00014386202,0.00013081964],"category_scores_gemma":[0.000239336,0.00009605746,0.00006125301,0.00011388039,0.00007106188,0.0000036578026,0.00006701488,0.00018671266,0.0001258812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028587236,0.000022279424,0.0014205942,0.000006434103,0.000024178047,0.0000023493556,0.0000285898,0.000029354069,0.9864765,0.00005860191,0.0086158095,0.0032867177],"study_design_scores_gemma":[0.00075556117,0.000116866235,0.0027072737,0.0000047688272,0.0000050768235,0.000025599873,0.000031656447,0.00006262207,0.71648806,0.000035784178,0.27963203,0.00013467933],"about_ca_topic_score_codex":0.00008677787,"about_ca_topic_score_gemma":0.00006523019,"teacher_disagreement_score":0.2710162,"about_ca_system_score_codex":0.000048177222,"about_ca_system_score_gemma":0.00013785633,"threshold_uncertainty_score":0.39171094},"labels":[],"label_agreement":null},{"id":"W2065549717","doi":"10.1038/sj.leu.2403466","title":"Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"University Health Network; Genome Canada","keywords":"Acute megakaryoblastic leukemia; Down syndrome; Trisomy; Leukemia; Biology; Genetics; Molecular biology","score_opus":0.007894675821363476,"score_gpt":0.23429260516055342,"score_spread":0.22639792933918995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065549717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654007,0.0008972508,0.00085854845,0.00018398711,0.00007074056,0.00022031067,0.000048041653,0.00005049189,0.0011305442],"genre_scores_gemma":[0.99755484,0.00009473698,0.0019671477,0.00018379334,0.000045310666,0.000010972897,0.00005118616,0.00001928824,0.00007271305],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988921,0.000018449733,0.0002945868,0.0002662029,0.00024516392,0.00028344424],"domain_scores_gemma":[0.99935025,0.00015384918,0.000060551865,0.00023146131,0.000031968582,0.00017189498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010767012,0.00017376272,0.00040855425,0.0001234345,0.000031045674,0.00000978565,0.00009410585,0.00015617503,0.000019852909],"category_scores_gemma":[0.00019314142,0.00014524424,0.000063593194,0.00022466773,0.00012663474,0.000058426565,0.0000461056,0.00032691265,0.000008137247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011926627,0.0018433875,0.23286246,0.0057154666,0.0029085972,0.061755437,0.012612929,0.10696324,0.48968166,0.015820285,0.0067458097,0.0511641],"study_design_scores_gemma":[0.0072378474,0.0009085827,0.96835643,0.0008988953,0.00030330633,0.00093437947,0.000041046464,0.0009485013,0.01899924,0.0008956231,0.0001899395,0.00028619388],"about_ca_topic_score_codex":0.00078494934,"about_ca_topic_score_gemma":0.0001071789,"teacher_disagreement_score":0.735494,"about_ca_system_score_codex":0.00061984546,"about_ca_system_score_gemma":0.0004110797,"threshold_uncertainty_score":0.5922888},"labels":[],"label_agreement":null},{"id":"W2067060241","doi":"10.1038/sj.leu.2404396","title":"Identification of Notch target genes in uncommitted T-cell progenitors: no direct induction of a T-cell specific gene program","year":2006,"lang":"en","type":"article","venue":"Leukemia","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Notch signaling pathway; HES1; Notch proteins; Biology; Hes3 signaling axis; Cell biology; Cyclin-dependent kinase 8; Cell fate determination; Signal transduction; Progenitor cell; Transcription factor; Gene; Haematopoiesis; Genetics; Stem cell","score_opus":0.005090533433687715,"score_gpt":0.21563489732500588,"score_spread":0.21054436389131817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067060241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970713,0.0010244967,0.00012005875,0.000008287105,0.00019985109,0.0003685008,0.000015007536,0.000012831108,0.0011796524],"genre_scores_gemma":[0.9943632,0.0000999112,0.0037744564,0.000004679691,0.00016416554,0.000053531556,0.00072900264,0.000013452179,0.00079763547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895746,0.00006614409,0.0004431626,0.00028114574,0.000100868405,0.00015125354],"domain_scores_gemma":[0.9993968,0.00000577866,0.00024273264,0.00022184127,0.000112657835,0.000020167005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001899331,0.00012606346,0.00015566811,0.000083177656,0.000027992815,0.0000059814215,0.00011530587,0.00022513974,0.000007760022],"category_scores_gemma":[0.000007827364,0.00012674622,0.00006256712,0.00021153652,0.00007776669,0.000006303689,0.00003827234,0.000056658802,0.000009916335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008040838,0.00021241106,0.023632549,0.00004589896,0.000010192576,5.954671e-7,0.000020924384,0.00026150193,0.9726053,0.0000037288066,0.00054847315,0.0025780299],"study_design_scores_gemma":[0.00050938746,0.00012223318,0.048443187,0.000007677225,0.000006634079,0.0000022157064,0.000016621569,0.000070497044,0.9463353,0.000047089492,0.00431616,0.0001230047],"about_ca_topic_score_codex":0.000062157866,"about_ca_topic_score_gemma":0.000021586084,"teacher_disagreement_score":0.026269995,"about_ca_system_score_codex":0.00006921755,"about_ca_system_score_gemma":0.00010229175,"threshold_uncertainty_score":0.5168561},"labels":[],"label_agreement":null},{"id":"W2068045978","doi":"10.1038/leu.2013.152","title":"Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Onyx Pharmaceuticals","keywords":"Carfilzomib; Internal medicine; Cytogenetics; Oncology; Medicine; Refractory (planetary science); Multiple myeloma; Fluorescence in situ hybridization; Confidence interval; Population; Gastroenterology; Biology; Lenalidomide; Genetics","score_opus":0.020091692711695797,"score_gpt":0.2568875595864741,"score_spread":0.23679586687477827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068045978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964939,0.0001678598,0.0000019152078,0.00013958568,0.00003948155,0.003011703,0.00002188064,0.00002407177,0.0000996258],"genre_scores_gemma":[0.9985911,0.00013040395,0.0005947142,0.000064140164,0.00002424422,0.00031662956,0.000043798766,0.000036356938,0.00019861288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979525,0.00029065317,0.00035490436,0.0004794021,0.00046404716,0.00045846295],"domain_scores_gemma":[0.9987006,0.00043254014,0.00011164222,0.00049538276,0.000061652834,0.00019814356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017080107,0.00031971483,0.0004858518,0.00019422175,0.000121101286,0.00006758374,0.00009738183,0.00009655732,0.000020150645],"category_scores_gemma":[0.00023557119,0.00017781857,0.000035325727,0.00020679485,0.00009424868,0.000115285664,0.00007378007,0.0002816039,0.0000145827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952961,0.0017253704,0.9565837,0.00001973051,0.00017265377,0.00014826853,0.0029907434,0.000010337528,0.00011530678,6.605511e-7,0.00001991811,0.03771805],"study_design_scores_gemma":[0.02726969,0.0048851045,0.96575874,0.000060440165,0.00009754134,0.000006365958,0.0013280846,0.00019702586,0.00015904453,0.000010260848,0.000061031933,0.00016669977],"about_ca_topic_score_codex":0.009151811,"about_ca_topic_score_gemma":0.0045310613,"teacher_disagreement_score":0.037551347,"about_ca_system_score_codex":0.0009653463,"about_ca_system_score_gemma":0.000101144535,"threshold_uncertainty_score":0.99744636},"labels":[],"label_agreement":null},{"id":"W2068834508","doi":"10.1038/leu.2010.159","title":"Insights into the stem cells of chronic myeloid leukemia","year":2010,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Myeloid leukemia; Biology; Somatic evolution in cancer; Phenotype; Cancer stem cell; Hematopoietic stem cell; Leukemia; Immunology; Myeloid; Cancer research; Cancer; Genetics; Gene","score_opus":0.025212852724935363,"score_gpt":0.29107243080304046,"score_spread":0.2658595780781051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068834508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020882576,0.9880554,0.000015161748,0.00003171767,0.0014642944,0.0029978927,0.000029888766,0.00017426912,0.0051431046],"genre_scores_gemma":[0.000510639,0.9842202,0.00024182531,0.00012052556,0.0015077025,0.00041763674,0.00022318368,0.00030627477,0.012452002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466914,0.00029992822,0.0019037983,0.0012269669,0.0010510973,0.0008490826],"domain_scores_gemma":[0.9939937,0.00070474204,0.0013657737,0.0033138427,0.00020525843,0.0004167058],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00033906056,0.0013732802,0.004223823,0.00043533684,0.00023529262,0.000052704105,0.0012694341,0.0017822828,0.0003503074],"category_scores_gemma":[0.00005726816,0.00082085,0.0016213075,0.0009836036,0.0006071998,0.00012613519,0.00047452268,0.0032773523,0.0013779053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002501531,0.000071042516,0.0000025173738,0.022067538,0.0007749262,0.00017290724,0.0004383541,0.0000053399153,0.00031641993,0.00026679778,0.0031119096,0.9727472],"study_design_scores_gemma":[0.002017987,0.00036503864,0.000006891011,0.015962986,0.003906425,0.00023324927,0.000039319348,0.00008335042,0.0015610737,0.000044333025,0.9751391,0.00064023765],"about_ca_topic_score_codex":0.0006292074,"about_ca_topic_score_gemma":0.00026000253,"teacher_disagreement_score":0.972107,"about_ca_system_score_codex":0.02631578,"about_ca_system_score_gemma":0.02441042,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W2069618057","doi":"10.1038/sj.leu.2402432","title":"A single split-signal FISH probe set allows detection of TAL1translocations as well as SIL-TAL1 fusion genes in a single test","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society","keywords":"Fusion gene; Biology; Gene; Chromosomal translocation; Genetics; Chromosome; Gene expression","score_opus":0.025086869094598573,"score_gpt":0.2611730302607784,"score_spread":0.23608616116617986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069618057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770804,0.00036906928,0.0009471707,0.00084507145,0.000097377655,0.0010408016,0.000028958211,0.00012373267,0.019467426],"genre_scores_gemma":[0.99255425,0.000103065555,0.0010876049,0.00041093523,0.00020624931,0.00009927577,0.000062428626,0.000065840366,0.0054103257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974377,0.00008725793,0.0006231373,0.0005325725,0.00074474147,0.0005745512],"domain_scores_gemma":[0.9984796,0.00037316667,0.00015628284,0.0005059652,0.00023101321,0.00025398386],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025443424,0.00028856908,0.00044012922,0.0004006624,0.00010981854,0.00003739506,0.00022513114,0.0003206964,0.0016123474],"category_scores_gemma":[0.00044781782,0.0002778319,0.00014476184,0.000969731,0.00021257802,0.00019199942,0.00008684362,0.00041712023,0.0008122241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002496194,0.00085752184,0.0019320729,0.00027044053,0.000038980244,0.0001986171,0.0010354354,0.00015643718,0.9723163,0.000020447622,0.0015725064,0.021351604],"study_design_scores_gemma":[0.011067077,0.0048373593,0.007730008,0.0010082105,0.00022617358,0.001364679,0.0009566735,0.05874873,0.88300824,0.00046921006,0.02986213,0.000721531],"about_ca_topic_score_codex":0.0018898662,"about_ca_topic_score_gemma":0.0010260579,"teacher_disagreement_score":0.0893081,"about_ca_system_score_codex":0.0026929444,"about_ca_system_score_gemma":0.00070999254,"threshold_uncertainty_score":0.9999674},"labels":[],"label_agreement":null},{"id":"W2070276500","doi":"10.1038/sj.leu.2403165","title":"Reply to Hasle et al","year":2003,"lang":"fr","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Environmental science","score_opus":0.027982919855833496,"score_gpt":0.31827630553378955,"score_spread":0.29029338567795604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070276500","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004257012,0.002367157,0.0010958895,0.8849192,0.005043951,0.0021081846,0.00021192327,0.00023042496,0.099766254],"genre_scores_gemma":[0.00019426404,0.00059433334,0.005549896,0.71336544,0.00479136,0.00023533455,0.00062638085,0.00037592533,0.27426705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900135,0.00096243614,0.0012748052,0.0022776807,0.0022135356,0.0032580362],"domain_scores_gemma":[0.9937042,0.00095807354,0.0002967309,0.0031517649,0.0005107297,0.0013785295],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.002019784,0.0013168756,0.0017804346,0.0008169111,0.00028242072,0.0002399754,0.001255926,0.001655388,0.009131145],"category_scores_gemma":[0.002092841,0.0013071683,0.00063019694,0.0013582443,0.00047193098,0.00024112735,0.00061699207,0.009687903,0.04104015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002457912,0.00006304374,0.00045804353,0.00049494853,0.00044010804,0.0083229765,0.0005461591,0.000086341555,0.0022826004,0.0004896131,0.97842926,0.008141111],"study_design_scores_gemma":[0.003246624,0.0007852175,0.00060980103,0.0011931405,0.00027234972,0.0011907449,0.0001368382,0.0003250753,0.0018748294,0.00011412254,0.9890549,0.0011963423],"about_ca_topic_score_codex":0.003709448,"about_ca_topic_score_gemma":0.000054554166,"teacher_disagreement_score":0.1745008,"about_ca_system_score_codex":0.017978124,"about_ca_system_score_gemma":0.009312221,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2070998855","doi":"10.1038/leu.2013.73","title":"The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Conquer Cancer Foundation; National Institutes of Health; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; U.S. Public Health Service; Canada Research Chairs","keywords":"EIF4E; Myeloid leukemia; Biology; Cancer research; Eukaryotic translation; Haematopoiesis; Translation (biology); Oncogene; Enhancer; Promoter; Myeloid; Molecular biology; Transcription factor; Messenger RNA; Genetics; Gene expression; Cell; Gene; Stem cell; Cell cycle","score_opus":0.012053357064637749,"score_gpt":0.21126916523818529,"score_spread":0.19921580817354753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070998855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919049,0.0036204283,0.00010220982,0.0007829094,0.00024964672,0.00040635324,0.00016045441,0.00003314998,0.002739953],"genre_scores_gemma":[0.9951631,0.0006158183,0.00013432502,0.00024939372,0.000018539236,0.000030637962,0.00019417643,0.000017502782,0.0035765255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99880546,0.00011724158,0.00044814884,0.00027421484,0.00006671922,0.00028818386],"domain_scores_gemma":[0.9994271,0.00013651577,0.00013883364,0.00019551143,0.00007687637,0.000025169675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013756081,0.00018903616,0.00028861786,0.00011021991,0.00016393569,0.000024838462,0.00013687763,0.000283522,0.0017164218],"category_scores_gemma":[0.00001149748,0.00014620322,0.0000818193,0.0001774598,0.00021469984,0.00019495116,0.000014146573,0.00026450446,0.00009360265],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002800691,0.000040886254,0.005167217,0.000069314905,0.00023063865,0.0000025127792,0.006491901,0.000024375751,0.9677294,0.00042461016,0.0035228988,0.01601616],"study_design_scores_gemma":[0.006214726,0.0003230463,0.6782505,0.00013387161,0.00015061644,0.000045679277,0.00030298694,0.0024124,0.26366124,0.0020064905,0.045912873,0.0005855888],"about_ca_topic_score_codex":0.0009315128,"about_ca_topic_score_gemma":0.00017254698,"teacher_disagreement_score":0.7040682,"about_ca_system_score_codex":0.0001742365,"about_ca_system_score_gemma":0.00018013429,"threshold_uncertainty_score":0.9991962},"labels":[],"label_agreement":null},{"id":"W2072876252","doi":"10.1038/sj.leu.2403702","title":"Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; Biology; B cell; Intracellular; Cell; Pathology; BCL10; Cell signaling; Cancer research; Immunology; Signal transduction; Cell biology; Medicine; Antibody; Genetics","score_opus":0.009223210128632177,"score_gpt":0.2203856454429748,"score_spread":0.21116243531434262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072876252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471194,0.00080856023,0.000049289436,0.00024096658,0.00005559124,0.0005481967,0.000009910515,0.000046190402,0.0035293372],"genre_scores_gemma":[0.99784446,0.000101077145,0.00096807635,0.00032268936,0.00011896596,0.00010753124,0.00009793305,0.00002685727,0.0004124252],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849206,0.000056856265,0.00044668745,0.00029446938,0.00039087926,0.0003190536],"domain_scores_gemma":[0.99925005,0.000078984776,0.00018573784,0.0002936869,0.000055571334,0.00013595923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015942084,0.00020245559,0.0004287728,0.00012529905,0.000030647752,0.000008513295,0.000100558,0.0001699662,0.00013588308],"category_scores_gemma":[0.000042049327,0.00016503346,0.00010788804,0.00017434434,0.000048064863,0.000085440035,0.00006245988,0.00010188751,0.00006733317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000497276,0.0058892774,0.4588615,0.00042885842,0.000088042696,0.00078758853,0.0018613234,0.00012773467,0.2724782,0.000011016777,0.002830933,0.25613827],"study_design_scores_gemma":[0.011069591,0.00029507422,0.4122215,0.0005156482,0.000057119483,0.000020773266,0.00005083703,0.00047521672,0.5740025,0.0000073778174,0.001141377,0.00014300729],"about_ca_topic_score_codex":0.0004884588,"about_ca_topic_score_gemma":0.00008276741,"teacher_disagreement_score":0.30152428,"about_ca_system_score_codex":0.0025755842,"about_ca_system_score_gemma":0.00050856493,"threshold_uncertainty_score":0.6735063},"labels":[],"label_agreement":null},{"id":"W2073057404","doi":"10.1038/leu.2008.232","title":"Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma","year":2008,"lang":"en","type":"letter","venue":"Leukemia","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Multiple myeloma; Clioquinol; Leukemia; Proteasome; Medicine; Hematology; Proteasome inhibitor; Bortezomib; Cancer research; Carfilzomib; Pharmacology; Internal medicine; Oncology; Biology; Genetics","score_opus":0.022702479554168,"score_gpt":0.2620038323956796,"score_spread":0.2393013528415116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073057404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571805,0.0023557742,0.000021138072,0.03693673,0.00018055644,0.0013514997,0.00011304996,0.000029941795,0.0018308051],"genre_scores_gemma":[0.84474313,0.0041294773,0.00024654844,0.13832267,0.0065304786,0.00068889983,0.0004391774,0.00018025223,0.004719386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997341,0.0003622424,0.0004086441,0.0010016091,0.00028060924,0.00060591265],"domain_scores_gemma":[0.9987597,0.00013263791,0.00023403522,0.000717012,0.000045445926,0.00011116448],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037754705,0.0005182256,0.0005002548,0.00008591045,0.00018683342,0.00007715489,0.00036773426,0.0017660147,0.000013355778],"category_scores_gemma":[0.00020994959,0.00040045023,0.00013231818,0.00012585716,0.0005305827,0.000011074416,0.00053050194,0.0022076112,0.000015034163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008149497,0.000066546134,0.011095621,0.0012601682,0.00029889328,0.000810761,0.00067595486,0.000015112045,0.17657737,0.000054949985,0.75769293,0.05063672],"study_design_scores_gemma":[0.0016925953,0.00048911583,0.016075017,0.00027424862,0.000050911778,0.0005492213,0.000015074989,0.00011787362,0.100129984,0.0002091417,0.8794389,0.0009579676],"about_ca_topic_score_codex":0.00012795221,"about_ca_topic_score_gemma":0.00008286572,"teacher_disagreement_score":0.1217459,"about_ca_system_score_codex":0.00017123761,"about_ca_system_score_gemma":0.000601757,"threshold_uncertainty_score":0.99984473},"labels":[],"label_agreement":null},{"id":"W2073162917","doi":"10.1038/leu.2013.15","title":"Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations","year":2013,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Electric Power Research Institute","keywords":"Biology; Molecular biology; Transgene; Haematopoiesis; Genetically modified mouse; Leukemia; Green fluorescent protein; Embryonic stem cell; Gene; Stem cell; Cancer research; Cell biology; Immunology; Genetics","score_opus":0.01770827251705164,"score_gpt":0.2904537892943207,"score_spread":0.27274551677726905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073162917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297531,0.00031964024,0.0004431285,0.06327599,0.00030195757,0.00298297,0.00023950377,0.00016238538,0.0025213151],"genre_scores_gemma":[0.58075374,0.00044540013,0.0058316025,0.3986376,0.0028910602,0.00088050973,0.0010379953,0.00042534986,0.009096725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537677,0.0005980475,0.00096496113,0.0011552272,0.00086919346,0.00103582],"domain_scores_gemma":[0.9961009,0.002314448,0.00023248357,0.0005875322,0.00028317943,0.00048144654],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00083114294,0.0007069233,0.0010187959,0.0010826613,0.00023645638,0.00031674013,0.00025381907,0.0011979329,0.00017434673],"category_scores_gemma":[0.0015979126,0.0006745125,0.00008367931,0.00065176794,0.00034703675,0.00040551266,0.00032920385,0.002757697,0.00027899016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003525716,0.00006833951,0.001869136,0.0022867103,0.00037220624,0.017011082,0.011169826,0.0008844881,0.11767011,0.000044648405,0.83303297,0.012064757],"study_design_scores_gemma":[0.088047825,0.008081808,0.15491295,0.013510935,0.002160305,0.011369543,0.005402658,0.06909618,0.012397718,0.0019235095,0.62222546,0.010871106],"about_ca_topic_score_codex":0.0015267957,"about_ca_topic_score_gemma":0.00008276861,"teacher_disagreement_score":0.34899935,"about_ca_system_score_codex":0.00742096,"about_ca_system_score_gemma":0.0045958264,"threshold_uncertainty_score":0.9995706},"labels":[],"label_agreement":null},{"id":"W2075274617","doi":"10.1038/leu.2013.224","title":"Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Cancer research; Biology; CHOP; Internal medicine; Lymphoma; Oncology; Medicine","score_opus":0.01151518917437346,"score_gpt":0.2321673165111979,"score_spread":0.22065212733682443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075274617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631256,0.00027009597,9.310822e-7,0.00015266554,0.0000657883,0.0022142734,0.000035075445,0.000037285306,0.00091132807],"genre_scores_gemma":[0.9978069,0.000034754306,0.000048964368,0.0001659218,0.00002974897,0.00057545933,0.000014890548,0.00002768016,0.0012956546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983397,0.00009336586,0.0004764609,0.00038755816,0.0003511621,0.00035176508],"domain_scores_gemma":[0.99897856,0.000098558885,0.00019178225,0.00048162803,0.000095728705,0.00015373183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000817904,0.00022973631,0.00039237537,0.00007847771,0.00006001906,0.000015862852,0.00012379218,0.0001526113,0.00005229657],"category_scores_gemma":[0.00023343753,0.00012430786,0.000093246206,0.00015181748,0.000044259123,0.00013467288,0.00017269213,0.00008249998,0.000040815685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018863313,0.0027647056,0.9738869,0.0001865683,0.000023419627,0.000030585452,0.00028959377,4.4927026e-7,0.019503174,0.00003440004,0.00035584104,0.0027357202],"study_design_scores_gemma":[0.03333341,0.00021518201,0.7250006,0.0006175021,0.0000496584,0.0000052527053,0.0000240463,0.00015580995,0.24027328,0.000044561682,0.00017315755,0.00010751768],"about_ca_topic_score_codex":0.00022447684,"about_ca_topic_score_gemma":0.000009889773,"teacher_disagreement_score":0.24888629,"about_ca_system_score_codex":0.0007052655,"about_ca_system_score_gemma":0.000110745415,"threshold_uncertainty_score":0.5069127},"labels":[],"label_agreement":null},{"id":"W2075841564","doi":"10.1038/leu.2014.67","title":"Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Louisiana State University","keywords":"GATA2; Myeloid leukemia; Biology; Cancer research; Epigenetics; Leukemia; Genetics; Myeloid; Gene; Transcription factor","score_opus":0.013007390370230706,"score_gpt":0.29419933267608517,"score_spread":0.2811919423058545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075841564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889187,0.0002667569,0.00027561974,0.00034248814,0.000105409075,0.0005426731,0.000028378678,0.00008433391,0.009435644],"genre_scores_gemma":[0.99533874,0.00025747909,0.00068496395,0.0003870663,0.0003700314,0.000020062496,0.00011579198,0.00007070266,0.0027551563],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99758595,0.00013856679,0.00049137085,0.0005137189,0.00066525926,0.0006051038],"domain_scores_gemma":[0.998191,0.0002718532,0.00019079408,0.00070342596,0.00023392492,0.00040898361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005578021,0.0003485228,0.0006161057,0.00033943827,0.00010935348,0.000026699263,0.00022859828,0.00030470546,0.0002783701],"category_scores_gemma":[0.0003006843,0.0002779207,0.00016465627,0.00043722402,0.00015711076,0.00016781225,0.00014391806,0.00057829,0.00022256577],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007176326,0.00016969118,0.04087589,0.00094921456,0.0010707229,0.00015309826,0.0010161544,0.0033015434,0.824496,0.0040142494,0.019026484,0.097750634],"study_design_scores_gemma":[0.0050334167,0.002515143,0.76019317,0.00026833286,0.00027100832,0.00025256132,0.000038076825,0.045909256,0.18264574,0.00043025095,0.002032191,0.00041084478],"about_ca_topic_score_codex":0.00022326164,"about_ca_topic_score_gemma":0.0000122427855,"teacher_disagreement_score":0.71931726,"about_ca_system_score_codex":0.0019549937,"about_ca_system_score_gemma":0.0010785019,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W2075960226","doi":"10.1038/sj.leu.2402255","title":"AC133 expression in human stem cells","year":2001,"lang":"nl","type":"review","venue":"Leukemia","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Cell biology; Context (archaeology); Progenitor cell; Immunology; Hematopoietic stem cell; Cell type; Cell; Genetics","score_opus":0.05067106177671841,"score_gpt":0.31677737343968737,"score_spread":0.26610631166296894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075960226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062090666,0.9512093,0.00005427011,0.000035931378,0.0038158165,0.0016345868,0.000038789527,0.00013411591,0.036868107],"genre_scores_gemma":[0.0005252382,0.87981445,0.00007484803,0.0006512864,0.002197819,0.00011375939,0.0003011757,0.00012393367,0.11619747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955264,0.00066574314,0.0014354256,0.0011024231,0.00040786248,0.00086219196],"domain_scores_gemma":[0.9974996,0.00027849057,0.0006281298,0.0011529599,0.000081537495,0.00035929098],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004212995,0.0008666756,0.0028801574,0.00047984795,0.0001642956,0.000028301289,0.00040184575,0.0016258421,0.008700427],"category_scores_gemma":[0.00002552631,0.0007117605,0.00063773437,0.0007767338,0.0001457333,0.000086067994,0.0002055212,0.0021374733,0.013724925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003379627,0.0005999268,0.00038303752,0.048951387,0.0002520633,0.0030168388,0.0005753831,0.00006274143,0.052445427,0.00018513906,0.20591837,0.6872717],"study_design_scores_gemma":[0.0020038418,0.0004204977,0.00012921516,0.028621366,0.00036635794,0.00011824466,0.00014272914,0.000019504765,0.0012463423,0.000024711922,0.9663006,0.0006065842],"about_ca_topic_score_codex":0.00011496737,"about_ca_topic_score_gemma":0.00001537515,"teacher_disagreement_score":0.76038224,"about_ca_system_score_codex":0.0020936423,"about_ca_system_score_gemma":0.0009698369,"threshold_uncertainty_score":0.99967027},"labels":[],"label_agreement":null},{"id":"W2076840161","doi":"10.1038/leu.2008.156","title":"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Farnesyltransferase; Chronic myelomonocytic leukemia; Farnesyltransferase inhibitor; Gastroenterology; Internal medicine; Medicine; Nausea; Prenylation; Myelodysplastic syndromes; Leukemia; Hematology; Immunology; Biology; Bone marrow","score_opus":0.0519968984772759,"score_gpt":0.27386489832119637,"score_spread":0.22186799984392047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076840161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970024,0.00037567777,0.00007651487,0.0006840287,0.000075595024,0.00078135356,0.00001165917,0.000056162193,0.00093656295],"genre_scores_gemma":[0.99529123,0.0006578678,0.0003202768,0.00065912155,0.00007580016,0.00006451531,0.000016379277,0.0000632007,0.002851596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974976,0.00015652883,0.0005392759,0.0005167329,0.00063189707,0.00065796793],"domain_scores_gemma":[0.9971114,0.0016239474,0.00013379018,0.00080717937,0.000095777614,0.00022790208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033009422,0.000325923,0.00061999215,0.00040182818,0.00014437624,0.00002164855,0.00027006256,0.00024192434,0.00023513225],"category_scores_gemma":[0.0009567599,0.00022904246,0.000110020235,0.0007224222,0.0006871537,0.00016950787,0.00018382042,0.0011005688,0.0001879729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017612485,0.0018210594,0.36182696,0.00788945,0.0032509682,0.07388227,0.014582801,0.055385426,0.15722284,0.056769904,0.18341167,0.066344164],"study_design_scores_gemma":[0.01456108,0.0037445282,0.8706441,0.001961333,0.00021655105,0.010814952,0.00022022659,0.07539335,0.0081705665,0.0008337804,0.012427269,0.0010122808],"about_ca_topic_score_codex":0.0006148858,"about_ca_topic_score_gemma":0.0000694771,"teacher_disagreement_score":0.50881714,"about_ca_system_score_codex":0.005937819,"about_ca_system_score_gemma":0.0031375175,"threshold_uncertainty_score":0.9978782},"labels":[],"label_agreement":null},{"id":"W2077522084","doi":"10.1038/leu.2011.378","title":"BCL2 mutations in diffuse large B-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Diffuse large B-cell lymphoma; Somatic hypermutation; Biology; Lymphoma; Cancer research; Germinal center; Mantle cell lymphoma; Germline mutation; Follicular lymphoma; Large-cell lymphoma; Mutation; B cell; Gene; Genetics; Immunology; Antibody","score_opus":0.020950733346727597,"score_gpt":0.24746990090036908,"score_spread":0.2265191675536415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077522084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412614,0.00023339533,0.000013771146,0.0000835838,0.00007968102,0.00020797028,0.000010247913,0.000050684903,0.05805926],"genre_scores_gemma":[0.9967903,0.00005515438,0.0007036681,0.000599551,0.000040762323,0.00008466878,0.000039824095,0.000016649328,0.0016694524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.000016963415,0.00017288262,0.00019036527,0.00011632294,0.0002428429],"domain_scores_gemma":[0.99954396,0.00003371844,0.000036307672,0.00025103247,0.000022819419,0.00011215584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005071525,0.00011375025,0.00017551363,0.0000906281,0.000037739104,0.000007219791,0.000052185216,0.00007292064,0.00022711202],"category_scores_gemma":[0.00001956957,0.00009238227,0.00007038364,0.00014918839,0.000023172128,0.000052220228,0.000026139298,0.00004020448,0.0005339895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021358611,0.027045226,0.9309439,0.0001006148,0.000105281,0.0024017547,0.006844246,0.0000010908495,0.00057281967,0.005271111,0.0055371146,0.020963231],"study_design_scores_gemma":[0.03881298,0.00018083163,0.9398225,0.000060793787,0.00009517492,0.00004699766,0.00027438058,0.00016924988,0.011962101,0.00035907605,0.008072882,0.00014306269],"about_ca_topic_score_codex":0.00066759036,"about_ca_topic_score_gemma":0.00014701368,"teacher_disagreement_score":0.05638981,"about_ca_system_score_codex":0.00066235365,"about_ca_system_score_gemma":0.00020618527,"threshold_uncertainty_score":0.68635327},"labels":[],"label_agreement":null},{"id":"W2077682394","doi":"10.1038/sj.leu.2402948","title":"Stem cells and diversity","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Stem cell; Diversity (politics); Biology; Medicine; Computational biology; Genetics; Anthropology; Sociology","score_opus":0.03822925441677991,"score_gpt":0.2715909743111523,"score_spread":0.2333617198943724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077682394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91010344,0.00023617159,0.000047569873,0.000060587972,0.000058836853,0.00015356786,0.0000011812135,0.000023447672,0.0893152],"genre_scores_gemma":[0.9728481,0.00006447395,0.00024430512,0.00016010979,0.000024305573,0.0000015174724,5.431814e-7,0.0000067016163,0.026649911],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929714,0.000040534742,0.0000689272,0.00015993162,0.0002420709,0.0001913822],"domain_scores_gemma":[0.99954253,0.00005391331,0.0000143968,0.0001683476,0.00003354018,0.00018724629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020411174,0.000062186555,0.00011942941,0.000037383892,0.00010383936,0.000009831073,0.000043714106,0.00005785739,0.0003535457],"category_scores_gemma":[0.000016472406,0.00005230377,0.000025066453,0.000094148665,0.000048146972,0.00002916164,0.000108784945,0.00014827763,0.00021233436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030143376,0.00013382184,0.75696594,0.0008613436,0.00015968517,0.001341782,0.0019491889,0.00001140744,0.13494235,0.008779954,0.045147065,0.04940606],"study_design_scores_gemma":[0.00685056,0.0007301955,0.13728277,0.0001669977,0.00014211978,0.0003430907,0.0010651362,0.0005556349,0.46643063,0.0006285955,0.3852653,0.0005389602],"about_ca_topic_score_codex":0.00008014851,"about_ca_topic_score_gemma":0.000004522666,"teacher_disagreement_score":0.61968315,"about_ca_system_score_codex":0.00019824169,"about_ca_system_score_gemma":0.00010726637,"threshold_uncertainty_score":0.38710776},"labels":[],"label_agreement":null},{"id":"W2077682572","doi":"10.1038/leu.2013.172","title":"Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institute on Aging","keywords":"Nuclear export signal; Biology; Monoclonal gammopathy of undetermined significance; Cell cycle; Molecular biology; Cancer research; RNA interference; Nuclear protein; Gene expression; Apoptosis; Cell nucleus; Gene; RNA; Monoclonal antibody; Transcription factor; Monoclonal; Genetics; Antibody","score_opus":0.0668419449408269,"score_gpt":0.3649538393636502,"score_spread":0.2981118944228233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077682572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956933,0.0007506338,0.000037309124,0.0009142809,0.0001883287,0.0014354148,0.000013557003,0.00010763305,0.00085949525],"genre_scores_gemma":[0.9957173,0.000076454264,0.0023834347,0.0006141145,0.00027699288,0.00019266756,0.000041482712,0.000074317104,0.0006232667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715793,0.00023306074,0.00050578924,0.0005673943,0.00066331855,0.0008725204],"domain_scores_gemma":[0.9979506,0.00067254296,0.0000841613,0.00049469486,0.0004559921,0.00034197356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034291227,0.00033912584,0.0005614184,0.00023496588,0.0003449832,0.00010200144,0.0002130547,0.0001710471,0.00043720682],"category_scores_gemma":[0.0030129217,0.00023525843,0.00015200835,0.0005461556,0.00044462612,0.00033109318,0.0002455437,0.00061861385,0.00079340924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015517019,0.0010269964,0.7187224,0.0005660588,0.001963811,0.0042556575,0.011633675,0.00010351215,0.2474685,0.0001479147,0.010872098,0.0016876665],"study_design_scores_gemma":[0.0076535996,0.00067104865,0.9355469,0.0004355982,0.00018815414,0.00035025843,0.0071159406,0.007646446,0.036359075,0.0013104243,0.0021768776,0.00054568995],"about_ca_topic_score_codex":0.0015940757,"about_ca_topic_score_gemma":0.000058757265,"teacher_disagreement_score":0.21682449,"about_ca_system_score_codex":0.0016608344,"about_ca_system_score_gemma":0.00043371352,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W2078157614","doi":"10.1038/sj.leu.2404527","title":"JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults","year":2007,"lang":"en","type":"letter","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut national de la recherche scientifique","keywords":"Acute megakaryoblastic leukemia; Down syndrome; Medicine; Leukemia; Mutation; Immunology; Pediatrics; Genetics; Biology; Gene; Psychiatry","score_opus":0.0069373402391127255,"score_gpt":0.24421775688056488,"score_spread":0.23728041664145216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078157614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630679,0.00058213493,0.00005354352,0.030588146,0.00047337465,0.0033351101,0.00074236933,0.000102391146,0.0010550546],"genre_scores_gemma":[0.8830506,0.0006343329,0.0013709447,0.10636245,0.00093339686,0.0012767472,0.0037960925,0.00024484584,0.0023305505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949186,0.00014096337,0.0012362679,0.0015800509,0.0008487557,0.0012754069],"domain_scores_gemma":[0.9976998,0.00067915936,0.0003592072,0.0008241326,0.0001029595,0.00033475566],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002962379,0.0011307133,0.0019229031,0.0014238287,0.00013341778,0.00009023883,0.00030388308,0.001487504,0.0003347205],"category_scores_gemma":[0.00012388505,0.0009233474,0.0002696514,0.0007813495,0.00026579585,0.00023713028,0.00016628612,0.002702031,0.00032110832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008818111,0.0005619122,0.42607495,0.001326106,0.0026466295,0.16820545,0.0015332084,0.00016089295,0.00005946626,0.00005200629,0.39428014,0.0042174147],"study_design_scores_gemma":[0.012574496,0.0012326345,0.9616713,0.0049153436,0.0007367788,0.011212421,0.000026575884,0.00027605405,0.000087388355,0.00013422304,0.006030586,0.0011021955],"about_ca_topic_score_codex":0.001701648,"about_ca_topic_score_gemma":0.00074037164,"teacher_disagreement_score":0.5355963,"about_ca_system_score_codex":0.004743106,"about_ca_system_score_gemma":0.0013118513,"threshold_uncertainty_score":0.9998088},"labels":[],"label_agreement":null},{"id":"W2079430799","doi":"10.1038/sj.leu.2402476","title":"HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis","year":2002,"lang":"en","type":"review","venue":"Leukemia","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":577,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mevalonate pathway; Farnesyl pyrophosphate; Statin; Geranylgeranyl pyrophosphate; Cancer research; Apoptosis; HMG-CoA reductase; In vivo; Pharmacology; Medicine; Cancer; Reductase; Biology; Internal medicine; Enzyme; Biochemistry","score_opus":0.014445255439201056,"score_gpt":0.25139725915004574,"score_spread":0.23695200371084468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079430799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005486366,0.9894266,0.000006792636,0.000029020262,0.0020728,0.00077828777,0.00022026809,0.000005907512,0.0019739536],"genre_scores_gemma":[0.0010332331,0.9946059,0.000074803735,0.00010487844,0.002821013,0.00010475491,0.0001044573,0.000057128742,0.0010938325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776614,0.000338181,0.00082888553,0.00048793078,0.00028051162,0.00029832884],"domain_scores_gemma":[0.9981272,0.00011373699,0.0007579657,0.0008304166,0.00008792473,0.00008272592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005262033,0.0004148023,0.0011949295,0.00007384434,0.000089074616,0.000025142792,0.00047262714,0.00025141254,0.000023651033],"category_scores_gemma":[0.000054469205,0.00022959782,0.00059050176,0.00023234557,0.0006691442,0.0000032760856,0.00016557558,0.00029052916,0.000007015479],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023143052,0.000075214644,0.0000010425891,0.0057712947,0.0003759723,5.2940493e-7,0.001004769,0.0000089617015,0.014941026,0.00053885044,0.19689816,0.78015274],"study_design_scores_gemma":[0.0010082101,0.00006895834,9.818841e-7,0.00078534195,0.00044329243,0.000010978266,0.00045490894,0.0000013273127,0.011425248,0.000025032072,0.98552114,0.0002546048],"about_ca_topic_score_codex":0.00030423675,"about_ca_topic_score_gemma":0.0000029823816,"teacher_disagreement_score":0.788623,"about_ca_system_score_codex":0.00006070029,"about_ca_system_score_gemma":0.00053946377,"threshold_uncertainty_score":0.93627274},"labels":[],"label_agreement":null},{"id":"W2079502160","doi":"10.1038/leu.2013.289","title":"A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia","year":2013,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Leukemia and Lymphoma Society","keywords":"Chronic lymphocytic leukemia; Allele; Mutation; Leukemia; Allele frequency; Mutation frequency; Oncology; Internal medicine; Immunology; Medicine; Biology; Cancer research; Genetics; Gene","score_opus":0.02554217843366553,"score_gpt":0.29812992508165825,"score_spread":0.27258774664799273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079502160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8972239,0.007460676,0.000070876726,0.067826845,0.0016704866,0.012732107,0.00016170966,0.0008064301,0.012046977],"genre_scores_gemma":[0.8933021,0.0014994389,0.00047196043,0.058930155,0.024602462,0.0025220115,0.0037976652,0.0008820113,0.0139922295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98878455,0.0008875695,0.0018342364,0.0019080169,0.0035858413,0.0029998138],"domain_scores_gemma":[0.9937979,0.0011578889,0.0008905889,0.0029133642,0.00063674554,0.0006035208],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0015399187,0.0014254297,0.0019397644,0.0007890656,0.0002899723,0.00038090625,0.0015800241,0.002836689,0.00092195143],"category_scores_gemma":[0.0012083559,0.0010117664,0.0005708825,0.0013873611,0.00075034995,0.0005631503,0.00054420676,0.0055625876,0.0018468054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007448822,0.000045038785,0.000704399,0.008051418,0.0007944443,0.014899189,0.005626027,0.0021254327,0.0021440003,0.000037493995,0.95328623,0.011541449],"study_design_scores_gemma":[0.13509105,0.005445945,0.020176768,0.027987735,0.0020941924,0.0050127427,0.00056317204,0.25389972,0.00207454,0.0009102806,0.5412717,0.0054722014],"about_ca_topic_score_codex":0.061675813,"about_ca_topic_score_gemma":0.00088459364,"teacher_disagreement_score":0.41201457,"about_ca_system_score_codex":0.5478425,"about_ca_system_score_gemma":0.22167309,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W2081439907","doi":"10.1038/sj.leu.2403994","title":"Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by Leguay et al","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Imatinib mesylate; Myeloid leukemia; Medicine; Imatinib; Mutation; Cancer research; Mesylate; Hematology; Leukemia; Internal medicine; Oncology; Biology; Genetics; Gene; Chemistry","score_opus":0.00928403131228904,"score_gpt":0.26138138869316924,"score_spread":0.2520973573808802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081439907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827686,0.0003441993,0.000029875577,0.012968935,0.000086118525,0.0023386388,0.00023049713,0.00026295675,0.00097019837],"genre_scores_gemma":[0.9814816,0.00004050155,0.0019114988,0.012148713,0.00005927715,0.00057021185,0.0007795859,0.0001638236,0.0028447756],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9953022,0.00039913048,0.00096455606,0.0010667627,0.0011761887,0.0010911867],"domain_scores_gemma":[0.9976576,0.00043825217,0.00039019735,0.00074368867,0.00028068648,0.0004896021],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009354987,0.00067251764,0.000865941,0.0004448937,0.00014553747,0.00008823363,0.00035051844,0.00033845336,0.0003961253],"category_scores_gemma":[0.0010921643,0.00058398943,0.0001670651,0.0011273127,0.00011215398,0.00039193494,0.00014763868,0.00072810316,0.00038042094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048180092,0.0034558882,0.09205131,0.00039151494,0.0021027662,0.0018928212,0.018499099,0.0030855916,0.14376387,0.00007053922,0.6349603,0.051546242],"study_design_scores_gemma":[0.10796492,0.014492218,0.5514956,0.0049688537,0.00083751715,0.00020150348,0.0005116146,0.012373732,0.14590022,0.00005595175,0.15831964,0.002878242],"about_ca_topic_score_codex":0.00092926645,"about_ca_topic_score_gemma":0.0014707253,"teacher_disagreement_score":0.47664064,"about_ca_system_score_codex":0.043140646,"about_ca_system_score_gemma":0.0048302836,"threshold_uncertainty_score":0.99966115},"labels":[],"label_agreement":null},{"id":"W2082132511","doi":"10.1038/sj.leu.2402744","title":"Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cytarabine; Diphtheria toxin; Myeloid leukemia; Leukemia; Medicine; Fludarabine; Internal medicine; Immunology; Fusion protein; Biology; Toxin; Chemotherapy; Microbiology; Recombinant DNA; Cyclophosphamide","score_opus":0.009823489357464573,"score_gpt":0.21517147231846986,"score_spread":0.2053479829610053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082132511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017596,0.0026220218,0.00045595964,0.000113117996,0.0013848137,0.0014452751,0.000113852686,0.00018591812,0.0035030905],"genre_scores_gemma":[0.9864486,0.000052408708,0.00080271624,0.00014002233,0.000044269556,0.0002045216,0.000105668674,0.0000863548,0.012115426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969844,0.0005727431,0.0008105488,0.0006869659,0.0001482843,0.00079704175],"domain_scores_gemma":[0.99785936,0.00011299573,0.00042191322,0.0013738453,0.00014480697,0.00008706523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006382405,0.0005081261,0.0007301328,0.00016328531,0.00026923703,0.000035096244,0.0010181185,0.0004525563,0.0019568976],"category_scores_gemma":[0.0003780866,0.00046077793,0.00034679376,0.00030898466,0.00031721426,0.00019653904,0.00028245169,0.0006310525,0.00046531632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009915165,0.00019399771,0.00022874716,0.00009378047,0.00018278018,0.000015984944,0.00031682636,0.00000907896,0.9872156,0.008435113,0.0009952012,0.0013213705],"study_design_scores_gemma":[0.0073860693,0.00053177937,0.0052092113,0.00026804683,0.000108379405,0.00004787469,0.0003242021,0.000017894241,0.9420746,0.0035944842,0.039748423,0.0006890176],"about_ca_topic_score_codex":0.00026028836,"about_ca_topic_score_gemma":0.000027414433,"teacher_disagreement_score":0.04514098,"about_ca_system_score_codex":0.0004506911,"about_ca_system_score_gemma":0.0006388393,"threshold_uncertainty_score":0.9997844},"labels":[],"label_agreement":null},{"id":"W2082267009","doi":"10.1038/sj.leu.2402876","title":"Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Arsenic; Buthionine sulfoximine; Glutathione; Cell culture; Biology; Apoptosis; Annexin; Cancer research; Chemistry; Biochemistry; Genetics; Enzyme; Retinoic acid","score_opus":0.0071849851130217,"score_gpt":0.23002346536575763,"score_spread":0.22283848025273592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082267009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851948,0.0028230897,0.0016760963,0.00010022781,0.00020714731,0.00026845382,0.000009847752,0.000029358172,0.009691002],"genre_scores_gemma":[0.9847845,0.00053848024,0.0038424588,0.0005373694,0.00014251153,0.000057284484,0.000047472568,0.00004635459,0.010003564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980899,0.00016541424,0.00043277495,0.0006169956,0.00023628229,0.00045861496],"domain_scores_gemma":[0.99907506,0.000042908614,0.00011577807,0.00053848303,0.0000869724,0.000140807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043364154,0.00027368107,0.0002614028,0.0001063144,0.00008508001,0.00004252978,0.00027000488,0.00026749747,0.00004341295],"category_scores_gemma":[0.0004419995,0.00027431917,0.00011980909,0.00035532578,0.00005747729,0.000008700517,0.000064199165,0.00020029845,0.00008590161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027035733,0.000055850825,0.0015699257,0.00009780804,0.000013509475,0.0000379401,0.00009038601,0.00047338338,0.99314034,0.00053445605,0.0034474249,0.00026860554],"study_design_scores_gemma":[0.0010825379,0.00011509164,0.0012807804,0.00005767838,0.0000148689805,0.000010614067,0.00014316884,0.000017582031,0.8011543,0.00048008785,0.19526559,0.0003776848],"about_ca_topic_score_codex":0.000028234468,"about_ca_topic_score_gemma":0.00030266275,"teacher_disagreement_score":0.19198604,"about_ca_system_score_codex":0.00024360002,"about_ca_system_score_gemma":0.0004664472,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W2083368306","doi":"10.1038/leu.2009.20","title":"Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Biology; Friend virus; RNA interference; Carcinogenesis; Cancer research; Leukemia; Oncogene; Phenotype; Murine leukemia virus; Haematopoiesis; Cell culture; Gene; Molecular biology; Virology; RNA; Immunology; Cell cycle; Cell biology; Genetics; Stem cell","score_opus":0.01272927749297223,"score_gpt":0.29117512616993857,"score_spread":0.2784458486769663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083368306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984218,0.0003893743,0.000047581252,0.00009927545,0.000036023135,0.00042735436,0.000010959828,0.000014917511,0.0005527458],"genre_scores_gemma":[0.9990609,0.00009719517,0.0000804817,0.00023057681,0.00029341117,0.00002926201,0.00012033185,0.000025202946,0.000062601226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980722,0.00035214753,0.00035949095,0.00051886134,0.00032891732,0.00036838072],"domain_scores_gemma":[0.99913055,0.000027521804,0.00012622942,0.000529021,0.00007978947,0.00010690806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068949535,0.00024572975,0.0002855528,0.000094927855,0.00017412353,0.00007496755,0.00029747927,0.00028901518,0.000011428999],"category_scores_gemma":[0.000042694857,0.00020040717,0.000051394505,0.00012823471,0.00014007436,0.000025996824,0.00008405858,0.0002849232,0.0000012434464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010084714,0.00007796498,0.0034261453,0.000015847849,0.0000143090465,0.000008016199,0.00056026294,0.00009481627,0.99124306,0.00014510061,0.00009848228,0.0033075481],"study_design_scores_gemma":[0.0028012113,0.004220859,0.029774146,0.0000384675,0.000015651503,0.000032201337,0.0004995463,0.0005551657,0.96115255,0.00041503893,0.00020505504,0.00029007444],"about_ca_topic_score_codex":0.000111789894,"about_ca_topic_score_gemma":0.0005969753,"teacher_disagreement_score":0.030090453,"about_ca_system_score_codex":0.000077193785,"about_ca_system_score_gemma":0.00023198723,"threshold_uncertainty_score":0.8172368},"labels":[],"label_agreement":null},{"id":"W2083588754","doi":"10.1038/sj.leu.2404695","title":"A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Biology; Chronic lymphocytic leukemia; Fluorescence in situ hybridization; B cell; Fusion gene; Trisomy; Cytogenetics; Breakpoint; Molecular biology; Gene rearrangement; Locus (genetics); Leukemia; Gene; Genetics; Cancer research; Chromosome; Antibody","score_opus":0.029370437840654736,"score_gpt":0.3068619537983945,"score_spread":0.27749151595773974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083588754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98266727,0.0048997547,0.010913923,0.000058698526,0.000113513124,0.000571728,0.000013231117,0.000074041076,0.00068786537],"genre_scores_gemma":[0.99249524,0.00065050245,0.005120377,0.00022829034,0.00010361355,0.000027534057,0.000040390547,0.0000351185,0.0012989488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99720275,0.00011826121,0.0007659367,0.0006106706,0.00069404824,0.0006083186],"domain_scores_gemma":[0.9978802,0.00049504533,0.00024069315,0.0007024121,0.00040080506,0.00028081072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000704349,0.00029290805,0.00079683587,0.0006531681,0.00014181182,0.0000394988,0.00021726915,0.00019560325,0.00011736099],"category_scores_gemma":[0.00022000054,0.0002391512,0.00021588683,0.0013221684,0.0004430787,0.00009606246,0.0001226614,0.00027352752,0.000018245517],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030267248,0.00039710154,0.02302521,0.004114044,0.0013569396,0.009866861,0.013682688,0.0026220493,0.9315873,0.00044182118,0.00064506393,0.009234198],"study_design_scores_gemma":[0.082249835,0.0020394658,0.49063674,0.0011044074,0.008725611,0.007758731,0.009964467,0.07879893,0.31260103,0.0009905614,0.0030452616,0.002084945],"about_ca_topic_score_codex":0.0047505153,"about_ca_topic_score_gemma":0.0010092995,"teacher_disagreement_score":0.61898625,"about_ca_system_score_codex":0.0073816846,"about_ca_system_score_gemma":0.003289926,"threshold_uncertainty_score":0.9964288},"labels":[],"label_agreement":null},{"id":"W2083666809","doi":"10.1038/sj.leu.2403650","title":"BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Cord blood; CD34; Severe combined immunodeficiency; Bone marrow; Cancer research; Myeloid; Nod; Immunology; Population; Transplantation; Stem cell; Virology; Internal medicine; Medicine; Cell biology; In vivo","score_opus":0.029275919322379315,"score_gpt":0.2967654724335959,"score_spread":0.2674895531112166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083666809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907568,0.0006998501,0.000018268624,0.00053383445,0.00024141737,0.0009298842,0.00001915724,0.00016111974,0.00663965],"genre_scores_gemma":[0.99133277,0.000039255865,0.00263594,0.00043591054,0.00030424894,0.00008177092,0.00018580616,0.00006265214,0.0049216496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997583,0.000059362133,0.00065741956,0.0006123479,0.00042658576,0.00066130597],"domain_scores_gemma":[0.9988071,0.000035869893,0.00013430836,0.00077905774,0.00007694792,0.00016671675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023163205,0.00033988018,0.00045419473,0.0002476824,0.00016495357,0.000030770578,0.00021187609,0.0001893753,0.00045380357],"category_scores_gemma":[0.000034377117,0.00033118183,0.00014701243,0.00046665675,0.00007539861,0.00017956595,0.000058827296,0.00051506184,0.00040377842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005842652,0.0023680488,0.055304494,0.0003174144,0.0002749359,0.00047651067,0.0031003756,0.0034168183,0.91614014,0.00094542827,0.0033865834,0.013685012],"study_design_scores_gemma":[0.029264858,0.0011632454,0.4822194,0.0006610035,0.0009640256,0.00064544426,0.0003205301,0.0026074331,0.46364158,0.00010714204,0.017222757,0.0011825623],"about_ca_topic_score_codex":0.0016110729,"about_ca_topic_score_gemma":0.00073330605,"teacher_disagreement_score":0.45249853,"about_ca_system_score_codex":0.003377721,"about_ca_system_score_gemma":0.00070506,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W2084403455","doi":"10.1038/sj.leu.2403222","title":"NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Stem Cell Network","keywords":"Nod; Progenitor cell; Stem cell; Regeneration (biology); Biology; Immunology; Cell biology; Cancer research; In vivo; Genetics","score_opus":0.020182534713018993,"score_gpt":0.2737957799411491,"score_spread":0.2536132452281301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084403455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975806,0.00060781004,0.00015972849,0.000023119635,0.00005743596,0.0009973557,0.000113043716,0.00004173218,0.00041919044],"genre_scores_gemma":[0.997706,0.000027756554,0.00039509323,0.00014414724,0.0001298167,0.00011170188,0.00016407589,0.000046997604,0.0012744111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981143,0.00020110494,0.00031781642,0.0007076091,0.00023012627,0.00042908112],"domain_scores_gemma":[0.9989758,0.000015738395,0.00008530218,0.00045274914,0.00017652239,0.00029387345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021179557,0.000335582,0.00027470043,0.00011122379,0.0003940146,0.00011467913,0.0002129817,0.0002440344,0.000026439167],"category_scores_gemma":[0.00002158426,0.0003462944,0.00006123835,0.00011874091,0.00017899626,0.000013702815,0.000089726636,0.00020161302,0.0000075034004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017327693,0.00006299703,0.00040626284,0.00005085782,0.00004447852,0.0000053124713,0.00027758573,0.000101199425,0.99807316,0.00014456233,0.00037983042,0.00028048566],"study_design_scores_gemma":[0.0019724686,0.0016259965,0.0007023729,0.000021895621,0.000019635512,0.0000073898314,0.00013442492,0.00003925127,0.99092484,0.000022146402,0.004126762,0.00040283197],"about_ca_topic_score_codex":0.00003284611,"about_ca_topic_score_gemma":0.00011353966,"teacher_disagreement_score":0.007148327,"about_ca_system_score_codex":0.00012297778,"about_ca_system_score_gemma":0.00014156871,"threshold_uncertainty_score":0.9998989},"labels":[],"label_agreement":null},{"id":"W2084507055","doi":"10.1038/leu.2008.206","title":"Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia","year":2008,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Université Laval; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Biology; Leukemia; Context (archaeology); Epigenetics; Stem cell; Immunology; Cancer research; In vivo; Cell biology; Genetics; Gene","score_opus":0.09552228716037843,"score_gpt":0.36064900140991857,"score_spread":0.26512671424954015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084507055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09708697,0.889082,0.00004139616,0.00003395205,0.00017398378,0.0034266158,0.00024238297,0.00023763743,0.009675051],"genre_scores_gemma":[0.0030112022,0.9838259,0.0041916952,0.00039735538,0.001331662,0.0006019427,0.0008343756,0.0005688227,0.005237012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99113303,0.0005423644,0.003317217,0.001966157,0.0015408032,0.0015004006],"domain_scores_gemma":[0.9944383,0.00057762297,0.0011189806,0.0024465774,0.00038136967,0.0010371716],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00063429755,0.001579279,0.0061584017,0.0019676741,0.00029330116,0.00006217996,0.0016283097,0.0017339407,0.00030877028],"category_scores_gemma":[0.00033913384,0.0014523035,0.0012283942,0.002320122,0.0004590323,0.00026038234,0.00094206,0.0027269863,0.00029544407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023136445,0.0009541585,0.0017933956,0.14028488,0.0026050336,0.0046972646,0.0082493685,0.0033199447,0.0626537,0.0010767507,0.10824968,0.66588444],"study_design_scores_gemma":[0.011188816,0.0016308557,0.00030113567,0.13015266,0.0032365166,0.0005675069,0.00054164237,0.0022084275,0.021083755,0.0015931301,0.82204765,0.0054478915],"about_ca_topic_score_codex":0.01270069,"about_ca_topic_score_gemma":0.00058002496,"teacher_disagreement_score":0.713798,"about_ca_system_score_codex":0.014522377,"about_ca_system_score_gemma":0.009792847,"threshold_uncertainty_score":0.99969554},"labels":[],"label_agreement":null},{"id":"W2086061986","doi":"10.1038/leu.2013.350","title":"New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)","year":2013,"lang":"en","type":"review","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"National Cancer Institute","keywords":"Daratumumab; Lenalidomide; Medicine; Multiple myeloma; Combination therapy; Cancer research; Panobinostat; Pharmacology; Histone deacetylase; Immunology; Biology; Histone","score_opus":0.08683142709177934,"score_gpt":0.3427305704482578,"score_spread":0.25589914335647845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086061986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012502181,0.97989786,0.0016057972,0.00036571507,0.0007683939,0.0038020713,0.00008760274,0.000055770597,0.00091461325],"genre_scores_gemma":[0.01835936,0.9709096,0.00763092,0.00006189375,0.00044642098,0.00035231205,0.0009970973,0.00008077182,0.0011616083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731773,0.00009881006,0.0009426127,0.0006172389,0.0006518263,0.0003717889],"domain_scores_gemma":[0.9980356,0.0006729973,0.0005058069,0.0005451404,0.000055513334,0.00018490768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042421097,0.00039711254,0.001223927,0.00036491267,0.00004108691,0.00005364937,0.00031843915,0.0003737457,0.0001798885],"category_scores_gemma":[0.00036110473,0.0002655809,0.00023048071,0.00036458042,0.00005621555,0.00012761005,0.00024737287,0.0007613311,0.000042013173],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010700176,0.000085879095,0.0028939077,0.0007006409,0.00030614054,0.00038092706,0.00016149112,6.4162396e-7,0.00019501065,0.00008434146,0.0006782489,0.99440575],"study_design_scores_gemma":[0.015185731,0.00024382902,0.0654145,0.046484448,0.0007524159,0.0013546613,0.00047006935,0.0019575756,0.0002592198,0.0013651412,0.8655798,0.0009326347],"about_ca_topic_score_codex":0.017909072,"about_ca_topic_score_gemma":0.0027778326,"teacher_disagreement_score":0.9934731,"about_ca_system_score_codex":0.0012825198,"about_ca_system_score_gemma":0.000756759,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W2086250536","doi":"10.1038/leu.2013.362","title":"Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Biology; DNA methylation; Myeloid leukemia; Epigenetics; Genetics; Cancer research; Gene; Gene expression","score_opus":0.01687621822198426,"score_gpt":0.2892591265371202,"score_spread":0.27238290831513595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086250536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850301,0.00022413893,0.00039319717,0.0015126159,0.00011396969,0.0013203239,0.000042550437,0.000107515116,0.011255587],"genre_scores_gemma":[0.98442316,0.0001764839,0.0071589234,0.00062936667,0.00012496235,0.00031632185,0.00022946698,0.00008192636,0.006859386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973069,0.00010853601,0.00085065566,0.0005176838,0.0004911247,0.0007251285],"domain_scores_gemma":[0.9980739,0.00031846348,0.00019620401,0.00075538707,0.00033291243,0.00032315074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002934077,0.00030853006,0.0006313743,0.00075730664,0.000104111416,0.000039186885,0.00037430198,0.0002803616,0.0011763555],"category_scores_gemma":[0.00026793045,0.0002965115,0.00019832309,0.0010648983,0.00032958778,0.00033204973,0.00015233946,0.0008090966,0.0016135483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036813933,0.0002768568,0.057113428,0.00048659262,0.0007373628,0.00047938523,0.0045836954,0.003696535,0.8665927,0.0024205542,0.036128934,0.027115839],"study_design_scores_gemma":[0.010684573,0.0005655795,0.9002017,0.00034566494,0.00041123817,0.0005400881,0.0018142302,0.036030147,0.039838478,0.004534294,0.004205668,0.0008283637],"about_ca_topic_score_codex":0.003743094,"about_ca_topic_score_gemma":0.0001657759,"teacher_disagreement_score":0.84308827,"about_ca_system_score_codex":0.005134841,"about_ca_system_score_gemma":0.0033388045,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W2086275775","doi":"10.1038/sj.leu.2404296","title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","year":2006,"lang":"en","type":"review","venue":"Leukemia","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1336,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Microvesicles; Cell biology; Biology; Cell; Secretion; Endosome; Cell signaling; Immune system; Organelle; Receptor; Mitochondrion; Signal transduction; Immunology; microRNA; Biochemistry; Intracellular","score_opus":0.01055598367897123,"score_gpt":0.2623132149103545,"score_spread":0.25175723123138327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086275775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03961133,0.95869315,0.00006244369,0.0000050667973,0.000061025068,0.0006544979,0.00014321283,0.000019235315,0.0007500317],"genre_scores_gemma":[0.010060498,0.9860695,0.0015020767,0.00005901002,0.000084831634,0.000053252228,0.0016364355,0.0001047782,0.00042963214],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979513,0.00022902492,0.00082826253,0.00054444745,0.00016511958,0.00028179877],"domain_scores_gemma":[0.9979556,0.0000616859,0.00063020596,0.0011045276,0.000068897716,0.00017907408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023364407,0.00042717304,0.00081645604,0.00010703885,0.00006360924,0.000026613732,0.00057399564,0.00054363796,0.000011172431],"category_scores_gemma":[0.00004501932,0.00041442053,0.000296514,0.00018884346,0.00015219137,0.000003637303,0.00032488845,0.0002352618,0.000011665525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007411701,0.00033413124,0.000073835035,0.021330785,0.00030688793,0.000026604974,0.00012732978,0.00002374784,0.8736419,0.00003727694,0.008844462,0.095178895],"study_design_scores_gemma":[0.0007856204,0.00010651605,0.00001924096,0.0012948827,0.0006642285,0.000014973015,0.000039030867,0.000010304183,0.25654334,0.000035892725,0.73975086,0.0007351317],"about_ca_topic_score_codex":0.00005388948,"about_ca_topic_score_gemma":0.000022070835,"teacher_disagreement_score":0.73090637,"about_ca_system_score_codex":0.00010872055,"about_ca_system_score_gemma":0.000589828,"threshold_uncertainty_score":0.9998308},"labels":[],"label_agreement":null},{"id":"W2086651719","doi":"10.1038/sj.leu.2403773","title":"The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Histone deacetylase inhibitor; Retinoid; Histone deacetylase; Tretinoin; Cancer research; Acute promyelocytic leukemia; Acute myeloblastic leukemia; Retinoic acid; Vorinostat; Leukemia; Biology; Cell culture; Pharmacology; Histone; Immunology; Biochemistry; Gene; Genetics","score_opus":0.00698725320488435,"score_gpt":0.242846804742137,"score_spread":0.23585955153725263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086651719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915,0.0025495456,0.0027726819,0.0006553043,0.0005175863,0.00044944062,0.000034423807,0.00007161468,0.0014494093],"genre_scores_gemma":[0.99316674,0.0015338643,0.0012383844,0.0009802473,0.00082639116,0.00008315597,0.00013257415,0.00009330265,0.0019453549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665946,0.0002456693,0.0006763725,0.00095750566,0.00045587483,0.0010051304],"domain_scores_gemma":[0.9984353,0.00006608442,0.00022176135,0.00089023606,0.00012388187,0.00026274126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080748566,0.00057057303,0.00043433288,0.00009313471,0.00028952258,0.00011923224,0.0005586533,0.00052832125,0.000025071187],"category_scores_gemma":[0.0001553576,0.00047860973,0.00029219544,0.00028346904,0.00041680236,0.000033328346,0.00020167488,0.0006790694,0.00008843072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033725254,0.00004462995,0.000053057724,0.000059432678,0.00010421188,0.00009850994,0.0003236095,0.0010333931,0.98127705,0.00002804094,0.004451633,0.0121891955],"study_design_scores_gemma":[0.001531295,0.00024106671,0.0002546423,0.000051810224,0.000100971745,0.000129148,0.00011630329,0.0013184819,0.9524712,0.000055010238,0.04314293,0.0005871182],"about_ca_topic_score_codex":0.000100092424,"about_ca_topic_score_gemma":0.00043344783,"teacher_disagreement_score":0.038691297,"about_ca_system_score_codex":0.0013874936,"about_ca_system_score_gemma":0.0012277509,"threshold_uncertainty_score":0.9997665},"labels":[],"label_agreement":null},{"id":"W2087027139","doi":"10.1038/leu.2012.95","title":"B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Universitaire de France; Agence Nationale de la Recherche; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"B cell; Oncomir; microRNA; Psychological repression; Biology; Cancer research; Transcription factor; Chromosomal translocation; Cell biology; Cell growth; Molecular biology; Antibody; Immunology; Gene expression; Gene; Genetics","score_opus":0.006532651369288731,"score_gpt":0.217169159989963,"score_spread":0.21063650862067426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087027139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936631,0.004805876,0.00010775493,0.000057994483,0.00032579585,0.00026731167,0.00006397464,0.0000071532786,0.00070107885],"genre_scores_gemma":[0.9973986,0.00011235865,0.0011501345,0.00011181887,0.00016979859,0.000018040917,0.000020962243,0.000024521776,0.0009937248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988744,0.000092073096,0.00039174157,0.00021718386,0.00015619196,0.0002683789],"domain_scores_gemma":[0.9992522,0.000009212958,0.00018196339,0.0004481861,0.000057308,0.000051109717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026590834,0.00016223089,0.00023698412,0.00003102362,0.000038777376,0.0000055678497,0.00023742577,0.00020379924,0.000027966504],"category_scores_gemma":[0.000011607504,0.0001261926,0.00020881675,0.00012838266,0.00008901253,0.000005755758,0.00004936217,0.00011740465,0.0000040115565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014122523,0.00013544381,0.0024299407,0.0000993248,0.000027621929,1.8532575e-7,0.00043712326,0.00018611952,0.99408025,0.000005232379,0.0020761772,0.0003813547],"study_design_scores_gemma":[0.0010304519,0.00006802989,0.001807266,0.000065923196,0.000022174372,0.0000036545196,0.000056418183,0.000270874,0.98539543,0.000027316451,0.011108624,0.0001438236],"about_ca_topic_score_codex":0.000275489,"about_ca_topic_score_gemma":0.000015729454,"teacher_disagreement_score":0.009032447,"about_ca_system_score_codex":0.00011851022,"about_ca_system_score_gemma":0.00021950122,"threshold_uncertainty_score":0.5145985},"labels":[],"label_agreement":null},{"id":"W2087111337","doi":"10.1038/sj.leu.2401980","title":"Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)","year":2000,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Medical Center, University of Rochester; National Institutes of Health; McMaster University; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Vincristine; Internal medicine; Asparaginase; Acute lymphocytic leukemia; Methotrexate; Cancer; Chemotherapy; Clinical trial; Pediatrics; Oncology; Leukemia; Surgery; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.038038731451942726,"score_gpt":0.35686289248677017,"score_spread":0.31882416103482747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087111337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012340167,0.81350046,0.000920351,0.000196165,0.00068163825,0.1658188,0.010077726,0.0006669546,0.006903869],"genre_scores_gemma":[0.00009546552,0.9037201,0.0035238306,0.00037190347,0.00161196,0.07691276,0.0036870288,0.00063738454,0.009439567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905188,0.0002595913,0.0030648212,0.0023203937,0.0018478854,0.001988491],"domain_scores_gemma":[0.99258035,0.001240352,0.0018442263,0.0026651546,0.00068392616,0.0009860044],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00065162533,0.0019436823,0.0062448373,0.0009370314,0.0002684168,0.00012701534,0.0014814563,0.0016356437,0.00023189127],"category_scores_gemma":[0.0007541648,0.0013981272,0.001309715,0.0017765911,0.0012569666,0.00036470732,0.00032399254,0.0014754251,0.0001907348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009871399,0.00040808646,0.00014570492,0.037555646,0.009045722,0.0010783097,0.00022722359,0.00046732643,0.000019491323,0.00018611336,0.0749902,0.86600477],"study_design_scores_gemma":[0.032427847,0.0020840822,0.00022138903,0.050053634,0.009194632,0.0012937926,0.000009503324,0.00031540167,0.000087131004,0.000021954673,0.90283644,0.001454197],"about_ca_topic_score_codex":0.0025763095,"about_ca_topic_score_gemma":0.00040883594,"teacher_disagreement_score":0.8645506,"about_ca_system_score_codex":0.016906112,"about_ca_system_score_gemma":0.054672264,"threshold_uncertainty_score":0.99966043},"labels":[],"label_agreement":null},{"id":"W2089532685","doi":"10.1038/leu.2014.44","title":"BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; U.S. Public Health Service","keywords":"Azacitidine; Myeloid; Gene silencing; Cancer research; RNA interference; Hypomethylating agent; Bcl-2 family; Biology; Gene expression; RNA; Gene; DNA methylation; Apoptosis; Programmed cell death; Genetics","score_opus":0.01767716885988376,"score_gpt":0.2858078276040187,"score_spread":0.26813065874413494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089532685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964461,0.0004264165,0.00007290754,0.00043490206,0.000055317934,0.00076201686,0.000007719065,0.00005579336,0.0017388549],"genre_scores_gemma":[0.99488854,0.00013688994,0.0026774383,0.0005424097,0.000100719175,0.000048019105,0.000005841688,0.0000528721,0.0015472504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997647,0.00030059068,0.0005335921,0.00045933013,0.00047669036,0.0005827944],"domain_scores_gemma":[0.99850523,0.00043329474,0.00014246709,0.00053069665,0.00015928144,0.00022902053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015563515,0.00025508372,0.0006449222,0.0004144365,0.000072793795,0.00002164007,0.00016127391,0.00022024596,0.000019239324],"category_scores_gemma":[0.0019801455,0.00022657703,0.000076772754,0.00039119215,0.0002585352,0.00013491909,0.00019650548,0.0004418538,0.000066682915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005090335,0.000053735897,0.043274347,0.00046522517,0.000027358687,0.00081280177,0.0012358198,0.00001754422,0.9345032,0.00015578006,0.00056778116,0.013796067],"study_design_scores_gemma":[0.0064244117,0.0016367735,0.6833847,0.0011269831,0.00004531045,0.0006219596,0.00077633094,0.0074928487,0.29221025,0.0002818502,0.0055676624,0.0004308757],"about_ca_topic_score_codex":0.0010327352,"about_ca_topic_score_gemma":0.00009114476,"teacher_disagreement_score":0.6422929,"about_ca_system_score_codex":0.0007862615,"about_ca_system_score_gemma":0.0010038444,"threshold_uncertainty_score":0.9239543},"labels":[],"label_agreement":null},{"id":"W2091962088","doi":"10.1038/leu.2012.184","title":"Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; University of British Columbia; National Natural Science Foundation of China","keywords":"Somatic hypermutation; Immunoglobulin heavy chain; Myeloid leukemia; Myeloid; Biology; Minimal residual disease; Antibody; Immunoglobulin gene; Haematopoiesis; Cancer research; Immunology; Leukemia; B cell; Stem cell; Genetics","score_opus":0.017394203566630566,"score_gpt":0.2744746978745839,"score_spread":0.2570804943079533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091962088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915604,0.0011315035,0.00074552273,0.001586071,0.00017555275,0.0013959453,0.000054059015,0.00022941023,0.0031215139],"genre_scores_gemma":[0.98176366,0.0003486833,0.010087612,0.0020984814,0.00051799696,0.00032582722,0.00028132612,0.00016552121,0.004410901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955848,0.00019148822,0.0008310557,0.00070857606,0.001097265,0.0015868407],"domain_scores_gemma":[0.9976254,0.00015979137,0.0002455097,0.0011675651,0.00020338818,0.00059832615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078924553,0.00059447624,0.0008850395,0.00054341747,0.0002478016,0.00006509237,0.00044661597,0.00043914097,0.00047197295],"category_scores_gemma":[0.00014472722,0.0004998983,0.00017478163,0.0010738531,0.00023674747,0.0006876008,0.00023308345,0.0011351418,0.0005967547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004417957,0.000575029,0.0656286,0.0007048853,0.0010035917,0.0012898117,0.015435572,0.0005004387,0.8814288,0.0004109224,0.01197711,0.016627282],"study_design_scores_gemma":[0.026497712,0.0017741973,0.20720412,0.0012220832,0.0007014674,0.002421354,0.0015504858,0.012280631,0.7316487,0.00048313927,0.012304422,0.0019116807],"about_ca_topic_score_codex":0.001083518,"about_ca_topic_score_gemma":0.000039019622,"teacher_disagreement_score":0.1497801,"about_ca_system_score_codex":0.008308341,"about_ca_system_score_gemma":0.0023903563,"threshold_uncertainty_score":0.99974525},"labels":[],"label_agreement":null},{"id":"W2094740058","doi":"10.1038/sj.leu.2402973","title":"Differential response of primitive human CD34− and CD34+ hematopoietic cells to the Notch ligand Jagged-1","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Notch signaling pathway; CD34; CD38; Haematopoiesis; Cell biology; Biology; Stem cell; Progenitor cell; Molecular biology; Immunology; Signal transduction","score_opus":0.00624838068126338,"score_gpt":0.23266535065843724,"score_spread":0.22641696997717387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094740058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986502,0.00012958217,0.00028577496,0.00011470361,0.000100055775,0.0001793691,0.000008549603,0.0000043485693,0.00052743335],"genre_scores_gemma":[0.9979901,0.000020255133,0.00022213292,0.00020543732,0.00003728469,0.000012396862,0.0000281603,0.000008889714,0.0014753855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927956,0.00012791349,0.00015488734,0.0002241774,0.000068231944,0.00014524812],"domain_scores_gemma":[0.999633,0.000024217474,0.000054870266,0.00019669766,0.000042170694,0.000049049446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018990783,0.00011014819,0.000112319605,0.000025453834,0.00010789152,0.00000967839,0.000092319,0.00013247663,0.000016731996],"category_scores_gemma":[0.00005629185,0.00008221783,0.000034898312,0.00006798402,0.00009827673,0.0000018569702,0.0000686275,0.00005677445,0.00000949113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019200146,0.000014495267,0.0013232086,0.000008889383,0.000027767985,8.705535e-7,0.00024671282,0.000008852006,0.9968109,0.00016696588,0.000903288,0.00029602982],"study_design_scores_gemma":[0.00035945204,0.00016251208,0.043660615,0.00001122549,0.000012474096,0.000011903262,0.00008545291,0.000001752834,0.9490854,0.000070842194,0.006432418,0.000105932624],"about_ca_topic_score_codex":0.000005282339,"about_ca_topic_score_gemma":0.00001703344,"teacher_disagreement_score":0.0477255,"about_ca_system_score_codex":0.000023162362,"about_ca_system_score_gemma":0.00008754718,"threshold_uncertainty_score":0.3352746},"labels":[],"label_agreement":null},{"id":"W2109151188","doi":"10.1038/leu.2009.205","title":"Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia","year":2009,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Queen Elizabeth II Health Sciences Centre; Moncton Hospital; Hôpital Charles-Le Moyne; Alberta Cancer Foundation; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Hematology; Internal medicine; Immunology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.010149224251827413,"score_gpt":0.24440445713149683,"score_spread":0.23425523287966943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109151188","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167254,0.0030358266,0.000039534978,0.035446055,0.0008126073,0.007837848,0.00025634014,0.0011454225,0.034700986],"genre_scores_gemma":[0.3617057,0.0007100877,0.0011851212,0.5236372,0.00798393,0.00058747426,0.014503729,0.0013991606,0.08828764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908865,0.0002841341,0.0013505311,0.002056558,0.0026466805,0.0027755774],"domain_scores_gemma":[0.9957653,0.00032472055,0.0004833807,0.0024291626,0.0004984543,0.00049896125],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00037137824,0.0015815411,0.0023629172,0.0012607701,0.00014434491,0.00014638944,0.0009701693,0.0027046162,0.0007921753],"category_scores_gemma":[0.00015575359,0.0012813269,0.00040039126,0.0017805663,0.00048644235,0.00026261245,0.00026080976,0.005048246,0.001367053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001724945,0.00013263403,0.0016856423,0.0023307498,0.00029990912,0.016974417,0.0001418332,0.001527114,0.00008550042,0.0000050878266,0.97021246,0.0048796954],"study_design_scores_gemma":[0.2341268,0.004482449,0.0062148827,0.004548542,0.0010988924,0.0008464692,0.000020397352,0.025027905,0.0014431651,0.00009076835,0.719058,0.0030417407],"about_ca_topic_score_codex":0.007817006,"about_ca_topic_score_gemma":0.000463635,"teacher_disagreement_score":0.5550197,"about_ca_system_score_codex":0.6133346,"about_ca_system_score_gemma":0.1672504,"threshold_uncertainty_score":0.9996933},"labels":[],"label_agreement":null},{"id":"W2113259374","doi":"10.1038/sj.leu.2404891","title":"Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity","year":2007,"lang":"en","type":"article","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University; Samuel Waxman Cancer Research Foundation","keywords":"Arsenic trioxide; Toxicity; Lymphoma; Arsenic; Trolox; Medicine; Pharmacology; Cancer research; Chemistry; Internal medicine","score_opus":0.006291114968736321,"score_gpt":0.22159257621353695,"score_spread":0.21530146124480062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113259374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898262,0.0032714708,0.0036091267,0.000019643025,0.00020252653,0.00039546995,0.0000022277504,0.000024584728,0.0026487282],"genre_scores_gemma":[0.9978449,0.0005608591,0.00041614653,0.00026484497,0.00036055094,0.000029225825,0.000013884034,0.000026519047,0.00048307682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985795,0.00011387068,0.00033626813,0.0003708043,0.00021555714,0.00038401445],"domain_scores_gemma":[0.99902034,0.0001427056,0.00023338383,0.00043840025,0.00010064456,0.00006454387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006570795,0.00021277979,0.0002293961,0.000040362556,0.00018357892,0.000022885079,0.00039239344,0.00024806763,0.000006385789],"category_scores_gemma":[0.00041820155,0.00015586744,0.00015915425,0.00019580376,0.00019034014,0.000007486171,0.00012347451,0.00018357956,0.000009647372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007863363,0.00003751329,0.00046717134,0.00018007113,0.00005027739,0.00001782757,0.00012449686,0.000039111736,0.97637224,0.0000269384,0.0001901279,0.022415617],"study_design_scores_gemma":[0.000715904,0.00021811023,0.003286068,0.000058568767,0.000026904181,0.000020774485,0.00010580342,0.00007230802,0.9893969,0.000035685483,0.0058705043,0.00019242913],"about_ca_topic_score_codex":0.000031089727,"about_ca_topic_score_gemma":0.000024546185,"teacher_disagreement_score":0.02222319,"about_ca_system_score_codex":0.00008101146,"about_ca_system_score_gemma":0.00024675406,"threshold_uncertainty_score":0.635609},"labels":[],"label_agreement":null},{"id":"W2115093629","doi":"10.1038/leu.2012.257","title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Bergonié; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"IGHV@; Biology; Waldenstrom macroglobulinemia; Lymphoplasmacytic Lymphoma; Macroglobulinemia; Immunoglobulin heavy chain; Lymphoma; Gene rearrangement; Antibody; Cancer research; Gene; Immunology; Genetics; Chronic lymphocytic leukemia; Leukemia; Multiple myeloma","score_opus":0.014378370570253981,"score_gpt":0.26924617946737595,"score_spread":0.25486780889712196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115093629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815107,0.0128329815,0.00018660526,0.00073746656,0.0003910547,0.00077083247,0.000034418874,0.00014315323,0.003392795],"genre_scores_gemma":[0.9895148,0.0011320122,0.0012800609,0.00078375294,0.0008845385,0.000097727614,0.00008340062,0.000085069965,0.006138614],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967902,0.00012432855,0.0004820099,0.0005887129,0.000874621,0.001140173],"domain_scores_gemma":[0.9979761,0.00043452432,0.00016888784,0.00070567674,0.00016212247,0.0005526837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062753854,0.0004963921,0.0005635952,0.00019466589,0.0004448862,0.00020386536,0.00024774455,0.00031646757,0.00016584487],"category_scores_gemma":[0.00018277614,0.00035671704,0.00012617528,0.00037965798,0.0007953342,0.0003791177,0.0003433431,0.00028210858,0.0001520841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012452317,0.0014337342,0.17005433,0.006356638,0.0045964755,0.009304776,0.027145583,0.0007062786,0.048446745,0.03096636,0.08025614,0.6082806],"study_design_scores_gemma":[0.13004352,0.0012942478,0.48602095,0.00097449095,0.002335913,0.16068211,0.0035685473,0.06275271,0.08982326,0.0026437875,0.057004232,0.002856207],"about_ca_topic_score_codex":0.001970027,"about_ca_topic_score_gemma":0.00025039478,"teacher_disagreement_score":0.6054244,"about_ca_system_score_codex":0.011140188,"about_ca_system_score_gemma":0.003945166,"threshold_uncertainty_score":0.9998885},"labels":[],"label_agreement":null},{"id":"W2129852181","doi":"10.1038/leu.2010.280","title":"Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb","year":2010,"lang":"en","type":"article","venue":"Leukemia","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Research; Leukemia and Lymphoma Society","keywords":"Biology; Zebrafish; Haematopoiesis; Gene knockdown; Erythropoiesis; microRNA; Cell biology; MYB; Cell fate determination; Transcription factor; Regulator; Blood cell; Thrombopoiesis; Hematopoietic stem cell; Cell; Stem cell; Genetics; Gene; Megakaryocyte; Internal medicine","score_opus":0.006824951238238447,"score_gpt":0.23210134660412224,"score_spread":0.22527639536588379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129852181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947617,0.00032206168,0.00051648536,0.0000948311,0.00040850838,0.00018217706,0.000019680298,0.000038825106,0.003655703],"genre_scores_gemma":[0.9945335,0.000027816974,0.0026774658,0.00046421046,0.00048239183,0.000022055081,0.00014796498,0.000046623274,0.0015979635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989004,0.000028503959,0.0002318643,0.00041130837,0.00011932681,0.0003085934],"domain_scores_gemma":[0.99908495,0.000010012015,0.00011229711,0.0006204197,0.00007352112,0.00009879339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007635335,0.00020983348,0.00014803173,0.000026404146,0.00008721917,0.000045929246,0.00028484038,0.00026600025,0.00012706342],"category_scores_gemma":[0.000040331135,0.00020809876,0.00013036431,0.00007891006,0.000105469335,0.000008661556,0.00013245655,0.00015814598,0.00013312191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021015201,0.000027522787,0.00091578026,0.00005240375,0.000013799105,0.000007306619,0.000055056833,0.000014092836,0.99036646,0.000052673062,0.008158221,0.00031568613],"study_design_scores_gemma":[0.00053524104,0.000036671263,0.0029666186,0.000010425722,0.000030199477,0.000047747366,0.00001770543,0.000040778836,0.92323494,0.0003424015,0.07247458,0.00026269062],"about_ca_topic_score_codex":0.000026644766,"about_ca_topic_score_gemma":0.000052292304,"teacher_disagreement_score":0.0671315,"about_ca_system_score_codex":0.00003288159,"about_ca_system_score_gemma":0.00014733625,"threshold_uncertainty_score":0.8486021},"labels":[],"label_agreement":null},{"id":"W2137749199","doi":"10.1038/sj.leu.2402238","title":"Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc − cystine transporter: a new action for an old drug","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":638,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; BC Cancer Agency; Ohio Cancer Research Associates","keywords":"Sulfasalazine; Cystine; Growth inhibition; Lymphoma; Pharmacology; Chemistry; Cancer research; Biology; Medicine; Biochemistry; In vitro; Immunology; Internal medicine; Cysteine","score_opus":0.01024197766002419,"score_gpt":0.23136421082996456,"score_spread":0.22112223316994037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137749199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954077,0.0003989767,0.003242419,0.00016431822,0.00016191907,0.00025459347,0.00010582951,0.000007893682,0.00025635844],"genre_scores_gemma":[0.99473137,0.00022341909,0.000348076,0.00018012716,0.00021258162,0.000018144196,0.00028642247,0.00002006991,0.0039797965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925864,0.000024707293,0.0002388371,0.00020648768,0.00011080875,0.00016053848],"domain_scores_gemma":[0.9994409,0.000005318628,0.00014703075,0.0002644956,0.0000794119,0.00006283113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008205276,0.00012082731,0.00015867925,0.000020597101,0.00002956353,0.0000047531203,0.0001247435,0.00011301337,0.0000063383523],"category_scores_gemma":[0.000018486611,0.00009307304,0.0001375451,0.00007801186,0.000049553717,0.000008712785,0.000019865482,0.000034099747,3.4571977e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022764804,0.000063565196,0.0005049834,0.00003967974,0.00002320498,3.4182824e-7,0.000107992055,0.00003142642,0.9811081,0.00009579737,0.012981109,0.004816105],"study_design_scores_gemma":[0.0018886261,0.00014932222,0.009422562,0.00001966226,0.00005810306,0.000012585038,0.000051400613,0.00009343276,0.9601874,0.00010775683,0.0279005,0.00010868609],"about_ca_topic_score_codex":0.00053731474,"about_ca_topic_score_gemma":0.00011957409,"teacher_disagreement_score":0.020920783,"about_ca_system_score_codex":0.000029268613,"about_ca_system_score_gemma":0.00014161847,"threshold_uncertainty_score":0.37954083},"labels":[],"label_agreement":null},{"id":"W2141772696","doi":"10.1038/sj.leu.2403836","title":"Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Acute myeloblastic leukemia; K562 cells; Cancer research; Biology; Myeloid; Haematopoiesis; Leukemia; Cell culture; Molecular biology; Stem cell; Immunology; Cell biology; Genetics","score_opus":0.014493267088491931,"score_gpt":0.2726629767075332,"score_spread":0.2581697096190413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141772696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945716,0.0002207986,0.00042573785,0.001658312,0.0002594605,0.00074470905,0.00004431204,0.00006752174,0.0020075443],"genre_scores_gemma":[0.9929133,0.00015370666,0.0007632211,0.0006061756,0.0003909229,0.000035980014,0.000024043598,0.000056945337,0.005055675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973038,0.00012910296,0.0006622429,0.00044745597,0.0008093487,0.00064809143],"domain_scores_gemma":[0.9987138,0.00008064435,0.00014934524,0.00072386366,0.00013427352,0.0001980989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026059608,0.0002942627,0.00052004115,0.00027275627,0.000086401524,0.000021177302,0.00047753562,0.00032256858,0.0005950985],"category_scores_gemma":[0.00012616804,0.0002138583,0.0003462861,0.00074110227,0.0002468485,0.00020695674,0.00011787248,0.0009943853,0.00027902308],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010207877,0.000111544985,0.0049312524,0.00015519655,0.00023108383,0.00012104172,0.0008958167,0.0015030307,0.9647624,0.00018126405,0.0038908983,0.022195708],"study_design_scores_gemma":[0.016224481,0.0006444779,0.59505516,0.00054449117,0.0005994028,0.00068265334,0.0003314555,0.035120457,0.33351198,0.00024555094,0.016337436,0.00070241926],"about_ca_topic_score_codex":0.00036227965,"about_ca_topic_score_gemma":0.00014527958,"teacher_disagreement_score":0.6312504,"about_ca_system_score_codex":0.0060153445,"about_ca_system_score_gemma":0.002490784,"threshold_uncertainty_score":0.9978004},"labels":[],"label_agreement":null},{"id":"W2142900411","doi":"10.1038/sj.leu.2403068","title":"Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Imatinib; Medicine; Myeloid leukemia; Internal medicine; Transplantation; Imatinib mesylate; Gastroenterology; Donor lymphocyte infusion; Leukemia; Stem cell; Philadelphia chromosome; Chronic leukemia; Immunology; Oncology; Hematopoietic stem cell transplantation; Acute leukemia; Chromosomal translocation; Biology","score_opus":0.009752043447362892,"score_gpt":0.24524773393457255,"score_spread":0.23549569048720967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142900411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943626,0.0004355518,0.0004100622,0.00013955936,0.00028368566,0.0029009269,0.000119095355,0.00009263363,0.0012558997],"genre_scores_gemma":[0.9887816,0.000099131365,0.0028298472,0.0009234635,0.000082196086,0.0010198611,0.00017964176,0.00012922581,0.005955074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967321,0.00026541442,0.0007955184,0.00083494006,0.0005023265,0.0008696761],"domain_scores_gemma":[0.9982593,0.00031696158,0.00016379292,0.0007463384,0.000136991,0.00037662374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061866624,0.00049469445,0.00064503966,0.00039128208,0.00009303315,0.00003319809,0.00018219562,0.0003440376,0.00018647597],"category_scores_gemma":[0.00011242313,0.00047870568,0.0002178986,0.00049652735,0.000050675295,0.00018147103,0.000029061779,0.00034563983,0.00030699666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15506051,0.0021726554,0.5944456,0.0070765116,0.000839276,0.002040546,0.025915194,0.0087613035,0.09899689,0.00043713048,0.020588024,0.08366636],"study_design_scores_gemma":[0.06274805,0.004429155,0.7936508,0.0012139136,0.00046730615,0.00008535909,0.00020714635,0.0005812921,0.09915913,0.00008564165,0.036163595,0.0012086178],"about_ca_topic_score_codex":0.000082804894,"about_ca_topic_score_gemma":0.000140525,"teacher_disagreement_score":0.19920519,"about_ca_system_score_codex":0.019116174,"about_ca_system_score_gemma":0.003088538,"threshold_uncertainty_score":0.99976647},"labels":[],"label_agreement":null},{"id":"W2144114332","doi":"10.1038/leu.2013.89","title":"SYK regulates mTOR signaling in AML","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; Howard Hughes Medical Institute","keywords":"Syk; PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; MAPK/ERK pathway; Idelalisib; Signal transduction; Cell biology; Kinase; Biology; Chemistry; Tyrosine kinase; Leukemia; Immunology; Ibrutinib; Chronic lymphocytic leukemia","score_opus":0.007333216753368255,"score_gpt":0.19728611949471944,"score_spread":0.18995290274135118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144114332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892951,0.0011736967,0.0000119492315,0.00019479514,0.0002752047,0.00012038213,0.0000025182376,0.000042179054,0.008884166],"genre_scores_gemma":[0.9758008,0.000016171058,0.00013814586,0.00017501522,0.000032655156,0.000018883346,0.000032812746,0.000009967749,0.023775542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936146,0.00003903372,0.00017220202,0.00016584281,0.00001411001,0.00024733972],"domain_scores_gemma":[0.999685,0.00004920033,0.000040581257,0.00018951322,0.000021930167,0.000013810065],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007197034,0.000092779715,0.00014978768,0.00006348466,0.000051645253,0.000012729632,0.00015042785,0.00015220164,0.006476667],"category_scores_gemma":[0.000025078854,0.00008086455,0.000034798766,0.000074981726,0.00006983046,0.00005818934,0.00005742304,0.00017549432,0.0031690055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000127671055,0.000019413212,0.0017746747,0.000015769381,0.000016062362,0.0000046844966,0.00024199563,0.000022826936,0.97547317,0.0006309776,0.017091021,0.004696671],"study_design_scores_gemma":[0.0029638882,0.00016424498,0.054332487,0.000120078184,0.000023674822,0.00004650923,0.00044402343,0.00014501004,0.63038486,0.002682014,0.30812994,0.00056328997],"about_ca_topic_score_codex":0.0012514711,"about_ca_topic_score_gemma":0.00007391769,"teacher_disagreement_score":0.3450883,"about_ca_system_score_codex":0.000098680706,"about_ca_system_score_gemma":0.00003886197,"threshold_uncertainty_score":0.9976072},"labels":[],"label_agreement":null},{"id":"W2147489705","doi":"10.1038/sj.leu.2403441","title":"Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Biology; Locus (genetics); ETV6; Gene; Chromosome 12; Chromosomal translocation; Genetics; Candidate gene; Allele; Cancer research; Molecular biology; Chromosome","score_opus":0.005275161563100203,"score_gpt":0.2388728560227701,"score_spread":0.2335976944596699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147489705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977188,0.0010906314,0.00079523015,0.000041211842,0.00006664672,0.00013964325,0.00007442956,0.0000041798576,0.00006923679],"genre_scores_gemma":[0.9988044,0.00020066036,0.0006204082,0.00006596561,0.000058602658,0.000021464735,0.00012946103,0.000012970827,0.000086063985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990364,0.000050196282,0.0002793537,0.0002929494,0.0001741197,0.00016702717],"domain_scores_gemma":[0.9994279,0.000020447067,0.00014285905,0.0002918592,0.0000655671,0.000051343417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011485561,0.00013287712,0.0001886874,0.0001002321,0.00006161662,0.000016593813,0.00015844323,0.000103965314,0.0000120100885],"category_scores_gemma":[0.00006181965,0.000101821184,0.000093607,0.0002971098,0.0000916659,0.000006267232,0.00012144313,0.00006178246,7.2128546e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005271516,0.000012963105,0.012476053,0.000013608356,0.00012963488,0.0000037641296,0.00013559016,0.05847063,0.92844516,0.000035156725,0.00001138564,0.000213344],"study_design_scores_gemma":[0.0007682534,0.000052658692,0.20816907,0.000028409508,0.00017082426,0.0000030937993,0.000012677423,0.001394056,0.78887224,0.00025682323,0.0001604804,0.00011142297],"about_ca_topic_score_codex":0.00030769134,"about_ca_topic_score_gemma":0.00038355333,"teacher_disagreement_score":0.19569302,"about_ca_system_score_codex":0.00015218346,"about_ca_system_score_gemma":0.00033868398,"threshold_uncertainty_score":0.41521472},"labels":[],"label_agreement":null},{"id":"W2149078110","doi":"10.1038/leu.2015.206","title":"Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK; Hospital for Sick Children; Children's Cancer and Leukaemia Group","keywords":"PTEN; Genotype; Mutation; Biology; Mutant; Cancer research; Gene; Genetics; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.027381028624260922,"score_gpt":0.2917980965882539,"score_spread":0.264417067963993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149078110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855552,0.000027734251,0.000015500817,0.000104730185,0.0002055897,0.0018388259,0.000103409766,0.000080638834,0.012068379],"genre_scores_gemma":[0.99668044,0.000025290143,0.00006455933,0.00032562116,0.0003180985,0.00012427718,0.00011801088,0.00010702476,0.0022366715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995365,0.00029746807,0.0009495992,0.00061435497,0.0018008393,0.0009727099],"domain_scores_gemma":[0.99651676,0.0010799404,0.0003894235,0.0010452998,0.00044571335,0.0005228717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006771009,0.0006071633,0.000982166,0.000670924,0.000082441744,0.000048484515,0.0005155626,0.0003355338,0.00013226192],"category_scores_gemma":[0.00086214003,0.00033341238,0.00028749186,0.0012053938,0.00023892938,0.00016280885,0.00012517099,0.0007179439,0.00030077543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.18510035,0.0013869872,0.78853434,0.00018203563,0.00049477955,0.0005894283,0.0010547896,0.003055414,0.000106499356,0.00022453036,0.01885719,0.00041366465],"study_design_scores_gemma":[0.40228602,0.030704005,0.55793357,0.00032148501,0.0009620454,0.00005990227,0.00029129256,0.005214137,0.0009489333,0.000112829024,0.00017426471,0.000991498],"about_ca_topic_score_codex":0.0012116464,"about_ca_topic_score_gemma":0.000033715223,"teacher_disagreement_score":0.23060076,"about_ca_system_score_codex":0.014479046,"about_ca_system_score_gemma":0.006365717,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W2152275695","doi":"10.1038/leu.2015.310","title":"Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis","year":2015,"lang":"en","type":"letter","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Hematology; Oncology; Intensive care medicine; Bone marrow","score_opus":0.01776370035701409,"score_gpt":0.2540666334176579,"score_spread":0.23630293306064382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152275695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555089,0.00007959424,6.850163e-7,0.03198241,0.00016090975,0.0019339271,0.00021089752,0.000046614892,0.010076073],"genre_scores_gemma":[0.7598041,0.0000424896,0.0005589357,0.2314994,0.001283296,0.0005748451,0.0034912443,0.00020245186,0.0025432017],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99741226,0.00008840547,0.00052330154,0.0005956564,0.0009279013,0.00045246157],"domain_scores_gemma":[0.9983614,0.00025837822,0.00029328393,0.0006662673,0.00027864095,0.00014204573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010067264,0.00050368253,0.001124724,0.0003636832,0.000025824225,0.000016737447,0.00013557338,0.0005920725,0.00013148636],"category_scores_gemma":[0.00010560703,0.00034816648,0.00015691292,0.00028350877,0.00009403578,0.00004405618,0.00004093733,0.0010746478,0.00014032242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001526334,0.00057704054,0.45021167,0.00029295817,0.0002670088,0.0003587837,0.00016519359,0.000009884825,0.0000014365805,0.000032121316,0.54402375,0.002533834],"study_design_scores_gemma":[0.019007552,0.0041284794,0.69450176,0.002336639,0.00032535143,0.00000644276,0.0000071724894,0.000008100507,0.00065776287,0.000025352567,0.27856088,0.0004345017],"about_ca_topic_score_codex":0.00022001515,"about_ca_topic_score_gemma":0.000014570816,"teacher_disagreement_score":0.26546285,"about_ca_system_score_codex":0.0014674398,"about_ca_system_score_gemma":0.00069614715,"threshold_uncertainty_score":0.99989706},"labels":[],"label_agreement":null},{"id":"W2159528874","doi":"10.1038/leu.2009.61","title":"Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Concordance; Staging system; Multiple myeloma; Univariate analysis; Oncology; Univariate; Progression-free survival; Internal medicine; Proportional hazards model; Overall survival; Transplantation; Multivariate analysis; Multivariate statistics; Cancer","score_opus":0.02316841703921429,"score_gpt":0.2838815156990666,"score_spread":0.2607130986598523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159528874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434394,0.00013129448,0.00030133536,0.002237925,0.00028985803,0.0013676225,0.000074300515,0.00013470463,0.0011190259],"genre_scores_gemma":[0.9987171,0.000009665857,0.00026047803,0.00053974526,0.00011959664,0.00009577031,0.00007848287,0.000026011116,0.00015311172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756014,0.00014563941,0.00051479606,0.0004170616,0.0007834434,0.00057894527],"domain_scores_gemma":[0.99885523,0.00029951913,0.00009779868,0.00045643514,0.00010010469,0.00019091967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003526722,0.00025426774,0.0003925577,0.0001964229,0.0003012486,0.00011535044,0.00039543048,0.00008098492,0.00001566841],"category_scores_gemma":[0.00010884207,0.00015044297,0.00011319075,0.00028720318,0.000039096845,0.000103691506,0.000065212946,0.00038222838,0.00009400808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070524187,0.00012849594,0.98122364,0.00023602974,0.00015306036,0.0003381582,0.005864057,0.00049469835,0.00058540615,0.00014724229,0.00048289113,0.009641051],"study_design_scores_gemma":[0.0054516434,0.00029357034,0.9114803,0.0013551327,0.000055685643,0.00005755838,0.0040461994,0.07478875,0.0016330986,0.0000026167388,0.0006648622,0.0001705586],"about_ca_topic_score_codex":0.0010368852,"about_ca_topic_score_gemma":0.00048456786,"teacher_disagreement_score":0.07429405,"about_ca_system_score_codex":0.0024402945,"about_ca_system_score_gemma":0.000269476,"threshold_uncertainty_score":0.6381285},"labels":[],"label_agreement":null},{"id":"W2163344214","doi":"10.1038/leu.2009.33","title":"New insights to the MLL recombinome of acute leukemias","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Minimal residual disease; Myeloid leukemia; Fusion gene; Chromosomal translocation; Leukemia; Gene; Acute leukemia; Cancer research; Breakpoint; Biology; Acute lymphocytic leukemia; Medicine; Lymphoblastic Leukemia; Genetics; Oncology","score_opus":0.019537398384540692,"score_gpt":0.2949568201005775,"score_spread":0.2754194217160368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163344214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9283035,0.00048271066,0.0014455866,0.021552967,0.00032129386,0.0012194015,0.000012103035,0.00017313988,0.046489343],"genre_scores_gemma":[0.9556379,0.00018871328,0.005299262,0.008087084,0.00066706847,0.000017993094,0.000033111246,0.000046781926,0.03002211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977074,0.00007422215,0.0005017184,0.000454097,0.0006780562,0.00058448664],"domain_scores_gemma":[0.997845,0.00012348012,0.0001147629,0.0011725518,0.00018979012,0.0005544094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028053526,0.0002781371,0.0005438964,0.00028067693,0.00011112432,0.00003286413,0.000629066,0.00021266082,0.00032907174],"category_scores_gemma":[0.00015976402,0.00018351377,0.0002069099,0.0010122794,0.00006965495,0.00012607948,0.00014683035,0.00071948365,0.0008335914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016998348,0.0001274991,0.0009449093,0.00007225621,0.00056062016,0.00074383244,0.0040504048,0.0001576905,0.100264244,0.0064329514,0.70961386,0.1753319],"study_design_scores_gemma":[0.012523387,0.004464382,0.21200931,0.0005042045,0.00078177487,0.0008788908,0.00041710574,0.0015231598,0.13731973,0.0067983535,0.62173945,0.0010402824],"about_ca_topic_score_codex":0.0004986025,"about_ca_topic_score_gemma":0.000029140128,"teacher_disagreement_score":0.2110644,"about_ca_system_score_codex":0.0019311312,"about_ca_system_score_gemma":0.0024091436,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W2165074939","doi":"10.1038/leu.2011.84","title":"Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis","year":2011,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; SickKids Foundation; University of Toronto; Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; Public Health Ontario; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Krebsliga Schweiz","keywords":"Meta-analysis; Prednisone; Medicine; Dexamethasone; Induction therapy; Lymphoblastic Leukemia; Oncology; Leukemia; Internal medicine; Induction chemotherapy; Immunology; Chemotherapy","score_opus":0.10416373955797026,"score_gpt":0.36273704157060044,"score_spread":0.2585733020126302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165074939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024007833,0.9822817,0.00051054475,0.00007483607,0.00014490189,0.016263522,0.00030467805,0.00013766058,0.00025814163],"genre_scores_gemma":[0.000058616344,0.985487,0.0017470059,0.00043465671,0.0001564323,0.009615907,0.0005981994,0.00028344657,0.0016187667],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9921758,0.00094825396,0.0028919198,0.0018785433,0.0009256024,0.0011798711],"domain_scores_gemma":[0.9929662,0.0023561118,0.0015363245,0.0022092718,0.00038327882,0.0005488633],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002119309,0.0016070295,0.018891472,0.0017587049,0.00015093217,0.000095503055,0.0007755816,0.0013552329,0.00033056038],"category_scores_gemma":[0.001754558,0.0010741083,0.0046817474,0.0035408796,0.00025533058,0.00024236614,0.00027454883,0.0012763772,0.00011189451],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002561789,0.00013698595,5.560697e-7,0.65994877,0.32637638,0.00009092326,0.00016252259,0.0000018877945,5.570744e-7,0.000082996325,0.00053029414,0.0124119865],"study_design_scores_gemma":[0.0055427365,0.00091784575,0.0000076987335,0.044900157,0.93532854,0.0006299343,0.000025280844,0.00007871947,0.0000020238651,0.000034844026,0.011668,0.00086420804],"about_ca_topic_score_codex":0.0002999039,"about_ca_topic_score_gemma":0.00005062582,"teacher_disagreement_score":0.6150486,"about_ca_system_score_codex":0.010169836,"about_ca_system_score_gemma":0.006415304,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W2207837802","doi":"10.1038/leu.2015.357","title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cancer research; Lymphoma; Medicine; Immunology; Peripheral T-cell lymphoma; Peripheral; T cell; Biology; Pathology; Internal medicine; Immune system","score_opus":0.03142646855532666,"score_gpt":0.28751407954854125,"score_spread":0.2560876109932146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207837802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754122,0.00043868358,0.000010040841,0.00018766597,0.00010391109,0.00018111693,0.0000040599107,0.00001981935,0.02364249],"genre_scores_gemma":[0.9981344,0.00001907434,0.0012693403,0.00008301871,0.00005140833,0.00004115841,0.00003063233,0.000010662471,0.00036033947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929506,0.000023650007,0.00021514352,0.00014302043,0.0001777886,0.00014531786],"domain_scores_gemma":[0.99955463,0.000048227983,0.00007198054,0.00015664638,0.000060851435,0.000107678265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080637656,0.000092312745,0.0001989167,0.000066918525,0.000016595535,0.0000063046828,0.00003811058,0.000050097136,0.000045443914],"category_scores_gemma":[0.00007276978,0.00007642147,0.000053285272,0.00016749947,0.000027874428,0.000051420302,0.000020664878,0.000051160237,0.000020005295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035545358,0.0016796822,0.8866487,0.00016956271,0.00008251938,0.00023452497,0.007288382,0.00054159865,0.004788865,0.00083343213,0.0033665078,0.09401074],"study_design_scores_gemma":[0.031024102,0.0014501048,0.8222654,0.0006186347,0.00014181537,0.00010212861,0.0035154487,0.004191017,0.124102496,0.00072780513,0.011476002,0.0003850363],"about_ca_topic_score_codex":0.00048650647,"about_ca_topic_score_gemma":0.000040905154,"teacher_disagreement_score":0.119313635,"about_ca_system_score_codex":0.0015118567,"about_ca_system_score_gemma":0.0006054755,"threshold_uncertainty_score":0.39534527},"labels":[],"label_agreement":null},{"id":"W2213050627","doi":"10.1038/leu.2015.243","title":"Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification","year":2015,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Risk stratification; Leukemia; Transplantation; Medicine; Cord blood; Oncology; Internal medicine; Hematology; Cytogenetics; Biology; Genetics; Gene","score_opus":0.01800898845357867,"score_gpt":0.2758178988531593,"score_spread":0.25780891039958065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2213050627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95454955,0.0010879746,0.001187553,0.032680668,0.0003110759,0.0068097715,0.0022762774,0.00024413098,0.00085301115],"genre_scores_gemma":[0.84685344,0.008049356,0.0058646356,0.10618453,0.00481784,0.0020174417,0.021967828,0.00070689747,0.003538067],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948098,0.00042133435,0.0013095384,0.0010650334,0.0014058567,0.0009884259],"domain_scores_gemma":[0.9951348,0.00085773104,0.0010678931,0.0016806512,0.0010348766,0.00022404882],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010451325,0.00078114506,0.0011504083,0.00041213882,0.00031428732,0.00007149511,0.0010107191,0.0021590882,0.00003516462],"category_scores_gemma":[0.00037264745,0.0005909795,0.0004451695,0.0007775215,0.0005145688,0.0001607487,0.00007842336,0.0044409293,0.00007472666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057464396,0.0004543306,0.0023618364,0.0056266813,0.010782773,0.0025347278,0.007012091,0.0055110743,0.078331105,0.00031134515,0.85764945,0.02367815],"study_design_scores_gemma":[0.096612886,0.030223822,0.31817082,0.0065292153,0.10263426,0.01721458,0.001219339,0.0073464215,0.07658337,0.013415119,0.3212311,0.008819079],"about_ca_topic_score_codex":0.00093074923,"about_ca_topic_score_gemma":0.000064913176,"teacher_disagreement_score":0.5364183,"about_ca_system_score_codex":0.0025896241,"about_ca_system_score_gemma":0.0056145755,"threshold_uncertainty_score":0.9996542},"labels":[],"label_agreement":null},{"id":"W2216303864","doi":"10.1038/leu.2015.356","title":"Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group","year":2015,"lang":"en","type":"review","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; University of Alberta","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Transplantation; Disease; Oncology; Internal medicine; Intensive care medicine; Autologous stem-cell transplantation","score_opus":0.08944497331140153,"score_gpt":0.36289546223945596,"score_spread":0.27345048892805446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216303864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002694066,0.9646622,0.00005304,0.00025744777,0.0010440999,0.0027519246,0.00019530093,0.0000501837,0.030716395],"genre_scores_gemma":[0.0036335646,0.98614043,0.00375914,0.000021978141,0.00015929335,0.00024784158,0.0007327816,0.00006293059,0.005242022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975465,0.00014618288,0.0008359912,0.0003716438,0.0008118264,0.0002878769],"domain_scores_gemma":[0.99802744,0.00021443935,0.00061141216,0.00083156215,0.00016651589,0.0001486219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041735746,0.00031586463,0.0011109809,0.00024295224,0.000064695094,0.000015586447,0.00061945064,0.00020878842,0.00010448726],"category_scores_gemma":[0.00013915211,0.00020212922,0.00057305157,0.0005009936,0.00011208922,0.000048051956,0.00047221058,0.00044446182,0.000056533783],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006972965,0.00015777706,0.00056143384,0.005010401,0.0015246384,0.00007050076,0.000043290973,7.5097444e-7,0.000002574817,0.0004470734,0.0034594275,0.9886524],"study_design_scores_gemma":[0.0024652998,0.00007569901,0.0010801785,0.0192288,0.0009179011,0.00005043527,0.000060110786,0.000067581226,0.000016130334,0.00004531342,0.9758472,0.00014539101],"about_ca_topic_score_codex":0.000063468615,"about_ca_topic_score_gemma":0.000017934246,"teacher_disagreement_score":0.98850703,"about_ca_system_score_codex":0.0013482736,"about_ca_system_score_gemma":0.00050673005,"threshold_uncertainty_score":0.82425904},"labels":[],"label_agreement":null},{"id":"W2259492344","doi":"10.1038/leu.2016.22","title":"Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Minor histocompatibility antigen; Human leukocyte antigen; Immunotherapy; Immunology; Biology; Haematopoiesis; Histocompatibility; Haplotype; Antigen; Major histocompatibility complex; Allele; Immune system; Stem cell; Gene; Genetics","score_opus":0.011682163349393135,"score_gpt":0.2376178965452023,"score_spread":0.22593573319580917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259492344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987738,0.0069134044,0.0035414828,0.00009265432,0.0001711953,0.0012012772,0.00020889778,0.000031133062,0.00010196448],"genre_scores_gemma":[0.9949386,0.00007801045,0.00079629495,0.0000663279,0.0000075556713,0.00017971048,0.000027714465,0.000026823565,0.00387894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986961,0.0001695971,0.00043468043,0.00029413425,0.000042974294,0.00036253384],"domain_scores_gemma":[0.99840677,0.00050082075,0.00040191464,0.00055533985,0.00012590158,0.000009245493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028376863,0.00022609445,0.000586582,0.0001019256,0.00010444942,0.00000583949,0.00030991592,0.00021979112,0.0001407731],"category_scores_gemma":[0.00006379927,0.00013194155,0.00019191977,0.00010469513,0.0006194271,0.00012473509,0.000020069174,0.00010460086,0.000005583963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011111872,0.00009712637,0.007750395,0.00012623482,0.000288984,6.429249e-7,0.00023159063,0.000023312907,0.97637117,0.00029728905,0.00047808513,0.003223277],"study_design_scores_gemma":[0.0052074543,0.0010950617,0.025545452,0.00018665071,0.00002908668,0.00001402104,0.00007640002,0.0000011400847,0.96197426,0.00008812139,0.005580712,0.0002016342],"about_ca_topic_score_codex":0.0008479492,"about_ca_topic_score_gemma":0.000086373206,"teacher_disagreement_score":0.017795056,"about_ca_system_score_codex":0.00038894653,"about_ca_system_score_gemma":0.00088160764,"threshold_uncertainty_score":0.538042},"labels":[],"label_agreement":null},{"id":"W2259852344","doi":"10.1038/leu.2016.19","title":"Identification of MYC mutations in acute myeloid leukemias with NUP98–NSD1 translocations","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chromosomal translocation; Myeloid leukemia; Cancer research; Identification (biology); Myeloid; Leukemia; Mutation; Biology; Genetics; Gene","score_opus":0.017242860189325155,"score_gpt":0.2882329442918651,"score_spread":0.27099008410253994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259852344","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10471201,0.0005318451,0.008323352,0.868377,0.0005588645,0.0051624454,0.0013236997,0.00042589233,0.010584914],"genre_scores_gemma":[0.49136472,0.0022295956,0.0066230725,0.30989626,0.009026224,0.0034671768,0.011588839,0.0013654567,0.16443865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948344,0.00022212324,0.0014754494,0.00108937,0.0013720833,0.0010065701],"domain_scores_gemma":[0.99622554,0.000515523,0.0006276778,0.0017266663,0.00070466,0.00019994185],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005512441,0.0006652742,0.0011889872,0.0014556667,0.00013141967,0.000056310128,0.0007188157,0.0014242651,0.00033823936],"category_scores_gemma":[0.00017883794,0.00051729474,0.00029916997,0.0014368185,0.0006788842,0.0003242939,0.000076238946,0.0032130585,0.00045103533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00071291917,0.00012276103,0.0014923807,0.0018537481,0.0013441453,0.0025659471,0.0018829559,0.00011884994,0.054608207,0.00031514635,0.92373925,0.011243709],"study_design_scores_gemma":[0.023509515,0.0014007707,0.020711716,0.0055791275,0.003778604,0.0021860779,0.0006016209,0.0020564161,0.07785732,0.0018293927,0.8575122,0.002977247],"about_ca_topic_score_codex":0.00043269593,"about_ca_topic_score_gemma":0.00011381662,"teacher_disagreement_score":0.55848074,"about_ca_system_score_codex":0.0057062013,"about_ca_system_score_gemma":0.006483688,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W2264231165","doi":"10.1038/leu.2016.11","title":"GFI1 as a novel prognostic and therapeutic factor for AML/MDS","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Histone acetyltransferase; Epigenetics; Cancer research; Myeloid leukemia; Leukemia; Histone; Biology; Zinc finger; Haematopoiesis; Downregulation and upregulation; Gene; Genetics; Stem cell; Transcription factor","score_opus":0.038548874968308874,"score_gpt":0.3211772837034835,"score_spread":0.2826284087351746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264231165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862985,0.00039288434,0.0049439715,0.004597804,0.00010720999,0.0014941137,0.000076680655,0.00014048415,0.0019483266],"genre_scores_gemma":[0.98505914,0.00007789288,0.0017176417,0.0013971302,0.00030514642,0.0001949158,0.0000078117455,0.000063609354,0.011176683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998518,0.000021694557,0.00021964757,0.0004112205,0.0003004916,0.00052895217],"domain_scores_gemma":[0.99852353,0.0006249514,0.00005424447,0.00037188697,0.00014862162,0.00027673392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017021346,0.00020744503,0.00030729568,0.00012177355,0.000087406486,0.000029730094,0.0001429548,0.00017591345,0.0002433573],"category_scores_gemma":[0.0006301092,0.00012456521,0.00008987643,0.00014520461,0.00017795053,0.00007651972,0.00007807888,0.0001949458,0.00018253081],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014173584,0.00013751359,0.026736278,0.00042734251,0.00037436196,0.00007894409,0.0007657021,4.6199034e-7,0.6390769,0.0042014364,0.0036170895,0.32316658],"study_design_scores_gemma":[0.05314585,0.006369827,0.43351454,0.0014661466,0.0007367082,0.0019018033,0.00040557855,0.0034197653,0.12161722,0.0063670264,0.3693626,0.0016929433],"about_ca_topic_score_codex":0.000047190133,"about_ca_topic_score_gemma":0.0000081816515,"teacher_disagreement_score":0.5174597,"about_ca_system_score_codex":0.0008533917,"about_ca_system_score_gemma":0.0009194725,"threshold_uncertainty_score":0.50796217},"labels":[],"label_agreement":null},{"id":"W2274774261","doi":"10.1038/leu.2016.4","title":"Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Sphingosine; Chronic lymphocytic leukemia; Sphingolipid; Lysosome; Biology; Sphingosine kinase; Programmed cell death; Cancer cell; Sphingosine-1-phosphate; Cell biology; Leukemia; Cancer research; Apoptosis; Biochemistry; Immunology; Cancer; Enzyme; Receptor","score_opus":0.017936935451636906,"score_gpt":0.2793650345160461,"score_spread":0.2614280990644092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274774261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850924,0.00084695965,0.0038332522,0.00062277453,0.0014863457,0.0020016402,0.000081165395,0.0005783236,0.0054571154],"genre_scores_gemma":[0.96962327,0.00025702882,0.0027794135,0.002023226,0.0033006582,0.00026403327,0.000033807133,0.00025830136,0.021460284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932565,0.0002438967,0.0010044228,0.0016091294,0.0016094865,0.0022765484],"domain_scores_gemma":[0.99567384,0.00038484027,0.0002499562,0.0017954609,0.00042661783,0.0014693146],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005538034,0.0008420453,0.0013971886,0.0006469251,0.00027411387,0.00011041501,0.0009342414,0.00048794033,0.0021813859],"category_scores_gemma":[0.00058838364,0.0006167783,0.00045536144,0.0012538502,0.00030540433,0.00038562575,0.00056629535,0.00054558436,0.0065934258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0025038058,0.00017059069,0.00035574232,0.0011638413,0.001473739,0.003011016,0.0013855487,0.00306326,0.82998204,0.0011587382,0.105075486,0.050656166],"study_design_scores_gemma":[0.07881222,0.0013624401,0.013623843,0.0013645977,0.0005455064,0.0023025442,0.000068582514,0.03325057,0.6270427,0.0009614521,0.23870735,0.0019581905],"about_ca_topic_score_codex":0.0024362546,"about_ca_topic_score_gemma":0.00010200352,"teacher_disagreement_score":0.28067368,"about_ca_system_score_codex":0.35700136,"about_ca_system_score_gemma":0.076327704,"threshold_uncertainty_score":0.99962837},"labels":[],"label_agreement":null},{"id":"W2278965102","doi":"10.1038/leu.2016.28","title":"Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Immunodeficiency; Lymphoblastic Leukemia; Medicine; Severe combined immunodeficiency; Immunology; Diabetes mellitus; Leukemia; Cancer research; Endocrinology; Immune system; Biology; Gene","score_opus":0.005866688241247728,"score_gpt":0.19536575690020963,"score_spread":0.1894990686589619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278965102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748016,0.0015516053,0.00037324618,0.006645603,0.0045919884,0.0013832723,0.00004131189,0.00013787465,0.010473501],"genre_scores_gemma":[0.9250154,0.000081983606,0.0001940554,0.023801178,0.0001644835,0.00029129765,0.0007981077,0.00015192482,0.049501598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652845,0.0003069599,0.001186889,0.0007864377,0.00016769812,0.0010235762],"domain_scores_gemma":[0.9975273,0.0005394414,0.00083188753,0.0008423857,0.00023876801,0.000020196136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042526776,0.0007547093,0.00086048647,0.00044982522,0.0003140069,0.000051169805,0.0010880438,0.00113975,0.00072488526],"category_scores_gemma":[0.000054104083,0.00045528015,0.00021036887,0.00042180653,0.00046719186,0.00021952749,0.00028470234,0.0020630031,0.0011424682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008295846,0.00014712133,0.0005147327,0.00057278154,0.0005118577,0.000030857318,0.0036590989,0.000025546124,0.7232089,0.000009946425,0.2677795,0.0027100488],"study_design_scores_gemma":[0.00975816,0.00204207,0.0023673645,0.003312738,0.00050328305,0.00027266692,0.0010289343,0.000100645695,0.5904697,0.000053309686,0.38801435,0.0020767539],"about_ca_topic_score_codex":0.00015290716,"about_ca_topic_score_gemma":0.000047849575,"teacher_disagreement_score":0.13273919,"about_ca_system_score_codex":0.0027046676,"about_ca_system_score_gemma":0.0019988124,"threshold_uncertainty_score":0.9997899},"labels":[],"label_agreement":null},{"id":"W2294720344","doi":"10.1038/leu.2016.37","title":"Estimating deep molecular responses in chronic myelogenous leukemia: a Bayesian approach","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Chronic myelogenous leukemia; Leukemia; Bayesian probability; Medicine; Oncology; Immunology; Artificial intelligence; Computer science","score_opus":0.015615159401913435,"score_gpt":0.2642797321289984,"score_spread":0.24866457272708498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294720344","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21016593,0.04248937,0.079042114,0.4931774,0.005593198,0.024029687,0.0008786694,0.0046885875,0.13993502],"genre_scores_gemma":[0.11510026,0.00059585756,0.10986553,0.6862206,0.03275783,0.0033761438,0.0049907006,0.0025024135,0.04459069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922207,0.00049580634,0.001414185,0.0021525605,0.0013559109,0.002360867],"domain_scores_gemma":[0.99577606,0.0005586084,0.0006205735,0.0025496825,0.0001481294,0.00034693768],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00058257475,0.0015137921,0.0021403593,0.0010580141,0.00018133293,0.000094198534,0.0008433352,0.0031375368,0.00043268295],"category_scores_gemma":[0.00049144065,0.0012703262,0.0006337617,0.0007139443,0.00037473536,0.00017364608,0.00034980272,0.0049445615,0.00058997615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0015061535,0.00021352706,0.0016016919,0.009848858,0.002792061,0.12444949,0.0017323851,0.0037300182,0.016862376,0.00010958991,0.72095734,0.11619648],"study_design_scores_gemma":[0.048392802,0.0027156097,0.0021927035,0.0127117615,0.0033108164,0.014332769,0.00012679872,0.09750362,0.0053718556,0.0016153991,0.80493855,0.0067873034],"about_ca_topic_score_codex":0.00092387013,"about_ca_topic_score_gemma":0.000062531384,"teacher_disagreement_score":0.19304316,"about_ca_system_score_codex":0.09023551,"about_ca_system_score_gemma":0.016789887,"threshold_uncertainty_score":0.9997611},"labels":[],"label_agreement":null},{"id":"W2300878904","doi":"10.1038/leu.2016.44","title":"Harmonemia: a universal strategy for flow cytometry immunophenotyping—A European LeukemiaNet WP10 study","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Medicine; Flow cytometry; Pathology; Internal medicine; Immunology","score_opus":0.038221568517568846,"score_gpt":0.299599397122505,"score_spread":0.26137782860493614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300878904","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053171616,0.0040637027,0.016674517,0.70352054,0.0057584113,0.033463754,0.0052626017,0.004377132,0.17370771],"genre_scores_gemma":[0.07628893,0.0005531607,0.0063087037,0.5617572,0.05619853,0.0009535192,0.007392991,0.0029255606,0.28762144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99149936,0.00082306,0.0012950968,0.0022446606,0.0016316756,0.0025061325],"domain_scores_gemma":[0.99428064,0.001026678,0.00057291647,0.0028215041,0.0007806923,0.00051756506],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0016894463,0.0014984697,0.002038133,0.0013406762,0.00043885433,0.00024923895,0.0017473305,0.0019362149,0.000977074],"category_scores_gemma":[0.0005232854,0.0012341539,0.00078373903,0.0009070942,0.00044989097,0.00033238932,0.0007087036,0.007161238,0.0020421864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011148325,0.000100863974,0.00016954656,0.00078636303,0.0013336455,0.009976199,0.00038352326,0.00001891625,0.0018936559,0.000013239158,0.9625097,0.021699533],"study_design_scores_gemma":[0.018568322,0.0025637904,0.0010225828,0.0007520859,0.0011951032,0.0005411821,0.00057830225,0.0007219301,0.000342186,0.00009944518,0.97200704,0.001608025],"about_ca_topic_score_codex":0.0003660616,"about_ca_topic_score_gemma":0.000014547513,"teacher_disagreement_score":0.14176337,"about_ca_system_score_codex":0.012581407,"about_ca_system_score_gemma":0.005570581,"threshold_uncertainty_score":0.99993616},"labels":[],"label_agreement":null},{"id":"W2311676973","doi":"10.1038/leu.2016.67","title":"Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pathogenesis; Lymphoma; Pathology; Biology; Bone marrow; Intravascular large B-cell lymphoma; Cancer research; Disease; Gene expression profiling; Gene; Medicine; Gene expression","score_opus":0.010032146743645623,"score_gpt":0.2189181853375946,"score_spread":0.208886038593949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311676973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985092,0.00062021456,0.00029469494,0.000052246887,0.000013354902,0.0002239141,0.000020654767,0.000020784846,0.00024491665],"genre_scores_gemma":[0.99715024,0.0003381883,0.0022036477,0.000119245036,0.000005742231,0.00005367985,0.000036888654,0.000015919635,0.00007643181],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998867,0.000024628062,0.00035689143,0.00028086326,0.00022026763,0.00025040354],"domain_scores_gemma":[0.9994111,0.000048078608,0.00008675642,0.0002863015,0.00004510033,0.00012263417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009455213,0.00015743673,0.00045721605,0.000339811,0.000027466273,0.0000067203314,0.00004621444,0.00008174682,0.000039666716],"category_scores_gemma":[0.000013136428,0.00010349968,0.00012282062,0.000355617,0.000036199126,0.00006308716,0.000059351336,0.000022610953,0.000007896934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039947417,0.0044533964,0.27411276,0.00016841247,0.0039630877,0.00032385543,0.007970694,0.00017950562,0.06711766,0.0006522035,0.00017042251,0.6404885],"study_design_scores_gemma":[0.022238405,0.00022972528,0.4689788,0.00020735149,0.0015186821,0.00001039899,0.0004945544,0.00286173,0.4998215,0.00005767432,0.003234066,0.000347106],"about_ca_topic_score_codex":0.00017661913,"about_ca_topic_score_gemma":0.00020608898,"teacher_disagreement_score":0.6401414,"about_ca_system_score_codex":0.0006353907,"about_ca_system_score_gemma":0.00018952944,"threshold_uncertainty_score":0.42205948},"labels":[],"label_agreement":null},{"id":"W2312433151","doi":"10.1038/sj.leu.2401870","title":"Autoantibodies to Abl and Bcr proteins","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"ABL; Immunoprecipitation; breakpoint cluster region; Biology; Autoantibody; Philadelphia chromosome; Leukemia; Immune system; Fusion protein; Immunology; Cancer research; Antibody; Cell biology; Tyrosine kinase; Receptor; Chromosomal translocation; Genetics; Signal transduction; Gene","score_opus":0.011829536000266101,"score_gpt":0.2645045572600215,"score_spread":0.2526750212597554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312433151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562007,0.00043874834,0.000014281523,0.0010644731,0.000045231038,0.0006916676,0.000007948972,0.00015974141,0.04137717],"genre_scores_gemma":[0.9551295,0.00015484603,0.0049098576,0.0014897446,0.00018909675,0.000076420634,0.000018068376,0.00003442744,0.037998043],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989391,0.000016169697,0.00017986068,0.00033400516,0.00020525014,0.00032558863],"domain_scores_gemma":[0.9993138,0.000026237212,0.00002188797,0.00036292168,0.00002597949,0.00024920073],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000068255285,0.00017928728,0.00026991352,0.000069714624,0.000080703954,0.000023061204,0.000065101056,0.00008912926,0.0018301709],"category_scores_gemma":[0.00004126509,0.00014911442,0.000048070717,0.00015022817,0.00005631005,0.00006297845,0.000035943827,0.00015107382,0.0011895115],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011918037,0.00031180392,0.060036503,0.00064531446,0.0005394472,0.0012404247,0.004646557,0.00013040048,0.025913334,0.00088188867,0.042818163,0.8616444],"study_design_scores_gemma":[0.010455536,0.001330597,0.4869264,0.00072896795,0.00026755227,0.0008605612,0.00013851233,0.0009848112,0.02008743,0.0004263482,0.47710028,0.00069299294],"about_ca_topic_score_codex":0.00059479097,"about_ca_topic_score_gemma":0.00003999059,"teacher_disagreement_score":0.86095136,"about_ca_system_score_codex":0.0011214125,"about_ca_system_score_gemma":0.00037994515,"threshold_uncertainty_score":0.9995882},"labels":[],"label_agreement":null},{"id":"W2312524572","doi":"10.1038/sj.leu.2402463","title":"Long-term outcome of allogeneic transplants in acute myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Term (time); Leukemia; Transplantation; Oncology; Immunology; Hematology; Myeloid; Outcome (game theory); Internal medicine","score_opus":0.03850079750921362,"score_gpt":0.30823014051609526,"score_spread":0.26972934300688167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312524572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901299,0.0008059272,0.00013157321,0.0005261007,0.0001634663,0.00075307745,0.000055579352,0.00011422859,0.007320158],"genre_scores_gemma":[0.9879912,0.0013510373,0.0008145436,0.000710179,0.00016336759,0.00005676214,0.00008372008,0.00009301715,0.008736185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963938,0.00011136928,0.0010339075,0.0006650446,0.00081452075,0.0009813312],"domain_scores_gemma":[0.9982077,0.00016272663,0.00017610383,0.0009461786,0.00011987053,0.00038742696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004167847,0.00042975624,0.0010077454,0.0005714845,0.00006291967,0.000020972027,0.00055156957,0.00044903855,0.0018869839],"category_scores_gemma":[0.0000996069,0.00038637442,0.0002935667,0.00075353094,0.00026478292,0.00019027959,0.00011660805,0.0010424034,0.00079750735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005689219,0.00016629128,0.9200006,0.00059615844,0.00032614355,0.00327975,0.0008194283,0.00007613788,0.058122437,0.0000905167,0.002191418,0.013762172],"study_design_scores_gemma":[0.010153369,0.00046999185,0.9532201,0.0004165073,0.00029927227,0.00094114285,0.0000495438,0.002281127,0.030709328,0.00003993553,0.0008564616,0.00056320423],"about_ca_topic_score_codex":0.0003125354,"about_ca_topic_score_gemma":0.00015255892,"teacher_disagreement_score":0.033219494,"about_ca_system_score_codex":0.00360509,"about_ca_system_score_gemma":0.0005076072,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W2313422008","doi":"10.1038/sj.leu.2401764","title":"CDP/Cut DNA binding activity is down-modulated in granulocytes, macrophages and erythrocytes but remains elevated in differentiating megakaryocytes","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Biology; Haematopoiesis; Cell cycle; Cell biology; Cell; DNA; DNA replication; Molecular biology; Cell type; Cell culture; Stem cell; Genetics","score_opus":0.005483223916501367,"score_gpt":0.21392742511940227,"score_spread":0.20844420120290091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313422008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988107,0.00044145493,0.000018189208,0.00005650904,0.00004640739,0.00021575748,0.00005614473,0.000023334544,0.00033147188],"genre_scores_gemma":[0.99766904,0.0011047758,0.00031975727,0.00010131371,0.000057099805,0.000016778138,0.00014536578,0.000039667953,0.0005462086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984519,0.000078706944,0.0003362436,0.00055335666,0.00012118869,0.00045859648],"domain_scores_gemma":[0.99943626,0.000030321411,0.0001022541,0.0003239471,0.000024568524,0.000082629915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016092962,0.0002872025,0.00030823186,0.00011669105,0.0001036259,0.000066467896,0.00018675899,0.00028428642,0.000071835835],"category_scores_gemma":[0.00003822099,0.00029494878,0.000065241264,0.0002262027,0.00007758475,0.000012597606,0.000117994736,0.0002337601,0.0000088892175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105136125,0.00005270887,0.025581885,0.000051331685,0.000034845987,0.000024050454,0.00023804074,0.00024654792,0.9679837,0.00000783893,0.00003342744,0.0056404504],"study_design_scores_gemma":[0.0023699983,0.00013918961,0.18928513,0.00010966589,0.00002137902,0.000036968857,0.00013715218,0.01828522,0.7886521,0.00017175385,0.00023519402,0.0005562393],"about_ca_topic_score_codex":0.0004740318,"about_ca_topic_score_gemma":0.0011461845,"teacher_disagreement_score":0.17933163,"about_ca_system_score_codex":0.00019508124,"about_ca_system_score_gemma":0.00009363978,"threshold_uncertainty_score":0.9999503},"labels":[],"label_agreement":null},{"id":"W2313668596","doi":"10.1038/sj.leu.2401855","title":"Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Montreal Clinical Research Institute; Royal Victoria Regional Health Centre","funders":"Medical Research Council","keywords":"Chromosomal translocation; Tyrosine kinase; Biology; ABL; Cancer research; breakpoint cluster region; Philadelphia chromosome; Mutant; Receptor tyrosine kinase; Phenotype; Molecular biology; Kinase; Mutagenesis; Cell biology; Genetics; Signal transduction; Gene","score_opus":0.015066016234404117,"score_gpt":0.25597965106315246,"score_spread":0.24091363482874834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313668596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888718,0.0009395176,0.000001962372,0.0006144011,0.000055710992,0.0005605643,0.0000121996745,0.000086309534,0.008857542],"genre_scores_gemma":[0.996378,0.00018918615,0.00038890057,0.00087782746,0.000117311916,0.000080061654,0.000050403825,0.00004445072,0.0018738726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980884,0.00014498505,0.00045339932,0.0004338721,0.000323461,0.00055587146],"domain_scores_gemma":[0.9989626,0.00021099059,0.00008206426,0.00056866,0.000031533356,0.00014415594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027478414,0.0002934708,0.00041158425,0.000171762,0.000087065484,0.00003731675,0.00020932118,0.00017395802,0.0011314079],"category_scores_gemma":[0.00019850992,0.00020966052,0.00007656359,0.0006736136,0.00014795175,0.00019554995,0.00004955424,0.0005840541,0.00015985635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015321634,0.0004952799,0.027521903,0.00014772866,0.00008650576,0.0037371537,0.0035135308,0.00080523477,0.90674627,0.00007111679,0.0012910342,0.054052066],"study_design_scores_gemma":[0.03224449,0.00039162324,0.28686345,0.0031403552,0.00022688424,0.000873008,0.0012688434,0.006676813,0.64949095,0.0005089571,0.017318917,0.0009957091],"about_ca_topic_score_codex":0.013768489,"about_ca_topic_score_gemma":0.00084019534,"teacher_disagreement_score":0.25934157,"about_ca_system_score_codex":0.0055380035,"about_ca_system_score_gemma":0.001052729,"threshold_uncertainty_score":0.99978167},"labels":[],"label_agreement":null},{"id":"W2314330969","doi":"10.1038/sj.leu.2401752","title":"Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Clonogenic assay; CD34; Biology; Autocrine signalling; Myeloid; Progenitor cell; Immunology; Interleukin 3; Population; Haematopoiesis; Cancer research; Myeloid leukemia; Megakaryocyte; Stem cell; Cell biology; In vitro; Cell culture; Antigen; Medicine; Interleukin 21; Biochemistry; Genetics","score_opus":0.008677923137142322,"score_gpt":0.2237158773523174,"score_spread":0.21503795421517508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314330969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966658,0.00027002342,0.00014299569,0.000020944277,0.000129244,0.0012907684,0.00024377047,0.00011125001,0.001125206],"genre_scores_gemma":[0.9929818,0.0001134555,0.00331915,0.0001298432,0.00015700019,0.00008936621,0.0014026911,0.00009296009,0.001713721],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972019,0.00009503034,0.00076809846,0.00075764424,0.000563465,0.0006138219],"domain_scores_gemma":[0.99846274,0.00014344828,0.00030854007,0.0007492272,0.000122057405,0.00021399691],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000888106,0.0004972286,0.00085398706,0.00021323375,0.00006397744,0.000020442385,0.0002190745,0.00030532238,0.0011687893],"category_scores_gemma":[0.000029097431,0.000420244,0.00016195682,0.00036986975,0.00015217751,0.00021145657,0.000057621495,0.0005167842,0.00022273313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011700042,0.0037190828,0.27439278,0.00079095794,0.0016723183,0.00047977516,0.005254965,0.0056861183,0.42090914,0.000022204686,0.0006006819,0.27477196],"study_design_scores_gemma":[0.027954934,0.000540493,0.6383034,0.00039311187,0.00027158146,0.0000041468156,0.00003277032,0.010563782,0.3210155,0.000006068871,0.0005297904,0.00038440776],"about_ca_topic_score_codex":0.003416052,"about_ca_topic_score_gemma":0.00047257377,"teacher_disagreement_score":0.36391065,"about_ca_system_score_codex":0.01567392,"about_ca_system_score_gemma":0.0022631492,"threshold_uncertainty_score":0.99982494},"labels":[],"label_agreement":null},{"id":"W2314531432","doi":"10.1038/sj.leu.2401660","title":"Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; McGill University","keywords":"Myeloid leukemia; Myeloid; Genotype; Glutathione S-transferase; Internal medicine; Medicine; Null cell; Leukemia; Oncology; Immunology; Gastroenterology; Biology; Glutathione; Gene; Genetics","score_opus":0.004666482318388887,"score_gpt":0.21099934394152214,"score_spread":0.20633286162313325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314531432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957128,0.001916601,0.00008645301,0.00017767437,0.000059226168,0.00031474326,0.00012595429,0.000041318424,0.0015652378],"genre_scores_gemma":[0.9893684,0.0043643867,0.00030582826,0.00040422435,0.000094945564,0.00004535683,0.0005818674,0.000047118465,0.0047879214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851495,0.00006533445,0.0003487479,0.00048250274,0.00012688349,0.00046160512],"domain_scores_gemma":[0.99947727,0.000008583982,0.000026127602,0.00033122805,0.00003345197,0.00012332168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000078775236,0.0003198648,0.00027572765,0.000070768685,0.000110718436,0.000030052157,0.00019376285,0.00028043217,0.00045952387],"category_scores_gemma":[0.0000054180223,0.0002901449,0.00013045978,0.00025959505,0.000085431275,0.000009991508,0.000015437965,0.00012831278,0.00017118914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011171229,0.00034879454,0.04833467,0.000022802384,0.0010567703,0.0002365438,0.0017149074,0.0030000356,0.7902651,0.0004567565,0.0008830286,0.15256348],"study_design_scores_gemma":[0.010492118,0.0015531381,0.38506067,0.000099833196,0.00030358674,0.0006828778,0.00005995315,0.00021399184,0.5756288,0.00026264263,0.024023596,0.001618769],"about_ca_topic_score_codex":0.00054099585,"about_ca_topic_score_gemma":0.00024966526,"teacher_disagreement_score":0.336726,"about_ca_system_score_codex":0.00011608786,"about_ca_system_score_gemma":0.00030903672,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W2314987545","doi":"10.1038/sj.leu.2401743","title":"Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Diphtheria toxin; Immunology; Leukemia; Myeloid; Cytotoxic T cell; Biology; Cancer research; Medicine; Toxin; In vitro; Microbiology","score_opus":0.007225716412735053,"score_gpt":0.21394429933497086,"score_spread":0.2067185829222358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314987545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944585,0.00009599711,0.00017122416,0.00020267308,0.0005409085,0.00077100843,0.00029939244,0.0002047047,0.0032556185],"genre_scores_gemma":[0.9733674,0.0000055702235,0.0008338099,0.0047209538,0.00009733838,0.000103529615,0.00028114265,0.00009585706,0.020494396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751633,0.00013187208,0.0005205774,0.0008644467,0.00013006927,0.00083672866],"domain_scores_gemma":[0.99863136,0.000058981033,0.00010650063,0.00096626993,0.00008481918,0.00015209233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011838567,0.00051539316,0.0005570436,0.00017377514,0.00033942284,0.00008039713,0.0007541166,0.0004027963,0.022491539],"category_scores_gemma":[0.00002509342,0.00043918454,0.00013301462,0.00034394066,0.000092746544,0.0001749918,0.00017936966,0.00047762433,0.011474674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011906049,0.00022464676,0.0015449149,0.000008919503,0.00025636549,0.000013305628,0.0047063,0.000057989873,0.9361754,0.00013189107,0.022401081,0.03328857],"study_design_scores_gemma":[0.007049971,0.0027160894,0.0877389,0.00022063866,0.0000906242,0.000009423659,0.00030561644,0.000004108116,0.6314913,0.00027355438,0.2688665,0.0012332572],"about_ca_topic_score_codex":0.0011837629,"about_ca_topic_score_gemma":0.00037281,"teacher_disagreement_score":0.3046841,"about_ca_system_score_codex":0.0007387408,"about_ca_system_score_gemma":0.00015388432,"threshold_uncertainty_score":0.999806},"labels":[],"label_agreement":null},{"id":"W2317478958","doi":"10.1038/sj.leu.2401657","title":"Serine/threonine phosphorylation in cytokine signal transduction","year":2000,"lang":"en","type":"review","venue":"Leukemia","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute; National Institute on Aging; National Institutes of Health; University of British Columbia","keywords":"Phosphorylation; Receptor tyrosine kinase; Tyrosine phosphorylation; Biology; Signal transduction; Cell biology; MAP2K7; AKT2; Tyrosine kinase; JAK-STAT signaling pathway; Cancer research; AKT1; Protein kinase A; Cyclin-dependent kinase 2; Protein kinase B","score_opus":0.03958424212897341,"score_gpt":0.32043935935553153,"score_spread":0.2808551172265581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317478958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044516372,0.99137217,0.00011098052,0.000059271042,0.00035636488,0.0009382442,0.00006930496,0.00014211987,0.006506363],"genre_scores_gemma":[0.0007353141,0.9946191,0.00021881965,0.000067823006,0.0008861827,0.0001394658,0.0010191032,0.00009869434,0.0022155533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787253,0.0000690945,0.00092001975,0.0005282181,0.00027544145,0.00033470624],"domain_scores_gemma":[0.9991593,0.000067277986,0.00021258299,0.00037865888,0.000053071588,0.00012912243],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016767884,0.00046561964,0.0015248134,0.0005027654,0.000059688176,0.000028843464,0.00011188259,0.0004227981,0.006223693],"category_scores_gemma":[0.000019780611,0.00040188865,0.00058250787,0.00071662193,0.00004046275,0.0001263296,0.000014472948,0.0010584135,0.00037662778],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084744766,0.000101224294,0.0000064918236,0.0038044916,0.00008784986,0.000099152036,0.00006257547,0.00007632535,0.00013217914,0.00003389636,0.0010175124,0.99449354],"study_design_scores_gemma":[0.00076245033,0.00020785662,0.000038310205,0.012794001,0.00064781215,0.0006094524,0.000008193669,0.0001770415,0.00026290648,0.000018923502,0.98414004,0.000332993],"about_ca_topic_score_codex":0.00024166548,"about_ca_topic_score_gemma":0.000043626038,"teacher_disagreement_score":0.9941606,"about_ca_system_score_codex":0.0013846443,"about_ca_system_score_gemma":0.00080059044,"threshold_uncertainty_score":0.9998433},"labels":[],"label_agreement":null},{"id":"W2319908039","doi":"10.1038/sj.leu.2402722","title":"PML a target of translocations in APL is a regulator of cellular senescence","year":2002,"lang":"en","type":"review","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Regulator; Senescence; Chromosomal translocation; Cellular senescence; Biology; Master regulator; Cell biology; Genetics; Cancer research; Computational biology; Transcription factor; Phenotype; Gene","score_opus":0.0205543791030389,"score_gpt":0.27500345122992165,"score_spread":0.2544490721268827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319908039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001164835,0.9954001,0.0017526123,0.000006756127,0.0000885874,0.00041531754,0.00009654703,0.0000072605094,0.0010679968],"genre_scores_gemma":[0.009055706,0.98796487,0.0010677596,0.000022206066,0.00012051838,0.00007088182,0.00026753746,0.000060429655,0.0013700668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978927,0.00012170941,0.0009257164,0.0005489917,0.00022726109,0.0002836614],"domain_scores_gemma":[0.99850434,0.00002744432,0.0004934499,0.0007916549,0.000113610135,0.00006947067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019439762,0.0003822492,0.0011006269,0.00015280551,0.000025919047,0.000007611833,0.00056722574,0.0007071025,0.00007542529],"category_scores_gemma":[0.00006408698,0.00035502404,0.00048057007,0.00045946173,0.00019207734,0.000004049005,0.00007608054,0.0002595346,0.000012971911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008079459,0.00065385853,0.00035047988,0.1653212,0.00090123306,0.00006908159,0.0012018428,0.00009340745,0.15563278,0.00058444205,0.006379719,0.66873115],"study_design_scores_gemma":[0.00033363578,0.000104355524,0.0000033565468,0.0041379943,0.00022014667,0.00002285524,0.000022427304,0.0000426615,0.1115472,0.00007104615,0.88307804,0.00041627765],"about_ca_topic_score_codex":0.000032718977,"about_ca_topic_score_gemma":0.000004348702,"teacher_disagreement_score":0.8766983,"about_ca_system_score_codex":0.00010564546,"about_ca_system_score_gemma":0.00096435775,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2322089364","doi":"10.1038/sj.leu.2401821","title":"The PEBP2β/CBFβ-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Cytoplasm; Fusion protein; Biology; Molecular biology; Gene; Subcellular localization; DNA; Nuclear localization sequence; Cell biology; Genetics","score_opus":0.010142556058730542,"score_gpt":0.24397304628322378,"score_spread":0.23383049022449323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322089364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798968,0.00059404754,0.000008838181,0.0023536577,0.000050179977,0.0012231262,0.000017187502,0.000050843337,0.01580536],"genre_scores_gemma":[0.99228805,0.001737549,0.00019265889,0.0009748067,0.00014909866,0.00005711781,0.000010413626,0.000063016974,0.004527293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741495,0.00031225992,0.0005028091,0.00045658086,0.0006878347,0.0006255864],"domain_scores_gemma":[0.998466,0.00036986775,0.00015021091,0.0007764178,0.00006670439,0.0001708133],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006452523,0.00028684118,0.00042867215,0.00015782072,0.00039885024,0.00005296917,0.00044240538,0.00021997397,0.0013128442],"category_scores_gemma":[0.00006319848,0.00016879218,0.000144992,0.0006886424,0.0005132068,0.0001751681,0.00010578647,0.0008960622,0.00019467855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016574435,0.00013793702,0.00068009476,0.00039111866,0.00009342934,0.00013667792,0.004574597,0.00006604699,0.9599624,0.00014162027,0.01474416,0.017414436],"study_design_scores_gemma":[0.026506951,0.0016484897,0.0075987177,0.0013104227,0.00042663884,0.00058672944,0.013506534,0.022314405,0.60969484,0.00038411564,0.31479818,0.0012239973],"about_ca_topic_score_codex":0.0020899472,"about_ca_topic_score_gemma":0.000044380206,"teacher_disagreement_score":0.35026762,"about_ca_system_score_codex":0.0015408694,"about_ca_system_score_gemma":0.0007756401,"threshold_uncertainty_score":0.9996001},"labels":[],"label_agreement":null},{"id":"W2322257489","doi":"10.1038/sj.leu.2401685","title":"Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Atomic Energy of Canada Limited","keywords":"CD80; Myeloid leukemia; Myeloid; CD40; Cytokine; CD34; Immunology; Antigen; Biology; Antigen presentation; Cancer research; Leukemia; Antigen-presenting cell; Stem cell; Cytotoxic T cell; T cell; Immune system; Cell biology; In vitro","score_opus":0.00738799721724276,"score_gpt":0.21433799429452327,"score_spread":0.2069499970772805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322257489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951385,0.001286482,0.00007322513,0.00003048387,0.00050083647,0.00022756323,0.00002885992,0.00003304419,0.0026809904],"genre_scores_gemma":[0.9812149,0.00039235558,0.00003648854,0.00005724084,0.000026725946,0.000006512895,0.00003769545,0.000017672133,0.018210437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988297,0.00024923275,0.00043494313,0.00018300273,0.0000610209,0.00024205803],"domain_scores_gemma":[0.9991095,0.000096309544,0.0002527813,0.00047015914,0.00006433129,0.000006937728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020910404,0.00015166828,0.00026705928,0.000066121735,0.00016340076,0.0000066718126,0.00029298468,0.0002315896,0.0014859814],"category_scores_gemma":[0.000013350614,0.00011212708,0.00018695302,0.0002400431,0.00024810722,0.00012349231,0.000051313786,0.00021311063,0.0001041738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009023127,0.000024718303,0.0014141542,0.000017970091,0.00032881377,3.5581039e-7,0.0004249615,0.00031436296,0.97628456,0.00010875766,0.00074553496,0.019433524],"study_design_scores_gemma":[0.00093619386,0.00008781467,0.14898682,0.000046284415,0.000077573895,0.000012387656,0.00003479802,0.000028871682,0.8184869,0.00007611191,0.03112995,0.00009626381],"about_ca_topic_score_codex":0.00022703926,"about_ca_topic_score_gemma":0.0000036719227,"teacher_disagreement_score":0.1577976,"about_ca_system_score_codex":0.00011431755,"about_ca_system_score_gemma":0.00019144286,"threshold_uncertainty_score":0.9994268},"labels":[],"label_agreement":null},{"id":"W2322266245","doi":"10.1038/sj.leu.2401718","title":"Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping","year":2000,"lang":"en","type":"letter","venue":"Leukemia","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; Ontario Institute for Cancer Research; University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Chromosomal translocation; Karyotype; breakpoint cluster region; Biology; Fish <Actinopterygii>; Fusion gene; Philadelphia chromosome; Chromosome; Reciprocal; ABL; Fusion; Genetics; Gene; Fishery; Signal transduction; Tyrosine kinase","score_opus":0.03050963647341292,"score_gpt":0.24171598528971647,"score_spread":0.21120634881630354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322266245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97620857,0.00078054966,0.0002666234,0.021019647,0.00015336767,0.0005950912,0.00043773698,0.000015166194,0.0005232409],"genre_scores_gemma":[0.972512,0.0022397037,0.0012527987,0.018896906,0.0012738649,0.000060694383,0.0025148778,0.00007504661,0.0011740857],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825674,0.00008631319,0.0006636586,0.0004775794,0.00019439208,0.0003212849],"domain_scores_gemma":[0.9992187,0.000033637363,0.00024422831,0.00037989282,0.000077652934,0.000045882887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012886515,0.00029820032,0.00044427774,0.00016034601,0.00006288954,0.000029407449,0.00021132512,0.0008049723,0.00019815627],"category_scores_gemma":[0.000010185404,0.00030195416,0.00013602819,0.00016301221,0.00013470737,0.000017936682,0.00008158633,0.00048126298,0.0000023945097],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002806306,0.0006188896,0.002606181,0.0035988966,0.00069781224,0.0003899761,0.003382395,0.007037129,0.7375639,0.0005110156,0.23628803,0.0044994545],"study_design_scores_gemma":[0.01022622,0.0022164346,0.010595406,0.0022127053,0.00052553316,0.0006594832,0.0003213425,0.002096424,0.26025233,0.0010669606,0.7072015,0.0026256652],"about_ca_topic_score_codex":0.00072821294,"about_ca_topic_score_gemma":0.00018956426,"teacher_disagreement_score":0.47731158,"about_ca_system_score_codex":0.00009456758,"about_ca_system_score_gemma":0.00039646678,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W2322831770","doi":"10.1038/sj.leu.2402077","title":"Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Vaccination; Immunology; CD8; Chemotherapy; Plasma cell; Cytotoxic T cell; Internal medicine; Bone marrow; Autologous stem-cell transplantation; Antibody; Cancer research; Oncology; Immune system; Biology; In vitro","score_opus":0.01081485154645055,"score_gpt":0.25448751284824833,"score_spread":0.2436726613017978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322831770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248886,0.0022085467,0.0024778072,0.00010561913,0.0010071724,0.0013580656,0.00004826348,0.0002403698,0.000065317974],"genre_scores_gemma":[0.99244875,0.00006222619,0.00057163124,0.000200807,0.00008783448,0.00054655154,0.0001293103,0.0000790441,0.005873839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981433,0.00022929328,0.0005074769,0.00048177553,0.00005459641,0.00058357045],"domain_scores_gemma":[0.9987723,0.00044094046,0.00019202367,0.0004903053,0.00007753246,0.000026901187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024108532,0.00038812947,0.00046869536,0.00023543503,0.00025298886,0.0000446075,0.00033841806,0.00034967912,0.00083228276],"category_scores_gemma":[0.00008769177,0.00035652032,0.0001818415,0.00018529576,0.000058096684,0.00023206862,0.000051829702,0.00033083317,0.00015727071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020387309,0.0012909593,0.00083329657,0.00003082363,0.00031925514,0.00003651088,0.0045175846,0.000022843766,0.905413,0.000009340862,0.00093773165,0.06620135],"study_design_scores_gemma":[0.057461005,0.0030593302,0.04452194,0.00006208629,0.000103822036,0.00013745879,0.00096365047,0.0005675881,0.8199465,0.00003484908,0.072442815,0.00069894496],"about_ca_topic_score_codex":0.00011666382,"about_ca_topic_score_gemma":0.000025783726,"teacher_disagreement_score":0.08546648,"about_ca_system_score_codex":0.00039374383,"about_ca_system_score_gemma":0.00014928207,"threshold_uncertainty_score":0.99988866},"labels":[],"label_agreement":null},{"id":"W2323809396","doi":"10.1038/sj.leu.2401975","title":"Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML)","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Progenitor cell; Haematopoiesis; Leukemia; Biology; Immunology; Stem cell; Cancer research; Internal medicine; Medicine; Cell biology","score_opus":0.009751766853521653,"score_gpt":0.2553992964289454,"score_spread":0.2456475295754237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323809396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874416,0.0002050484,0.000070412134,0.00009528398,0.000071666684,0.0024924884,0.00040842398,0.00015984758,0.009055219],"genre_scores_gemma":[0.99081945,0.00019812855,0.0046971086,0.0003732215,0.00024447084,0.0002325993,0.00072700233,0.00014071842,0.002567289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957519,0.00016298475,0.00071006163,0.0008541109,0.0012513588,0.001269586],"domain_scores_gemma":[0.99729645,0.00019565185,0.00025030383,0.0009088806,0.00066149834,0.0006871959],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013967195,0.00055632676,0.0009976557,0.00022335586,0.00017659951,0.000040998788,0.000343573,0.00034114963,0.0013118485],"category_scores_gemma":[0.00010757713,0.00042374193,0.00018948592,0.00057867245,0.0005381064,0.00026035987,0.00011038844,0.00087704125,0.0003422445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038854264,0.0024228247,0.7083043,0.00095497974,0.009735155,0.003141551,0.040992312,0.00044829893,0.048685413,0.00044669653,0.010098293,0.13591592],"study_design_scores_gemma":[0.037232257,0.007487253,0.61313,0.001099146,0.0021419665,0.0002900222,0.001509183,0.00082454877,0.32202137,0.00047400736,0.0118984645,0.0018917931],"about_ca_topic_score_codex":0.0014059378,"about_ca_topic_score_gemma":0.00005446154,"teacher_disagreement_score":0.27333593,"about_ca_system_score_codex":0.005200689,"about_ca_system_score_gemma":0.0056257145,"threshold_uncertainty_score":0.9998214},"labels":[],"label_agreement":null},{"id":"W2326874649","doi":"10.1038/sj.leu.2402385","title":"Workshop on haploidentical stem cell transplantation: Chicago, Illinois, USA, 18-19 November 2000","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Transplantation; Stem cell; Gerontology; Medicine; Oncology; Immunology; Biology; Internal medicine; Genetics","score_opus":0.03466231920067794,"score_gpt":0.2668707934885858,"score_spread":0.23220847428790783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326874649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81634396,0.00044474984,0.0033287914,0.0010162061,0.00046210166,0.00068900664,0.000038492897,0.00018795546,0.17748876],"genre_scores_gemma":[0.95063585,0.00082635717,0.00088051014,0.002026873,0.00031668544,0.000041224434,0.00007838823,0.00006527453,0.04512883],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977128,0.000070830865,0.0005365719,0.0005217348,0.00068510004,0.0004729814],"domain_scores_gemma":[0.9986618,0.00032833044,0.00008798843,0.0004777962,0.0000616804,0.00038240012],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016035233,0.00030863076,0.00041002175,0.00015100575,0.000114446164,0.000046450823,0.00015101579,0.0003085416,0.009507541],"category_scores_gemma":[0.000011541102,0.0002843957,0.00017250405,0.00032572603,0.00009146339,0.00011049362,0.000008123943,0.000506615,0.0056166216],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009413327,0.00797647,0.15357561,0.023312598,0.0018049198,0.024109365,0.09220044,0.0077931355,0.1571138,0.013088888,0.36575222,0.14385922],"study_design_scores_gemma":[0.06838277,0.0026085465,0.31780568,0.008596195,0.0054975743,0.008834552,0.0028639033,0.03262631,0.3864479,0.00050111744,0.1597167,0.006118738],"about_ca_topic_score_codex":0.000045189397,"about_ca_topic_score_gemma":0.000031261367,"teacher_disagreement_score":0.22933412,"about_ca_system_score_codex":0.00050163985,"about_ca_system_score_gemma":0.00014839324,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W2327541094","doi":"10.1038/sj.leu.2402579","title":"Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study","year":2002,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mantle cell lymphoma; Nucleoside; Chemotherapy; Lymphoma; Nucleoside analogue; Cancer research; Medicine; Virology; Biology; Internal medicine; Oncology; Genetics","score_opus":0.017660610305329557,"score_gpt":0.2774025378247684,"score_spread":0.25974192751943886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327541094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95543617,0.0007280417,0.0004410985,0.032610357,0.00021312901,0.004268514,0.00008291607,0.000115889,0.0061039054],"genre_scores_gemma":[0.8418912,0.000058056485,0.0019507267,0.14265384,0.00040198085,0.0002542203,0.000074477546,0.0003020475,0.012413433],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951085,0.00024068342,0.0009787087,0.0011855543,0.0014390143,0.0010475782],"domain_scores_gemma":[0.9971029,0.00021760294,0.0002703921,0.0019520149,0.00020185126,0.00025520427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047741842,0.00065554795,0.0014287697,0.000856541,0.00005496592,0.00003720313,0.0005874187,0.00095110916,0.00029814045],"category_scores_gemma":[0.000103118065,0.0006422479,0.00029088772,0.0011191455,0.000110045294,0.00005294103,0.00021646735,0.0012189506,0.00019169076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004578327,0.00076809956,0.000056773883,0.0016630467,0.00024731318,0.5295379,0.0020762847,0.00004304459,0.0036243503,0.000017401948,0.46078908,0.00071884994],"study_design_scores_gemma":[0.376866,0.008039051,0.0009578901,0.0065941876,0.0020120377,0.03867972,0.009333646,0.00740839,0.12998922,0.0016269365,0.41192105,0.0065718475],"about_ca_topic_score_codex":0.0079477895,"about_ca_topic_score_gemma":0.0010166559,"teacher_disagreement_score":0.4908582,"about_ca_system_score_codex":0.033383347,"about_ca_system_score_gemma":0.00532939,"threshold_uncertainty_score":0.99960285},"labels":[],"label_agreement":null},{"id":"W2328357571","doi":"10.1038/sj.leu.2402372","title":"Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Lymphoma; Follicular lymphoma; Molecular biology; Cell culture; Locus (genetics); Flow cytometry; Fluorescence in situ hybridization; Chromosome; Cancer research; Gene; Genetics; Immunology","score_opus":0.01789644976041673,"score_gpt":0.2392136427432839,"score_spread":0.22131719298286717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328357571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96848786,0.02968475,0.00017608845,0.000076568635,0.00010165248,0.00018322823,0.000023296945,0.000036750294,0.0012298025],"genre_scores_gemma":[0.987887,0.0013747273,0.00008778193,0.00022466548,0.000010127688,0.000008974483,0.000084934145,0.000015725818,0.010306026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988853,0.00014228623,0.00038182826,0.00025087883,0.000045436213,0.00029430148],"domain_scores_gemma":[0.9993468,0.00012398955,0.00013169202,0.00031793135,0.000052363626,0.000027253278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007970263,0.00020451641,0.00053124846,0.00032604433,0.00015154676,0.000016514072,0.00017467994,0.00021465064,0.0011622781],"category_scores_gemma":[0.0000095653295,0.00018165715,0.00024579503,0.00048078166,0.00017883365,0.0000896455,0.000028815215,0.00011726491,0.00004692645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029340308,0.00014898951,0.0004914676,0.000030161385,0.002151772,0.000007709932,0.0032425546,0.00007107119,0.9702096,0.00015902487,0.00261315,0.020581115],"study_design_scores_gemma":[0.010940899,0.00087511825,0.044269115,0.000054431548,0.0019575458,0.000038772392,0.00089701934,0.00020339957,0.7482505,0.00008434425,0.19187538,0.0005534751],"about_ca_topic_score_codex":0.00084339216,"about_ca_topic_score_gemma":0.000035542926,"teacher_disagreement_score":0.22195908,"about_ca_system_score_codex":0.00008978383,"about_ca_system_score_gemma":0.000057135392,"threshold_uncertainty_score":0.9997508},"labels":[],"label_agreement":null},{"id":"W2328382622","doi":"10.1038/sj.leu.2402079","title":"Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190bcr/abl transgenic mice","year":2001,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Medical Research Council Canada","keywords":"Apoptosis; Bone marrow; Biology; Genetically modified mouse; Leukemia; Carcinogenesis; B cell; Cancer research; Flow cytometry; Transgene; Molecular biology; Immunology; Antibody; Cancer; Biochemistry; Genetics","score_opus":0.017765350528368383,"score_gpt":0.28255142525930055,"score_spread":0.2647860747309322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328382622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908434,0.00072857074,0.00008790696,0.00020176874,0.00014369347,0.001031787,0.00003810659,0.00004646165,0.006878288],"genre_scores_gemma":[0.9799575,0.0011636757,0.0005499352,0.00010848558,0.00013704668,0.00006139873,0.00003646021,0.000073887626,0.01791159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971326,0.00016539189,0.0008456808,0.00047585805,0.0007460191,0.00063443324],"domain_scores_gemma":[0.99832743,0.0002817005,0.00018397109,0.0008353013,0.00016236515,0.00020922611],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005743314,0.00028459175,0.00084791286,0.00042443105,0.00002629728,0.000009904247,0.00036160322,0.00030457403,0.0034838424],"category_scores_gemma":[0.000076105935,0.00027801073,0.00028957604,0.0008679378,0.00022126258,0.00011604021,0.000064266256,0.00058068486,0.000028677701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041336655,0.00026495822,0.0056925174,0.00067181926,0.00011428044,0.000020517096,0.0016523395,0.00026125944,0.98027277,0.000012619712,0.0016594994,0.005243738],"study_design_scores_gemma":[0.0064092083,0.00053213147,0.020257711,0.00034619076,0.000107649335,0.000035113153,0.00015159263,0.000928076,0.9654398,0.00007235793,0.005493264,0.00022693536],"about_ca_topic_score_codex":0.00199305,"about_ca_topic_score_gemma":0.0001715888,"teacher_disagreement_score":0.014833015,"about_ca_system_score_codex":0.00077817595,"about_ca_system_score_gemma":0.0006920308,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W2332896732","doi":"10.1038/sj.leu.2401633","title":"Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport","year":2000,"lang":"en","type":"article","venue":"Leukemia","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphoblast; Nucleoside; Cytotoxicity; Efflux; Thymidine; Chemistry; Cell culture; In vivo; Biochemistry; Intracellular; Nucleoside analogue; In vitro; Pharmacology; Molecular biology; Biology","score_opus":0.007750756681584007,"score_gpt":0.23506802222329345,"score_spread":0.22731726554170945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332896732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797624,0.0011482551,0.00023073553,0.00001235986,0.000015552037,0.00019980555,0.000056825425,0.000005560829,0.00035466359],"genre_scores_gemma":[0.99855745,0.00023647996,0.00050177146,0.00003787098,0.000055679335,0.000009617081,0.00028765312,0.00001861489,0.00029486595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986953,0.000057360794,0.0005772352,0.00032188886,0.00016657682,0.00018163396],"domain_scores_gemma":[0.9994106,0.0000075563125,0.00022128322,0.00022860864,0.00007233019,0.00005957717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001328539,0.00017945532,0.0003320824,0.00005628422,0.000028290684,0.0000034997445,0.00013375029,0.00018939989,0.000089339475],"category_scores_gemma":[0.000008718577,0.00017534701,0.00007126278,0.00013493928,0.00014513177,0.000020748357,0.000026062447,0.000082593324,3.729752e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032753136,0.00015447782,0.003811438,0.0001046704,0.000030173092,0.0000015987929,0.0003220945,0.00018161794,0.9942468,0.00003171397,0.00058313564,0.00020476201],"study_design_scores_gemma":[0.0015054106,0.0007262203,0.00874324,0.00012878909,0.00002698782,0.0000043070772,0.00009110694,0.00012086173,0.9883446,0.000059662438,0.00008739561,0.00016140961],"about_ca_topic_score_codex":0.0003947829,"about_ca_topic_score_gemma":0.000044625536,"teacher_disagreement_score":0.005902177,"about_ca_system_score_codex":0.000052187264,"about_ca_system_score_gemma":0.00009851338,"threshold_uncertainty_score":0.7150443},"labels":[],"label_agreement":null},{"id":"W2333656541","doi":"10.1038/sj.leu.2402773","title":"Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; University of Calgary","keywords":"Breakpoint; ETV6; Fusion transcript; Biology; Genetics; Chromosomal translocation; Gene rearrangement; Chromosomal rearrangement; Myeloid leukemia; Alu element; Gene duplication; Gene; Chromosome; Cancer research; Karyotype; Genome; Human genome","score_opus":0.021484259173320305,"score_gpt":0.27737966425519384,"score_spread":0.25589540508187353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333656541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922662,0.002326659,0.00003422254,0.0003480028,0.000026653328,0.00046526472,0.000008174549,0.000027024154,0.00449784],"genre_scores_gemma":[0.99754953,0.00059365784,0.0009956601,0.00042121683,0.00004100282,0.00002482916,0.000008951338,0.000034275166,0.0003308782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984963,0.000072519586,0.00032232952,0.0003528712,0.00037508106,0.00038091317],"domain_scores_gemma":[0.9992008,0.000033501787,0.00006281798,0.00046635116,0.000054935033,0.000181545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018691254,0.00017074154,0.0003569637,0.00022322721,0.000027973669,0.000010596965,0.00014209509,0.00013826933,0.00018737193],"category_scores_gemma":[0.00010664798,0.00016142915,0.00007068208,0.00034447672,0.00012299212,0.000048046637,0.00012654398,0.00031068688,0.00006387907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028447516,0.00063626026,0.40595314,0.0007508132,0.00039791886,0.0013606254,0.0020283903,0.00011046524,0.5289088,0.00016364094,0.0047559217,0.05464953],"study_design_scores_gemma":[0.008835658,0.00059409306,0.783032,0.0003031857,0.00010028288,0.00023079035,0.00010060233,0.002618458,0.20125747,0.0001330498,0.0024607203,0.00033371386],"about_ca_topic_score_codex":0.00016485242,"about_ca_topic_score_gemma":0.000019410814,"teacher_disagreement_score":0.37707883,"about_ca_system_score_codex":0.00046257506,"about_ca_system_score_gemma":0.00012106705,"threshold_uncertainty_score":0.658289},"labels":[],"label_agreement":null},{"id":"W2334657738","doi":"10.1038/sj.leu.2403028","title":"Coculture and transplant of purified CD34+Lin− and CD34−Lin− cells reveals functional interaction between repopulating hematopoietic stem cells","year":2003,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Haematopoiesis; CD34; Biology; Stem cell; CD38; Progenitor cell; Transplantation; Immunology; Cord blood; Cell biology; Molecular biology; Cancer research; Internal medicine; Medicine","score_opus":0.02833121761842319,"score_gpt":0.25794301370382267,"score_spread":0.22961179608539947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334657738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441993,0.0003113728,0.002317335,0.00008758341,0.00028101273,0.0005794053,0.000050183346,0.000060047376,0.0018931117],"genre_scores_gemma":[0.9966928,0.0001636903,0.0017931486,0.00009296451,0.00011030347,0.000017589244,0.000076492746,0.00003804913,0.0010150037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787164,0.00014026524,0.00083343574,0.00047188348,0.00039816924,0.00028458686],"domain_scores_gemma":[0.9987704,0.00033696424,0.0003063174,0.0002727072,0.00010893441,0.00020468458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004564628,0.00028104655,0.00061938615,0.00012227288,0.00010690807,0.00002954809,0.00004834408,0.00028751534,0.00008370153],"category_scores_gemma":[0.000020754247,0.00024866164,0.00009905292,0.00018112929,0.00008774588,0.00013491289,0.0000099412255,0.00037194882,0.000014835635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034103153,0.00008947015,0.08683707,0.0046581207,0.00026449977,0.0001364917,0.006519904,0.00013078265,0.8979938,0.0009932505,0.000572332,0.0014632598],"study_design_scores_gemma":[0.0044029774,0.00030251412,0.030000748,0.0023459608,0.0009269442,0.0012521135,0.0022803887,0.00028146236,0.9562886,0.00039992327,0.0010178392,0.0005005349],"about_ca_topic_score_codex":0.0000472519,"about_ca_topic_score_gemma":0.0000068272548,"teacher_disagreement_score":0.058294807,"about_ca_system_score_codex":0.00014857887,"about_ca_system_score_gemma":0.00010557243,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2335560000","doi":"10.1038/sj.leu.2402522","title":"Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide","year":2002,"lang":"en","type":"article","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Cancer Research Society","keywords":"Telomerase; Downregulation and upregulation; Etoposide; DNA damage; Telomere; Telomerase reverse transcriptase; Apoptosis; Biology; Cancer research; Cell cycle; DNA repair; Programmed cell death; Cell cycle checkpoint; Molecular biology; Cell biology; DNA; Chemotherapy; Genetics; Gene","score_opus":0.028847785566358565,"score_gpt":0.27795512840505343,"score_spread":0.24910734283869487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335560000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997081,0.00018937503,0.000011590515,0.00020984923,0.00009993203,0.0005340803,0.000011479166,0.00005793011,0.0018047714],"genre_scores_gemma":[0.9980303,0.0001341932,0.00021946359,0.00015959697,0.00010371729,0.0000109723605,0.000008892388,0.000038965387,0.0012938648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975968,0.0003039571,0.0007966049,0.00045059025,0.00048930093,0.00036275102],"domain_scores_gemma":[0.9981163,0.00032040873,0.0004679689,0.00082444237,0.00012945235,0.00014141235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045262784,0.0002878113,0.00074966025,0.00021016678,0.00010240881,0.000012954395,0.00025340033,0.00017718569,0.00018487562],"category_scores_gemma":[0.00010885143,0.00019959563,0.00020171095,0.00074080715,0.00048100576,0.00017501606,0.000068293535,0.00054190034,0.0000076263254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005706611,0.0004498557,0.52097774,0.0003215611,0.00010250083,0.00009802992,0.0019441574,0.00047976864,0.44881585,0.000039973736,0.0009096154,0.025290256],"study_design_scores_gemma":[0.0028618718,0.00016696236,0.57538104,0.00044881226,0.0000878613,0.000016756176,0.00017127619,0.002105857,0.4183893,0.000017034708,0.00018150872,0.00017172439],"about_ca_topic_score_codex":0.0019269247,"about_ca_topic_score_gemma":0.0003917379,"teacher_disagreement_score":0.05440328,"about_ca_system_score_codex":0.0005163683,"about_ca_system_score_gemma":0.00027078277,"threshold_uncertainty_score":0.81392735},"labels":[],"label_agreement":null},{"id":"W2337104547","doi":"10.1038/leu.2016.80","title":"The role of the RAS pathway in iAMP21-ALL","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek; National Cancer Research Institute; British Heart Foundation; Hospital for Sick Children; Children's Cancer and Leukaemia Group","keywords":"Internal medicine; Cancer research; Medicine; Biology; Psychology","score_opus":0.010731373142791302,"score_gpt":0.25573435807006256,"score_spread":0.24500298492727127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337104547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96466,0.0004999552,0.000054492568,0.0044115316,0.00016620378,0.0004749118,0.000009921939,0.000030231897,0.029692745],"genre_scores_gemma":[0.99295765,0.000082320934,0.000059650745,0.00035328316,0.00012497077,0.000031104017,9.129035e-7,0.000022745076,0.00636734],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849564,0.000101132406,0.0002905606,0.00019687293,0.0005120991,0.00040370715],"domain_scores_gemma":[0.99833393,0.0006853554,0.00008116928,0.0007277375,0.000080975835,0.00009085674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004481701,0.00011777977,0.00019314555,0.000050676208,0.000063281,0.000009874019,0.00041883305,0.00011235487,0.00007943024],"category_scores_gemma":[0.00072524743,0.000044582528,0.000100861325,0.00025852755,0.00029803,0.0000454315,0.00020410035,0.00022366922,0.00013082656],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009901922,0.00012695589,0.091758825,0.000076734585,0.00016805861,0.00009078149,0.0013802116,0.000012087716,0.6338422,0.01919908,0.014522366,0.23783255],"study_design_scores_gemma":[0.010969696,0.0002991934,0.13001227,0.0007009649,0.00004744448,0.00016282819,0.0006871691,0.0011509772,0.36019322,0.0133183235,0.48216435,0.0002935584],"about_ca_topic_score_codex":0.00028601222,"about_ca_topic_score_gemma":0.00013368983,"teacher_disagreement_score":0.46764198,"about_ca_system_score_codex":0.0016939519,"about_ca_system_score_gemma":0.001546915,"threshold_uncertainty_score":0.44296253},"labels":[],"label_agreement":null},{"id":"W2343457318","doi":"10.1038/leu.2015.171","title":"Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children’s Oncology Group","year":2015,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Ethnic group; SNP; Internal medicine; Oncology; Medicine; Clinical Oncology; Association (psychology); Single-nucleotide polymorphism; Genetics; Biology; Genotype; Cancer; Psychology; Gene","score_opus":0.056168856421066636,"score_gpt":0.36833967446116556,"score_spread":0.31217081804009894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343457318","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6685096,0.00089236925,0.00009302239,0.32517582,0.0005598325,0.0023692267,0.00019199181,0.0000976103,0.0021105248],"genre_scores_gemma":[0.3777742,0.0015696358,0.0065171053,0.57049125,0.023253573,0.00055958267,0.011193557,0.0005684922,0.008072571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99417883,0.0010806309,0.0017493798,0.0009445272,0.0014238857,0.0006227631],"domain_scores_gemma":[0.99398255,0.0027363345,0.001619877,0.0011323465,0.0003696825,0.00015922514],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0046154954,0.00044418278,0.0016148763,0.00024598977,0.000057580815,0.000031085412,0.0004049958,0.002845543,0.00005908064],"category_scores_gemma":[0.0041970476,0.0002962968,0.00020482247,0.00048551083,0.0002495268,0.00011509407,0.00025325024,0.0075421273,0.000035354606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025628062,0.00010606144,0.6002093,0.0000535263,0.0006141599,0.001148676,0.0007352721,0.0000024899273,0.00001983161,0.0000041380204,0.39345622,0.0033940745],"study_design_scores_gemma":[0.0064277723,0.00065828423,0.92026997,0.00024415302,0.0005911977,0.00045959614,0.00004936951,0.000068790534,0.0000055772553,0.00019265617,0.070760146,0.00027251925],"about_ca_topic_score_codex":0.0064166053,"about_ca_topic_score_gemma":0.0006172199,"teacher_disagreement_score":0.3226961,"about_ca_system_score_codex":0.0072463164,"about_ca_system_score_gemma":0.0043915734,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W2345645288","doi":"10.1038/leu.2015.233","title":"Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group","year":2015,"lang":"en","type":"review","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Myelofibrosis; Alemtuzumab; Stem cell; Hematopoietic stem cell transplantation; Internal medicine; Cytopenia; Oncology; Immunology; Bone marrow","score_opus":0.03782294263671929,"score_gpt":0.3153776842246661,"score_spread":0.2775547415879468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345645288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04013526,0.9549761,0.00003045538,0.000032156764,0.000103025865,0.0024505078,0.000115875184,0.000029687739,0.0021269643],"genre_scores_gemma":[0.018724993,0.977085,0.0006039014,0.000049392394,0.0000464393,0.000983538,0.0023428998,0.00004125802,0.00012259513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981171,0.00011830652,0.00067975593,0.0004999803,0.00040434982,0.0001804935],"domain_scores_gemma":[0.99909735,0.000064677915,0.00045308948,0.00020071017,0.00006408012,0.00012007958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027228118,0.0003333148,0.00096930354,0.00025242142,0.000027877591,0.000023972974,0.00012337475,0.00023128741,0.000011209163],"category_scores_gemma":[0.000001673946,0.00027562547,0.00008837009,0.00021407616,0.000051297502,0.00005576048,0.000026766862,0.00019746792,0.0000065512163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014932021,0.0003657792,0.0051833834,0.034316566,0.00037634966,0.00011815621,0.000550688,0.0000048333623,0.000012161685,0.000077791214,0.00013730486,0.9587077],"study_design_scores_gemma":[0.023011478,0.002665417,0.042063836,0.18640164,0.013372752,0.00083137664,0.001345784,0.00022562483,0.00088835246,0.00015844045,0.7265682,0.0024671066],"about_ca_topic_score_codex":0.000020741796,"about_ca_topic_score_gemma":0.00001316665,"teacher_disagreement_score":0.95624053,"about_ca_system_score_codex":0.0009567175,"about_ca_system_score_gemma":0.0003180229,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W2398639705","doi":"10.1038/leu.2011.256","title":"Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Takeda Oncology; Koninklijke Nederlandse Akademie van Wetenschappen","keywords":"Bortezomib; Proteasome; Protein subunit; Proteasome inhibitor; Mutant; Cancer research; Multiple myeloma; Biology; Cell biology; Biochemistry; Immunology; Gene","score_opus":0.04165090137066048,"score_gpt":0.2578321363683535,"score_spread":0.21618123499769304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398639705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945463,0.00024517882,0.0004221235,0.00026484288,0.00019183305,0.0018329644,0.00016842876,0.000017043149,0.0023113107],"genre_scores_gemma":[0.99548745,0.000037647726,0.0017602603,0.0007665761,0.00009728646,0.00039160062,0.000013574764,0.000050929182,0.0013946899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819005,0.00013226486,0.00046102045,0.00048534636,0.0002153224,0.00051601784],"domain_scores_gemma":[0.9986114,0.000060266808,0.0002379447,0.000881481,0.000105982486,0.00010290866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006443734,0.00026851724,0.00027194366,0.00007429234,0.0002118969,0.000028790193,0.00076385355,0.00023091258,0.000040853225],"category_scores_gemma":[0.00018400942,0.00018444433,0.0002290306,0.00036817495,0.00012854235,0.000009727703,0.0002195468,0.00021746215,0.000010135934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039130138,0.000030039828,0.0017177453,0.000116352174,0.000055052387,0.0000030917681,0.0020602897,0.000023747069,0.99293065,0.00041882804,0.0015100676,0.00074286317],"study_design_scores_gemma":[0.0007308595,0.00016499133,0.005578025,0.00016363725,0.000030723382,0.000004172337,0.00046981973,0.00007039838,0.9807425,0.0006075246,0.0111614,0.0002759581],"about_ca_topic_score_codex":0.0002910901,"about_ca_topic_score_gemma":0.00067274546,"teacher_disagreement_score":0.01218813,"about_ca_system_score_codex":0.0003014429,"about_ca_system_score_gemma":0.00063999253,"threshold_uncertainty_score":0.75214213},"labels":[],"label_agreement":null},{"id":"W2400101856","doi":"10.1038/leu.2016.145","title":"KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"William Lawrence and Blanche Hughes Foundation; Fondation Tuck; Leukemia and Lymphoma Society","keywords":"Tolerability; Myeloid leukemia; Medicine; Haematopoiesis; Leukemia; Progenitor cell; Cancer research; Internal medicine; Pharmacology; Oncology; Immunology; Stem cell; Biology; Adverse effect","score_opus":0.016177063618313624,"score_gpt":0.2453413937067642,"score_spread":0.22916433008845058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400101856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929028,0.00013439707,0.00002543609,0.00061989826,0.00016639993,0.00069256144,0.00017808613,0.00011849937,0.0051618805],"genre_scores_gemma":[0.9940821,0.00044736554,0.00070159923,0.0015407691,0.0005320039,0.000030186331,0.00008283137,0.00010949733,0.002473646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710643,0.00014625267,0.0007298799,0.0007679472,0.0006225972,0.00062690134],"domain_scores_gemma":[0.99799156,0.00036548448,0.00035794266,0.00047437177,0.0003474636,0.00046318147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037421467,0.0004168375,0.00069393247,0.00024592265,0.00017244807,0.00005911594,0.00014687769,0.0004327021,0.000577414],"category_scores_gemma":[0.0002911846,0.0003223158,0.0000941732,0.00035705598,0.00037830998,0.00036735393,0.0002189502,0.000532824,0.00013658444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000493177,0.00004082786,0.0009177369,0.00016587191,0.00014465932,0.00012683164,0.0015401356,0.000002365681,0.9628377,0.00002778519,0.021968948,0.011733979],"study_design_scores_gemma":[0.009500542,0.0007523182,0.008294568,0.0005472623,0.000104271334,0.000087552355,0.0006952386,0.005871175,0.96131456,0.000019796034,0.012296121,0.0005166121],"about_ca_topic_score_codex":0.000106161235,"about_ca_topic_score_gemma":0.00005804513,"teacher_disagreement_score":0.011217367,"about_ca_system_score_codex":0.0018099826,"about_ca_system_score_gemma":0.0010379704,"threshold_uncertainty_score":0.9999229},"labels":[],"label_agreement":null},{"id":"W2400297147","doi":"10.1038/leu.2016.152","title":"Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; European Hematology Association","keywords":"Immune system; Toll-like receptor; Malignancy; Ligand (biochemistry); Receptor; Cancer research; Immune receptor; Immunology; Biology; Innate immune system; Genetics","score_opus":0.011096234771815709,"score_gpt":0.23870091101783047,"score_spread":0.22760467624601477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400297147","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66980326,0.030849218,0.00020868522,0.19002011,0.069874585,0.0045799455,0.0009708798,0.0011855788,0.032507733],"genre_scores_gemma":[0.107911095,0.0013717145,0.00007339344,0.08240501,0.0016093918,0.00040568202,0.008805599,0.00027911505,0.797139],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702793,0.0006225709,0.00093756197,0.0006698674,0.00013182119,0.00061026565],"domain_scores_gemma":[0.99777734,0.0002912923,0.0009973674,0.00069238804,0.00021973348,0.000021879316],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002908226,0.00054556463,0.0007272441,0.00031555607,0.00019383118,0.000029015744,0.00029975118,0.0024781574,0.0026991987],"category_scores_gemma":[0.00008549576,0.00042904436,0.00035371844,0.0001478222,0.00016790412,0.00023532147,0.0001228984,0.0017967502,0.0033643395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005522382,0.000037913298,0.0000070952374,0.00009924424,0.00006395114,0.000006950985,0.00007559591,1.47570365e-8,0.49795964,0.0000016471041,0.49864736,0.0025483454],"study_design_scores_gemma":[0.0011351337,0.00037528653,0.0000089449695,0.00069921045,0.000045850258,0.000029126466,0.000020592866,1.4634901e-7,0.49934328,0.0000057224597,0.49807817,0.00025853975],"about_ca_topic_score_codex":0.00006196169,"about_ca_topic_score_gemma":8.5229345e-7,"teacher_disagreement_score":0.7646313,"about_ca_system_score_codex":0.0005090015,"about_ca_system_score_gemma":0.00031888852,"threshold_uncertainty_score":0.9998161},"labels":[],"label_agreement":null},{"id":"W2461798448","doi":"10.1038/leu.2016.175","title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Center for Research Resources; National Institute of General Medical Sciences; Lymphoma Research Foundation","keywords":"Biology; Follicular lymphoma; Gene; Transcription factor; Cancer research; Genetics; Epigenetics; PTEN; Lymphoma; Signal transduction; PI3K/AKT/mTOR pathway; Immunology","score_opus":0.009936883995875695,"score_gpt":0.23402337441748855,"score_spread":0.22408649042161286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461798448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983645,0.00005889086,0.00045739656,0.00016981343,0.000018189652,0.00023624378,0.00003217606,0.000035411693,0.0006273808],"genre_scores_gemma":[0.999448,0.000079608064,0.00007852942,0.00005137602,0.000008085217,0.00003818671,0.00014048147,0.000009596779,0.00014612869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.00003481537,0.0002424483,0.00015388991,0.00024322026,0.00012175365],"domain_scores_gemma":[0.99943644,0.000102558355,0.00013475752,0.00014438936,0.00011645474,0.00006542693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001047167,0.00011377498,0.00032302737,0.00009099526,0.000043971657,0.000012647758,0.000025757112,0.00007377355,0.000061993785],"category_scores_gemma":[0.000032402033,0.0000663178,0.00011644792,0.00032680566,0.000053987416,0.00012763125,0.000005892822,0.000013818787,0.000013569912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058177824,0.00050266384,0.9511878,0.00008008679,0.005605807,0.00013133195,0.0019131518,0.00002118389,0.011428777,0.0011419449,0.00018444545,0.027221022],"study_design_scores_gemma":[0.011438427,0.00032042645,0.87204754,0.00016896662,0.0028719294,0.000019116223,0.00012820226,0.00028131893,0.112385884,0.00019752422,0.000034158773,0.00010653115],"about_ca_topic_score_codex":0.00018145738,"about_ca_topic_score_gemma":0.00008121444,"teacher_disagreement_score":0.1009571,"about_ca_system_score_codex":0.00051961216,"about_ca_system_score_gemma":0.0001251111,"threshold_uncertainty_score":0.27043614},"labels":[],"label_agreement":null},{"id":"W2514334447","doi":"10.1038/leu.2016.244","title":"Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institute of General Medical Sciences; Wellcome Trust","keywords":"Phosphorylation; Sphingosine; Cancer research; Kinase; Receptor; Pharmacology; Cytotoxicity; Leukemia; Sphingosine-1-phosphate; In vivo; Chemistry; Biochemistry; Biology; Cell biology; In vitro; Immunology; Genetics","score_opus":0.011115380720965752,"score_gpt":0.24759333943522122,"score_spread":0.23647795871425548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514334447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888737,0.0000901025,0.010102622,0.00007110852,0.00020566337,0.00016287541,0.000018278457,0.000024285817,0.00043767138],"genre_scores_gemma":[0.9982562,0.00017061217,0.00087343634,0.00007314125,0.00032495437,0.000014819624,0.000038618808,0.00002267188,0.00022555525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886286,0.00007682733,0.00026763618,0.000380339,0.0001702994,0.00024206466],"domain_scores_gemma":[0.99920094,0.000045314187,0.000283307,0.0003014174,0.000100933066,0.00006807375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026622223,0.000179077,0.00025497892,0.000072683404,0.0000751735,0.000014665308,0.00015498577,0.00021099733,0.00005665081],"category_scores_gemma":[0.00026718088,0.0001398302,0.00009362044,0.00014601002,0.00012403364,0.000026314437,0.000051639527,0.00009216711,0.0000086476675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013173936,0.000017810886,0.005361959,0.000018359246,0.00004341446,1.5054265e-7,0.000087118504,0.00003281668,0.98106927,0.000058830563,0.00015695422,0.013021571],"study_design_scores_gemma":[0.0010540681,0.00006984882,0.014751614,0.00009416386,0.000020486585,0.0000020559708,0.000039456627,0.00008354284,0.98236984,0.000046843783,0.0012758435,0.00019225445],"about_ca_topic_score_codex":0.00011864215,"about_ca_topic_score_gemma":0.000008852713,"teacher_disagreement_score":0.012829317,"about_ca_system_score_codex":0.00009281575,"about_ca_system_score_gemma":0.00029910504,"threshold_uncertainty_score":0.570211},"labels":[],"label_agreement":null},{"id":"W2530614832","doi":"10.1038/leu.2016.275","title":"Isocitrate dehydrogenase mutations in myeloid malignancies","year":2016,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Celgene","keywords":"IDH2; Isocitrate dehydrogenase; Biology; Myeloid leukemia; IDH1; Myeloid; Cancer research; Myelodysplastic syndromes; Epigenetics; Histone; Mutation; Genetics; Gene; Biochemistry; Enzyme; Immunology","score_opus":0.04582845719732767,"score_gpt":0.35164557350211884,"score_spread":0.30581711630479114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530614832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047496994,0.98958987,0.00003840054,0.0001946132,0.00016120767,0.001741336,0.00016537706,0.00015470236,0.007479501],"genre_scores_gemma":[0.000071037684,0.9827378,0.0004905657,0.00024250954,0.0004860297,0.000619101,0.00037866028,0.00019091771,0.014783386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962277,0.00027235117,0.0010882698,0.0008354521,0.00057752477,0.0009987231],"domain_scores_gemma":[0.9976674,0.00051374384,0.0003083895,0.0009770433,0.00014413556,0.00038930099],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056110637,0.00068717013,0.0023904738,0.0008633948,0.0001011227,0.000050833485,0.00048183464,0.00083358184,0.00062493613],"category_scores_gemma":[0.00045482806,0.0004787372,0.0007410391,0.0011354386,0.00028199516,0.000142237,0.0001939504,0.0013368288,0.003916742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000030411087,0.00005277294,0.000032585176,0.015816154,0.00030160448,0.0019824249,0.00013971631,0.0000015442548,0.000065239336,0.0005729954,0.0065978616,0.9744067],"study_design_scores_gemma":[0.0012576137,0.000078457444,0.000024998948,0.02563838,0.00043058762,0.0006020453,0.00003196555,0.000019944038,0.000054229095,0.0001422718,0.97122234,0.00049715204],"about_ca_topic_score_codex":0.000123688,"about_ca_topic_score_gemma":0.00004210253,"teacher_disagreement_score":0.97390956,"about_ca_system_score_codex":0.0073331,"about_ca_system_score_gemma":0.0087438105,"threshold_uncertainty_score":0.9997664},"labels":[],"label_agreement":null},{"id":"W2544886025","doi":"10.1038/leu.2016.302","title":"Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Cancer research; Biology; Haematopoiesis; Myeloid; Progenitor cell; Receptor tyrosine kinase; Stem cell; Leukemia; Hematopoietic stem cell; Immunology; Receptor; Genetics","score_opus":0.02650162313280356,"score_gpt":0.28890859544666486,"score_spread":0.2624069723138613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544886025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96675587,0.0009248401,0.022719089,0.003138597,0.00034649135,0.0011834112,0.00017992238,0.0006462699,0.004105505],"genre_scores_gemma":[0.9828711,0.00042047646,0.0032303687,0.0022048543,0.0011064156,0.00011891341,0.000416427,0.00028275582,0.009348668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99407953,0.0003238199,0.001169949,0.0014703188,0.0013203985,0.0016360087],"domain_scores_gemma":[0.9967356,0.000196502,0.00021940439,0.0016215596,0.0004168093,0.00081016583],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00066866324,0.0008153347,0.001208877,0.00046619485,0.0004384939,0.00013643337,0.00088974205,0.00082158623,0.0022401921],"category_scores_gemma":[0.00015508734,0.0006012067,0.0005157458,0.00067666447,0.00038846067,0.0004995602,0.00021996499,0.0011904078,0.0012191425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014994091,0.00010846311,0.00059879705,0.00006629696,0.0009605288,0.0010610593,0.0006026117,0.0006747613,0.97841537,0.00021845364,0.003296886,0.0124973785],"study_design_scores_gemma":[0.06639974,0.00558285,0.008308877,0.0035543686,0.0045976066,0.00196056,0.0012564991,0.18942933,0.6398157,0.052977603,0.02013392,0.0059829806],"about_ca_topic_score_codex":0.003835091,"about_ca_topic_score_gemma":0.00010067857,"teacher_disagreement_score":0.33859968,"about_ca_system_score_codex":0.006923323,"about_ca_system_score_gemma":0.0023101522,"threshold_uncertainty_score":0.9996439},"labels":[],"label_agreement":null},{"id":"W2554059528","doi":"10.1038/leu.2016.325","title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Chinese Academy of Medical Sciences; Chinese Academy of Sciences; Academy of Medical Sciences","keywords":"Cancer research; Bortezomib; microRNA; Gene silencing; Epigenetics; Chromosome instability; Biology; Ectopic expression; Multiple myeloma; DNA methylation; Transfection; Cell culture; Apoptosis; Gene expression; Immunology; Chromosome; Gene; Genetics","score_opus":0.016305459054739496,"score_gpt":0.2615476411607951,"score_spread":0.2452421821060556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554059528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966504,0.0018533512,0.000021604666,0.00031952068,0.00003422298,0.00045902305,0.0000429208,0.000029719617,0.0005892211],"genre_scores_gemma":[0.9976312,0.00017160778,0.001420326,0.000025536605,0.000039248676,0.00004399895,0.000017572846,0.00002158799,0.00062891404],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825054,0.00011602266,0.00041516378,0.00042520507,0.00034440847,0.0004486595],"domain_scores_gemma":[0.9988202,0.00046768374,0.00010968804,0.00030532372,0.00007813028,0.00021900954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033201,0.00018301909,0.00037482567,0.000104181614,0.0000700895,0.000009762393,0.00010413148,0.0000969228,0.00007510284],"category_scores_gemma":[0.0009867081,0.00012709635,0.00005164367,0.00019965904,0.00021796412,0.0001229435,0.000085189255,0.00016366718,0.000010993274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038645745,0.000098748445,0.41365483,0.00023162237,0.00003360318,0.000070158094,0.0006805561,5.040437e-7,0.57256365,0.000009422631,0.00030523704,0.011965211],"study_design_scores_gemma":[0.0053684646,0.00009814989,0.55947524,0.0005365598,0.000014982966,0.0000057926745,0.00024279134,0.00013869665,0.4334913,0.0000932825,0.00038466655,0.00015006127],"about_ca_topic_score_codex":0.0006529786,"about_ca_topic_score_gemma":0.00056357577,"teacher_disagreement_score":0.14582042,"about_ca_system_score_codex":0.0005937967,"about_ca_system_score_gemma":0.0002652599,"threshold_uncertainty_score":0.51828384},"labels":[],"label_agreement":null},{"id":"W2558012555","doi":"10.1038/leu.2016.366","title":"Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma","year":2016,"lang":"en","type":"article","venue":"Leukemia","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Boréal","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Genetic heterogeneity; Cancer research; Biopsy; Tumour heterogeneity; Multiple myeloma; Liquid biopsy; Bone marrow; Digital polymerase chain reaction; Mutation; Biology; Pathology; Medicine; Internal medicine; Oncology; Cancer; Polymerase chain reaction; Gene; Genetics; Phenotype","score_opus":0.009532461115117703,"score_gpt":0.23078557925056492,"score_spread":0.2212531181354472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558012555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922281,0.00020386721,0.007065892,0.000119182165,0.00003652872,0.00009722478,0.0001158931,0.0000084281555,0.00012488534],"genre_scores_gemma":[0.9989931,0.00004603441,0.00045222678,0.00014307753,0.0001242295,0.000023916971,0.00015059269,0.000016667625,0.00005016157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990935,0.000034670218,0.00017328013,0.00035197867,0.00013389379,0.00021271722],"domain_scores_gemma":[0.9994492,0.000054593314,0.0000934215,0.00022683747,0.000049005925,0.00012694664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089313755,0.00014264794,0.00014809087,0.00007187862,0.000056164103,0.000028138782,0.0001065761,0.00006884026,0.000023390405],"category_scores_gemma":[0.000103637176,0.0001074094,0.00009730556,0.0001363467,0.00008077086,0.0000058741434,0.00005483537,0.00004496525,0.000005164926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021546573,0.000027795682,0.8342395,0.000011565621,0.0001816198,0.00013823804,0.000020478077,0.0048306943,0.15690315,0.00008038867,0.000053074375,0.00329802],"study_design_scores_gemma":[0.00094211136,0.00007288778,0.8912202,0.00002973368,0.00013791224,0.000018286095,0.000022632048,0.0010546416,0.105845265,0.00017886338,0.0002230026,0.00025444097],"about_ca_topic_score_codex":0.00023149788,"about_ca_topic_score_gemma":0.0035195083,"teacher_disagreement_score":0.056980707,"about_ca_system_score_codex":0.0001321264,"about_ca_system_score_gemma":0.00035480608,"threshold_uncertainty_score":0.43800282},"labels":[],"label_agreement":null},{"id":"W2558303915","doi":"10.1038/leu.2016.336","title":"Cardiologist’s perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia","year":2016,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hôpital du Saint-Sacrement; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal; Montreal Heart Institute; Jewish General Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Chronic myeloid leukaemia; Myeloid leukaemia; Perspective (graphical); Adverse effect; Myeloid; Internal medicine; Intensive care medicine; Oncology","score_opus":0.02773850650527052,"score_gpt":0.2892765878858304,"score_spread":0.26153808138055984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558303915","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036326453,0.01169172,0.0017699947,0.88361317,0.0020124742,0.027123213,0.003710891,0.00019537898,0.033556685],"genre_scores_gemma":[0.6127433,0.029899983,0.008656123,0.18492186,0.017007755,0.009361745,0.0027770435,0.0011235568,0.1335086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969036,0.0003834848,0.0008255637,0.0008607447,0.00036467245,0.00066192937],"domain_scores_gemma":[0.9969499,0.0007619582,0.00051958056,0.0015099279,0.00016972641,0.00008888615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065650913,0.00061232946,0.0010052457,0.0002705571,0.00014725733,0.00000563535,0.000542339,0.00031434835,0.00005073588],"category_scores_gemma":[0.00008789156,0.00033134606,0.00040145862,0.00029325523,0.00028377355,0.00005803542,0.0002599115,0.0006739191,0.000043724758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081542606,0.000098913646,0.0027157029,0.0017978282,0.005990619,0.00040783358,0.004093685,0.0013484132,0.000364916,0.00043733924,0.9112312,0.07069811],"study_design_scores_gemma":[0.009107799,0.0012487927,0.015518912,0.0017019559,0.0014787241,0.000067189496,0.0008216095,0.00010826036,0.00032841455,0.00018360716,0.9690278,0.0004069437],"about_ca_topic_score_codex":0.0019307169,"about_ca_topic_score_gemma":0.0004189005,"teacher_disagreement_score":0.6986913,"about_ca_system_score_codex":0.032414593,"about_ca_system_score_gemma":0.0017475646,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W2568151229","doi":"10.1038/leu.2016.395","title":"PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; Sunnybrook Hospital","funders":"Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; Peroxisome proliferator-activated receptor delta; Cancer research; CD5; Biology; Peroxisome proliferator-activated receptor; Haematopoiesis; Nuclear receptor; Cancer cell; Hematology; Stem cell; Immunology; Leukemia; Receptor; Internal medicine; Cancer; Lymphoma; Cell biology; Medicine; Transcription factor; Biochemistry; Genetics","score_opus":0.011485521863010014,"score_gpt":0.2593321655696836,"score_spread":0.24784664370667356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568151229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778472,0.016534423,0.00010445314,0.000012450948,0.0005340673,0.00019217914,0.00011099443,0.000013714354,0.0046505146],"genre_scores_gemma":[0.9904999,0.0076121143,0.00015882685,0.00009506969,0.00039796688,0.000047183126,0.0001306548,0.0000343179,0.0010239313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985212,0.00007138021,0.00035479834,0.00042540228,0.00018946022,0.00043775863],"domain_scores_gemma":[0.99860466,0.000021268073,0.00021375858,0.0009427477,0.00010050446,0.00011706928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002633048,0.00021431706,0.00034586524,0.00005228963,0.00014911195,0.000051800915,0.00055562996,0.00024591177,0.00014533442],"category_scores_gemma":[0.00013125001,0.00021285043,0.00012210393,0.00006597253,0.00029367005,0.000013410583,0.00017221316,0.00012585922,0.000027696902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007994012,0.00005553935,0.0017948357,0.0001970841,0.000107313186,0.000013632676,0.00006243385,0.003639957,0.9755079,0.0017252337,0.0043452615,0.012470869],"study_design_scores_gemma":[0.0021242027,0.00018468652,0.0028427118,0.00008229192,0.000047234458,0.0000028765112,0.000026239708,0.0019275799,0.92434645,0.0006517955,0.067416154,0.00034779805],"about_ca_topic_score_codex":0.00080579205,"about_ca_topic_score_gemma":0.0008458599,"teacher_disagreement_score":0.06307089,"about_ca_system_score_codex":0.00095376984,"about_ca_system_score_gemma":0.003310203,"threshold_uncertainty_score":0.8679789},"labels":[],"label_agreement":null},{"id":"W2575321765","doi":"10.1038/leu.2017.17","title":"The clonal origins of leukemic progression of myelodysplasia","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Exome sequencing; Genetics; Mutation; Exome; Myeloid leukemia; Somatic evolution in cancer; Myelodysplastic syndromes; Somatic cell; Germline mutation; DNA methylation; Gene; Myeloid; Leukemia; Cancer research; Immunology; Bone marrow; Gene expression","score_opus":0.023828967406149936,"score_gpt":0.3466196165419312,"score_spread":0.32279064913578126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575321765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820157,0.00035124327,0.000045789555,0.0012343882,0.0002173027,0.0004988052,0.000015368856,0.000032370324,0.015589008],"genre_scores_gemma":[0.99513274,0.0003474866,0.0012444488,0.000049821047,0.00024693873,0.00002948147,0.000013044077,0.0000342091,0.0029018412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979794,0.000057003585,0.00048292187,0.0002777693,0.0007661189,0.0004367626],"domain_scores_gemma":[0.9972644,0.00023736192,0.0004921017,0.001521351,0.00031679883,0.00016798856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065153994,0.00018299754,0.00042494936,0.000091750895,0.00044702363,0.00003931899,0.00080840423,0.00018264835,0.000064949374],"category_scores_gemma":[0.0007525092,0.00011257149,0.00017407075,0.00012277516,0.0009877918,0.00012972772,0.00031029672,0.00053382514,0.000051401257],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040822537,0.00022895353,0.16969134,0.0010085292,0.0005951176,0.00027846548,0.0007544914,0.000024151046,0.5035532,0.042487074,0.027242677,0.25005373],"study_design_scores_gemma":[0.007389062,0.0011633688,0.47929418,0.0009935042,0.00020081566,0.00028058907,0.00024750925,0.0032651157,0.388513,0.0011222186,0.1171923,0.0003383566],"about_ca_topic_score_codex":0.00045857724,"about_ca_topic_score_gemma":0.000029018727,"teacher_disagreement_score":0.30960283,"about_ca_system_score_codex":0.0016295305,"about_ca_system_score_gemma":0.0023473368,"threshold_uncertainty_score":0.45905322},"labels":[],"label_agreement":null},{"id":"W2582892663","doi":"10.1038/leu.2017.30","title":"Biological and clinical consequences of NPM1 mutations in AML","year":2017,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"NPM1; Myeloid leukemia; Haematopoiesis; Mutation; Leukemia; Myeloid; Cancer research; Bone marrow; Gene mutation; Biology; Gene; Medicine; Stem cell; Immunology; Genetics; Karyotype","score_opus":0.2722373400079822,"score_gpt":0.4954348384625376,"score_spread":0.2231974984545554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582892663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003441639,0.9914052,0.0000041225862,0.00013907603,0.00011169642,0.0009529594,0.000058157962,0.000017753471,0.0038694104],"genre_scores_gemma":[0.0011514304,0.996933,0.0007073065,0.000042769607,0.00019177972,0.000055748944,0.00014347026,0.000025252146,0.00074923254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973897,0.00038886748,0.0011488328,0.0005174517,0.00022992128,0.0003252558],"domain_scores_gemma":[0.9972091,0.00135432,0.0004960977,0.0006461107,0.00009069253,0.00020368675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011471224,0.00028361953,0.0024961245,0.0002897927,0.00006063911,0.0000234403,0.00035694166,0.0008453494,0.00012852393],"category_scores_gemma":[0.0029264393,0.00018904192,0.00037751114,0.00019567103,0.0019286879,0.000047086072,0.00020938853,0.0013192804,0.000099077246],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003012274,0.000041832383,0.0024774428,0.0040661213,0.00015829476,0.00042194006,0.000024979836,4.7250843e-8,0.0000029601383,0.00018517092,0.00054697145,0.9920441],"study_design_scores_gemma":[0.0011680924,0.00035495157,0.0029677139,0.010723337,0.00045989096,0.00047757238,0.000029617531,0.000013410498,0.000003275243,0.0002450622,0.98332775,0.00022934284],"about_ca_topic_score_codex":0.00018569423,"about_ca_topic_score_gemma":0.00003053343,"teacher_disagreement_score":0.9918148,"about_ca_system_score_codex":0.00064258784,"about_ca_system_score_gemma":0.0044846814,"threshold_uncertainty_score":0.7955632},"labels":[],"label_agreement":null},{"id":"W2584583937","doi":"10.1038/leu.2017.47","title":"Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Saint John Regional Hospital","funders":"Università degli Studi di Brescia","keywords":"Chlorambucil; Lenalidomide; Chronic lymphocytic leukemia; Internal medicine; Medicine; Randomized controlled trial; Oncology; Hematology; Fludarabine; Leukemia; Chemotherapy; Cyclophosphamide; Multiple myeloma","score_opus":0.05146143683170001,"score_gpt":0.36742473943474935,"score_spread":0.31596330260304933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584583937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996145,0.00049155916,0.00014609395,0.00020426414,0.0007823821,0.017521722,0.000025938425,0.00009377035,0.0007727977],"genre_scores_gemma":[0.99398583,0.0003567435,0.00008717787,0.00014732426,0.0008865871,0.0022942815,0.00009115329,0.00014931525,0.0020015996],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950157,0.00026802393,0.0011917074,0.00093923206,0.0016113749,0.0009739988],"domain_scores_gemma":[0.9925071,0.0023573376,0.0010350775,0.0030171187,0.0007448679,0.00033852295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019055245,0.00065183506,0.002011793,0.00020768614,0.0008697079,0.00019250195,0.001163639,0.00026884797,0.00025561254],"category_scores_gemma":[0.0023680613,0.00038261904,0.0005396043,0.00028073238,0.0009381777,0.0002927482,0.00022169862,0.00044944606,0.000070070644],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9847583,0.0009571825,0.00010910684,0.00025043133,0.0017659741,0.0000686971,0.0011822202,0.00075824343,0.00003287152,0.000097336386,0.00079288404,0.009226722],"study_design_scores_gemma":[0.95760316,0.014905815,0.00021634832,0.0002933359,0.00092211546,0.000015652837,0.00016993498,0.019907534,0.0018908298,0.00007196812,0.003594739,0.0004085556],"about_ca_topic_score_codex":0.008687309,"about_ca_topic_score_gemma":0.0005304052,"teacher_disagreement_score":0.036495656,"about_ca_system_score_codex":0.08449256,"about_ca_system_score_gemma":0.047996905,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W2592973432","doi":"10.1038/leu.2017.81","title":"High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"mTORC1; Pentose phosphate pathway; Myeloid leukemia; Glycolysis; Cancer research; Biology; Leukemia; Myeloid; Pharmacology; Biochemistry; Signal transduction; Metabolism; PI3K/AKT/mTOR pathway; Immunology","score_opus":0.012914908594169449,"score_gpt":0.27787442286273506,"score_spread":0.2649595142685656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592973432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420846,0.0000329154,0.00080333574,0.0020018057,0.00026952097,0.0010391612,0.00009172948,0.00014923299,0.001403842],"genre_scores_gemma":[0.99464095,0.000314437,0.0016087643,0.0005905221,0.0004924282,0.00010094067,0.000059467693,0.00007319573,0.0021193041],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99687594,0.00022904889,0.00040403384,0.000987621,0.00068531296,0.00081806554],"domain_scores_gemma":[0.99746996,0.0002235616,0.000253415,0.0012936348,0.00018895588,0.0005704688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008584518,0.00044284711,0.0008070565,0.00052246294,0.00057607313,0.00023656603,0.00014049036,0.00045618525,0.000087953835],"category_scores_gemma":[0.00042218348,0.000437388,0.00015018722,0.0003732308,0.00033882697,0.0007774657,0.000532637,0.0010770856,0.00023520233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016983852,0.00008725324,0.005805541,0.00008205255,0.00021197497,0.0021559265,0.000580419,0.0002361491,0.9368193,0.00011727005,0.0060532927,0.04615245],"study_design_scores_gemma":[0.0049934573,0.00042577344,0.50310874,0.0003201259,0.00022681203,0.00029898103,0.000087815664,0.0045680306,0.48329645,0.00010360705,0.002049593,0.0005205771],"about_ca_topic_score_codex":0.0064808745,"about_ca_topic_score_gemma":0.0014547654,"teacher_disagreement_score":0.49730322,"about_ca_system_score_codex":0.0062737972,"about_ca_system_score_gemma":0.0010570972,"threshold_uncertainty_score":0.9998078},"labels":[],"label_agreement":null},{"id":"W2594720997","doi":"10.1038/leu.2017.74","title":"HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Fondation ARC pour la Recherche sur le Cancer; Achievement Rewards for College Scientists Foundation","keywords":"Suppressor; Cell biology; Biology; Cell growth; Gene isoform; Transcription factor; Translation (biology); Messenger RNA; Cancer research; Molecular biology; Gene; Genetics","score_opus":0.007765462628590564,"score_gpt":0.21438481507017448,"score_spread":0.20661935244158391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594720997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973634,0.0004695066,0.000028897442,0.00015840428,0.00030937037,0.0005698221,0.0005737603,0.000027733035,0.0004991218],"genre_scores_gemma":[0.99867946,0.000017618362,0.00013585284,0.000046516245,0.000034662065,0.00006299813,0.00017072717,0.000020558713,0.00083160476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985961,0.00012919371,0.00047555732,0.00037664414,0.00007099098,0.00035155757],"domain_scores_gemma":[0.99901,0.00007667788,0.00038838884,0.00043173946,0.000060924594,0.000032260905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013228202,0.00022453784,0.00049232756,0.000110179164,0.00016291253,0.000013247536,0.00033760254,0.0002841807,0.00014950811],"category_scores_gemma":[0.00014015961,0.00018050772,0.00008366666,0.00006461949,0.00033110884,0.00013958038,0.00030951694,0.0003179199,0.00013533905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041447292,0.00011952695,0.005102665,0.000075762,0.000041287618,0.00000894496,0.0009960347,0.0000013612168,0.98905385,0.000021188318,0.0040471125,0.00011780691],"study_design_scores_gemma":[0.0023474728,0.0002016967,0.025292462,0.0004148322,0.000018859972,0.0000011202279,0.00007843285,0.0000018053076,0.9705282,0.00026510592,0.00065862905,0.00019141764],"about_ca_topic_score_codex":0.003963068,"about_ca_topic_score_gemma":0.00018254288,"teacher_disagreement_score":0.020189796,"about_ca_system_score_codex":0.00013252093,"about_ca_system_score_gemma":0.000102770886,"threshold_uncertainty_score":0.7360891},"labels":[],"label_agreement":null},{"id":"W2594926959","doi":"10.1038/leu.2017.80","title":"Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; European Hematology Association","keywords":"PTEN; PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Leukemia; Biology; microRNA; Apoptosis; Cell growth; Suppressor; Signal transduction; Cell biology; Immunology; Gene; Genetics","score_opus":0.021409491153115686,"score_gpt":0.30043500509929805,"score_spread":0.27902551394618236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594926959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9005266,0.00031906855,0.08776176,0.0009814632,0.00057227595,0.0028059722,0.00028521678,0.00017105664,0.006576601],"genre_scores_gemma":[0.96797734,0.000031206146,0.027339365,0.0003349084,0.00043544805,0.00030644998,0.000101517406,0.00014731413,0.003326454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952741,0.000082957995,0.0012023556,0.0010053285,0.0010972121,0.0013379907],"domain_scores_gemma":[0.9956939,0.0011067119,0.00051980757,0.0015283299,0.0006680245,0.0004832013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012529589,0.0005385219,0.0012445141,0.00045802508,0.00046517365,0.00015150286,0.00080086925,0.0006875037,0.00016448088],"category_scores_gemma":[0.0029295408,0.00051666354,0.00035101396,0.00031711438,0.00042347002,0.00054685137,0.00038664177,0.00058114156,0.00007399609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001537228,0.0002572092,0.00077738514,0.0009109112,0.00014092473,0.000105560044,0.000414172,0.0005410417,0.98399,0.009466389,0.0013927303,0.0004664598],"study_design_scores_gemma":[0.03610081,0.0015879488,0.009969437,0.0021394703,0.0010423196,0.0004181901,0.0004376921,0.34632885,0.5633561,0.036536645,0.00090818305,0.0011743688],"about_ca_topic_score_codex":0.0008379791,"about_ca_topic_score_gemma":0.000040919924,"teacher_disagreement_score":0.4206339,"about_ca_system_score_codex":0.005862923,"about_ca_system_score_gemma":0.0039021461,"threshold_uncertainty_score":0.9997285},"labels":[],"label_agreement":null},{"id":"W2605270513","doi":"10.1038/leu.2017.111","title":"Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Alberta Cancer Foundation; University of Calgary","funders":"Celgene","keywords":"Medicine; Lenalidomide; Thalidomide; Internal medicine; Multiple myeloma; Melphalan; Randomized controlled trial; Dexamethasone; Gastroenterology; Prednisone; Surgery","score_opus":0.03900635522089815,"score_gpt":0.31998645323623537,"score_spread":0.2809800980153372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605270513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900355,0.00012850511,0.00007679013,0.001238716,0.000069603564,0.00704087,0.000048036512,0.000017079052,0.0013449389],"genre_scores_gemma":[0.9953291,0.00010275643,0.0011502136,0.00006372798,0.00013356036,0.0018437371,0.000062536375,0.000024784174,0.0012896127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854505,0.00009920321,0.00035356107,0.00028573233,0.00034388984,0.0003725591],"domain_scores_gemma":[0.99622804,0.0025011848,0.00024208106,0.0008237813,0.000090542875,0.00011436787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054611143,0.00021373923,0.00085603254,0.00010698482,0.00024947387,0.000056215275,0.0002491544,0.000093398274,0.000024823572],"category_scores_gemma":[0.0018212858,0.00010753505,0.00027033087,0.00006277507,0.00026517248,0.00007568516,0.000025441777,0.00010241231,0.0000066505004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9606542,0.00045491767,0.022291742,0.00004816076,0.00040754073,0.00029774444,0.0010742979,0.00002494032,0.00008077933,0.00014241584,0.00020351411,0.014319752],"study_design_scores_gemma":[0.9413606,0.0032031504,0.050334513,0.00013941032,0.0002130068,0.000012951738,0.00027593144,0.0013277191,0.0014667516,0.00008454926,0.0014757501,0.00010565986],"about_ca_topic_score_codex":0.004336471,"about_ca_topic_score_gemma":0.0052079125,"teacher_disagreement_score":0.02804277,"about_ca_system_score_codex":0.00038263056,"about_ca_system_score_gemma":0.00032199145,"threshold_uncertainty_score":0.65554756},"labels":[],"label_agreement":null},{"id":"W2605372253","doi":"10.1038/leu.2017.108","title":"A novel AHI-1–BCR-ABL–DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Deutsche Krebshilfe; University of British Columbia","keywords":"Ponatinib; Autophagy; Cancer research; Stem cell; Biology; Cell biology; Endocytosis; Myeloid leukemia; Tyrosine kinase; Dasatinib; Progenitor cell; Imatinib mesylate; Immunology; Signal transduction; Cell; Apoptosis; Imatinib; Biochemistry","score_opus":0.0414186278086687,"score_gpt":0.2650314953372631,"score_spread":0.2236128675285944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605372253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909414,0.0014796681,0.00028250404,0.00019718734,0.00024967804,0.001355202,0.00010154238,0.00018191802,0.005210919],"genre_scores_gemma":[0.9913783,0.0005179704,0.0038104542,0.0002840463,0.0002045417,0.00011633365,0.00013437738,0.00011178546,0.0034422083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99677974,0.00006796983,0.000813519,0.00092318194,0.0006143795,0.00080119225],"domain_scores_gemma":[0.99699026,0.00015555893,0.0007602839,0.0015687405,0.00025107892,0.0002741002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001974395,0.0006373546,0.0012570334,0.00013428158,0.00044749855,0.000099830904,0.0004776886,0.00036287447,0.00018217361],"category_scores_gemma":[0.00032176322,0.00053365907,0.00023509597,0.00015249274,0.0010159912,0.0004394355,0.00038740205,0.00045235347,0.00008155308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048197623,0.00019860899,0.00044990345,0.00052120193,0.00043713968,0.00007082918,0.0021064396,0.000027926762,0.99364704,0.00013017838,0.0005324247,0.0013963185],"study_design_scores_gemma":[0.011639485,0.00045136147,0.023085356,0.000857856,0.0004203339,0.000088399625,0.00031259694,0.0019905202,0.9593126,0.00006619038,0.0013100073,0.00046528052],"about_ca_topic_score_codex":0.0026152867,"about_ca_topic_score_gemma":0.00006434417,"teacher_disagreement_score":0.03433444,"about_ca_system_score_codex":0.0028388384,"about_ca_system_score_gemma":0.0014673067,"threshold_uncertainty_score":0.9997115},"labels":[],"label_agreement":null},{"id":"W2607944311","doi":"10.1038/leu.2017.122","title":"Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Onyx Pharmaceuticals; Amgen","keywords":"Carfilzomib; Lenalidomide; Medicine; Autologous stem-cell transplantation; Multiple myeloma; Oncology; Internal medicine; Dexamethasone; Bortezomib; Hazard ratio; Salvage therapy; Transplantation; Chemotherapy; Confidence interval","score_opus":0.019377839062738305,"score_gpt":0.2684230750100851,"score_spread":0.24904523594734682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607944311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972523,0.0004081299,0.0000047821536,0.00011723295,0.000054385448,0.000710175,0.00006972415,0.000021200678,0.0013620849],"genre_scores_gemma":[0.99857724,0.00015978733,0.0003115126,0.0000362086,0.000014071686,0.0000291983,0.000027609054,0.000023799605,0.00082058436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986297,0.000056811987,0.00031973777,0.00035440794,0.00025043217,0.000388895],"domain_scores_gemma":[0.9989412,0.00018876906,0.0001353124,0.00047611567,0.00004755642,0.0002110882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012724542,0.0002086418,0.00048332012,0.00011937851,0.00017857192,0.00003036563,0.000099318335,0.00014695732,0.000011633913],"category_scores_gemma":[0.000083705134,0.00016158313,0.000057392528,0.000039740644,0.00019717863,0.00012976576,0.00009341798,0.00022486069,0.0000060179336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002415142,0.00013789721,0.9602523,0.00025323732,0.00007255932,0.00047011502,0.0012721559,9.606562e-7,0.0004187232,0.0000082361175,0.000011732152,0.03468694],"study_design_scores_gemma":[0.020163897,0.00030484932,0.9767059,0.00030859344,0.00006679549,0.000017536611,0.00006893268,0.00022646163,0.0018882033,0.0000068746594,0.00011181793,0.00013011364],"about_ca_topic_score_codex":0.00061709876,"about_ca_topic_score_gemma":0.00021059092,"teacher_disagreement_score":0.03455683,"about_ca_system_score_codex":0.00019565366,"about_ca_system_score_gemma":0.00009157771,"threshold_uncertainty_score":0.6589169},"labels":[],"label_agreement":null},{"id":"W2617245115","doi":"10.1038/leu.2017.162","title":"PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; St. Michael's Hospital; Toronto General Hospital; University of Toronto; Sunnybrook Hospital","funders":"Canadian Institutes of Health Research","keywords":"Signal transduction; Peroxisome proliferator-activated receptor delta; Biology; Autocrine signalling; STAT protein; Cancer research; Janus kinase 2; Cytokine; Cell biology; Janus kinase; Peroxisome proliferator-activated receptor; Endocrinology; Internal medicine; Receptor; Transcription factor; Nuclear receptor; Immunology; STAT3; Biochemistry; Medicine","score_opus":0.011145398359631836,"score_gpt":0.2420906343519165,"score_spread":0.23094523599228467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617245115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989799,0.0002240448,0.000040237086,0.00008954628,0.00014197135,0.0001555608,0.000016560056,0.000014095381,0.0003380335],"genre_scores_gemma":[0.99875724,0.00024856342,0.00029109383,0.00016243888,0.00017680826,0.000019517283,0.000036130325,0.000033121505,0.00027506944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989036,0.00003972451,0.00021034878,0.00043284646,0.00010437918,0.00030909953],"domain_scores_gemma":[0.999205,0.000008098985,0.00012240707,0.0005265905,0.000032908098,0.00010500352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016264572,0.00020083098,0.00020269214,0.000049526494,0.00015401153,0.0001089557,0.0003044733,0.000230962,0.000017354727],"category_scores_gemma":[0.000051699408,0.00018655151,0.000044268807,0.000032525862,0.00011092714,0.000014924666,0.00021489403,0.00015937864,0.000010055211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054266966,0.000017321068,0.010283516,0.00002250857,0.000025120018,0.000009166514,0.000041602947,0.00033607922,0.98805773,0.0000063795164,0.000077129596,0.0010691708],"study_design_scores_gemma":[0.0009794421,0.00007378039,0.0025121944,0.000049758495,0.0000084388,0.000012912522,0.00001969298,0.00040078672,0.99355906,0.000030985328,0.002123422,0.00022954414],"about_ca_topic_score_codex":0.00021178497,"about_ca_topic_score_gemma":0.00007279623,"teacher_disagreement_score":0.0077713216,"about_ca_system_score_codex":0.000055555407,"about_ca_system_score_gemma":0.00007328546,"threshold_uncertainty_score":0.760735},"labels":[],"label_agreement":null},{"id":"W2618292946","doi":"10.1038/leu.2017.159","title":"A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Azacitidine; Panobinostat; Chronic myelomonocytic leukemia; Neutropenia; Myelodysplastic syndromes; International Prognostic Scoring System; Regimen; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Bone marrow; Clinical trial; Toxicity","score_opus":0.028693664420219048,"score_gpt":0.334618221240216,"score_spread":0.305924556819997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618292946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559146,0.00002971798,0.000056207788,0.00028456404,0.00005848892,0.0025846772,0.000044071585,0.00006502127,0.0012857751],"genre_scores_gemma":[0.9964307,0.000038443293,0.0009879087,0.00017675145,0.00011381745,0.00017366296,0.000045362598,0.000099084566,0.0019342822],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99681175,0.00011702891,0.0005584277,0.0007421959,0.0009538296,0.0008167792],"domain_scores_gemma":[0.9972194,0.0001290196,0.0003545578,0.001563729,0.00035659943,0.00037672778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034089413,0.0004428209,0.00093140197,0.00031655474,0.00018796437,0.00007442786,0.00057040463,0.00015853757,0.0002771971],"category_scores_gemma":[0.0003095257,0.0002750223,0.00006155071,0.00031232915,0.00043553763,0.0003453325,0.00027067369,0.00081012887,0.00007413157],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28098485,0.020836823,0.56987137,0.002425789,0.0017938816,0.031829044,0.03807893,0.00031052958,0.007802447,0.000038718124,0.007040793,0.038986836],"study_design_scores_gemma":[0.62727696,0.049928408,0.26442823,0.004500127,0.000589834,0.00039300404,0.016878776,0.018550651,0.014408525,0.000005674607,0.0018535248,0.001186304],"about_ca_topic_score_codex":0.005776031,"about_ca_topic_score_gemma":0.0072333976,"teacher_disagreement_score":0.34629208,"about_ca_system_score_codex":0.0016324355,"about_ca_system_score_gemma":0.0015977877,"threshold_uncertainty_score":0.9999702},"labels":[],"label_agreement":null},{"id":"W2618381598","doi":"10.1038/leu.2017.171","title":"Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Deutsche Krebshilfe; Terry Fox Research Institute; Deutsche Forschungsgemeinschaft","keywords":"RUNX1; Biology; Myeloid; Myelopoiesis; Epigenomics; Cancer research; Transcription factor; Epigenetics; Myeloid leukemia; Cellular differentiation; Haematopoiesis; DNA methylation; Cell biology; Molecular biology; Stem cell; Genetics; Gene; Gene expression","score_opus":0.03526885580970547,"score_gpt":0.31712891689365286,"score_spread":0.2818600610839474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618381598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98007053,0.00012058467,0.00040440855,0.001779654,0.00034983558,0.0008737011,0.000017755527,0.00014465065,0.016238863],"genre_scores_gemma":[0.9923412,0.0004409912,0.002658489,0.00057893555,0.0005645982,0.000066798726,0.000043778335,0.00013412298,0.0031710886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962881,0.0000967919,0.0007314706,0.0009488817,0.0006807737,0.0012539396],"domain_scores_gemma":[0.9965343,0.00013713543,0.00030468276,0.0023852976,0.00015366045,0.00048492695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095858163,0.0004724967,0.00087759277,0.00044381258,0.0005243765,0.00020322982,0.0010765585,0.0005041042,0.00016518941],"category_scores_gemma":[0.00043905491,0.0004441915,0.00023679959,0.00025412373,0.00024180615,0.00043888553,0.0004829533,0.0016414801,0.0009039031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072745135,0.00007035208,0.011418389,0.00012008084,0.00020282011,0.0034627435,0.00090747734,0.00015521256,0.95533425,0.0004992919,0.001176893,0.025925033],"study_design_scores_gemma":[0.025680155,0.0010016548,0.16869408,0.001455395,0.00052815466,0.0017172404,0.00064986723,0.087237805,0.6950837,0.002411061,0.013268752,0.0022721859],"about_ca_topic_score_codex":0.00214942,"about_ca_topic_score_gemma":0.00027879822,"teacher_disagreement_score":0.2602506,"about_ca_system_score_codex":0.006183795,"about_ca_system_score_gemma":0.0023993892,"threshold_uncertainty_score":0.999874},"labels":[],"label_agreement":null},{"id":"W2625253716","doi":"10.1038/leu.2017.138","title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":354,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Janssen Pharmaceuticals","keywords":"Multiple myeloma; Medicine; Internal medicine; Carfilzomib; Oncology; Proteasome inhibitor; Lenalidomide; Refractory (planetary science); Hematology; Natural history; Pomalidomide; Bortezomib; Biology","score_opus":0.01825545139266853,"score_gpt":0.293698689027516,"score_spread":0.27544323763484746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625253716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428177,0.0012649485,0.0000010451996,0.00014846053,0.0004378142,0.0020650842,0.000007706612,0.00004338324,0.0017498177],"genre_scores_gemma":[0.9901871,0.000016540731,0.00040389327,0.00009736788,0.0001558572,0.00014689677,0.00001015976,0.00003858518,0.008943603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982309,0.00008422496,0.0003477901,0.0004439914,0.0005202277,0.00037289454],"domain_scores_gemma":[0.99813855,0.000058691985,0.00021001708,0.0010979216,0.000162458,0.00033233472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002864379,0.00023800552,0.00044738114,0.00018684754,0.00015676137,0.000030328945,0.00023029718,0.000098168224,0.000049756858],"category_scores_gemma":[0.00047699537,0.0001924958,0.000100585756,0.000040157618,0.00020897617,0.0002440816,0.00026227417,0.00035462654,0.000051634775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008658757,0.0023809301,0.6440898,0.00059874094,0.0011823724,0.0009841169,0.018889593,0.0000010901753,0.20506631,0.000017566326,0.009565456,0.10856527],"study_design_scores_gemma":[0.01158385,0.0012518308,0.97461826,0.00027906595,0.00008262097,0.000012721,0.000548155,0.00015010902,0.0030361037,0.000004803076,0.0082323095,0.00020017705],"about_ca_topic_score_codex":0.0013494713,"about_ca_topic_score_gemma":0.000071419294,"teacher_disagreement_score":0.33052847,"about_ca_system_score_codex":0.0021516215,"about_ca_system_score_gemma":0.0005314268,"threshold_uncertainty_score":0.7849751},"labels":[],"label_agreement":null},{"id":"W2730057868","doi":"10.1038/leu.2017.250","title":"SHP2 is required for BCR-ABL1-induced hematologic neoplasia","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Cancer research; Philadelphia chromosome; Tyrosine kinase; ABL; Biology; MAPK/ERK pathway; Myeloid leukemia; breakpoint cluster region; Leukemia; Kinase; Signal transduction; Immunology; Cell biology; Genetics; Chromosomal translocation; Receptor","score_opus":0.052665312393913935,"score_gpt":0.3294850386991547,"score_spread":0.27681972630524077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730057868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736609,0.00020413796,0.00011815197,0.0027831055,0.00058697973,0.0012458327,0.00003413991,0.00020881952,0.021157926],"genre_scores_gemma":[0.98252565,0.000041012456,0.0031872706,0.0013715205,0.00041336266,0.00021838998,0.00006275061,0.000070376926,0.012109656],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979531,0.000020356265,0.00040181933,0.00064393226,0.00032287958,0.0006578855],"domain_scores_gemma":[0.997308,0.00012962498,0.00032345628,0.0018406827,0.00011948073,0.0002787677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018275605,0.00035226488,0.0006695497,0.00008430155,0.0005337311,0.00010003636,0.0004363854,0.0003502643,0.00036929525],"category_scores_gemma":[0.00056908693,0.00029670968,0.0002835253,0.000065874105,0.00012146772,0.00021303326,0.00014490994,0.0002536934,0.00059623865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048480756,0.0011028898,0.10881579,0.0031382288,0.003168083,0.00340192,0.004453273,0.000011749471,0.22737403,0.009772815,0.46019465,0.1737185],"study_design_scores_gemma":[0.07957001,0.003639384,0.17426315,0.0016611442,0.0020897521,0.0027993342,0.00053253776,0.007976805,0.5402911,0.0085876705,0.17622371,0.002365426],"about_ca_topic_score_codex":0.00036277276,"about_ca_topic_score_gemma":0.000048715385,"teacher_disagreement_score":0.31291705,"about_ca_system_score_codex":0.0026232612,"about_ca_system_score_gemma":0.0012048038,"threshold_uncertainty_score":0.9999485},"labels":[],"label_agreement":null},{"id":"W2744041560","doi":"10.1038/leu.2017.247","title":"Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto; McMaster University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Imatinib; Medicine; Randomized controlled trial; Oncology; Internal medicine; Myeloid leukemia","score_opus":0.023929054748583402,"score_gpt":0.2993948302622677,"score_spread":0.2754657755136843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744041560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432195,0.000034809313,0.00006625393,0.0032433898,0.0005055827,0.0066621494,0.00004351813,0.00009814368,0.00502419],"genre_scores_gemma":[0.9915544,0.0000059019067,0.0019958185,0.0015900255,0.00023599685,0.0006622886,0.0001343166,0.00008832889,0.0037329206],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954953,0.00047539824,0.0011670903,0.0010216467,0.0009576887,0.00088288344],"domain_scores_gemma":[0.9959071,0.00079048536,0.0004542744,0.0019611965,0.000273409,0.0006135244],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014817879,0.00056654925,0.001585956,0.0004848762,0.00027583094,0.0001298935,0.00054942095,0.0002737744,0.00007299647],"category_scores_gemma":[0.016299736,0.00047874954,0.0005296237,0.00023534232,0.000116230316,0.000117096475,0.0003540186,0.00043209936,0.00035785398],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9886918,0.00053051114,0.0008107961,0.000057431265,0.0002299116,0.0009496617,0.0014008643,0.00034155272,0.0005514435,0.00007715589,0.00070950313,0.0056493427],"study_design_scores_gemma":[0.9683108,0.004534452,0.020912142,0.00048849836,0.00029036234,0.000020061987,0.00019540169,0.00065347017,0.0034849811,0.00006739501,0.0005672913,0.00047515077],"about_ca_topic_score_codex":0.000976035,"about_ca_topic_score_gemma":0.000109096785,"teacher_disagreement_score":0.020381033,"about_ca_system_score_codex":0.005884054,"about_ca_system_score_gemma":0.0014521088,"threshold_uncertainty_score":0.9997664},"labels":[],"label_agreement":null},{"id":"W2748412021","doi":"10.1038/leu.2017.269","title":"RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo","year":2017,"lang":"en","type":"letter","venue":"Leukemia","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); University of British Columbia; BC Cancer Agency","funders":"","keywords":"RNA interference; Leukemia; In vivo; RNA; Oncogene; Fusion gene; Oncogene Proteins; Biology; Cancer research; Virology; Computational biology; Fusion; Genetics; Gene; Regulation of gene expression; Cell cycle","score_opus":0.01306351804502774,"score_gpt":0.2583927460120305,"score_spread":0.24532922796700277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748412021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757568,0.0018451859,0.00025342393,0.009251546,0.0012216354,0.0006084967,0.00045371492,0.00005014097,0.010559045],"genre_scores_gemma":[0.870032,0.0005826128,0.00010873642,0.07916176,0.003447089,0.00012406845,0.0031732207,0.00015927064,0.043211225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967472,0.00013648027,0.000610996,0.0013053798,0.00036198756,0.0008379438],"domain_scores_gemma":[0.99773043,0.000019641968,0.0004701814,0.0015209978,0.00014078915,0.00011797025],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00018606467,0.0007053544,0.0006406825,0.00019330853,0.00023687564,0.00016401328,0.00168142,0.0018534159,0.00022730565],"category_scores_gemma":[0.0000671978,0.00070195476,0.00031124864,0.000078868135,0.0002285804,0.000012451851,0.00066634297,0.0014926388,0.00014771943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028385404,0.000014412418,0.00013337715,0.000043672404,0.000041651478,0.0001727566,0.000046700334,0.000029089815,0.4676241,7.3377424e-7,0.53148085,0.0003842825],"study_design_scores_gemma":[0.0008672112,0.0005052797,0.000103483566,0.00035154255,0.000041548687,0.00003121977,0.000017922215,0.00012309132,0.40623945,0.00003449505,0.5908293,0.0008554184],"about_ca_topic_score_codex":0.000803589,"about_ca_topic_score_gemma":0.00035183856,"teacher_disagreement_score":0.1057248,"about_ca_system_score_codex":0.0007203759,"about_ca_system_score_gemma":0.0006383064,"threshold_uncertainty_score":0.99954313},"labels":[],"label_agreement":null},{"id":"W2755752847","doi":"10.1038/leu.2017.290","title":"Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia","year":2017,"lang":"en","type":"letter","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Lymphoblastic Leukemia; Immune system; Immunology; Antigen; Medicine; Acute lymphocytic leukemia; Leukemia; Asparaginase","score_opus":0.04461783480646685,"score_gpt":0.32009800181135867,"score_spread":0.2754801670048918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755752847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907792,0.0039886134,0.011355341,0.07346505,0.0026675367,0.012572596,0.0036622426,0.00045866298,0.0010507666],"genre_scores_gemma":[0.52372414,0.0018410217,0.010225,0.06774988,0.011075523,0.0020370514,0.006814872,0.0012343823,0.37529814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99611974,0.00039431974,0.0011261338,0.0007095974,0.0008850774,0.0007651281],"domain_scores_gemma":[0.9948763,0.0010036755,0.0010522855,0.0018838167,0.0010564607,0.00012745545],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011491603,0.00054743723,0.0018425101,0.00055564457,0.00017651854,0.000048659393,0.0006042191,0.0013764554,0.00065381435],"category_scores_gemma":[0.0012160006,0.00050156924,0.00074192125,0.000200198,0.00037588493,0.00009892542,0.00008296084,0.0011463834,0.00003051918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009761985,0.000043911226,0.000090527894,0.00068597693,0.0014811538,0.0003123519,0.00014068444,0.000042514654,0.77586806,0.000001515855,0.21040855,0.0011627766],"study_design_scores_gemma":[0.038867455,0.0022284344,0.0054253982,0.0014252667,0.0020951573,0.00033202328,0.000016608361,0.07165547,0.5026444,0.000019274154,0.37438193,0.00090854696],"about_ca_topic_score_codex":0.0007586054,"about_ca_topic_score_gemma":0.000017348,"teacher_disagreement_score":0.37424737,"about_ca_system_score_codex":0.0026111112,"about_ca_system_score_gemma":0.0048695416,"threshold_uncertainty_score":0.99991995},"labels":[],"label_agreement":null},{"id":"W2756391540","doi":"10.1038/leu.2017.284","title":"RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Fms-Like Tyrosine Kinase 3; Myeloid leukemia; Biology; Ribosomal s6 kinase; Cancer research; Kinase; Gene knockdown; Ectopic expression; Cytarabine; Apoptosis; Cell biology; Signal transduction; Protein kinase B; Gene; P70-S6 Kinase 1; Genetics; Mutation","score_opus":0.01693530138355899,"score_gpt":0.27507780823067185,"score_spread":0.2581425068471129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756391540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250077,0.0006717326,0.010056824,0.007917584,0.0014795699,0.0018895927,0.00016563683,0.00025604703,0.052555326],"genre_scores_gemma":[0.9326792,0.00018650868,0.0051941457,0.002741147,0.0013382575,0.00013953641,0.000091542825,0.00012086684,0.057508845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982598,0.00002570345,0.0002751745,0.0005442349,0.00039686024,0.00049823965],"domain_scores_gemma":[0.99846524,0.000027194661,0.00019036411,0.00091509026,0.00010412489,0.00029798987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015601813,0.0003163793,0.00052011904,0.00012892587,0.00032684393,0.000113331465,0.00025570916,0.00019221689,0.0006995175],"category_scores_gemma":[0.000024118917,0.00025556903,0.00012827094,0.00017689954,0.00011153138,0.00027317886,0.00007826345,0.0005266971,0.00016521757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03838067,0.0011948657,0.14164396,0.00070908293,0.008557253,0.0073909806,0.034289848,0.00068122643,0.2644489,0.027204016,0.1660459,0.30945328],"study_design_scores_gemma":[0.06263421,0.007419403,0.44119835,0.00244196,0.0017245911,0.00093282864,0.0019279956,0.0040282123,0.15022208,0.01181428,0.31264353,0.0030125757],"about_ca_topic_score_codex":0.004262524,"about_ca_topic_score_gemma":0.0011117177,"teacher_disagreement_score":0.3064407,"about_ca_system_score_codex":0.0015853138,"about_ca_system_score_gemma":0.0022089405,"threshold_uncertainty_score":0.9999896},"labels":[],"label_agreement":null},{"id":"W2768722269","doi":"10.1038/leu.2017.330","title":"Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis","year":2017,"lang":"en","type":"letter","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Term (time); Medicine; Internal medicine; Oncology; Bone marrow","score_opus":0.02789968569867325,"score_gpt":0.29448953559155167,"score_spread":0.2665898498928784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768722269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8651893,0.012076148,0.000036552727,0.11338363,0.00044561477,0.007170464,0.0010465108,0.00003602294,0.00061573694],"genre_scores_gemma":[0.8666728,0.058676086,0.0026238272,0.042341422,0.0085744755,0.004761782,0.002513783,0.0004470238,0.013388809],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982419,0.000046058703,0.00055806077,0.00053692184,0.00029719283,0.0003198633],"domain_scores_gemma":[0.9972412,0.0012117543,0.00052046403,0.00078181917,0.0001485582,0.00009622153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010954088,0.0004898464,0.0012431456,0.00011065171,0.00020417893,0.000037912872,0.00012154855,0.000487999,0.000040208608],"category_scores_gemma":[0.00008280506,0.0002853422,0.00026334767,0.00004791472,0.00038671357,0.00004158763,0.00005464509,0.0002624032,0.0000025781128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006389005,0.0021303666,0.30679077,0.007953692,0.0094973445,0.000693283,0.0043532806,0.0000057834577,0.0016362746,0.00019254582,0.34100616,0.31935152],"study_design_scores_gemma":[0.022698736,0.0076629063,0.5190185,0.002288057,0.0039729583,0.00015025688,0.000027645245,0.000039138256,0.018284475,0.000034229462,0.42533064,0.0004925021],"about_ca_topic_score_codex":0.00015215494,"about_ca_topic_score_gemma":0.000030387655,"teacher_disagreement_score":0.318859,"about_ca_system_score_codex":0.00033659214,"about_ca_system_score_gemma":0.00027189177,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2769007711","doi":"10.1038/leu.2017.299","title":"HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Shanghai Hospital Development Center; Science and Technology Commission of Shanghai Municipality; University of British Columbia; University of Texas MD Anderson Cancer Center; National Natural Science Foundation of China; Cancer Prevention and Research Institute of Texas","keywords":"Cancer research; Diffuse large B-cell lymphoma; microRNA; Gene knockdown; Cell growth; Protein kinase B; Biology; HDAC6; PI3K/AKT/mTOR pathway; Lymphoma; Histone deacetylase; In vivo; Apoptosis; Signal transduction; Cell biology; Histone; Immunology; Gene","score_opus":0.010720303980935958,"score_gpt":0.2567826952914495,"score_spread":0.24606239131051352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769007711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975698,0.0008215441,0.000029405152,0.00022415063,0.00008659267,0.00036595363,0.0000637208,0.000015767442,0.00082307553],"genre_scores_gemma":[0.9963454,0.00015347985,0.00096377963,0.00006633367,0.00016866361,0.00007920854,0.00017407045,0.00004088911,0.002008156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985259,0.00009022614,0.00021398245,0.0005276747,0.00019639413,0.00044583474],"domain_scores_gemma":[0.99886405,0.000020076832,0.00012618348,0.0007793422,0.00008477036,0.00012554327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025865942,0.00022242109,0.00022186035,0.000078479345,0.00034802768,0.00020378416,0.00038401136,0.00025485223,0.000018098908],"category_scores_gemma":[0.0002664722,0.00021033095,0.00006188212,0.000046138797,0.00018533214,0.000025258407,0.00034631434,0.00011559684,0.000016570613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015033991,0.00044433406,0.015758837,0.00009471105,0.000025636105,0.000014900047,0.00023378507,0.0000024466171,0.97722405,0.000021953916,0.005675481,0.00035353703],"study_design_scores_gemma":[0.004790512,0.00013542197,0.003970018,0.000032775228,0.0000084554285,0.00001698715,0.00004747246,0.00011281532,0.97928697,0.00007824474,0.01127356,0.0002467507],"about_ca_topic_score_codex":0.000132173,"about_ca_topic_score_gemma":0.00011748417,"teacher_disagreement_score":0.011788819,"about_ca_system_score_codex":0.00010145823,"about_ca_system_score_gemma":0.00021990736,"threshold_uncertainty_score":0.8577047},"labels":[],"label_agreement":null},{"id":"W2774700270","doi":"10.1038/leu.2017.331","title":"Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Transplantation; Oncology; Population; Internal medicine; Multiple myeloma; Hematopoietic stem cell transplantation","score_opus":0.01723027951420258,"score_gpt":0.2772434045291609,"score_spread":0.2600131250149583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774700270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697083,0.000072741546,0.0000431973,0.00028259165,0.000086358625,0.0015219457,0.00015361268,0.00009366368,0.0007750718],"genre_scores_gemma":[0.9921884,0.00002374633,0.00094856846,0.00011900293,0.00005145733,0.0002814746,0.00008601852,0.000056493715,0.0062448317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979471,0.000074213734,0.00039837763,0.00051558757,0.0004026138,0.00066211814],"domain_scores_gemma":[0.998467,0.0002480381,0.00016399751,0.0007328445,0.00006925567,0.00031883476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001157988,0.0003319431,0.00053540757,0.0001844627,0.00018799282,0.000109231216,0.00021933617,0.0002491353,0.00022140301],"category_scores_gemma":[0.00045265717,0.00026039474,0.00018177666,0.000056799894,0.00013404388,0.0002544738,0.00006282154,0.0003958407,0.0004479046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013336007,0.00022536617,0.9760346,0.00028100307,0.0000853893,0.0028879906,0.0009432847,9.3245524e-7,0.016504707,0.0000022530714,0.000040219995,0.0016606913],"study_design_scores_gemma":[0.010710844,0.00036540278,0.9771829,0.00019512368,0.00009752917,0.000070323455,0.000026531878,0.002725738,0.00832337,0.00003052842,0.000031074993,0.00024059779],"about_ca_topic_score_codex":0.0015070607,"about_ca_topic_score_gemma":0.0007910723,"teacher_disagreement_score":0.009377243,"about_ca_system_score_codex":0.00053250464,"about_ca_system_score_gemma":0.00028431424,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2780360473","doi":"10.1038/s41375-018-0039-7","title":"Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Minimal residual disease; Medicine; Internal medicine; Complete remission; Oncology; Bone marrow; Flow cytometry; Gastroenterology; Chemotherapy; Immunology","score_opus":0.015476926641515605,"score_gpt":0.31846013167724796,"score_spread":0.30298320503573234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780360473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854215,0.00031375463,0.002862744,0.0010477543,0.0005657306,0.0016627994,0.00009303796,0.00016016289,0.00787255],"genre_scores_gemma":[0.9857507,0.000282461,0.010027004,0.0016047662,0.001164689,0.00016659495,0.00045412307,0.00010421796,0.00044546602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99394363,0.00044326246,0.0015950524,0.0013039553,0.0015605218,0.0011535614],"domain_scores_gemma":[0.99485284,0.0017072122,0.0007108986,0.001878281,0.00038907374,0.0004617105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016275668,0.00060117006,0.0013888943,0.00080834614,0.0002349376,0.000046438014,0.0009882423,0.0008502181,0.00075654144],"category_scores_gemma":[0.0023523525,0.00040688744,0.0003283994,0.0028578853,0.00086739275,0.00018132225,0.0007803652,0.0013608325,0.00016993986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0055911033,0.0028831793,0.7234973,0.00021886553,0.0032465213,0.018148113,0.00298399,0.000564575,0.07345933,0.00040682877,0.101779595,0.067220636],"study_design_scores_gemma":[0.012311444,0.0026236717,0.9580113,0.0003924064,0.0006133799,0.0046009864,0.00012703481,0.01642373,0.0020765485,0.0004132259,0.001974983,0.00043128492],"about_ca_topic_score_codex":0.0033377984,"about_ca_topic_score_gemma":0.00018411496,"teacher_disagreement_score":0.23451404,"about_ca_system_score_codex":0.015817078,"about_ca_system_score_gemma":0.009258867,"threshold_uncertainty_score":0.9998383},"labels":[],"label_agreement":null},{"id":"W2789326640","doi":"10.1038/s41375-017-0005-9","title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Mitacs; Hungarian Scientific Research Fund; Austrian Science Fund","keywords":"Cancer research; STAT5; Myeloid leukemia; Mediator; Leukemia; Haematopoiesis; Tyrosine kinase; Transcription factor; Myeloid; Biology; Medicine; Immunology; Signal transduction; Internal medicine; Stem cell; Cell biology; Gene","score_opus":0.024414295980904506,"score_gpt":0.3269247589845998,"score_spread":0.3025104630036953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789326640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017657,0.00012308908,0.00020919292,0.00062034576,0.00020028642,0.00071126455,0.000030806405,0.00011563021,0.017812805],"genre_scores_gemma":[0.9927314,0.00029343952,0.0021950551,0.0013922569,0.00045939127,0.000063473075,0.00007889735,0.000053122647,0.002732943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739736,0.0001265534,0.0006469203,0.00052039133,0.0005893159,0.00071948284],"domain_scores_gemma":[0.9986057,0.00013457594,0.0001759608,0.0005081161,0.0003214934,0.0002540963],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061806664,0.00027946173,0.0005831225,0.0005245042,0.00007586361,0.000016779344,0.00022753,0.00029375454,0.0010905574],"category_scores_gemma":[0.00017526613,0.00024887093,0.00013468559,0.0010550687,0.0005500817,0.00021684868,0.00020176134,0.0007754722,0.0005278633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021507186,0.00014229126,0.013285215,0.00023240793,0.00020127036,0.000856107,0.0010544006,0.00003153395,0.9312499,0.00051667343,0.03592753,0.014351921],"study_design_scores_gemma":[0.013860557,0.0020672749,0.079990886,0.00037261055,0.00023348043,0.000308779,0.00038929304,0.0054695643,0.88116115,0.0009969166,0.01462465,0.00052480836],"about_ca_topic_score_codex":0.0005346322,"about_ca_topic_score_gemma":0.0000806608,"teacher_disagreement_score":0.066705674,"about_ca_system_score_codex":0.0050122724,"about_ca_system_score_gemma":0.0023434388,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W2789467971","doi":"10.1038/s41375-018-0069-1","title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Podoplanin; Acute promyelocytic leukemia; Cancer research; Leukemia; Platelet activation; Myeloid leukemia; Platelet; Retinoic acid; Immunology; Medicine; Biology; Gene; Biochemistry","score_opus":0.0131680544633953,"score_gpt":0.2505899100240271,"score_spread":0.23742185556063178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789467971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955302,0.00040999037,0.00007805106,0.00010593242,0.00030269753,0.0006520787,0.00007938527,0.000042118783,0.0027995366],"genre_scores_gemma":[0.9977267,0.000029494699,0.0003301166,0.00012563083,0.00016435586,0.000010952065,0.000042753734,0.000026442316,0.0015435645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842113,0.00010104525,0.0005589543,0.0002517848,0.0004353651,0.00023173781],"domain_scores_gemma":[0.9987261,0.000078268815,0.0003469055,0.0005726944,0.00016203194,0.000113943905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022158175,0.00018804414,0.00047780943,0.00005304715,0.000090716814,0.000011583382,0.00021124908,0.00014447965,0.00015429861],"category_scores_gemma":[0.00007269169,0.000116958734,0.00017376535,0.00024787855,0.0002070849,0.000082610626,0.000035845165,0.00004541133,0.000027074124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092175795,0.00006547961,0.03157711,0.0008411586,0.00015361384,0.00002104119,0.0019041651,0.000033735025,0.95265985,0.00007771103,0.011047298,0.0006970896],"study_design_scores_gemma":[0.004158917,0.0002659343,0.056350857,0.0019309447,0.00034370334,0.00012890022,0.00025485668,0.0007443737,0.9351721,0.000128334,0.00036356,0.00015753575],"about_ca_topic_score_codex":0.00014728351,"about_ca_topic_score_gemma":0.000010680882,"teacher_disagreement_score":0.024773749,"about_ca_system_score_codex":0.00039476296,"about_ca_system_score_gemma":0.001009363,"threshold_uncertainty_score":0.47694385},"labels":[],"label_agreement":null},{"id":"W2791154088","doi":"10.1038/s41375-018-0023-2","title":"Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; Pfizer","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Medicine; Lymphoma; Open label; Internal medicine; Oncology; Phases of clinical research; Randomized controlled trial; Clinical trial; Leukemia; Chemistry; Discovery and development of mTOR inhibitors; Chronic lymphocytic leukemia","score_opus":0.026927290412992036,"score_gpt":0.30075145038505535,"score_spread":0.27382415997206333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791154088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899439,0.0001283833,0.000006154189,0.00010663421,0.0005117838,0.0031699303,0.00016199946,0.000036709498,0.005934485],"genre_scores_gemma":[0.9977636,0.00005912476,0.0002511012,0.00020903154,0.00017940083,0.00026775425,0.00038916373,0.00003825738,0.0008425771],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99823487,0.00015953695,0.00045544145,0.00042014892,0.00048358538,0.00024640764],"domain_scores_gemma":[0.9981592,0.0004988899,0.00029923025,0.0006424963,0.00028288306,0.00011725121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024486159,0.00027120844,0.0007076931,0.00005447349,0.00011669509,0.0000691795,0.00041837333,0.00007297858,0.00033548145],"category_scores_gemma":[0.00012943218,0.00014600152,0.000102082,0.00017483156,0.00018666107,0.000121282515,0.00016944334,0.000055338718,0.00013094548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63243026,0.020566689,0.31562144,0.000019784486,0.0034828603,0.00009077748,0.0041580363,0.0000010876105,0.000084363106,0.00004670649,0.012691104,0.010806926],"study_design_scores_gemma":[0.94632715,0.0046160854,0.041791905,0.00012612925,0.0013859239,9.966041e-7,0.00047469555,0.00011738341,0.002141281,0.000009593947,0.0028425648,0.00016630984],"about_ca_topic_score_codex":0.0026890335,"about_ca_topic_score_gemma":0.00018567983,"teacher_disagreement_score":0.3138969,"about_ca_system_score_codex":0.0005114788,"about_ca_system_score_gemma":0.00027889802,"threshold_uncertainty_score":0.5953769},"labels":[],"label_agreement":null},{"id":"W2792274945","doi":"10.1038/s41375-018-0012-5","title":"Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Research Manitoba; Leukemia and Lymphoma Society","keywords":"Idelalisib; PI3K/AKT/mTOR pathway; Stromal cell; Chronic lymphocytic leukemia; Cancer research; Cell migration; Cell biology; Jurkat cells; Biology; Chemokine; T cell; Cell; Immunology; Leukemia; Signal transduction; Ibrutinib; Biochemistry; Inflammation","score_opus":0.01601825668664608,"score_gpt":0.2885638050431393,"score_spread":0.2725455483564932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792274945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965527,0.00058732246,0.00021034983,0.00027578432,0.00006641843,0.00057045993,0.000016695434,0.00003960863,0.0016806712],"genre_scores_gemma":[0.99653983,0.000076052966,0.001008306,0.000256433,0.00029834337,0.00008432617,0.000052461517,0.000026920583,0.0016573268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988242,0.000022962546,0.000235789,0.00033269936,0.00021278742,0.00037160274],"domain_scores_gemma":[0.9992677,0.00019756444,0.000048299975,0.00025896696,0.00009625945,0.00013123442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002042629,0.00014120231,0.00023217213,0.00009799682,0.00007191716,0.0000302652,0.00007710006,0.00010099125,0.000054412914],"category_scores_gemma":[0.00016622043,0.00011843865,0.000048585753,0.00015864061,0.00017734985,0.000072750736,0.000043259046,0.00010231168,0.0000422621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01641529,0.0010921478,0.28534773,0.0049375854,0.0002480342,0.0018309598,0.008868902,0.00006332,0.44778767,0.0031067429,0.15516864,0.07513295],"study_design_scores_gemma":[0.03601173,0.0015403491,0.095193855,0.00068984815,0.000117287236,0.00022189025,0.0004736724,0.053711094,0.7764415,0.0008668074,0.0342314,0.00050053035],"about_ca_topic_score_codex":0.0019468024,"about_ca_topic_score_gemma":0.0036053143,"teacher_disagreement_score":0.32865384,"about_ca_system_score_codex":0.0061136144,"about_ca_system_score_gemma":0.0023643144,"threshold_uncertainty_score":0.99770176},"labels":[],"label_agreement":null},{"id":"W2792798899","doi":"10.1038/s41375-018-0094-0","title":"Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia &amp; lymphoma study","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; BC Children's Hospital; Hospital for Sick Children; University of British Columbia; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoblastic lymphoma; Lymphoma; Lymphoblastic Leukemia; Internal medicine; Leukemia; Salvage therapy; Retrospective cohort study; Oncology; Complete remission; Pediatrics; Bone marrow; Population; Childhood leukemia; Overall survival; Chemotherapy; Immunology; T cell; Biology","score_opus":0.01337186297240948,"score_gpt":0.28688613522743894,"score_spread":0.27351427225502944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792798899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965234,0.00084852875,0.0009920613,0.000075012766,0.00026013656,0.0033568921,0.000064323205,0.0002951986,0.004455511],"genre_scores_gemma":[0.9933449,0.00022743376,0.0027878068,0.0006600539,0.00045949643,0.00027160984,0.000095403426,0.00028028685,0.0018730323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99236226,0.00034731522,0.0018194002,0.0016975298,0.0020456451,0.00172782],"domain_scores_gemma":[0.99538845,0.0006156043,0.0006551766,0.0021512671,0.00056421076,0.00062532054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008373735,0.001117208,0.0019557893,0.0010237095,0.00027631456,0.00007685563,0.0011251899,0.0005810532,0.0002148078],"category_scores_gemma":[0.00035722682,0.00086738594,0.00033248588,0.0022683183,0.0010879865,0.00059688627,0.0004416651,0.0008866195,0.000526887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007618649,0.003106617,0.94902253,0.00034849817,0.001668431,0.00065875927,0.006158989,0.0006802,0.005636471,0.00009492314,0.0006637682,0.02434214],"study_design_scores_gemma":[0.08775035,0.00717284,0.88960254,0.0006068931,0.0013592907,0.0011799915,0.0011460569,0.0026976012,0.0059340964,0.00013007148,0.0010503964,0.0013698862],"about_ca_topic_score_codex":0.0016933312,"about_ca_topic_score_gemma":0.0012387024,"teacher_disagreement_score":0.0801317,"about_ca_system_score_codex":0.013746957,"about_ca_system_score_gemma":0.007408435,"threshold_uncertainty_score":0.99937767},"labels":[],"label_agreement":null},{"id":"W2794594588","doi":"10.1038/s41375-018-0117-x","title":"Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer","year":2018,"lang":"en","type":"review","venue":"Leukemia","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Walloon excellence in life sciences and biotechnology; Fonds De La Recherche Scientifique - FNRS; Austrian Science Fund; Ludwig Institute for Cancer Research","keywords":"STAT5; Chromatin remodeling; Biology; Cancer research; Chromatin; Transcription factor; Cell biology; STAT3; JAK-STAT signaling pathway; Histone; Signal transduction; Genetics; Gene; Receptor tyrosine kinase","score_opus":0.06830776827759728,"score_gpt":0.36662066959640066,"score_spread":0.2983129013188034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794594588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03337037,0.96484965,0.00040980786,0.00007386768,0.00007275443,0.00071029866,0.00010934583,0.00002791625,0.00037600932],"genre_scores_gemma":[0.0173125,0.9805341,0.0015497592,0.000052934924,0.0001810289,0.000088398054,0.00013845107,0.000047290912,0.00009558298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998682,0.00004603612,0.0006533226,0.00033837615,0.00012634881,0.0001539209],"domain_scores_gemma":[0.99906075,0.00015899616,0.0003390412,0.00027488417,0.00009205152,0.00007426165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001857692,0.00021394044,0.00084025774,0.000264498,0.000055259963,0.000016543054,0.00004661291,0.00015740375,0.00007594641],"category_scores_gemma":[0.000060465027,0.00018025847,0.000093258794,0.00021920311,0.00006155064,0.00004636227,0.000032240154,0.00026559227,0.0000037288348],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067468005,0.00010871335,0.00014254711,0.03160463,0.00024043619,0.000008551267,0.0012471952,0.00032912166,0.016460642,0.0008659663,0.0009319025,0.9479928],"study_design_scores_gemma":[0.0038895656,0.0013311965,0.0021664256,0.30157128,0.003983163,0.000946348,0.0002971118,0.010791757,0.010529428,0.0030478828,0.6596411,0.0018047879],"about_ca_topic_score_codex":0.00023365463,"about_ca_topic_score_gemma":0.00003701342,"teacher_disagreement_score":0.94618803,"about_ca_system_score_codex":0.00043278746,"about_ca_system_score_gemma":0.00043956641,"threshold_uncertainty_score":0.73507273},"labels":[],"label_agreement":null},{"id":"W2802564323","doi":"10.1038/s41375-018-0140-y","title":"Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Cancer Research Society","keywords":"EZH2; Bortezomib; Gene silencing; Cancer research; Proteasome inhibitor; microRNA; Biology; Downregulation and upregulation; Cell culture; Multiple myeloma; Molecular biology; Histone; Gene; Immunology; Genetics","score_opus":0.005888001624775818,"score_gpt":0.23031644078870167,"score_spread":0.22442843916392585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802564323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483466,0.0007225264,0.0031763082,0.00020070575,0.000090299196,0.00035090873,0.000055735556,0.00001673176,0.000552142],"genre_scores_gemma":[0.9957041,0.000004979536,0.0027022315,0.00012824693,0.00014330533,0.000028507407,0.00026203392,0.000024965439,0.001001596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987356,0.000071056515,0.00038678732,0.00039013103,0.0001508815,0.000265524],"domain_scores_gemma":[0.999131,0.000033250813,0.00015952684,0.00042434092,0.0001783643,0.0000734919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002316899,0.00016061892,0.00018931123,0.000080459475,0.000069407244,0.000017901502,0.00018321481,0.00014929367,0.000021908632],"category_scores_gemma":[0.00026823152,0.00017388961,0.000060798364,0.00026062748,0.00012457078,0.000008882576,0.00009481034,0.000053684733,0.000013477954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024290451,0.00002341884,0.010205246,0.00003291072,0.000021200936,5.453343e-7,0.0001268439,0.0001570675,0.97309816,0.00012863819,0.014770036,0.0011930414],"study_design_scores_gemma":[0.000995802,0.000042992146,0.14206149,0.00009434402,0.000010270935,6.406487e-7,0.000034023207,0.0007151292,0.8371407,0.00028707273,0.018420966,0.00019656806],"about_ca_topic_score_codex":0.000092601826,"about_ca_topic_score_gemma":0.0009787697,"teacher_disagreement_score":0.13595743,"about_ca_system_score_codex":0.00018966134,"about_ca_system_score_gemma":0.000104737526,"threshold_uncertainty_score":0.70910126},"labels":[],"label_agreement":null},{"id":"W2805411213","doi":"10.1038/s41375-018-0162-5","title":"Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Alberta; Public Health Ontario; University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Quality of life (healthcare); Grip strength; Myeloid leukemia; Physical therapy; Internal medicine","score_opus":0.014280271677585511,"score_gpt":0.2855574451650214,"score_spread":0.2712771734874359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805411213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987391,0.00014939411,0.00012264209,0.00010617287,0.00019052363,0.00037588633,0.00004909373,0.00001561427,0.00025156076],"genre_scores_gemma":[0.9985004,0.00035233697,0.00003769344,0.0007785442,0.00017948683,0.000019290197,0.000011628512,0.000024307488,0.00009633432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868965,0.000051070703,0.0004870746,0.00027906086,0.00029901907,0.00019414398],"domain_scores_gemma":[0.99862766,0.00013522196,0.00031023673,0.000248998,0.000612851,0.00006504043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016624172,0.00017736155,0.00068047247,0.00014319828,0.000013305715,0.000002896049,0.00005328229,0.00012929284,0.00006829069],"category_scores_gemma":[0.00020389102,0.00016181779,0.00013466337,0.00026928663,0.0005182353,0.000102979066,0.00006899285,0.00020681127,0.0000049334744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014075269,0.00012347546,0.9454438,0.00039136724,0.0009465229,0.000008242021,0.002718732,0.0000021382289,0.023931684,0.00002305757,0.0003548961,0.011980836],"study_design_scores_gemma":[0.004716329,0.0011964794,0.9828553,0.00046242579,0.00017707857,0.0000021061303,0.000239886,0.00006737952,0.009971915,0.00017046274,0.000008117384,0.00013251055],"about_ca_topic_score_codex":0.001575846,"about_ca_topic_score_gemma":0.0013460602,"teacher_disagreement_score":0.03741153,"about_ca_system_score_codex":0.00043013203,"about_ca_system_score_gemma":0.00026115688,"threshold_uncertainty_score":0.6598738},"labels":[],"label_agreement":null},{"id":"W2806893210","doi":"10.1038/s41375-018-0158-1","title":"Response kinetics and factors predicting survival in core-binding factor leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Leukemia; Kinetics; Oncology; Cancer research; Immunology; Internal medicine; Biology; Medicine","score_opus":0.047954288853922694,"score_gpt":0.3224987165656892,"score_spread":0.27454442771176646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806893210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590766,0.00007483483,0.000080840065,0.00030317451,0.00037020602,0.00055345846,0.000047647864,0.00017515279,0.0024870383],"genre_scores_gemma":[0.9958353,0.000045015844,0.0008107935,0.00021568792,0.00045074758,0.000015889025,0.000037338126,0.00009043606,0.0024987909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693364,0.0002157502,0.00055969215,0.0006763579,0.00069142156,0.0009231368],"domain_scores_gemma":[0.99765134,0.0009775348,0.00013338952,0.0005908729,0.00018440266,0.0004624862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088563655,0.00038041567,0.00058684294,0.0005335893,0.00016903729,0.000069974456,0.0002631583,0.0003889239,0.00025906402],"category_scores_gemma":[0.0022170409,0.00033637416,0.00008634322,0.0007174802,0.00048780837,0.00018134076,0.00030501015,0.00097327336,0.00011212687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003235963,0.000041241965,0.7204798,0.000105138024,0.00007448214,0.00029852195,0.004302015,0.00000834721,0.26760328,0.00007077256,0.0013173524,0.0024631019],"study_design_scores_gemma":[0.0050028274,0.001250134,0.93764776,0.0003003867,0.000045662033,0.00012325331,0.0014172085,0.0059802444,0.042406704,0.00005245362,0.0053331023,0.0004402831],"about_ca_topic_score_codex":0.000713351,"about_ca_topic_score_gemma":0.00024175021,"teacher_disagreement_score":0.22519659,"about_ca_system_score_codex":0.0054639773,"about_ca_system_score_gemma":0.0013601121,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W2807075145","doi":"10.1038/s41375-018-0167-0","title":"Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer research; Stem cell; Haematopoiesis; Myeloid leukemia; Biology; Leukemia; Progenitor cell; Population; Myeloid; Immunology; Medicine; Cell biology","score_opus":0.04710331547225144,"score_gpt":0.3552115564327113,"score_spread":0.30810824096045986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807075145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755432,0.00018909301,0.00008425734,0.0009817451,0.00040750497,0.0018985128,0.00001937457,0.00007054662,0.020805743],"genre_scores_gemma":[0.995215,0.00005796049,0.0008167865,0.00086788536,0.0007437866,0.00016564626,0.00004016276,0.000076269986,0.0020165038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951583,0.0007763358,0.00091820565,0.00077186245,0.0016185322,0.0007567534],"domain_scores_gemma":[0.9965654,0.00036288064,0.0003146789,0.0011574107,0.001366957,0.0002326847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030112318,0.00035437974,0.00064031885,0.0003032709,0.00015558425,0.00002979037,0.0006061752,0.0005141429,0.00028765408],"category_scores_gemma":[0.0025244225,0.00026414986,0.0002646952,0.0015580719,0.0007467107,0.00014892436,0.0004138227,0.001369006,0.00020518254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006693475,0.0008361843,0.145571,0.00045152107,0.0016585218,0.00018484872,0.008138909,0.00057668425,0.6925527,0.0011561363,0.069984205,0.07219586],"study_design_scores_gemma":[0.017542712,0.0017217541,0.30706367,0.00070321193,0.00097564154,0.00020834537,0.00037294283,0.056414805,0.6100038,0.0012294735,0.0031400751,0.0006235235],"about_ca_topic_score_codex":0.000704505,"about_ca_topic_score_gemma":0.0006651131,"teacher_disagreement_score":0.16149268,"about_ca_system_score_codex":0.008343049,"about_ca_system_score_gemma":0.009217962,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2808926344","doi":"10.1038/s41375-018-0166-1","title":"Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Deutsche Krebshilfe","keywords":"Myeloid leukemia; Myeloid; Biology; Myeloproliferative Disorders; Cancer research; Leukemia; Gene knockdown; Immunology; Apoptosis; Genetics","score_opus":0.02630895190364619,"score_gpt":0.3133176343384345,"score_spread":0.28700868243478833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808926344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574256,0.00016461422,0.00009595286,0.0004830484,0.00010948726,0.00061414693,0.000047358364,0.000056933237,0.0026858833],"genre_scores_gemma":[0.9962082,0.000042854583,0.0013056165,0.00039190837,0.00032065713,0.0000628585,0.000039728555,0.000038156348,0.001590044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997797,0.00009661434,0.00045894415,0.0005099783,0.0006146154,0.00052283355],"domain_scores_gemma":[0.9985642,0.00012861044,0.00012179654,0.00053382857,0.00030507043,0.0003465256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029137003,0.00022882568,0.00040842794,0.00030861254,0.00009223093,0.000017100543,0.00026616722,0.00014743698,0.00019308555],"category_scores_gemma":[0.0008319214,0.00018800421,0.00009076468,0.0005499304,0.00044249813,0.00017659723,0.0002107946,0.00044533485,0.00015010752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025976012,0.00014542267,0.0142192915,0.00020038597,0.000017782833,0.00026490766,0.0020086698,0.000011896501,0.97695947,0.00016692984,0.0022971332,0.0011104884],"study_design_scores_gemma":[0.0028920337,0.0003903217,0.10164274,0.00044599193,0.000038568985,0.000029868244,0.00044370565,0.0013951097,0.8920045,0.000097468044,0.00040550323,0.0002141908],"about_ca_topic_score_codex":0.0006284069,"about_ca_topic_score_gemma":0.000049819955,"teacher_disagreement_score":0.08742345,"about_ca_system_score_codex":0.0011767385,"about_ca_system_score_gemma":0.002275704,"threshold_uncertainty_score":0.7666589},"labels":[],"label_agreement":null},{"id":"W2809367512","doi":"10.1038/s41375-018-0179-9","title":"Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Imatinib; Internal medicine; Myeloid leukemia; Cohort; Imatinib mesylate; Transplantation; Prospective cohort study; Surgery; Gastroenterology","score_opus":0.014608484347654034,"score_gpt":0.2794650063076702,"score_spread":0.26485652196001613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809367512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936951,0.0008712532,0.000059831353,0.00015831314,0.00022160073,0.0034291563,0.00042998142,0.00018010865,0.00095465407],"genre_scores_gemma":[0.9932564,0.00036132286,0.0011703827,0.00022976611,0.0021796715,0.00020972751,0.0012601501,0.00010494093,0.0012276404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961822,0.00011386574,0.0009866583,0.0012933473,0.0005518411,0.00087211153],"domain_scores_gemma":[0.9978683,0.00009180604,0.00036480147,0.0011261688,0.00009269607,0.00045620865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022315628,0.00072363246,0.0011411638,0.00025203958,0.00016055883,0.000057922407,0.00020999578,0.0003725169,0.0003113318],"category_scores_gemma":[0.00010140787,0.00054240436,0.00014072441,0.00031231635,0.00037874066,0.00020373549,0.00011406182,0.0004852094,0.00027866327],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7369467,0.0046563004,0.062743604,0.00017011842,0.0024322376,0.0013532693,0.0063310075,0.00011339908,0.006278677,0.000018953508,0.00505186,0.17390385],"study_design_scores_gemma":[0.89345884,0.015059911,0.075344086,0.0014678846,0.0007439331,0.00022395556,0.00008431609,0.0032953592,0.008412215,0.00003629172,0.001215137,0.00065807113],"about_ca_topic_score_codex":0.01636795,"about_ca_topic_score_gemma":0.0038934092,"teacher_disagreement_score":0.17324577,"about_ca_system_score_codex":0.01736987,"about_ca_system_score_gemma":0.003916286,"threshold_uncertainty_score":0.99970275},"labels":[],"label_agreement":null},{"id":"W2883385515","doi":"10.1038/s41375-018-0215-9","title":"Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; Foundation Medicine; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; American Society of Hematology; Cycle for Survival; Robert Wood Johnson Foundation","keywords":"Somatic evolution in cancer; Chronic lymphocytic leukemia; Biology; Mutation; Gene; Leukemia; Genetics; Cancer research","score_opus":0.035348244830359886,"score_gpt":0.3128845966772866,"score_spread":0.2775363518469267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883385515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743158,0.00027480684,0.00009426187,0.00009883094,0.00053692464,0.0008365224,0.000020415577,0.00028680472,0.023535587],"genre_scores_gemma":[0.9894625,0.00008393947,0.00037946456,0.00097016635,0.0014224108,0.000040072075,0.000053565007,0.00007339841,0.0075144754],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99543446,0.00011396988,0.0007714492,0.0009405322,0.0013514938,0.0013880719],"domain_scores_gemma":[0.99760425,0.00021794597,0.00015441846,0.001156476,0.00024319295,0.0006237224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007434935,0.0004593524,0.0007786587,0.0004902373,0.00034447323,0.000029400748,0.00064942386,0.0004650064,0.0014227547],"category_scores_gemma":[0.00045759612,0.0004330692,0.00026825254,0.0009820393,0.00082309573,0.0003027068,0.001303022,0.00073434983,0.0026211923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.016412461,0.0005177014,0.754786,0.0058881184,0.0017815437,0.025904724,0.012681569,0.011843543,0.021629618,0.0057236813,0.10815641,0.034674633],"study_design_scores_gemma":[0.16048954,0.0032205174,0.30446115,0.0013543357,0.00047064156,0.002257328,0.0005063752,0.47980213,0.010620902,0.0007660766,0.034240976,0.0018100257],"about_ca_topic_score_codex":0.009988809,"about_ca_topic_score_gemma":0.0012263863,"teacher_disagreement_score":0.4679586,"about_ca_system_score_codex":0.52146304,"about_ca_system_score_gemma":0.08324273,"threshold_uncertainty_score":0.9998121},"labels":[],"label_agreement":null},{"id":"W2884362356","doi":"10.1038/s41375-018-0210-1","title":"Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Servier; Astex Pharmaceuticals; Astellas Pharma; Gilead Sciences; Ablynx; Teva Pharmaceutical Industries; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Internal medicine; Tolerability; Gastroenterology; Peripheral edema; Nausea; Discontinuation; Adverse effect; Refractory (planetary science); Minimal residual disease; Progressive disease; Leukemia; Surgery; Disease","score_opus":0.009278922816624076,"score_gpt":0.21848579014866723,"score_spread":0.20920686733204316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884362356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96484554,0.0017367908,0.00018978196,0.00007125736,0.0023509725,0.00033779917,0.000023208368,0.00020669008,0.030237973],"genre_scores_gemma":[0.97911066,0.00008056883,0.0004876206,0.00072300894,0.00018159344,0.000049912505,0.000053738535,0.000059017413,0.019253869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977819,0.00020254383,0.00053294626,0.00059584127,0.000071953364,0.00081482995],"domain_scores_gemma":[0.9988539,0.00010297147,0.00017504781,0.00074635824,0.000071628565,0.00005006626],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003461013,0.00035799373,0.00042428213,0.00024120012,0.00025378636,0.000028477836,0.00053988176,0.00066722586,0.0023840014],"category_scores_gemma":[0.00007059163,0.00034023824,0.00014220674,0.0003041813,0.00034137937,0.00016229297,0.00019490994,0.0009002268,0.0071637766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002347457,0.00012370288,0.00083001255,0.000023094435,0.00003875637,0.0000476186,0.00088851404,0.000010178554,0.96931636,0.0011337497,0.020693747,0.00665951],"study_design_scores_gemma":[0.005524439,0.0009039047,0.01145625,0.00009342743,0.000031982887,0.000072748255,0.00049751526,0.00007210775,0.69927263,0.00095295184,0.2804376,0.00068442075],"about_ca_topic_score_codex":0.0007174623,"about_ca_topic_score_gemma":0.00036520205,"teacher_disagreement_score":0.27004373,"about_ca_system_score_codex":0.0010672681,"about_ca_system_score_gemma":0.0005767366,"threshold_uncertainty_score":0.999905},"labels":[],"label_agreement":null},{"id":"W2885865993","doi":"10.1038/s41375-018-0229-3","title":"Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"China Scholarship Council; Tekes; Academy of Finland","keywords":"Transplantation; Human leukocyte antigen; Oncology; Biology; Haematopoiesis; Population; Exome sequencing; Stem cell; Internal medicine; Immunology; Medicine; Bioinformatics; Genetics; Gene; Antigen","score_opus":0.0184548152876578,"score_gpt":0.2451735464951082,"score_spread":0.2267187312074504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885865993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345636,0.00009713172,0.0013857208,0.000020347132,0.0002299076,0.00046202992,0.000045124387,0.000027610433,0.004275776],"genre_scores_gemma":[0.99818623,0.0002115007,0.0011393158,0.000030276535,0.00004887947,0.00001591023,0.000072156654,0.000024593415,0.0002711598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853486,0.000067183915,0.00068650435,0.00023947973,0.00028881515,0.00018314034],"domain_scores_gemma":[0.9992864,0.00006875701,0.000197068,0.0002740926,0.000105674575,0.00006798723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027820744,0.00013116535,0.00034519433,0.00022151133,0.000019584755,0.0000024650537,0.00008493804,0.00016435974,0.00010180342],"category_scores_gemma":[0.000006092737,0.00012906652,0.00007316865,0.00025520503,0.000107276515,0.000062510226,0.0000070098035,0.0001171051,0.000055683427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073712977,0.00014574232,0.3268233,0.0021454676,0.000035694473,0.000043515658,0.0071753813,0.00009022458,0.6614992,0.000112959344,0.00007203698,0.001119349],"study_design_scores_gemma":[0.0029505617,0.00041943172,0.4786876,0.00069234107,0.00016251758,0.00010941041,0.00019485591,0.0004891008,0.5161179,0.00005697192,0.000037730915,0.000081614504],"about_ca_topic_score_codex":0.000085401225,"about_ca_topic_score_gemma":0.000025106217,"teacher_disagreement_score":0.1518643,"about_ca_system_score_codex":0.00025120514,"about_ca_system_score_gemma":0.00019529472,"threshold_uncertainty_score":0.526318},"labels":[],"label_agreement":null},{"id":"W2887418186","doi":"10.1038/s41375-018-0227-5","title":"The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent","keywords":"Medicine; Myeloid leukemia; Internal medicine; Oncology; Proportional hazards model; Multivariate analysis; Myeloid; Quartile; Risk stratification; Gene signature; Clinical significance; Leukemia; Gene; Gene expression; Biology; Confidence interval","score_opus":0.012333704885818317,"score_gpt":0.2658568440210441,"score_spread":0.2535231391352258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887418186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134374,0.0010586955,0.00025474565,0.000479144,0.00038415045,0.0012235194,0.000047989786,0.00021642122,0.0049915942],"genre_scores_gemma":[0.9832367,0.0031907007,0.00093490304,0.00029710744,0.001104703,0.00015197994,0.00017603481,0.000104852494,0.010803074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99571973,0.00048600088,0.0008078505,0.00085868983,0.0010654341,0.0010622882],"domain_scores_gemma":[0.99696773,0.00053855823,0.00047062756,0.0012200953,0.00045096796,0.00035199051],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014497407,0.0004508195,0.0005082369,0.00031811863,0.0006499995,0.00013716676,0.0007250531,0.00075030065,0.00009473382],"category_scores_gemma":[0.0002608517,0.00032032584,0.00018683335,0.0013766938,0.0002562485,0.00025110116,0.00022890119,0.0020536394,0.00046678216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022311625,0.0002809793,0.072798334,0.00016366695,0.00028137118,0.0004212828,0.0031849646,0.00025548314,0.7796351,0.00013060482,0.11806803,0.02254907],"study_design_scores_gemma":[0.014235619,0.0016207823,0.31952173,0.00024078842,0.0008327237,0.00009404658,0.0012900807,0.020192008,0.6282214,0.0006121882,0.0117429495,0.0013956855],"about_ca_topic_score_codex":0.00030212692,"about_ca_topic_score_gemma":0.0002768814,"teacher_disagreement_score":0.24672338,"about_ca_system_score_codex":0.0059825876,"about_ca_system_score_gemma":0.002802807,"threshold_uncertainty_score":0.9999249},"labels":[],"label_agreement":null},{"id":"W2891752553","doi":"10.1038/s41375-018-0247-1","title":"Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?","year":2018,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Clinical trial; Adverse effect; Internal medicine; Intensive care medicine; Cancer; Oncology","score_opus":0.2008790955792837,"score_gpt":0.4662470239497821,"score_spread":0.2653679283704984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891752553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004264758,0.9810921,0.00019565178,0.00087527797,0.0017848309,0.009849315,0.00011022978,0.00014507074,0.0016827856],"genre_scores_gemma":[0.00028068095,0.97679114,0.0009349369,0.0019009829,0.0076343534,0.0015475989,0.0005181774,0.00037301384,0.010019084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98300415,0.0036451556,0.0070136,0.0032366326,0.001504419,0.0015960514],"domain_scores_gemma":[0.98977286,0.0020967042,0.0016138903,0.0048885173,0.0005489781,0.0010790491],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.021014642,0.0017200513,0.012461051,0.00076186884,0.00023932905,0.000055846947,0.00125547,0.001987941,0.00026119736],"category_scores_gemma":[0.013497202,0.0011709036,0.004502034,0.0015166973,0.00019551402,0.00014901192,0.0014281864,0.0020699697,0.003748928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00025540724,0.000041781568,0.0011398819,0.004584539,0.008794546,0.0025498974,0.00010294594,0.000095981195,0.0000031916243,0.000002345925,0.124885015,0.8575445],"study_design_scores_gemma":[0.004358084,0.00051117013,0.0007830921,0.020934682,0.008373742,0.0051715006,0.00003668419,0.000094133546,0.0000028153759,0.000017222648,0.95875007,0.00096682424],"about_ca_topic_score_codex":0.0011220626,"about_ca_topic_score_gemma":0.000060099814,"teacher_disagreement_score":0.85657763,"about_ca_system_score_codex":0.034550376,"about_ca_system_score_gemma":0.020131668,"threshold_uncertainty_score":0.9995546},"labels":[],"label_agreement":null},{"id":"W2892949113","doi":"10.1038/s41375-018-0257-z","title":"Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; National Institute for Health and Care Research; Celgene","keywords":"Azacitidine; Medicine; Internal medicine; Myeloid leukemia; Cytogenetics; Cytarabine; Oncology; Myelodysplastic syndromes; Leukemia; Neuroblastoma RAS viral oncogene homolog; Karyotype; Decitabine; Gastroenterology; Cancer; Biology; Bone marrow; Chromosome; Genetics; DNA methylation; Gene","score_opus":0.012867545244878556,"score_gpt":0.27467918526775975,"score_spread":0.2618116400228812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892949113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997288,0.00006611674,0.00018354351,0.00010042175,0.000035621844,0.0010861793,0.00017263654,0.00008321832,0.0009842593],"genre_scores_gemma":[0.9928921,0.000066165245,0.004535171,0.00024928083,0.00014151081,0.00011354599,0.0007836035,0.00008324736,0.0011353868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974627,0.00008456513,0.00040455224,0.0006600598,0.0007599301,0.0006281958],"domain_scores_gemma":[0.99794096,0.00011862858,0.00012757622,0.00047068708,0.0009998279,0.0003422941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012254388,0.0003817322,0.0004878331,0.00032890675,0.000195796,0.000055805922,0.00018466469,0.00020844852,0.00018978883],"category_scores_gemma":[0.00007778255,0.00026513965,0.00004209106,0.0009033626,0.00075869623,0.00020094764,0.00011105936,0.00045472427,0.000050995808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004491194,0.000099735495,0.98711944,0.00014855652,0.00034204844,0.0006755729,0.0011167299,0.0001377482,0.0036869345,0.00006358232,0.00018469343,0.0019337495],"study_design_scores_gemma":[0.018748678,0.0029147707,0.9611791,0.00031042166,0.00027005878,0.00024262637,0.00045589017,0.00048912794,0.014500373,0.000015583413,0.0004479757,0.00042540848],"about_ca_topic_score_codex":0.0005927705,"about_ca_topic_score_gemma":0.0009252141,"teacher_disagreement_score":0.025940368,"about_ca_system_score_codex":0.0024971988,"about_ca_system_score_gemma":0.0026826104,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W2893765519","doi":"10.1038/s41375-018-0265-z","title":"Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Vanderbilt University; York University; Eberhard Karls Universität Tübingen; McMaster University; NYU Langone Medical Center; Kaiser Permanente","keywords":"Medicine; Refractory (planetary science); Minimal residual disease; Salvage therapy; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Lymphoblastic Leukemia; Leukemia; Chemotherapy; Pediatrics; Oncology","score_opus":0.008638915841045569,"score_gpt":0.25025952232160636,"score_spread":0.2416206064805608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893765519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543686,0.00008454445,0.00040565757,0.00011020776,0.00039869585,0.0010055811,0.000033932403,0.00022928188,0.012295265],"genre_scores_gemma":[0.993571,0.00009825661,0.0013852152,0.0009124881,0.0010191038,0.000076313765,0.00014347343,0.00017475247,0.0026194064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951159,0.00013233477,0.00081235135,0.0010783982,0.001470884,0.0013901681],"domain_scores_gemma":[0.99703366,0.00039035256,0.0002673417,0.0011452305,0.00057082996,0.00059256406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033547793,0.00062479486,0.0008315042,0.0009417157,0.00018663931,0.000061606544,0.00053340767,0.00051092525,0.0004101118],"category_scores_gemma":[0.00044394724,0.00049915945,0.00013718053,0.0017930581,0.0005100268,0.00040002595,0.00029288192,0.00093514466,0.0015905346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011440231,0.0009078811,0.94051737,0.00053728773,0.0004748441,0.0019175243,0.0018003121,0.00014745901,0.001891224,0.0003166382,0.030938014,0.009111197],"study_design_scores_gemma":[0.04077924,0.0050082905,0.9426511,0.0003794248,0.0005885451,0.00017159522,0.00009621889,0.004569176,0.0010268901,0.0001405993,0.0036312346,0.0009577061],"about_ca_topic_score_codex":0.0004241764,"about_ca_topic_score_gemma":0.00016943517,"teacher_disagreement_score":0.02933901,"about_ca_system_score_codex":0.018660018,"about_ca_system_score_gemma":0.00747789,"threshold_uncertainty_score":0.999746},"labels":[],"label_agreement":null},{"id":"W2893881916","doi":"10.1038/s41375-018-0297-4","title":"Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Blood Cancer UK; National Cancer Research Institute; Kay Kendall Leukaemia Fund; Wellcome Trust; Hospital for Sick Children; Leuka","keywords":"Multiplex; Biology; Copy-number variation; Exome sequencing; Molecular biology; Genetics; Gene; Mutation; Genome","score_opus":0.011017656103155771,"score_gpt":0.26166252455544525,"score_spread":0.2506448684522895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893881916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994391,0.00021920062,0.00024543534,0.00015996699,0.00020944011,0.00086518575,0.000042752028,0.000105748186,0.0037612307],"genre_scores_gemma":[0.9873297,0.0001930048,0.00053248036,0.0003647774,0.00009427905,0.000072805706,0.0000754224,0.00010357572,0.011233913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533516,0.00015340564,0.00086538284,0.0012740585,0.0011723543,0.0011996212],"domain_scores_gemma":[0.9976224,0.0002878611,0.00025965736,0.0009454852,0.00020468669,0.00067996763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062869344,0.00062221865,0.0012430573,0.0013788919,0.0002583121,0.00016283707,0.00040725156,0.0004402482,0.00039026845],"category_scores_gemma":[0.00016200566,0.00057179766,0.00020233078,0.0019544493,0.00063651166,0.00050947675,0.000572209,0.0005077689,0.0005825514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042914217,0.0011286727,0.72270226,0.0018606782,0.010180329,0.022796491,0.0081324745,0.00007963261,0.22271478,0.000066987304,0.002804942,0.0032413315],"study_design_scores_gemma":[0.012142519,0.0022263445,0.9714848,0.000662632,0.0027657032,0.0024337494,0.00019837901,0.0036860625,0.0030058313,0.00037160557,0.0002491447,0.00077327],"about_ca_topic_score_codex":0.0029972773,"about_ca_topic_score_gemma":0.00031023694,"teacher_disagreement_score":0.2487825,"about_ca_system_score_codex":0.002953228,"about_ca_system_score_gemma":0.0008283124,"threshold_uncertainty_score":0.99967337},"labels":[],"label_agreement":null},{"id":"W2897636215","doi":"10.1038/s41375-018-0276-9","title":"Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McMaster University; Juravinski Cancer Centre","funders":"Cilag; Pharmacyclics; H. Lundbeck A/S; Astellas Pharma; Genentech; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Amgen","keywords":"Ibrutinib; Bendamustine; Chronic lymphocytic leukemia; Medicine; Internal medicine; Rituximab; Placebo; Ofatumumab; Hazard ratio; Alemtuzumab; Oncology; Lymphoma; Gastroenterology; Leukemia; Confidence interval; Pathology; Transplantation","score_opus":0.028886440725654154,"score_gpt":0.30821709139374126,"score_spread":0.2793306506680871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897636215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925456,0.0016674206,0.00002037401,0.00016052242,0.00048921595,0.002681098,0.00021517466,0.000220651,0.0019999542],"genre_scores_gemma":[0.9961321,0.00022022484,0.00031031598,0.00051692955,0.0012633805,0.0001337467,0.00029646876,0.00015909976,0.00096778624],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928102,0.00053502916,0.0021088044,0.0017081039,0.0013602886,0.0014775834],"domain_scores_gemma":[0.9942147,0.0015408251,0.00060491805,0.0026074995,0.000495976,0.0005360444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015566128,0.0008259388,0.0015522422,0.00053817633,0.00034692814,0.00011083432,0.001005819,0.00053555856,0.00022436457],"category_scores_gemma":[0.0016450346,0.00063748844,0.00020370242,0.0020089922,0.0012109004,0.00018138018,0.0007392572,0.0005778529,0.00029582172],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.26623288,0.024149688,0.010826034,0.0040389425,0.008905026,0.023508757,0.1291145,0.006705713,0.08028851,0.0009821561,0.0889323,0.35631552],"study_design_scores_gemma":[0.6766621,0.006310464,0.007347339,0.00115829,0.0006688796,0.00071190775,0.003499911,0.28488412,0.014078563,0.00011478026,0.0036811894,0.000882435],"about_ca_topic_score_codex":0.059127003,"about_ca_topic_score_gemma":0.0068889423,"teacher_disagreement_score":0.41042924,"about_ca_system_score_codex":0.18189262,"about_ca_system_score_gemma":0.07704456,"threshold_uncertainty_score":0.9996076},"labels":[],"label_agreement":null},{"id":"W2904444738","doi":"10.1038/s41375-018-0321-8","title":"HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Imatinib; Biomarker; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; Imatinib mesylate; Medicine; Haematopoiesis; Myeloid; Oncology; Biology; Stem cell; Internal medicine; Cancer; Genetics; Receptor","score_opus":0.01940578935515964,"score_gpt":0.3067759477697558,"score_spread":0.2873701584145962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904444738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868954,0.0010753524,0.00411205,0.0013087683,0.00028113366,0.003716241,0.00009219737,0.00021532376,0.002303549],"genre_scores_gemma":[0.9847549,0.000113919436,0.006599694,0.004272216,0.00046835945,0.0011723097,0.00008635025,0.00017540499,0.0023568238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99626726,0.00019194478,0.0007320417,0.0011067115,0.00059067074,0.0011113685],"domain_scores_gemma":[0.99743104,0.00038094807,0.00018200952,0.0012409486,0.00030660466,0.00045844575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007574766,0.00059843686,0.00077140843,0.00054407155,0.00015357613,0.000049023023,0.00038010697,0.00040709117,0.00061425276],"category_scores_gemma":[0.00047201657,0.00054324087,0.00030745554,0.00095121923,0.000249268,0.0001650437,0.0001414856,0.00035700048,0.0005570075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06618299,0.00034058306,0.006624488,0.00033272407,0.0013054366,0.00064521795,0.010647773,0.00029424054,0.76712257,0.00010976904,0.024206188,0.12218804],"study_design_scores_gemma":[0.07820289,0.017647937,0.21146064,0.0015522985,0.00041421416,0.00037011263,0.0005807599,0.05996357,0.49716407,0.0008011283,0.12997296,0.0018694345],"about_ca_topic_score_codex":0.00034366397,"about_ca_topic_score_gemma":0.00011259221,"teacher_disagreement_score":0.2699585,"about_ca_system_score_codex":0.0279196,"about_ca_system_score_gemma":0.0058219293,"threshold_uncertainty_score":0.99981415},"labels":[],"label_agreement":null},{"id":"W2905008735","doi":"10.1038/s41375-018-0307-6","title":"Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Minimal residual disease; Medicine; Hazard ratio; Risk stratification; Internal medicine; Cumulative incidence; Oncology; Flow cytometry; Leukemia; Immunology; Confidence interval; Cohort","score_opus":0.01391951932901362,"score_gpt":0.27943743343600896,"score_spread":0.2655179141069953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905008735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986821,0.00040384344,0.006111269,0.00058077485,0.00030249197,0.0014839257,0.00031772096,0.00027583243,0.0037031472],"genre_scores_gemma":[0.9847649,0.0002752406,0.0059857443,0.00031971475,0.00065113243,0.00024090198,0.00086127076,0.000129062,0.0067720637],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9950506,0.00022904725,0.00104444,0.001316582,0.0012757226,0.0010835722],"domain_scores_gemma":[0.9965028,0.00046780205,0.00039389284,0.0014166337,0.00047804078,0.00074081286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090646424,0.00052522076,0.0006048629,0.0006464264,0.00031614423,0.00016979058,0.0005395475,0.0004229949,0.0002851816],"category_scores_gemma":[0.0012472541,0.0004935101,0.00014495672,0.0015775987,0.0006037911,0.00048338537,0.00015758615,0.00069069077,0.0012969133],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012844075,0.0011643791,0.081298634,0.0011742245,0.00038271127,0.0006560494,0.001494779,0.0009056324,0.54273665,0.00044596128,0.34485734,0.012039539],"study_design_scores_gemma":[0.025037266,0.0028364782,0.20748112,0.00096454215,0.0014072336,0.00017492939,0.00080190884,0.5667002,0.17992185,0.0012829634,0.0113941,0.0019974052],"about_ca_topic_score_codex":0.0009793887,"about_ca_topic_score_gemma":0.00008596721,"teacher_disagreement_score":0.5657946,"about_ca_system_score_codex":0.008987706,"about_ca_system_score_gemma":0.0071443217,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W2905344869","doi":"10.1038/s41375-018-0312-9","title":"Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":489,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"European Hematology Association; Pfizer","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Myeloid leukemia; Oncology; Confidence interval","score_opus":0.008878858709095296,"score_gpt":0.24681879256374548,"score_spread":0.23793993385465018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905344869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964133,0.00008726975,0.0018201122,0.00002025409,0.00018016648,0.0012717339,0.00008777026,0.000044836925,0.00007455473],"genre_scores_gemma":[0.9950094,0.00008167533,0.0036836818,0.000098230215,0.0001450715,0.00017492009,0.00018434225,0.00009614209,0.0005265036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99708796,0.00028611792,0.00073241745,0.0007971582,0.00047350992,0.000622862],"domain_scores_gemma":[0.99791217,0.00026739074,0.0005876924,0.0006959009,0.00036540683,0.00017146466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037076641,0.0005737564,0.0015055822,0.00016662925,0.00014875211,0.000033478955,0.00041409908,0.00028808028,0.000040006325],"category_scores_gemma":[0.00047602315,0.00034374374,0.00010896086,0.00047281967,0.0008657203,0.000017958317,0.00017827879,0.00031193314,0.000025615673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6038018,0.0005797527,0.36928043,0.0002978222,0.0023123284,0.00022515398,0.0016494631,0.0037285099,0.015440856,0.0000142898125,0.0009780434,0.0016915945],"study_design_scores_gemma":[0.68015784,0.018060198,0.21235332,0.0011962844,0.0011603687,0.00006119907,0.00035952425,0.002793081,0.08148793,0.000019934592,0.00057522487,0.0017751066],"about_ca_topic_score_codex":0.00053973607,"about_ca_topic_score_gemma":0.00229722,"teacher_disagreement_score":0.15692711,"about_ca_system_score_codex":0.0002934675,"about_ca_system_score_gemma":0.00094666006,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W2908744276","doi":"10.1038/s41375-018-0351-2","title":"TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; National Institute of Diabetes and Digestive and Kidney Diseases; Blood Cancer UK; Deutsche Forschungsgemeinschaft; National Cancer Institute; Washington University in St. Louis; Vanderbilt University; National Institute for Health and Care Research; Associazione Italiana per la Ricerca sul Cancro; Celgene","keywords":"Myelodysplastic syndromes; International Prognostic Scoring System; Internal medicine; Monosomy; Karyotype; Biology; Oncology; Chromosome 7 (human); Genetics; Medicine; Chromosome; Bone marrow; Gene","score_opus":0.017877490743142606,"score_gpt":0.2753827537101337,"score_spread":0.2575052629669911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908744276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937315,0.00016400951,0.00080641295,0.00043632044,0.00013337279,0.0013910943,0.000022507209,0.0002763481,0.0073968084],"genre_scores_gemma":[0.9925908,0.00002567593,0.0037939684,0.00024406046,0.0001545722,0.00010490449,0.00054278714,0.000102871534,0.0024403944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705684,0.000106372056,0.00040709888,0.00067482184,0.0008797717,0.00087511935],"domain_scores_gemma":[0.99780655,0.0007490672,0.0001476693,0.0006304902,0.00024462232,0.0004216203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024369279,0.0003894188,0.0006026832,0.00028761872,0.00016048494,0.00009502913,0.00024417092,0.00016274517,0.00080927025],"category_scores_gemma":[0.0005191443,0.0002928454,0.000092272676,0.00064228417,0.0002835987,0.00023472763,0.000150525,0.0005305617,0.0013675035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016031737,0.0001547783,0.97198796,0.0014394469,0.0004109018,0.0012666893,0.0012182285,0.00035474275,0.007338852,0.0012259228,0.003219278,0.0097800465],"study_design_scores_gemma":[0.00476724,0.0020149553,0.9744233,0.0004898484,0.0002720272,0.0007785914,0.00037474532,0.009795966,0.0007331371,0.0004282929,0.0054346886,0.00048721305],"about_ca_topic_score_codex":0.00070538133,"about_ca_topic_score_gemma":0.0002531776,"teacher_disagreement_score":0.009441223,"about_ca_system_score_codex":0.0019881902,"about_ca_system_score_gemma":0.0013622575,"threshold_uncertainty_score":0.9999524},"labels":[],"label_agreement":null},{"id":"W2913456279","doi":"10.1038/s41375-019-0381-4","title":"Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Glucocorticoid receptor; Cancer research; Biology; Leukemia; Internal medicine; Glucocorticoid; Pharmacology; Immunology; Medicine","score_opus":0.014529211504162443,"score_gpt":0.27968211880645083,"score_spread":0.2651529073022884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913456279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761593,0.0014952504,0.000018187093,0.00028007032,0.000922537,0.003194146,0.000008223348,0.00025172526,0.017670592],"genre_scores_gemma":[0.9718464,0.00046366005,0.00031064663,0.001045236,0.0006096399,0.00021993261,0.00006634717,0.00014852747,0.025289634],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9946394,0.00020910022,0.0009970515,0.0012440238,0.0012854665,0.0016249844],"domain_scores_gemma":[0.9959452,0.00062173797,0.00024265228,0.0026769857,0.00015341656,0.00036000175],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011308626,0.000539117,0.00090220256,0.0002708327,0.00011165202,0.00012655392,0.0008396055,0.00047279868,0.0021341855],"category_scores_gemma":[0.00025864306,0.00039166314,0.0003635153,0.0013667453,0.00035237876,0.00021020252,0.0004269113,0.0011318449,0.013409292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008033041,0.0003863265,0.021396553,0.007708874,0.0013510269,0.0027236098,0.006459348,0.07079414,0.66518694,0.004170879,0.072800085,0.13898918],"study_design_scores_gemma":[0.09851997,0.0023461154,0.0061073615,0.002037149,0.00025064708,0.001110718,0.0012732255,0.4530638,0.1460865,0.00024283078,0.28727067,0.0016910358],"about_ca_topic_score_codex":0.0058479942,"about_ca_topic_score_gemma":0.00020089319,"teacher_disagreement_score":0.5191004,"about_ca_system_score_codex":0.37440866,"about_ca_system_score_gemma":0.10043522,"threshold_uncertainty_score":0.99985355},"labels":[],"label_agreement":null},{"id":"W2913683730","doi":"10.1038/s41375-019-0386-z","title":"A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ministry of Science and Technology, Israel; Israel Science Foundation; Council for Higher Education; Israel Cancer Research Fund","keywords":"Biology; Haematopoiesis; Leukemia; Stem cell; Cancer research; Population; Transcriptome; Immunology; Genetics; Gene expression; Gene; Medicine","score_opus":0.01872517658327876,"score_gpt":0.2959579050251315,"score_spread":0.2772327284418527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913683730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877773,0.00015962169,0.008989348,0.00051616196,0.00009902228,0.0021978926,0.00011372111,0.00006173473,0.00008518314],"genre_scores_gemma":[0.9937716,0.000013215514,0.0031163103,0.0004465849,0.000103327904,0.00010324319,0.000024258567,0.00007590438,0.0023455317],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974361,0.00025809408,0.0005072685,0.0006614939,0.00041866847,0.00071834336],"domain_scores_gemma":[0.99768025,0.0010742121,0.00015129588,0.00060862186,0.00010254895,0.0003830631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022772239,0.00033539548,0.0006203326,0.00019724619,0.00021837054,0.00007897477,0.0001509895,0.00011332404,0.00001301974],"category_scores_gemma":[0.00020694666,0.00025283766,0.00010540616,0.00025699998,0.00017267745,0.00013332703,0.00029362753,0.0007781301,0.0000065001236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010748167,0.000078442565,0.16719924,0.002861983,0.00012230803,0.00030715318,0.0042335144,0.00063506793,0.8193813,0.000120244105,0.00017481335,0.0038111305],"study_design_scores_gemma":[0.035774235,0.0006738079,0.31372595,0.0012733722,0.000768864,0.00081731175,0.0056230687,0.42098093,0.21686675,0.0009116088,0.00079393294,0.0017901814],"about_ca_topic_score_codex":0.0031193162,"about_ca_topic_score_gemma":0.000816375,"teacher_disagreement_score":0.60251456,"about_ca_system_score_codex":0.0011624134,"about_ca_system_score_gemma":0.0006477614,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W2914157523","doi":"10.1038/s41375-018-0374-8","title":"Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma","year":2019,"lang":"en","type":"letter","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Emory University; U.S. Department of Health and Human Services","keywords":"Venetoclax; Multiple myeloma; Medicine; Oncology; Immunology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.06348571096583726,"score_gpt":0.3297354700999637,"score_spread":0.2662497591341264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914157523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95399046,0.00010109048,0.000037871192,0.04237746,0.0006060605,0.0018845294,0.00056204776,0.00006656347,0.000373895],"genre_scores_gemma":[0.935045,0.00004155669,0.0011428741,0.052306,0.0028600814,0.00011894641,0.0029640824,0.00012153908,0.005399944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555296,0.0011089385,0.00087484816,0.0007814476,0.0009907102,0.00069107424],"domain_scores_gemma":[0.99507135,0.0033991914,0.00028974816,0.00085125637,0.00022155221,0.00016689986],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001506705,0.00039981198,0.0011234873,0.0004249699,0.000045929755,0.000014008981,0.00012257186,0.0012213669,0.00009774354],"category_scores_gemma":[0.002725073,0.00034896383,0.0003896275,0.0002612885,0.00023529337,0.00005040334,0.00013708933,0.0030242847,0.00015551769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02116636,0.00015416808,0.64366865,0.0009852786,0.0006099112,0.010207966,0.0000615219,0.0001814888,0.0034952615,0.0000015863914,0.31653568,0.0029321497],"study_design_scores_gemma":[0.01045048,0.0011964246,0.94314706,0.0008141705,0.00013565955,0.00021385605,0.000019206545,0.008061323,0.0027752444,0.000010003128,0.032852,0.00032458158],"about_ca_topic_score_codex":0.0010527261,"about_ca_topic_score_gemma":0.00014740576,"teacher_disagreement_score":0.2994784,"about_ca_system_score_codex":0.002502621,"about_ca_system_score_gemma":0.00529088,"threshold_uncertainty_score":0.9998962},"labels":[],"label_agreement":null},{"id":"W2918528718","doi":"10.1038/s41375-019-0426-8","title":"Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia","year":2019,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Vanderbilt University","keywords":"Medicine; Family medicine; University hospital; General hospital; Pediatrics; Library science; Gerontology","score_opus":0.00758178584025361,"score_gpt":0.24131255076013094,"score_spread":0.23373076491987732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918528718","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5463365,0.00272291,0.0004700938,0.0003305875,0.12005321,0.009081493,0.00062423624,0.00127878,0.3191022],"genre_scores_gemma":[0.19751337,0.0026574451,0.00040611715,0.0014064761,0.0074764714,0.00035113405,0.0066110073,0.0010595426,0.78251845],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9903719,0.00027734888,0.0016291181,0.0023504011,0.0032162738,0.0021549813],"domain_scores_gemma":[0.9940823,0.000883521,0.0009794263,0.002381226,0.00088022253,0.00079330604],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00043258807,0.0017086333,0.0025819642,0.0023126504,0.00020429998,0.00014408465,0.0010709425,0.003059924,0.00064372504],"category_scores_gemma":[0.00083236874,0.0014469861,0.00044437326,0.0025364023,0.0003506514,0.00047373565,0.0005746373,0.006448973,0.0027863265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003499043,0.00035396777,0.041808028,0.001296325,0.00047897437,0.0013971736,0.0002799158,0.00029079785,0.000015450896,0.000010529355,0.94877,0.0017998335],"study_design_scores_gemma":[0.07729522,0.009064475,0.5427128,0.006461933,0.004714281,0.0008447977,0.00019742291,0.01879319,0.000057699828,0.000051176437,0.33515897,0.0046479856],"about_ca_topic_score_codex":0.0009144365,"about_ca_topic_score_gemma":0.0002740873,"teacher_disagreement_score":0.613611,"about_ca_system_score_codex":0.064309865,"about_ca_system_score_gemma":0.04039166,"threshold_uncertainty_score":0.999566},"labels":[],"label_agreement":null},{"id":"W2921339524","doi":"10.1038/s41375-019-0424-x","title":"Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL","year":2019,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pharmacyclics; Genentech; China Scholarship Council; Prothena; Kite Pharma; Eberhard Karls Universität Tübingen; McMaster University; Gilead Sciences; Vanderbilt University; PharmaMar; Celgene; Amyloidosis Foundation; Teva Pharmaceutical Industries; Kaiser Permanente; Alnylam Pharmaceuticals; European Regional Development Fund; Sanofi; York University; Bristol-Myers Squibb; Cilag; NYU Langone Medical Center; Instituto de Salud Carlos III; Amgen","keywords":"Translation (biology); Internal ribosome entry site; Biology; Mutation; Ribosomal RNA; Ribosome; Virology; Genetics; Computational biology; Gene; RNA; Messenger RNA","score_opus":0.025697381962529464,"score_gpt":0.3027038462777395,"score_spread":0.27700646431521003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921339524","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03269792,0.009445653,0.003441426,0.014667559,0.13320847,0.010508039,0.00023086244,0.0008762869,0.7949238],"genre_scores_gemma":[0.19332209,0.0016410836,0.00024705482,0.001385511,0.0065472713,0.00032338,0.0033393311,0.00029316248,0.7929011],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537957,0.0003220256,0.0008758497,0.00091523776,0.0017083014,0.00079902285],"domain_scores_gemma":[0.99743354,0.0008087496,0.00035171272,0.0009853712,0.00022441628,0.00019619672],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006391647,0.0005917171,0.00087241596,0.0005621363,0.00014251882,0.000116020296,0.0004685315,0.0013352324,0.0004339477],"category_scores_gemma":[0.00047403967,0.0004403992,0.0003092209,0.0006239914,0.0002114649,0.00022257821,0.000114018614,0.0032903652,0.00089376396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006253143,0.000092722425,0.00044755626,0.00051118387,0.00024057517,0.0005720051,0.0021060563,0.00057670573,0.00048559805,0.000054534947,0.9710768,0.023210976],"study_design_scores_gemma":[0.01307397,0.0009700069,0.025396336,0.002791883,0.0007508107,0.0015921768,0.0013266698,0.16887441,0.0004652736,0.00033992325,0.7832229,0.0011956352],"about_ca_topic_score_codex":0.0013362004,"about_ca_topic_score_gemma":0.0010007088,"teacher_disagreement_score":0.18785386,"about_ca_system_score_codex":0.0077488758,"about_ca_system_score_gemma":0.005844819,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W2950655888","doi":"10.1038/s41375-019-0512-y","title":"Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia","year":2019,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institute for Health and Care Research; Howard Hughes Medical Institute","keywords":"Myeloid leukemia; Disease; Medicine; Drug resistance; Cancer; Bioinformatics; Intensive care medicine; Oncology; Internal medicine; Biology; Genetics","score_opus":0.05262389046321067,"score_gpt":0.3617774958511126,"score_spread":0.30915360538790193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950655888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088867615,0.98429143,0.001363216,0.00012652572,0.0007751115,0.010299636,0.00015751006,0.00016023875,0.0019376632],"genre_scores_gemma":[0.0006414769,0.9870182,0.003526612,0.00028748377,0.0011362546,0.0026400378,0.002623463,0.00031543017,0.0018110342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950126,0.00040246014,0.0015952218,0.001303146,0.0006447648,0.0010418036],"domain_scores_gemma":[0.9949392,0.0016397726,0.0011862805,0.0019001133,0.00013372833,0.00020091102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012169243,0.0010555625,0.0029504215,0.00043682937,0.00025045255,0.00013475903,0.00068236794,0.0008967265,0.00027913452],"category_scores_gemma":[0.00028352605,0.0007228065,0.0012883822,0.00060241664,0.00014326724,0.00013141677,0.00017252559,0.00210843,0.0006750755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007772046,0.000056099925,0.00027112948,0.023185553,0.00061828987,0.00003613306,0.00004432581,0.0007755064,0.000013547032,0.00015421287,0.0011037296,0.97366375],"study_design_scores_gemma":[0.0073389052,0.0004160585,0.0004967458,0.012553832,0.00404287,0.000054347256,0.000021634092,0.0075505013,0.0000070908413,0.000060496648,0.96678746,0.00067006744],"about_ca_topic_score_codex":0.00060133764,"about_ca_topic_score_gemma":0.00015358298,"teacher_disagreement_score":0.9729937,"about_ca_system_score_codex":0.12828366,"about_ca_system_score_gemma":0.04988622,"threshold_uncertainty_score":0.9995223},"labels":[],"label_agreement":null},{"id":"W2952863579","doi":"10.1038/s41375-019-0505-x","title":"The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"European Hematology Association","keywords":"Myeloid leukemia; Myeloid; Internal medicine; Medicine; Oncology; Leukemia; Angiogenesis; Receptor; Cancer research; Biology; Immunology","score_opus":0.013890176045384707,"score_gpt":0.2434346588322465,"score_spread":0.2295444827868618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952863579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271303,0.00012551362,0.000012411835,0.0008463967,0.0019966832,0.0006301788,0.00004923754,0.00016641013,0.003460132],"genre_scores_gemma":[0.9702119,0.00073190127,0.00012664692,0.011494729,0.000337114,0.0000464464,0.000010109093,0.00011941175,0.016921692],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960633,0.00049695413,0.00062989676,0.001193578,0.00049895165,0.001117334],"domain_scores_gemma":[0.99824536,0.00038052478,0.0002454666,0.0008896392,0.00005131382,0.00018768769],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002449822,0.00048211167,0.00048437857,0.00011644305,0.00036984036,0.0002075882,0.0012555446,0.00019053281,0.0007893739],"category_scores_gemma":[0.000097352895,0.00034882087,0.00026324773,0.00065865833,0.00028191876,0.00033180253,0.0004193605,0.0010349228,0.005503084],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038756282,0.000029547002,0.00035175818,0.000012671821,0.000015485008,0.00005481336,0.00015160438,0.00034117323,0.98318076,0.0010616521,0.010908786,0.0035041946],"study_design_scores_gemma":[0.0018129899,0.00069729914,0.0053816414,0.000054992895,0.000024625444,0.00006896339,0.00008085143,0.0034067987,0.45368636,0.0010216096,0.5329883,0.00077554863],"about_ca_topic_score_codex":0.0002022196,"about_ca_topic_score_gemma":0.000013834173,"teacher_disagreement_score":0.5294944,"about_ca_system_score_codex":0.00068616495,"about_ca_system_score_gemma":0.00038969287,"threshold_uncertainty_score":0.9998964},"labels":[],"label_agreement":null},{"id":"W2958858057","doi":"10.1038/s41375-019-0485-x","title":"Genetic characterization of ABT-199 sensitivity in human AML","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Université du Québec; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Biology; Cancer research; Computational biology; Genetics; Oncology","score_opus":0.012969382715629836,"score_gpt":0.2766586464065515,"score_spread":0.26368926369092166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958858057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962378,0.000011963714,0.00009526584,0.00016278651,0.000064637185,0.0005159449,0.000008334587,0.00003330147,0.0028699464],"genre_scores_gemma":[0.9970368,0.000020696061,0.0002597304,0.0002504645,0.00011092004,0.00000906867,0.000081292725,0.000028801876,0.0022022207],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998773,0.00007626004,0.00029604614,0.00026726894,0.000304954,0.00028249365],"domain_scores_gemma":[0.9992628,0.000046243415,0.0000889589,0.00042923048,0.00008641927,0.00008635889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028899263,0.00012287819,0.0003390936,0.00021927796,0.000020265965,0.000008142073,0.00007516822,0.00014211364,0.00025806014],"category_scores_gemma":[0.000046656063,0.00011810429,0.00005956801,0.00032879785,0.00006139948,0.00007839455,0.000072249706,0.00032390293,0.0002022046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007073875,0.000031893975,0.2014738,0.00013482763,0.000013384994,0.000080624115,0.00017696574,0.00002082987,0.7960047,0.00010715048,0.00006594605,0.0018190987],"study_design_scores_gemma":[0.0018003539,0.0001388802,0.90017813,0.000111595764,0.000013418811,0.00004414454,0.000027197731,0.0026546712,0.09431138,0.00002884425,0.00058865105,0.00010272266],"about_ca_topic_score_codex":0.00045374018,"about_ca_topic_score_gemma":0.000052624706,"teacher_disagreement_score":0.70169336,"about_ca_system_score_codex":0.00088662544,"about_ca_system_score_gemma":0.00038718496,"threshold_uncertainty_score":0.48161533},"labels":[],"label_agreement":null},{"id":"W2959447361","doi":"10.1038/s41375-019-0514-9","title":"Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome","year":2019,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Chronic Disease Prevention and Health Promotion; University of California, San Diego; Centers for Disease Control and Prevention; New York State Department of Health; California Department of Public Health; University of Washington; National Institute of Environmental Health Sciences; University of California, Los Angeles; Duke University; Pediatric Cancer Research Foundation; Washington State University; Children's Hospital Los Angeles; National Cancer Institute; Kaiser Permanente; University of Southern California; Cedars-Sinai Medical Center; Alex's Lemonade Stand Foundation for Childhood Cancer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Lymphoblastic Leukemia; Gene; Chromosome; Genetics; Biology; Leukemia; Oncology; Medicine; Cancer research; Internal medicine","score_opus":0.0146532794705063,"score_gpt":0.2701016453979362,"score_spread":0.25544836592742987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959447361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29628593,0.6942685,0.00013835322,0.000078416655,0.00015540872,0.0070497924,0.0010603963,0.00023236255,0.0007308],"genre_scores_gemma":[0.014964873,0.9698279,0.00044612668,0.00030591965,0.00024256507,0.0007207113,0.001680497,0.0005230728,0.011288352],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99306625,0.0005994617,0.001195317,0.0018475952,0.0017479061,0.0015434766],"domain_scores_gemma":[0.9953651,0.0007864342,0.0012261576,0.0018819026,0.00026055123,0.00047989693],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00097484037,0.0014663022,0.0040529026,0.0005567096,0.00038466463,0.0002011166,0.0007375439,0.0012497669,0.00028960867],"category_scores_gemma":[0.00031647878,0.0008397284,0.00033418546,0.0019364269,0.0005559344,0.00030294026,0.00058346713,0.0019431025,0.0004678087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012011644,0.002192698,0.33540866,0.06345158,0.15699244,0.016989268,0.0075096344,0.002429607,0.0004132278,0.00023490402,0.024092535,0.3782738],"study_design_scores_gemma":[0.10187032,0.0113004735,0.31558377,0.13046177,0.09453176,0.18165903,0.00013570175,0.011783038,0.000097146774,0.00014529534,0.14218825,0.010243458],"about_ca_topic_score_codex":0.0024772072,"about_ca_topic_score_gemma":0.00035924118,"teacher_disagreement_score":0.36803034,"about_ca_system_score_codex":0.03004391,"about_ca_system_score_gemma":0.01315167,"threshold_uncertainty_score":0.99980867},"labels":[],"label_agreement":null},{"id":"W2969766498","doi":"10.1038/s41375-019-0546-1","title":"Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing","year":2019,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"Myeloid leukemia; Transcriptome; Genome; Biology; Myeloid; Genetics; Computational biology; Gene; Immunology; Gene expression","score_opus":0.01857236055710469,"score_gpt":0.26149952350665656,"score_spread":0.24292716294955188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969766498","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92843086,0.0030863537,0.0002982108,0.057909336,0.0008732256,0.004002992,0.0024617123,0.00045259733,0.0024847009],"genre_scores_gemma":[0.18614104,0.012058307,0.0038092574,0.52576536,0.005653659,0.0009873138,0.030308245,0.0021659583,0.23311089],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917328,0.00058373006,0.0016863346,0.0023487185,0.0013576543,0.0022907984],"domain_scores_gemma":[0.99612194,0.0005356598,0.00058396044,0.0019761762,0.00029672333,0.00048556484],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0010321237,0.0015066598,0.002465176,0.0017334939,0.0002955318,0.00021229839,0.0011224188,0.003157821,0.00058233837],"category_scores_gemma":[0.0002685924,0.0014277492,0.0005635975,0.0012613246,0.00059511926,0.00046509693,0.00039519876,0.012580844,0.0019221321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00035705746,0.000020707901,0.00077012356,0.0009292064,0.0008249988,0.004333862,0.0011010346,0.00010007675,0.35172078,0.0000035710184,0.63878936,0.0010492336],"study_design_scores_gemma":[0.012688762,0.00060899026,0.007861889,0.0015602409,0.0019823124,0.0011432145,0.0009516022,0.0043978365,0.0016695218,0.0001441935,0.9645398,0.0024516296],"about_ca_topic_score_codex":0.0048035863,"about_ca_topic_score_gemma":0.00012755074,"teacher_disagreement_score":0.74228984,"about_ca_system_score_codex":0.03096319,"about_ca_system_score_gemma":0.008452547,"threshold_uncertainty_score":0.99976826},"labels":[],"label_agreement":null},{"id":"W2970358718","doi":"10.1038/s41375-019-0559-9","title":"MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Rituximab; Follicular lymphoma; Hazard ratio; Gastroenterology; Refractory (planetary science); Surgery; Oncology; Lymphoma; Confidence interval; Leukemia; Biology","score_opus":0.0195550374906363,"score_gpt":0.2789786274909884,"score_spread":0.2594235900003521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970358718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368185,0.0005494192,0.0000013878288,0.00175348,0.00051505025,0.0019906966,0.000039183313,0.00004916014,0.0014197814],"genre_scores_gemma":[0.99180156,0.0000947063,0.0002438623,0.0018602762,0.00039860388,0.00047959757,0.00006617351,0.000048132057,0.0050070705],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972551,0.0003711223,0.00069851335,0.00057125196,0.0005327002,0.0005713378],"domain_scores_gemma":[0.99777746,0.0010184125,0.00014461348,0.0008679281,0.00005023424,0.00014136625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010017026,0.00036562994,0.00071639055,0.00031082978,0.000042766445,0.00003560727,0.00022506865,0.00027579753,0.0010511513],"category_scores_gemma":[0.00051657076,0.00022029715,0.00017292549,0.00056582445,0.00007019728,0.00009608968,0.00008658147,0.00051119376,0.00055823853],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93190885,0.0014960527,0.03768291,0.00018889757,0.00012598235,0.008127376,0.0046821604,0.00032579663,0.0007931988,0.0000958595,0.008447879,0.0061250473],"study_design_scores_gemma":[0.34659174,0.006447457,0.58953077,0.00077265175,0.00021048213,0.00031956483,0.0008018886,0.0010443893,0.00065356726,0.00003380273,0.05309986,0.00049379555],"about_ca_topic_score_codex":0.0011052437,"about_ca_topic_score_gemma":0.0007196342,"teacher_disagreement_score":0.5853171,"about_ca_system_score_codex":0.00395001,"about_ca_system_score_gemma":0.0020699017,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W2970398865","doi":"10.1038/s41375-019-0554-1","title":"Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"F. Hoffmann-La Roche; Roche","keywords":"Fludarabine; Medicine; Obinutuzumab; Cyclophosphamide; Internal medicine; Chronic lymphocytic leukemia; Neutropenia; Tolerability; Gastroenterology; Clinical endpoint; Surgery; Oncology; Adverse effect; Leukemia; Chemotherapy; Clinical trial","score_opus":0.008137454278293835,"score_gpt":0.24417642207480791,"score_spread":0.23603896779651407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970398865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946969,0.0008510995,0.0000035783407,0.000026794636,0.00007764058,0.0036624225,0.000024681909,0.000057245987,0.0005996251],"genre_scores_gemma":[0.996627,0.00009991843,0.00003325204,0.0001156517,0.000044309407,0.00012205069,0.000057308225,0.00007310231,0.0028274509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958848,0.00019278062,0.00083439174,0.000934714,0.0012942717,0.00085906003],"domain_scores_gemma":[0.99721473,0.00029713393,0.00031715544,0.0016722427,0.00025047385,0.000248231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047808728,0.000485099,0.0014017136,0.0006016233,0.000087298016,0.00003745111,0.0005113622,0.00024227251,0.00020877091],"category_scores_gemma":[0.00012909282,0.0003126119,0.00022727251,0.0034396711,0.00030208408,0.0001726956,0.00042083807,0.00052827527,0.000044278135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028008812,0.00014916593,0.957304,0.00073263847,0.002311222,0.00019722193,0.0026734355,0.032080594,0.00012683505,0.000026641199,0.00008668143,0.0015107011],"study_design_scores_gemma":[0.08110272,0.0020667133,0.78262836,0.00050648017,0.0022748448,0.00004228914,0.0003057224,0.13033284,0.00024892457,0.000010281266,0.00011124519,0.00036959915],"about_ca_topic_score_codex":0.058393903,"about_ca_topic_score_gemma":0.011755152,"teacher_disagreement_score":0.23103733,"about_ca_system_score_codex":0.27620634,"about_ca_system_score_gemma":0.045169022,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W2980937306","doi":"10.1038/s41375-019-0602-x","title":"Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; TG Therapeutics; Astellas Pharma; BeiGene; Gilead Sciences; GlaxoSmithKline; Pharmacyclics; Genentech; Sunesis; Teva Pharmaceutical Industries; Celgene; AstraZeneca; Bristol-Myers Squibb","keywords":"Ibrutinib; Chlorambucil; Internal medicine; Neutropenia; Medicine; Chronic lymphocytic leukemia; IGHV@; Adverse effect; Hematology; Oncology; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.0243989745233313,"score_gpt":0.31682641648231563,"score_spread":0.29242744195898435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980937306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514717,0.00023073416,0.000022075954,0.00009081201,0.000096505595,0.0040785596,0.00023794419,0.000019105531,0.0000770847],"genre_scores_gemma":[0.9988234,0.00009644711,0.00012663333,0.000041115134,0.0000708034,0.00006388657,0.000217699,0.00004358712,0.0005164346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982374,0.0000579463,0.0004463586,0.00040898367,0.00053988333,0.0003094834],"domain_scores_gemma":[0.9976087,0.0011066409,0.00018912807,0.00079786463,0.00017542955,0.00012224364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002193253,0.00020918371,0.0005847287,0.00006154819,0.00005246209,0.000011130994,0.00018708457,0.00009138399,0.00008288454],"category_scores_gemma":[0.00017214146,0.00012841067,0.00010058424,0.00017888863,0.00014914614,0.000048534122,0.000099295554,0.000115568524,0.000009113764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056822646,0.0040786806,0.8651747,0.00034378527,0.0014452968,0.000061365274,0.0057012914,0.000054855947,0.00032837145,0.000018168052,0.00043893052,0.065531924],"study_design_scores_gemma":[0.37594348,0.014141169,0.60457,0.0004189527,0.0005201485,0.0000049370474,0.00025743397,0.0010048037,0.0014529116,0.000007923651,0.0015045548,0.00017370215],"about_ca_topic_score_codex":0.0014337174,"about_ca_topic_score_gemma":0.0003807659,"teacher_disagreement_score":0.31912082,"about_ca_system_score_codex":0.0037399663,"about_ca_system_score_gemma":0.0014448187,"threshold_uncertainty_score":0.9779882},"labels":[],"label_agreement":null},{"id":"W2987205136","doi":"10.1038/s41375-019-0621-7","title":"Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML","year":2019,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Signal transduction; Protein kinase B; Cancer research; Mutant; Leukemia; Biology; Medicine; Genetics; Gene","score_opus":0.016957897085136894,"score_gpt":0.28056003888363545,"score_spread":0.26360214179849856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987205136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91838026,0.0011546531,0.000026908356,0.070337884,0.0006219665,0.0023639272,0.000038684957,0.000092047776,0.006983656],"genre_scores_gemma":[0.49748167,0.00035998118,0.0010651062,0.48332563,0.0041424986,0.00009983696,0.00039300168,0.00043375426,0.0126985265],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99651384,0.00023554172,0.0006114632,0.0008346991,0.00095318217,0.0008512894],"domain_scores_gemma":[0.99701095,0.0016515597,0.00026070018,0.0008404868,0.000110550405,0.00012575551],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00041574257,0.00054334354,0.0013317653,0.00085215975,0.000045316672,0.00003934396,0.00032138248,0.001434246,0.00005985992],"category_scores_gemma":[0.0005807792,0.00048080992,0.00017163045,0.0004214708,0.00018898878,0.00008421087,0.00019900865,0.004449761,0.00012538205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006770134,0.000068587855,0.0029170075,0.012825892,0.00035292996,0.012208059,0.0007112198,0.000050454055,0.1353249,0.000022807046,0.8243487,0.010492442],"study_design_scores_gemma":[0.031332027,0.0049560578,0.008024254,0.042541556,0.0010715018,0.00115269,0.0001769762,0.002718314,0.48244783,0.00040205225,0.42224345,0.0029332773],"about_ca_topic_score_codex":0.0003696686,"about_ca_topic_score_gemma":0.000005401084,"teacher_disagreement_score":0.42089862,"about_ca_system_score_codex":0.002594993,"about_ca_system_score_gemma":0.0012593932,"threshold_uncertainty_score":0.9998621},"labels":[],"label_agreement":null},{"id":"W2990541675","doi":"10.1038/s41375-019-0651-1","title":"MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute","funders":"Canadian Institutes of Health Research; Barncancerfonden; Deutsche Krebshilfe; Cancerfonden; Wilhelm Sander-Stiftung","keywords":"Biology; Hox gene; microRNA; Cancer research; Myeloid; Epigenetics; Myeloid leukemia; Transcription factor; Haematopoiesis; Cell biology; Effector; Regulation of gene expression; Stem cell; Genetics; Gene","score_opus":0.005668419307746502,"score_gpt":0.22396567933092992,"score_spread":0.21829726002318342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990541675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985982,0.00022216504,0.000026734524,0.000085029365,0.00014220057,0.00052044756,0.000026969381,0.000008205578,0.00037001324],"genre_scores_gemma":[0.9975594,0.000009911965,0.000803088,0.000182513,0.00006364848,0.000019764475,0.000023562246,0.000020428792,0.0013176437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919754,0.000025094063,0.0002076948,0.00026675593,0.00011859078,0.00018429277],"domain_scores_gemma":[0.9992203,0.0000050832114,0.00012061437,0.000568771,0.0000484801,0.00003671067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084005995,0.000117959804,0.00012180622,0.00002886634,0.000017212627,0.000010257157,0.00025376622,0.0001586676,0.000038679427],"category_scores_gemma":[0.000013789337,0.000094881536,0.000113209266,0.00014068488,0.00006329293,0.0000029813655,0.00013005557,0.00007572939,0.000023357017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003526179,0.00005335311,0.009796616,0.000045520792,0.000017158809,1.509952e-7,0.000047100813,0.00010746493,0.9875848,0.000026390451,0.0015965572,0.0006895697],"study_design_scores_gemma":[0.0006455725,0.000045642813,0.112777226,0.000037804308,0.0000089509485,0.000002140417,0.000016026193,0.00019522468,0.86527884,0.0000232637,0.020856256,0.0001130678],"about_ca_topic_score_codex":0.00004286598,"about_ca_topic_score_gemma":0.000021064956,"teacher_disagreement_score":0.122306034,"about_ca_system_score_codex":0.00008040253,"about_ca_system_score_gemma":0.00020179861,"threshold_uncertainty_score":0.38691568},"labels":[],"label_agreement":null},{"id":"W2993594890","doi":"10.1038/s41375-019-0666-7","title":"An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Frailty in Older Adults","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Université Laval; Nova Scotia Health Authority; Royal Victoria Hospital; Royal Victoria Regional Health Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Centre hospitalier de l'Université Laval; Alberta Hospital Edmonton; University of British Columbia; McGill University Health Centre; University of Ottawa; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; University of Alberta Hospital; Health Sciences Centre; University Health Network; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Multivariate analysis; Internal medicine; Multivariate statistics; International Prognostic Scoring System; Quality of life (healthcare); Prospective cohort study; Confidence interval; Myelodysplastic syndromes; Statistics","score_opus":0.04173860977919456,"score_gpt":0.33041990073038574,"score_spread":0.28868129095119116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993594890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865347,0.000017838729,0.0038496433,0.00040798786,0.0009316076,0.0030682583,0.000024232973,0.00029448105,0.0048712525],"genre_scores_gemma":[0.99488205,0.0000045104225,0.0016382942,0.0024449406,0.0003758827,0.00013737446,0.00022867614,0.00005534983,0.00023291004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966002,0.00014843678,0.0009713162,0.00060808513,0.0010847485,0.0005872115],"domain_scores_gemma":[0.9971531,0.00071337365,0.00025294157,0.0009753113,0.00035911423,0.0005461657],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006397831,0.00037868283,0.00054933614,0.00040519427,0.00009000263,0.000112499474,0.0003077003,0.00037665313,0.00031863645],"category_scores_gemma":[0.001358739,0.00034513464,0.00014702449,0.0005565624,0.000052879743,0.0005924859,0.00008492717,0.00095594703,0.003091748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010494281,0.00032827223,0.9375801,0.00019578045,0.000046458816,0.00004333383,0.00084463076,0.017109368,0.00020294,0.00022759459,0.0012738813,0.04109823],"study_design_scores_gemma":[0.00466897,0.0028457763,0.91947126,0.0010188742,0.000052889234,0.00001783353,0.00018354469,0.06597545,0.00046132703,0.000059775015,0.004843785,0.0004005346],"about_ca_topic_score_codex":0.000073595875,"about_ca_topic_score_gemma":0.000028327797,"teacher_disagreement_score":0.048866082,"about_ca_system_score_codex":0.0009266626,"about_ca_system_score_gemma":0.00066844263,"threshold_uncertainty_score":0.99990004},"labels":[],"label_agreement":null},{"id":"W2996605016","doi":"10.1038/s41375-019-0681-8","title":"NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Government of Canada","keywords":"CTCF; NPM1; Biology; Myeloid leukemia; Cell biology; Gene; Molecular biology; Cancer research; Genetics; Transcription factor; Enhancer","score_opus":0.004963690041945267,"score_gpt":0.2180798199614845,"score_spread":0.21311612991953924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996605016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561674,0.00015668772,0.0023898054,0.00006471932,0.0006782986,0.00021167578,0.000015900787,0.000036365567,0.010829828],"genre_scores_gemma":[0.9915257,0.00019809087,0.00050681323,0.00072737783,0.00027531755,0.000014368542,0.00038714835,0.000038226426,0.0063269334],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989239,0.000038567832,0.00022077771,0.00041717192,0.00012556648,0.00027399993],"domain_scores_gemma":[0.99943155,0.000008957388,0.00007335475,0.00039350797,0.000046157365,0.000046472993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006838267,0.00018558424,0.00016286274,0.00005558765,0.000069810965,0.00003252808,0.00014008848,0.0002866734,0.00019956172],"category_scores_gemma":[0.000019944742,0.00017956286,0.00008767775,0.00019516156,0.000041632924,0.00001779564,0.00007026504,0.00017214156,0.00030504356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028221495,0.000016388321,0.018720357,0.000032560343,0.00009295939,0.000007070128,0.00017604373,0.0028333645,0.95848596,0.0006007549,0.015563978,0.0031883346],"study_design_scores_gemma":[0.0045464947,0.0009526122,0.06265541,0.00007653899,0.00014337532,0.00015835026,0.0006736268,0.0030658399,0.31391042,0.0014158784,0.61123174,0.0011697207],"about_ca_topic_score_codex":0.00015956553,"about_ca_topic_score_gemma":0.00015917345,"teacher_disagreement_score":0.64457554,"about_ca_system_score_codex":0.00026217516,"about_ca_system_score_gemma":0.00021184252,"threshold_uncertainty_score":0.7322361},"labels":[],"label_agreement":null},{"id":"W3001021240","doi":"10.1038/s41375-020-0712-5","title":"Simplified frailty assessment tools: are we really capturing frailty or something else?","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Frailty in Older Adults","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Gerontology; Medicine; MEDLINE; Intensive care medicine; Biology","score_opus":0.11321900170982327,"score_gpt":0.3428776299719856,"score_spread":0.22965862826216235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001021240","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001779229,0.00047266055,0.0016658064,0.9693794,0.0020672153,0.0020321393,0.00054218835,0.0012686831,0.02079267],"genre_scores_gemma":[0.0070395223,0.00049517886,0.012491188,0.9152886,0.016189164,0.00028593285,0.0023688546,0.0005815046,0.045260042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251527,0.0002952797,0.001478269,0.0019828754,0.0021677408,0.0015605695],"domain_scores_gemma":[0.99470943,0.0012981303,0.0009578616,0.0021397104,0.00032654265,0.00056830066],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00035724242,0.001396201,0.0023365244,0.0004203036,0.00031381182,0.00038532732,0.0011013659,0.0025409402,0.0013671957],"category_scores_gemma":[0.0013930403,0.0011892687,0.00068488304,0.0006343826,0.00021775733,0.00039863383,0.0006160894,0.01122248,0.0005378448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015699351,0.000038479215,0.00023211616,0.00296254,0.0006081863,0.013670487,0.0008745414,0.000055493052,0.00057471136,0.000015752763,0.9669168,0.0138939265],"study_design_scores_gemma":[0.003278058,0.00036777987,0.0022380291,0.0038047202,0.0007164098,0.00041532246,0.0003649313,0.00058904925,0.00054421276,0.00048376422,0.9858545,0.0013431924],"about_ca_topic_score_codex":0.00048768695,"about_ca_topic_score_gemma":0.00014898734,"teacher_disagreement_score":0.054090794,"about_ca_system_score_codex":0.0045970636,"about_ca_system_score_gemma":0.0033185198,"threshold_uncertainty_score":0.9998788},"labels":[],"label_agreement":null},{"id":"W3003215342","doi":"10.1038/s41375-019-0702-7","title":"In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Pedigree chart; Exome sequencing; Multiplex; Exome; Genetics; Leukemia; Hairy cell leukemia; Biology; Medicine; Oncology; Mutation; Gene","score_opus":0.04943081365974037,"score_gpt":0.29210880692044167,"score_spread":0.2426779932607013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003215342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821533,0.0005872517,0.00030618903,0.011328552,0.00069714885,0.0027780654,0.00030235227,0.00012571647,0.0017214401],"genre_scores_gemma":[0.9432284,0.0002175891,0.005391773,0.04177231,0.0045750756,0.00011181723,0.0004095634,0.0004708493,0.0038225797],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9909459,0.00037556762,0.0021287512,0.0016463267,0.0030705414,0.0018329492],"domain_scores_gemma":[0.995553,0.0011129411,0.00053721026,0.0016946922,0.00049294234,0.00060917926],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004946287,0.0010529938,0.0024574555,0.0014148554,0.00009280852,0.000050952443,0.0013052396,0.0016504877,0.00026401706],"category_scores_gemma":[0.00088997785,0.0010086262,0.0006529417,0.0015049159,0.0005244347,0.00018720314,0.0008820852,0.004258463,0.00011950524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023505185,0.00017637192,0.02037805,0.033855785,0.0007256959,0.02464011,0.018526776,0.013083117,0.20072173,0.000006038745,0.6830339,0.0025019601],"study_design_scores_gemma":[0.10052883,0.007596939,0.042438738,0.01804604,0.0021884437,0.0015079511,0.006068691,0.19634272,0.48888746,0.00019973257,0.12889099,0.007303443],"about_ca_topic_score_codex":0.021910904,"about_ca_topic_score_gemma":0.00039415914,"teacher_disagreement_score":0.55414283,"about_ca_system_score_codex":0.07438177,"about_ca_system_score_gemma":0.04527086,"threshold_uncertainty_score":0.9996456},"labels":[],"label_agreement":null},{"id":"W3004303031","doi":"10.1038/s41375-020-0711-6","title":"Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"Janssen Research and Development; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Yale University","keywords":"Lenalidomide; Medicine; Internal medicine; Daratumumab; Dexamethasone; Multiple myeloma; Population; Gastroenterology; Refractory (planetary science); Oncology; Surgery","score_opus":0.06341334890599047,"score_gpt":0.35578240967606056,"score_spread":0.2923690607700701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004303031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913469,0.0015995427,0.00010268796,0.00044480138,0.000096523494,0.0051029595,0.00005833755,0.00005466019,0.0011936163],"genre_scores_gemma":[0.9963413,0.0001593793,0.0018930964,0.00029593942,0.00007855,0.00037800273,0.00006542215,0.000060216433,0.0007281235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965183,0.00063631823,0.0008775212,0.00075897,0.00064437225,0.0005644972],"domain_scores_gemma":[0.9974411,0.0010016599,0.00025760717,0.00055002194,0.00013423609,0.0006153783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095813297,0.00039538543,0.0018598874,0.00024787072,0.00011240984,0.000059678096,0.00034263913,0.0001599966,0.00012976593],"category_scores_gemma":[0.0033661325,0.0003130571,0.00012763937,0.0005620002,0.00026786988,0.00022034558,0.00040876295,0.0005933168,0.00003325572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90057594,0.005241921,0.01792486,0.00034858525,0.0015001558,0.0031026178,0.007194368,0.000011528671,0.023073751,0.00006675298,0.0008346994,0.040124826],"study_design_scores_gemma":[0.9719147,0.0037682634,0.008041672,0.0001869162,0.0003279216,0.000037101465,0.0013000595,0.010319337,0.0035263232,0.000049164973,0.0002539573,0.0002745823],"about_ca_topic_score_codex":0.0021248544,"about_ca_topic_score_gemma":0.00039798394,"teacher_disagreement_score":0.071338765,"about_ca_system_score_codex":0.0005847837,"about_ca_system_score_gemma":0.0007967549,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W3004897183","doi":"10.1038/s41375-020-0726-z","title":"Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Doris Duke Charitable Foundation","keywords":"Medicine; Immunosuppression; Internal medicine; Disease; Population; Oncology; Asymptomatic; Graft-versus-host disease; Hematopoietic stem cell transplantation; Cumulative incidence; Transplantation; Immunology","score_opus":0.01327352336295214,"score_gpt":0.2400462223600315,"score_spread":0.22677269899707936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004897183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943466,0.00028336814,0.0011587775,0.00021474386,0.000067945366,0.0011557629,0.0024462512,0.000041798805,0.00028472286],"genre_scores_gemma":[0.9978753,0.0005218874,0.00091958366,0.00020523867,0.000027028695,0.00003498118,0.0003625264,0.00003611277,0.00001734224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984232,0.000095528536,0.0004974545,0.0004497556,0.00028933914,0.00024472672],"domain_scores_gemma":[0.9985845,0.0002622757,0.00022615527,0.00025226857,0.00010137944,0.0005734106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020427158,0.00024083178,0.00042064924,0.00005558851,0.00008913236,0.000015544352,0.00006553988,0.0001288357,0.000029750598],"category_scores_gemma":[0.00013010537,0.00021386116,0.00011161574,0.00012327259,0.00014372123,0.00006293156,0.000013226187,0.00019498373,0.000002314449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014985481,0.00013409897,0.9837862,0.004604347,0.00021068665,0.00004617231,0.005505827,0.000013823575,0.0030248465,0.000049011192,0.00016449169,0.00096193154],"study_design_scores_gemma":[0.008126685,0.0006802087,0.97744936,0.00022415975,0.0023408926,0.000010744549,0.00047981853,0.0015987388,0.008586669,0.00015594604,0.00005842862,0.00028833025],"about_ca_topic_score_codex":0.00044917894,"about_ca_topic_score_gemma":0.000059891212,"teacher_disagreement_score":0.0066281375,"about_ca_system_score_codex":0.000062634834,"about_ca_system_score_gemma":0.00022195655,"threshold_uncertainty_score":0.87210053},"labels":[],"label_agreement":null},{"id":"W3005289851","doi":"10.1038/s41375-020-0718-z","title":"Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; National Cancer Institute; Pharmacyclics; Chugai Pharmaceutical; Janssen Research and Development; National Institutes of Health; Glenmark Pharmaceuticals; Adaptive Biotechnologies; Array BioPharma; Yale University; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Winship Cancer Institute; Pfizer; Memorial Sloan-Kettering Cancer Center; Multiple Myeloma Research Foundation","keywords":"Clinical endpoint; Medicine; Dosing; Internal medicine; Multiple myeloma; Gastroenterology; Confidence interval; Phases of clinical research; Surgery; Clinical trial","score_opus":0.03634479394324643,"score_gpt":0.32998234699099743,"score_spread":0.293637553047751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005289851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057634,0.000116868774,0.002263309,0.00013141584,0.00018703255,0.015957644,0.00056868256,0.00015595832,0.00004273275],"genre_scores_gemma":[0.9876127,0.00021601588,0.00850839,0.00043528524,0.00020084094,0.0021820683,0.0005083942,0.00015117285,0.00018513322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99644315,0.00038253845,0.00074212474,0.0009865039,0.0006560252,0.00078965945],"domain_scores_gemma":[0.9970429,0.00086405635,0.00043416634,0.00063182914,0.00027166042,0.00075536984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038389355,0.00057535956,0.0014297348,0.00014339061,0.00039163177,0.00019564011,0.0005203561,0.00012090975,0.00016088506],"category_scores_gemma":[0.0014896621,0.0003631,0.00015261708,0.0003300269,0.00016587347,0.00035509077,0.00028298976,0.0005107689,0.000067744506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7024389,0.007071707,0.20410304,0.00011637021,0.0020806673,0.00025219514,0.0018648059,0.000011473725,0.00008692035,0.0000016992944,0.0005810393,0.08139121],"study_design_scores_gemma":[0.91981953,0.019641204,0.027994512,0.00015063585,0.0007747966,0.0000030602573,0.0005580549,0.029120672,0.000809122,0.0000060442712,0.00071911694,0.00040324728],"about_ca_topic_score_codex":0.0020043126,"about_ca_topic_score_gemma":0.0004302669,"teacher_disagreement_score":0.21738066,"about_ca_system_score_codex":0.00055807637,"about_ca_system_score_gemma":0.00033942677,"threshold_uncertainty_score":0.9998821},"labels":[],"label_agreement":null},{"id":"W3005910409","doi":"10.1038/s41375-020-0733-0","title":"ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Fonds de Recherche du Québec - Santé; Kiadis Pharma","keywords":"Medicine; Cyclophosphamide; Internal medicine; Hematopoietic stem cell transplantation; Umbilical cord; Graft-versus-host disease; Leukemia; Oncology; Acute leukemia; Transplantation; Gastroenterology; Immunology; Surgery; Chemotherapy","score_opus":0.01966888093114525,"score_gpt":0.2632451259246569,"score_spread":0.24357624499351163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005910409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348956,0.0001973422,0.0001603924,0.0015093166,0.00018068757,0.0005500556,0.000027080223,0.000117077754,0.0037684978],"genre_scores_gemma":[0.9960769,0.00012221897,0.0012551089,0.0015049927,0.00022111394,0.00005443162,0.000070398855,0.000059413986,0.0006354467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997903,0.00008132671,0.0005714214,0.0005923022,0.00042667336,0.00042529212],"domain_scores_gemma":[0.999046,0.00015647068,0.00009193382,0.00025520645,0.00005299965,0.00039736726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016699963,0.00030305286,0.00055931916,0.000095077026,0.000039402054,0.000065481734,0.00012240508,0.00023467657,0.00012674507],"category_scores_gemma":[0.00008392687,0.00028064902,0.000102669794,0.00021574886,0.00011445741,0.00015733975,0.000057821726,0.0004073084,0.000100154895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050189113,0.00013435617,0.065025054,0.0019405207,0.00026629397,0.0031121313,0.008619994,0.000006263905,0.91149163,0.0003002936,0.0015109326,0.0025736126],"study_design_scores_gemma":[0.025372177,0.0018599906,0.6758113,0.0010832278,0.0011297155,0.00047326589,0.0011697687,0.010059049,0.27884027,0.00033558407,0.0024484375,0.0014172212],"about_ca_topic_score_codex":0.00009659261,"about_ca_topic_score_gemma":0.000029731196,"teacher_disagreement_score":0.6326514,"about_ca_system_score_codex":0.00041314284,"about_ca_system_score_gemma":0.00044750568,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W3007405904","doi":"10.1038/s41375-020-0777-1","title":"CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Agence Nationale de la Recherche","keywords":"Interleukin-3 receptor; CD28; Plasmacytoid dendritic cell; Cancer research; Biology; Effector; Immunotherapy; Immunology; T cell; Immune system; Antigen; Dendritic cell","score_opus":0.021698490980137833,"score_gpt":0.26845814996873685,"score_spread":0.24675965898859903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007405904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97404087,0.00021776554,0.000082823484,0.0010027465,0.00025310618,0.00060169364,0.000015137009,0.00013012206,0.023655752],"genre_scores_gemma":[0.984994,0.00014326024,0.0003416449,0.0019374753,0.00047838932,0.00003718387,0.00002617217,0.000091471804,0.011950399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755687,0.00009890845,0.00042006932,0.000572512,0.00061336317,0.00073826214],"domain_scores_gemma":[0.9985181,0.00035007158,0.000055930024,0.0004367931,0.00007278906,0.00056633126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001722467,0.00028821712,0.0005222853,0.00018721275,0.00005475023,0.0000440852,0.00028191373,0.00021091494,0.0026023057],"category_scores_gemma":[0.00014772992,0.00028645108,0.00015768682,0.00062769436,0.00011639185,0.00007949129,0.00013072917,0.00096784526,0.0021420766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006432724,0.000104412975,0.011656092,0.0005258308,0.00004434933,0.0018520184,0.001746135,0.0013292822,0.9724804,0.00003626928,0.0077940943,0.0017878091],"study_design_scores_gemma":[0.0144961355,0.0013212453,0.009743106,0.00030133463,0.00014627069,0.00019855225,0.0009059808,0.03018155,0.819465,0.0001135769,0.12227915,0.00084808905],"about_ca_topic_score_codex":0.00021352067,"about_ca_topic_score_gemma":0.00013150414,"teacher_disagreement_score":0.15301543,"about_ca_system_score_codex":0.000890978,"about_ca_system_score_gemma":0.0007680799,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W3007944408","doi":"10.1038/s41375-020-0770-8","title":"Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Blinatumomab; Refractory (planetary science); Lymphoblastic Leukemia; Medicine; Leukemia; Acute lymphocytic leukemia; Oncology; Internal medicine; Pediatrics; Immunology; Biology","score_opus":0.01480790314190162,"score_gpt":0.24972852884735422,"score_spread":0.2349206257054526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007944408","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7586452,0.0043840744,0.00071470294,0.17674379,0.010073644,0.015956499,0.0026849944,0.0020532093,0.028743895],"genre_scores_gemma":[0.41292918,0.007931923,0.008334817,0.47078815,0.035695303,0.00275974,0.010679431,0.004353909,0.04652753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98888296,0.00053356617,0.0015246518,0.0025476704,0.0042623854,0.002248771],"domain_scores_gemma":[0.9931582,0.0024540725,0.0009858909,0.0016244773,0.00094234734,0.0008349611],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00028276723,0.0018513856,0.0026826349,0.0013904059,0.0002322751,0.0001367056,0.0012681365,0.0025387893,0.00032684745],"category_scores_gemma":[0.0009460181,0.0015193302,0.00055110565,0.0022991935,0.00040333916,0.00040334073,0.00041410117,0.008628157,0.00067841413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.032039996,0.0003332222,0.004814931,0.0009028035,0.0006286935,0.010988612,0.00063375296,0.00002904338,0.00003994918,0.0000027017695,0.94831485,0.001271445],"study_design_scores_gemma":[0.23999245,0.034356646,0.010576574,0.0010639456,0.0032721173,0.0001285593,0.00006484939,0.0009642085,0.00059764093,0.00015095939,0.7045368,0.004295263],"about_ca_topic_score_codex":0.0003944722,"about_ca_topic_score_gemma":0.000033191176,"teacher_disagreement_score":0.345716,"about_ca_system_score_codex":0.109528586,"about_ca_system_score_gemma":0.022333482,"threshold_uncertainty_score":0.9994231},"labels":[],"label_agreement":null},{"id":"W3008231845","doi":"10.1038/s41375-020-0756-6","title":"Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Agence Nationale de la Recherche","keywords":"Medicine; Nausea; Neutropenia; Vomiting; Adverse effect; Internal medicine; Diarrhea; Gastroenterology; Pharmacology; Chemotherapy","score_opus":0.12874029171053453,"score_gpt":0.4011546406214203,"score_spread":0.2724143489108858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008231845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974626,0.00012815435,0.00005186268,0.0005948697,0.00016061003,0.0011413493,0.0001022098,0.00003526966,0.00032308584],"genre_scores_gemma":[0.99713975,0.000087023036,0.0006998567,0.0017381714,0.00014304103,0.00007825003,0.00007652218,0.000010112212,0.000027249807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971602,0.00065277185,0.0014054857,0.00036116343,0.00020693465,0.00021346919],"domain_scores_gemma":[0.9972204,0.0021724969,0.00024327807,0.00012559163,0.00008276092,0.00015547885],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.000937701,0.00016469216,0.0012429878,0.00005091124,0.000021806422,0.0000042329552,0.00012250546,0.00016597947,0.0002721744],"category_scores_gemma":[0.015728157,0.000108769585,0.00015575648,0.00038257593,0.00011432006,0.000049677274,0.00010219731,0.00046143236,0.000023103197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010981778,0.0008650617,0.92179537,0.000080495076,0.00010597972,0.00009449456,0.0032161756,0.00004373207,0.026596753,0.0000049505466,0.0019293054,0.03428589],"study_design_scores_gemma":[0.027941052,0.00085828267,0.93345994,0.0001777345,0.000048426115,2.151944e-7,0.000525617,0.020548953,0.014463366,0.000016135484,0.0017981638,0.00016213376],"about_ca_topic_score_codex":0.00039031464,"about_ca_topic_score_gemma":0.00006829955,"teacher_disagreement_score":0.034123756,"about_ca_system_score_codex":0.0001776638,"about_ca_system_score_gemma":0.000159622,"threshold_uncertainty_score":0.9925628},"labels":[],"label_agreement":null},{"id":"W3009449110","doi":"10.1038/s41375-020-0754-8","title":"The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK− anaplastic large cell lymphoma by regulating the DNA helicase HELLS","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Weill Cornell Medical College; Ministero della Salute; York University; Leukemia and Lymphoma Society","keywords":"Anaplastic lymphoma kinase; Biology; Anaplastic large-cell lymphoma; Cancer research; Chromatin; Phenotype; Transcriptome; Gene knockdown; Helicase; DNA methylation; DNA; Cell biology; Gene; Genetics; RNA; Gene expression; Lymphoma; Immunology","score_opus":0.00770100918189433,"score_gpt":0.22811352685057007,"score_spread":0.22041251766867573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009449110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8408075,0.011049399,0.13553703,0.005916606,0.0005789229,0.00211668,0.00049369753,0.00006517239,0.003434989],"genre_scores_gemma":[0.9968334,0.0002565086,0.00008175921,0.0016931319,0.0002980143,0.000048850874,0.00006101982,0.000056197863,0.0006711625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799764,0.00018196243,0.00037704874,0.00043584948,0.0004341024,0.0005733805],"domain_scores_gemma":[0.99844337,0.00032570984,0.00021885379,0.00071061373,0.00015098148,0.00015045749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041436817,0.00025174223,0.00021714176,0.000016481596,0.00041652157,0.00008478221,0.00078046875,0.00019243728,0.000024004996],"category_scores_gemma":[0.00060507853,0.00014503644,0.00017411548,0.00027766795,0.00023407472,0.0000047564677,0.00036564565,0.0002722586,0.000037526028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043311325,0.000046070098,0.0000026834553,0.000028926901,0.000108922555,0.0000043605087,0.00012866697,0.0011992012,0.98745626,0.00033862545,0.00847783,0.0017753313],"study_design_scores_gemma":[0.0037602386,0.0005285782,0.000040333452,0.000024225252,0.00008519842,0.000013794716,0.00029691658,0.02423067,0.8513431,0.000055093944,0.11938702,0.00023482894],"about_ca_topic_score_codex":0.00006294061,"about_ca_topic_score_gemma":0.000079989615,"teacher_disagreement_score":0.15602586,"about_ca_system_score_codex":0.000090466005,"about_ca_system_score_gemma":0.00043706823,"threshold_uncertainty_score":0.59144145},"labels":[],"label_agreement":null},{"id":"W3009593455","doi":"10.1038/s41375-020-0790-4","title":"Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Research Resources; National Cancer Institute; National Heart, Lung, and Blood Institute; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services","keywords":"Immunology; Tretinoin; Cancer research; Medicine; Biology; Retinoic acid; Genetics; Cell culture","score_opus":0.01512663434072427,"score_gpt":0.21567905494888145,"score_spread":0.20055242060815717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009593455","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.906634,0.00814429,0.009098625,0.06862476,0.0018937981,0.0019745796,0.0011256062,0.00027233304,0.002232053],"genre_scores_gemma":[0.24457821,0.0019315844,0.008644753,0.67877215,0.03538567,0.00030303164,0.022899479,0.0010150479,0.0064700767],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967861,0.00020989591,0.0005907305,0.0013005915,0.00047199352,0.00064068777],"domain_scores_gemma":[0.99853766,0.00003222624,0.00045058684,0.0007972099,0.000055697095,0.00012662674],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00010136878,0.000686727,0.000529609,0.00007129842,0.00023651122,0.0001192018,0.00060510053,0.0017422221,0.00013861268],"category_scores_gemma":[0.0001523136,0.00071893114,0.00032124776,0.00015197226,0.00020539138,0.000009157239,0.00031442652,0.0017929858,0.000114576775],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001083081,0.000008110902,0.00008551232,0.00019946862,0.00014502356,0.00023897948,0.000040706633,0.0000364747,0.770845,2.3759164e-7,0.2281167,0.00017547912],"study_design_scores_gemma":[0.0005515457,0.00014053068,0.000034589895,0.00013371409,0.00014478879,0.000023742492,0.000026443868,0.00032378174,0.3294524,0.000058381844,0.66844594,0.0006641457],"about_ca_topic_score_codex":0.0004031557,"about_ca_topic_score_gemma":0.000007142683,"teacher_disagreement_score":0.66205573,"about_ca_system_score_codex":0.0006556224,"about_ca_system_score_gemma":0.00060322747,"threshold_uncertainty_score":0.99955374},"labels":[],"label_agreement":null},{"id":"W3009600316","doi":"10.1038/s41375-020-0791-3","title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Nomogram; International Prognostic Index; Medicine; Internal medicine; Oncology; Cohort; Anthracycline; Brier score; Lymphoma; Diffuse large B-cell lymphoma; Surgery; Cancer; Artificial intelligence; Breast cancer; Computer science","score_opus":0.03260578287880242,"score_gpt":0.3267888867971584,"score_spread":0.294183103918356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009600316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88397914,0.00041658833,0.11311312,0.00044589266,0.00001369271,0.0019610447,0.00001616893,0.000014613283,0.000039749615],"genre_scores_gemma":[0.9848681,0.000208788,0.014144517,0.00046041486,0.0000622313,0.00018749379,0.000043543016,0.000023065546,0.0000018627572],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989473,0.000051684758,0.0004061985,0.00030158128,0.00017126146,0.0001219653],"domain_scores_gemma":[0.9985016,0.0009118403,0.00026805256,0.00016226534,0.00009918653,0.00005706993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032398084,0.00013228535,0.0003144579,0.000047102203,0.00005582753,0.000028581268,0.00006242588,0.00011000226,0.0000017220145],"category_scores_gemma":[0.00014023234,0.00008613188,0.000051481024,0.00014152216,0.000063903404,0.00007939201,0.000009481627,0.000058100744,3.6087962e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045057465,0.0007682789,0.6133944,0.00020502301,0.00010677853,9.2392315e-7,0.0030374886,0.0008315924,0.00019922033,0.00018563651,0.00010865825,0.37665626],"study_design_scores_gemma":[0.025625374,0.0021037122,0.3405289,0.00031878368,0.00040527666,0.000006248142,0.00021882444,0.6254327,0.0018031994,0.0031593344,0.00023108606,0.00016653127],"about_ca_topic_score_codex":0.000033317014,"about_ca_topic_score_gemma":0.0000125536235,"teacher_disagreement_score":0.6246011,"about_ca_system_score_codex":0.000087844775,"about_ca_system_score_gemma":0.0001664674,"threshold_uncertainty_score":0.3512356},"labels":[],"label_agreement":null},{"id":"W3009751715","doi":"10.1038/s41375-020-0776-2","title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","year":2020,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1510,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Europe; Scheme for Promotion of Academic and Research Collaboration; Sun Pharma; Servier; Astellas Pharma; Incyte; Italfarmaco; Seagen; Agios Pharmaceuticals; Astex Pharmaceuticals; Celgene; Daiichi-Sankyo; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Gilead Sciences; Ariad Pharmaceuticals; Amgen; Pfizer; Ascentage Pharma","keywords":"Medicine; Dasatinib; Nilotinib; Bosutinib; Discontinuation; Imatinib; Myeloid leukemia; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Intensive care medicine","score_opus":0.04811984751068918,"score_gpt":0.33357866587836627,"score_spread":0.28545881836767706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009751715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014894673,0.9722241,0.0003072627,0.00066314294,0.0008841562,0.0056043793,0.00096210616,0.00085800583,0.01848196],"genre_scores_gemma":[0.000025437408,0.9618719,0.006488719,0.0006299658,0.0056349984,0.0012201493,0.011744171,0.00087033527,0.011514305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923265,0.00054164993,0.0025321257,0.002343633,0.0006770897,0.0015790084],"domain_scores_gemma":[0.9943925,0.0009825489,0.001452723,0.0019352057,0.00019490127,0.0010421125],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00061638164,0.002006306,0.005048637,0.00042069238,0.0005140917,0.00019213418,0.0009845461,0.00095016917,0.0009842302],"category_scores_gemma":[0.00064773,0.0017929254,0.0023623533,0.0012130017,0.00019806591,0.00023838997,0.00046245198,0.0021838872,0.00317014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000055071327,0.000044431617,0.0000026382668,0.020052614,0.0012898317,0.00054611254,0.00014476097,0.000008845145,0.000012386382,0.00008992318,0.10927632,0.86847705],"study_design_scores_gemma":[0.0055919685,0.0007023793,0.0000059359268,0.021948995,0.006536294,0.0013239552,0.00004505554,0.00042393405,0.000023577464,0.00002112533,0.96206456,0.001312216],"about_ca_topic_score_codex":0.00017342604,"about_ca_topic_score_gemma":0.00004545317,"teacher_disagreement_score":0.86716485,"about_ca_system_score_codex":0.065407835,"about_ca_system_score_gemma":0.022333974,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W3014563464","doi":"10.1038/s41375-020-0808-y","title":"H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; Blood Cancer UK; University of Oxford; Research Councils UK; Bloodwise; Wellcome Trust; Lady Tata Memorial Trust; Ministerio de Economía y Competitividad; Cancer Research UK; Leukaemia UK; Medical Research Foundation; National Institute for Health and Care Research; European Hematology Association","keywords":"Leukemia; Biology; Stem cell; Cancer research; Enhancer; Cancer stem cell; Cancer; Genetics; Gene; Transcription factor","score_opus":0.025357778417561753,"score_gpt":0.2960044509883657,"score_spread":0.27064667257080394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014563464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896283,0.00022048669,0.00009377702,0.0030269441,0.0001731474,0.0014402849,0.000019450441,0.000033659,0.0053639426],"genre_scores_gemma":[0.98637414,0.00021012215,0.000074596384,0.00094380684,0.00023905224,0.00015911534,0.000006232814,0.000046335255,0.011946572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998166,0.00016790113,0.00045250758,0.00043052263,0.00043601493,0.00034700127],"domain_scores_gemma":[0.9989114,0.00021817366,0.00018650424,0.00041063942,0.00012749436,0.00014583049],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024023927,0.00022216522,0.00044369663,0.0000995341,0.00005998305,0.00003384801,0.00019469067,0.00014745962,0.0016819804],"category_scores_gemma":[0.000044345106,0.00016456362,0.00012913247,0.0004623024,0.00016064178,0.00017842505,0.00013002635,0.00076528545,0.000029273355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010940795,0.000053366275,0.005785529,0.0003031099,0.00006706557,0.000008786765,0.0018202567,0.00006413992,0.9616154,0.0000086709315,0.0015677189,0.027611895],"study_design_scores_gemma":[0.004037275,0.00023292495,0.0408819,0.00037066356,0.000062590865,0.0000064785504,0.00040128356,0.0049372306,0.9259803,0.00003328861,0.022865007,0.00019103262],"about_ca_topic_score_codex":0.00056966447,"about_ca_topic_score_gemma":0.00011422735,"teacher_disagreement_score":0.035635054,"about_ca_system_score_codex":0.0012422428,"about_ca_system_score_gemma":0.00069332006,"threshold_uncertainty_score":0.9992306},"labels":[],"label_agreement":null},{"id":"W3015379990","doi":"10.1038/s41375-020-0811-3","title":"Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Naito Foundation","keywords":"Monoclonal antibody; Immunology; Lymphoma; Immunity; Adenosine; Medicine; Antibody; Virology; Biology; Cancer research; Immune system; Internal medicine","score_opus":0.012707821760483006,"score_gpt":0.2422747517276983,"score_spread":0.22956692996721528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015379990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276143,0.0024612905,0.0007894928,0.00043848273,0.0020830212,0.00026354496,0.000056131536,0.00033978274,0.0008068036],"genre_scores_gemma":[0.9888888,0.00029659597,0.000050609542,0.0021324407,0.00013562065,0.000011931613,0.0060450337,0.000053099575,0.0023858892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779046,0.00042125286,0.00057220506,0.00054060697,0.00009501162,0.0005804732],"domain_scores_gemma":[0.99908566,0.000107148684,0.0002662117,0.0003073836,0.00013649806,0.00009709714],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020580273,0.00037855253,0.00047132935,0.00009957785,0.00047686504,0.00007262271,0.0004153646,0.0004346445,0.0045003006],"category_scores_gemma":[0.00012860191,0.00037167908,0.00014367895,0.00028426092,0.00014813848,0.0005728085,0.00015398771,0.00063113787,0.002544709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027268732,0.00017088892,0.0063159196,0.000021114563,0.00018546321,0.0000110906185,0.00046299718,0.00007285652,0.9150898,0.0000114980185,0.076564595,0.0008211063],"study_design_scores_gemma":[0.0049470738,0.000791166,0.022114364,0.00005949184,0.00010959046,0.0000731174,0.0012265992,0.0029482867,0.66584367,0.0000065438485,0.30107716,0.0008029525],"about_ca_topic_score_codex":0.0005941231,"about_ca_topic_score_gemma":0.0000017852495,"teacher_disagreement_score":0.24924612,"about_ca_system_score_codex":0.00027899555,"about_ca_system_score_gemma":0.00016204167,"threshold_uncertainty_score":0.9998735},"labels":[],"label_agreement":null},{"id":"W3017155204","doi":"10.1038/s41375-020-0835-8","title":"Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Department of Health and Human Services","keywords":"Myeloid leukemia; Myelodysplastic syndromes; Telomerase; Medicine; Myeloid; Oncology; Immunology; Cancer research; Biology; Genetics; Bone marrow; Gene","score_opus":0.013152287724201269,"score_gpt":0.22940673468255232,"score_spread":0.21625444695835105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017155204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98608196,0.000057887333,0.00012811414,0.011523719,0.00075940223,0.0009137536,0.00038297835,0.00008929228,0.00006290461],"genre_scores_gemma":[0.8441665,0.0008532849,0.0006000519,0.14191312,0.003539538,0.0000738248,0.0074915406,0.0002406925,0.0011214503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958231,0.0001748602,0.0013265169,0.0010957511,0.0009987031,0.000581079],"domain_scores_gemma":[0.9979535,0.00029580112,0.0006731365,0.00053220685,0.00025023095,0.00029516694],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00017777862,0.0006461411,0.0015393167,0.00060928095,0.00007887493,0.000036726502,0.0002007953,0.0009779914,0.00017147326],"category_scores_gemma":[0.00020211961,0.0005548617,0.00016016576,0.0008721345,0.00028778106,0.0002370572,0.00012389202,0.002524388,0.00007133325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019697307,0.00018113726,0.95190984,0.0017461634,0.00043701028,0.004359384,0.00013862169,0.000004193678,0.0003635467,0.0000048083084,0.036765978,0.0021196061],"study_design_scores_gemma":[0.006269765,0.0010865895,0.9848154,0.00041770362,0.00084273453,0.00020168912,0.0000047029657,0.000121612684,0.000021433088,0.000010578503,0.00566004,0.0005477071],"about_ca_topic_score_codex":0.000045795015,"about_ca_topic_score_gemma":0.0000034751467,"teacher_disagreement_score":0.14191546,"about_ca_system_score_codex":0.0005192992,"about_ca_system_score_gemma":0.0017165309,"threshold_uncertainty_score":0.99977684},"labels":[],"label_agreement":null},{"id":"W3023266336","doi":"10.1038/s41375-020-0813-1","title":"Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; McGill University Health Centre","funders":"Bristol-Myers Squibb","keywords":"Lenalidomide; Pomalidomide; Daratumumab; Medicine; Internal medicine; Multiple myeloma; Neutropenia; Dexamethasone; Oncology; Regimen; Refractory (planetary science); Febrile neutropenia; Surgery; Chemotherapy; Biology","score_opus":0.03163110271519153,"score_gpt":0.28793509524778443,"score_spread":0.2563039925325929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023266336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363077,0.0018467865,0.000021142667,0.0012458427,0.00004919582,0.0008948366,0.000038162263,0.00009056477,0.0021826765],"genre_scores_gemma":[0.9954644,0.00032375217,0.0020949773,0.0007956685,0.00016441879,0.0002344953,0.00006091224,0.00005340119,0.00080799975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793077,0.0001417996,0.00039021438,0.0006294255,0.0003508086,0.00055698835],"domain_scores_gemma":[0.9985542,0.00029274312,0.0000727459,0.0003773422,0.000050461815,0.0006525029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012307541,0.0003392599,0.0005938108,0.00016266866,0.00007216307,0.000039190316,0.00008581504,0.0001790512,0.00020609015],"category_scores_gemma":[0.0004739887,0.00026665907,0.00012926565,0.00029997202,0.00011926855,0.00011690042,0.00008123246,0.00033865194,0.00018532191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021079311,0.0005282339,0.873936,0.00022229255,0.0004231018,0.0077405875,0.0022174541,0.000020716685,0.017882386,0.000035928948,0.0007747546,0.07513921],"study_design_scores_gemma":[0.050390787,0.0024949638,0.912408,0.00020296505,0.00013773725,0.00013676294,0.0002556203,0.00474727,0.013542502,0.000039366125,0.015229703,0.0004142976],"about_ca_topic_score_codex":0.00077746063,"about_ca_topic_score_gemma":0.00040081728,"teacher_disagreement_score":0.07472491,"about_ca_system_score_codex":0.0010913474,"about_ca_system_score_gemma":0.00033711485,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W3026980848","doi":"10.1038/s41375-020-0874-1","title":"Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Foundation; U.S. Department of Health and Human Services","keywords":"Chimeric antigen receptor; Immune system; Immunology; Cytokine; Antigen; T cell; Autocrine signalling; Cancer research; Immunotherapy; Biology; Interleukin 2; Endogeny; Medicine; Receptor; Internal medicine; Endocrinology","score_opus":0.05250146682893192,"score_gpt":0.2856146705085528,"score_spread":0.2331132036796209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026980848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911798,0.0005789732,0.000019022124,0.0025630514,0.00009324732,0.0004327701,0.000059104346,0.000102473,0.004971538],"genre_scores_gemma":[0.99220544,0.00013678096,0.00017539764,0.0019239306,0.0005041667,0.000021096634,0.000028343251,0.00003737134,0.0049674506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984406,0.00014264291,0.00023131524,0.00042512102,0.00042576776,0.0003345315],"domain_scores_gemma":[0.99895114,0.00022291842,0.00005543142,0.0003077754,0.000103426086,0.00035928626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004226304,0.00017969827,0.00031812824,0.00007715243,0.00010343936,0.000039865277,0.000110910296,0.00011305366,0.0008507071],"category_scores_gemma":[0.0002878867,0.00015780452,0.000084763305,0.00027290924,0.00016158418,0.000076762735,0.00010645114,0.00044511966,0.00010134345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050350293,0.000043006312,0.0020222776,0.00013807909,0.000052837568,0.00029232752,0.0006120582,0.000002280599,0.98595995,0.000019720917,0.0012346421,0.0045877732],"study_design_scores_gemma":[0.0049201883,0.001751361,0.04626303,0.000030938852,0.00008576619,0.00032433853,0.00042871753,0.00024431857,0.81395525,0.000057560464,0.13165163,0.00028691444],"about_ca_topic_score_codex":0.00022906189,"about_ca_topic_score_gemma":0.0000050118724,"teacher_disagreement_score":0.17200473,"about_ca_system_score_codex":0.0003224315,"about_ca_system_score_gemma":0.00068617787,"threshold_uncertainty_score":0.9314646},"labels":[],"label_agreement":null},{"id":"W3032537564","doi":"10.1038/s41375-020-0855-4","title":"Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Lenalidomide; Dexamethasone; Medicine; Internal medicine; Profiling (computer programming); Oncology; Immune system; Immunology; Computer science","score_opus":0.025229035277628615,"score_gpt":0.2772892025512971,"score_spread":0.2520601672736685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032537564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976499,0.0001934939,0.00034289763,0.00009397674,0.0000048451216,0.0009007204,0.000013526812,0.0000471323,0.00075349415],"genre_scores_gemma":[0.988934,0.00003274162,0.010550129,0.00008188674,0.000025868441,0.00004473139,0.00010532211,0.000037645677,0.00018771758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874395,0.000047551828,0.0002256686,0.00031596035,0.0003798828,0.00028696927],"domain_scores_gemma":[0.9991334,0.00006877197,0.000111590685,0.00021988346,0.00016903019,0.00029733658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055700504,0.0002054012,0.00049988757,0.00006166778,0.000062951236,0.000015454827,0.00006388338,0.000060097795,0.00005193886],"category_scores_gemma":[0.00012430246,0.00010954783,0.000030742744,0.00029966477,0.00014736765,0.00008871906,0.00004012256,0.00019022595,0.000007877859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026614804,0.00013392215,0.961835,0.0002934129,0.00041060537,0.00022542749,0.00040730005,0.000014048633,0.003915572,0.000007428098,0.000011046608,0.006131392],"study_design_scores_gemma":[0.06739308,0.0123831825,0.72659355,0.00057489186,0.0005507447,0.000100235986,0.00048203816,0.0130587695,0.17832553,0.0000034644804,0.0001444033,0.00039011968],"about_ca_topic_score_codex":0.00025570256,"about_ca_topic_score_gemma":0.000053741824,"teacher_disagreement_score":0.2352415,"about_ca_system_score_codex":0.00013883872,"about_ca_system_score_gemma":0.00025259797,"threshold_uncertainty_score":0.44672307},"labels":[],"label_agreement":null},{"id":"W3036501203","doi":"10.1038/s41375-020-0929-3","title":"Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Chronic myelomonocytic leukemia; Cancer research; Azacitidine; Trametinib; In vivo; Medicine; Transplantation; Leukemia; Biology; Immunology; Bone marrow; Cancer; Myelodysplastic syndromes; MAPK/ERK pathway; Internal medicine; KRAS; Gene; Gene expression; Signal transduction; DNA methylation","score_opus":0.020389211421344124,"score_gpt":0.2670072797449849,"score_spread":0.24661806832364078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036501203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930662,0.0009690839,0.0019358153,0.00040313473,0.000043537355,0.0023332129,0.00012255067,0.000093965,0.0010324924],"genre_scores_gemma":[0.99713284,0.000464788,0.000946223,0.00033410083,0.00007019752,0.00037898566,0.00011971549,0.00009147676,0.00046169007],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99661225,0.00021208546,0.0008479123,0.000825284,0.0005859739,0.0009164651],"domain_scores_gemma":[0.9986246,0.00025555605,0.00017978193,0.00046957706,0.000078288846,0.0003921788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026355317,0.00047922594,0.0010876772,0.00039521584,0.00006491025,0.000028918132,0.0002931241,0.00025191155,0.00009936961],"category_scores_gemma":[0.00008877198,0.00044703533,0.00022608406,0.00097242557,0.00016721108,0.00026103418,0.000105561405,0.00075484085,0.000031059368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040801405,0.0002800118,0.007569122,0.00093589595,0.00030591842,0.00057503185,0.014784085,0.047558982,0.9021886,0.000024056199,0.0030038438,0.018694337],"study_design_scores_gemma":[0.016431822,0.0011472501,0.0012078739,0.0006079341,0.0001344306,0.00002223277,0.00070975913,0.49703076,0.48191488,0.00003407167,0.00037374516,0.0003852485],"about_ca_topic_score_codex":0.005319165,"about_ca_topic_score_gemma":0.00087089377,"teacher_disagreement_score":0.44947177,"about_ca_system_score_codex":0.010301197,"about_ca_system_score_gemma":0.0023453091,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W3036919729","doi":"10.1038/s41375-020-0935-5","title":"Male predominance in AML is associated with specific preleukemic mutations","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Leukemia; Genetics; Preleukemia; Mutation; Hematology; Medicine; Cancer research; Immunology; Gene","score_opus":0.02285359932203269,"score_gpt":0.2645555930208941,"score_spread":0.24170199369886142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036919729","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15305611,0.0012142772,0.0001635268,0.8127954,0.00034306882,0.0041375654,0.00070845755,0.00049586484,0.027085746],"genre_scores_gemma":[0.05644411,0.0007420366,0.0020981159,0.81471324,0.0043444387,0.0007711881,0.0056431973,0.00062634045,0.11461732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497783,0.00022326518,0.00081078394,0.0013924232,0.0013282974,0.0012673975],"domain_scores_gemma":[0.99741673,0.0005173459,0.0003971205,0.0011192262,0.0002948189,0.0002547514],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00021370547,0.0007684621,0.0013953663,0.0005649589,0.0001245519,0.00009458481,0.0006565416,0.0014290313,0.0012188915],"category_scores_gemma":[0.00038834856,0.00069575006,0.00025143375,0.0015974087,0.0004297449,0.00017859714,0.00018439599,0.0075847087,0.0011307164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003275431,0.000039300245,0.002867382,0.00034377608,0.0002514864,0.020096187,0.00070192834,0.00002670169,0.00037818006,0.0000064338665,0.9743678,0.0005933022],"study_design_scores_gemma":[0.009090981,0.0007000273,0.006770111,0.0022649749,0.00030606665,0.0014237831,0.00010464962,0.0020285477,0.00092781836,0.0001513776,0.97514856,0.0010831269],"about_ca_topic_score_codex":0.00027866632,"about_ca_topic_score_gemma":0.00005614287,"teacher_disagreement_score":0.096612014,"about_ca_system_score_codex":0.012345933,"about_ca_system_score_gemma":0.005039679,"threshold_uncertainty_score":0.9998673},"labels":[],"label_agreement":null},{"id":"W3038278697","doi":"10.1038/s41375-020-0958-y","title":"Targeting nuclear import and export in hematological malignancies","year":2020,"lang":"en","type":"review","venue":"Leukemia","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Karyopherin; Importin; Nuclear transport; Biology; Carcinogenesis; Cancer research; Nuclear localization sequence; Cancer; Cell nucleus; Gene; Genetics","score_opus":0.01561377391950826,"score_gpt":0.2565196548240379,"score_spread":0.2409058809045296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038278697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029054426,0.99573195,0.00000662895,0.0000114971235,0.00012682816,0.00019407431,0.000009158125,0.000019293791,0.0009951028],"genre_scores_gemma":[0.0010830817,0.99775416,0.00035854217,0.00016011449,0.00028593795,0.00001212979,0.00015819634,0.000044668486,0.00014319451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989431,0.00004200896,0.0003218925,0.00043347376,0.00007213283,0.00018738241],"domain_scores_gemma":[0.9996162,0.000006827154,0.00013107811,0.00016902975,0.0000106586185,0.000066201945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008125444,0.00024114014,0.0006484138,0.000033947414,0.000037213766,0.000021962582,0.00012083051,0.00045586633,0.000055552377],"category_scores_gemma":[0.000056872632,0.00019398556,0.00013158601,0.000082528204,0.00004886987,0.000002239661,0.00016981452,0.00024907885,0.000022102744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077323144,0.000027999276,0.00040384108,0.011782623,0.00023636625,0.00070606987,0.00012879803,0.0000012501799,0.0043157376,0.0012081326,0.043278646,0.9378332],"study_design_scores_gemma":[0.00008843749,0.00006682974,0.0000318366,0.0003324992,0.00004494296,0.00019935003,0.000017568162,0.0000041895287,0.000016112655,0.000018562423,0.9989664,0.00021326057],"about_ca_topic_score_codex":0.0000035714834,"about_ca_topic_score_gemma":0.0000020759403,"teacher_disagreement_score":0.95568776,"about_ca_system_score_codex":0.00004513866,"about_ca_system_score_gemma":0.00012415877,"threshold_uncertainty_score":0.79105014},"labels":[],"label_agreement":null},{"id":"W3040782867","doi":"10.1038/s41375-020-0979-6","title":"Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Rosetrees Trust; National Cancer Institute; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Pomalidomide; Myelofibrosis; Myeloproliferative neoplasm; Medicine; Polycythemia vera; Hematology; Spliceosome; Neoplasm; Myeloproliferative Disorders; Internal medicine; Pathology; Bone marrow; Biology; Genetics; Multiple myeloma; Gene","score_opus":0.011972133214173054,"score_gpt":0.23844778537906933,"score_spread":0.22647565216489626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040782867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7110295,0.00010725368,0.00007317975,0.28418085,0.000049036513,0.0034826174,0.0004926506,0.00015538395,0.00042951814],"genre_scores_gemma":[0.7505658,0.00015713823,0.003134212,0.2384503,0.00032333907,0.003044559,0.0009570147,0.00033196594,0.0030356674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952383,0.00050333125,0.0006404404,0.0015877086,0.0011302994,0.0008999171],"domain_scores_gemma":[0.9967977,0.0012445685,0.00044910275,0.00062210776,0.0003447117,0.0005418367],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00017954133,0.0011683094,0.0018772366,0.0005658519,0.0004132683,0.0001826566,0.00021820147,0.00071336835,0.00007502866],"category_scores_gemma":[0.00016716887,0.0008000745,0.000121576966,0.0012677868,0.00033423147,0.00021828363,0.00008134138,0.002696497,0.00006762745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05850556,0.0006998647,0.757716,0.0008617442,0.0036548027,0.067048185,0.024389133,0.0012167395,0.0011770584,0.00004386345,0.08394771,0.0007393152],"study_design_scores_gemma":[0.02964258,0.015437096,0.90561116,0.01250192,0.0029106622,0.0027608608,0.0031555833,0.0006608809,0.0016977988,0.000048647686,0.022786623,0.0027861698],"about_ca_topic_score_codex":0.0012695659,"about_ca_topic_score_gemma":0.007849155,"teacher_disagreement_score":0.14789516,"about_ca_system_score_codex":0.0018149938,"about_ca_system_score_gemma":0.0016850837,"threshold_uncertainty_score":0.99960434},"labels":[],"label_agreement":null},{"id":"W3042695800","doi":"10.1038/s41375-020-0962-2","title":"The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Vector Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; University of Pennsylvania; Terry Fox Research Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Mevalonate pathway; Geranylgeranylation; Bortezomib; Geranylgeranyl pyrophosphate; Statin; Cancer research; Apoptosis; Mevalonic acid; Proteasome inhibitor; Biology; Multiple myeloma; Carfilzomib; Medicine; Pharmacology; Prenylation; Internal medicine; Immunology; Biochemistry","score_opus":0.014261039356308661,"score_gpt":0.24714935867607665,"score_spread":0.232888319319768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042695800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926456,0.001409745,0.00051559455,0.0007607994,0.0022043646,0.00026535083,0.0001873078,0.000020687947,0.0019905104],"genre_scores_gemma":[0.99332327,0.00032261937,0.00021818226,0.0011880986,0.0039667464,0.000026517358,0.00008135337,0.000018910692,0.00085427734],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903506,0.00009058386,0.00019664984,0.0003292059,0.00014597028,0.00020254643],"domain_scores_gemma":[0.9992677,0.00002842692,0.0000896183,0.00035449286,0.00014269383,0.00011707616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017562162,0.00012686415,0.00015282583,0.000008710202,0.00015333634,0.000019644289,0.00021667212,0.00011472796,0.000027852115],"category_scores_gemma":[0.0001603192,0.000098949655,0.00011137267,0.00008057907,0.00012039596,0.000007746945,0.00008648392,0.00012243453,0.000009221076],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043329893,0.00003271884,0.0011619678,0.000025644087,0.000074637486,1.3626628e-7,0.0006314871,0.0001357782,0.950527,0.00022732037,0.023624586,0.023125427],"study_design_scores_gemma":[0.0004991201,0.00013248801,0.0074821655,0.000002929018,0.000012913575,0.0000014208553,0.0001476147,0.00032594916,0.45976982,0.00008063659,0.5314375,0.00010744241],"about_ca_topic_score_codex":0.000190614,"about_ca_topic_score_gemma":0.00013086815,"teacher_disagreement_score":0.5078129,"about_ca_system_score_codex":0.000041752362,"about_ca_system_score_gemma":0.0002754747,"threshold_uncertainty_score":0.40350497},"labels":[],"label_agreement":null},{"id":"W3081310922","doi":"10.1038/s41375-020-01026-y","title":"Revised 15-item MDS-specific frailty scale maintains prognostic potential","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Frailty in Older Adults","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université Laval; Royal Victoria Hospital; Research Institute in Oncology and Hematology; Royal Victoria Regional Health Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; Centre hospitalier de l'Université Laval; Alberta Hospital Edmonton; University of British Columbia; St. Paul's Hospital; Dr. Georges-L.-Dumont University Hospital Centre; McGill University Health Centre; University of Ottawa; McMaster University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; University of Alberta Hospital; Health Sciences Centre; University Health Network; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Scale (ratio); Gerontology; Oncology; Medicine; Internal medicine; Geography; Cartography","score_opus":0.02503049695921051,"score_gpt":0.2541493104975626,"score_spread":0.22911881353835212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081310922","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066833333,0.0014709865,0.001151584,0.97221667,0.0028106312,0.0033291075,0.00038456795,0.0011110151,0.010842117],"genre_scores_gemma":[0.015857887,0.00035327012,0.0035214152,0.9079416,0.03185331,0.00023555773,0.0054346723,0.0005196031,0.034282696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455464,0.00020338685,0.0010169941,0.0015428233,0.0014611466,0.0012209907],"domain_scores_gemma":[0.9969796,0.00032408308,0.00039320494,0.0015681215,0.00026955392,0.0004654137],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00014531882,0.0009793948,0.0014950631,0.00028840324,0.00017898646,0.00016368015,0.0007283217,0.0016493005,0.0021562034],"category_scores_gemma":[0.00048809545,0.00093390665,0.00069347734,0.0005598951,0.00034195292,0.0001222284,0.00028262884,0.005752481,0.004092375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012399247,0.000036993137,0.00059175974,0.0014623326,0.000198803,0.012336692,0.00018427403,0.000004803042,0.0007172995,0.000008228511,0.97980493,0.004529918],"study_design_scores_gemma":[0.00291467,0.00038794635,0.0032107525,0.0017845699,0.0005579375,0.0007411953,0.00003611117,0.00037646783,0.0003078818,0.0001925489,0.98860365,0.000886254],"about_ca_topic_score_codex":0.000066452536,"about_ca_topic_score_gemma":0.000007806673,"teacher_disagreement_score":0.06427507,"about_ca_system_score_codex":0.0018757618,"about_ca_system_score_gemma":0.0010118039,"threshold_uncertainty_score":0.9996468},"labels":[],"label_agreement":null},{"id":"W3083246189","doi":"10.1038/s41375-020-01021-3","title":"Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Celgene; Bristol-Myers Squibb","keywords":"Lenalidomide; Pomalidomide; Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Refractory (planetary science); Oncology; Thalidomide; Gastroenterology; Materials science","score_opus":0.03002251729832317,"score_gpt":0.2784020533142037,"score_spread":0.24837953601588053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083246189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911226,0.0012818945,0.00023360158,0.004544324,0.000022319397,0.0039386856,0.0003055791,0.00022135863,0.00033997704],"genre_scores_gemma":[0.9796828,0.00056262716,0.010369811,0.00095139723,0.000088048175,0.0009826852,0.00060779514,0.00013298776,0.006621824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726206,0.000074601114,0.00048254235,0.0009158393,0.00042076994,0.00084420457],"domain_scores_gemma":[0.9973404,0.000764771,0.00017928303,0.000507049,0.00012385068,0.0010846471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012450886,0.00059703237,0.0010586113,0.0000938712,0.00034486558,0.00006504372,0.000133152,0.00019930773,0.00011373735],"category_scores_gemma":[0.0005091459,0.0003931913,0.00024108043,0.00022573523,0.00017794273,0.00014580885,0.000090568785,0.00017633867,0.000061597595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026900923,0.00054783595,0.92339027,0.0004362634,0.0023182086,0.0008229267,0.0011108563,0.00004801771,0.006509004,0.0000132588575,0.011149466,0.02675299],"study_design_scores_gemma":[0.30725282,0.023533445,0.37779552,0.00061593595,0.003250308,0.0006992633,0.0004674498,0.025600245,0.1359841,0.000019518207,0.12273519,0.0020462195],"about_ca_topic_score_codex":0.0008656276,"about_ca_topic_score_gemma":0.0004703956,"teacher_disagreement_score":0.54559475,"about_ca_system_score_codex":0.0015295421,"about_ca_system_score_gemma":0.0002897689,"threshold_uncertainty_score":0.999852},"labels":[],"label_agreement":null},{"id":"W3092183154","doi":"10.1038/s41375-020-01051-x","title":"Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","year":2020,"lang":"en","type":"review","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Medicine; Disease; Risk stratification; Bone marrow; Monoclonal; Oncology; Immunology; Pathology; Internal medicine; Monoclonal antibody; Antibody","score_opus":0.07765431955879935,"score_gpt":0.3379218021911808,"score_spread":0.2602674826323814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092183154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0995844,0.8983559,0.000008105129,0.00002279855,0.000029857647,0.0017663608,0.0001394434,0.00001866182,0.000074491014],"genre_scores_gemma":[0.15079238,0.8478762,0.0005328012,0.000005820568,0.000065175016,0.00054291834,0.000087963796,0.000047436024,0.000049323535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801886,0.00009522627,0.0006570237,0.00054701313,0.00026368554,0.0004182177],"domain_scores_gemma":[0.99851173,0.0005846846,0.00029461808,0.0003011526,0.00002843784,0.00027937017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000097383505,0.00044717823,0.002228457,0.00041440115,0.000035632,0.000013069323,0.000087928776,0.00019602948,0.000014271345],"category_scores_gemma":[0.00012642892,0.00034718853,0.00023326787,0.00039068772,0.0001380359,0.00004856085,0.00008830929,0.00017395525,0.0000027931196],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014912074,0.0001482036,0.020236038,0.0093568545,0.0003390937,0.0007165891,0.00045453684,8.923013e-7,0.000032248343,0.000009016896,0.000002883088,0.9685545],"study_design_scores_gemma":[0.05420495,0.014548108,0.11569122,0.13602667,0.00758588,0.0013748845,0.00094027614,0.008903307,0.010647687,0.00010276601,0.6464961,0.0034781508],"about_ca_topic_score_codex":0.00043149252,"about_ca_topic_score_gemma":0.000077938064,"teacher_disagreement_score":0.9650764,"about_ca_system_score_codex":0.00071601843,"about_ca_system_score_gemma":0.0004415117,"threshold_uncertainty_score":0.999898},"labels":[],"label_agreement":null},{"id":"W3093984006","doi":"10.1038/s41375-020-01073-5","title":"Systemic mastocytosis with acute myeloid leukemia occurs from mutually exclusive clones expressing KITD816V and FLT3-ITD","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Systemic mastocytosis; Myeloid leukemia; Myeloid; Leukemia; Hematology; Immunology; Medicine; Cancer research; Biology; Bone marrow","score_opus":0.009930376796427323,"score_gpt":0.20231017286943445,"score_spread":0.19237979607300712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093984006","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69547963,0.060140524,0.0023294403,0.20133698,0.009449867,0.00528525,0.009214612,0.002233093,0.014530631],"genre_scores_gemma":[0.26107213,0.0038651717,0.0033231606,0.6243809,0.009239249,0.00071116677,0.025503343,0.0011316398,0.07077323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607646,0.00034030643,0.00078949676,0.0015974634,0.00018367979,0.0010125826],"domain_scores_gemma":[0.99778235,0.00038208344,0.0007276096,0.0009050001,0.00010252867,0.000100403384],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0000680862,0.0011195356,0.0016367817,0.00024278418,0.0005337281,0.00017173444,0.0007853284,0.002104311,0.0007792454],"category_scores_gemma":[0.000024474375,0.0009500079,0.00023467542,0.0002144121,0.00070831296,0.00018755309,0.00050372415,0.0034777166,0.0005392475],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066449435,0.000012724122,0.00021353705,0.0005821792,0.0017386999,0.0033603874,0.002247299,0.000013183756,0.18622665,0.000026651614,0.8029683,0.0019458488],"study_design_scores_gemma":[0.003657896,0.00044177246,0.00021169343,0.0014062774,0.0015092841,0.0015115672,0.00053914945,0.00003019787,0.014154729,0.00007709596,0.9748135,0.0016468419],"about_ca_topic_score_codex":0.0010053015,"about_ca_topic_score_gemma":0.00005373871,"teacher_disagreement_score":0.43440747,"about_ca_system_score_codex":0.0008019419,"about_ca_system_score_gemma":0.00088928407,"threshold_uncertainty_score":0.99929506},"labels":[],"label_agreement":null},{"id":"W3111359490","doi":"10.1038/s41375-020-01103-2","title":"SARS-CoV-2 antibody responses in patients with acute leukaemia","year":2020,"lang":"en","type":"letter","venue":"Leukemia","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Thailand Science Research and Innovation; Francis Crick Institute; Wellcome Trust","keywords":"Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Antibody; 2019-20 coronavirus outbreak; Hematology; Immunology; Leukemia; Virology; Internal medicine; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.04464749916394197,"score_gpt":0.36269210769594323,"score_spread":0.3180446085320013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111359490","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48735163,0.000080546466,0.000016397435,0.5101804,0.0002660466,0.0010050175,0.000172415,0.00016260486,0.00076493004],"genre_scores_gemma":[0.0801374,0.00006572735,0.00024659885,0.9144042,0.0017700844,0.000028094819,0.0018922114,0.00016297928,0.0012926623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663574,0.00016259773,0.0005848027,0.00083031005,0.0009146594,0.0008718937],"domain_scores_gemma":[0.99828166,0.00027643563,0.00026077006,0.0008196079,0.00017614964,0.0001854064],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00012161074,0.00059990387,0.0011536625,0.0005055178,0.00007678267,0.000050807426,0.00028301487,0.0009927119,0.00004969698],"category_scores_gemma":[0.00033300172,0.0004813014,0.00016180222,0.00059358176,0.00012073543,0.00012379322,0.000106335596,0.0038054702,0.0002713048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031795744,0.00003542287,0.07630713,0.001018141,0.00017964565,0.011509656,0.00030424242,3.2150515e-7,0.0007467768,0.0000022728013,0.905927,0.0007898343],"study_design_scores_gemma":[0.0055410075,0.0015509952,0.21196803,0.0013368758,0.00031282066,0.00006227662,0.0000066867774,0.000013553011,0.0009450803,0.00003528328,0.7776434,0.0005839996],"about_ca_topic_score_codex":0.0013041903,"about_ca_topic_score_gemma":0.000114715534,"teacher_disagreement_score":0.40721422,"about_ca_system_score_codex":0.0028604844,"about_ca_system_score_gemma":0.005252684,"threshold_uncertainty_score":0.99976385},"labels":[],"label_agreement":null},{"id":"W3112358011","doi":"10.1038/s41375-020-01100-5","title":"Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting","year":2020,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Flow cytometry; Value (mathematics); Oncology; Internal medicine; Medicine; Predictive value; Cancer research; Immunology; Statistics; Mathematics","score_opus":0.023987975549879952,"score_gpt":0.2958163284981245,"score_spread":0.27182835294824453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112358011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854869,0.00010508833,0.009332833,0.0017734594,0.000114476185,0.001789302,0.000115847804,0.000075800126,0.0012062821],"genre_scores_gemma":[0.9750373,0.00000864125,0.022448767,0.0018059256,0.00016689568,0.0001394579,0.00013054353,0.0000563075,0.00020616494],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99787366,0.00010205207,0.0006172519,0.00045570673,0.00046514798,0.00048618825],"domain_scores_gemma":[0.9986889,0.0005782461,0.00012916655,0.00027845852,0.00010612093,0.00021913504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043618,0.00019583665,0.00042898406,0.00034927184,0.000019234365,0.00001080967,0.00017838055,0.0002410247,0.000052599316],"category_scores_gemma":[0.0013842079,0.00018694931,0.0001242977,0.0006580141,0.000062561216,0.000101618134,0.00007154106,0.0004659748,0.00003708848],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022275427,0.0021167672,0.3336661,0.012706779,0.00029667176,0.0008543677,0.013808864,0.06943851,0.4923508,0.00010490297,0.042932544,0.009448303],"study_design_scores_gemma":[0.024945617,0.00070041715,0.014183226,0.00048498056,0.000064483844,0.0000057293882,0.00019821162,0.9241243,0.03396146,0.000020004307,0.0011683122,0.0001432274],"about_ca_topic_score_codex":0.00013664151,"about_ca_topic_score_gemma":0.000016163174,"teacher_disagreement_score":0.85468584,"about_ca_system_score_codex":0.0023935076,"about_ca_system_score_gemma":0.001225722,"threshold_uncertainty_score":0.7623572},"labels":[],"label_agreement":null},{"id":"W3121343412","doi":"10.1038/s41375-021-01137-0","title":"Germline variants drive myelodysplastic syndrome in young adults","year":2021,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Germline; Myelodysplastic syndromes; Medicine; Germline mutation; Oncology; Genetics; Internal medicine; Biology; Mutation; Gene; Bone marrow","score_opus":0.014173326233849343,"score_gpt":0.26321503250872463,"score_spread":0.2490417062748753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121343412","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38711554,0.0020861556,0.00027465678,0.57464087,0.0034236778,0.003800705,0.00049410237,0.00057860115,0.02758571],"genre_scores_gemma":[0.19455495,0.0011891067,0.003494823,0.6563803,0.012768412,0.0006899059,0.010947541,0.0010122366,0.11896276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361134,0.00031665765,0.0010931853,0.0016681575,0.0015799279,0.0017307465],"domain_scores_gemma":[0.9967048,0.0006064551,0.00028711726,0.0016661105,0.00039388772,0.00034159573],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00042365465,0.0009150314,0.0018154767,0.0010491919,0.00009627941,0.00010477411,0.00069960265,0.0026547215,0.0016733049],"category_scores_gemma":[0.0009480496,0.00088510953,0.00038685458,0.0012897368,0.00023330608,0.00016609435,0.00050269807,0.009609832,0.0014490495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029168493,0.00006511823,0.0032651455,0.0017383627,0.0003514683,0.19170673,0.00029924317,0.000019972402,0.00028067268,0.0000158181,0.8011399,0.00082591287],"study_design_scores_gemma":[0.034534656,0.0018177935,0.27138096,0.021295758,0.0014569355,0.06756297,0.0003815953,0.011601291,0.00044419253,0.0003283344,0.5845284,0.004667151],"about_ca_topic_score_codex":0.0013956532,"about_ca_topic_score_gemma":0.00031501663,"teacher_disagreement_score":0.26811582,"about_ca_system_score_codex":0.007307061,"about_ca_system_score_gemma":0.004896356,"threshold_uncertainty_score":0.99935997},"labels":[],"label_agreement":null},{"id":"W3128046611","doi":"10.1038/s41375-021-01150-3","title":"Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Blood Cancer UK; CHILDREN with CANCER UK; National Cancer Research Institute; Guy's and St Thomas' Charity; Cancer Research UK; National Institute for Health and Care Research","keywords":"Haematopoiesis; Chromosomal translocation; Hematology; Biology; Immunology; Cancer research; Oncology; Stem cell; Medicine; Genetics; Gene","score_opus":0.027463614899632307,"score_gpt":0.2927900817349424,"score_spread":0.26532646683531014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128046611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98112667,0.0012653922,0.0010446943,0.004538433,0.00010064901,0.00054558954,0.000097175405,0.00027431527,0.011007059],"genre_scores_gemma":[0.98154366,0.00030419484,0.0076469686,0.0013017978,0.0002380424,0.00012071693,0.0007732118,0.00010245404,0.007968946],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973363,0.00014435653,0.0004916668,0.00070755417,0.0006954795,0.000624626],"domain_scores_gemma":[0.9978889,0.00035641855,0.0001221355,0.0008678453,0.00040109956,0.0003635855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020688173,0.00033939164,0.0005970674,0.00012798423,0.00025690012,0.0000722833,0.0002460971,0.0002889391,0.0011038668],"category_scores_gemma":[0.00020968216,0.0002823067,0.00015851174,0.0008903956,0.00022885592,0.000118944365,0.000059205475,0.0009907393,0.00009389523],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007704143,0.0014930946,0.25440037,0.0009575602,0.0073137903,0.015251626,0.037198525,0.0041317707,0.5020109,0.006585328,0.041134816,0.12181811],"study_design_scores_gemma":[0.04610105,0.0011718911,0.49064052,0.0024440826,0.0011246788,0.0032017261,0.0047794282,0.02409337,0.38083637,0.0030541194,0.040025946,0.0025267978],"about_ca_topic_score_codex":0.002238682,"about_ca_topic_score_gemma":0.00062253897,"teacher_disagreement_score":0.23624018,"about_ca_system_score_codex":0.0016190151,"about_ca_system_score_gemma":0.004539213,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W3132405511","doi":"10.1038/s41375-021-01180-x","title":"Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Internal medicine; Serum protein electrophoresis; Hematology; Surrogate endpoint; Gastroenterology; Oncology; Immunology; Monoclonal; Antibody; Monoclonal antibody","score_opus":0.04591227923151518,"score_gpt":0.34574227588327006,"score_spread":0.29982999665175486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132405511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769366,0.00018961314,0.000059877224,0.0007273112,0.000073925316,0.0008725617,0.00010775686,0.000059583665,0.00021570324],"genre_scores_gemma":[0.985571,0.000021481957,0.0121015,0.000088775945,0.000039870498,0.00025602843,0.00008974345,0.000046390534,0.0017851943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976919,0.00019624359,0.0002926757,0.0005423151,0.00071554957,0.0005612897],"domain_scores_gemma":[0.9982188,0.0004105863,0.00007976395,0.00048563327,0.000338661,0.0004665914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023758967,0.0002500962,0.0003520754,0.00017094522,0.00013262474,0.000055903496,0.000094869756,0.00007113893,0.00005331407],"category_scores_gemma":[0.0011354457,0.00019667778,0.00007289181,0.00048814938,0.0000837843,0.00023299929,0.000105545194,0.00037035032,0.00003431782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007911904,0.00052601,0.9816992,0.00018285602,0.00012538028,0.0034879926,0.0006196494,0.00018248291,0.0026902205,0.00002043813,0.00006903504,0.0024848317],"study_design_scores_gemma":[0.01007102,0.000619126,0.97713625,0.00079875294,0.000048251866,0.000008902932,0.0009436369,0.0030178686,0.006852902,0.000025710688,0.00028461477,0.00019297047],"about_ca_topic_score_codex":0.00027991983,"about_ca_topic_score_gemma":0.00009222766,"teacher_disagreement_score":0.012122653,"about_ca_system_score_codex":0.0016512689,"about_ca_system_score_gemma":0.0024852774,"threshold_uncertainty_score":0.8020287},"labels":[],"label_agreement":null},{"id":"W3135647768","doi":"10.1038/s41375-021-01179-4","title":"Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Novartis; U.S. Department of Health and Human Services","keywords":"Midostaurin; Medicine; Internal medicine; Cytarabine; Oncology; Cumulative incidence; Myeloid leukemia; Preleukemia; Maintenance therapy; Transplantation; Surgery; Leukemia; Chemotherapy","score_opus":0.02581105720882084,"score_gpt":0.3097408282084322,"score_spread":0.28392977099961136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135647768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703875,0.0026421114,0.000046007488,0.013727793,0.0009231287,0.0018083641,0.00005262105,0.00018520732,0.01022723],"genre_scores_gemma":[0.94848555,0.003962472,0.0023501038,0.0039105993,0.0021188622,0.0005670351,0.00026618032,0.00020646573,0.03813275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942663,0.00055547524,0.0011627143,0.0012603336,0.0013454054,0.0014098161],"domain_scores_gemma":[0.9964479,0.00065934926,0.00025137854,0.0017833872,0.0003730292,0.00048492843],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00129483,0.00060815027,0.0010584107,0.0002062875,0.00032410925,0.0001825065,0.00083753624,0.0006711348,0.0007583978],"category_scores_gemma":[0.0013789359,0.00045237434,0.00038568434,0.0018040834,0.00048129653,0.0003058376,0.00051957957,0.0030210465,0.00070007687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.069696836,0.00078247586,0.002360873,0.0005467453,0.0018786966,0.035158124,0.00597538,0.00055787363,0.65153193,0.0032809384,0.17950718,0.048722927],"study_design_scores_gemma":[0.19086641,0.0021294595,0.012731387,0.0013693639,0.0010497813,0.0036957765,0.0038501094,0.0071510486,0.54826176,0.0016751372,0.22504,0.0021797407],"about_ca_topic_score_codex":0.0006269428,"about_ca_topic_score_gemma":0.00042883147,"teacher_disagreement_score":0.121169575,"about_ca_system_score_codex":0.007817882,"about_ca_system_score_gemma":0.010067242,"threshold_uncertainty_score":0.9997928},"labels":[],"label_agreement":null},{"id":"W3138442763","doi":"10.1038/s41375-021-01203-7","title":"Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Deutsche Krebshilfe; FP7 Health; Novo Nordisk Fonden; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Lymphoblastic Leukemia; Medicine; Term (time); Internal medicine; Pediatrics; Leukemia; Oncology","score_opus":0.009808131559939204,"score_gpt":0.26264494241367903,"score_spread":0.2528368108537398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138442763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956441,0.0004399973,0.002280133,0.00011771427,0.00012819111,0.0005517786,0.000022665537,0.00007801067,0.00073743175],"genre_scores_gemma":[0.9964988,0.00051462586,0.0019804225,0.00009686564,0.00018584635,0.00008749568,0.00015904321,0.0000646426,0.00041221362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971204,0.00009555295,0.0007905051,0.00071819045,0.00072127127,0.00055409665],"domain_scores_gemma":[0.9983487,0.00030825112,0.00015924494,0.00064751937,0.00024848114,0.0002877626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025709262,0.0003277452,0.0007188022,0.00045470294,0.000069419526,0.00003151107,0.00017679077,0.00034117338,0.00006382939],"category_scores_gemma":[0.00029187446,0.00032619495,0.00011461228,0.0012731066,0.00017853883,0.00019921258,0.00021643235,0.00043273548,0.00004616388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009699362,0.0003434482,0.77765787,0.0030168365,0.00039118534,0.0054764366,0.0010626409,0.0006524261,0.18987492,0.00089297065,0.00043288694,0.019228444],"study_design_scores_gemma":[0.006519515,0.0004910876,0.927278,0.0003049211,0.00062979007,0.00872185,0.00017461849,0.044761274,0.010155404,0.0004354279,0.000056456745,0.00047165432],"about_ca_topic_score_codex":0.00024120779,"about_ca_topic_score_gemma":0.00008808427,"teacher_disagreement_score":0.17971951,"about_ca_system_score_codex":0.0045654844,"about_ca_system_score_gemma":0.002889805,"threshold_uncertainty_score":0.999919},"labels":[],"label_agreement":null},{"id":"W3154274746","doi":"10.1038/s41375-021-01247-9","title":"External validation of the FIRST trial’s simplified frailty score in a population-based cohort","year":2021,"lang":"en","type":"letter","venue":"Leukemia","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Cohort; Medicine; Population; Internal medicine; Oncology; Gerontology; Environmental health","score_opus":0.038301317875196146,"score_gpt":0.2844795929350848,"score_spread":0.24617827505988865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154274746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74461275,0.00012019898,0.000107718755,0.24964465,0.0015946405,0.002814403,0.0000996459,0.00006255333,0.0009434451],"genre_scores_gemma":[0.6281354,0.000011327546,0.00037258223,0.35825664,0.0039015054,0.00029231465,0.0030908873,0.00013945479,0.0057999077],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971702,0.00015629793,0.00086207886,0.0005285719,0.00095413247,0.0003287031],"domain_scores_gemma":[0.9977387,0.00037512882,0.0004974279,0.0011706592,0.0001702143,0.000047848942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025644794,0.000339833,0.00077614427,0.00020161291,0.000059272512,0.00003363438,0.0003385103,0.0009239446,0.0004486525],"category_scores_gemma":[0.000729656,0.0002680144,0.00034381964,0.00044900147,0.000071153605,0.00005344501,0.00007433667,0.0017827436,0.000020058776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013838394,0.00008071508,0.46009904,0.0011648502,0.00011518111,0.00032279897,0.00012388047,0.00068469305,0.00014695586,0.000007752026,0.5353145,0.00055580086],"study_design_scores_gemma":[0.041166116,0.00020321271,0.8424617,0.005872879,0.0004936854,0.00004763372,0.000008850621,0.00075122714,0.003724054,0.00026753108,0.10445185,0.0005512588],"about_ca_topic_score_codex":0.0026051188,"about_ca_topic_score_gemma":0.00043289666,"teacher_disagreement_score":0.43086264,"about_ca_system_score_codex":0.0015118931,"about_ca_system_score_gemma":0.0011782654,"threshold_uncertainty_score":0.99997723},"labels":[],"label_agreement":null},{"id":"W3158136113","doi":"10.1038/s41375-021-01257-7","title":"Hairy cell leukemia and COVID-19 adaptation of treatment guidelines","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cilag; Canadian Institutes of Health Research; Kite Pharma; Genentech; Ascentage Pharma; Pharmacyclics; Agios Pharmaceuticals; Astellas Pharma; Adaptive Biotechnologies; Astex Pharmaceuticals; H. Lundbeck A/S; TG Therapeutics; Royal Marsden NHS Foundation Trust; CancerCare Manitoba Foundation; MEI Pharma; MacroGenics; Sunesis; University of Pittsburgh; AbbVie; National Cancer Institute; Servier; Gilead Sciences; Teva Pharmaceutical Industries; Celgene; Novartis; Pfizer; Biogen; AstraZeneca; Amgen; National Institutes of Health; Leukemia and Lymphoma Society of Canada; BeiGene; Hairy Cell Leukemia Research Foundation; GlaxoSmithKline","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Medicine; Hairy cell leukemia; Immunosuppression; Intensive care medicine; Life expectancy; Leukemia; 2019-20 coronavirus outbreak; Immunology; Disease; Virology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.1891866795627362,"score_gpt":0.4336963452685132,"score_spread":0.244509665705777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158136113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014833931,0.9951183,0.00046459973,0.00007076382,0.00017463474,0.00159303,0.00010367748,0.00008959858,0.0022370566],"genre_scores_gemma":[0.000033317145,0.9837425,0.0032940505,0.00026248934,0.0005062148,0.00023127644,0.0008986363,0.00013650705,0.010895014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959179,0.00027643595,0.0015458225,0.0009898868,0.0006929721,0.0005769464],"domain_scores_gemma":[0.9962473,0.00083317474,0.00059899775,0.0011893415,0.0003870036,0.00074416964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005111861,0.00074494694,0.0032980726,0.000424164,0.00010456579,0.00004350248,0.00025140613,0.0007787566,0.0002913652],"category_scores_gemma":[0.0011094834,0.0005678361,0.000770971,0.0006504678,0.00026894675,0.00007206118,0.0002296286,0.00045965932,0.00007840685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000055249584,0.00006117296,0.0000040208524,0.053895567,0.00048185702,0.0008184744,0.00036355504,0.00027860963,0.0000051894567,0.00010682429,0.011349593,0.9325799],"study_design_scores_gemma":[0.008387472,0.0004653251,4.6941562e-7,0.008899462,0.0021834457,0.00126082,0.00024169599,0.0063377363,0.000033871205,0.0000124363505,0.9717754,0.00040183577],"about_ca_topic_score_codex":0.007350176,"about_ca_topic_score_gemma":0.00021085065,"teacher_disagreement_score":0.96042585,"about_ca_system_score_codex":0.14809367,"about_ca_system_score_gemma":0.20012872,"threshold_uncertainty_score":0.9996773},"labels":[],"label_agreement":null},{"id":"W3160346821","doi":"10.1038/s41375-021-01260-y","title":"Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Myeloid leukemia; Internal medicine; Adverse effect; Tyrosine-kinase inhibitor; Imatinib; Surgery; Cancer","score_opus":0.009310910288651317,"score_gpt":0.24042484876914275,"score_spread":0.23111393848049144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160346821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443144,0.0015932439,0.000019189909,0.00027536732,0.00029207312,0.0011101385,0.00011684896,0.00020406512,0.001957648],"genre_scores_gemma":[0.9836689,0.00040753087,0.0012422139,0.0005743094,0.00045968077,0.0002209785,0.00153702,0.00019963428,0.0116896955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582267,0.00013687584,0.00082361157,0.0013430074,0.0007752233,0.0010985974],"domain_scores_gemma":[0.99659806,0.00009528576,0.0002564456,0.002269156,0.00024169586,0.00053932855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014105883,0.0008242473,0.0010612858,0.00027985574,0.00011758557,0.00006775834,0.0003376862,0.00043821862,0.004161248],"category_scores_gemma":[0.00010917576,0.0006567221,0.00025110485,0.00071149797,0.00014980856,0.00032108164,0.00028545997,0.0006155435,0.00049826066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0032376123,0.0006824705,0.9706334,0.00038147316,0.00038866245,0.003281314,0.00025766258,0.00007959972,0.0012993634,0.000021930084,0.0009837836,0.018752737],"study_design_scores_gemma":[0.0498705,0.0018880775,0.92088467,0.0010795115,0.0003824569,0.0001811013,0.00002316636,0.00009089278,0.01926709,0.000034504927,0.005613945,0.00068407814],"about_ca_topic_score_codex":0.00021894832,"about_ca_topic_score_gemma":0.0020540478,"teacher_disagreement_score":0.049748715,"about_ca_system_score_codex":0.02762262,"about_ca_system_score_gemma":0.0064981193,"threshold_uncertainty_score":0.99958843},"labels":[],"label_agreement":null},{"id":"W3160513889","doi":"10.1038/s41375-021-01285-3","title":"Treatment resistance in diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Genome Canada; Leukemia and Lymphoma Society of Canada; European Hematology Association","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Resistance (ecology); Hematology; Cancer research; Oncology; Internal medicine; Pathology; Immunology; Biology","score_opus":0.030187779597018564,"score_gpt":0.31277867400067955,"score_spread":0.282590894403661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160513889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005124321,0.9815447,6.761547e-7,0.00004954011,0.00018603893,0.0010835195,0.00012465075,0.000057230154,0.016441256],"genre_scores_gemma":[0.00028618594,0.97860986,0.00027773005,0.000120537086,0.00020239303,0.0008507727,0.0008279482,0.00008988799,0.018734684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975631,0.00013443634,0.0006870225,0.00078043016,0.00028248862,0.00055246905],"domain_scores_gemma":[0.998341,0.00020727851,0.00022530125,0.0009688878,0.000036609792,0.00022089087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000073228155,0.000664036,0.0028106135,0.00019960002,0.000056240868,0.000040395324,0.00012890696,0.00043693683,0.00010068511],"category_scores_gemma":[0.000032345037,0.00046342492,0.0009016755,0.00044470903,0.000027518656,0.000034190518,0.00007169764,0.00012214722,0.00039419983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028692393,0.013049118,0.00028923491,0.010240701,0.00043093646,0.010582508,0.00015321985,2.5035904e-8,1.1720229e-7,0.0006684997,0.004314858,0.9602421],"study_design_scores_gemma":[0.021971213,0.00013415908,0.00017381157,0.01529365,0.0016533238,0.00012561967,0.000016813952,9.795068e-7,0.0000102970025,0.0000066278826,0.9602812,0.00033229857],"about_ca_topic_score_codex":0.00015036302,"about_ca_topic_score_gemma":0.00033838104,"teacher_disagreement_score":0.9599098,"about_ca_system_score_codex":0.011221068,"about_ca_system_score_gemma":0.0027504896,"threshold_uncertainty_score":0.9997817},"labels":[],"label_agreement":null},{"id":"W3160777207","doi":"10.1038/s41375-021-01290-6","title":"JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polycythemia vera; Phlebotomy; Erythropoietin; Medicine; Erythropoietin receptor; Erythropoiesis; Thrombocytosis; Internal medicine; Anemia","score_opus":0.09408255662853951,"score_gpt":0.36896144369121614,"score_spread":0.2748788870626766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160777207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082539635,0.99448144,0.000052288895,0.000053099957,0.00031595305,0.003181121,0.00006772801,0.00009537177,0.001670469],"genre_scores_gemma":[0.00011457715,0.99364746,0.00041304654,0.0002516524,0.00037565414,0.0035824613,0.0011252312,0.0001238696,0.00036606728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967951,0.00036227168,0.0008691171,0.0010602309,0.00040906577,0.00050418254],"domain_scores_gemma":[0.99748147,0.0010199065,0.000339968,0.00069120043,0.00012140931,0.0003460349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020182374,0.00090968766,0.0037316508,0.00019939934,0.00014102922,0.0000961502,0.00013908348,0.0004052515,0.00016646553],"category_scores_gemma":[0.00024330035,0.0006141615,0.0006821252,0.0004988461,0.00011857701,0.00004025562,0.00013402423,0.00084840215,0.00016271874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065195422,0.00038169284,0.00018819042,0.017696125,0.0010425367,0.0001720851,0.000120376855,7.674272e-7,1.5203676e-7,0.00043319818,0.0016185206,0.97833985],"study_design_scores_gemma":[0.0011316494,0.00020093704,0.00016514423,0.026946828,0.0065934034,0.00064330664,0.000027008544,0.00002367189,0.0000067349324,0.00001804492,0.96374184,0.00050140335],"about_ca_topic_score_codex":0.000018582603,"about_ca_topic_score_gemma":0.000006318081,"teacher_disagreement_score":0.97783846,"about_ca_system_score_codex":0.0010689395,"about_ca_system_score_gemma":0.0014214087,"threshold_uncertainty_score":0.999631},"labels":[],"label_agreement":null},{"id":"W3161357565","doi":"10.1038/s41375-021-01279-1","title":"Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Myeloproliferative Disorders; Polycythemia vera; Hematology; Hematologic Neoplasms; Myelofibrosis; Internal medicine; Cancer; Bone marrow","score_opus":0.03891481730790351,"score_gpt":0.33515257241971297,"score_spread":0.29623775511180944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161357565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083763,0.000024377547,0.000024403313,0.00056772155,0.00072612514,0.0016211636,0.0015028961,0.00007770841,0.004617986],"genre_scores_gemma":[0.99153703,0.000039411265,0.0014373983,0.0013057587,0.0004136362,0.00046943288,0.0038823604,0.00004302484,0.0008719256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997643,0.00014549145,0.000490402,0.00085506664,0.00055241084,0.00031366487],"domain_scores_gemma":[0.9981528,0.00043209482,0.00014790882,0.0005146391,0.0005286715,0.00022387988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015584413,0.0003270634,0.000640914,0.000097005875,0.00015992511,0.000094628675,0.00013216372,0.00011585031,0.00014494387],"category_scores_gemma":[0.0006687988,0.00026212275,0.00013088493,0.00014845094,0.00003337009,0.00017597764,0.00006204445,0.00017963586,0.00011136589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005053611,0.0066669458,0.9669101,0.000013323125,0.0015772986,0.00043523803,0.003860838,0.000081169004,0.00041326345,0.0002760862,0.0051230784,0.009589006],"study_design_scores_gemma":[0.022327026,0.0028946411,0.93112236,0.00014151084,0.0003033387,0.0000066921857,0.0006459388,0.00083789206,0.036112446,0.000091197646,0.005209157,0.00030781902],"about_ca_topic_score_codex":0.0002087955,"about_ca_topic_score_gemma":0.00037830128,"teacher_disagreement_score":0.035787802,"about_ca_system_score_codex":0.0005761909,"about_ca_system_score_gemma":0.00037141936,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W3161919645","doi":"10.1038/s41375-021-01261-x","title":"Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Corporation","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Anemia; Adverse effect; Dosing; Internal medicine; Polycythemia vera; Gastroenterology; Hemoglobin; Phases of clinical research; Surgery; Clinical trial; Bone marrow","score_opus":0.03425455265126314,"score_gpt":0.31733399499282644,"score_spread":0.2830794423415633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161919645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661744,0.0003627973,0.000016046259,0.00022060206,0.000009939057,0.0024563596,0.00016991826,0.0000037423758,0.00014314192],"genre_scores_gemma":[0.99894077,0.00022804974,0.00033670172,0.00006281876,0.000022203314,0.00028743834,0.00009060017,0.00001129504,0.000020140706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990974,0.00006433661,0.00028662698,0.00023455606,0.00017508144,0.00014200213],"domain_scores_gemma":[0.9989435,0.0005381292,0.00011203914,0.00024835696,0.00011247012,0.000045474553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112623486,0.00015504748,0.00036830295,0.00003282074,0.000077363606,0.000016024833,0.000032780492,0.000039642007,0.0000061367186],"category_scores_gemma":[0.000037398833,0.00007247412,0.0000368535,0.00014347902,0.00008839529,0.000030251535,0.000012504552,0.00005314359,6.044079e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011636969,0.028718725,0.8505425,0.00032863117,0.0006452035,0.00006732638,0.023899881,0.00009157462,0.00091198116,0.0010857022,0.000063170475,0.08200836],"study_design_scores_gemma":[0.06397943,0.011647944,0.91571045,0.00018030485,0.0005366632,0.000012450725,0.0031829309,0.00009149886,0.0042889547,0.000012779238,0.00027205003,0.000084516396],"about_ca_topic_score_codex":0.00020360855,"about_ca_topic_score_gemma":0.00017268136,"teacher_disagreement_score":0.08192384,"about_ca_system_score_codex":0.00011689821,"about_ca_system_score_gemma":0.00015431049,"threshold_uncertainty_score":0.2955409},"labels":[],"label_agreement":null},{"id":"W3162506674","doi":"10.1038/s41375-021-01264-8","title":"Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sun Yat-sen University Cancer Center; Sun Yat-sen University; National Institute for Health and Care Research","keywords":"Tocilizumab; Medicine; Jadad scale; Meta-analysis; Internal medicine; Confidence interval; Relative risk; Cohort study; Cohort; Coronavirus disease 2019 (COVID-19); Coronavirus; MEDLINE; Disease; Infectious disease (medical specialty); Biology","score_opus":0.26789140176604714,"score_gpt":0.5105199397974708,"score_spread":0.24262853803142365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162506674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.46293e-7,0.99324477,0.000031471158,0.0011794503,0.000008531094,0.004809829,0.00063525874,0.00002567997,0.00006427203],"genre_scores_gemma":[0.000024085502,0.99194485,0.00007152853,0.0028737015,0.000014278424,0.0014321695,0.00024804907,0.000048171296,0.003343188],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99445015,0.0011692494,0.0019256388,0.0009911183,0.0010454035,0.0004184384],"domain_scores_gemma":[0.98546505,0.0110706305,0.00085255416,0.0016186342,0.00022280331,0.0007703321],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0018536757,0.0006239609,0.019740002,0.0005973763,0.00005836663,0.00002279622,0.00032861103,0.00020352952,0.00066529703],"category_scores_gemma":[0.04309852,0.00035063754,0.0038433468,0.0025951713,0.00031051086,0.000045050583,0.0003439142,0.0007699075,0.000017645652],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016722623,0.000050769722,0.000020009675,0.831059,0.1667642,0.00045474226,0.000037390546,0.0000051953775,6.20223e-9,0.00003965491,0.00019853818,0.0013537881],"study_design_scores_gemma":[0.0003390677,0.00008485912,0.000021043918,0.11725123,0.77840847,0.0000078323,0.000019654135,0.0000133088815,5.5730967e-9,0.0000031011075,0.103613615,0.00023783559],"about_ca_topic_score_codex":0.0007175966,"about_ca_topic_score_gemma":0.00030175902,"teacher_disagreement_score":0.71380776,"about_ca_system_score_codex":0.0021871775,"about_ca_system_score_gemma":0.0073009883,"threshold_uncertainty_score":0.99989456},"labels":[],"label_agreement":null},{"id":"W3170616394","doi":"10.1038/s41375-021-01314-1","title":"Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP","year":2021,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Max-Planck-Gesellschaft; Michael Smith Health Research BC","keywords":"Lymphoma; Classical Hodgkin lymphoma; Stage (stratigraphy); Oncology; Outcome (game theory); Internal medicine; Medicine; Hodgkin lymphoma; Gene expression; Cancer research; Gene; Biology; Genetics; Mathematics","score_opus":0.019679951194619863,"score_gpt":0.2598461626357538,"score_spread":0.24016621144113393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170616394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91354185,0.0008106948,0.00008928069,0.080223314,0.00041036148,0.0017495978,0.00062562764,0.00036175008,0.0021875123],"genre_scores_gemma":[0.51274,0.00014895281,0.008208445,0.41775057,0.003267845,0.0024994474,0.019337177,0.00048736253,0.035560194],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653465,0.0001597045,0.00071085495,0.0011008229,0.00082759146,0.00066639273],"domain_scores_gemma":[0.99816287,0.00026696766,0.00026190627,0.0009852614,0.00012016989,0.00020284619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008876699,0.00071595365,0.0012330813,0.00032858338,0.00008006398,0.00005497535,0.00015344501,0.0011395294,0.00040536196],"category_scores_gemma":[0.000060954964,0.00051592564,0.00028729977,0.00040832572,0.00009951104,0.0000863979,0.000052918484,0.0007702645,0.00006605079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016089071,0.001079061,0.5498849,0.0007572419,0.00041256662,0.049565688,0.00007938035,0.00037480867,0.0030168525,0.00000280359,0.3820489,0.011168879],"study_design_scores_gemma":[0.050921045,0.0024879624,0.40155944,0.004079223,0.001055854,0.00030123792,0.00006165985,0.0012507095,0.077155896,0.0000049883392,0.45988286,0.0012391058],"about_ca_topic_score_codex":0.00023419183,"about_ca_topic_score_gemma":0.00005230792,"teacher_disagreement_score":0.40080187,"about_ca_system_score_codex":0.005560355,"about_ca_system_score_gemma":0.0015305234,"threshold_uncertainty_score":0.9997292},"labels":[],"label_agreement":null},{"id":"W3172501391","doi":"10.1038/s41375-021-01308-z","title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; U.S. Department of Health and Human Services; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"HSF1; Biology; Cancer research; Myeloid leukemia; Leukemia; eIF4A; Initiation factor; Gene knockdown; Eukaryotic initiation factor; Cell culture; Heat shock protein; Translation (biology); Hsp70; Genetics; Messenger RNA; Gene","score_opus":0.07219252452039793,"score_gpt":0.3509922953089347,"score_spread":0.2787997707885368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172501391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28961036,0.7065214,0.00015551246,0.000090224436,0.00016476633,0.0023741764,0.00037630054,0.00009678539,0.0006105055],"genre_scores_gemma":[0.15406454,0.84383416,0.00026440795,0.00004946546,0.00024253422,0.00014494671,0.0011425187,0.00014434617,0.00011306517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954139,0.00061312126,0.0012630901,0.0010955727,0.0008630884,0.0007511988],"domain_scores_gemma":[0.9973622,0.00087812863,0.0004760226,0.0007270128,0.00023589178,0.00032076627],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041219956,0.00084723945,0.0034171944,0.0011089368,0.00009617723,0.00007602968,0.00017726567,0.0013962261,0.0002336789],"category_scores_gemma":[0.00043925486,0.00076559884,0.0005135986,0.0013640022,0.00019477156,0.0007169992,0.00015852283,0.0019854028,0.000020658441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015232444,0.00014601684,0.0007039872,0.02840291,0.00025988845,0.00024488708,0.00067042036,0.000007960056,0.009160552,0.00002617722,0.0001949692,0.9600299],"study_design_scores_gemma":[0.025426699,0.0024576224,0.059889313,0.23111874,0.004852824,0.0017958373,0.00072239945,0.0030717575,0.117391996,0.00020255736,0.5459736,0.0070966613],"about_ca_topic_score_codex":0.00084405445,"about_ca_topic_score_gemma":0.00010430641,"teacher_disagreement_score":0.95293325,"about_ca_system_score_codex":0.008833692,"about_ca_system_score_gemma":0.005578168,"threshold_uncertainty_score":0.99990016},"labels":[],"label_agreement":null},{"id":"W3184895242","doi":"10.1038/s41375-021-01323-0","title":"Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"National Cancer Institute; Astellas Pharma; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; MacroGenics; National Institutes of Health; Arog Pharmaceuticals; Astex Pharmaceuticals; Sunesis; Jazz Pharmaceuticals; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Agios Pharmaceuticals","keywords":"Midostaurin; Myeloid leukemia; NPM1; Internal medicine; Oncology; Cumulative incidence; Fms-Like Tyrosine Kinase 3; Medicine; Leukemia; Transplantation; Biology; Mutation; Gene; Genetics","score_opus":0.014340783538162613,"score_gpt":0.3084374591255631,"score_spread":0.2940966755874005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184895242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961103,0.00069086434,0.00004221582,0.00031037294,0.000053731725,0.0012444339,0.000063408486,0.00006823827,0.0014163915],"genre_scores_gemma":[0.997989,0.00026161017,0.0005641639,0.00013289397,0.000080265505,0.00007373741,0.00029124427,0.0000625755,0.0005445394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681985,0.00031305157,0.00087164465,0.0006781516,0.0006966594,0.00062060944],"domain_scores_gemma":[0.99802965,0.00025919618,0.0001994772,0.0008228512,0.0003787911,0.00031001272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070857216,0.0003658672,0.000803479,0.00042548537,0.00006760155,0.0000552555,0.00017405661,0.00029967722,0.000060138682],"category_scores_gemma":[0.0009763149,0.00031287703,0.00017783613,0.0012875868,0.00011760351,0.00019036599,0.00028208096,0.0009504182,0.000039726867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031899214,0.0004499951,0.6851345,0.00023101846,0.0006505151,0.0060530105,0.0035020304,0.0008223712,0.29478395,0.000020676685,0.0015408075,0.0036212357],"study_design_scores_gemma":[0.015447443,0.0020140596,0.947192,0.00028856727,0.00031643748,0.00046976362,0.0010531216,0.007596268,0.025166558,0.00004321147,0.00007949985,0.00033303397],"about_ca_topic_score_codex":0.0009822082,"about_ca_topic_score_gemma":0.00025942453,"teacher_disagreement_score":0.26961738,"about_ca_system_score_codex":0.0023428984,"about_ca_system_score_gemma":0.0035846909,"threshold_uncertainty_score":0.99993235},"labels":[],"label_agreement":null},{"id":"W3186824000","doi":"10.1038/s41375-021-01342-x","title":"Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Ibrutinib; Bendamustine; Medicine; Internal medicine; Adverse effect; Rituximab; Cumulative incidence; Gastroenterology; Chronic lymphocytic leukemia; Lymphoma; Leukemia; Cohort","score_opus":0.018122859463453794,"score_gpt":0.29060930895170584,"score_spread":0.27248644948825207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186824000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258447,0.00055741,0.00009036926,0.0008464867,0.00022794674,0.0010789764,0.000024489596,0.000114651266,0.0044752294],"genre_scores_gemma":[0.97086245,0.00024893414,0.0030981065,0.00074412365,0.00036587025,0.00011044118,0.00021178609,0.000107643515,0.02425063],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99619323,0.0001308931,0.00065644574,0.0009146079,0.0011342496,0.00097057165],"domain_scores_gemma":[0.9977398,0.00028304456,0.00017613635,0.0010353159,0.00040651206,0.00035921694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003675049,0.00038132217,0.00072987826,0.00014017365,0.00009828654,0.00003514036,0.00026959198,0.0002457559,0.0014900506],"category_scores_gemma":[0.0008704326,0.00029959664,0.00012081158,0.0010180105,0.00015208515,0.00020576805,0.00028667584,0.000726395,0.00030480008],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0819399,0.012470842,0.24234447,0.02049975,0.0043000416,0.14219952,0.042349994,0.04024638,0.0067559476,0.0012187961,0.23059064,0.17508373],"study_design_scores_gemma":[0.54539925,0.0021701176,0.24624145,0.014371925,0.00059029576,0.0017027946,0.0037091738,0.0660513,0.0072753313,0.00009579311,0.109912686,0.0024798992],"about_ca_topic_score_codex":0.0012175079,"about_ca_topic_score_gemma":0.0007259048,"teacher_disagreement_score":0.46345934,"about_ca_system_score_codex":0.034546472,"about_ca_system_score_gemma":0.020324614,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W3203854025","doi":"10.1038/s41375-021-01427-7","title":"Stress hematopoiesis induces a proliferative advantage in TET2 deficiency","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's Hospital of Eastern Ontario; Canada's Michael Smith Genome Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; Dalhousie University","funders":"","keywords":"Haematopoiesis; Biology; Zebrafish; Context (archaeology); Stem cell; Immunology; Myeloid; Cancer research; Bone marrow; Leukemia; Hematopoietic stem cell; Epigenetics; Cell biology; Genetics; Gene","score_opus":0.020542052222839887,"score_gpt":0.3113501834843941,"score_spread":0.2908081312615542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203854025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676784,0.0008809905,0.00007513775,0.0013412654,0.00007415311,0.00043509222,0.000022161332,0.0000764323,0.029416317],"genre_scores_gemma":[0.9931213,0.00013988966,0.0017853267,0.0006318595,0.00012983734,0.000097132055,0.000058916754,0.00003797009,0.0039977394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997859,0.0001279681,0.0003725013,0.0005291206,0.0005294907,0.0005819264],"domain_scores_gemma":[0.9988256,0.00018175978,0.00006294332,0.0005151196,0.0002122208,0.00020232529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025696433,0.00022001073,0.00045083603,0.00023471628,0.00008461129,0.000047539776,0.00018423659,0.00018671103,0.00042966052],"category_scores_gemma":[0.00067195966,0.00019257002,0.00009265746,0.00096648856,0.00012536436,0.00018137203,0.00019366867,0.0007430999,0.00017808838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012581842,0.0018310223,0.37327522,0.0027536266,0.00031575025,0.02847566,0.01788323,0.00022933811,0.5227349,0.012618192,0.009687028,0.028937869],"study_design_scores_gemma":[0.007660378,0.00038921932,0.091973394,0.0010060531,0.00008995493,0.0011804377,0.014402273,0.0013299313,0.87605435,0.001102281,0.004084615,0.00072710274],"about_ca_topic_score_codex":0.00012976218,"about_ca_topic_score_gemma":0.00017039651,"teacher_disagreement_score":0.3533195,"about_ca_system_score_codex":0.0017144913,"about_ca_system_score_gemma":0.0028215023,"threshold_uncertainty_score":0.7852778},"labels":[],"label_agreement":null},{"id":"W3206289367","doi":"10.1038/s41375-021-01449-1","title":"Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Cardinal Health; Sierra Oncology; CTI Biopharma; Incyte; Gilead Sciences; Actinium Pharmaceuticals; Helsinn; Bristol-Myers Squibb; AstraZeneca; Celgene; Pfizer; Constellation Pharmaceuticals; Agios Pharmaceuticals","keywords":"Medicine; Myelofibrosis; Cumulative incidence; Cyclophosphamide; Internal medicine; Transplantation; Gastroenterology; Bone marrow; Incidence (geometry); Surgery; Splenectomy; Graft-versus-host disease; Busulfan; Total body irradiation; Chemotherapy; Spleen","score_opus":0.00641380598825172,"score_gpt":0.22876650480061012,"score_spread":0.2223526988123584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206289367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979493,0.00010059551,0.000053749758,0.00017046284,0.000028170021,0.001541175,0.000051752377,0.00003162339,0.00007317436],"genre_scores_gemma":[0.99628663,0.00030653356,0.0021182701,0.0003693276,0.000021823858,0.0003682792,0.00036303123,0.000034462144,0.00013163434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846923,0.000085964566,0.00030610748,0.00050274935,0.00037205484,0.0002638939],"domain_scores_gemma":[0.99931043,0.000102635,0.00006556695,0.00018571159,0.00018959025,0.00014605893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065098575,0.00026130083,0.00036552598,0.00009412903,0.00007432823,0.000050744864,0.000036917176,0.00007612021,0.00007711335],"category_scores_gemma":[0.000017996472,0.00016698823,0.0000318307,0.00022041591,0.000047505255,0.00015632794,0.000010066356,0.00015262415,0.000007666354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008907476,0.0020242846,0.9821815,0.00026979335,0.00033340172,0.0023050096,0.0021823,0.000020450561,0.00083575194,0.0000130991175,0.0000028946092,0.00092405797],"study_design_scores_gemma":[0.029021224,0.0033112061,0.9548495,0.0005475498,0.0011987017,0.00012387338,0.00059048,0.000020522975,0.010127006,0.0000015546664,0.000007241907,0.00020114255],"about_ca_topic_score_codex":0.00023052271,"about_ca_topic_score_gemma":0.0039314795,"teacher_disagreement_score":0.027331984,"about_ca_system_score_codex":0.00014736247,"about_ca_system_score_gemma":0.00023103862,"threshold_uncertainty_score":0.6809582},"labels":[],"label_agreement":null},{"id":"W3208779542","doi":"10.1038/s41375-021-01451-7","title":"p21-Activated kinases as promising therapeutic targets in hematological malignancies","year":2021,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"Leukemia and Lymphoma Society of Canada","keywords":"PAK1; Biology; CDC42; Kinase; Haematopoiesis; Stem cell; Cancer research; RAC1; Signal transduction; Cell biology","score_opus":0.0629476624436725,"score_gpt":0.3517173697215428,"score_spread":0.2887697072778703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208779542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028150917,0.9922468,0.0000050671006,0.000051888983,0.00022817243,0.0017911945,0.00001618339,0.0001852249,0.0026603856],"genre_scores_gemma":[0.0013540142,0.99441,0.00037963045,0.00026412608,0.00017143358,0.0004150483,0.00069271954,0.00014725603,0.0021658193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962914,0.00032787357,0.0010361931,0.0010430557,0.00049755175,0.00080395077],"domain_scores_gemma":[0.9979758,0.0004258955,0.00040351227,0.00088568934,0.00008562275,0.00022342805],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021244505,0.00089115126,0.003921449,0.00031306804,0.0000820837,0.00005963971,0.000269529,0.00092885125,0.0010270617],"category_scores_gemma":[0.00041695585,0.00065337133,0.0007255432,0.00086144026,0.00013478634,0.000087398534,0.00017803868,0.0011176622,0.00037479235],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000705957,0.0004241742,0.0001313398,0.025743525,0.0010608255,0.012721712,0.0002245779,0.0000019432237,0.00016398793,0.00044858476,0.0010718548,0.9579369],"study_design_scores_gemma":[0.0021548183,0.00020150725,0.00006445477,0.055340316,0.0013760892,0.0038767084,0.000078210534,0.000006724442,0.00081954524,0.00009002142,0.93532646,0.0006651224],"about_ca_topic_score_codex":0.00017435323,"about_ca_topic_score_gemma":0.000016368207,"teacher_disagreement_score":0.95727175,"about_ca_system_score_codex":0.008887413,"about_ca_system_score_gemma":0.0066132825,"threshold_uncertainty_score":0.99988616},"labels":[],"label_agreement":null},{"id":"W3211565834","doi":"10.1038/s41375-021-01454-4","title":"Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"AL amyloidosis; Amyloidosis; Medicine; Multiple myeloma; Internal medicine; Monoclonal gammopathy of undetermined significance; Family history; Gastroenterology; Hazard ratio; Cohort; Family aggregation; Disease; Immunology; Immunoglobulin light chain; Confidence interval; Monoclonal; Antibody","score_opus":0.014922197300437649,"score_gpt":0.23336242953106298,"score_spread":0.21844023223062534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211565834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495107,0.0018246843,0.000011504946,0.00010321071,0.000103711325,0.00042070157,0.000057781814,0.000032716678,0.0024945973],"genre_scores_gemma":[0.9946823,0.0003643421,0.00024287614,0.00013482485,0.000014365589,0.000044886925,0.00011106014,0.00003625224,0.0043690754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984216,0.00011589988,0.0003012247,0.0003993417,0.0003739212,0.00038801783],"domain_scores_gemma":[0.9990085,0.00026219155,0.00011798957,0.00029616058,0.0001230722,0.00019212265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015296061,0.0002078606,0.00051148765,0.00012947053,0.000030614643,0.000008645517,0.00007178977,0.00013473455,0.00003536818],"category_scores_gemma":[0.00020158905,0.0001756086,0.00007346794,0.00022548644,0.00011562002,0.00006555199,0.00006029969,0.00026209163,0.000007767031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009741166,0.0003690323,0.7833795,0.00033845386,0.00031065318,0.00033042015,0.0010622042,0.0000062431004,0.20675468,0.0000029267887,0.0013718352,0.0050999443],"study_design_scores_gemma":[0.028121898,0.00066758686,0.9326645,0.00059642707,0.00014614587,0.000038718703,0.0013370177,0.015025227,0.019201396,0.00000561737,0.0018555357,0.00033991394],"about_ca_topic_score_codex":0.0031780007,"about_ca_topic_score_gemma":0.0028159479,"teacher_disagreement_score":0.18755329,"about_ca_system_score_codex":0.0023737699,"about_ca_system_score_gemma":0.0012556826,"threshold_uncertainty_score":0.71611106},"labels":[],"label_agreement":null},{"id":"W3212777568","doi":"10.1038/s41375-021-01468-y","title":"Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia","year":2021,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Myeloid leukemia; Cancer research; Myeloid; Biology; Medicine; Leukemia; Immunology; Chronic lymphocytic leukemia","score_opus":0.026652094669841975,"score_gpt":0.2921734056609885,"score_spread":0.2655213109911465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212777568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82237077,0.00015199033,0.0002171366,0.17105736,0.0008148428,0.0034474165,0.00019045842,0.0004280827,0.001321975],"genre_scores_gemma":[0.5131828,0.00027765025,0.0023227148,0.44100922,0.009582273,0.0009766512,0.011768648,0.0009531289,0.019926878],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99071676,0.0010698873,0.0014202357,0.002386517,0.0021300435,0.0022765826],"domain_scores_gemma":[0.9952673,0.0007333072,0.00045295834,0.0021773342,0.00074737525,0.00062172406],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00095119845,0.0014078661,0.0024766233,0.0015788415,0.00020378293,0.00028548233,0.0005936501,0.003251645,0.0003968335],"category_scores_gemma":[0.0011419806,0.0014046796,0.0005982229,0.0021916092,0.00014647709,0.00029370084,0.00075371994,0.009062545,0.0009033787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00059570244,0.00006065618,0.001171746,0.0011085636,0.0010409745,0.050811037,0.0010161216,0.000103103,0.3192384,0.000008494675,0.61911047,0.005734728],"study_design_scores_gemma":[0.021918302,0.002512343,0.09394037,0.009188039,0.003042855,0.007890317,0.0004121712,0.020188175,0.55829257,0.00044315995,0.27478,0.007391672],"about_ca_topic_score_codex":0.0035592758,"about_ca_topic_score_gemma":0.00076115003,"teacher_disagreement_score":0.34433046,"about_ca_system_score_codex":0.039499026,"about_ca_system_score_gemma":0.01347532,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W3217253848","doi":"10.1038/s41375-021-01488-8","title":"Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Subgroup analysis; Medicine; Multiple myeloma; Internal medicine; Oncology; Confidence interval","score_opus":0.029499066880206554,"score_gpt":0.2957577830302103,"score_spread":0.26625871615000374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217253848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996885,0.0010953884,0.00020591501,0.00015550104,0.00004568303,0.0006090533,0.00030853218,0.000040308576,0.0006546335],"genre_scores_gemma":[0.99726176,0.00026296687,0.0011154413,0.00011926483,0.00002798164,0.00019342366,0.00055403094,0.000029551255,0.0004355481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766004,0.00019929736,0.0004844182,0.0005016976,0.0006387177,0.000515848],"domain_scores_gemma":[0.9985328,0.0005775244,0.00011654671,0.00045287848,0.000050843573,0.0002694109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040251645,0.00024190544,0.0008673473,0.000876104,0.00015206153,0.000017675076,0.00017054104,0.00008966988,0.0004535361],"category_scores_gemma":[0.00018175365,0.000221211,0.00021444388,0.0016756596,0.00010846607,0.000089311776,0.00011907154,0.00045278465,0.000007015833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006140099,0.0003888481,0.9638229,0.00017139365,0.0018120175,0.002133659,0.0017420232,0.0029399742,0.0128643,0.000066455155,0.0003370663,0.007581266],"study_design_scores_gemma":[0.027565207,0.00040220842,0.9169525,0.00005635664,0.0009995826,0.00005566775,0.0004889116,0.0469231,0.005579523,0.00003733637,0.0007000328,0.00023956198],"about_ca_topic_score_codex":0.008497382,"about_ca_topic_score_gemma":0.0039557195,"teacher_disagreement_score":0.046870388,"about_ca_system_score_codex":0.0009340288,"about_ca_system_score_gemma":0.00037313884,"threshold_uncertainty_score":0.9981051},"labels":[],"label_agreement":null},{"id":"W4200614427","doi":"10.1038/s41375-021-01459-z","title":"Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia","year":2021,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Chronic myelomonocytic leukemia; In vivo; Medicine; Leukemia; Cancer research; Drug; Oncology; Immunology; Pharmacology; Biology; Bone marrow; Genetics; Myelodysplastic syndromes","score_opus":0.014528428426693354,"score_gpt":0.2684379888895411,"score_spread":0.2539095604628478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200614427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8883639,0.031354774,0.0032238716,0.00038161615,0.018100066,0.013150138,0.0013774558,0.0004723666,0.043575794],"genre_scores_gemma":[0.53240836,0.01618987,0.0010450165,0.00033751057,0.0014054383,0.003124026,0.00683369,0.0007301016,0.437926],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934499,0.0005130548,0.0016436096,0.0016906303,0.0011953651,0.0015074228],"domain_scores_gemma":[0.9970411,0.00050824304,0.0005433357,0.0012255422,0.0002810274,0.00040077095],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00050888595,0.0011607148,0.0027066204,0.0013375654,0.0001373607,0.000080395286,0.00047418854,0.0013699351,0.00028934213],"category_scores_gemma":[0.00017750576,0.0011544846,0.0006052751,0.0016601639,0.00028739873,0.00028777012,0.00020264706,0.003500566,0.000026069994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003235552,0.0007184116,0.0010392497,0.0033897238,0.0012379428,0.0024244005,0.007343197,0.025484491,0.075565614,0.000005642301,0.852339,0.027216757],"study_design_scores_gemma":[0.029530551,0.002341912,0.0009658937,0.016108176,0.0011653993,0.0003971908,0.0020820359,0.709748,0.20420296,0.000042105537,0.031362355,0.0020533644],"about_ca_topic_score_codex":0.01733656,"about_ca_topic_score_gemma":0.009256294,"teacher_disagreement_score":0.8209767,"about_ca_system_score_codex":0.042604886,"about_ca_system_score_gemma":0.014655708,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W4205825534","doi":"10.1038/s41375-021-01485-x","title":"Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca","keywords":"Obinutuzumab; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Ibrutinib; Internal medicine; Bruton's tyrosine kinase; Oncology; Clinical endpoint; Leukemia; Clinical trial; Chemotherapy; Tyrosine kinase; Cyclophosphamide","score_opus":0.04697134715739797,"score_gpt":0.3070144821862215,"score_spread":0.26004313502882354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205825534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863912,0.0008261295,0.0000020625805,0.0012732219,0.00076410815,0.008485844,0.000080009195,0.0001586317,0.0020188214],"genre_scores_gemma":[0.9852361,0.0004349711,0.0000658186,0.003207384,0.0009027328,0.0010636536,0.0003404806,0.0004083946,0.008340461],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9899402,0.0008650591,0.0019836295,0.0022953674,0.0027251292,0.0021905599],"domain_scores_gemma":[0.9940449,0.0016321139,0.00081846735,0.0029992033,0.00018562928,0.0003197145],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009653304,0.0015938982,0.003763272,0.0009630586,0.0003393888,0.00012858344,0.0014091044,0.0011368614,0.0005323],"category_scores_gemma":[0.00047453312,0.0010732386,0.00039451604,0.0025429267,0.0008602855,0.00020910313,0.0012703065,0.0045212395,0.000043766515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.69547105,0.0010107533,0.036389515,0.011579299,0.010569213,0.044250645,0.04320714,0.085892476,0.00034605633,0.00011506915,0.063952155,0.007216627],"study_design_scores_gemma":[0.82698697,0.01707989,0.005915364,0.0039801635,0.0020861337,0.0012753806,0.004245053,0.08680954,0.0003050274,0.000010897343,0.049221855,0.002083711],"about_ca_topic_score_codex":0.056718696,"about_ca_topic_score_gemma":0.022279173,"teacher_disagreement_score":0.49195614,"about_ca_system_score_codex":0.76474977,"about_ca_system_score_gemma":0.27279362,"threshold_uncertainty_score":0.9996809},"labels":[],"label_agreement":null},{"id":"W4220719076","doi":"10.1038/s41375-022-01513-4","title":"IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Israel Cancer Association; Government of Canada; Ontario Institute for Cancer Research; Israel Science Foundation; Ontario Ministry of Research and Innovation; Princess Margaret Cancer Foundation","keywords":"Stem cell; Importin; Biology; Progenitor cell; Cell biology; Gene knockdown; Nuclear transport; Haematopoiesis; Cancer research; Genetics; Gene; Cytoplasm; Cell nucleus","score_opus":0.005249871445689,"score_gpt":0.19195904461623,"score_spread":0.186709173170541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220719076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986278,0.00051881454,0.000013025311,0.00014866718,0.00014795165,0.00015027057,0.000057839065,0.000005333954,0.00033029562],"genre_scores_gemma":[0.997681,0.0001269054,0.00016141532,0.0006360863,0.00008728218,0.000007321963,0.000014875762,0.0000188885,0.0012661893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951893,0.000020490144,0.00010722396,0.00018859487,0.00006410595,0.000100656165],"domain_scores_gemma":[0.99969,0.000010986128,0.00006841175,0.00018667536,0.000017400715,0.000026528118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093959556,0.00007767277,0.00009139223,0.000013627233,0.00014743143,0.000012340143,0.00008442707,0.000058101876,0.000041945324],"category_scores_gemma":[0.0000015969218,0.000060587787,0.000039581595,0.000034082208,0.00006386406,0.0000026183252,0.00014398713,0.000066082175,5.70325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012816214,0.0000056110057,0.00025956193,0.000036765327,0.00003734511,6.779537e-7,0.00021936519,0.000028989667,0.9572076,0.00010990062,0.03666011,0.0053058756],"study_design_scores_gemma":[0.0005312607,0.00044770926,0.0012833725,0.0000034679028,0.000045686815,0.000024192452,0.0007671519,0.00045029476,0.5750689,0.00026844066,0.4209762,0.00013334471],"about_ca_topic_score_codex":0.000023751521,"about_ca_topic_score_gemma":0.0000021797455,"teacher_disagreement_score":0.3843161,"about_ca_system_score_codex":0.000012738331,"about_ca_system_score_gemma":0.000026060592,"threshold_uncertainty_score":0.24706982},"labels":[],"label_agreement":null},{"id":"W4220835528","doi":"10.1038/s41375-022-01544-x","title":"Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Myelofibrosis; Cohort; Medicine; Internal medicine; Oncology; Ruxolitinib; Term (time); Bone marrow","score_opus":0.030032981912128946,"score_gpt":0.30582845099942824,"score_spread":0.2757954690872993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220835528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487062,0.0067461897,0.000036662837,0.040052414,0.00037539966,0.0024003189,0.001505345,0.00006307049,0.00011436757],"genre_scores_gemma":[0.60397923,0.011166507,0.002908233,0.30833974,0.0023070266,0.0018215053,0.068311416,0.00052136014,0.00064498826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954654,0.0004931435,0.0012142779,0.0015486374,0.00080879347,0.0004697385],"domain_scores_gemma":[0.9969494,0.00051921245,0.000459469,0.0017829492,0.00012825642,0.00016071032],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00035445826,0.0006742262,0.0017416739,0.0002563253,0.00006627058,0.00006257359,0.00049202284,0.0010415904,0.00073708204],"category_scores_gemma":[0.00015184087,0.00057631475,0.00026061613,0.0003291307,0.00027256345,0.00011717058,0.00047569704,0.0025063218,0.000022560813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048770173,0.00027201328,0.81681347,0.00014674611,0.0014968795,0.0072195353,0.00010507874,0.0000026312637,0.00061864953,0.0000037969003,0.17129065,0.0015428492],"study_design_scores_gemma":[0.013097947,0.0021906893,0.88990813,0.0017350862,0.0014489779,0.00014660262,0.000039022572,0.00036519236,0.0025117046,0.00007914901,0.087503746,0.0009737616],"about_ca_topic_score_codex":0.0005592369,"about_ca_topic_score_gemma":0.00008339318,"teacher_disagreement_score":0.344727,"about_ca_system_score_codex":0.00032470463,"about_ca_system_score_gemma":0.0007111862,"threshold_uncertainty_score":0.99979496},"labels":[],"label_agreement":null},{"id":"W4221000304","doi":"10.1038/s41375-022-01529-w","title":"Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Asymptomatic; Multiple myeloma; Proteinuria; AL amyloidosis; Excretion; Gastroenterology; Medicine; Immunoglobulin light chain; Internal medicine; Urine; Amyloidosis; Retrospective cohort study; Urology; Kidney; Antibody; Immunology","score_opus":0.014563577989093355,"score_gpt":0.2679453236427972,"score_spread":0.25338174565370386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221000304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66725963,0.0023992702,0.00019272952,0.29217204,0.00064365094,0.028140958,0.0014004605,0.0010530371,0.0067381975],"genre_scores_gemma":[0.6353172,0.00057569076,0.039110184,0.16010459,0.016866699,0.058625594,0.025028577,0.0021753495,0.062196102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99408793,0.0005955855,0.0007352233,0.0011575292,0.0022153656,0.0012083679],"domain_scores_gemma":[0.997154,0.0003309022,0.0004885608,0.0015643289,0.0001239472,0.00033827804],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043627236,0.0008013726,0.0010880207,0.0006957891,0.00028317445,0.00009310965,0.00059572066,0.000796016,0.0010056804],"category_scores_gemma":[0.0006407275,0.0005783242,0.00022304052,0.00067316054,0.00014108683,0.00016113621,0.00037839875,0.004284298,0.00011715171],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005763685,0.0007391553,0.17266776,0.0026112695,0.0014167365,0.03816192,0.001441152,0.00008402794,0.0004378795,0.0000060196166,0.7543495,0.022320896],"study_design_scores_gemma":[0.075270265,0.011743111,0.20261012,0.007828083,0.00098809,0.0014699362,0.00020654748,0.036860157,0.004467823,0.0003292748,0.6557234,0.0025032158],"about_ca_topic_score_codex":0.0010273863,"about_ca_topic_score_gemma":0.00039463566,"teacher_disagreement_score":0.13206744,"about_ca_system_score_codex":0.0029966163,"about_ca_system_score_gemma":0.0019779585,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4223576903","doi":"10.1038/s41375-022-01569-2","title":"Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100","year":2022,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple myeloma; Proteinuria; Asymptomatic; Medicine; Immunoglobulin light chain; Monoclonal; Internal medicine; Oncology; Immunology; Monoclonal antibody; Antibody; Kidney","score_opus":0.01198347319694225,"score_gpt":0.27003634590276215,"score_spread":0.2580528727058199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223576903","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52443534,0.022767175,0.0009668991,0.006882411,0.08134389,0.082335636,0.003029873,0.0043548634,0.2738839],"genre_scores_gemma":[0.2251716,0.00096090836,0.0058453325,0.00026389383,0.005831695,0.01859767,0.01007484,0.00071014813,0.7325439],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9945009,0.0005015582,0.0007678391,0.0011647209,0.002067653,0.000997349],"domain_scores_gemma":[0.9970393,0.00023815292,0.00057983224,0.0014265702,0.00018108085,0.0005350332],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004927062,0.00080114155,0.001132671,0.0007158385,0.00040939127,0.00009977367,0.0005009586,0.00068922166,0.0012508379],"category_scores_gemma":[0.0012083213,0.0006019121,0.00022519211,0.0009459222,0.00013602326,0.00017901199,0.00037032133,0.003511567,0.00009789961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046908613,0.00088659604,0.078986324,0.0010751148,0.0008034173,0.004247237,0.0010474244,0.00010571907,0.00010344295,0.0000054300494,0.8755022,0.032546226],"study_design_scores_gemma":[0.045321923,0.009957089,0.4042388,0.010842724,0.0007819967,0.0012941923,0.00048675772,0.14976726,0.0016892077,0.00012114644,0.37369674,0.0018021354],"about_ca_topic_score_codex":0.0014905457,"about_ca_topic_score_gemma":0.0022573953,"teacher_disagreement_score":0.5018054,"about_ca_system_score_codex":0.0040393663,"about_ca_system_score_gemma":0.0040407395,"threshold_uncertainty_score":0.99978393},"labels":[],"label_agreement":null},{"id":"W4223991603","doi":"10.1038/s41375-022-01550-z","title":"Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Cytokine release syndrome; Minimal residual disease; Blinatumomab; Internal medicine; Refractory (planetary science); Hematopoietic stem cell transplantation; Acute lymphocytic leukemia; Chemotherapy; Pediatrics; Gastroenterology; Leukemia; Lymphoblastic Leukemia; Cancer; Disease; Immunotherapy","score_opus":0.007083279023805119,"score_gpt":0.23065583200335218,"score_spread":0.22357255297954706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223991603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609756,0.00023153909,0.0000047133663,0.00006459405,0.00022708384,0.0008420816,0.000071548675,0.000111212714,0.0023496465],"genre_scores_gemma":[0.9899068,0.00028592325,0.0000583219,0.00034650907,0.00006227125,0.00017461581,0.00023168884,0.00010320267,0.00883067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967954,0.00020683918,0.0004380728,0.0006464056,0.0011796204,0.00073364127],"domain_scores_gemma":[0.9987102,0.0001814305,0.00017537238,0.0004771773,0.00016644748,0.00028936952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034907926,0.00032681762,0.0005338934,0.0005138701,0.00024758867,0.000041681003,0.00023758886,0.000168998,0.001396349],"category_scores_gemma":[0.00015789828,0.00030426934,0.0000838489,0.0012069723,0.000100216166,0.00015280773,0.00026983084,0.0010566233,0.00004997842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019418531,0.00036567933,0.98851305,0.00010782595,0.00022594696,0.0015524364,0.0009918729,0.000113276605,0.0014509044,0.000011913039,0.002413356,0.0023118893],"study_design_scores_gemma":[0.016784461,0.0022298014,0.97855866,0.000060618207,0.00024511042,0.00029511424,0.00015269786,0.0007670636,0.00006660594,0.000029717048,0.00042457783,0.0003855693],"about_ca_topic_score_codex":0.001080917,"about_ca_topic_score_gemma":0.00029975714,"teacher_disagreement_score":0.014842608,"about_ca_system_score_codex":0.00764596,"about_ca_system_score_gemma":0.0013539324,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W4240441585","doi":"10.1038/s41375-021-01396-x","title":"Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study","year":2021,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Dosing; Anemia; Medicine; Internal medicine; Intensive care medicine; Bone marrow","score_opus":0.029868034284706118,"score_gpt":0.3113404190433497,"score_spread":0.28147238475864356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240441585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894061,0.0017895474,0.000014760422,0.0001823909,0.000699758,0.0060772416,0.0006035872,0.000008878966,0.0012177255],"genre_scores_gemma":[0.99223775,0.0022067076,0.00016573496,0.00008716643,0.00032395445,0.0011605696,0.0015168922,0.000051084575,0.002250124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831456,0.00011820813,0.00053528947,0.0004653248,0.00034465818,0.00022193798],"domain_scores_gemma":[0.99812186,0.0007933202,0.00035545367,0.0004340506,0.00022624366,0.00006908758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016643085,0.00038190396,0.0009075518,0.00009105818,0.0001402976,0.000035709163,0.000068625806,0.00018896819,0.000012650799],"category_scores_gemma":[0.000069366135,0.00018668838,0.00008982488,0.00023437016,0.00015538513,0.000035940513,0.000022166956,0.0002549671,7.848835e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045849044,0.10805702,0.3948362,0.0038944483,0.005833689,0.00032297333,0.07009809,0.00023731244,0.000115648065,0.00049325026,0.09937355,0.2708888],"study_design_scores_gemma":[0.10061203,0.04442054,0.8214852,0.002459423,0.0035028066,0.000057541576,0.007188332,0.00031593366,0.00046818727,0.000007022647,0.019075785,0.0004072005],"about_ca_topic_score_codex":0.0006064051,"about_ca_topic_score_gemma":0.0005375994,"teacher_disagreement_score":0.42664903,"about_ca_system_score_codex":0.00036118677,"about_ca_system_score_gemma":0.00052718946,"threshold_uncertainty_score":0.7612931},"labels":[],"label_agreement":null},{"id":"W4244065648","doi":"10.1038/s41375-019-0672-9","title":"Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia","year":2019,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Minimal residual disease; Risk stratification; Flow cytometry; Lymphoblastic Leukemia; Medicine; Residual; Oncology; Disease; Leukemia; Stratification (seeds); Immunology; Internal medicine; Pathology; Biology; Computer science","score_opus":0.011991864171385461,"score_gpt":0.268770546546948,"score_spread":0.2567786823755625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244065648","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34145734,0.03663901,0.032413002,0.006010352,0.22586477,0.044038914,0.017195946,0.0053641787,0.2910165],"genre_scores_gemma":[0.15009755,0.004809639,0.001731024,0.00042482285,0.0036699397,0.0008621837,0.024130685,0.0006017876,0.81367236],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9906089,0.00044976134,0.0019792211,0.0026975158,0.002627772,0.0016368742],"domain_scores_gemma":[0.99327064,0.0009798163,0.001288344,0.0027601665,0.0007285133,0.0009725387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0011346675,0.001333897,0.0017243746,0.0015046265,0.00034769403,0.00036708798,0.001025131,0.0021851833,0.0004379153],"category_scores_gemma":[0.0021753646,0.0013188806,0.00042800675,0.0022128287,0.00043745578,0.00057002495,0.00029420806,0.004069903,0.001846356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0030929295,0.0003452178,0.0026383805,0.0017688925,0.00027165515,0.00034866884,0.00019073587,0.0011400027,0.004822083,0.000014155043,0.9834678,0.001899457],"study_design_scores_gemma":[0.017493095,0.0019754213,0.026099013,0.0048241774,0.0035749648,0.00029968275,0.00058197364,0.70357037,0.0054010446,0.00016888173,0.2327566,0.0032547854],"about_ca_topic_score_codex":0.0019435134,"about_ca_topic_score_gemma":0.0001363044,"teacher_disagreement_score":0.7507112,"about_ca_system_score_codex":0.028577374,"about_ca_system_score_gemma":0.0331544,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W4254490542","doi":"10.1038/leu.2017.333","title":"Erratum: Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches","year":2017,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"License; Computational biology; Leukemia; Computer science; Medicine; Biology; Internal medicine","score_opus":0.06472148087172934,"score_gpt":0.31382822482485834,"score_spread":0.24910674395312898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254490542","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46466404,0.019746456,0.00088044355,0.015383131,0.17741735,0.019978322,0.00092300825,0.0015039402,0.2995033],"genre_scores_gemma":[0.3712638,0.0012391105,0.00023240737,0.00023175757,0.011580067,0.00028635332,0.00370812,0.00035791128,0.61110044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99406797,0.0002879333,0.0009755353,0.001446187,0.0020691992,0.0011531799],"domain_scores_gemma":[0.99439466,0.00009358906,0.0013542861,0.0031220205,0.00047748792,0.0005579668],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008712028,0.0010097761,0.0032052253,0.0020557595,0.00037562833,0.00030337367,0.001711964,0.0024198294,0.0003993608],"category_scores_gemma":[0.00043365153,0.00089373876,0.0012477756,0.0012139915,0.00050441886,0.00020011811,0.0006069498,0.003753647,0.0000901064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011501092,0.00019376143,0.00021797507,0.0014404409,0.017655848,0.0003293687,0.0009052914,0.000019435874,0.027961222,0.00047335087,0.9403489,0.009304255],"study_design_scores_gemma":[0.05935335,0.008680593,0.114905596,0.008026343,0.20432672,0.0006926487,0.0025782874,0.050321218,0.11156902,0.016847607,0.41064584,0.012052768],"about_ca_topic_score_codex":0.0030674315,"about_ca_topic_score_gemma":0.00051249185,"teacher_disagreement_score":0.5297031,"about_ca_system_score_codex":0.0025741435,"about_ca_system_score_gemma":0.009725928,"threshold_uncertainty_score":0.9993513},"labels":[],"label_agreement":null},{"id":"W4281618698","doi":"10.1038/s41375-022-01602-4","title":"Elucidating the importance and regulation of key enhancers for human MEIS1 expression","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Michael Smith Health Research BC; Government of Canada; Terry Fox Foundation; Genome British Columbia","keywords":"Transcription factor; Enhancer; Biology; Myeloid leukemia; In silico; Cancer research; Locus (genetics); Transcriptional regulation; Regulation of gene expression; Regulator; Genetics; Gene; Cell biology","score_opus":0.007532661366015999,"score_gpt":0.28413893954524005,"score_spread":0.27660627817922406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281618698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433274,0.00059931417,0.014592792,0.000029133114,0.000046458692,0.00012539886,0.000007799674,0.0000041172825,0.00026223424],"genre_scores_gemma":[0.99853134,0.00001252335,0.00094574085,0.000040531482,0.00006805117,0.00004833555,0.00005050522,0.000008100268,0.0002948458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996501,0.000011586778,0.000097522294,0.00011520735,0.00005436338,0.00007119476],"domain_scores_gemma":[0.9997726,0.0000088937195,0.000051749594,0.000141031,0.000013538347,0.000012200201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011903407,0.000045218832,0.00004756035,0.0000090171,0.00012945202,0.0000038994863,0.00006668124,0.000021671965,0.000013871172],"category_scores_gemma":[0.000017128363,0.000038438135,0.000024500563,0.000025760535,0.000017364007,0.0000010773575,0.000072894654,0.000035733654,4.3061632e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012636545,0.0000019349686,0.00048426725,0.0000142174285,0.0000048937054,4.647558e-8,0.00009609309,0.003204204,0.9945904,0.00015570835,0.00059185695,0.0008437542],"study_design_scores_gemma":[0.0002281763,0.000081794846,0.0031411636,0.0000049609694,0.000005965094,0.000002178087,0.00015493251,0.00075649534,0.9837445,0.00017609909,0.011647399,0.00005632708],"about_ca_topic_score_codex":0.0000069664684,"about_ca_topic_score_gemma":0.000007195658,"teacher_disagreement_score":0.014198614,"about_ca_system_score_codex":0.000016000746,"about_ca_system_score_gemma":0.000021285941,"threshold_uncertainty_score":0.15674616},"labels":[],"label_agreement":null},{"id":"W4281620754","doi":"10.1038/s41375-022-01610-4","title":"Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Germline; Bone marrow; Lymphoblastic Leukemia; Medicine; Germline mutation; Cancer research; Mutation; Bone marrow failure; Leukemia; Haematopoiesis; Internal medicine; Biology; Genetics; Gene; Stem cell","score_opus":0.0031068417403617415,"score_gpt":0.19647998280656986,"score_spread":0.19337314106620812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281620754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978408,0.0010946129,0.00020063513,0.00010394285,0.000049669114,0.00032381338,0.00031243643,0.000017838944,0.00005621332],"genre_scores_gemma":[0.9963671,0.000015991674,0.0012203896,0.0003332175,0.00004106778,0.00016379295,0.001521276,0.00003316085,0.000304036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890935,0.000051050563,0.00019365069,0.00038718848,0.00019553825,0.00026319502],"domain_scores_gemma":[0.999475,0.000014164296,0.00008989223,0.00029972638,0.000043202752,0.00007800668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000781889,0.00017584187,0.00015666705,0.00006990123,0.00014620612,0.00002335098,0.00015169181,0.00006511768,0.000055896828],"category_scores_gemma":[0.000035400066,0.0001719146,0.000029811743,0.00019395842,0.00008337903,0.00000885011,0.00027310135,0.00014726327,0.0000047748886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063339234,0.00087584235,0.6758193,0.0003184327,0.00093617867,0.0007847108,0.00077342783,0.026277335,0.21681906,0.0030369787,0.049836498,0.018188346],"study_design_scores_gemma":[0.034158647,0.005632417,0.6192615,0.00013803093,0.00042540426,0.00036960052,0.00043683016,0.0025292984,0.26765776,0.0009437223,0.06564174,0.0028050428],"about_ca_topic_score_codex":0.00009661949,"about_ca_topic_score_gemma":0.000109764274,"teacher_disagreement_score":0.05655774,"about_ca_system_score_codex":0.00032352045,"about_ca_system_score_gemma":0.00033963102,"threshold_uncertainty_score":0.7010474},"labels":[],"label_agreement":null},{"id":"W4281951662","doi":"10.1038/s41375-022-01589-y","title":"Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Scheme for Promotion of Academic and Research Collaboration; Sun Pharma; National Cancer Institute; Incyte; Jazz Pharmaceuticals; Ariad Pharmaceuticals; Celgene; Gilead Sciences; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Bosutinib; Imatinib; Medicine; Internal medicine; Cumulative incidence; Adverse effect; Myeloid leukemia; Oncology; Surgery; Nilotinib; Transplantation","score_opus":0.050703384527734714,"score_gpt":0.32363280685004,"score_spread":0.27292942232230527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281951662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750615,0.0036644738,0.00017722476,0.0028628996,0.0040651364,0.0069751744,0.0038911924,0.00043920462,0.002863189],"genre_scores_gemma":[0.9710548,0.00032428472,0.0012751197,0.0011600886,0.008460777,0.0040765954,0.008414598,0.00025049128,0.0049832747],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99410355,0.0003042071,0.0014262472,0.0014539117,0.0012769217,0.0014351731],"domain_scores_gemma":[0.9931678,0.0034832857,0.0007295901,0.002082503,0.00013626099,0.00040054863],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009784207,0.0007991508,0.0010896646,0.00015279459,0.001274556,0.00010834362,0.0009930155,0.0003318333,0.0019149997],"category_scores_gemma":[0.0014217161,0.0006470094,0.0007854441,0.00065010675,0.0002965645,0.00020474233,0.00052567193,0.0015921311,0.00022099519],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.50246024,0.0011912286,0.00009373777,0.00023564899,0.002034507,0.0010377744,0.0030198735,0.0046327156,0.0038987654,0.00056360953,0.32626835,0.15456356],"study_design_scores_gemma":[0.65186363,0.012226047,0.00040649422,0.00014822333,0.0010181335,0.000073731986,0.0005314487,0.013510841,0.0017208938,0.00017882315,0.31771442,0.0006072824],"about_ca_topic_score_codex":0.0025593303,"about_ca_topic_score_gemma":0.00073586614,"teacher_disagreement_score":0.15395628,"about_ca_system_score_codex":0.047629822,"about_ca_system_score_gemma":0.017423917,"threshold_uncertainty_score":0.99959815},"labels":[],"label_agreement":null},{"id":"W4283271244","doi":"10.1038/s41375-022-01613-1","title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms","year":2022,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3904,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Hospital for Sick Children","funders":"Sahlgrenska Akademin; National Cancer Institute; Department of Laboratory Medicine and Pathology, University of Washington; School of Medicine, Indiana University; University of Texas MD Anderson Cancer Center; Universitätsklinikum Jena; Hospital for Sick Children; University of California, San Diego; National University Cancer Institute, Singapore; Medizinischen Hochschule Hannover; Université de Montréal; Centre National de la Recherche Scientifique; School of Medicine, Stanford University; Fudan University; Institut Gustave-Roussy; Sahlgrenska Universitetssjukhuset; Vrije Universiteit Amsterdam; University of Oxford; Wellcome Trust; University of Southampton; University of Alabama; Texas Children's Hospital; Amsterdam University Medical Centers; Moffitt Cancer Center; Institut National de la Santé et de la Recherche Médicale; University of Washington; Memorial Sloan-Kettering Cancer Center; Knight Cancer Institute, Oregon Health and Science University; Universität Ulm; University of Texas Southwestern Medical Center; Imperial College London; Children's Hospital Los Angeles; National Institute for Health and Care Research; Assistance publique-Hôpitaux de Paris; Massachusetts General Hospital; Université Paris-Saclay; University of Alabama at Birmingham; Nationwide Children's Hospital; Cincinnati Children's Hospital Medical Center; Centre International de Recherche sur le Cancer; Göteborgs Universitet; Radboud Universiteit; Radboud Universitair Medisch Centrum; Università degli Studi di Milano; University of Pennsylvania","keywords":"Histiocyte; Myeloid; Disease; Hematologic Neoplasms; Medicine; Computational biology; Computer science; Biology; Pathology; Immunology; Cancer; Internal medicine","score_opus":0.04478243319244866,"score_gpt":0.3376422626290177,"score_spread":0.292859829436569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283271244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048764757,0.99365664,0.0000887586,0.0016033086,0.000643023,0.0024464147,0.00013171855,0.000057536672,0.000884958],"genre_scores_gemma":[0.00221637,0.9935517,0.00012849669,0.00014892612,0.00028535892,0.00015341188,0.00055842474,0.00011371358,0.0028435974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626786,0.00065379875,0.0012371208,0.00046731738,0.0009733722,0.00040055127],"domain_scores_gemma":[0.995967,0.001234087,0.001335884,0.0010426596,0.00026509684,0.00015529315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010457858,0.0003584656,0.0014535085,0.00033418485,0.0004787921,0.000036013753,0.0005455898,0.00019460065,0.00017004446],"category_scores_gemma":[0.0012465508,0.00022082319,0.00025078809,0.0020535304,0.00047590747,0.00007693309,0.0003159161,0.0009819603,0.000013544498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007921431,0.00013305385,0.0003989306,0.048882145,0.0003601416,0.00001944406,0.00055624946,0.0000054979364,0.00008669014,0.010554086,0.049556524,0.889368],"study_design_scores_gemma":[0.0008764591,0.00015192611,0.0011167616,0.0073226993,0.00073907996,0.000668202,0.00021525884,0.00021535723,0.00013326437,0.0000890302,0.98824894,0.00022302424],"about_ca_topic_score_codex":0.0002367015,"about_ca_topic_score_gemma":0.00011179809,"teacher_disagreement_score":0.9386924,"about_ca_system_score_codex":0.0067227506,"about_ca_system_score_gemma":0.009647319,"threshold_uncertainty_score":0.9970903},"labels":[],"label_agreement":null},{"id":"W4285731053","doi":"10.1038/s41375-022-01641-x","title":"PARP14 is a novel target in STAT6 mutant follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Deutschen Konsortium für Translationale Krebsforschung; Else Kröner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Amgen","keywords":"Biology; Chromatin immunoprecipitation; Transactivation; Follicular lymphoma; Downregulation and upregulation; Molecular biology; Cell biology; Gene expression; Cancer research; Promoter; Lymphoma; Gene; Immunology; Genetics","score_opus":0.009853362402010126,"score_gpt":0.21723673357842083,"score_spread":0.2073833711764107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285731053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859316,0.0009329556,0.00039071302,0.00034915938,0.0043206457,0.00026339138,0.000023962633,0.00008126996,0.005044723],"genre_scores_gemma":[0.97342765,0.000020688603,0.000051154777,0.0018970404,0.000018468721,0.00011691735,0.00018328823,0.000017340202,0.024267474],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990696,0.00010663032,0.0002516871,0.00025046096,0.000043283162,0.0002783807],"domain_scores_gemma":[0.99962413,0.000036436704,0.00008221853,0.000224182,0.000021219648,0.000011793206],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016417226,0.00012464312,0.00016995003,0.00012484218,0.0002142343,0.000009524061,0.00015083789,0.000092399125,0.013372971],"category_scores_gemma":[0.00002001585,0.00012751922,0.00008851955,0.00017826217,0.000034913926,0.00008056802,0.000116824696,0.00029456886,0.0008469427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010146787,0.00033649005,0.001244077,0.000009461769,0.00011833328,0.000027130296,0.0018512439,0.0004829623,0.90951,0.0007877397,0.08269881,0.0019190526],"study_design_scores_gemma":[0.005244944,0.00014932676,0.0025425765,0.000006220267,0.000010140835,0.00015288069,0.00089161197,0.00025959802,0.08031943,0.000068870526,0.91018116,0.00017321542],"about_ca_topic_score_codex":0.00059535267,"about_ca_topic_score_gemma":0.000007643258,"teacher_disagreement_score":0.8291906,"about_ca_system_score_codex":0.00073037145,"about_ca_system_score_gemma":0.00015418224,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W4286562026","doi":"10.1038/s41375-022-01637-7","title":"Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sierra Oncology","keywords":"Ruxolitinib; Myelofibrosis; Internal medicine; Medicine; Anemia; Phases of clinical research; Survival analysis; Clinical trial; Randomized controlled trial; Gastroenterology; Oncology; Bone marrow","score_opus":0.030805311245682452,"score_gpt":0.3067301174061303,"score_spread":0.27592480616044784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286562026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970007,0.00012171972,0.0000035830678,0.0005228944,0.000052749292,0.0014988763,0.00017655501,0.000009639937,0.0006132747],"genre_scores_gemma":[0.9985932,0.000037863134,0.000104863146,0.00054362556,0.000032093038,0.00047502277,0.00015345242,0.000019052959,0.00004081036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979404,0.00043430447,0.00059304707,0.0002974661,0.0004939612,0.00024078863],"domain_scores_gemma":[0.99865645,0.00075208175,0.00021186352,0.00026979053,0.00004480668,0.00006501336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009756904,0.00019004417,0.0007369639,0.00015800563,0.00007579969,0.000015148946,0.000096763215,0.00004463821,0.00023161662],"category_scores_gemma":[0.0002012834,0.00011569882,0.00007182205,0.00032043425,0.000052274827,0.000055280292,0.000071827024,0.00024609666,0.0000018019333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030863027,0.0016854439,0.98464316,0.000059218593,0.00008903425,0.000046466143,0.0014305108,0.00014639721,0.0001603129,0.00064251217,0.00052923383,0.0074814097],"study_design_scores_gemma":[0.03245121,0.0030897358,0.96080273,0.00007200361,0.00009628789,0.0000058499418,0.00041666324,0.00008761639,0.0006629967,0.00015593773,0.0020203115,0.00013865814],"about_ca_topic_score_codex":0.00035451117,"about_ca_topic_score_gemma":0.00010010668,"teacher_disagreement_score":0.029364908,"about_ca_system_score_codex":0.00033361683,"about_ca_system_score_gemma":0.00017921269,"threshold_uncertainty_score":0.4718061},"labels":[],"label_agreement":null},{"id":"W4289549935","doi":"10.1038/s41375-022-01650-w","title":"Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Bundesministerium für Bildung und Forschung; Universität Ulm; Deutsche Forschungsgemeinschaft","keywords":"Midostaurin; NPM1; Myeloid leukemia; Neuroblastoma RAS viral oncogene homolog; Cancer research; Mutation; CEBPA; Biology; Oncology; Internal medicine; Dasatinib; Leukemia; Fms-Like Tyrosine Kinase 3; Medicine; Genetics; Gene; Imatinib; KRAS","score_opus":0.012386208442374405,"score_gpt":0.2550006434376942,"score_spread":0.2426144349953198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289549935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274653,0.00013428414,0.00003094961,0.00047971567,0.0002981373,0.0029734534,0.00033709584,0.00018069352,0.002819137],"genre_scores_gemma":[0.9920167,0.000025186058,0.0003729355,0.0006320896,0.00025420278,0.0004680928,0.0012802669,0.0001551963,0.0047953613],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952882,0.00049291254,0.0009706919,0.00080081885,0.0016127125,0.00083468494],"domain_scores_gemma":[0.99713343,0.00030148696,0.0005516863,0.0013030692,0.0003765999,0.0003336999],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084008684,0.0005386022,0.000969035,0.0003835578,0.0005940316,0.000057758683,0.0008322458,0.00022425034,0.0012394577],"category_scores_gemma":[0.00016277436,0.00035067115,0.00025336776,0.0014897581,0.0003762667,0.00014305365,0.0005201537,0.0017764274,0.00009856652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5671316,0.0015344566,0.25587982,0.00045797607,0.0066737304,0.0019534773,0.010020345,0.010029884,0.055968873,0.00073737715,0.08157259,0.0080398815],"study_design_scores_gemma":[0.5631775,0.024677195,0.31928468,0.00023753995,0.003953433,0.00064993685,0.0039015566,0.02713865,0.03220131,0.00024571037,0.021935029,0.00259746],"about_ca_topic_score_codex":0.0010288235,"about_ca_topic_score_gemma":0.00007526431,"teacher_disagreement_score":0.06340484,"about_ca_system_score_codex":0.0052031507,"about_ca_system_score_gemma":0.0046510347,"threshold_uncertainty_score":0.9998945},"labels":[],"label_agreement":null},{"id":"W4291227654","doi":"10.1038/s41375-022-01658-2","title":"Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Oncology; Internal medicine; Blastoid; International Prognostic Index; Cohort; Medicine; CDKN2A; Hematology; Gene expression profiling; Lymphoma; Clinical trial; Splenic marginal zone lymphoma; Cancer research; Biology; Bioinformatics; Diffuse large B-cell lymphoma; Leukemia; Gene; Gene expression; Genetics; Cancer; Chronic lymphocytic leukemia; Discovery and development of mTOR inhibitors","score_opus":0.028188912443140247,"score_gpt":0.3080516541544759,"score_spread":0.2798627417113356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291227654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578255,0.000119420656,0.0000014956834,0.000102351354,0.00008957983,0.0018393416,0.000023793777,0.00003641049,0.0020050372],"genre_scores_gemma":[0.9951498,0.00002774225,0.00009471944,0.0004094388,0.000046078243,0.0003868459,0.000023832376,0.000068912115,0.0037926335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99632823,0.0005101657,0.0007872117,0.00052048196,0.0011657914,0.0006881349],"domain_scores_gemma":[0.99781513,0.0007763437,0.00024003412,0.0009960443,0.000051933635,0.00012049328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009231271,0.00031290538,0.0008415624,0.0004216822,0.00009166869,0.000017612425,0.00056316116,0.00016263989,0.00036039742],"category_scores_gemma":[0.00035651942,0.0001737904,0.00013082367,0.0011784409,0.00017333703,0.00005834875,0.00020049168,0.000503306,0.000017413735],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.752797,0.008488979,0.10105348,0.0014629004,0.0003310678,0.09661284,0.008726988,0.0018966065,0.011646576,0.00005121078,0.002058794,0.0148735205],"study_design_scores_gemma":[0.9113816,0.012382324,0.037519425,0.00031575325,0.00021880874,0.0012542431,0.0039960193,0.0123157045,0.016044514,0.000021260024,0.0038881826,0.00066218834],"about_ca_topic_score_codex":0.0045476775,"about_ca_topic_score_gemma":0.00080254,"teacher_disagreement_score":0.15858454,"about_ca_system_score_codex":0.015443737,"about_ca_system_score_gemma":0.012684909,"threshold_uncertainty_score":0.99291223},"labels":[],"label_agreement":null},{"id":"W4292749472","doi":"10.1038/s41375-022-01680-4","title":"Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Nilotinib; Medicine; Oncology; Myeloid leukemia; Internal medicine; Hazard ratio; microRNA; Proportional hazards model; Leukemia; Myeloid; Immunology; Imatinib; Biology; Confidence interval","score_opus":0.0264201446789562,"score_gpt":0.3250337087642593,"score_spread":0.2986135640853031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292749472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635684,0.0006969619,0.000022142613,0.00024755756,0.0004317132,0.0017485232,0.00025076524,0.00002525949,0.00022024222],"genre_scores_gemma":[0.9987575,0.0001381656,0.00005096094,0.00006458233,0.00008255373,0.00019040545,0.000111891444,0.000042087362,0.00056189665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9936472,0.0015908891,0.0026218158,0.0006921828,0.0010723037,0.00037559003],"domain_scores_gemma":[0.9949555,0.001372526,0.0018490587,0.0014888741,0.00021479519,0.00011926691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038915724,0.00029846735,0.0013695984,0.00084186177,0.00009797551,0.0000067739434,0.00059174624,0.00025752073,0.00026533927],"category_scores_gemma":[0.0018660888,0.00025146574,0.0010291899,0.0031292466,0.0007002612,0.00007933021,0.00036429003,0.0006711916,0.0000075439516],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.35789195,0.0012579432,0.06853584,0.0003142566,0.009332376,0.0000754858,0.002514095,0.009911245,0.5458786,0.00012069482,0.0010739329,0.0030935605],"study_design_scores_gemma":[0.10794452,0.0065914793,0.65845615,0.0002313561,0.008432885,0.00005198659,0.001218303,0.010421875,0.20529424,0.00009679761,0.00091496116,0.00034545627],"about_ca_topic_score_codex":0.0020772151,"about_ca_topic_score_gemma":0.00030071274,"teacher_disagreement_score":0.5899203,"about_ca_system_score_codex":0.013962675,"about_ca_system_score_gemma":0.0115685975,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W4296690243","doi":"10.1038/s41375-022-01697-9","title":"A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Computational biology; Biology; Epigenetics; Myeloid leukemia; Stem cell; CRISPR; Population; Cancer stem cell; Genome editing; Genetics; Cancer research; Gene; Medicine","score_opus":0.014939317964728915,"score_gpt":0.2476150822208278,"score_spread":0.23267576425609887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296690243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941545,0.00014289268,0.003233605,0.0006458194,0.00003175342,0.00078247284,0.000032280313,0.00003891641,0.00093775813],"genre_scores_gemma":[0.99763495,0.00007267216,0.001206453,0.00057188055,0.000024678755,0.00012301415,0.0001260463,0.000042972886,0.00019731416],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981841,0.00018420084,0.00043579878,0.00033486297,0.0005115487,0.0003495114],"domain_scores_gemma":[0.9991302,0.00021186721,0.00015381046,0.00031785909,0.000084021165,0.00010226495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004590261,0.00016640357,0.00039607479,0.00021126244,0.00019836526,0.000023760955,0.00026611806,0.00007315749,0.000050165425],"category_scores_gemma":[0.00008988642,0.00013355684,0.00005149976,0.00045823955,0.00014554501,0.00010986708,0.0006196577,0.00074442424,0.000001952069],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005741303,0.000057526497,0.0021812886,0.0001973671,0.00005414493,0.000046707235,0.008208309,0.0015854794,0.9840726,0.00006377538,0.00036818773,0.0025904293],"study_design_scores_gemma":[0.020473879,0.0014260865,0.045193266,0.00049192604,0.00020001354,0.00040677979,0.020526133,0.7798208,0.12960213,0.00043211272,0.0005995736,0.00082728115],"about_ca_topic_score_codex":0.00019554491,"about_ca_topic_score_gemma":0.000035426754,"teacher_disagreement_score":0.85447055,"about_ca_system_score_codex":0.0027299454,"about_ca_system_score_gemma":0.0011313012,"threshold_uncertainty_score":0.7138712},"labels":[],"label_agreement":null},{"id":"W4304975951","doi":"10.1038/s41375-022-01716-9","title":"JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Cancer research; In vivo; Inhibitor of apoptosis; Apoptosis; Progenitor cell; Leukemia; Ruxolitinib; Biology; Immunology; Pharmacology; Stem cell; Programmed cell death; Bone marrow; Cell biology","score_opus":0.012837700992749966,"score_gpt":0.2645748773929479,"score_spread":0.25173717640019794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304975951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611098,0.00005513049,0.0043933894,0.005528199,0.00027342528,0.0014329212,0.00009465368,0.0003665536,0.026745925],"genre_scores_gemma":[0.9828607,0.000005159887,0.0063086897,0.0050598467,0.00045995924,0.00039246245,0.00019042812,0.0001207543,0.004602043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960025,0.0001772778,0.00042595743,0.0007957437,0.0016459918,0.00095255725],"domain_scores_gemma":[0.99808073,0.00026780512,0.000112396454,0.0005339101,0.00027888865,0.0007262646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000505691,0.00036301758,0.0004922174,0.0004230868,0.00034638125,0.000056298722,0.00024518796,0.0001471338,0.00088428234],"category_scores_gemma":[0.00054582173,0.00031743295,0.0001055622,0.001323068,0.00014692426,0.00014091836,0.00045163106,0.0010481542,0.00034896546],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01849091,0.0016149542,0.0073091835,0.0007458282,0.0012905181,0.01295127,0.008207522,0.02034405,0.41629544,0.015402037,0.49049878,0.006849508],"study_design_scores_gemma":[0.03643164,0.021290876,0.028010227,0.00088270445,0.0008842884,0.006557063,0.0031973757,0.021528168,0.15264127,0.002327808,0.7228606,0.0033880132],"about_ca_topic_score_codex":0.00027642463,"about_ca_topic_score_gemma":0.000027490409,"teacher_disagreement_score":0.26365417,"about_ca_system_score_codex":0.00946026,"about_ca_system_score_gemma":0.0036706203,"threshold_uncertainty_score":0.99992776},"labels":[],"label_agreement":null},{"id":"W4306941118","doi":"10.1038/s41375-022-01724-9","title":"Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Takeda Oncology; Genentech; National Institutes of Health; Astellas Pharma; Pfizer; Incyte; CTI Biopharma; bluebird bio; Agios Pharmaceuticals; Syndax Pharmaceuticals; National Heart, Lung, and Blood Institute; Edward P. Evans Foundation; Acceleron; Astex Pharmaceuticals; Daiichi-Sankyo; MacroGenics; Celldex Therapeutics; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Apellis Pharmaceuticals; Alexion Pharmaceuticals; Daiichi Sankyo Europe; Servier; Aplastic Anemia and MDS International Foundation; Gilead Sciences; BioCryst; Celgene; Bristol-Myers Squibb; AstraZeneca; Cardinal Health; Amgen; American Cancer Society","keywords":"Myelodysplastic syndromes; Consistency (knowledge bases); Medicine; Myeloid; Perspective (graphical); Oncology; Myeloid leukemia; Internal medicine; Immunology; Computer science; Bone marrow; Artificial intelligence","score_opus":0.0518485078356917,"score_gpt":0.32790933514638804,"score_spread":0.27606082731069637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306941118","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11721603,0.00042547262,0.00019900683,0.84681,0.0022124632,0.0048031164,0.0017656616,0.00007835641,0.026489895],"genre_scores_gemma":[0.82569957,0.00023748337,0.0021935164,0.119822785,0.0021608127,0.0025458252,0.0016606138,0.00036959958,0.045309823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670124,0.00015762265,0.00082686095,0.0006717333,0.0011681668,0.00047435958],"domain_scores_gemma":[0.99499714,0.0029667607,0.000590309,0.00092818274,0.0004578507,0.000059729464],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004313339,0.00035657626,0.00081579457,0.0009255766,0.00013600237,0.000021053615,0.0009993986,0.00057723006,0.0006486423],"category_scores_gemma":[0.002732433,0.0002902959,0.0004651299,0.0008031832,0.00044034852,0.000059172657,0.0003333278,0.0032586278,0.0000117607715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010972308,0.00022965706,0.0027372825,0.0010194428,0.0009970156,0.0003048009,0.002725561,0.00045407133,0.0021342323,0.006144552,0.9815025,0.00065368577],"study_design_scores_gemma":[0.019026026,0.0027105734,0.036865696,0.007976375,0.0019874878,0.0012658729,0.020617738,0.008976668,0.0053086365,0.0042788903,0.88904387,0.0019421758],"about_ca_topic_score_codex":0.0002983596,"about_ca_topic_score_gemma":0.00006513027,"teacher_disagreement_score":0.7269872,"about_ca_system_score_codex":0.008796448,"about_ca_system_score_gemma":0.003997591,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W4307114719","doi":"10.1038/s41375-022-01711-0","title":"Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"Cilag; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research Council; Celgene; Janssen Pharmaceuticals; Gilead Sciences; Servier; Amgen; Pfizer; GlaxoSmithKline; World Health Organization; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Genome-wide association study; Biology; Heritability; Genetics; Genetic association; Genetic architecture; Germline; Missing heritability problem; Locus (genetics); Quantitative trait locus; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.015973320079582,"score_gpt":0.2779399029163564,"score_spread":0.2619665828367744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307114719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960847,0.0005639624,0.00007262684,0.0004339229,0.0003586128,0.001385542,0.00020841444,0.000098402066,0.0007938295],"genre_scores_gemma":[0.99473226,0.000014943264,0.0010162238,0.00038097656,0.0002279487,0.0012245227,0.0005472072,0.00004151507,0.001814403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.00006643967,0.00039825996,0.0005027848,0.00034025346,0.0003628962],"domain_scores_gemma":[0.9988558,0.00019497998,0.0001321436,0.0005996614,0.00007073708,0.00014664541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000240011,0.00022700174,0.0004331926,0.00007463062,0.000343881,0.000032611628,0.00016270246,0.00006343286,0.00049973326],"category_scores_gemma":[0.00006202726,0.00019607591,0.00023751959,0.00018120093,0.00007180991,0.000037671725,0.0001609487,0.00007887759,0.00004750042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012627589,0.0016049703,0.88002455,0.00037655313,0.0002781791,0.0003269799,0.00042487396,0.00005379474,0.0037819548,0.00026143604,0.023910576,0.08769335],"study_design_scores_gemma":[0.0064313705,0.00086575455,0.9677108,0.00003120916,0.00026994024,0.00009619749,0.000122029785,0.0016108239,0.009985226,0.0004261962,0.012231583,0.00021886858],"about_ca_topic_score_codex":0.00074278103,"about_ca_topic_score_gemma":0.00022866919,"teacher_disagreement_score":0.087686226,"about_ca_system_score_codex":0.0018084539,"about_ca_system_score_gemma":0.00043664424,"threshold_uncertainty_score":0.7995744},"labels":[],"label_agreement":null},{"id":"W4307776418","doi":"10.1038/s41375-022-01738-3","title":"Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; St. Jude Children's Research Hospital; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Agios Pharmaceuticals; Takeda Oncology; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; CTI Biopharma; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Pharmacyclics; bluebird bio; Sanofi; TG Therapeutics; Medac; Jazz Pharmaceuticals; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; CSL Behring; Novartis Pharmaceuticals Corporation; National Center for Advancing Translational Sciences; HistoGenetics; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Incyte; Servier; Gilead Sciences; Moonshot Research and Development Program; Celgene; Bristol-Myers Squibb; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Hematopoietic cell; Transplantation; Oncology; Surgery; Haematopoiesis; Stem cell","score_opus":0.01866235932603248,"score_gpt":0.30959229976373803,"score_spread":0.29092994043770554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307776418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849063,0.00005170901,0.000047559653,0.00013396973,0.000049859256,0.0006647843,0.00036941786,0.00003257132,0.00015949013],"genre_scores_gemma":[0.998457,0.00016258555,0.00007934524,0.00011676269,0.000020950925,0.0000901493,0.0009553864,0.0000267919,0.00009100266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00022745968,0.0005129571,0.0004374876,0.0006591561,0.0003635687],"domain_scores_gemma":[0.99910164,0.00015236676,0.00015885646,0.00036791674,0.00006744666,0.000151797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037023256,0.00023256837,0.00061384996,0.001020589,0.00010173016,0.000012931381,0.00014809844,0.000118919605,0.00025332285],"category_scores_gemma":[0.000049035058,0.00019157118,0.00024310342,0.0010444364,0.000090235335,0.00009528152,0.000047364592,0.0005693394,0.0000042659212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016674063,0.00029199777,0.9805446,0.00007571751,0.00085716404,0.000056389184,0.0015279736,0.003529226,0.008830454,0.000022945696,0.00006766479,0.0025284493],"study_design_scores_gemma":[0.004021196,0.0010186163,0.9907264,0.000047944344,0.00052875065,0.000025813652,0.000102327205,0.0018360561,0.0014832279,0.000025804786,0.000018286408,0.0001655665],"about_ca_topic_score_codex":0.002838434,"about_ca_topic_score_gemma":0.00029006388,"teacher_disagreement_score":0.010181799,"about_ca_system_score_codex":0.0023129373,"about_ca_system_score_gemma":0.0005148526,"threshold_uncertainty_score":0.7812046},"labels":[],"label_agreement":null},{"id":"W4310273448","doi":"10.1038/s41375-022-01762-3","title":"Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Bristol-Myers Squibb Canada; Janssen Biotech; Associazione Italiana per la Ricerca sul Cancro; Sanofi; Meso Scale Diagnostics; AbbVie; Pfizer; Novartis Pharmaceuticals Corporation; Gilead Foundation; Celgene; Bayer; Celltrion Healthcare; European Hematology Association; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Amgen; Roche","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Medicine; Immunology; Multiple myeloma; Lymphoma","score_opus":0.020630221361695348,"score_gpt":0.29052392489038853,"score_spread":0.2698937035286932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310273448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843141,0.0008396934,0.00008283788,0.0034737086,0.0007619431,0.003044382,0.00065470644,0.00009450398,0.0067341267],"genre_scores_gemma":[0.99311435,0.00014592794,0.0015873031,0.0011160289,0.00025041398,0.00033410592,0.00012582075,0.00011468985,0.0032113858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99494547,0.00056582683,0.0014054879,0.0007228265,0.0012319963,0.0011284027],"domain_scores_gemma":[0.99670637,0.0010428034,0.00045197023,0.0012128192,0.00029707802,0.00028894743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019086219,0.00040252358,0.0007377406,0.00021248961,0.0002947466,0.000029372588,0.0007464491,0.0001271292,0.00040031996],"category_scores_gemma":[0.0014846954,0.0003321555,0.00035566944,0.00078567176,0.0005258494,0.000030907388,0.0010604595,0.0010209351,0.00003378645],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011339799,0.0036764797,0.102471426,0.006723653,0.0018032233,0.016128575,0.008390795,0.038074832,0.051961716,0.0073227435,0.67895955,0.07314722],"study_design_scores_gemma":[0.23211408,0.0044281124,0.054908432,0.0019475602,0.001572967,0.010436185,0.009152911,0.099228576,0.07444652,0.002229964,0.5064055,0.0031292473],"about_ca_topic_score_codex":0.0011403343,"about_ca_topic_score_gemma":0.0002448409,"teacher_disagreement_score":0.22077428,"about_ca_system_score_codex":0.025570761,"about_ca_system_score_gemma":0.01205526,"threshold_uncertainty_score":0.99991304},"labels":[],"label_agreement":null},{"id":"W4318220699","doi":"10.1038/s41375-023-01822-2","title":"Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations","year":2023,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Myeloid leukemia; Clinical trial; Hematopoietic stem cell transplantation; Transplantation; Disease; Regimen; Intensive care medicine; Oncology; Internal medicine; Pediatrics; Immunology","score_opus":0.03833482069215284,"score_gpt":0.3354612498558526,"score_spread":0.29712642916369975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318220699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007833417,0.9871995,0.000030436304,0.00007036376,0.00044872938,0.0033255774,0.00033396613,0.00017228081,0.0005857506],"genre_scores_gemma":[0.0026695486,0.9916586,0.0005328192,0.00003471246,0.00061555114,0.0004671523,0.0023799152,0.00019342445,0.0014482411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633974,0.00010129646,0.0012645853,0.0010330507,0.0006631698,0.0005981368],"domain_scores_gemma":[0.9981241,0.00008138093,0.0006893817,0.00080103084,0.00007292297,0.0002311389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002391875,0.0007873055,0.0018732923,0.0009299144,0.00006827987,0.00003767533,0.0004645727,0.00040015622,0.0001560829],"category_scores_gemma":[0.000024748173,0.00065108266,0.00028972948,0.0010704783,0.00011701319,0.00013838669,0.00037403707,0.0008193081,0.0001452011],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014384571,0.00029525295,0.0015336111,0.022332327,0.0016251539,0.0004940089,0.0001398085,0.000015471753,9.583189e-7,0.00003066918,0.0026841473,0.97070473],"study_design_scores_gemma":[0.06929293,0.0018556997,0.023756841,0.28680933,0.01092862,0.0017954551,0.0002154858,0.0005022553,0.000020397427,0.000026799962,0.60182464,0.0029715772],"about_ca_topic_score_codex":0.0004281905,"about_ca_topic_score_gemma":0.00009821337,"teacher_disagreement_score":0.96773314,"about_ca_system_score_codex":0.019052323,"about_ca_system_score_gemma":0.0033558684,"threshold_uncertainty_score":0.99959403},"labels":[],"label_agreement":null},{"id":"W4318485463","doi":"10.1038/s41375-023-01829-9","title":"Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institute for Health and Care Research; Novartis Pharmaceuticals Corporation","keywords":"Bosutinib; Discontinuation; Medicine; Tolerability; Internal medicine; Adverse effect; Imatinib; Myeloid leukemia; Clinical endpoint; Oncology; Nilotinib; Gastroenterology; Randomized controlled trial","score_opus":0.02015551723185398,"score_gpt":0.2940192947944369,"score_spread":0.2738637775625829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318485463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908283,0.002944916,0.000013272045,0.00020021007,0.0004011803,0.0028998668,0.00015095735,0.00066970254,0.0018916468],"genre_scores_gemma":[0.9832115,0.00082275487,0.0001849991,0.00014154574,0.0009314298,0.0004922504,0.0016498535,0.00033066666,0.01223497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9928457,0.00022491427,0.0017219881,0.0017626053,0.0013508548,0.0020939403],"domain_scores_gemma":[0.99584424,0.00029853923,0.0007450392,0.0020888753,0.00026893363,0.00075434183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006580261,0.0012469323,0.0020646788,0.0010085695,0.00024285344,0.00006392767,0.00057704607,0.00057144533,0.0008064163],"category_scores_gemma":[0.00021281179,0.0010766084,0.00051354273,0.0028049387,0.00058752263,0.00039328614,0.00045512748,0.0010042181,0.00091154885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.033412203,0.0023128742,0.20720719,0.008282974,0.0032174718,0.019906344,0.008046589,0.0058544623,0.55079496,0.00021519701,0.042160988,0.11858877],"study_design_scores_gemma":[0.3367937,0.019355638,0.09623286,0.012932354,0.0026297548,0.0017529024,0.000527885,0.015642049,0.4970107,0.00003814941,0.013721435,0.0033625928],"about_ca_topic_score_codex":0.0018593885,"about_ca_topic_score_gemma":0.0038301998,"teacher_disagreement_score":0.30338147,"about_ca_system_score_codex":0.056382578,"about_ca_system_score_gemma":0.010254351,"threshold_uncertainty_score":0.99986637},"labels":[],"label_agreement":null},{"id":"W4318619600","doi":"10.1038/s41375-023-01833-z","title":"KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Science and Engineering Research Board; Canadian Cancer Society Research Institute; Israel Science Foundation; Indian Council of Medical Research; Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University; Council of Scientific and Industrial Research, India; Department of Biotechnology, Ministry of Science and Technology, India","keywords":"Synthetic lethality; Cancer research; Myeloid leukemia; DNA repair; Poly ADP ribose polymerase; Biology; NPM1; Leukemia; DNA damage; Histone; Epigenetics; Daunorubicin; Gene; Immunology; Genetics; DNA; Polymerase","score_opus":0.02156514824758506,"score_gpt":0.29873715392631883,"score_spread":0.2771720056787338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318619600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963472,0.00016652435,0.00021269447,0.0011697605,0.00008763906,0.0008404237,0.00007311036,0.00046057883,0.00064210594],"genre_scores_gemma":[0.9924027,0.0005734275,0.0027006804,0.0005348533,0.0003282973,0.00006221444,0.00039770725,0.000089609406,0.0029105137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970736,0.00018704314,0.0006923158,0.0007942116,0.0006134594,0.00063939794],"domain_scores_gemma":[0.99811214,0.0002817392,0.00018577457,0.000628991,0.00035179427,0.000439576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089326507,0.00038222823,0.00072910584,0.00072576775,0.00023702843,0.00004889948,0.00010198862,0.0003276805,0.000050383893],"category_scores_gemma":[0.00040324486,0.0003511944,0.00013881353,0.0011203255,0.00039800577,0.00023014753,0.00034423626,0.0004911805,0.000085492684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065769936,0.000022362272,0.005683612,0.00038512598,0.00027597306,0.000624869,0.001348314,0.00008294142,0.96984875,0.0006575429,0.014815276,0.0055975053],"study_design_scores_gemma":[0.005678269,0.0013502573,0.23027942,0.00071710086,0.00048442444,0.0008974164,0.0010340656,0.007608981,0.7461253,0.0020327405,0.0030716665,0.0007203939],"about_ca_topic_score_codex":0.0005516763,"about_ca_topic_score_gemma":0.00012527689,"teacher_disagreement_score":0.2245958,"about_ca_system_score_codex":0.0014773224,"about_ca_system_score_gemma":0.00062493427,"threshold_uncertainty_score":0.999894},"labels":[],"label_agreement":null},{"id":"W4320730501","doi":"10.1038/s41375-023-01841-z","title":"Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Terry Fox Research Institute; Michael Smith Health Research BC; Government of Canada; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"RUNX1; microRNA; Focal adhesion; Cancer research; Leukemia; Kinase; Biology; Medicine; Immunology; Stem cell; Signal transduction; Cell biology; Genetics; Haematopoiesis; Gene","score_opus":0.005283187182853093,"score_gpt":0.22405320229796696,"score_spread":0.21877001511511387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320730501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984584,0.00011674197,0.00092810823,0.00008066126,0.00006283487,0.00022935132,0.00006592479,0.000026689637,0.000031274543],"genre_scores_gemma":[0.998751,0.00004211618,0.00006723523,0.000050815637,0.00006749791,0.000022211092,0.00080936024,0.000022132233,0.00016762622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907106,0.00009270223,0.00024860044,0.000262773,0.00013335237,0.00019151911],"domain_scores_gemma":[0.99945,0.000023409473,0.00014727406,0.0002698209,0.000055323708,0.00005415896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016204265,0.000120958946,0.00014392198,0.000083872575,0.000032239663,0.000007759894,0.00010822617,0.00020820682,0.000018459654],"category_scores_gemma":[0.00012061932,0.00012398454,0.00006231602,0.00024477302,0.000044879056,0.0000060473035,0.00004201103,0.000077386365,0.00001803413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002217934,0.0000284907,0.0055874693,0.000021481956,0.000025117915,0.0000019907072,0.000014978956,0.0019453239,0.9845404,0.000031441647,0.0051406273,0.0024408903],"study_design_scores_gemma":[0.0019160729,0.00009692809,0.13339446,0.000031976142,0.00001757299,6.567902e-7,0.0000121510575,0.0031067836,0.85925967,0.0001477113,0.0018858529,0.0001301664],"about_ca_topic_score_codex":0.00033229674,"about_ca_topic_score_gemma":0.00002906885,"teacher_disagreement_score":0.127807,"about_ca_system_score_codex":0.000110647685,"about_ca_system_score_gemma":0.00009859319,"threshold_uncertainty_score":0.5055943},"labels":[],"label_agreement":null},{"id":"W4321014555","doi":"10.1038/s41375-023-01853-9","title":"KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Georgia Clinical and Translational Science Alliance; Alex's Lemonade Stand Foundation for Childhood Cancer; Gabrielle's Angel Foundation for Cancer Research; U.S. Department of Health and Human Services; National Institutes of Health; Alvin J. Siteman Cancer Center; Institute of Clinical and Translational Sciences; Leukemia and Lymphoma Society; Children's Discovery Institute; National Cancer Institute","keywords":"Demethylase; Biology; Cancer research; Epigenetics; Carcinogenesis; Haematopoiesis; Mutation; Histone; Gene; Genetics; Leukemia; Stem cell","score_opus":0.03570552351531043,"score_gpt":0.305034363630348,"score_spread":0.2693288401150376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321014555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909512,0.0000570763,0.00013461348,0.0009891458,0.00041237622,0.0011607473,0.00011457384,0.0006638454,0.005516442],"genre_scores_gemma":[0.98966205,0.00006265995,0.0007760784,0.00096819527,0.0009820161,0.00018151915,0.0002481471,0.00012625908,0.0069930735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966761,0.00010285349,0.00043331066,0.00074119377,0.0010534901,0.0009930639],"domain_scores_gemma":[0.99796104,0.0004410286,0.0001087422,0.0008151982,0.00015012012,0.00052384945],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028266505,0.00034345384,0.0005329685,0.00029873056,0.00011152203,0.00005858863,0.0004375546,0.00039750114,0.0005533307],"category_scores_gemma":[0.0003318131,0.00030079528,0.00019711816,0.00091298297,0.000094122726,0.00011194359,0.00033498695,0.00074612786,0.00782398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038837275,0.00007464599,0.0004541487,0.00017246307,0.00027959887,0.0019036165,0.00074613886,0.00008737785,0.94814825,0.000045558503,0.03749897,0.0102008525],"study_design_scores_gemma":[0.010159168,0.0006583988,0.014272214,0.0004640192,0.0002278906,0.00007323216,0.00044450667,0.019604027,0.9302782,0.0006432125,0.022481441,0.0006936949],"about_ca_topic_score_codex":0.002116518,"about_ca_topic_score_gemma":0.00008688391,"teacher_disagreement_score":0.019516649,"about_ca_system_score_codex":0.0031116747,"about_ca_system_score_gemma":0.0024113145,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W4321482739","doi":"10.1038/s41375-023-01856-6","title":"Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study","year":2023,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Childhood leukemia; Clinical trial; Lymphoma; Leukemia; Oncology; Internal medicine; Pediatrics; Lymphoblastic Leukemia","score_opus":0.048490770584382135,"score_gpt":0.3727920895735582,"score_spread":0.3243013189891761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321482739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95597655,0.00077441253,0.0000092158725,0.03477293,0.0006986711,0.0068626585,0.00050753285,0.00017815363,0.0002198959],"genre_scores_gemma":[0.9112593,0.00054895954,0.00009248708,0.08150655,0.0020469932,0.0010181329,0.0022198628,0.0004117564,0.00089597405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98651505,0.0030610978,0.0037601707,0.0023770563,0.0027804011,0.0015062273],"domain_scores_gemma":[0.9869284,0.008655539,0.0014360592,0.002347322,0.00024519002,0.00038751593],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005537967,0.0012270027,0.0038793415,0.00075589976,0.00021207295,0.00020078896,0.0010542632,0.0016710456,0.0000719099],"category_scores_gemma":[0.0041407696,0.00075792527,0.00037286838,0.0015373814,0.00068995846,0.00030727332,0.00067142013,0.0046581444,0.000053610464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006543895,0.0026959265,0.7113665,0.00031344462,0.0025897776,0.11723953,0.0059629856,0.00001516973,0.00000756051,0.000002695015,0.104225695,0.04903683],"study_design_scores_gemma":[0.10292182,0.0044389563,0.8476438,0.0015671672,0.0011047155,0.0008826541,0.0006213251,0.00016462694,0.0000045556576,0.00028146076,0.039292403,0.00107653],"about_ca_topic_score_codex":0.012819239,"about_ca_topic_score_gemma":0.0031417196,"teacher_disagreement_score":0.13627729,"about_ca_system_score_codex":0.00840312,"about_ca_system_score_gemma":0.009214041,"threshold_uncertainty_score":0.99962497},"labels":[],"label_agreement":null},{"id":"W4321787519","doi":"10.1038/s41375-023-01837-9","title":"Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AOP Orphan; Swedish Orphan Biovitrum; RWTH Aachen University; Astellas Pharma; Deutsche Forschungsgemeinschaft; Syndax Pharmaceuticals; Sierra Oncology; Incyte; Agios Pharmaceuticals; Jazz Pharmaceuticals; Gilead Sciences; Celgene; AstraZeneca; Ariad Pharmaceuticals; Amgen; Pfizer; Alexion Pharmaceuticals","keywords":"Essential thrombocythemia; Pegylated interferon; Medicine; Myeloproliferative Disorders; Internal medicine; Hematology; Oncology; Polycythemia vera; Immunology; Ribavirin","score_opus":0.019057850718400677,"score_gpt":0.30487386581736764,"score_spread":0.285816015098967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321787519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950277,0.000026665208,0.0000061436804,0.00006800786,0.00007282163,0.0046531837,0.00004187051,0.00007447404,0.000029137496],"genre_scores_gemma":[0.99915075,0.000017525264,0.00007231581,0.000072362855,0.00001255254,0.00048062787,0.000050645125,0.00005207021,0.000091129805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969531,0.00065716467,0.00081207574,0.0006509352,0.0005753007,0.00035138946],"domain_scores_gemma":[0.9981172,0.00033096096,0.0004346592,0.0006602772,0.00032401277,0.00013286942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003572636,0.00043559005,0.0010235187,0.00021078585,0.00013783498,0.000022323065,0.00018484774,0.00013619543,0.000026346408],"category_scores_gemma":[0.00017216214,0.00024951945,0.00012696961,0.0007069361,0.00022184031,0.00007894641,0.0002466262,0.00030649672,0.000011200402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008430203,0.009716017,0.9649584,0.000075642085,0.0012161271,0.00024147154,0.0120217465,0.000017399201,0.0031011917,0.000013683059,0.000063625004,0.00014448662],"study_design_scores_gemma":[0.033997934,0.014462463,0.9227008,0.00027512442,0.0006090225,0.000030881416,0.0033877287,0.00049998524,0.023806542,0.0000064756255,0.000005567177,0.00021745046],"about_ca_topic_score_codex":0.00016367246,"about_ca_topic_score_gemma":0.00021419115,"teacher_disagreement_score":0.04225758,"about_ca_system_score_codex":0.0002056973,"about_ca_system_score_gemma":0.00016608759,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W4360948865","doi":"10.1038/s41375-023-01870-8","title":"Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932","year":2023,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"BD Biosciences; National Cancer Institute; St. Baldrick's Foundation; U.S. Department of Health and Human Services","keywords":"Cog; Medicine; Intensity (physics); Oncology; Internal medicine; Pediatrics; Computer science","score_opus":0.01614932245850796,"score_gpt":0.2796584168557118,"score_spread":0.2635090943972038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360948865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.896756,0.00009849134,0.000589401,0.09643383,0.00047704377,0.0028924001,0.0005429781,0.0008260019,0.001383832],"genre_scores_gemma":[0.4780568,0.00029382188,0.0061047985,0.4444671,0.009019261,0.0007056135,0.015613989,0.0020757301,0.043662902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99198574,0.00021734924,0.0011764939,0.0021746377,0.002651468,0.0017942935],"domain_scores_gemma":[0.9947998,0.0008851914,0.0008871221,0.0025526625,0.00045213944,0.00042306818],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00073249236,0.0012569309,0.002565274,0.00090790633,0.00014903212,0.00015403975,0.00071942265,0.0013421446,0.00012098296],"category_scores_gemma":[0.00084428745,0.00086766866,0.00032729903,0.0010538411,0.0005600807,0.00018216985,0.00049299264,0.0070476444,0.00043975146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080127537,0.000044451866,0.5257004,0.00015123675,0.0023152619,0.060942266,0.00034480053,0.000067918765,0.000025192308,0.0000015170201,0.40952057,0.00008515994],"study_design_scores_gemma":[0.042250115,0.0012973333,0.8998212,0.008666129,0.0042922636,0.012796528,0.00039182996,0.0017538267,0.00037508228,0.00028916952,0.024722034,0.003344468],"about_ca_topic_score_codex":0.023436015,"about_ca_topic_score_gemma":0.0015787641,"teacher_disagreement_score":0.41869923,"about_ca_system_score_codex":0.009947495,"about_ca_system_score_gemma":0.004757452,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W4367050222","doi":"10.1038/s41375-023-01898-w","title":"Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Venetoclax; Ibrutinib; CD40; Cancer research; Chronic lymphocytic leukemia; Bruton's tyrosine kinase; Idelalisib; Medicine; Leukemia; Immunology; Biology; Receptor; Internal medicine; Cytotoxic T cell; Tyrosine kinase; In vitro; Biochemistry","score_opus":0.03847559440720295,"score_gpt":0.3173478667495473,"score_spread":0.27887227234234435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367050222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955362,0.00006686651,0.00030378115,0.0007705726,0.000109684544,0.0013662474,0.000012277678,0.00028718784,0.0015471745],"genre_scores_gemma":[0.9954032,0.000011967486,0.001068074,0.00022452409,0.00023818525,0.00007358223,0.00011132671,0.000057955123,0.0028112214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980409,0.000085228174,0.0003629306,0.00048941164,0.00050275144,0.0005187605],"domain_scores_gemma":[0.9990479,0.00016452873,0.00006711432,0.00035581182,0.00008625292,0.00027842404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048787845,0.00020820605,0.0003026835,0.00021769614,0.00011217933,0.000060782757,0.00009108247,0.00019845826,0.000046569097],"category_scores_gemma":[0.0001435372,0.00020324127,0.00006629044,0.00060894154,0.00005290514,0.00011629839,0.00008772238,0.00026221215,0.00030935762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003354635,0.00000920422,0.000045322,0.00024779025,0.000039235885,0.00007487179,0.0018085561,0.0003481268,0.9331336,0.00003215996,0.0044827024,0.05944299],"study_design_scores_gemma":[0.011825169,0.00048815305,0.0014478398,0.00070043345,0.00006258214,0.00010251074,0.00047371577,0.26746148,0.7076915,0.00014617061,0.009180737,0.00041975206],"about_ca_topic_score_codex":0.00070312293,"about_ca_topic_score_gemma":0.000044525936,"teacher_disagreement_score":0.26711336,"about_ca_system_score_codex":0.00886901,"about_ca_system_score_gemma":0.00224736,"threshold_uncertainty_score":0.99493575},"labels":[],"label_agreement":null},{"id":"W4375850381","doi":"10.1038/s41375-023-01921-0","title":"Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932","year":2023,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Medicine; Pediatrics; Oncology; Internal medicine; Computer science; Artificial intelligence","score_opus":0.013411014013707782,"score_gpt":0.2815601296790998,"score_spread":0.26814911566539207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375850381","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204402,0.0006416805,0.0019372887,0.0020433203,0.031895753,0.00618349,0.00081192027,0.0023248119,0.033721544],"genre_scores_gemma":[0.2927544,0.00081794366,0.0017096541,0.0018111361,0.005854435,0.00044820766,0.011276406,0.0012003629,0.68412745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9926873,0.00018177787,0.0011790021,0.0021040149,0.0024126,0.0014353066],"domain_scores_gemma":[0.99489945,0.000603446,0.0010128287,0.0022269422,0.00062657695,0.00063072785],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000783657,0.0012079675,0.0025497477,0.0009053678,0.00021153533,0.00015794123,0.00058372517,0.0011349273,0.00015006903],"category_scores_gemma":[0.0014843319,0.00086729834,0.00031665424,0.0014276874,0.0005093046,0.00019516199,0.00045983045,0.005693424,0.00034260508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013867368,0.00008562236,0.4263986,0.0001064539,0.0020726884,0.012156815,0.00042053542,0.00013247985,0.000009000067,0.0000021455414,0.5570401,0.00018879361],"study_design_scores_gemma":[0.023292622,0.0011743025,0.9313177,0.009856465,0.00284642,0.009540067,0.0008284265,0.006390039,0.00013034616,0.00009151498,0.012482136,0.0020499888],"about_ca_topic_score_codex":0.031006504,"about_ca_topic_score_gemma":0.008072258,"teacher_disagreement_score":0.6504059,"about_ca_system_score_codex":0.01273761,"about_ca_system_score_gemma":0.009082645,"threshold_uncertainty_score":0.9993778},"labels":[],"label_agreement":null},{"id":"W4384819561","doi":"10.1038/s41375-023-01962-5","title":"Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748","year":2023,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Agriculture and Biological Studies","field":"Agricultural and Biological Sciences","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University of British Columbia; University Health Network","funders":"World Health Organization","keywords":"Leukemia; Medicine; Pathology; Internal medicine","score_opus":0.020244557736322583,"score_gpt":0.23242527304405677,"score_spread":0.2121807153077342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384819561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39059266,0.023529269,0.00019857418,0.13501613,0.3359906,0.013394226,0.004729289,0.0031333396,0.093415886],"genre_scores_gemma":[0.48990136,0.008370689,0.000026984524,0.0026596955,0.013471151,0.0002545904,0.009033168,0.000029923574,0.47625244],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99677163,0.00037604253,0.00095676695,0.0006396503,0.0007815848,0.00047433397],"domain_scores_gemma":[0.9969195,0.00060317636,0.0016518353,0.00025033773,0.0004802419,0.0000948999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000507309,0.0004662759,0.00079804217,0.000039835293,0.0009136342,0.000061482395,0.0009488255,0.00055927935,0.0002705892],"category_scores_gemma":[0.00045861877,0.00013580413,0.00033473247,0.0032631636,0.00035501164,0.000101528705,0.0003553362,0.0007276566,0.000068349436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023739582,0.000045837016,0.0033301439,0.00007096507,0.000044545464,9.765025e-7,0.000106657106,0.000014680446,0.003718607,0.00018397208,0.98469764,0.007762246],"study_design_scores_gemma":[0.00027787188,0.0003571168,0.52650213,0.0007700251,0.0001478455,0.000057399207,0.0015938268,0.00025844574,0.0047993,0.00035059665,0.46432176,0.0005636918],"about_ca_topic_score_codex":0.0018275856,"about_ca_topic_score_gemma":0.010696168,"teacher_disagreement_score":0.52317196,"about_ca_system_score_codex":0.0013339042,"about_ca_system_score_gemma":0.00046820633,"threshold_uncertainty_score":0.7027028},"labels":[],"label_agreement":null},{"id":"W4384923858","doi":"10.1038/s41375-023-01973-2","title":"Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?","year":2023,"lang":"en","type":"review","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities; Chinese Academy of Medical Sciences; University of Toronto; National Natural Science Foundation of China; National Institute for Health and Care Research","keywords":"Stem cell; Haematopoiesis; CD34; Granulocyte; Transplantation; Immunology; Hematopoietic stem cell; Biology; Medicine; Cell biology; Internal medicine","score_opus":0.05350681731589124,"score_gpt":0.28101455868946956,"score_spread":0.22750774137357832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022021718,0.9365904,0.0010203163,0.00023520885,0.00083449134,0.010858849,0.027117908,0.0003782317,0.00094287796],"genre_scores_gemma":[0.01193125,0.980374,0.00030378855,0.0002941333,0.00019447383,0.00064616394,0.0015035894,0.0006008804,0.004151747],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930284,0.00039372203,0.0020945289,0.0019300223,0.001164405,0.0013889305],"domain_scores_gemma":[0.9942443,0.0014446374,0.0021051527,0.0012715905,0.000268847,0.00066552253],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00075837894,0.001969715,0.006213574,0.0008027084,0.000252127,0.00013336458,0.0007053735,0.0018339709,0.00007129901],"category_scores_gemma":[0.0000034517275,0.0016756697,0.0018751307,0.0007990899,0.00025617125,0.00021933042,0.000036966398,0.0012642782,0.00012431858],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028611484,0.0005149696,0.00009891598,0.94192106,0.0023573567,0.0046335463,0.007695781,0.000014220107,0.0025541983,0.000045852088,0.0029781302,0.034324847],"study_design_scores_gemma":[0.0326412,0.0033652107,0.00038684683,0.59652394,0.057899326,0.00465935,0.009955688,0.00047898505,0.19721523,0.00011414948,0.08965215,0.007107919],"about_ca_topic_score_codex":0.00008620817,"about_ca_topic_score_gemma":0.000046747045,"teacher_disagreement_score":0.34539708,"about_ca_system_score_codex":0.0005779658,"about_ca_system_score_gemma":0.00090535026,"threshold_uncertainty_score":0.9994618},"labels":[],"label_agreement":null},{"id":"W4385999452","doi":"10.1038/s41375-023-02006-8","title":"Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Department of Biotechnology, Ministry of Science and Technology, India; Ohio State University","keywords":"Mantle cell lymphoma; Cancer research; Fibroblast growth factor receptor 1; In vivo; Biology; Lymphoma; Cell growth; Cell cycle checkpoint; Cell cycle; Medicine; Fibroblast growth factor; Immunology; Cancer; Receptor; Internal medicine","score_opus":0.0239461135196629,"score_gpt":0.27954306190334705,"score_spread":0.25559694838368413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385999452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958949,0.000037313148,0.00026224836,0.0018945851,0.00010030751,0.00090376305,0.00004549756,0.00006262386,0.0007987303],"genre_scores_gemma":[0.9979114,0.00005136016,0.00016616473,0.00044968465,0.0003049699,0.0002408065,0.00011168846,0.0000557015,0.0007082371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974298,0.0004691328,0.00038112485,0.0006107671,0.00043963606,0.0006695341],"domain_scores_gemma":[0.99871594,0.00020096869,0.000078149715,0.0007364328,0.00013837706,0.00013012254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575833,0.00026194728,0.00018166445,0.00010291111,0.0002934024,0.00013204169,0.0007169959,0.0002168558,0.000048698166],"category_scores_gemma":[0.00045501388,0.0001700146,0.00011197766,0.0007636314,0.00013576841,0.000016422584,0.0004255011,0.00031112696,0.00029471776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002011301,0.000055198394,0.014451417,0.000058548627,0.000027024098,0.0000051533684,0.0007227779,0.0005833626,0.97644955,0.00011962651,0.0047319434,0.0025942896],"study_design_scores_gemma":[0.0013033167,0.0006038593,0.20172776,0.00007227362,0.000007951343,0.00000790359,0.000629297,0.0018534679,0.78193516,0.00023145783,0.011156026,0.00047155836],"about_ca_topic_score_codex":0.00014815135,"about_ca_topic_score_gemma":0.0001666712,"teacher_disagreement_score":0.1945144,"about_ca_system_score_codex":0.00027624716,"about_ca_system_score_gemma":0.000357976,"threshold_uncertainty_score":0.6932994},"labels":[],"label_agreement":null},{"id":"W4386423632","doi":"10.1038/s41375-023-01978-x","title":"Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","year":2023,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; World Health Organization","keywords":"Germline; Hodgkin lymphoma; Lymphoma; Biology; Genetics; Medicine; Computational biology; Immunology; Gene","score_opus":0.019204196609360447,"score_gpt":0.29091253425279445,"score_spread":0.271708337643434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386423632","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6879294,0.008515387,0.00034766074,0.0017757482,0.24446984,0.013032752,0.0025764734,0.0021394875,0.039213244],"genre_scores_gemma":[0.3056113,0.0007997478,0.0005032468,0.00033802344,0.008401518,0.002347918,0.013554271,0.0003476593,0.6680963],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996555,0.00007788508,0.00089676765,0.0012005892,0.000583841,0.00068596087],"domain_scores_gemma":[0.99721575,0.000496924,0.00044140138,0.0012511882,0.0003045162,0.00029025026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028730085,0.0007306774,0.0013864723,0.0002299586,0.00028902083,0.000117486255,0.00028148733,0.00089011947,0.00022882078],"category_scores_gemma":[0.00035832007,0.00061739655,0.00068367546,0.00039064532,0.00017023354,0.000055752444,0.00015821653,0.00036004712,0.0005239119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039351705,0.00040510713,0.032048035,0.001181995,0.00043272885,0.00031020725,0.00009177677,0.0000041458165,0.000036132504,0.000008201779,0.92788094,0.037207194],"study_design_scores_gemma":[0.004905265,0.0008584641,0.7666039,0.001278519,0.0013214772,0.00012711284,0.000060094844,0.0024498631,0.0012084945,0.00017958097,0.22039251,0.0006147241],"about_ca_topic_score_codex":0.0021277433,"about_ca_topic_score_gemma":0.00315486,"teacher_disagreement_score":0.73455584,"about_ca_system_score_codex":0.0034079028,"about_ca_system_score_gemma":0.0019334032,"threshold_uncertainty_score":0.9996277},"labels":[],"label_agreement":null},{"id":"W4386572280","doi":"10.1038/s41375-023-02023-7","title":"Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank","year":2023,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Impact; Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Veterans Affairs","keywords":"Biobank; Haematopoiesis; Cancer; Indeterminate; Hematology; Hematologic Neoplasms; Immunology; Medicine; Transformation (genetics); Biology; Internal medicine; Stem cell; Bioinformatics; Genetics","score_opus":0.018684913357260705,"score_gpt":0.28252277725024993,"score_spread":0.26383786389298924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386572280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88656235,0.00021807454,0.00010260143,0.10936021,0.00022614101,0.001609278,0.0014049349,0.00016081307,0.00035558973],"genre_scores_gemma":[0.89956146,0.0018322143,0.00002370758,0.089966066,0.0006812418,0.0006374718,0.005989634,0.000171982,0.0011362473],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99565923,0.0005506122,0.0009020417,0.0005541217,0.001548802,0.00078521523],"domain_scores_gemma":[0.9977418,0.0006322521,0.0007272458,0.0005197807,0.0003008071,0.00007811945],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009819852,0.0005265197,0.0010625626,0.0006054931,0.00013785635,0.000048908423,0.0003740586,0.0016704716,0.0002518758],"category_scores_gemma":[0.00034613887,0.00034614612,0.00026284397,0.0015696406,0.00031437495,0.00014222894,0.000052707743,0.0039642444,0.00006061324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031273524,0.000059565908,0.017832007,0.0008509247,0.0005956112,0.0008841823,0.0016393121,0.000054290405,0.0005809698,0.0000021936005,0.9767066,0.000481599],"study_design_scores_gemma":[0.08867828,0.008837472,0.39932692,0.0222677,0.014534914,0.003543077,0.0040614507,0.06111995,0.09264953,0.0020603195,0.29312006,0.009800334],"about_ca_topic_score_codex":0.0074440017,"about_ca_topic_score_gemma":0.0010747297,"teacher_disagreement_score":0.68358654,"about_ca_system_score_codex":0.0023474288,"about_ca_system_score_gemma":0.0015870038,"threshold_uncertainty_score":0.999899},"labels":[],"label_agreement":null},{"id":"W4387057720","doi":"10.1038/s41375-023-02031-7","title":"Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; Acceleron; Celgene; Bristol-Myers Squibb","keywords":"Myelodysplastic syndromes; Erythropoiesis; Medicine; Refractory (planetary science); Ineffective erythropoiesis; Anemia; Internal medicine; Intensive care medicine; Bone marrow; Biology","score_opus":0.026013440952805944,"score_gpt":0.2829500220984105,"score_spread":0.2569365811456046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387057720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783325,0.00005994739,0.0007474855,0.0000461542,0.0000724308,0.0009833667,0.000034516936,0.00013063106,0.0000922063],"genre_scores_gemma":[0.9983141,0.00043133006,0.00036219976,0.00003317284,0.0000353487,0.0000429468,0.000120967234,0.000102008285,0.00055792346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973371,0.00006639047,0.0005210193,0.0006203124,0.0008522655,0.0006029263],"domain_scores_gemma":[0.9985559,0.00035504714,0.00021830895,0.00040389452,0.00020665681,0.00026020323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023747334,0.00036926023,0.00063729053,0.00060947664,0.00015172819,0.000039886592,0.00014724974,0.00018128319,0.00023377953],"category_scores_gemma":[0.00018543506,0.0002561445,0.00004961876,0.0009798554,0.00017508767,0.0002837958,0.00011971328,0.0005161059,0.000024361672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033968901,0.00016689666,0.9732252,0.0009821577,0.00015985183,0.0007672225,0.0018856629,0.005437058,0.0013014878,0.000003679836,0.000020236226,0.012653667],"study_design_scores_gemma":[0.009930192,0.0019358555,0.9660788,0.0020917126,0.0001631724,0.000083098515,0.0003472538,0.018361825,0.00068706874,0.000008365177,0.0000050149642,0.00030761244],"about_ca_topic_score_codex":0.00049150723,"about_ca_topic_score_gemma":0.0016253943,"teacher_disagreement_score":0.012924767,"about_ca_system_score_codex":0.00087063765,"about_ca_system_score_gemma":0.0004268596,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W4387330115","doi":"10.1038/s41375-023-02048-y","title":"European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia","year":2023,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute for Health and Care Research; North Carolina Pork Council","keywords":"Medicine; Myeloid leukemia; Hematology; Myeloid; Internal medicine; Oncology; Intensive care medicine","score_opus":0.07640124886457271,"score_gpt":0.347823993219408,"score_spread":0.27142274435483527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387330115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039995695,0.9903854,0.00006507525,0.00031692095,0.0006419431,0.0056947493,0.0009895606,0.0002620224,0.0016043481],"genre_scores_gemma":[0.000020227879,0.9878226,0.0010315737,0.00015979732,0.00074946956,0.0030414842,0.0014048466,0.0003863925,0.0053836126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959325,0.0002893605,0.001485592,0.0010567347,0.0004738534,0.00076195435],"domain_scores_gemma":[0.99553376,0.001503954,0.0008840617,0.0016587678,0.0001491985,0.00027023893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009844915,0.0009211968,0.0022292123,0.0003596306,0.00031811805,0.00006609051,0.00064335606,0.0003994131,0.00015447605],"category_scores_gemma":[0.00012641867,0.0006582208,0.0007192135,0.0010250432,0.00029937483,0.00010098765,0.0005044101,0.00078767544,0.00034896703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021708347,0.00004624629,0.000010724531,0.058656804,0.0028133271,0.00012712902,0.00007882788,0.000009159818,6.141681e-7,0.0003995097,0.065902054,0.8719339],"study_design_scores_gemma":[0.0027200927,0.0002765603,0.00011588665,0.03240478,0.008127912,0.00007530273,0.00008798885,0.00010940784,0.000009116028,0.000021495753,0.9555592,0.00049223757],"about_ca_topic_score_codex":0.00014682117,"about_ca_topic_score_gemma":0.000051488172,"teacher_disagreement_score":0.88965714,"about_ca_system_score_codex":0.01458832,"about_ca_system_score_gemma":0.004139364,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W4387665269","doi":"10.1038/s41375-023-02064-y","title":"Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Takeda Medical Research Foundation; Gilead Sciences; Roche; AstraZeneca; Miltenyi Biotec; Novartis; Deutsche Krebshilfe; Amgen; Pfizer; AbbVie; Staatssekretariat für Bildung, Forschung und Innovation; Merck","keywords":"Medicine; ABVD; Stage (stratigraphy); Internal medicine; Progression-free survival; Nuclear medicine; Hodgkin lymphoma; Hodgkin's lymphoma; Lymphoma; Randomized controlled trial; Overall survival; Oncology; Gastroenterology; Chemotherapy; Vincristine","score_opus":0.035273216745741055,"score_gpt":0.29185858039651585,"score_spread":0.2565853636507748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387665269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335825,0.000103844555,5.943542e-7,0.0002982966,0.00043515817,0.0011755164,0.000046953835,0.000044455002,0.004536924],"genre_scores_gemma":[0.98927736,0.00019590324,0.00006245359,0.00006268009,0.0000749594,0.0001958081,0.000027786145,0.000026480571,0.010076564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984051,0.000087113556,0.00052454777,0.00028406916,0.00038440988,0.00031473287],"domain_scores_gemma":[0.99884504,0.00018472433,0.00019359613,0.0006422695,0.00005095576,0.00008340049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020138125,0.00021077746,0.0005945409,0.00015419754,0.000044853787,0.000009200678,0.00014194133,0.00008732714,0.00007003772],"category_scores_gemma":[0.00010894462,0.00012933718,0.00033993146,0.0006207146,0.000075979224,0.000043734843,0.000069649795,0.000043084703,0.00006320878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030165007,0.0052753002,0.87154084,0.0005047103,0.0016262663,0.0017414654,0.008169248,0.00040545815,0.010625883,0.003725193,0.012901997,0.05331865],"study_design_scores_gemma":[0.25240177,0.0022336715,0.64666957,0.00031354805,0.0003195378,0.000022706387,0.00039706958,0.00036231277,0.08974765,0.00015902167,0.0071829697,0.00019015765],"about_ca_topic_score_codex":0.008508043,"about_ca_topic_score_gemma":0.00043676686,"teacher_disagreement_score":0.22487125,"about_ca_system_score_codex":0.0014401647,"about_ca_system_score_gemma":0.0008395747,"threshold_uncertainty_score":0.9980944},"labels":[],"label_agreement":null},{"id":"W4387705970","doi":"10.1038/s41375-023-02062-0","title":"Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; University of British Columbia","funders":"Deutsche Forschungsgemeinschaft; Mitacs; Government of Canada; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Imatinib; Medicine; Imatinib mesylate; Myeloid leukemia; Oncology; Internal medicine; Receiver operating characteristic; Proportional hazards model; Tyrosine-kinase inhibitor; Biomarker; microRNA; Hazard ratio; Bioinformatics; Cancer; Biology","score_opus":0.03580934012816729,"score_gpt":0.33614623320482173,"score_spread":0.30033689307665445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387705970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674094,0.00035232125,0.00004151223,0.0006282327,0.0002774651,0.0014852551,0.00012786487,0.0001792971,0.00016711208],"genre_scores_gemma":[0.994486,0.0008309979,0.0005416046,0.00017704183,0.00013149822,0.00036022355,0.00014777374,0.000077825265,0.0032470669],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996088,0.00036284418,0.0015358564,0.0008934366,0.00047493042,0.00064493215],"domain_scores_gemma":[0.99660367,0.0016079482,0.00036071078,0.0009473428,0.00011273671,0.00036761467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022410827,0.0003539756,0.0007962135,0.000549689,0.00009669833,0.00002623214,0.00023527312,0.00038048756,0.00018888738],"category_scores_gemma":[0.002094628,0.0003365395,0.00018057888,0.0012331671,0.00021558719,0.00014375577,0.0003713657,0.00034901738,0.0005806566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006647537,0.00018231533,0.3828953,0.0005675057,0.00037110597,0.0003376315,0.0011721335,0.00042714304,0.57300967,0.000014522065,0.012034397,0.022340784],"study_design_scores_gemma":[0.00889752,0.00061756995,0.91163844,0.0006245618,0.00017432986,0.00005683015,0.00010030605,0.01128529,0.062665425,0.000029864146,0.0036380114,0.00027187553],"about_ca_topic_score_codex":0.0006545116,"about_ca_topic_score_gemma":0.00009819875,"teacher_disagreement_score":0.52874315,"about_ca_system_score_codex":0.0137266675,"about_ca_system_score_gemma":0.0023984245,"threshold_uncertainty_score":0.9999087},"labels":[],"label_agreement":null},{"id":"W4388447055","doi":"10.1038/s41375-023-02041-5","title":"PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Juravinski Cancer Centre","funders":"Else Kröner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Dr. Mildred Scheel Stiftung für Krebsforschung; European Commission","keywords":"Myeloid leukemia; Downregulation and upregulation; Biology; Cancer research; Gene knockdown; Cell biology; Biochemistry; Apoptosis","score_opus":0.01220320127860157,"score_gpt":0.27920573329759335,"score_spread":0.26700253201899177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388447055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827356,0.0027825227,0.00002892882,0.0021901922,0.00015042786,0.00091945345,0.00014787936,0.00018618933,0.005320862],"genre_scores_gemma":[0.9709765,0.0026634156,0.0020632332,0.0010055489,0.00025437327,0.00013342738,0.0001054681,0.00013116086,0.022666888],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960798,0.00017468847,0.000785368,0.0009284555,0.00092870876,0.0011029751],"domain_scores_gemma":[0.99785525,0.0003198795,0.0001879594,0.00092849956,0.00026810306,0.0004403224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008478843,0.00046204042,0.0011166038,0.0008443507,0.00012271723,0.000043545366,0.00038156653,0.00032645767,0.00014487516],"category_scores_gemma":[0.00027266878,0.0004301322,0.00020239773,0.002170996,0.000417172,0.00028441477,0.0003859928,0.00097557256,0.0003164012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008521618,0.0003232611,0.08040233,0.0029600086,0.0038413652,0.0067283623,0.053105306,0.00031767087,0.5935273,0.013021058,0.2142922,0.022959488],"study_design_scores_gemma":[0.016091535,0.00026047076,0.68288255,0.0015557973,0.0007704792,0.00020188627,0.0015775026,0.010647777,0.24864922,0.0030407463,0.032985676,0.0013363477],"about_ca_topic_score_codex":0.00097260386,"about_ca_topic_score_gemma":0.00025621723,"teacher_disagreement_score":0.60248023,"about_ca_system_score_codex":0.0022799098,"about_ca_system_score_gemma":0.0019122651,"threshold_uncertainty_score":0.99981505},"labels":[],"label_agreement":null},{"id":"W4389047718","doi":"10.1038/s41375-023-02093-7","title":"Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Daiichi Sankyo Europe; Moonshot Research and Development Program; Kobayashi Foundation for Cancer Research; Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; SGH Foundation; SENSHIN Medical Research Foundation; University of Tsukuba; Yasuda Memorial Medical Foundation; Japan Agency for Medical Research and Development","keywords":"Biology; Immune system; CD8; Phenotype; Tumor microenvironment; Follicular lymphoma; T cell; Single-cell analysis; Cell; Immunology; Cancer research; Lymphoma; Gene; Genetics","score_opus":0.016589786416554578,"score_gpt":0.23540848384223204,"score_spread":0.21881869742567744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389047718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915095,0.0033844525,0.0000050049944,0.00022248605,0.00014796742,0.0003780192,0.000020294923,0.00016934199,0.0041629397],"genre_scores_gemma":[0.99723005,0.00025931402,0.00023715581,0.0003355842,0.000105928346,0.00006674236,0.00012765832,0.00003549201,0.0016020979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986966,0.000043228523,0.00023781235,0.000405715,0.00025020738,0.00036641708],"domain_scores_gemma":[0.99921614,0.00009052625,0.00009539382,0.00037704958,0.00004954885,0.00017136162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010327576,0.00022020367,0.00031830167,0.00009135427,0.00017846402,0.000027542686,0.000063285515,0.00009782911,0.000030781215],"category_scores_gemma":[0.000029370833,0.00018416444,0.00014743474,0.0002224596,0.00006569177,0.000055911223,0.00014176984,0.000044096338,0.00061488367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016354322,0.0033437884,0.27681226,0.001386364,0.00071171543,0.0066021136,0.0020353496,0.00032402345,0.64467365,0.00037571878,0.03239833,0.029701285],"study_design_scores_gemma":[0.009089284,0.0005115088,0.31546843,0.000104316336,0.00028577144,0.00014919793,0.00009430324,0.0007622234,0.6611367,0.000069086214,0.01207183,0.00025738293],"about_ca_topic_score_codex":0.00027895742,"about_ca_topic_score_gemma":0.00004521334,"teacher_disagreement_score":0.03865617,"about_ca_system_score_codex":0.0014834543,"about_ca_system_score_gemma":0.00014073859,"threshold_uncertainty_score":0.79032904},"labels":[],"label_agreement":null},{"id":"W4389794367","doi":"10.1038/s41375-023-02107-4","title":"DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; University of Toronto; University Health Network; Institute for Research in Immunology and Cancer","funders":"Institut de Valorisation des Données; Canada First Research Excellence Fund; Université de Montréal; Government of Canada; Génome Québec; Compute Canada; Canadian Institutes of Health Research; Genome Canada","keywords":"Haploinsufficiency; Biology; Cancer research; Myeloid leukemia; Monosomy; Genetics; Transcriptome; Chromosome 7 (human); Leukemia; Gene; Chromosome; Phenotype; Gene expression; Karyotype","score_opus":0.03124381591636909,"score_gpt":0.31058397425217127,"score_spread":0.27934015833580217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389794367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885855,0.00010141149,0.00010054224,0.003651318,0.00050185114,0.0012977454,0.0000595482,0.00045699946,0.005245134],"genre_scores_gemma":[0.9859674,0.00012731257,0.0018434131,0.00090168044,0.00072612776,0.00035184668,0.00009233405,0.00011693862,0.009872972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958732,0.0001316939,0.0006843101,0.000977155,0.001034441,0.0012991886],"domain_scores_gemma":[0.99772006,0.00033020022,0.000099946345,0.0010635103,0.00021903831,0.0005672601],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034196133,0.00040006908,0.0006658914,0.0010063575,0.00017340691,0.00007699997,0.00057732995,0.00032817904,0.00014195537],"category_scores_gemma":[0.0012416926,0.00038319742,0.00016317004,0.0033672662,0.00009859999,0.00019490227,0.00032770817,0.00091156573,0.00169276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027884038,0.00041929792,0.0252631,0.0006153275,0.0001866356,0.0015476592,0.004164908,0.0013712501,0.745665,0.001129865,0.21080682,0.006041707],"study_design_scores_gemma":[0.018878443,0.001713476,0.20703325,0.0022422802,0.00022444745,0.000060707505,0.0038676488,0.0056578824,0.68512255,0.0007163613,0.07212421,0.0023587581],"about_ca_topic_score_codex":0.0012481167,"about_ca_topic_score_gemma":0.001296112,"teacher_disagreement_score":0.18177015,"about_ca_system_score_codex":0.0032649778,"about_ca_system_score_gemma":0.0018076174,"threshold_uncertainty_score":0.999862},"labels":[],"label_agreement":null},{"id":"W4389949008","doi":"10.1038/s41375-023-02110-9","title":"Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Chronic myelomonocytic leukemia; Myeloid leukemia; Internal medicine; Oncology; Myelodysplastic syndromes; Leukemia; Myeloid; Refractory (planetary science); Gastroenterology; Bone marrow; Biology","score_opus":0.021973059342996197,"score_gpt":0.30872909073866134,"score_spread":0.28675603139566513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389949008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963845,0.000047320056,0.000039011913,0.0002892903,0.00083004026,0.0019190983,0.00019198918,0.00017075373,0.00012799575],"genre_scores_gemma":[0.99442023,0.0014949037,0.00044185243,0.00026940525,0.00057725684,0.00009436184,0.0008644671,0.0001239824,0.0017135133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495775,0.0005216235,0.0016243212,0.0011226002,0.00097469636,0.00079900335],"domain_scores_gemma":[0.99616325,0.0015925481,0.0006227365,0.0007596059,0.00027176668,0.0005901033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014530782,0.0005059589,0.0012554898,0.00062617345,0.00013573987,0.000055846653,0.00023848897,0.0008156731,0.000048006375],"category_scores_gemma":[0.001361057,0.00041614173,0.00014227057,0.0011752682,0.000729903,0.0003765305,0.00039351796,0.0018559615,0.00006216083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15068236,0.00070873724,0.78887045,0.0003364415,0.00055846636,0.00036433578,0.00044542964,0.000010561018,0.0024675317,0.00004311755,0.0022818337,0.053230707],"study_design_scores_gemma":[0.12529244,0.00783745,0.8618734,0.0003692205,0.00039956885,0.000015002319,0.000039038743,0.0009985433,0.00018170686,0.000025060963,0.0025964216,0.0003721688],"about_ca_topic_score_codex":0.00020895804,"about_ca_topic_score_gemma":0.000060800798,"teacher_disagreement_score":0.07300291,"about_ca_system_score_codex":0.0011423323,"about_ca_system_score_gemma":0.002065182,"threshold_uncertainty_score":0.99982905},"labels":[],"label_agreement":null},{"id":"W4390226028","doi":"10.1038/s41375-023-02117-2","title":"Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"U.S. Food and Drug Administration; National Cancer Institute; National Institutes of Health; Universität Zürich; Mochida Memorial Foundation for Medical and Pharmaceutical Research; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Boettcher Foundation; Uehara Memorial Foundation","keywords":"GPX4; Lipid peroxidation; Mitochondrion; Apoptosis; Programmed cell death; Myeloid leukemia; Cancer research; Biology; Cell biology; Gene knockdown; Chemistry; Oxidative stress; Biochemistry","score_opus":0.017557963604489153,"score_gpt":0.2651483724861873,"score_spread":0.24759040888169812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390226028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955094,0.000081202656,0.000040669504,0.0009879278,0.00038629223,0.0005219456,0.00004199774,0.0002036578,0.002226905],"genre_scores_gemma":[0.9966484,0.00032832118,0.00049997243,0.00032457925,0.000305036,0.0001482044,0.00047518633,0.000047845933,0.0012225001],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99802977,0.000058534388,0.00060970365,0.00040825678,0.00049805024,0.0003957024],"domain_scores_gemma":[0.99908984,0.000085753505,0.00017154036,0.00038183082,0.000135202,0.00013582651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018790898,0.00021716364,0.00049532816,0.00047385087,0.000054640208,0.000016921429,0.00009822265,0.00026607316,0.00033987762],"category_scores_gemma":[0.00012688212,0.00020570887,0.00017234003,0.0016355718,0.00009993215,0.00015375446,0.000071542956,0.00029336364,0.00023674419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012690822,0.00011591693,0.041805394,0.00034538584,0.00022399155,0.000087693516,0.0013246251,0.00069873274,0.90170324,0.00040113906,0.041744597,0.010280213],"study_design_scores_gemma":[0.008666489,0.00055449,0.6717776,0.00082235294,0.00029232563,0.000028909957,0.00038149027,0.0071080625,0.30338827,0.0004704902,0.0060313023,0.00047822163],"about_ca_topic_score_codex":0.00035838108,"about_ca_topic_score_gemma":0.000080861806,"teacher_disagreement_score":0.6299722,"about_ca_system_score_codex":0.001246575,"about_ca_system_score_gemma":0.00060539023,"threshold_uncertainty_score":0.8388564},"labels":[],"label_agreement":null},{"id":"W4390348169","doi":"10.1038/s41375-023-02122-5","title":"In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tyrosine kinase; In vitro; Mutation; Pharmacology; Kinase; Tyrosine-kinase inhibitor; Protein kinase domain; Cancer research; Medicine; Biology; Biochemistry; Internal medicine; Mutant; Signal transduction","score_opus":0.023020767430470195,"score_gpt":0.29210742132784256,"score_spread":0.26908665389737235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390348169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676985,0.00012082296,0.000040927116,0.0009238703,0.00013841412,0.0017994272,0.000028699904,0.00008870763,0.00008927227],"genre_scores_gemma":[0.9969062,0.000010864354,0.0022291557,0.00010849591,0.00009386766,0.00017508441,0.0001245547,0.000070436065,0.00028130683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974854,0.00012606374,0.00063696987,0.0005353503,0.0007136593,0.0005025295],"domain_scores_gemma":[0.9976948,0.00086584524,0.0003717191,0.0007241203,0.00016665884,0.00017685643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005709885,0.0003393728,0.0006639642,0.00047764165,0.00008885457,0.000021743439,0.00023531883,0.00010966775,0.00003903458],"category_scores_gemma":[0.0007895583,0.00022266935,0.00008129242,0.0026865988,0.00017099905,0.00019002293,0.000115195806,0.00030624887,0.000045935012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023930985,0.0003880151,0.005167662,0.0009455981,0.00022656839,0.0016842631,0.0072454223,0.0034412565,0.9513072,0.00008687521,0.0012048231,0.004371352],"study_design_scores_gemma":[0.018127758,0.0027067803,0.03665418,0.0072171954,0.00037972062,0.000080579644,0.0029468618,0.0009805189,0.93041307,0.00002796691,0.000045144,0.00042023187],"about_ca_topic_score_codex":0.0005609071,"about_ca_topic_score_gemma":0.00004745386,"teacher_disagreement_score":0.03148652,"about_ca_system_score_codex":0.0022366121,"about_ca_system_score_gemma":0.0011665261,"threshold_uncertainty_score":0.90801924},"labels":[],"label_agreement":null},{"id":"W4391046269","doi":"10.1038/s41375-024-02151-8","title":"Inherent genome instability underlies trisomy 21-associated myeloid malignancies","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Hannah's Heroes Foundation; Emory University; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; Howard Hughes Medical Institute; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer; Leukemia and Lymphoma Society; National Cancer Institute; Ludwig Center at Harvard; U.S. Department of Health and Human Services","keywords":"Genome instability; Biology; Cancer research; Myeloid leukemia; Myeloid; Chromosome instability; GATA1; Aneuploidy; Genetics; Haematopoiesis; Stem cell; Chromosome; Gene; DNA damage","score_opus":0.030824037240009594,"score_gpt":0.2963716986218021,"score_spread":0.26554766138179253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391046269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96448797,0.003940888,0.00028846043,0.0028391303,0.00039009048,0.0009363805,0.00007387877,0.0008380886,0.026205115],"genre_scores_gemma":[0.97108257,0.00044917568,0.00038034745,0.00064465497,0.00035154363,0.00013066588,0.00018908893,0.00009441312,0.026677528],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969151,0.00015210683,0.0005725447,0.00073742843,0.0007808562,0.00084198907],"domain_scores_gemma":[0.99835485,0.00032356233,0.00006669892,0.0006945174,0.0002149727,0.00034541258],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00077099015,0.00037287403,0.0006032828,0.00033487988,0.00016663341,0.00016781347,0.00029970537,0.00035020337,0.0009767604],"category_scores_gemma":[0.00053313276,0.00030914505,0.00028325614,0.0010501065,0.00031798676,0.00023394295,0.00024581156,0.0010760274,0.0010596621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026015532,0.0015345705,0.061512534,0.00885405,0.0050569507,0.00747182,0.014960489,0.00049588387,0.5115695,0.019787757,0.17365839,0.1924965],"study_design_scores_gemma":[0.0078246845,0.0014515172,0.3448744,0.0013558188,0.00062459294,0.0004512195,0.0026922352,0.0081985155,0.019428449,0.0032825668,0.6082209,0.0015951272],"about_ca_topic_score_codex":0.0003104998,"about_ca_topic_score_gemma":0.00010828112,"teacher_disagreement_score":0.49214107,"about_ca_system_score_codex":0.00804082,"about_ca_system_score_gemma":0.003121748,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W4391304166","doi":"10.1038/s41375-024-02159-0","title":"Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Ponatinib; Medicine; Internal medicine; Myeloid leukemia; Oncology; Clinical trial; Dasatinib; Imatinib","score_opus":0.02249795429420004,"score_gpt":0.30090854300413006,"score_spread":0.27841058870993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391304166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887161,0.0072586546,0.00023612635,0.0006679055,0.00023863636,0.002026675,0.00035209648,0.00011207382,0.0003916894],"genre_scores_gemma":[0.9965314,0.00050050725,0.00068678695,0.00007495327,0.0003136053,0.00015751967,0.0012111651,0.000092823524,0.0004311871],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968501,0.0002332155,0.0009945721,0.00077490887,0.00065561745,0.00049161614],"domain_scores_gemma":[0.9973969,0.0010510396,0.000338274,0.00092184026,0.000117711956,0.00017423021],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007442967,0.00046060293,0.0009530262,0.00020837934,0.00008803333,0.00007755552,0.0002492443,0.00027406876,0.00018036507],"category_scores_gemma":[0.0003609467,0.00029895874,0.00015456234,0.00060998544,0.0002680815,0.0002388276,0.000106728156,0.00062713405,0.00004356421],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014749311,0.0022041656,0.11406353,0.004660702,0.005457898,0.0009523606,0.010841495,0.0075794486,0.016543001,0.011488043,0.0070332657,0.8044268],"study_design_scores_gemma":[0.12554911,0.006427001,0.48686835,0.006741677,0.002911597,0.0000921443,0.0006415344,0.3587463,0.005099499,0.0010780558,0.0044094087,0.0014353218],"about_ca_topic_score_codex":0.0023488512,"about_ca_topic_score_gemma":0.0009621798,"teacher_disagreement_score":0.80299145,"about_ca_system_score_codex":0.02069566,"about_ca_system_score_gemma":0.0049100295,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W4391559562","doi":"10.1038/s41375-024-02155-4","title":"Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Royal Victoria Regional Health Centre; London Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; McGill University; University of Ottawa; Sunnybrook Health Science Centre; Jewish General Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont; Health Sciences Centre; University Health Network; Ottawa Hospital; Western University; University of Toronto; Newfoundland and Labrador Centre for Applied Health Research","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Essential thrombocythemia; Myelofibrosis; Polycythemia vera; Internal medicine; Cohort; Population; Myeloproliferative neoplasm; Myeloid leukemia; Pediatrics; Bone marrow","score_opus":0.013928911740136649,"score_gpt":0.2933344691302155,"score_spread":0.27940555739007883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391559562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948847,0.0016685107,0.000002304486,0.00027038375,0.00016372549,0.0024689115,0.00013492144,0.000023855217,0.00038266252],"genre_scores_gemma":[0.9984249,0.0005311423,0.00016619463,0.0002874193,0.00006923082,0.00020901537,0.000053340544,0.00003933913,0.00021945674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980181,0.00010242873,0.0005342238,0.0006197254,0.00033423485,0.00039130694],"domain_scores_gemma":[0.9985515,0.00014507367,0.000100398014,0.0003022831,0.00015459114,0.0007461434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026265456,0.00034714938,0.0008972548,0.00034305226,0.000100253346,0.000054044867,0.000078251665,0.00017601102,0.000029356626],"category_scores_gemma":[0.00008858519,0.00023699632,0.000089834204,0.00023622859,0.00023468111,0.00010056555,0.000035895886,0.00036198934,0.0000045614483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036130854,0.00023432855,0.98598486,0.00038151088,0.0011837113,0.0009332488,0.0026717256,3.3084083e-7,0.0000057745538,0.00015788079,0.0002171489,0.007868173],"study_design_scores_gemma":[0.0039090435,0.0021971343,0.99058867,0.0014607247,0.0006434354,0.00020187418,0.00062396884,0.000043068972,0.00007507338,0.000008689938,0.000043978074,0.00020432836],"about_ca_topic_score_codex":0.36761352,"about_ca_topic_score_gemma":0.9451145,"teacher_disagreement_score":0.57750094,"about_ca_system_score_codex":0.00044320305,"about_ca_system_score_gemma":0.0014807655,"threshold_uncertainty_score":0.96644294},"labels":[],"label_agreement":null},{"id":"W4391840358","doi":"10.1038/s41375-024-02166-1","title":"Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Seattle Children's Research Institute; Children's Hospital of Philadelphia; St. Baldrick's Foundation; St. Jude Children's Research Hospital; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Cog; Risk stratification; Medicine; Oncology; Internal medicine; Lymphoblastic Leukemia; Categorical variable; Risk assessment; Proportional hazards model; Leukemia; Machine learning; Artificial intelligence; Computer science","score_opus":0.006122668115488886,"score_gpt":0.26323771332275137,"score_spread":0.25711504520726247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391840358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94060785,0.00071143056,0.052469276,0.00022309879,0.00030208306,0.002870389,0.00024751155,0.00041180366,0.002156552],"genre_scores_gemma":[0.9868915,0.00064963364,0.007030755,0.00014890936,0.00068811874,0.00063605845,0.0014267883,0.00015633952,0.002371878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961949,0.00009380358,0.0007567305,0.0014354693,0.00067804626,0.0008410735],"domain_scores_gemma":[0.99770236,0.00049431477,0.00028861864,0.0008085724,0.00025364346,0.00045251107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005517553,0.0005262931,0.00071441534,0.0003323892,0.0002585973,0.00015817652,0.00025183876,0.0005132646,0.0000473049],"category_scores_gemma":[0.00027085884,0.00041238707,0.00017201959,0.00054381497,0.00035302632,0.00028507455,0.00011624877,0.00074677466,0.000076302116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048769288,0.002448872,0.07255333,0.00649771,0.016265709,0.014392514,0.018463051,0.0010965265,0.26768738,0.0066105304,0.11476388,0.4304512],"study_design_scores_gemma":[0.09680446,0.022861224,0.58037806,0.0038486954,0.011134714,0.08300781,0.0011329126,0.12154933,0.07113363,0.0016445325,0.0025730338,0.0039315815],"about_ca_topic_score_codex":0.0011611007,"about_ca_topic_score_gemma":0.00024149324,"teacher_disagreement_score":0.5078247,"about_ca_system_score_codex":0.006932168,"about_ca_system_score_gemma":0.005081573,"threshold_uncertainty_score":0.9998328},"labels":[],"label_agreement":null},{"id":"W4392298541","doi":"10.1038/s41375-024-02191-0","title":"Nucleic acid therapeutics as differentiation agents for myeloid leukemias","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nucleic acid; Myeloid leukemia; Biology; Acute promyelocytic leukemia; Leukemia; Myeloid; Cancer research; Immunology; Gene; Retinoic acid; Genetics","score_opus":0.0401082372443879,"score_gpt":0.33620798485267117,"score_spread":0.2960997476082833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392298541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721321,0.0021710766,0.005694266,0.0038984339,0.0011011175,0.001826448,0.00006446202,0.0007960263,0.012316106],"genre_scores_gemma":[0.96695745,0.0005252017,0.0014332142,0.002813955,0.0010107346,0.0002227528,0.00032510053,0.00017316874,0.02653843],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752045,0.000057525922,0.00042843426,0.0006582238,0.00062432804,0.00071102584],"domain_scores_gemma":[0.99866176,0.00022440562,0.00006138806,0.00060496846,0.00017655488,0.00027093117],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034052864,0.00034626498,0.0004124471,0.00032988365,0.00017559878,0.00019144709,0.00028590707,0.00034571285,0.00062947423],"category_scores_gemma":[0.00013994325,0.00029168083,0.00032371568,0.00050424825,0.00011121353,0.00021674186,0.00011377975,0.0006792496,0.0014192294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018503556,0.00024203515,0.0025391458,0.002975875,0.0022102029,0.0006710396,0.0037956156,0.000060258943,0.5132421,0.0220174,0.15740445,0.29299152],"study_design_scores_gemma":[0.006800914,0.0012355911,0.013741794,0.0007327449,0.0009873646,0.00046101346,0.00044127842,0.10185841,0.1468105,0.0060088444,0.72002125,0.00090032676],"about_ca_topic_score_codex":0.00006797386,"about_ca_topic_score_gemma":0.0000081552425,"teacher_disagreement_score":0.56261677,"about_ca_system_score_codex":0.003897094,"about_ca_system_score_gemma":0.0017695718,"threshold_uncertainty_score":0.9999535},"labels":[],"label_agreement":null},{"id":"W4392348082","doi":"10.1038/s41375-024-02201-1","title":"Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol","year":2024,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb Canada; Otsuka America Pharmaceutical; Jazz Pharmaceuticals; Novartis Pharmaceuticals Corporation; Takeda Pharmaceuticals U.S.A.","keywords":"Lymphoblastic Leukemia; Medicine; Asparaginase; Acute lymphocytic leukemia; Leukemia; Hematology; Pediatrics; Internal medicine; Oncology","score_opus":0.016249767174672452,"score_gpt":0.2740317495823974,"score_spread":0.25778198240772493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392348082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67122585,0.000044780678,0.002804256,0.029422918,0.000500977,0.27900094,0.0011222911,0.0028396575,0.013038342],"genre_scores_gemma":[0.38116407,0.000018101793,0.00313589,0.17488942,0.0076736766,0.37541267,0.019295944,0.0032441888,0.035166048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98957485,0.0002862325,0.001320514,0.0027464658,0.0037516598,0.002320278],"domain_scores_gemma":[0.9948366,0.00047395428,0.0007569792,0.0019986683,0.0012184781,0.0007152734],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00028142543,0.0020972805,0.002296887,0.0013592239,0.00039850236,0.00041093607,0.0008624642,0.0021489738,0.0003005741],"category_scores_gemma":[0.0001360297,0.001438308,0.00038005132,0.0018267364,0.0009398563,0.00045099712,0.00054010167,0.0049933093,0.00066938775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014245713,0.00028107053,0.011234285,0.0076659387,0.00356837,0.033563323,0.0006044568,0.00039716144,0.00006840956,0.000017853441,0.9274237,0.0009296948],"study_design_scores_gemma":[0.26777643,0.022186637,0.13201167,0.09144555,0.018219221,0.0069086044,0.00023552022,0.14365627,0.0019046516,0.00019959251,0.30291873,0.01253711],"about_ca_topic_score_codex":0.0018971427,"about_ca_topic_score_gemma":0.0000853852,"teacher_disagreement_score":0.624505,"about_ca_system_score_codex":0.028346984,"about_ca_system_score_gemma":0.008354795,"threshold_uncertainty_score":0.99917686},"labels":[],"label_agreement":null},{"id":"W4392590850","doi":"10.1038/s41375-024-02202-0","title":"Correction: Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia","year":2024,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Cancer Prevention and Research Institute of Texas","keywords":"Myeloid leukemia; Leukemia; Myeloid; Cancer research; Biology; Medicine; Immunology","score_opus":0.012345268916425439,"score_gpt":0.2565863285531751,"score_spread":0.24424105963674966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392590850","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21358076,0.018655991,0.00029550778,0.0061686197,0.42392224,0.0073692417,0.0014442625,0.0018222921,0.32674107],"genre_scores_gemma":[0.23250604,0.008711187,0.0008207199,0.0013119618,0.016384536,0.0010967153,0.013487317,0.0006120225,0.7250695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583346,0.00011205909,0.001349686,0.0010728237,0.0010463871,0.00058559945],"domain_scores_gemma":[0.9980259,0.000106362175,0.0005154975,0.0007715649,0.00035215874,0.00022852934],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00021495011,0.00070161576,0.001462943,0.0010001791,0.00008050562,0.00007309037,0.0002032556,0.0017637665,0.0010785917],"category_scores_gemma":[0.00019786811,0.00067059335,0.0005750216,0.0016672913,0.00020105526,0.00018577925,0.00014977148,0.0025966736,0.00030613344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005882509,0.00007500075,0.00033120107,0.0010235044,0.00040023559,0.000092138216,0.00039557664,0.00005611875,0.009111407,0.000038110025,0.984354,0.0035344097],"study_design_scores_gemma":[0.0069410373,0.0015165133,0.027104577,0.017508049,0.0034430826,0.0002968472,0.00036780906,0.010235683,0.030320052,0.00037205417,0.9001236,0.0017707286],"about_ca_topic_score_codex":0.00094547897,"about_ca_topic_score_gemma":0.00042735215,"teacher_disagreement_score":0.40753773,"about_ca_system_score_codex":0.006023404,"about_ca_system_score_gemma":0.0042151674,"threshold_uncertainty_score":0.99983454},"labels":[],"label_agreement":null},{"id":"W4392614927","doi":"10.1038/s41375-024-02210-0","title":"Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier","year":2024,"lang":"en","type":"letter","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Simon Fraser University; Terry Fox Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; National Cancer Institute; BC Cancer Foundation; University of British Columbia; Deutsche Forschungsgemeinschaft; Michael Smith Health Research BC; Leukemia and Lymphoma Society of Canada; Simon Fraser University; Cancer Prevention and Research Institute of Texas","keywords":"APOBEC; Multiple myeloma; Classifier (UML); Inflammation; Medicine; Biology; Internal medicine; Genetics; Computer science; Genome; Gene; Artificial intelligence","score_opus":0.026128593397258114,"score_gpt":0.2744422811506523,"score_spread":0.24831368775339416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392614927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5254866,0.00089479133,0.00089686626,0.4439023,0.0013851057,0.004865153,0.0017103315,0.0021476855,0.01871115],"genre_scores_gemma":[0.6609839,0.00016785489,0.027901368,0.22024591,0.017856197,0.0015564825,0.029546233,0.001125199,0.040616825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958999,0.00021040002,0.0005169767,0.001128729,0.0012918314,0.00095212675],"domain_scores_gemma":[0.997328,0.00052206806,0.00025699518,0.0012927796,0.00022100189,0.00037916965],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023268192,0.00071638194,0.0008263228,0.00053056434,0.00023708641,0.00020811953,0.00028292462,0.0010546175,0.00051975244],"category_scores_gemma":[0.00027042784,0.00051529217,0.00024809252,0.00040369635,0.00019137317,0.0001397571,0.000067715344,0.0035836326,0.0012700368],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019973402,0.00009078314,0.028528016,0.0016160267,0.0017660983,0.024035655,0.00022762877,0.00021412483,0.00023407,0.000037760252,0.8957528,0.04549968],"study_design_scores_gemma":[0.011821913,0.0022201652,0.032451402,0.0020533476,0.0011441227,0.00020883993,0.000057145575,0.03335653,0.0023451142,0.00022257271,0.9129964,0.0011224179],"about_ca_topic_score_codex":0.002498828,"about_ca_topic_score_gemma":0.0004609844,"teacher_disagreement_score":0.2236564,"about_ca_system_score_codex":0.0017016352,"about_ca_system_score_gemma":0.0019502911,"threshold_uncertainty_score":0.9997299},"labels":[],"label_agreement":null},{"id":"W4393097001","doi":"10.1038/s41375-024-02221-x","title":"The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; BC Children's Hospital","funders":"Michael Cuccione Foundation; Government of Canada; CIHR Skin Research Training Centre; Leukemia and Lymphoma Society of Canada","keywords":"Aneuploidy; Biology; Leukemia; Trisomy; Cancer research; Population; Preleukemia; Immunology; Genetics; Medicine; Gene; Chromosome","score_opus":0.019134441986378963,"score_gpt":0.2761657624896823,"score_spread":0.2570313205033033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393097001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94789904,0.0020841034,0.026507664,0.0015723715,0.00056126516,0.0012242977,0.00049222744,0.00058093644,0.019078096],"genre_scores_gemma":[0.93612576,0.0008418792,0.0034032078,0.001260278,0.0003918423,0.0001291891,0.00005334536,0.0002246067,0.057569917],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956026,0.000039524195,0.0008763257,0.00088558457,0.0014792336,0.0011167035],"domain_scores_gemma":[0.9967463,0.0009145411,0.00014716209,0.0013764941,0.00033751913,0.00047799555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005406285,0.0005538596,0.00073256996,0.00032402185,0.00027502666,0.00015550005,0.0007886062,0.0004242292,0.00012229619],"category_scores_gemma":[0.00025459772,0.00037694658,0.00047047262,0.00090081006,0.0005757207,0.00022630034,0.00046268498,0.0008556714,0.0006721122],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013313746,0.00019798877,0.00011821059,0.0012861559,0.0012168123,0.00030956225,0.0019891355,0.004836322,0.85437566,0.0048789615,0.12599374,0.0034660741],"study_design_scores_gemma":[0.005350274,0.00038470497,0.000068890826,0.0003827022,0.00070311956,0.00040876537,0.00020259994,0.87200576,0.109482594,0.00078274874,0.009774808,0.0004530405],"about_ca_topic_score_codex":0.00022247234,"about_ca_topic_score_gemma":0.000011567444,"teacher_disagreement_score":0.86716944,"about_ca_system_score_codex":0.007310491,"about_ca_system_score_gemma":0.010259433,"threshold_uncertainty_score":0.9998683},"labels":[],"label_agreement":null},{"id":"W4393220438","doi":"10.1038/s41375-024-02231-9","title":"Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Internal medicine; Chemotherapy; Gastroenterology; Rituximab; Aggressive lymphoma; Oncology; Surgery","score_opus":0.009715735242453978,"score_gpt":0.2747426015366222,"score_spread":0.2650268662941682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393220438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034107,0.005896592,0.000009121762,0.0006484444,0.00058308296,0.0013919652,0.00023746124,0.000081388986,0.00081085885],"genre_scores_gemma":[0.9966655,0.00064041157,0.00020324493,0.0007144268,0.0004518933,0.00022369227,0.00062866596,0.00004839401,0.00042376638],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833155,0.00006724064,0.0003727413,0.0005351253,0.0003868706,0.00030645213],"domain_scores_gemma":[0.99876434,0.00040371338,0.00014482344,0.0005219405,0.000047353966,0.000117855925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095800475,0.00027725523,0.00036432734,0.000075457196,0.000064254265,0.000082928265,0.00013117195,0.00011122258,0.00006954937],"category_scores_gemma":[0.00005719012,0.00014942496,0.00012313717,0.0002599772,0.00007020399,0.00016549378,0.000023313756,0.0001270202,0.000055998553],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25481436,0.00778465,0.08535954,0.00008660205,0.0009306892,0.004992228,0.0040971865,0.000053142976,0.0004751688,0.00007246102,0.005901663,0.6354323],"study_design_scores_gemma":[0.71093136,0.0029238279,0.27507713,0.001288673,0.0002944238,0.000014615271,0.000042302465,0.00023810228,0.0024447008,0.00002983097,0.0064107818,0.0003042225],"about_ca_topic_score_codex":0.0003841162,"about_ca_topic_score_gemma":0.000056375895,"teacher_disagreement_score":0.6351281,"about_ca_system_score_codex":0.001619628,"about_ca_system_score_gemma":0.00048428756,"threshold_uncertainty_score":0.6093373},"labels":[],"label_agreement":null},{"id":"W4393317016","doi":"10.1038/s41375-024-02232-8","title":"The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of General Medical Sciences; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Progenitor cell; Biology; Progenitor; Immunology; Hematology; Cancer research; Stem cell; Medicine; Cell biology","score_opus":0.012170754481678904,"score_gpt":0.2865384473150275,"score_spread":0.27436769283334855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393317016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877106,0.002986656,0.000016838252,0.0009252926,0.00031459206,0.0007311179,0.000005570493,0.000103808125,0.0072055445],"genre_scores_gemma":[0.99803853,0.0001878546,0.00012661106,0.00013010378,0.00028933058,0.000092073686,0.000008867066,0.000050722167,0.00107589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979931,0.0000540368,0.0004276613,0.0003646741,0.0006200762,0.0005404226],"domain_scores_gemma":[0.9989526,0.00027850678,0.000052311196,0.00049902906,0.00007673759,0.00014077287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003970587,0.0001967864,0.00030585038,0.00014828799,0.0000513283,0.000046688016,0.00029831723,0.00016318852,0.00003731899],"category_scores_gemma":[0.00019003177,0.00013055564,0.00012925416,0.00057956,0.00015279281,0.000079773345,0.00012535039,0.0005431979,0.000161271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009764987,0.00018617626,0.008925294,0.0009621255,0.00038643624,0.0006845479,0.003260627,0.000056922014,0.8038748,0.0035690044,0.004891832,0.17222574],"study_design_scores_gemma":[0.005292206,0.0006352427,0.016766695,0.0019320803,0.00016071681,0.0004568502,0.0016714709,0.093416706,0.76947707,0.002162715,0.10747603,0.00055222044],"about_ca_topic_score_codex":0.00046557104,"about_ca_topic_score_gemma":0.000056529592,"teacher_disagreement_score":0.17167352,"about_ca_system_score_codex":0.0027077945,"about_ca_system_score_gemma":0.0021528974,"threshold_uncertainty_score":0.70807886},"labels":[],"label_agreement":null},{"id":"W4393948046","doi":"10.1038/s41375-024-02239-1","title":"High-plex imaging and cellular neighborhood spatial analysis reveals multiple immune escape and suppression patterns in diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"letter","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Terry Fox Research Institute","funders":"BC Cancer Foundation; Terry Fox Research Institute","keywords":"Lymphoma; Immune system; Biology; Diffuse large B-cell lymphoma; Immune escape; Immunology; Cancer research","score_opus":0.00595107593452828,"score_gpt":0.21825239909151986,"score_spread":0.21230132315699157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393948046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479028,0.01145907,0.0000990442,0.03845148,0.00042697394,0.0007925369,0.00061020703,0.000104594874,0.00015326425],"genre_scores_gemma":[0.95878446,0.0010994211,0.00011975385,0.0343584,0.0010198844,0.00014306995,0.00339353,0.00012507127,0.00095638126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670076,0.00014927729,0.0007464037,0.0011850693,0.0004909062,0.00072758034],"domain_scores_gemma":[0.9984397,0.0002835251,0.00024157896,0.00080180616,0.00004850535,0.00018482812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018214257,0.00072199514,0.0014556949,0.0007490196,0.00010123623,0.00017878982,0.00014992425,0.00063455326,0.00015639268],"category_scores_gemma":[0.000037120764,0.00057733,0.00035703936,0.00038934092,0.000060996386,0.0001031372,0.00034424404,0.0006458608,0.000039236304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017075417,0.0019318813,0.8394223,0.0024698188,0.0018098385,0.02098487,0.0008020734,0.000002988651,0.003504777,0.000009999091,0.118493944,0.010396753],"study_design_scores_gemma":[0.080708034,0.00033435784,0.8094883,0.0034061067,0.014438467,0.00020438022,0.00020348457,0.018045759,0.012537642,0.00019709143,0.058500152,0.0019362437],"about_ca_topic_score_codex":0.0062246094,"about_ca_topic_score_gemma":0.0002026257,"teacher_disagreement_score":0.08053728,"about_ca_system_score_codex":0.0009852047,"about_ca_system_score_gemma":0.00015934499,"threshold_uncertainty_score":0.9996678},"labels":[],"label_agreement":null},{"id":"W4394872794","doi":"10.1038/s41375-024-02250-6","title":"Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Fonds Léon Fredericq; Koning Boudewijnstichting; Leukemia and Lymphoma Society; Cancer Research Society; Fonds De La Recherche Scientifique - FNRS","keywords":"Autophagy; Myeloid leukemia; Biology; Myeloid; Downregulation and upregulation; Cancer research; Immune system; Innate immune system; Leukemia; Antigen; Cytotoxic T cell; CD8; Immunology; Apoptosis; Genetics; Gene","score_opus":0.016776492747696888,"score_gpt":0.2621263199802574,"score_spread":0.24534982723256055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394872794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979672,0.01779556,0.0003645248,0.000055599055,0.00039923802,0.00026278713,0.000057413563,0.000050824085,0.0013420277],"genre_scores_gemma":[0.9946262,0.0026551958,0.00036236498,0.00011603143,0.00020912578,0.000055598193,0.0005838779,0.000062028535,0.0013295483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819744,0.00010413707,0.00041738694,0.00059420045,0.00021851885,0.00046832065],"domain_scores_gemma":[0.99932504,0.000026450876,0.00006880566,0.00043892473,0.00004113857,0.000099669036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035782877,0.0002764973,0.00022142896,0.00012340308,0.00007831164,0.00008940705,0.00028879754,0.0003107086,0.000051424933],"category_scores_gemma":[0.000055345794,0.0002775898,0.00013362868,0.00029977396,0.0000407189,0.000010736372,0.00014249764,0.00027303625,0.00006668456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056462242,0.000017621805,0.00069102447,0.000026770174,0.00012622905,0.000036614863,0.0000817357,0.0000520873,0.9887643,0.00004926644,0.00068535685,0.009412574],"study_design_scores_gemma":[0.0007125256,0.00031267662,0.00319829,0.000035333225,0.00004396574,0.00001588083,0.000022453652,0.00048331748,0.9719095,0.00022014228,0.02273126,0.00031461444],"about_ca_topic_score_codex":0.0002034961,"about_ca_topic_score_gemma":0.00007105132,"teacher_disagreement_score":0.022045903,"about_ca_system_score_codex":0.0005976194,"about_ca_system_score_gemma":0.0005019212,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W4395689019","doi":"10.1038/s41375-024-02254-2","title":"The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MSD K.K.; Bristol-Myers Squibb Canada; Sanofi-Aventis Korea Company; Servier; Miltenyi Biotec; Takeda Pharmaceutical Company; AbbVie; Janssen Pharmaceuticals; Gilead Sciences; Roche; Novartis; Merck; GlaxoSmithKline; Celgene; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Falk Foundation","keywords":"Mantle cell lymphoma; Medicine; Bortezomib; Leukocytopenia; Internal medicine; Cytarabine; Rituximab; Autologous stem-cell transplantation; Neutropenia; Oncology; Gastroenterology; Surgery; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.018981698256178164,"score_gpt":0.28300044277037933,"score_spread":0.26401874451420115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395689019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458356,0.0037511021,0.00002525338,0.0005500569,0.000796254,0.0034573714,0.00011219312,0.000038759023,0.006685424],"genre_scores_gemma":[0.9933756,0.001768723,0.0006886835,0.00030593094,0.00035497535,0.00029211614,0.00007187969,0.000070317146,0.0030717778],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968788,0.0007623877,0.0010068149,0.00053117773,0.00041471748,0.00040609136],"domain_scores_gemma":[0.99700475,0.0016311574,0.00033938437,0.0007809355,0.00007695063,0.00016684821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018936911,0.00034435815,0.0010921246,0.00011528853,0.00015739998,0.00008602094,0.000377935,0.00012964288,0.00009145386],"category_scores_gemma":[0.00021677866,0.00018311595,0.00018150423,0.00056762865,0.00023890329,0.000106795414,0.00031962682,0.00013261488,0.000044229273],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7881023,0.010293923,0.0000739894,0.00037295918,0.00043850526,0.00075397047,0.00092234317,0.000048563827,0.0040776157,0.00056376244,0.036444847,0.15790717],"study_design_scores_gemma":[0.97059804,0.0016975654,0.0012412827,0.00082534354,0.0006650741,0.000036534693,0.00011416099,0.00093015406,0.01034968,0.00018513318,0.013135093,0.00022190744],"about_ca_topic_score_codex":0.0012413552,"about_ca_topic_score_gemma":0.00016070234,"teacher_disagreement_score":0.18249571,"about_ca_system_score_codex":0.0007236865,"about_ca_system_score_gemma":0.00069922424,"threshold_uncertainty_score":0.7467252},"labels":[],"label_agreement":null},{"id":"W4399459365","doi":"10.1038/s41375-024-02280-0","title":"Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms","year":2024,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; University of Alberta; University of Manitoba; CancerCare Manitoba","funders":"Università degli Studi di Perugia; Medical Center, University of Rochester; Skånes universitetssjukhus; Universität Zürich; Uniwersytet Łódzki; Ohio State University; Queen's University; Monash University; University of Southampton; Peter MacCallum Cancer Centre; Università degli Studi di Siena; University of Alberta; Northwell Health; Lunds Universitet; National Cancer Institute; University of Rochester; University of Texas MD Anderson Cancer Center; Northwestern University; Memorial Sloan-Kettering Cancer Center","keywords":"Hairy cell leukemia; Leukemia; Medicine; Pathology; Biology; Immunology","score_opus":0.03488911613471097,"score_gpt":0.29381392581385446,"score_spread":0.2589248096791435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399459365","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11731691,0.021993114,0.012102571,0.66179276,0.021911798,0.019500196,0.002433502,0.0062279436,0.1367212],"genre_scores_gemma":[0.14687532,0.009046365,0.0029693665,0.41835827,0.03755618,0.003214554,0.015356268,0.002350658,0.36427304],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98898274,0.00056613993,0.002063228,0.0032608048,0.003174393,0.001952708],"domain_scores_gemma":[0.9935591,0.0010315441,0.0010028573,0.003016854,0.00066804397,0.00072155264],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00135701,0.0016163366,0.0021392356,0.0014054485,0.0004768437,0.00078416907,0.0010593014,0.0035859335,0.0005585429],"category_scores_gemma":[0.0006707629,0.0015372274,0.00055004057,0.001585394,0.0009785923,0.0006852544,0.00055273256,0.0047304532,0.0024428456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00058383046,0.000060887996,0.000078946694,0.005824929,0.00018405034,0.0077890335,0.0007317928,0.00001781863,0.0034638003,0.00040794178,0.9777115,0.0031454451],"study_design_scores_gemma":[0.012310283,0.00054852734,0.0007260372,0.006932402,0.001108281,0.012964487,0.0004866608,0.25514328,0.004611841,0.0006220782,0.7026483,0.0018978358],"about_ca_topic_score_codex":0.0018318633,"about_ca_topic_score_gemma":0.000074380936,"teacher_disagreement_score":0.27506325,"about_ca_system_score_codex":0.10402363,"about_ca_system_score_gemma":0.049960565,"threshold_uncertainty_score":0.9996584},"labels":[],"label_agreement":null},{"id":"W4399740140","doi":"10.1038/s41375-024-02309-4","title":"Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis","year":2024,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple myeloma; Amyloidosis; Medicine; Pathology; AL amyloidosis; Plasma cell; Primary systemic amyloidosis; Internal medicine; Oncology; Immunology; Systemic disease; Immunopathology; Antibody; Immunoglobulin light chain","score_opus":0.0067980464792902215,"score_gpt":0.2078033948761539,"score_spread":0.20100534839686368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399740140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065133,0.043926276,0.000025527073,0.00016613203,0.032212645,0.0013145083,0.0007028942,0.00012183493,0.01501693],"genre_scores_gemma":[0.7573268,0.008028237,0.000048084185,0.00031802678,0.00028721467,0.00028555706,0.0015512864,0.00020511707,0.23194969],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740833,0.00015015907,0.00058334845,0.0010642178,0.00031393865,0.00048003337],"domain_scores_gemma":[0.99858844,0.00013231057,0.00048805936,0.0005669618,0.00010125651,0.00012298401],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017594929,0.00068580464,0.00089374126,0.00022167893,0.000047846966,0.000028803908,0.00029457046,0.0011137088,0.000014485419],"category_scores_gemma":[0.00013633889,0.000638643,0.00024394509,0.00020842852,0.00021750807,0.000008973621,0.00020067039,0.0007328116,0.000011085349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021449155,0.00014852325,0.034306366,0.0004405483,0.0006958208,0.000023979228,0.00039842658,0.000021192303,0.028088454,6.996829e-7,0.93461746,0.0010440316],"study_design_scores_gemma":[0.010864322,0.0024093087,0.05851924,0.003095896,0.00153804,0.000053243934,0.0020000152,0.0051820152,0.020676339,0.000008032232,0.8924778,0.003175724],"about_ca_topic_score_codex":0.0022230507,"about_ca_topic_score_gemma":0.0061643594,"teacher_disagreement_score":0.21693276,"about_ca_system_score_codex":0.002496145,"about_ca_system_score_gemma":0.0016395815,"threshold_uncertainty_score":0.9996065},"labels":[],"label_agreement":null},{"id":"W4400259216","doi":"10.1038/s41375-024-02306-7","title":"Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100","year":2024,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Proteinuria; Multiple myeloma; Asymptomatic; Immunoglobulin light chain; Medicine; Internal medicine; Monoclonal; Oncology; Immunology; Monoclonal antibody; Antibody; Kidney","score_opus":0.011684794658361837,"score_gpt":0.27594138818056174,"score_spread":0.2642565935221999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400259216","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4013916,0.054438643,0.0013198706,0.010202954,0.10848762,0.08060063,0.0027088746,0.0065694107,0.3342804],"genre_scores_gemma":[0.1952702,0.0009089788,0.004756168,0.00014740111,0.0072642495,0.008318246,0.004384335,0.00062334037,0.7783271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950846,0.000283411,0.0007660465,0.001230796,0.0016632153,0.00097194046],"domain_scores_gemma":[0.99739933,0.00019411976,0.00037053225,0.0012716929,0.00020764997,0.0005566583],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00040885198,0.0008589092,0.0011133349,0.000778256,0.00020075189,0.00017259442,0.00039416715,0.0009941661,0.00026460877],"category_scores_gemma":[0.0009908357,0.0005927012,0.00023999858,0.00094093214,0.00015053467,0.00017529217,0.00025777504,0.0034243865,0.0004046572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026227538,0.00049707585,0.027151696,0.0023567993,0.00095928623,0.005370275,0.00092175335,0.000032168526,0.00012255741,0.000008088566,0.9259337,0.034023844],"study_design_scores_gemma":[0.038925752,0.0093027875,0.23032935,0.055271596,0.0016216128,0.0018264333,0.0003611762,0.31618485,0.004101199,0.0004119527,0.33932132,0.0023420006],"about_ca_topic_score_codex":0.0010518989,"about_ca_topic_score_gemma":0.0028111718,"teacher_disagreement_score":0.5866124,"about_ca_system_score_codex":0.0029300004,"about_ca_system_score_gemma":0.0039400877,"threshold_uncertainty_score":0.99965245},"labels":[],"label_agreement":null},{"id":"W4400452962","doi":"10.1038/s41375-024-02330-7","title":"Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"GlaxoSmithKline","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Myeloproliferative neoplasm; Context (archaeology); Extramedullary hematopoiesis; Anemia; Clinical trial; Population; Internal medicine; Intensive care medicine; Bone marrow; Haematopoiesis; Stem cell","score_opus":0.019302411383895744,"score_gpt":0.3254109324200806,"score_spread":0.30610852103618486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400452962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95487267,0.00020750858,0.00018982863,0.012470221,0.00023073042,0.002007874,0.0002483037,0.0001290327,0.029643824],"genre_scores_gemma":[0.97027475,0.00014671168,0.026694711,0.0017892547,0.00010655491,0.00044239496,0.00033218617,0.000032430296,0.00018098761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980285,0.00015719171,0.00046888407,0.00065653166,0.00040877805,0.00028008915],"domain_scores_gemma":[0.99856067,0.000714728,0.00010506008,0.00036026887,0.00009144701,0.00016783108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002122673,0.00027543996,0.00041481477,0.00008449291,0.00006593479,0.00008382854,0.00006919849,0.0000944875,0.00013983411],"category_scores_gemma":[0.000095413154,0.00017803056,0.000070214235,0.0004371505,0.00006422865,0.000100327474,0.000051992665,0.0003014611,0.00018197218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008549584,0.0030419999,0.7860738,0.00008962157,0.0022368182,0.0027218345,0.0004102256,0.00003378456,0.0000015171752,0.011490053,0.01145068,0.17390007],"study_design_scores_gemma":[0.01609789,0.0047956933,0.9293211,0.0019095755,0.0010352274,0.00004154353,0.00046055164,0.00033902007,0.000044618675,0.00030575646,0.04531032,0.0003386896],"about_ca_topic_score_codex":0.00077193003,"about_ca_topic_score_gemma":0.0008035175,"teacher_disagreement_score":0.17356136,"about_ca_system_score_codex":0.0011898844,"about_ca_system_score_gemma":0.00019547706,"threshold_uncertainty_score":0.72598755},"labels":[],"label_agreement":null},{"id":"W4401431750","doi":"10.1038/s41375-024-02325-4","title":"GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Hospital for Sick Children; Leukemia and Lymphoma Society of Canada","keywords":"GNAS complex locus; HDAC3; Biology; Cancer research; Molecular mimicry; Histone deacetylase; Genetics; Histone; Immune system; Gene","score_opus":0.0105947287563996,"score_gpt":0.24188752115100087,"score_spread":0.23129279239460127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778192,0.0061404677,0.00016412554,0.00046780874,0.0069316556,0.00017127275,0.0000066969956,0.000311194,0.007987572],"genre_scores_gemma":[0.9510288,0.00021427627,0.00001862126,0.00035442988,0.000040025203,0.00002315171,0.00028020062,0.000029170786,0.04801128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998594,0.00024706972,0.00043605262,0.00037202064,0.000034096574,0.00031678224],"domain_scores_gemma":[0.99956596,0.00012480632,0.00006324787,0.00019989542,0.000034630975,0.000011432174],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018064676,0.00020789693,0.00020944851,0.0002652063,0.00010726091,0.0000621974,0.000095090225,0.00038378956,0.0021048307],"category_scores_gemma":[0.000057629717,0.00019254324,0.00013453116,0.00023751409,0.00010698094,0.0004440937,0.000068019755,0.0004261778,0.0051541603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010423827,0.00007621979,0.00012306085,0.00004106944,0.00012698834,0.000059492773,0.0016954866,0.000021599008,0.95492285,0.0020390998,0.03043243,0.009419341],"study_design_scores_gemma":[0.0023495224,0.0004429443,0.004299777,0.00060588535,0.000058518184,0.00047198974,0.0007869743,0.0002588743,0.7129642,0.0012293102,0.27614057,0.00039144486],"about_ca_topic_score_codex":0.00048662024,"about_ca_topic_score_gemma":0.000037581005,"teacher_disagreement_score":0.24570815,"about_ca_system_score_codex":0.0006807166,"about_ca_system_score_gemma":0.0001315041,"threshold_uncertainty_score":0.9988074},"labels":[],"label_agreement":null},{"id":"W4401542936","doi":"10.1038/s41375-024-02367-8","title":"Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Agricultural Research Institute of Ontario; University of Toronto; National Research Council Canada; AGADA Biosciences; University of Ottawa","funders":"CIHR Skin Research Training Centre; Government of Canada; Terry Fox Foundation; Leukemia and Lymphoma Society of Canada; University of Ottawa; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Zebrafish; Biology; Diamond–Blackfan anemia; GATA1; Cytopenia; Myeloid; Genetics; Mutation; Mutant; Phenotype; Haematopoiesis; Cancer research; Cell biology; Bone marrow; Stem cell; Gene; Immunology; RNA","score_opus":0.006466452706737296,"score_gpt":0.2410408821191135,"score_spread":0.23457442941237622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401542936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943491,0.00389895,0.000038608538,0.00018573199,0.000110760506,0.0001536499,0.000025468451,0.000008140964,0.001229572],"genre_scores_gemma":[0.9985125,0.00020826372,0.0003656243,0.00026330046,0.00006649212,0.000023208931,0.000026282209,0.000017278655,0.0005170523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937624,0.000018092504,0.00013638359,0.0002615514,0.00005937922,0.00014835907],"domain_scores_gemma":[0.9997366,0.000005776263,0.000015851683,0.000171428,0.000013853898,0.00005649347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053267675,0.000104376246,0.00014523487,0.000049970164,0.0000141987175,0.0000224664,0.000082389524,0.00007501138,0.000017778424],"category_scores_gemma":[0.000012816077,0.000094458286,0.000041857696,0.000104187784,0.000033607506,0.000004105869,0.00008453104,0.00005189237,0.000014692186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021152454,0.00014747532,0.03556717,0.00018350226,0.00025976825,0.000111310546,0.0005083635,0.00011082224,0.9127277,0.0014888931,0.009116734,0.0395667],"study_design_scores_gemma":[0.002727728,0.00034398396,0.08251669,0.00015145897,0.00010750205,0.00003599825,0.000090398804,0.000115877985,0.7922866,0.00095693883,0.12021683,0.00044998608],"about_ca_topic_score_codex":0.00016586136,"about_ca_topic_score_gemma":0.00023226345,"teacher_disagreement_score":0.12044114,"about_ca_system_score_codex":0.000015211786,"about_ca_system_score_gemma":0.00006448248,"threshold_uncertainty_score":0.3851897},"labels":[],"label_agreement":null},{"id":"W4401644713","doi":"10.1038/s41375-024-02371-y","title":"Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Transplantation; Clinical endpoint; Primary central nervous system lymphoma; Phases of clinical research; Diffuse large B-cell lymphoma; Lymphoma; Surgery","score_opus":0.024714393681672813,"score_gpt":0.39680129149011356,"score_spread":0.37208689780844073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401644713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541306,0.0024270944,0.0000114983095,0.00019498504,0.00022442357,0.00094145705,0.0007432263,0.000026478116,0.000017799113],"genre_scores_gemma":[0.9972323,0.0023389575,0.0000408746,0.000022229973,0.000062864,0.000047944348,0.00017248192,0.000015505953,0.00006681383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852866,0.00013551042,0.0006693748,0.000388164,0.0001513303,0.00012693419],"domain_scores_gemma":[0.99880034,0.00058111176,0.00019962699,0.00016579806,0.000121320445,0.00013180434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074475526,0.0001487169,0.0004903222,0.00006720063,0.000065670276,0.00008242077,0.000022590551,0.00013340806,0.0000075446374],"category_scores_gemma":[0.0009453368,0.00010771176,0.000055508503,0.00023927445,0.00015249306,0.00014293015,0.000032538814,0.00012501546,0.0000019698539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000343852,0.0008004498,0.96872133,0.000075741125,0.00017688912,0.000017823262,0.0024428854,4.2130404e-7,0.00011007073,0.00014178555,0.0008112767,0.026357466],"study_design_scores_gemma":[0.013063858,0.0005837735,0.9821801,0.00014559155,0.00037270205,0.0000051421252,0.0006839267,0.0004021729,0.00139772,0.00018693316,0.00088850607,0.000089581954],"about_ca_topic_score_codex":0.00042261643,"about_ca_topic_score_gemma":0.00043095447,"teacher_disagreement_score":0.026267884,"about_ca_system_score_codex":0.00032988688,"about_ca_system_score_gemma":0.0002650574,"threshold_uncertainty_score":0.43923584},"labels":[],"label_agreement":null},{"id":"W4401731539","doi":"10.1038/s41375-024-02358-9","title":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Government of Ontario; Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Biology; Myeloid leukemia; Epigenetics; Stem cell; Somatic evolution in cancer; Leukemia; Compartment (ship); Computational biology; Genetic heterogeneity; Cell; Cancer research; Immunology; Genetics; Cancer; Gene; Phenotype","score_opus":0.027819333456021975,"score_gpt":0.24869087295872522,"score_spread":0.22087153950270325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401731539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901206,0.0062317513,0.0025411393,0.00044602455,0.00013526797,0.00052068604,0.000039318602,0.00011575061,0.0009579879],"genre_scores_gemma":[0.9882018,0.00025918218,0.00016807267,0.000057119843,0.00015771567,0.000084735446,0.00006889423,0.00005243893,0.01095004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815196,0.000055157423,0.00042514218,0.00047233832,0.0006120174,0.0002834077],"domain_scores_gemma":[0.9991894,0.000084186286,0.00006498412,0.00031520886,0.00018961758,0.00015662918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003092713,0.00021112448,0.0002863095,0.00022080274,0.000093001225,0.00007118604,0.00009318345,0.00012554188,0.00012324513],"category_scores_gemma":[0.000015618944,0.00015242967,0.000077701334,0.00037991125,0.00032749627,0.00017139515,0.00003294342,0.00037731248,0.000095360294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010072979,0.0000646912,0.006191635,0.0033468406,0.0002186753,0.0001334548,0.0010979768,0.00028130817,0.971561,0.0010281347,0.003603893,0.011465082],"study_design_scores_gemma":[0.004578045,0.0009807843,0.3529827,0.001367022,0.00072280155,0.00087970635,0.0009749198,0.04066366,0.5808458,0.00030682652,0.014990872,0.000706905],"about_ca_topic_score_codex":0.00009055387,"about_ca_topic_score_gemma":0.000020074436,"teacher_disagreement_score":0.39071524,"about_ca_system_score_codex":0.0012287279,"about_ca_system_score_gemma":0.0018762178,"threshold_uncertainty_score":0.62159014},"labels":[],"label_agreement":null},{"id":"W4402149322","doi":"10.1038/s41375-024-02385-6","title":"Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials","year":2024,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Myeloid leukemia; Medicine; Chronic myeloid leukaemia; Oncology; Internal medicine; Nilotinib; Imatinib","score_opus":0.020066686339406815,"score_gpt":0.29356906947169065,"score_spread":0.2735023831322838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402149322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88617724,0.053184427,0.0002284579,0.0016689195,0.03318174,0.010916146,0.0033543645,0.00046932942,0.010819386],"genre_scores_gemma":[0.81422734,0.007261035,0.00070664036,0.00027587105,0.0070649055,0.0010795654,0.04360437,0.0006272823,0.125153],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99420804,0.00041936725,0.0018525445,0.0014979996,0.0012621431,0.000759912],"domain_scores_gemma":[0.9951807,0.0011546203,0.0013289894,0.0017542517,0.0003120908,0.00026932158],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091305387,0.0011029807,0.0023830049,0.0004397482,0.00015619035,0.00012398725,0.00048071772,0.0012606229,0.0003033303],"category_scores_gemma":[0.0008003979,0.00075757864,0.00035799138,0.00092345325,0.00044549778,0.00020679318,0.0002419331,0.0029473824,0.00005879243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006443427,0.00097618054,0.0051088817,0.003655389,0.0040156823,0.00042933534,0.0024534333,0.0014332274,0.0002211384,0.0003986219,0.854263,0.12060166],"study_design_scores_gemma":[0.18911675,0.015159562,0.18105082,0.041000657,0.015497947,0.00032692877,0.0011665613,0.3667882,0.00077180244,0.00077911234,0.18367887,0.0046627717],"about_ca_topic_score_codex":0.0049545984,"about_ca_topic_score_gemma":0.0037458148,"teacher_disagreement_score":0.67058414,"about_ca_system_score_codex":0.052556083,"about_ca_system_score_gemma":0.016684204,"threshold_uncertainty_score":0.9994875},"labels":[],"label_agreement":null},{"id":"W4402445062","doi":"10.1038/s41375-024-02395-4","title":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation; U.S. Department of Health and Human Services","keywords":"Medicine; Internal medicine; Cohort; Lymphoblastic Leukemia; Trisomy; Oncology; Leukemia; Pediatrics; Gastroenterology; Biology","score_opus":0.012698212034741137,"score_gpt":0.2997504726423136,"score_spread":0.28705226060757244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402445062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950218,0.00059386506,0.00022132226,0.000086205735,0.00075184664,0.0013840235,0.00016139468,0.00015562912,0.0016239103],"genre_scores_gemma":[0.99702364,0.0002066344,0.0005537026,0.00008798259,0.00034630118,0.00022505465,0.00003763557,0.0001350926,0.0013839675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554765,0.0002141651,0.0012819131,0.00092159613,0.0012057142,0.00082894915],"domain_scores_gemma":[0.99709976,0.0009939006,0.00024030708,0.001046848,0.00024361475,0.00037555982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007861542,0.00050896587,0.0014662823,0.000619208,0.000079003956,0.000032756827,0.0005015621,0.00050245825,0.0003607069],"category_scores_gemma":[0.00033652657,0.00041777687,0.0003885601,0.0009857503,0.0005311053,0.00019811183,0.00050342066,0.0007099785,0.00021397154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010830394,0.0023666746,0.9210381,0.0033103796,0.0040659723,0.017151605,0.008514249,0.00010257418,0.008659712,0.0003669255,0.0059830737,0.017610338],"study_design_scores_gemma":[0.019451182,0.011641254,0.94073546,0.0021417574,0.0039346847,0.002827138,0.0008209109,0.011499774,0.0043839887,0.00018304573,0.0015327337,0.00084805593],"about_ca_topic_score_codex":0.0011722515,"about_ca_topic_score_gemma":0.0006049825,"teacher_disagreement_score":0.019697374,"about_ca_system_score_codex":0.007843911,"about_ca_system_score_gemma":0.0051780627,"threshold_uncertainty_score":0.9998274},"labels":[],"label_agreement":null},{"id":"W4402827770","doi":"10.1038/s41375-024-02420-6","title":"Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Swedish Orphan Biovitrum; F. Hoffmann-La Roche; Incyte; BeiGene; Gilead Sciences; MorphoSys; Celgene; Eli Lilly and Company; AstraZeneca; Agios Pharmaceuticals; Roche; Amgen","keywords":"Lymphoma; Medicine; Retrospective cohort study; Oncology; Internal medicine; Randomized controlled trial; Pediatrics","score_opus":0.02574011826774529,"score_gpt":0.3359160215656327,"score_spread":0.3101759032978874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402827770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896776,0.0034225183,0.00095958414,0.00012609876,0.00033820182,0.004001813,0.0012855034,0.00006916038,0.0001195088],"genre_scores_gemma":[0.99655694,0.0009792446,0.0009647943,0.00009276257,0.00018730035,0.00055168266,0.00033967313,0.00006332273,0.00026426796],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741036,0.0002066558,0.0011053947,0.00046570227,0.0004794098,0.0003324657],"domain_scores_gemma":[0.99649566,0.001993293,0.0006465658,0.00042439293,0.00030376227,0.00013634769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008614624,0.0003651617,0.0025256441,0.00017806538,0.00008149023,0.000028211554,0.000102786296,0.00012988661,0.00011405445],"category_scores_gemma":[0.0005038402,0.00019247505,0.0005825289,0.00031518395,0.00012469557,0.00010626377,0.000027499913,0.000089743146,0.000007702724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7697752,0.055708636,0.13542262,0.00071640575,0.0059227785,0.00006943992,0.003737684,0.000016652757,0.0006541003,0.0020946339,0.004721983,0.021159884],"study_design_scores_gemma":[0.94608474,0.0053169783,0.012653656,0.00044201515,0.0021268162,0.0000025317886,0.000058047386,0.001754191,0.029600065,0.00024683005,0.0014965825,0.00021752973],"about_ca_topic_score_codex":0.0009540169,"about_ca_topic_score_gemma":0.000105637504,"teacher_disagreement_score":0.17630957,"about_ca_system_score_codex":0.0008030202,"about_ca_system_score_gemma":0.00044789538,"threshold_uncertainty_score":0.7848905},"labels":[],"label_agreement":null},{"id":"W4403378905","doi":"10.1038/s41375-024-02363-y","title":"Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Mayo Clinic; U.S. Department of Health and Human Services","keywords":"Multiple myeloma; Cancer research; Hematology; Biology; Internal medicine; Immunology; Pathology; Medicine; Computational biology","score_opus":0.009022850324882072,"score_gpt":0.20859480624776375,"score_spread":0.19957195592288168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403378905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591875,0.00078286417,0.0012686136,0.00023864828,0.00029589803,0.00017448576,0.00001447757,0.0000494315,0.0012568093],"genre_scores_gemma":[0.9913033,0.000038471902,0.00087661046,0.00015726616,0.0003071145,0.00004987417,0.00028738735,0.000026981184,0.006952968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990629,0.00003682672,0.00016409402,0.00038526245,0.00015969292,0.00019122697],"domain_scores_gemma":[0.9996028,0.000017049453,0.000032308406,0.00025247614,0.000031222076,0.00006413666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010448242,0.00014510877,0.000095814095,0.00006419107,0.000071081675,0.000041718326,0.00008846999,0.00016043705,0.0001242601],"category_scores_gemma":[0.000041994575,0.00011312946,0.0000500115,0.00013078818,0.000053436477,0.000010180175,0.00009775346,0.00010399551,0.000060425125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017331653,0.000020610561,0.0031705208,0.000034800054,0.000017013586,0.000044731678,0.000034950986,0.00030484534,0.9651099,0.00021061569,0.029162593,0.0017161036],"study_design_scores_gemma":[0.00070943224,0.00009347889,0.014098501,0.00012466301,0.000005915365,0.0000618194,0.000018378403,0.0011831435,0.81249356,0.00005217876,0.1709681,0.00019083275],"about_ca_topic_score_codex":0.000027853022,"about_ca_topic_score_gemma":0.00011565582,"teacher_disagreement_score":0.15261634,"about_ca_system_score_codex":0.00013913006,"about_ca_system_score_gemma":0.00014073178,"threshold_uncertainty_score":0.46132857},"labels":[],"label_agreement":null},{"id":"W4403538079","doi":"10.1038/s41375-024-02431-3","title":"Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Institutes of Health; National Cancer Institute; Fondazione Città della Speranza; Lymphoma Research Foundation; U.S. Department of Health and Human Services","keywords":"Lymphoma; Transcriptome; Biology; Cancer research; Tropomyosin; Cell cycle; Actin; Cell; Targeted therapy; Immunology; Gene; Gene expression; Genetics; Cancer","score_opus":0.01701707335172056,"score_gpt":0.2442203755642656,"score_spread":0.22720330221254503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403538079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96455824,0.033061087,0.000014026534,0.00017398887,0.00015078894,0.0003307226,0.000052785676,0.00003849418,0.0016198547],"genre_scores_gemma":[0.9944135,0.0041969777,0.00076816423,0.00017176985,0.00011037527,0.00002294445,0.000011075763,0.000028571672,0.00027661977],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998853,0.000040023726,0.00039651647,0.00030417778,0.00021434091,0.00019192585],"domain_scores_gemma":[0.99932915,0.00013834937,0.00009700212,0.0002780949,0.000052520572,0.000104875646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015564871,0.00018144144,0.00040845393,0.00011442086,0.00002433501,0.000015900507,0.000067731664,0.00008222368,0.000020621648],"category_scores_gemma":[0.000016739024,0.0001440528,0.00015334316,0.00024924692,0.00008573282,0.000054181106,0.000013495888,0.000048897953,0.0000035147286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005832114,0.0028709143,0.44069737,0.009339282,0.0013852001,0.0012055597,0.0022643635,0.000009789209,0.41027018,0.0013702703,0.022859903,0.10189506],"study_design_scores_gemma":[0.011906386,0.0017288848,0.3200468,0.0007012201,0.0008740125,0.00010570044,0.00013848503,0.00014124652,0.65015745,0.0004645194,0.013314446,0.00042080306],"about_ca_topic_score_codex":0.00007343475,"about_ca_topic_score_gemma":0.000014537825,"teacher_disagreement_score":0.2398873,"about_ca_system_score_codex":0.00038444778,"about_ca_system_score_gemma":0.0002710594,"threshold_uncertainty_score":0.5874303},"labels":[],"label_agreement":null},{"id":"W4403679163","doi":"10.1038/s41375-024-02442-0","title":"Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro; Warszawski Uniwersytet Medyczny; Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; National Institute of General Medical Sciences; Uniwersytet Warszawski; Canadian Institute for Advanced Research; Brown University","keywords":"Chronic lymphocytic leukemia; Leukemia; Immunology; Cancer research; Hematology; Medicine; Biology","score_opus":0.013900576264419241,"score_gpt":0.2601581089757024,"score_spread":0.24625753271128317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403679163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839966,0.009358101,0.00038701913,0.0007495821,0.00040102648,0.0015636808,0.00002125931,0.0004709746,0.0030517003],"genre_scores_gemma":[0.99513817,0.000485567,0.00014607681,0.00081162504,0.0008060209,0.0007501722,0.00015365102,0.000089125024,0.0016196081],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975504,0.000083248866,0.00059998076,0.00065871765,0.00048113984,0.00062648306],"domain_scores_gemma":[0.9991127,0.0000852971,0.000069507965,0.00043358142,0.000077429126,0.00022147837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033416186,0.00034990913,0.00056563684,0.00036010193,0.00007404376,0.00013814672,0.00015280904,0.0003155562,0.00048347362],"category_scores_gemma":[0.00009537919,0.00030441448,0.00020498985,0.00081091275,0.000088779416,0.00022664286,0.00005024009,0.0005021869,0.00064876635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010361369,0.00008693098,0.006590159,0.0035914748,0.00052719685,0.0009216745,0.001480478,0.0052787308,0.92378676,0.0026868184,0.013615422,0.040398203],"study_design_scores_gemma":[0.011916427,0.001389163,0.0071310056,0.0032509307,0.0004790843,0.00010627293,0.00017178238,0.573,0.34335834,0.00031070178,0.05782759,0.0010586837],"about_ca_topic_score_codex":0.001069448,"about_ca_topic_score_gemma":0.00015010062,"teacher_disagreement_score":0.5804284,"about_ca_system_score_codex":0.038991574,"about_ca_system_score_gemma":0.009505057,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W4403851941","doi":"10.1038/s41375-024-02400-w","title":"Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital Maisonneuve-Rosemont; Université de Montréal; University of British Columbia; Centre hospitalier de l'Université Laval; Discovery Centre; McGill University; McGill University Health Centre; Institute for Research in Immunology and Cancer; BC Cancer Agency; Centre hospitalier universitaire de Québec; IONICS Mass Spectrometry (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"CIHR Skin Research Training Centre; Fonds de Recherche du Québec - Santé; CHU Sainte-Justine Foundation; Cancer Research Society; Terry Fox Research Institute; Université de Montréal; Canadian Cancer Society Research Institute; Terry Fox Foundation; National Institutes of Health; Children's Hospital Foundation; Government of Canada; National Cancer Institute; Molson Foundation; Canadian Institutes of Health Research; JW and HM Goodman Family Foundation","keywords":"Leukemia; Human cell; Primary (astronomy); Cancer research; Medicine; Cell culture; Biology; Immunology; Genetics","score_opus":0.03877647701958165,"score_gpt":0.3104672159798481,"score_spread":0.27169073896026646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403851941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691286,0.0038629828,0.0018785456,0.00017421253,0.00020347456,0.0013411256,0.0001357753,0.00067700155,0.022598276],"genre_scores_gemma":[0.9764838,0.00039178642,0.007668818,0.00045818943,0.00073984836,0.0001334938,0.0007926991,0.00026258294,0.013068769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99447757,0.00020808366,0.0014172462,0.0015087245,0.001061347,0.0013270342],"domain_scores_gemma":[0.9968507,0.00045622818,0.0002889394,0.0012191313,0.00042966678,0.0007553303],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00080784876,0.0010158647,0.0019461105,0.0010523759,0.0004056593,0.00022242009,0.0006972495,0.0007254386,0.00026121657],"category_scores_gemma":[0.000073163385,0.0009514513,0.0004914636,0.0012829748,0.0007592266,0.00040814723,0.0006681846,0.0023378846,0.00013856242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041103803,0.000079980004,0.00081651326,0.0027478074,0.0011349191,0.0014850026,0.0026586298,0.00058608607,0.96478695,0.0014896226,0.021357697,0.00244578],"study_design_scores_gemma":[0.013801809,0.002495653,0.021493008,0.003309999,0.0023117762,0.001222398,0.0015509782,0.04363012,0.8902715,0.0005103402,0.0168902,0.002512242],"about_ca_topic_score_codex":0.0012266061,"about_ca_topic_score_gemma":0.00006820256,"teacher_disagreement_score":0.07451545,"about_ca_system_score_codex":0.007882524,"about_ca_system_score_gemma":0.004127687,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W4404446659","doi":"10.1038/s41375-024-02454-w","title":"The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"National Institute of General Medical Sciences; Government of Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Evasion (ethics); Immune system; SIGLEC; Myeloid leukemia; Immunology; Myeloid; Receptor; Biology; Leukemia; Immune checkpoint; Glycosyltransferase; Cancer research; Immunotherapy; Gene; Genetics","score_opus":0.008475191046312858,"score_gpt":0.23367992655058842,"score_spread":0.22520473550427555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404446659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8355656,0.12228119,0.0044060503,0.007947154,0.02459285,0.0024511642,0.000097581666,0.00066771364,0.0019906603],"genre_scores_gemma":[0.95724016,0.008181498,0.000029857876,0.00034493953,0.00015114782,0.00041497912,0.00032403186,0.00008589792,0.033227492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975903,0.00016164989,0.00087639585,0.0005619096,0.00009800301,0.00071171153],"domain_scores_gemma":[0.99716675,0.0019437029,0.00013691554,0.0006331441,0.000089223184,0.000030268933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010186596,0.00041820295,0.00041411756,0.0001485879,0.0009830722,0.00023074789,0.000587938,0.00042760695,0.0005936334],"category_scores_gemma":[0.00024767464,0.00025914432,0.00044093805,0.0003635545,0.0002833007,0.0003274387,0.00010413855,0.0011770914,0.0008260862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012452424,0.000032136897,0.000017126249,0.000045466593,0.00045481208,0.000004083569,0.0009434641,0.000033280892,0.94422644,0.0005148118,0.026731888,0.025751263],"study_design_scores_gemma":[0.000970864,0.00020216404,0.00020178308,0.00021030317,0.000108694534,0.000045878754,0.0007803796,0.0005920703,0.59792143,0.00006365242,0.3986668,0.00023596297],"about_ca_topic_score_codex":0.00047783495,"about_ca_topic_score_gemma":0.00006808668,"teacher_disagreement_score":0.37193492,"about_ca_system_score_codex":0.0012119708,"about_ca_system_score_gemma":0.00038392743,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W4404644989","doi":"10.1038/s41375-024-02475-5","title":"Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"","keywords":"Dimethyl fumarate; Graft-versus-host disease; Germinal center; Peripheral blood mononuclear cell; Multiple sclerosis; Hematopoietic stem cell transplantation; Immunology; Medicine; Cancer research; Inflammation; Stem cell; Cellular differentiation; Transplantation; Biology; B cell; Internal medicine; Gene; Antibody","score_opus":0.01291408955497524,"score_gpt":0.2669682045747233,"score_spread":0.25405411501974806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404644989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980123,0.005850336,0.00975477,0.0007882358,0.0009134777,0.00053436635,0.000073097326,0.00047037093,0.001492383],"genre_scores_gemma":[0.9969355,0.000300607,0.00015036002,0.00014063029,0.00037887567,0.000058392103,0.00074451533,0.00006706224,0.0012240615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983248,0.000066292836,0.0003851216,0.0004635525,0.0003946119,0.00036560296],"domain_scores_gemma":[0.9991417,0.00021917811,0.00006981385,0.00023727315,0.000060086008,0.0002719597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017029463,0.00025771608,0.00027185844,0.00014909347,0.000098220495,0.00010647953,0.000077218494,0.00012414945,0.0003768038],"category_scores_gemma":[0.00004816737,0.00023173697,0.00012951114,0.0003949714,0.0000617597,0.00020424396,0.000024023384,0.0003060229,0.0006459224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008199106,0.000107996464,0.0046242643,0.004915081,0.00036089067,0.0005207161,0.0013298684,0.00005552466,0.9617279,0.0008937817,0.008236645,0.016407387],"study_design_scores_gemma":[0.01375683,0.00091867644,0.064480886,0.007561618,0.003224536,0.00012228402,0.0004324832,0.118693404,0.7741022,0.0011080866,0.013677235,0.0019217472],"about_ca_topic_score_codex":0.000097494216,"about_ca_topic_score_gemma":0.000016368173,"teacher_disagreement_score":0.18762572,"about_ca_system_score_codex":0.00097507355,"about_ca_system_score_gemma":0.0004051577,"threshold_uncertainty_score":0.94499594},"labels":[],"label_agreement":null},{"id":"W4404940529","doi":"10.1038/s41375-024-02487-1","title":"Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia","year":2024,"lang":"en","type":"erratum","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Obinutuzumab; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Internal medicine; Oncology; Leukemia; Cancer research; Immunology; Chemotherapy; Cyclophosphamide","score_opus":0.03698168111577174,"score_gpt":0.313390055003235,"score_spread":0.2764083738874633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404940529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95574987,0.0036984375,0.0000038529847,0.000040332616,0.016143182,0.0075825537,0.00005584039,0.00026530455,0.016460653],"genre_scores_gemma":[0.8502829,0.0013567739,0.00003126925,0.00003335866,0.0011595715,0.00053176953,0.00020336243,0.00034882373,0.14605214],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99137205,0.00047018877,0.0019541965,0.0023104248,0.0021173314,0.0017758043],"domain_scores_gemma":[0.9951473,0.0010316253,0.0006356322,0.0024605,0.0002706538,0.00045432357],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.000887621,0.0016108183,0.0036661348,0.001015098,0.0002512606,0.000198306,0.00097545877,0.0013033123,0.00018742554],"category_scores_gemma":[0.0006560345,0.0010461838,0.0003990524,0.0031452994,0.00084958813,0.00021387347,0.00089591765,0.0037068697,0.00011080924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.5558157,0.0013093104,0.016339991,0.018998846,0.013274221,0.017364832,0.054425288,0.06627371,0.00023085879,0.00024205445,0.2377292,0.017995965],"study_design_scores_gemma":[0.5294312,0.013929104,0.0066008917,0.017625585,0.0028737173,0.0014614953,0.006473165,0.39159322,0.00028714174,0.0000125525075,0.027824735,0.0018872116],"about_ca_topic_score_codex":0.05438285,"about_ca_topic_score_gemma":0.09010755,"teacher_disagreement_score":0.36947495,"about_ca_system_score_codex":0.74214256,"about_ca_system_score_gemma":0.37266758,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W4406385834","doi":"10.1038/s41375-024-02506-1","title":"Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Janssen Research and Development","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Medicine","score_opus":0.020560870229512286,"score_gpt":0.309989620882545,"score_spread":0.2894287506530327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406385834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607694,0.00029317682,0.000046535017,0.00013150927,0.000056264253,0.001188686,0.000053804906,0.000021553695,0.002131515],"genre_scores_gemma":[0.9980233,0.000022352098,0.00020158674,0.000045401197,0.000011025628,0.0000646563,0.000053596563,0.000014462914,0.0015636393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978103,0.0002892367,0.00063125737,0.00037989658,0.0005363675,0.00035296503],"domain_scores_gemma":[0.99817234,0.00046384547,0.00017641882,0.0009037959,0.00018928813,0.000094337534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041362236,0.00021437736,0.0009546377,0.00082852406,0.000066074994,0.000010939508,0.00027994264,0.00011289603,0.000099285],"category_scores_gemma":[0.000659854,0.00014096026,0.00030126,0.0039043634,0.00015882737,0.000052282237,0.00017023562,0.0002934512,0.000006068367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021205125,0.00077362155,0.9845655,0.00010189519,0.0035407213,0.000109867724,0.000999302,0.0006346124,0.0048855375,0.00006800556,0.00010655568,0.002093853],"study_design_scores_gemma":[0.016211636,0.00024016308,0.9573375,0.00013653006,0.0015996216,0.0000022741276,0.0008822295,0.01202286,0.011414456,0.000022543714,0.000044049084,0.000086119726],"about_ca_topic_score_codex":0.009750238,"about_ca_topic_score_gemma":0.006822551,"teacher_disagreement_score":0.027228,"about_ca_system_score_codex":0.0009368224,"about_ca_system_score_gemma":0.000574016,"threshold_uncertainty_score":0.99684393},"labels":[],"label_agreement":null},{"id":"W4406753131","doi":"10.1038/s41375-024-02491-5","title":"Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba","funders":"National Health and Medical Research Council; University of New South Wales; Medical Research Council; University of Manitoba; CancerCare Manitoba Foundation; Sylvia and Charles Viertel Charitable Foundation","keywords":"Biology; Cancer research; Stem cell; Autocrine signalling; Progenitor cell; Cytokine; Immunology; Cell biology; Cell culture","score_opus":0.011265148140405721,"score_gpt":0.27878053607953496,"score_spread":0.2675153879391292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406753131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811993,0.00027062526,0.0032159246,0.0007853145,0.0004789136,0.0017407425,0.000024913586,0.00034495103,0.011939284],"genre_scores_gemma":[0.97665375,0.000038570593,0.005388802,0.0016925476,0.0003420866,0.00031473118,0.000054704284,0.00014039132,0.015374432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99435323,0.00015227025,0.0012093482,0.0013829045,0.0011491106,0.001753153],"domain_scores_gemma":[0.9970176,0.0007171211,0.00020393875,0.0010778835,0.00034285392,0.00064058776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007177834,0.00072542904,0.0011802762,0.0010268406,0.00021594374,0.00014892893,0.0008080768,0.00045847698,0.00016836326],"category_scores_gemma":[0.0010755843,0.0007160781,0.00025058872,0.0025955082,0.00013056456,0.0002886007,0.0005550033,0.0010822591,0.00060878356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003509368,0.00026430498,0.013105007,0.0012032038,0.0003639022,0.0021120275,0.0017069892,0.0044579078,0.95453835,0.0005561583,0.015919691,0.0022630983],"study_design_scores_gemma":[0.056746226,0.0024888196,0.14742656,0.0075248335,0.0012828746,0.00029560257,0.0009479829,0.13774069,0.63081676,0.0017379047,0.009160441,0.0038313337],"about_ca_topic_score_codex":0.0011382614,"about_ca_topic_score_gemma":0.000060011116,"teacher_disagreement_score":0.3237216,"about_ca_system_score_codex":0.019931441,"about_ca_system_score_gemma":0.0067351647,"threshold_uncertainty_score":0.999529},"labels":[],"label_agreement":null},{"id":"W4406848242","doi":"10.1038/s41375-024-02482-6","title":"International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma","year":2025,"lang":"en","type":"review","venue":"Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Institute of Cancer Research; McMaster University","funders":"","keywords":"Chimeric antigen receptor; Immunotherapy; Multiple myeloma; Medicine; Antigen; Oncology; Immunology; Internal medicine; Immune system","score_opus":0.08323822165411887,"score_gpt":0.3775774111568178,"score_spread":0.29433918950269894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406848242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035918265,0.9777511,0.0011426867,0.0002772986,0.0015656633,0.006235982,0.00024623857,0.00015644629,0.012265423],"genre_scores_gemma":[0.00016470447,0.9828617,0.002757207,0.00020874303,0.0007667928,0.0012554231,0.0024672362,0.00017070473,0.009347463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689627,0.00025558742,0.0011816741,0.0007061117,0.00046651025,0.00049385166],"domain_scores_gemma":[0.99626297,0.0019491066,0.000623733,0.0008962001,0.00018143008,0.00008655263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052775,0.00068302825,0.0022768301,0.00081111817,0.0001502128,0.00006578723,0.00046425976,0.00051173783,0.0014421291],"category_scores_gemma":[0.000097957454,0.0005640462,0.0013162574,0.00048539357,0.00008858903,0.00006754603,0.000051615476,0.00038258178,0.000021653208],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012758768,0.00020447717,0.00005078888,0.0029633215,0.0018107195,0.000012694211,0.00025801288,0.0000030737062,0.0014525306,0.000102345104,0.00046867496,0.9913975],"study_design_scores_gemma":[0.0058349483,0.0013420951,0.00003842359,0.012386794,0.00025430913,0.00004419534,0.00004856371,0.00022390102,0.00059090694,0.00004219882,0.9788294,0.0003642959],"about_ca_topic_score_codex":0.00014710269,"about_ca_topic_score_gemma":0.000023305534,"teacher_disagreement_score":0.9910332,"about_ca_system_score_codex":0.009119548,"about_ca_system_score_gemma":0.0011835033,"threshold_uncertainty_score":0.9996811},"labels":[],"label_agreement":null},{"id":"W4407918247","doi":"10.1038/s41375-025-02537-2","title":"Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Haploinsufficiency; Myelodysplastic syndromes; Neoplasm; Hematology; Cancer research; microRNA; Biology; Medicine; Internal medicine; Oncology; Phenotype; Pathology; Gene; Genetics; Bone marrow","score_opus":0.011827659451562616,"score_gpt":0.27093641985761885,"score_spread":0.25910876040605624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407918247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97955304,0.0026223555,0.00037685514,0.00081437203,0.00015407646,0.0006457177,0.00002589848,0.000071858434,0.015735827],"genre_scores_gemma":[0.984763,0.00026683728,0.0033500579,0.00035848448,0.000053080512,0.00005098161,0.000023594952,0.000037324135,0.011096625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970568,0.00012087409,0.000785348,0.00063533377,0.00062865624,0.0007730308],"domain_scores_gemma":[0.99828887,0.00051652634,0.00013754738,0.00061141304,0.00022367277,0.00022196793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073965196,0.00031791563,0.00077927136,0.00071682816,0.00012583108,0.00003494972,0.00032026705,0.00029719205,0.00007945741],"category_scores_gemma":[0.0011140963,0.00028590145,0.000101687205,0.0012562809,0.0003582928,0.00016204703,0.0002914861,0.0007888139,0.000039619328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005929162,0.0010283048,0.336928,0.0058482233,0.00050615415,0.0020823327,0.003189329,0.0014064764,0.58092785,0.012791657,0.04144628,0.0079162065],"study_design_scores_gemma":[0.013174084,0.0011477194,0.9014419,0.002379489,0.00034184934,0.0002575369,0.0017873362,0.015631922,0.0414604,0.0021965753,0.019347088,0.0008341556],"about_ca_topic_score_codex":0.002255413,"about_ca_topic_score_gemma":0.0008419094,"teacher_disagreement_score":0.56451386,"about_ca_system_score_codex":0.0015583003,"about_ca_system_score_gemma":0.0029370657,"threshold_uncertainty_score":0.9999593},"labels":[],"label_agreement":null},{"id":"W4408061910","doi":"10.1038/s41375-024-02505-2","title":"Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Daratumumab; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Oncology","score_opus":0.027483650340193993,"score_gpt":0.3332355615420652,"score_spread":0.3057519112018712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408061910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757744,0.0010551305,0.00033010892,0.0012066131,0.00022402145,0.0009938244,0.000042515858,0.00013088512,0.00843949],"genre_scores_gemma":[0.98941517,0.00045133565,0.00071910897,0.0006339554,0.000068653084,0.00018283034,0.00019347949,0.000036031368,0.008299418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975387,0.00011125948,0.00051944004,0.0005708805,0.00046803014,0.00079172506],"domain_scores_gemma":[0.9984557,0.0004690181,0.00006406425,0.0006337464,0.00007220742,0.00030525224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026137434,0.00036313388,0.0007647659,0.0005447933,0.00010878959,0.00005802381,0.00024911732,0.00021717075,0.00028236752],"category_scores_gemma":[0.000239728,0.0002890663,0.00021885312,0.0006941754,0.00011133701,0.00014315863,0.00006706042,0.00051317335,0.00023967288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011602978,0.00031497312,0.9717307,0.00029947516,0.00030380787,0.0040667127,0.00021031147,0.000014823516,0.0020024052,0.00021922028,0.0011636289,0.018513653],"study_design_scores_gemma":[0.022680793,0.00013856102,0.9691707,0.00058539934,0.00012626589,0.0000422482,0.000039683386,0.00023053317,0.006182788,0.00014287647,0.000440468,0.00021967503],"about_ca_topic_score_codex":0.0013328978,"about_ca_topic_score_gemma":0.0013640187,"teacher_disagreement_score":0.021520495,"about_ca_system_score_codex":0.0009877445,"about_ca_system_score_gemma":0.0006594089,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W4408159145","doi":"10.1038/s41375-025-02543-4","title":"Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations","year":2025,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; BC Children's Hospital","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Immunology","score_opus":0.023016166871779986,"score_gpt":0.3202360191588415,"score_spread":0.2972198522870615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408159145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049916566,0.98571193,0.00012337136,0.00010753017,0.00083213084,0.0059044487,0.00050721684,0.00024661087,0.001575119],"genre_scores_gemma":[0.0087969,0.9790195,0.00077786046,0.000090314585,0.0017473759,0.0012899154,0.004523023,0.00030839493,0.003446718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157345,0.00030804976,0.002756061,0.0024730896,0.0013088264,0.0015805193],"domain_scores_gemma":[0.9954438,0.00022272741,0.0015490586,0.002068932,0.00020665242,0.0005088081],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00051994575,0.0020147497,0.0040612454,0.0020003074,0.00022764823,0.00011432269,0.0013484299,0.0011244932,0.00053269864],"category_scores_gemma":[0.000058724003,0.0017801127,0.0007956948,0.0021724286,0.00036201224,0.00040649076,0.00096396916,0.002217925,0.00013794217],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002682418,0.00032040637,0.00068353984,0.050681103,0.0023962206,0.0004774974,0.00012569703,0.00014504175,0.000011662414,0.00009031751,0.0037018424,0.94109845],"study_design_scores_gemma":[0.07116379,0.002939818,0.0074918624,0.28008747,0.012210895,0.0015006567,0.000102142025,0.0011636273,0.00012022096,0.000031556854,0.61925906,0.003928883],"about_ca_topic_score_codex":0.0010549265,"about_ca_topic_score_gemma":0.0004101864,"teacher_disagreement_score":0.93716955,"about_ca_system_score_codex":0.15939522,"about_ca_system_score_gemma":0.03517355,"threshold_uncertainty_score":0.9992595},"labels":[],"label_agreement":null},{"id":"W4408246053","doi":"10.1038/s41375-025-02548-z","title":"Living, not just surviving, with chronic myeloid leukemia – quality of life to the front of the line","year":2025,"lang":"en","type":"review","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Front line; Quality of life (healthcare); Leukemia; Medicine; Myeloid; Immunology; Biology; History","score_opus":0.05066295497651767,"score_gpt":0.338302432049059,"score_spread":0.28763947707254134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408246053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002872861,0.9862673,0.00012591416,0.00030101833,0.0008064725,0.0047805826,0.0004288118,0.00010174945,0.004315261],"genre_scores_gemma":[0.008026431,0.96443105,0.00033750286,0.0006597907,0.0009241655,0.0005232404,0.00014352589,0.0001946723,0.0247596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929419,0.0009934223,0.0025023448,0.0011533888,0.0015393054,0.0008696413],"domain_scores_gemma":[0.9906274,0.0023408805,0.002083769,0.0041888007,0.00040001606,0.00035911903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017654378,0.0011937162,0.0049496465,0.00031413845,0.00020768515,0.000032994238,0.001781091,0.00075897743,0.00047799025],"category_scores_gemma":[0.0022091956,0.00060075754,0.0014590283,0.001306149,0.00044977272,0.000068857626,0.0010572778,0.0016443598,0.00012551785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00053864677,0.000452251,0.0023345924,0.22137387,0.0062083416,0.000038386504,0.0016897072,0.000621142,0.000047136575,0.00048928044,0.029915363,0.7362913],"study_design_scores_gemma":[0.0028205232,0.00072018936,0.0059324824,0.10999949,0.0057499446,0.00006056932,0.00010624257,0.00006274571,0.00012696032,0.000003962379,0.8736185,0.00079837727],"about_ca_topic_score_codex":0.006422456,"about_ca_topic_score_gemma":0.0059333006,"teacher_disagreement_score":0.84370315,"about_ca_system_score_codex":0.017152017,"about_ca_system_score_gemma":0.044220887,"threshold_uncertainty_score":0.9996444},"labels":[],"label_agreement":null},{"id":"W4408301977","doi":"10.1038/s41375-025-02550-5","title":"Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Swiss Cancer Research Foundation; European Federation of Pharmaceutical Industries and Associations; Universität Basel; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; McGill University; European Commission; Amgen; Cancer Prevention and Research Institute of Texas; National Science Foundation","keywords":"JAK2 V617F; Myeloproliferative Disorders; Hematology; SOCS2; Polycythemia vera; Ruxolitinib; Cancer research; Biology; Leukemia; Janus kinase 2; Immunology; Myelofibrosis; Medicine; Genetics; Bone marrow; Receptor; Gene; Suppressor","score_opus":0.011048397314771523,"score_gpt":0.2797456143309054,"score_spread":0.26869721701613386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408301977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939395,0.00031590904,0.0012332894,0.0014460551,0.00004200331,0.0013812482,0.00020783927,0.00003060894,0.0014035429],"genre_scores_gemma":[0.988948,0.00014978166,0.0045823674,0.0011500214,0.000012992291,0.00048286188,0.000037913986,0.000031117757,0.0046049766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801415,0.000108097236,0.0006734983,0.00049510057,0.00035358034,0.0003555437],"domain_scores_gemma":[0.9987568,0.00024428213,0.00016005166,0.00042851767,0.00025324023,0.00015708857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017957926,0.0003218872,0.0008506018,0.0003762442,0.00004260722,0.000013420294,0.00015652213,0.00018768078,0.000022943474],"category_scores_gemma":[0.00033178853,0.00027650266,0.00016425959,0.00046728985,0.00013500765,0.00007506946,0.00011832889,0.00023609574,0.000009912023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003465277,0.0009686173,0.11946176,0.00040980813,0.00055225356,0.00006595199,0.0024956102,0.003649785,0.85723704,0.006314008,0.0029263773,0.0024534974],"study_design_scores_gemma":[0.0040884386,0.0008303907,0.010070346,0.00040706122,0.00012159045,0.0000035205294,0.00022521766,0.009197201,0.9741357,0.00049593434,0.00020320475,0.00022140727],"about_ca_topic_score_codex":0.00026783944,"about_ca_topic_score_gemma":0.00010719517,"teacher_disagreement_score":0.11689863,"about_ca_system_score_codex":0.00056773337,"about_ca_system_score_gemma":0.0010661857,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W4408506484","doi":"10.1038/s41375-025-02558-x","title":"The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"Barncancerfonden; Cancerfonden; Deutsche Forschungsgemeinschaft; Government of Canada; Natural Sciences and Engineering Research Council of Canada; Deutsche Krebshilfe; Wilhelm Sander-Stiftung; Leukemia and Lymphoma Society of Canada; Canadian Institutes of Health Research; European Hematology Association; Västra Götalandsregionen","keywords":"Myeloid leukemia; Cancer research; Adverse effect; Leukemia; Medicine; Myeloid; Immunology; Internal medicine","score_opus":0.005398891580550538,"score_gpt":0.2527481021155626,"score_spread":0.24734921053501205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408506484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855418,0.00046208114,0.008640156,0.00030341628,0.0007834348,0.0015249624,0.000037491744,0.00004956675,0.0026570673],"genre_scores_gemma":[0.98764294,0.0006840366,0.0020731932,0.0007538214,0.0011457892,0.00068595144,0.00038276755,0.000051123487,0.006580385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829125,0.00017941392,0.0003821576,0.0005518887,0.00022011936,0.000375177],"domain_scores_gemma":[0.9987578,0.000060662238,0.00026371542,0.0007252491,0.00013268084,0.000059940965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016461992,0.00027134316,0.00017815443,0.000039954433,0.00043113463,0.000068156725,0.00040999643,0.00032363477,0.000028067248],"category_scores_gemma":[0.00018634294,0.00021611726,0.00021799686,0.00021729704,0.0001699456,0.000025745527,0.00020094613,0.00022648438,0.00005246596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007202274,0.00001743877,0.00024226689,0.000027383585,0.0002830577,0.0000012099682,0.00008520148,0.0003615732,0.9704887,0.000121737736,0.024238702,0.0034124872],"study_design_scores_gemma":[0.0013908659,0.00007089783,0.0025255275,0.000043510358,0.00012278745,0.0000037561197,0.00006315055,0.0003281828,0.8016148,0.00069001154,0.19291337,0.00023313836],"about_ca_topic_score_codex":0.00009747007,"about_ca_topic_score_gemma":0.00008093573,"teacher_disagreement_score":0.1688739,"about_ca_system_score_codex":0.00054439204,"about_ca_system_score_gemma":0.00089032896,"threshold_uncertainty_score":0.8813006},"labels":[],"label_agreement":null},{"id":"W4408660014","doi":"10.1038/s41375-025-02552-3","title":"Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Medicine; Immunotherapy; Foundation (evidence); Gerontology; Internal medicine; Oncology; Database; Cancer; History; Computer science","score_opus":0.020780248770691657,"score_gpt":0.33998575072949977,"score_spread":0.3192055019588081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408660014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940555,0.000026097481,0.0007717055,0.00009644676,0.000032107262,0.00048019466,0.00016194083,0.00004399662,0.004331981],"genre_scores_gemma":[0.99141616,0.0000983336,0.0019025556,0.00006202065,0.000018946124,0.000045106095,0.0029787794,0.000017792401,0.0034603253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844545,0.00006870354,0.00043870934,0.000346585,0.000490699,0.0002098707],"domain_scores_gemma":[0.99857545,0.000118602504,0.00019533935,0.00071531953,0.0002991429,0.000096162774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001519476,0.00019161022,0.0005495323,0.00083284214,0.000048859667,0.000020284422,0.0001996917,0.0000624024,0.0004588889],"category_scores_gemma":[0.000061236926,0.00013780117,0.00015483655,0.001125202,0.00012962747,0.00021795103,0.000041062638,0.0001346976,0.0000050242675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035537076,0.00046953195,0.9678479,0.00009000441,0.0038661654,0.00009194964,0.00021321888,0.000016161934,0.003834951,0.00039717308,0.00003499258,0.019584259],"study_design_scores_gemma":[0.008628018,0.0002262025,0.97574914,0.0001692838,0.00048730712,0.0000017747818,0.000091646405,0.0018997475,0.012511995,0.000013831917,0.00012525158,0.0000957918],"about_ca_topic_score_codex":0.010513048,"about_ca_topic_score_gemma":0.004102645,"teacher_disagreement_score":0.019488467,"about_ca_system_score_codex":0.0004416955,"about_ca_system_score_gemma":0.00024688538,"threshold_uncertainty_score":0.99607605},"labels":[],"label_agreement":null},{"id":"W4408990065","doi":"10.1038/s41375-025-02563-0","title":"Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Moonshot Research and Development Program; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; Gilead Sciences; Kobayashi Foundation for Cancer Research; Japan Science and Technology Agency; Leukemia and Lymphoma Society","keywords":"Tumor microenvironment; Biology; Lymphoma; Chromosome instability; Follicular lymphoma; Exome sequencing; Genome instability; Immune system; Exome; Cancer research; Peripheral T-cell lymphoma; T cell; Immunology; Oncology; Medicine; Chromosome; Gene; Mutation; Genetics","score_opus":0.003155162568191225,"score_gpt":0.20795986439047304,"score_spread":0.2048047018222818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408990065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133873,0.0045168954,0.000036569825,0.00063577306,0.00008685528,0.00036240037,0.00000873652,0.00003969508,0.0029743607],"genre_scores_gemma":[0.99045837,0.0002607591,0.001277238,0.001673041,0.000022456104,0.000061103776,0.000015297775,0.000019865385,0.006211871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990829,0.000019984132,0.00016668039,0.00033786942,0.00015047227,0.0002420727],"domain_scores_gemma":[0.9995078,0.000049937677,0.000050597162,0.0002711595,0.000012185435,0.00010835699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002571357,0.00022809167,0.00031410003,0.000053509983,0.00008887288,0.000033320186,0.000056350676,0.00006460485,0.0000548293],"category_scores_gemma":[0.000005898751,0.00014505531,0.00006794795,0.000071499824,0.00010789543,0.000030075795,0.000052705007,0.00006447063,0.00002054089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031445269,0.0002713453,0.9878594,0.0001110883,0.00027032857,0.0005812137,0.00018744929,0.00010144884,0.001869735,0.00011052406,0.001401286,0.0069217146],"study_design_scores_gemma":[0.0074433624,0.0003081542,0.9806606,0.0001261552,0.00034979518,0.000060082897,0.00007784874,0.00022937711,0.0051887864,0.000038392023,0.0053634066,0.00015403621],"about_ca_topic_score_codex":0.00018594894,"about_ca_topic_score_gemma":0.000028427745,"teacher_disagreement_score":0.00719881,"about_ca_system_score_codex":0.0006038056,"about_ca_system_score_gemma":0.00017222398,"threshold_uncertainty_score":0.59151834},"labels":[],"label_agreement":null},{"id":"W4409286918","doi":"10.1038/s41375-025-02593-8","title":"DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"Directorate for Biological Sciences; Barts Health NHS Trust; University College London Hospitals NHS Foundation Trust; Université de Montréal; Semmelweis Egyetem; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; Kay Kendall Leukaemia Fund; Österreichischen Akademie der Wissenschaften; Helsingin Yliopisto; Francis Crick Institute; Genome Canada; European Hematology Association; Centre hospitalier universitaire Sainte-Justine; University College London; Helsinki Institute of Life Science, Helsingin Yliopisto; Queen Mary University of London; Barts Charity; Veterinärmedizinische Universität Wien; Cancer Research Institute","keywords":"Biology; Transcriptome; Fusion gene; Gene; Activator (genetics); Fusion protein; Leukemia; Hox gene; Myeloid leukemia; Cancer research; Chromosomal translocation; Promoter; Genetics; Transcription factor; Computational biology; Gene expression","score_opus":0.016974482969315183,"score_gpt":0.3151619623183538,"score_spread":0.2981874793490386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409286918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788748,0.00050273153,0.0012415311,0.001044274,0.0005147297,0.0007368009,0.000049112175,0.0001688275,0.01686721],"genre_scores_gemma":[0.98378897,0.00023303964,0.0012784936,0.0010140374,0.0005726961,0.000078169556,0.00017081264,0.00006869412,0.0127950795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964845,0.00016922984,0.0006883666,0.0007591954,0.001092969,0.0008057505],"domain_scores_gemma":[0.9978891,0.00017952055,0.00015479227,0.00093819725,0.0003738081,0.00046456294],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000522422,0.0004030664,0.00071569934,0.0005245483,0.00018060712,0.000055786462,0.000553151,0.00046696066,0.0011494204],"category_scores_gemma":[0.00026448772,0.0003764837,0.00026611102,0.00067910715,0.00032172483,0.00037423545,0.00015863785,0.0008717062,0.00017630696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023468276,0.0002568601,0.0047376016,0.0005176947,0.0005115033,0.00025046087,0.0004621234,0.00017207261,0.9597931,0.012551707,0.005223097,0.013176958],"study_design_scores_gemma":[0.009286523,0.0006633225,0.050754927,0.00037880207,0.00042056173,0.00023533015,0.0006752204,0.0017496704,0.89909244,0.0016207293,0.0345837,0.00053881016],"about_ca_topic_score_codex":0.0010103679,"about_ca_topic_score_gemma":0.00010158744,"teacher_disagreement_score":0.060700685,"about_ca_system_score_codex":0.0042868243,"about_ca_system_score_gemma":0.008882672,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W4409446835","doi":"10.1038/s41375-025-02577-8","title":"Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ADD Centre","funders":"Helsinki Institute of Life Science, Helsingin Yliopisto; Syöpäjärjestöt; Institut National Du Cancer; Sächsisches Staatsministerium für Wissenschaft und Kunst; José Carreras Leukämie-Stiftung; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; Fondation de France; Sigrid Juséliuksen Säätiö; Signe ja Ane Gyllenbergin Säätiö; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Wilhelm Sander-Stiftung; European Commission; Dr. Mildred Scheel Stiftung für Krebsforschung","keywords":"Cancer research; STAT5; Biology; Phosphorylation; Cell biology","score_opus":0.026410887587738418,"score_gpt":0.326483067400875,"score_spread":0.3000721798131366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409446835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426569,0.0006534318,0.00024903924,0.00038055133,0.00018242322,0.0014334179,0.000033530287,0.00019069173,0.054220024],"genre_scores_gemma":[0.97645205,0.00029070335,0.00032060497,0.00094508205,0.00018978864,0.00032371594,0.00018483996,0.000065871245,0.021227343],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99621695,0.00009098924,0.0008140684,0.0009243781,0.00073871977,0.001214901],"domain_scores_gemma":[0.99818903,0.0002973515,0.000116861636,0.00089031557,0.00016124643,0.0003452114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041108023,0.00050817855,0.0007765124,0.0007364708,0.00013918297,0.00009770796,0.00016278219,0.0003911021,0.00032961124],"category_scores_gemma":[0.00025472807,0.00045244882,0.00021423987,0.001278433,0.00025204747,0.0002180393,0.00017083704,0.0004947882,0.0004898123],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0344939,0.0069159023,0.007827442,0.007065771,0.0037821652,0.045564502,0.010649582,0.048286397,0.35736075,0.10090304,0.05060744,0.32654312],"study_design_scores_gemma":[0.44914842,0.006655739,0.021072857,0.00412102,0.00091322983,0.0044175778,0.004565567,0.25297886,0.21300523,0.0074793445,0.033220362,0.0024218075],"about_ca_topic_score_codex":0.016783655,"about_ca_topic_score_gemma":0.0011706217,"teacher_disagreement_score":0.4146545,"about_ca_system_score_codex":0.23271477,"about_ca_system_score_gemma":0.081706144,"threshold_uncertainty_score":0.99979275},"labels":[],"label_agreement":null},{"id":"W4410174850","doi":"10.1038/s41375-025-02635-1","title":"Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"Terry Fox Foundation; National Cancer Institute; Government of Canada; V Foundation for Cancer Research; Cancer Research Foundation; Northwestern University; Canadian Institutes of Health Research; Veski; Leukemia and Lymphoma Society; Leukemia and Lymphoma Society of Canada","keywords":"CHEK2; Myeloid leukemia; Germline; Myeloid; Leukemia; Biology; Allele; Loss of heterozygosity; Cancer research; Internal medicine; Germline mutation; Immunology; Genetics; Medicine; Gene; Mutation","score_opus":0.008917620548598631,"score_gpt":0.28365386292353134,"score_spread":0.2747362423749327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410174850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740343,0.00045431996,0.006803414,0.006546908,0.0002215439,0.0009439962,0.00005402544,0.00022858237,0.010712893],"genre_scores_gemma":[0.9646539,0.00006217494,0.0024614164,0.006749655,0.00016636262,0.00016161431,0.00014007444,0.000042814314,0.025561962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981224,0.000052175797,0.00037752112,0.00048326195,0.00039585185,0.0005687811],"domain_scores_gemma":[0.99881756,0.000080534424,0.000048944094,0.00060572335,0.00017130356,0.00027593228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025830843,0.00023778537,0.00040775043,0.00024555463,0.00012210103,0.00005505945,0.00024732668,0.00020626347,0.0002270725],"category_scores_gemma":[0.00022280515,0.0002181766,0.00010122127,0.0006887537,0.00007973585,0.0000937826,0.00018841082,0.0003627212,0.0004109918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005976496,0.00012288081,0.0023794067,0.00049769186,0.00016131668,0.00030814245,0.0005007939,0.000018479053,0.601734,0.0009371932,0.38399708,0.008745354],"study_design_scores_gemma":[0.012799717,0.0018544475,0.11377129,0.003115141,0.00068678835,0.0010943934,0.0006094911,0.0072591202,0.6469529,0.0018259748,0.20848024,0.0015504478],"about_ca_topic_score_codex":0.00018068853,"about_ca_topic_score_gemma":0.00000910233,"teacher_disagreement_score":0.17551684,"about_ca_system_score_codex":0.0018547227,"about_ca_system_score_gemma":0.0008686437,"threshold_uncertainty_score":0.8896983},"labels":[],"label_agreement":null},{"id":"W4410810346","doi":"10.1038/s41375-025-02656-w","title":"Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Ministero della Salute; Erdheim-Chester Disease Global Alliance","keywords":"Erdheim–Chester disease; Cluster (spacecraft); Medicine; Disease; Pathology; Histiocytosis; Computer science","score_opus":0.020010392349229862,"score_gpt":0.3363810103923122,"score_spread":0.31637061804308236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410810346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700163,0.0005063536,0.0006723471,0.0069498387,0.00015069293,0.0003336566,0.000015281836,0.000022806997,0.021332739],"genre_scores_gemma":[0.977176,0.000047149148,0.0001452184,0.0029280975,0.000048494272,0.000013391035,0.000025453122,0.000006591791,0.019609584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990722,0.00006253722,0.0003704068,0.00020512252,0.00014926746,0.00014048562],"domain_scores_gemma":[0.99907976,0.00016908949,0.00007846062,0.0005433414,0.000033511165,0.00009586286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020833104,0.000097462405,0.00035702737,0.00009635625,0.000046793943,0.000008983634,0.00009314078,0.00005685135,0.00018134783],"category_scores_gemma":[0.0001521057,0.000057990685,0.00035793555,0.00046588233,0.00012281648,0.000019882365,0.000044976423,0.000119293574,0.0000529365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042394878,0.00023944065,0.97106475,0.00007204182,0.002377143,0.0000420259,0.00008755067,0.00005384601,0.000003994404,0.0012633868,0.019901901,0.0044699907],"study_design_scores_gemma":[0.0022535748,0.000069521004,0.97647464,0.00007601511,0.0056632007,9.847143e-7,0.00003827002,0.0011514437,0.000023337905,0.0020557542,0.012127654,0.00006563004],"about_ca_topic_score_codex":0.00006428474,"about_ca_topic_score_gemma":0.00004118125,"teacher_disagreement_score":0.0077742483,"about_ca_system_score_codex":0.0001334633,"about_ca_system_score_gemma":0.0003034114,"threshold_uncertainty_score":0.23647915},"labels":[],"label_agreement":null},{"id":"W4411779851","doi":"10.1038/s41375-025-02667-7","title":"Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"Agencia Estatal de Investigación; European Regional Development Fund; AstraZeneca; Agència de Gestió d'Ajuts Universitaris i de Recerca; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; Eusko Jaurlaritza; Associazione Italiana per la Ricerca sul Cancro; National Cancer Institute; Knut och Alice Wallenbergs Stiftelse; Southern University of Science and Technology; Science for Life Laboratory; National Natural Science Foundation of China; Vetenskapsrådet; Karolinska Institutet; Institució Catalana de Recerca i Estudis Avançats; European Commission; Ministerio de Ciencia e Innovación; Ministerstvo Zdravotnictví Ceské Republiky; Fundación Española de Hematología y Hemoterapia; Generalitat de Catalunya; Radiumhemmets Forskningsfonder; Cancerfonden; European Hematology Association; Amgen; American Association for Cancer Research; Centres de Recerca de Catalunya","keywords":"Biology; RNA; Disease; Genetics; Mutation; Gene; Medicine; Pathology","score_opus":0.01469504721946702,"score_gpt":0.2821158762193912,"score_spread":0.2674208289999242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411779851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9234322,0.0022782735,0.0002195186,0.0015937315,0.0003257856,0.0007551093,0.000022834969,0.00013977748,0.07123278],"genre_scores_gemma":[0.97312695,0.00020092749,0.000700427,0.0008303473,0.0001894228,0.000102733255,0.00011312524,0.000037488524,0.024698565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979911,0.00005600463,0.0003806506,0.00052136916,0.0004702622,0.00058062875],"domain_scores_gemma":[0.9985579,0.0002463175,0.000049642626,0.0007484745,0.000091899645,0.0003057679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016497528,0.00022884783,0.0003340546,0.0003999758,0.000094272626,0.00005580246,0.00025493972,0.0002023021,0.00039399564],"category_scores_gemma":[0.00013366721,0.00021331439,0.00013701839,0.0010253642,0.00014612239,0.00010298412,0.00013633937,0.00062690885,0.0005216301],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014199256,0.004086334,0.060202334,0.010404465,0.00076231355,0.029353121,0.0062352857,0.01154901,0.097787976,0.08421958,0.60925317,0.07194717],"study_design_scores_gemma":[0.15094557,0.00043355342,0.2543403,0.0033374936,0.00053429534,0.00039054675,0.0017604647,0.11974199,0.038245652,0.009222032,0.41921544,0.0018326901],"about_ca_topic_score_codex":0.0003353726,"about_ca_topic_score_gemma":0.00008966386,"teacher_disagreement_score":0.19413795,"about_ca_system_score_codex":0.02064659,"about_ca_system_score_gemma":0.012561141,"threshold_uncertainty_score":0.99303675},"labels":[],"label_agreement":null},{"id":"W4412187071","doi":"10.1038/s41375-025-02664-w","title":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Discontinuation; Dosing; Intensive care medicine; Disease; Transplantation; Myeloid leukemia; Quality of life (healthcare); Tyrosine-kinase inhibitor; Disease management; MEDLINE; Family medicine; Internal medicine; Cancer","score_opus":0.023097088389205465,"score_gpt":0.2976016508790599,"score_spread":0.2745045624898544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412187071","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17136124,0.025076985,0.05013758,0.03213803,0.0064237867,0.017860556,0.00059244403,0.0013325824,0.6950768],"genre_scores_gemma":[0.85512626,0.00459281,0.012706597,0.0025528353,0.00066840864,0.0007724447,0.0007066008,0.00015676107,0.1227173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975993,0.00009314606,0.00078882783,0.00060252764,0.00032440436,0.00059181615],"domain_scores_gemma":[0.9977212,0.00040307315,0.0002500763,0.0013444016,0.00015671941,0.00012451786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058023224,0.00038883157,0.0005206053,0.00021516129,0.00031705596,0.000037911675,0.00054454483,0.0001365803,0.00038602663],"category_scores_gemma":[0.000050860453,0.00029724167,0.00034069922,0.0006719565,0.00019727068,0.00009581506,0.0002727701,0.00038996723,0.00015934475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000674419,0.00026479887,0.0012399158,0.0031393056,0.004561024,0.00011025156,0.0004171904,0.0013649729,0.0021876898,0.02288647,0.40679067,0.5563633],"study_design_scores_gemma":[0.015752638,0.00045773637,0.02345703,0.0020939256,0.0024459932,0.000038580016,0.0006176973,0.006985557,0.006436271,0.0007220234,0.9405519,0.00044067457],"about_ca_topic_score_codex":0.000230317,"about_ca_topic_score_gemma":0.000044744902,"teacher_disagreement_score":0.683765,"about_ca_system_score_codex":0.011787378,"about_ca_system_score_gemma":0.0024102784,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W4412188741","doi":"10.1038/s41375-025-02690-8","title":"A genome-wide association study identifies an African-specific locus on chromosome 21q22.12 associated with Burkitt lymphoma risk and survival","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Simon Fraser University; Universität Ulm","keywords":"Genome-wide association study; Biology; Allele; Genetics; Locus (genetics); Genetic association; Minor allele frequency; Odds ratio; Single-nucleotide polymorphism; Population; Allele frequency; Oncology; Internal medicine; Medicine; Gene; Genotype","score_opus":0.010179248605141966,"score_gpt":0.23873413844574445,"score_spread":0.2285548898406025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412188741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647267,0.0005962373,0.000032303677,0.0004261662,0.00029358917,0.00079771754,0.000050537274,0.00020476647,0.01112604],"genre_scores_gemma":[0.9933682,0.00035844106,0.000009639655,0.00046361814,0.00010619351,0.00007368534,0.00010508327,0.000047540114,0.005467586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974124,0.0003017637,0.00040102407,0.00064009253,0.00071315333,0.0005315761],"domain_scores_gemma":[0.9984073,0.0004009107,0.00038228286,0.0004321074,0.00020809878,0.0001693071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007536931,0.0003371416,0.00065714854,0.00025373136,0.00035303907,0.00015625033,0.00015038167,0.00025744532,0.000053166546],"category_scores_gemma":[0.0005992519,0.00029546238,0.00009234967,0.000707754,0.00007814314,0.00017788014,0.000054433465,0.0003439531,0.000022876606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009310706,0.00088575296,0.98745835,0.000028180077,0.001058113,0.00009806621,0.0025505691,0.00009884,0.00042928665,0.00005083806,0.003335023,0.0030759422],"study_design_scores_gemma":[0.011792522,0.0015145141,0.97643214,0.00011808188,0.00048708371,7.840562e-7,0.0057306862,0.000058487683,0.000114414834,0.00025635,0.003172083,0.00032286972],"about_ca_topic_score_codex":0.0012462217,"about_ca_topic_score_gemma":0.0028724908,"teacher_disagreement_score":0.011026196,"about_ca_system_score_codex":0.004708791,"about_ca_system_score_gemma":0.0005199925,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W4414125452","doi":"10.1038/s41375-025-02752-x","title":"Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survival","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust","keywords":"Androgen receptor; Androgen; Myeloid leukemia; Estrogen receptor; Leukemia; Estrogen; Myeloid; Chemotherapy","score_opus":0.030477353974341974,"score_gpt":0.30333075602871284,"score_spread":0.27285340205437086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414125452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989275,0.00026958372,0.0027630513,0.00066256255,0.00072480045,0.0018980551,0.0012754503,0.00013047791,0.0030010173],"genre_scores_gemma":[0.9760608,0.00015071465,0.008886266,0.00081848446,0.0004895455,0.00022314297,0.00018066072,0.0001275305,0.01306285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960661,0.00016699028,0.0009003392,0.00097587705,0.00089944265,0.0009912828],"domain_scores_gemma":[0.99674845,0.0010415816,0.0002673845,0.0010825397,0.00050358113,0.00035647204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008939119,0.0005357582,0.001185518,0.00049297075,0.0002212917,0.000070270726,0.0006737617,0.00055207586,0.0004859435],"category_scores_gemma":[0.0003124217,0.00048796134,0.00040846958,0.0006232009,0.000196378,0.00016290408,0.0002889887,0.00077444676,0.00014339834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004147045,0.00011552346,0.00049585314,0.0006225362,0.0009516894,0.00009545344,0.00024271493,0.00032350246,0.96769845,0.0014995355,0.012689425,0.011118282],"study_design_scores_gemma":[0.008184885,0.00058667385,0.00032251663,0.0004874516,0.00038989008,0.000019447203,0.00022750146,0.0005891138,0.97217137,0.00033326301,0.01628142,0.0004064971],"about_ca_topic_score_codex":0.00023343644,"about_ca_topic_score_gemma":0.000010587846,"teacher_disagreement_score":0.013214195,"about_ca_system_score_codex":0.0020632222,"about_ca_system_score_gemma":0.0025933778,"threshold_uncertainty_score":0.99975723},"labels":[],"label_agreement":null},{"id":"W4415100934","doi":"10.1038/s41375-025-02754-9","title":"Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus","year":2025,"lang":"en","type":"review","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Hematopoietic cell; MEDLINE; Hematology; Haematopoiesis; Hematopoietic stem cell transplantation; Transplantation","score_opus":0.04881192111003129,"score_gpt":0.35144795871386036,"score_spread":0.30263603760382907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415100934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026766502,0.99199176,0.0001353882,0.00013823582,0.000901708,0.0022549827,0.00025776034,0.00011694787,0.003935547],"genre_scores_gemma":[0.000737676,0.9870761,0.005434091,0.0003141263,0.00025559092,0.0021994796,0.0021177027,0.00008660714,0.0017786025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750596,0.000100758494,0.0008304234,0.00080648845,0.00036114678,0.00039522402],"domain_scores_gemma":[0.99809307,0.000827348,0.00025769672,0.00048907055,0.00008431837,0.0002484925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020242203,0.0006230028,0.001936968,0.00023889927,0.0001698871,0.000064049775,0.00022504706,0.00046805758,0.00007508013],"category_scores_gemma":[0.000111668305,0.0004655868,0.0010504986,0.00015958158,0.000029558933,0.000051394138,0.000042248834,0.0003294681,0.000033208245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025651624,0.00054834905,0.00039612895,0.041731,0.0015463389,0.0006934109,0.001094492,0.000004144309,0.00005066789,0.0011912935,0.0064006327,0.946087],"study_design_scores_gemma":[0.002550939,0.0003270335,0.00001804211,0.07616932,0.0027163432,0.00020907712,0.000097410826,0.000066586574,0.00047308925,0.000034984303,0.91684306,0.00049410627],"about_ca_topic_score_codex":0.000033681816,"about_ca_topic_score_gemma":0.0000041520666,"teacher_disagreement_score":0.94559294,"about_ca_system_score_codex":0.00094709673,"about_ca_system_score_gemma":0.0015772771,"threshold_uncertainty_score":0.9997796},"labels":[],"label_agreement":null},{"id":"W4415248847","doi":"10.1038/s41375-025-02783-4","title":"OGG1 activation improves T cell resilience to oxidative stress after allo-SCT and T cell engager exposure","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science for Life Laboratory; European Regional Development Fund; Deutsche Forschungsgemeinschaft; Karolinska Institutet; European Commission; European Federation of Pharmaceutical Industries and Associations; McGill University; Diamond Light Source; Friedrich-Alexander-Universität Erlangen-Nürnberg","keywords":"T cell; Oxidative stress; Cytotoxic T cell; T lymphocyte; Resilience (materials science); Cell growth; Cell; Regulatory T cell","score_opus":0.004411473820002763,"score_gpt":0.21386549217472076,"score_spread":0.209454018354718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415248847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98341846,0.0006230531,0.0010148925,0.00020789605,0.0013779585,0.0002592947,0.0000049709865,0.00005640885,0.013037036],"genre_scores_gemma":[0.9125657,0.00004453535,0.00008076302,0.0010954561,0.00002142563,0.000054063486,0.000040485815,0.000008000243,0.086089544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906236,0.00014957576,0.0002060615,0.0003316414,0.000028270872,0.0002221075],"domain_scores_gemma":[0.9994593,0.00013981079,0.00007223026,0.00023511484,0.00007392326,0.000019586718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011210447,0.00016089392,0.00015161697,0.00014125477,0.00017314918,0.000034058572,0.00010922548,0.00020664776,0.00045188176],"category_scores_gemma":[0.000058940965,0.00014701985,0.000043436976,0.00014779376,0.000060841994,0.00021345117,0.00009147535,0.0004032807,0.00030070532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004227355,0.00004684995,0.000989666,0.000035602523,0.000023628876,0.0000010323448,0.0009584441,0.000018935107,0.981078,0.000045215464,0.012804115,0.0035757562],"study_design_scores_gemma":[0.0006538989,0.00016585561,0.019656435,0.00005314014,0.000018794226,0.0000014861123,0.0010175466,0.00000893079,0.8948059,0.000017005179,0.08346347,0.00013754581],"about_ca_topic_score_codex":0.00014731105,"about_ca_topic_score_gemma":0.000017321338,"teacher_disagreement_score":0.08627212,"about_ca_system_score_codex":0.00016210898,"about_ca_system_score_gemma":0.00008188345,"threshold_uncertainty_score":0.59952956},"labels":[],"label_agreement":null},{"id":"W4415279518","doi":"10.1038/s41375-025-02779-0","title":"DNA methylation alterations in acute lymphoblastic leukemia survivors with late neurocognitive deficits","year":2025,"lang":"en","type":"letter","venue":"Leukemia","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mental Health Research Canada; Ontario Genomics; Université de Montréal; Hospital for Sick Children; SickKids Foundation; University of Toronto; McMaster University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Sickkids Research Institute; Hospital for Sick Children; Université de Montréal; University of Toronto; Leukemia and Lymphoma Society of Canada; Ontario Brain Institute; McMaster University; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Neurocognitive; DNA methylation; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Hematology; Leukemia","score_opus":0.017693915326446503,"score_gpt":0.2774573163614805,"score_spread":0.25976340103503404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415279518","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4835246,0.0005760347,0.004291322,0.47661763,0.0023721904,0.005159827,0.00093606237,0.0008774504,0.025644904],"genre_scores_gemma":[0.09194418,0.00022559852,0.0011284095,0.87684923,0.0032306698,0.00052957534,0.00514461,0.00033516547,0.020612566],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947553,0.0005746867,0.0011979331,0.0013758338,0.0011755814,0.00092065573],"domain_scores_gemma":[0.99651927,0.0013643912,0.0005388931,0.0009901662,0.0004024626,0.00018481349],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00046568792,0.00093970884,0.001531595,0.0010415892,0.00018045669,0.00013302676,0.0003685301,0.0011910865,0.000120644116],"category_scores_gemma":[0.0004172668,0.00089259574,0.00029349964,0.0013402811,0.00019322726,0.00026931046,0.0001422691,0.0031713683,0.0001544242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027179709,0.00023059739,0.005391313,0.004918739,0.0032978114,0.009246949,0.008106207,0.0029629562,0.00088063243,0.00023805693,0.9560612,0.0059476085],"study_design_scores_gemma":[0.042830326,0.004298013,0.14342515,0.03136146,0.0130815515,0.0014345488,0.001107874,0.010811971,0.009046909,0.0027923817,0.7304797,0.009330094],"about_ca_topic_score_codex":0.004312544,"about_ca_topic_score_gemma":0.004511144,"teacher_disagreement_score":0.4002316,"about_ca_system_score_codex":0.004086242,"about_ca_system_score_gemma":0.0052654324,"threshold_uncertainty_score":0.9997369},"labels":[],"label_agreement":null},{"id":"W4416333261","doi":"10.1038/s41375-025-02801-5","title":"Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes","year":2025,"lang":"en","type":"article","venue":"Leukemia","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Fusion gene; Gene; Nanopore sequencing; DNA sequencing; genomic DNA; Tyrosine kinase; Genome; Fusion protein","score_opus":0.029817694741827713,"score_gpt":0.3069775602455511,"score_spread":0.2771598655037234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520774,0.0013251815,0.0050410377,0.0011278617,0.00018210578,0.00046445764,0.0000066650973,0.000113750844,0.0065312115],"genre_scores_gemma":[0.98811084,0.00008357216,0.003975861,0.001368783,0.00008772433,0.000030912866,0.000040629606,0.000030922904,0.0062707607],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867475,0.000023100258,0.0002647208,0.0004262751,0.00028044076,0.0003306907],"domain_scores_gemma":[0.99918807,0.00004936972,0.00006356516,0.00040680333,0.00014737408,0.00014482177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015571745,0.00021577861,0.00037551278,0.00021661208,0.00016717278,0.000043865337,0.00011969509,0.000113016875,0.00008128333],"category_scores_gemma":[0.00006854726,0.00017014843,0.00007016751,0.0005336284,0.00006244246,0.00009086693,0.000095988114,0.00018875462,0.000035168163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023378613,0.00028179755,0.13273782,0.0011451846,0.0006468258,0.0024241165,0.004339501,0.0017285584,0.6369239,0.00852812,0.007698038,0.2012083],"study_design_scores_gemma":[0.009977208,0.0027293623,0.8121422,0.0120724095,0.0011003168,0.00069139287,0.0079597235,0.0018076717,0.1235722,0.0021595857,0.024054963,0.0017330002],"about_ca_topic_score_codex":0.0005397588,"about_ca_topic_score_gemma":0.0002993827,"teacher_disagreement_score":0.6794044,"about_ca_system_score_codex":0.0006245133,"about_ca_system_score_gemma":0.00062390015,"threshold_uncertainty_score":0.69384515},"labels":[],"label_agreement":null}]}